II 
(Non-legislative acts) 
REGUL ATIONS 
COMMISSION IMPLEMENTING REGUL ATION (EU) 2021/403 
of 24 March 2021 
laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the 
European Parliament and of the Council as regards model animal health certificates and model 
animal health/off icial certificates, for the entr y into the Union and movements betw een Member 
States of consignments of certain categor ies of terrest rial animals and germinal products thereof, 
official certification regarding such certificates and repealing Decision 2010/470/EU 
(Text with EEA relevance) 
THE EUR OPEAN COMMISSION, 
Havi ng regar d to the Treaty on the Functioning of the European Union, 
Havi ng regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on 
transmissible animal diseases and amending and repealing certain acts in the area of animal health (Animal Health Law)(1), 
and in particular Article 146(2), point (a) of the first subparagraph of Article 156(2) and Articles 162(5), 238(3) and 239(3) 
thereof, 
Havi ng regard to Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official 
controls and other official activities perf ormed to ensure the application of food and feed law, rules on animal health and 
welf are, plant health and plant protection products, amending Regulations (EC) No 999/2001, (EC) No 396/2005, (EC) 
No 1069/2009, (EC) No 1107/2009, (EU) No 1151/2012, (EU) No 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the 
European Parliament and of the Council, Council Regulations (EC) No 1/2005 and (EC) No 1099/2009 and Council 
Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC and repealing Regulations (EC) 
No 854/2004 and (EC) No 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 
89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Offici al 
Controls Regulation) (2), and in particular points (a) and (c) of the first paragraph of Article 90 and Article 126(3) thereof, 
Whereas: 
(1) Regulation (EU) 2016/429 lays down rules on animal diseases that are transmissible to animals or to humans, 
including requirements for official animal health certificat ion for various mov ements of terrestrial animals and their 
products. It also empo wers the Commission to adopt imple menting acts laying down rules for model forms for 
animal health certificates and declarations as well rules concer ning the information to be contained in certain 
documents and declarations required for the entr y into the Union of consignments of animals and of germinal 
products. In addition, that Regulation empowers the Commission to lay down special rules concer ning model 
forms for the animal health certificates, declarations and other documents for certain catego ries of animals and 
germinal products. Regulation (EU) 2016/429 also provid es that animal health certificates may include other 
information required under other Union legislation. 
(1)OJ L 84, 31.3.2016, p. 1.
(2)OJ L 95, 7.4.2017, p. 1.EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                           L 113/1   
(2) Further more, in accordance with Article 146(2) as well as with point (a) of the first subparagraph of Article 156(2) 
and Article 162(5) of Regulation (EU) 2016/429, that Regulation emp owers the Commission to adopt 
imp lementing acts laying down rules for model forms of animal health certificates for mov ements to another 
Member State of certain terrestrial animals and germinal products of those terrestrial animals. 
(3) Theref ore, for the unif orm imp lementation of rules laid down in Regulation (EU) 2016/429, model animal health 
certificates and animal health/off icial certificates containing the animal health requirements for move ments 
between Member State s and for entr y into the Union of certain terrestr ial animals and of germinal products of 
those terrestr ial animals should be set out in this Regulation. 
(4) Commission Delegat ed Regulation (EU) 2020/686 (3) lays down supplementing rules as regards registere d and 
approved germinal product establishments and the traceability and animal health requirements for mov ements 
within the Union of germinal products of certain terrestrial animals. Annex IV to that Regulation lays down 
supplementing rules concer ning information to be contained in the animal health certificate for germinal products 
of bovine, porcine, ovine, capr ine and equine animals and of other animals listed therein, mov ed between Member 
State s. In accordance with that Regulation, such animal health certificates should contain, inter alia, relevant 
information on animal health situation. Theref ore, supplementing rules and requirements laid down in Delegat ed 
Regulation (EU) 2020/686 should be taken into account in this Regulation and model certificates set out herein. 
(5) Commission Delegat ed Regulation (EU) 2020/688 (4) lays down supplementing rules for the prevention and control 
of animal diseases transmissible to animals or to humans laid down in Article 5(1) of Regulation (EU) 2016/429 as 
regards movements within the Union of terrestr ial animals and hatch ing eggs. That Regulation lays down specifi c 
requirements for such mov ements and supplementing rules for animal health certification, in particular , rules 
regarding information to be contained in the animal health certificates for certain terrestr ial animals and hatching 
eggs moved to another Member State. Theref ore, this Regulation and the model certificates set out herein should 
take into account the supplementing rules laid down in Delegat ed Regulation (EU) 2020/688. 
(6) Commission Delegat ed Regulation (EU) 2020/692 (5) lays down supplementing animal health requirements for 
entr y into the Union of, inter alia, certain terrestr ial animals and germinal products of the species and catego ries of 
kept terrestrial animals listed therein. In particular , in accordance with that Regulation, such consignments shall be 
accompan ied by an animal health certificate, and if provi ded in that Regulation, by declarations or other 
documents. Theref ore, the relevant guarant ees laid down in Delegat ed Regulation (EU) 2020/692 should take into 
account by the model certificates set out in this Regulation. 
(7) In addition, Deleg ated Regulation (EU) 2020/686 lays down particular definitions for, inter alia, certain germinal 
products and germinal products establishments. Further more, for the purposes of that Delega ted Regulation, 
Delegat ed Regulation (EU) 2020/692 lays down specific definit ions for, inter alia, certain terrestr ial animals, as well 
as defines “specified pathogen -free eggs” and “unique approval number”. Theref ore, this Regulation should also have 
regard to certain definitions laid down in Delegat ed Regulations (EU) 2020/686 and (EU) 2020/692. 
(3)Commission Delegat ed Regulation (EU) 2020/686 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European 
Parliament and of the Council as regar ds the approval of germinal product establishments and the traceability and animal health 
requirements for movements within the Union of germinal products of certain kept terrestrial animals (OJ L 174, 3.6.2020, p. 1).
(4)Commission Delegat ed Regulation (EU) 2020/688 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European 
Parliament and of the Council, as regards animal health requirements for movements within the Union of terrestr ial animals and 
hatc hing eggs (OJ L 174, 3.6.2020, p. 140).
(5)Commission Delegat ed Regulation (EU) 2020/692 of 30 Januar y 2020 supplementing Regulation (EU) 2016/429 of the European 
Parliament and of the Council as regar ds rules for entr y into the Union, and the mov ement and handling after entr y of consignments 
of certain animals, germinal products and products of animal origin (OJ L 174, 3.6.2020, p. 379).EN Offi cial Jour nal of the European Union L 113/2                                                                                                                                           31.3.2021   
(8) Model certificates required for animal health, animal welf are and for public health reasons are currently laid down in 
various legal acts. For reasons of clarity and legal certainty , as well as for easy access by the compet ent author ities, 
the relevant operat ors and the public, it is appropr iate to consolidate model certificates for the movements between 
Member States and for entr y into the Union of consignments of certain catego ries of terrestr ial animals and germinal 
products thereof in one sing le legal act. 
(9) Commission Implementing Regulation (EU) 2020/2235 (6) lays down the model animal health certificates, model 
official certificates and model animal health/off icial certificates for the mov ements within the Union or between 
Member State s of consignments of animals and products, provid ing for the compati bility of such certificates with 
the Trade Control and Exper t System (TRA CES) and for facilitation of the system of certification in the Union. 
Theref ore, the model animal health certificates and animal health/offici al certificates for the move ments between 
Member States of the consignments of certain catego ries of terrestrial animals and germinal products thereof set 
out in this Regulation should be drawn up on the basis of the model animal health certificate and the model animal 
health/official certificate for mov ements between Member States set out in Chapt er 1 of Annex I to Implementing 
Regulation (EU) 2020/2235. 
(10) Further more, in order to ensure consistency and to impro ve efficiency of the certification, the model animal health 
certificates and the animal health/off icial certificates for the entr y into the Union of consignments of certain 
catego ries of terrestrial animals and germinal products thereof set out in this Regulation should be drawn up on the 
basis of the model animal health certificate and on the basis of the model animal health/official certificate for the 
entr y into the Union set out in Chapt er 3 of Annex I to Implementing Regulation (EU) 2020/2235. 
(11) Article 237(1)(a) of Regulation (EU) 2016/429 provides that the Member States shall permit the entr y into the Union 
of consignments of animals, germinal products and products of animal origin if they are accompan ied by an animal 
health certificate, unless a derog ation is provided for in Article 237(4)(a) of that Regulation. Article 126(2)(c) of 
Regulation (EU) 2017/625 establishes the requirement that consignments of certain animals and goods entering the 
Union are to be accompanied by an official certificate, an official attestation or any other evidence that the 
consignments compl y with the relevant requirements established by the rules refer red to in Article 1(2) of that 
Regulation. Theref ore, in order to avoid inconsiste ncies and to facilitat e official controls upon the entr y into the 
Union of consignments of certain categor ies of terrestr ial animals and germinal products thereof, this Regulation 
should set out model animal health certificates and a model animal health/official certificates for such consignments 
entering the Union. 
(12) Regulation (EU) 2017/625 lays down rules for the perf ormance of official controls and other official activities 
performe d by the compet ent author ities of the Member States to ensure compl iance with the rules refer red to in 
Article 1(2) of that Regulation, which compr ise, among others, rules on food safety at all stages of production, 
processing and distr ibution and animal health and welfare requirements. That Regulation provid es for certain rules 
on official certification when the rules refer red to in its Article 1(2) require the issuance of official certificates. In 
particular , that Regulation emp owers the Commission to adopt implementing acts laying down rules concer ning 
model official certificates and for the issuance and replacement of such certificates. In the absence of more specifi c 
rules in Regulation (EU) 2016/429, relevant rules on official certificat ion apply to the animal health certificates and 
to the animal health/official certificates set out in this Regulation. 
(13) The rules referred to in Article 1(2) of Regulation (EU) 2017/625 include animal health requirements, but also, inter 
alia, rules in the area of food safety and animal welf are. In the interests of legal clarity, and in order to minimise the 
administrative burden during the issuance of certificates, this Regulation should include animal health certificates 
and animal health/off icial certificates, to be signed by the official veterinar ian. In order to facilitate the performa nce 
(6)Commission Implementing Regulation (EU) 2020/2235 of 16 December 2020 laying down rules for the application of Regulations 
(EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates, model 
official certificates and model animal health/official certificates, for the entr y into the Union and movements within the Union of 
consignments of certain categor ies of animals and goods, official certification regarding such certificates and repealing Regulation (EC) 
No 599/2004, Implementing Regulations (EU) No 636/2014 and (EU) 2019/628, Directive 98/68/EC and Decisions 2000/572/EC, 
2003/779/EC and 2007/240/EC (OJ L 442, 30.12.2020, p. 1).EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                           L 113/3   
of official controls upon the entr y into the Union, and within the Union, of consignments of certain categor ies of 
terrestrial animals and germinal products thereof and reduce administrative burden, model animal health 
certificates and model animal health/official certificates set out in this Regulation should comply with Regulation 
(EU) 2016/429 and with Regulation (EU) 2017/625. 
(14) To facilitat e official controls at the border control posts of entr y into the Union, the requirements for certificates for 
the entr y into the Union should include linguistic requirements. 
(15) Regulation (EU) 2016/429 aims at reducing the administrative burden in relation to certification and notification by 
using information technology as far as possible for multiple purposes. In addition, that Regulation lays down certain 
rules regarding the possibility for electronic animal health certificates to accompan y certain consignments instead of 
animal health certificates issued on paper . Regulation (EU) 2017/625 provides that the Information Management 
System for Official Controls (IMSOC) is to allow for the production, handling and transmission of official 
certificates, including in electronic form. Commission Imp lementing Regulation (EU) 2019/1715 (7) provides that 
TRA CES is the IMSOC compo nent enabling certificates to be produced electronically , thus preventing possible 
fraudulent or deceptive practices in respect of animal health certificates or animal health/official certificates. 
Theref ore, in order to ensure an adequat e level of secur ity of electronic means of certificat ion and taking into 
account the aim to harmonise the process of certification, model certificates set out in this Regulation should be 
compati ble with TRA CES. 
(16) Point (c) of the first paragraph of Article 90 of Regulation (EU) 2017/625 empo wers the Commission to adopt 
imp lementing acts laying down rules concer ning the procedures to be follo wed for the issuance of replacement 
certificates. Theref ore, it is appropr iate to establish common requirements as regar ds the replacement of certificates, 
which should apply to animal health certificates and to animal health/off icial certificates, to be signed by the official 
veteri narian, and these common requirements should be set out in this Regulation. 
(17) To avoid misuse and abuse, it is impor tant to lay down rules concer ning the cases where a replacement certificate 
may be issued and the requirements that such certificates need to meet. These cases should be limite d to 
administrative errors and to cases where the initial certificate has been damaged or lost. 
(18) Model animal health certificates and model animal health/official certificates for mov ements of certain categor ies of 
terrestrial animals and germinal products thereof should contain details of the consignment and specific animal and 
public health information, as well as animal welf are information, where necessar y, certified by the official 
veteri narian. In the case of mov ements between Member States, both model animal health certificates and animal 
health/official certificates should contain a part designated to draw up a record of official controls performed during 
such mov ements and at the place of destination, as well as the results of those official controls. 
(19) Commission Decision 2010/470/EU (8) lays down model health certificates for trade within the Union in semen, ova 
and embr yos of animals of the equine, ovine and capr ine species and in ova and embr yos of animals of the porcine 
species, having regar d to Council Directive 92/65/EEC (9). However , Regulation (EU) 2016/429 repealed and 
replaced Directive 92/65/EEC as from 21 Apr il 2021. In addition, Regulation (EU) 2016/429 as well as other Union 
legislation repealed certain other acts mentioned in the model certificates set out in that Decision. Theref ore, for 
(7)Commission Implementing Regulation (EU) 2019/1715 of 30 September 2019 laying down rules for the functioning of the 
information management system for official controls and its system components (‘the IMSOC Regulation’) (OJ L 261, 14.10.2019, p. 
37).
(8)Commission Decision 2010/470/EU of 26 August 2010 laying down model health certificates for trade within the Union in semen, 
ova and embr yos of animals of the equine, ovine and capr ine species and in ova and embr yos of animals of the porcine species (OJ L 
228, 31.8.2010, p. 15).
(9)Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements govern ing trade in and impor ts into the 
Community of animals, semen, ova and embr yos not subject to animal health requirements laid down in specific Community rules 
referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268 14.9.1992, p. 54).EN Offi cial Jour nal of the European Union L 113/4                                                                                                                                           31.3.2021   
reasons of harmonisation and clarity, in order to avoid duplication of rules, the model health certificates laid down 
in Decision 2010/470/EU should be replaced by the model certificates laid down in this Regulation and Decision 
2010/470/EU should be repealed. 
(20) It is appropr iate to introduce a transitional period to take into account the specific situation of compet ent author ities 
in third countr ies that need to make the necessar y arrang ements to ensure compl iance with this Regulation and the 
specifi c situation of shipments of consignments of terrestrial animals and germinal products thereof accompanied 
by certificates issued in accordance with Commission Regulations (EC) No 798/2008 (10) and (EU) No 206/2010 
(11), Commission Implemen ting Regulations (EU) No 139/2013 (12) and (EU) 2018/659 (13), Commission Decisions 
2006/168/EC (14), 2010/470/EU and 2010/472/EU (15) as well as those issued in accordance with Commission 
Implementing Decisions 2011/630/EU (16), 2012/137/EU (17) and (EU) 2019/294 (18) before the date of application 
of this Regulation. 
(21) As Regulation (EU) 2016/429 applies with effect from 21 Apr il 2021, this Regulation should also apply from that 
date . 
(22) The measures provid ed for in this Regulation are in accordance with the opinion of the Standing Committ ee on 
Plants, Animals, Food and Feed, 
HAS ADOPTED THIS REGUL ATION: 
Article 1 
Subject matter and scope 
1. This Regulation lays down rules regarding animal health certificates provi ded for in Regulation (EU) 2016/429 and 
animal health/ official certificates based on Regulation (EU) 2016/429 and on Regulation (EU) 2017/625 and as regar ds 
the issuance and replacement of those certificates required for the entr y into the Union (19), mov ements within the Union 
and between Member States of certain consignments of terrestr ial animals and germinal products thereof (hereinaf ter 
together referred to as ‘the certificates’). 
(10)Commission Regulation (EC) No 798/2008 of 8 Aug ust 2008 laying down a list of third countr ies, territories, zones or compar tments 
from which poultr y and poultr y products may be impor ted into and transit through the Community and the veterinar y certification 
requirements (OJ L 226, 23.8.2008, p. 1).
(11)Commission Regulation (EU) No 206/2010 of 12 March 2010 laying down lists of third countr ies, territories or parts thereof 
author ised for the introduction into the European Union of certain animals and fresh meat and the veterinar y certification 
requirements (OJ L 73, 20.3.2010, p. 1).
(12)Commission Implementing Regulation (EU) No 139/2013 of 7 Januar y 2013 laying down animal health conditions for impor ts of 
certain birds into the Union and the quarantine conditions thereof (OJ L 47, 20.2.2013, p. 1).
(13)Commission Implementing Regulation (EU) 2018/659 of 12 Apr il 2018 on the conditions for the entr y into the Union of live 
equidae and of semen, ova and embr yos of equidae (OJ L 110, 30.4.2018, p. 1).
(14)Commission Decision 2006/168/EC of 4 Januar y 2006 establishing the animal health and veterinar y certification requirements for 
impor ts into the Community of bovine embr yos and repealing Decision 2005/217/EC (OJ L 57, 28.2.2006, p. 19).
(15)Commission Decision 2010/472/EU of 26 Aug ust 2010 on impor ts of semen, ova and embr yos of animals of the ovine and capr ine 
species into the Union (OJ L 228, 31.8.2010, p. 74).
(16)Commission Implementing Decision 2011/630/EU of 20 September 2011 on impor ts into the Union of semen of domestic animals 
of the bovine species (OJ L 247, 24.9.2011, p. 32).
(17)Commission Implementing Decision 2012/137/EU of 1 March 2012 on impo rts into the Union of semen of domestic animals of the 
porcine species (OJ L 64, 3.3.2012, p. 29).
(18)Commission Implementin g Decision (EU) 2019/294 of 18 Febr uary 2019 laying down the list of territories and third countr ies 
author ised for impo rts into the Union of dogs, cats and ferrets and the model animal health certificate for such impor ts (OJ L 48, 
20.02.2019, p. 41).
(19)In accordance with the Agreement on the withdrawal of the Unit ed Kingdom of Great Britain and Nor ther n Ireland from the 
European Union and the European Atomic Energy Community , and in particular Article 5(4) of the Prot ocol on Ireland / Nor ther n 
Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Regulation references to “Union” include the United 
Kingdom in respect of Nor ther n Ireland.EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                           L 113/5   
2. This Regulation establishes model certificates, in the form of animal health certificates or animal health/off icial 
certificates: 
(a) for mov ements between Member States of consignments of certain categor ies of terrestrial animals and germinal 
products thereof (Annex I); and 
(b) for the entr y into the Union of consignments of certain catego ries of terrestrial animals and germinal products thereof 
(Annex II). 
3. This Regulation establishes model declarations accompan ying animal health certificates or animal health/off icial 
certificates for the move ments within the Union and for the entr y into the Union of certain categor ies of terrestrial 
animals (Annex III). 
Article 2 
Def initions 
For the purposes of this Regulation, the followi ng definitions shall apply: 
(1) ‘registe red germinal product establishment’ means a germinal product establishment as defined in point (1) of 
Article 2 of Delegat ed Regulation (EU) 2020/686; 
(2) ‘approv ed germinal product establishment’ means a germinal product establishment as defined in point (2) of 
Article 2 of Delegat ed Regulation (EU) 2020/686; 
(3) ‘semen’ means semen as defined in point (14) of Article 2 of Delegat ed Regulation (EU) 2020/686; 
(4) ‘oocytes’ means oocyt es as defined in point (15) of Article 2 of Delegat ed Regulation (EU) 2020/686; 
(5) ‘embr yo’ means embr yo as defined in point (16) of Article 2 of Delega ted Regulation (EU) 2020/686; 
(6) ‘semen collection centre’ means a germinal product establishment as defined in point (11) of Article 2 of Deleg ated 
Regulation (EU) 2020/686; 
(7) ‘embr yo collection team’ means a germinal product establishment as defined in point (12) of Article 2 of Delegat ed 
Regulation (EU) 2020/686; 
(8) ‘embr yo production team’ means a germinal product establishment as defined in point (13) of Article 2 of Delegat ed 
Regulation (EU) 2020/686; 
(9) ‘germin al product processing establishment’ means a germinal product establishment as defined in point (18) of 
Article 2 of Delegat ed Regulation (EU) 2020/686; 
(10) ‘germin al product storage centre’ means a germinal product establishment as defined in point (19) of Article 2 of 
Delegat ed Regulation (EU) 2020/686; 
(11) ‘bovi ne animal’ means bovine animal as defined in point (5) of Article 2 of Deleg ated Regulation (EU) 2020/692; 
(12) ‘ovine animal’ means an ovine animal as defined in point (6) of Article 2 of Delega ted Regulation (EU) 2020/692; 
(13) ‘capr ine animal’ means a capr ine animal as defined in point (7) of Article 2 of Delegat ed Regulation (EU) 2020/692; 
(14) ‘equine animal’ means an equine animal as defined in point (9) of Article 2 of Delegat ed Regulation (EU) 2020/692; 
(15) ‘camelid animal’ means a camelid animal as defined in point (10) of Article 2 of Delegat ed Regulation (EU) 2020/692; 
(16) ‘cervid animal’ means a cervid animal as defined in point (11) of Article 2 of Delegat ed Regulation (EU) 2020/692; 
(17) ‘registe red equine animal’ means registere d equine animal as defined in point (12) of Article 2 of Delegat ed Regulation 
(EU) 2020/692; 
(18) ‘day-old chic ks’ means day-old chicks as defined in point (19) of Article 2 of Delegat ed Regulation (EU) 2020/692; 
(19) ‘specified pathogen -free eggs’ means hatch ing eggs as defined in point (26) of Article 2 of Delegat ed Regulation (EU) 
2020/692; EN Offi cial Jour nal of the European Union L 113/6                                                                                                                                           31.3.2021   
(20) ‘honeybee’ means an animal as defined in point (20) of Article 2 of Delegat ed Regulation (EU) 2020/692; 
(21) ‘bumble bee’ means an animal as defined in point (21) of Article 2 of Deleg ated Regulation (EU) 2020/692; 
(22) ‘unique approval number ’ means a number as defined in point (25) of Article 2 of Delegat ed Regulation (EU) 
2020/692. 
Article 3 
Completion of animal health certificates and of animal health/off icial certificates for consignments of terrest rial 
animals and germinal products thereof 
1. Certificates for mov ements between Member States of consignments of terrestr ial animals and germinal products 
thereof, set out in Annex I to this Regulation, shall be duly compl eted and signed by an official veteri narian in accordance 
with the explanato ry note s provid ed for in Chapt er 2 of Annex I to Imp lementing Regulation (EU) 2020/2235. 
2. Certificates for the entr y into the Union of consignments of terrestrial animals and germinal products thereof, set out 
in Annex II to this Regulation, shall be duly compl eted and signed by an official veteri narian in accordance with the 
explanato ry notes provided for in Chapt er 4 of Annex I to Implementing Regulation (EU) 2020/2235. 
3. Operato rs responsible for consignments refer red to in paragraphs 1 and 2 shall provide the compet ent author ity with 
the information on the descr iption of such consignments as descr ibed in Part I of the model certificates set out in Annexes I 
and II, respectively . 
Article 4 
Requirements for certificates for terrest rial animals and germinal products 
1. The official veterinar ian shall compl ete certificates for consignments of terrestr ial animals and germinal products in 
accordance with the follo wing requirements: 
(a) the certificate shall bear the signature of the official veterinar ian and the official stam p; the colour of the signature and 
the colour of the stam p, other than of an embossed or waterm arked stam p, must be diffe rent to the colour of the 
printing; 
(b) where the certificate contains multiple or alternati ve statements, the state ments which are not relevant must be crossed 
out, initialled and stampe d by the official veterinar ian, or compl etely removed from the certificate; 
(c) the certificate must consist of one of the following: 
(i) a sing le sheet of paper; 
(ii) several sheets of paper where all sheets are indivisible and constitute an integrat ed whole; 
(iii) a sequence of pages with each page numbered so as to indicate that it is a particular page in a finite sequence; 
(d) where the certificate consists of a sequence of page s as referred to in point (c)(iii), of this paragraph, each page must 
bear the unique code referred to in Article 89(1)(a) of Regulation (EU) 2017/625, the signature of the official 
veteri narian and the official stamp; 
(e) in the case of certificates for mov ements of consignments between Member States, the certificate must accompan y the 
consignment until it reac hes the place of destination in the Union; 
(f) in the case of certificates for the entr y into the Union of consignments, the certificate must be present ed to the 
compet ent author ity of the border control post of entr y into the Union where the consignment is subjected to official 
controls; 
(g) the certificate must be issued before the consignment to whic h it relates leaves the control of the compet ent author ity 
issuing the certificate; 
(h) in the case of certificates for the entr y into the Union, the certificate must be drawn up in the official language, or in 
one of the official languag es, of the Member State of the border control post of entr y into the Union. EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                           L 113/7   
2. By way of derogat ion to point (h) of paragraph 1 a Member State may consent to certificates being drawn up in 
another official language of the Union and accompan ied, if necessar y, by an authenticated translation. 
3. Points (a) to (e) of paragraph 1 do not apply to electronic certificates issued in accordance with the requirements of 
Article 39(1) of Implementing Regulation (EU) 2019/1715. 
4. Points (b), (c) and (d) of paragraph 1 shall not apply to certificates issued in paper and compl eted in, and printed from, 
TRA CES. 
Article 5 
Replacement of certificates for terrest rial animals and germinal products 
1. Com petent author ities shall only issue replacement certificates for consignments of terrestrial animals and germinal 
products in the case of administrative errors in the initial certificate or where the initial certificate has been damaged or lost. 
2. In the replacement certificate, the compet ent author ity shall not modify information in the initial certificate 
concer ning the identif ication of the consignment, its traceability and the guarant ees provided for in the initial certificate 
for the consignment. 
3. In the replacement certificate the compet ent author ity shall: 
(a) make clear reference to the unique code referred to in Article 89(1)(a) of Regulation (EU) 2017/625 and the date of 
issue of the initial certificate, and clearly state that it replaces the initial certificate; 
(b) indicate a new certificate number different to that of the initial certificate; 
(c) indicate the date when it was issued, as opposed to the date of issue of the initial certificate; 
(d) produce an original document issued in paper , excep t in the case of electronic replacement certificates submitted in 
TRA CES. 
4. In the case of entr y into the Union of consignments, the compet ent author ity of the border control post of entr y into 
the Union may refrain from requesting the operat or responsible for the consignment to provid e a replacement certificate 
when information concer ning the consignee, the importer, the border control post of entr y into the Union or the means of 
transpor t chang es after the certificate has been issued and such new information is provided by the operat or responsible for 
the consignment. 
Article 6 
Model animal health certificates for the movements betw een Member States of certain categor ies of ungulates 
The animal health certificates referred to in Article 1(2)(a) to be used for the move ments between Member State s of certain 
catego ries of ungulates shall correspond to one of the followi ng models, depending on the species concer ned: 
(a) BOV-INTRA-X drawn up in accordance with the model set out in Chapt er 1 of Annex I, for bovine animals not 
intended for slaughter; 
(b) BOV-INTRA- Y drawn up in accordance with the model set out in Chapt er 2 of Annex I, for bovine animals intended 
for slaughter; 
(c) POR -INTRA-X drawn up in accordance with the model set out in Chapt er 3 of Annex I, for porcine animals not 
intended for slaughter; 
(d) POR -INTRA- Y drawn up in accordance with the model set out in Chapt er 4 of Annex I, for porcine animals intended 
for slaughter; 
(e) OV/CAP-INTRA -X drawn up in accordance with the model set out in Chapt er 5 of Annex I, for ovine and capr ine 
animals not intended for slaughter; 
(f) OV/CAP-INTRA -Y drawn up in accordance with the model set out in Chapt er 6 of Annex I, for ovine and capr ine 
animals intended for slaughter; EN Offi cial Jour nal of the European Union L 113/8                                                                                                                                           31.3.2021   
(g) EQUI-INTRA-IND drawn up in accordance with the model set out in Chapt er 7 of Annex I, for an individual equine 
animal not intended for slaughter; 
(h) EQUI-INTRA-CON drawn up in accordance with the model set out in Chapt er 8 of Annex I, for a consignment of 
equine animals; 
(i) CAM-INTRA-X drawn up in accordance with the model set out in Chapt er 9 of Annex I, for camelid animals not 
intended for slaughter; 
(j) CAM-INTRA- Y drawn up in accordance with the model set out in Chapt er 10 of Annex I, for camelid animals intende d 
for slaughter; 
(k) CER -INTRA-X drawn up in accordance with the model set out in Chapt er 11 of Annex I, for cervid animals not 
intended for slaughter; 
(l) CER -INTRA- Y drawn up in accordance with the model set out in Chapt er 12 of Annex I, for cervid animals intended 
for slaughter; 
(m) OTHER -UNGUL ATES-INTRA-X drawn up in accordance with the model set out in Chapt er 13 of Annex I, for kept 
ungulates, other than bovine, ovine, capr ine, porcine, equine, camelid and cervid animals, not intended for slaughter; 
(n) OTHER -UNGUL ATES-INTRA- Y drawn up in accordance with the model set out in Chapt er 14 of Annex I, for kept 
ungulates other than bovin e, ovine, capr ine, porcine, equine, camelid and cervid animals intended for slaughter . 
Article 7 
Model animal health certificates and animal health/off icial certificates for the movements betw een Member States 
of certain categor ies of birds and germinal products thereof 
The animal health certificates and animal health/official certificates referred to in Article 1(2)(a) to be used for the 
mov ements between Member States of certain cate gories of birds and germinal products thereof shall correspond to one 
of the followi ng models, depending on catego ries of birds and products concer ned: 
(a) POU-INTRA-HEP drawn up in accordance with the model set out in Chapt er 15 of Annex I, for hatching eggs of 
poultr y; 
(b) POU-INTRA-DOC drawn up in accordance with the model set out in Chapt er 16 of Annex I, for day-old chic ks; 
(c) POU-INTRA-X drawn up in accordance with the model set out in Chapt er 17 of Annex I, for breeding poultr y or 
productive poultr y; 
(d) POU-INTRA-L T20 drawn up in accordance with the model set out in Chapt er 18 of Annex I, for less than 20 heads of 
poultr y other than ratites or less than 20 hatc hing eggs of poultr y other than ratite s; 
(e) POU-INTRA- Y drawn up in accordance with the model set out in Chapt er 19 of Annex I, for poultr y intended for 
slaughter; 
(f) POU-INTRA-SPF drawn up in accordance with the model set out in Chapt er 20 of Annex I, for specifi ed pathogen -free 
eggs; 
(g) CAPTIVE-BIRDS-INTRA drawn up in accordance with the model set out in Chapt er 21 of Annex I, for captive birds; 
(h) HE-C APTIVE-BIRDS-INTRA drawn up in accordance with the model set out in Chapt er 22 of Annex I, for hatch ing 
eggs of captive birds. 
Article 8 
Model animal health certificates for the movements betw een Member States of certain types of germinal 
products of bovine animals 
The animal health certificates referred to in Article 1(2)(a) to be used for movements between Member States of certain 
types of germinal products of bovine animals shall correspond to one of the follo wing models, depending on type of the 
products concer ned: EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                           L 113/9   
(a) BOV-SEM-A-INTRA drawn up in accordance with the model set out in Chapt er 23 of Annex I, for consignment of 
semen of bovine animals collect ed, processed and store d in accordance with Regulation (EU) 2016/429 and Delegat ed 
Regulation (EU) 2020/686 after 20 Apr il 2021, dispatched from the semen collection centre where the semen was 
collected; 
(b) BOV-SEM-B-INTRA drawn up in accordance with the model set out in Chapt er 24 of Annex I, for consignment of 
stoc ks of semen of bovine animals collected, processed and stored after 31 December 2004 and before 21 Apr il 2021, 
in accordance with Council Directive 88/407/EEC (20), as amended by Council Directive 2003/43/EC (21), dispatche d 
after 20 Apr il 2021 from the semen collection centre where the semen was collected; 
(c) BOV-SEM-C-INTRA drawn up in accordance with the model set out in Chapt er 25 of Annex I, for consignments of 
stoc ks of semen of bovine animals collect ed, processed and stored before 1 Januar y 2005 in accordance with Council 
Directive 88/407/EEC, as amended by Council Directive 93/60/EEC, dispatched after 20 Apr il 2021 from the semen 
collection centre where the semen was collected; 
(d) BOV-OOCY TES-EMB-A-INTRA drawn up in accordance with the model set out in Chapt er 26 of Annex I, for 
consignment of oocyte s and embr yos of bovine animals collect ed or produced, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021, dispatc hed by the 
embr yo collection or production team by which the oocytes or embr yos were collect ed or produced; 
(e) BOV-EMB-B-INTRA drawn up in accordance with the model set out in Chapt er 27 of Annex I, for consignment of 
stoc ks of embr yos of bovine animals collect ed or produced, processed, and store d before 21 Apr il 2021 in accordance 
with Council Directive 89/556/EEC (22), dispatch ed after 20 Apr il 2021 by the embr yo collection or production team 
by which the embr yos were collect ed or produced; 
(f) BOV-GP-PROCESSING-INTRA drawn up in accordance with the model set out in Chapt er 28 of Annex I, for 
consignments of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of bovine animals collect ed, processed and store d in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of bovine animals collected, processed and store d in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 Apr il 2021; 
— stoc ks of semen of bovine animals collected, processed and stored before 1 Januar y 2005 in accordance with 
Council Directive 88/407/EEC as amended by Council Directive 93/60/EEC; 
— oocytes and embr yos of bovine animals collected or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of embr yos of bovine animals collected or produced, processed and stored in accordance with Directive 
89/556/EEC before 21 Apr il 2021; 
(g) BOV-GP-STORA GE-INTRA drawn up in accordance with the model set out in Chapt er 29 of Annex I, for consignments 
of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product storag e centre: 
— semen of bovine animals collect ed, processed and store d in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of bovine animals collected, processed and store d in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 Apr il 2021; 
(20)Council Directive 88/407/EEC of 14 June 1988 laying down the animal health requirements applicable to intra- Community trade in 
and impor ts of semen of domestic animals of the bovine species (OJ L 194, 22.7.1988, p. 10).
(21)Council Directive 2003/43/EC of 26 May 2003 amending Directive 88/407/EEC laying down the animal health requirements 
applicable to intra-Community trade in and impo rts of semen of domestic animals of the bovin e species (OJ L 143, 11.6.2003, p. 23).
(22)Council Directive 89/556/EEC of 25 Sept ember 1989 on animal health conditions governing intra-Community trade in and 
impor tation from third countr ies of embr yos of domestic animals of the bovin e species (OJ L 302, 19.10.1989, p. 1).EN Offi cial Jour nal of the European Union L 113/10                                                                                                                                         31.3.2021   
— stoc ks of semen of bovine animals collected, processed and stored before 1 Januar y 2005 in accordance with 
Council Directive 88/407/EEC as amended by Council Directive 93/60/EEC; 
— oocytes and embr yos of bovine animals collected or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of embr yos of bovine animals collected or produced, processed and stored in accordance with Directive 
89/556/EEC before 21 Apr il 2021. 
Article 9 
Model animal health certificates for the movements betw een Member States of certain types of germinal 
products of ovine and capr ine animals 
The animal health certificates referred to in Article 1(2)(a) to be used for movements between Member States of certain 
types of germinal products of ovine and capr ine animals shall correspond to one of the followi ng models, depending on 
the type of products concer ned: 
(a) OV/CAP-SEM-A -INTRA drawn up in accordance with the model set out in Chapt er 30 of Annex I, for consignments of 
semen of ovine and capr ine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021, dispatche d from the semen collection centre where the 
semen was collect ed; 
(b) OV/CAP-SEM-B-I NTRA drawn up in accordance with the model set out in Chapt er 31 of Annex I, for consignments of 
stoc ks of semen of ovine and capr ine animals collected, processed and store d in accordance with Directive 92/65/EEC 
after 31 August 2010 and before 21 Apr il 2021, dispatched after 20 Apr il 2021 from the semen collection centre 
where the semen was collected; 
(c) OV/CAP-SEM-C -INTRA drawn up in accordance with the model set out in Chapt er 32 of Annex I, for consignments of 
stoc ks of semen of ovine and capr ine animals collected, processed and store d in accordance with Directive 92/65/EEC 
before 1 Sept ember 2010, dispatche d after 20 Apr il 2021 from the semen collection centre where the semen was 
collected; 
(d) OV/CAP-OOC YTES-EMB-A-INTRA drawn up in accordance with the model set out in Chapt er 33 of Annex I, for 
consignments of oocyt es and embr yos of ovine and capr ine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Deleg ated Regulation (EU) 2020/686 after 20 Apr il 2021, dispatche d 
by the embr yo collection or production team by which the oocytes or embr yos were collect ed or produced; 
(e) OV/CAP-OOC YTES-EMB-B-INTRA drawn up in accordance with the model set out in Chapt er 34 of Annex I, for 
consignments of stoc ks of oocytes and embr yos of ovine and capr ine animals collected or produced, processed and 
stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 21 Apr il 2021, dispatch ed after 
20 Apr il 2021 by the embr yo collection or production team by which the oocytes or embr yos were collect ed or 
produced; 
(f) OV/CAP-OOC YTES-EMB-C-INTRA drawn up in accordance with the model set out in Chapt er 35 of Annex I, for 
consignments of stoc ks of oocytes and embr yos of ovine and capr ine animals collected or produced, processed and 
stored in accordance with Directive 92/65/EEC before 1 September 2010, dispatched after 20 Apr il 2021 by the 
embr yo collection or production team by which the oocyte s or embr yos were collect ed or produced; 
(g) OV/CAP-GP -PROCESSING-INTRA drawn up in accordance with the model set out in Chapt er 36 of Annex I, for 
consignments of germinal products liste d below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of ovine and capr ine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 
and Delega ted Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of ovine and capr ine animals collect ed, processed and stored in accordance with Council Directive 
92/65/EEC after 31 August 2010 and before 21 Apr il 2021; 
— stoc ks of semen of ovine and capr ine animals collect ed, processed and stored in accordance with Council Directive 
92/65/EEC before 1 Sept ember 2010; EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                         L 113/11   
— oocytes and embr yos of ovine and capr ine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of oocytes and embr yos of ovine and capr ine animals collect ed or produced, processed and stored in 
accordance with Council Directive 92/65/EEC after 31 August 2010 and before 21 Apr il 2021; 
— stoc ks of oocytes and embr yos of ovine and capr ine animals collect ed or produced, processed and stored in 
accordance with Council Directive 92/65/EEC before 1 Septembe r 2010; 
(h) OV/CAP-GP -STORA GE-INTRA drawn up in accordance with the model set out in Chapt er 37 of Annex I, for 
consignments of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product stora ge 
centre: 
— semen of ovine and capr ine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 
and Delega ted Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of ovine and capr ine animals collect ed, processed and stored in accordance with Council Directive 
92/65/EEC after 31 August 2010 and before 21 Apr il 2021; 
— stoc ks of semen of ovine and capr ine animals collect ed, processed and stored in accordance with Council Directive 
92/65/EEC before 1 Sept ember 2010; 
— oocytes and embr yos of ovine and capr ine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of oocytes and embr yos of ovine and capr ine animals collect ed or produced, processed and stored in 
accordance with Council Directive 92/65/EEC after 31 August 2010 and before 21 Apr il 2021; 
— stoc ks of oocytes and embr yos of ovine and capr ine animals collect ed or produced, processed and stored in 
accordance with Council Directive 92/65/EEC before 1 Septembe r 2010. 
Article 10 
Model animal health certificates for the movements betw een Member States of certain types of germinal 
products of porcine animals 
The animal health certificates referred to in Article 1(2)(a) to be used for movements between Member States of certain 
types of germinal products of porcine animals shall correspond to one of the followi ng models, depending on the type of 
products concer ned: 
(a) POR -SEM-A-INTRA drawn up in accordance with the model set out in Chapt er 38 of Annex I, for consignments of 
semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021, dispatc hed from the semen collection centre where the 
semen was collect ed; 
(b) POR -SEM-B-INTRA drawn up in accordance with the model set out in Chapt er 39 of Annex I, for consignments of 
stoc ks of semen of porcine animals collected, processed and store d in accordance with Directive 90/429/EEC (23) 
before 21 Apr il 2021, dispatch ed after 20 Apr il 2021 from the semen collection centre where the semen was collect ed; 
(c) POR -OOCY TES-EMB-A-INTRA drawn up in accordance with the model set out in Chapt er 40 of Annex I, for 
consignments of oocyt es and embr yos of porcine animals collect ed or produced, processed and store d in accordance 
with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021, dispatc hed by the 
embr yo collection or production team by which the oocytes or embr yos were collect ed or produced; 
(23)Council Directive 90/429/EEC of 26 June 1990 laying down the animal health requirements applicable to intra-Community trade in 
and impor ts of semen of domestic animals of the porcine species (OJ L 224, 18.8.1990, p. 62).EN Offi cial Jour nal of the European Union L 113/12                                                                                                                                         31.3.2021   
(d) POR -OOCY TES-EMB-B-INTRA drawn up in accordance with the model set out in Chapt er 41 of Annex I, for 
consignments of stocks of oocyt es and embr yos of porcine animals collect ed or produced, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 21 Apr il 2021, dispatched after 20 Apr il 2021 
by the embr yo collection or production team by which the oocytes or embr yos were collect ed or produced; 
(e) POR -OOCY TES-EMB-C-INTRA drawn up in accordance with the model set out in Chapt er 42 of Annex I, for 
consignments of stocks of oocyt es and embr yos of porcine animals collect ed or produced, processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010, dispatche d after 20 Apr il 2021 by the embr yo 
collection or production team by which the oocyte s or embr yos were collect ed or produced; 
(f) POR -GP-PROCESSING-INTRA drawn up in accordance with the model set out in Chapt er 43 of Annex I, for 
consignments of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of porcine animals collect ed, processed and store d in accordance with Council Directive 
90/429/EEC before 21 Apr il 2021; 
— oocytes and embr yos of porcine animals collect ed or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of porcine animals collected or produced, processed and store d in accordance with 
Directive 92/65/EEC after 31 August 2010 and before 21 Apr il 2021; 
— stoc ks of oocyte s and embr yos of porcine animals collected or produced, processed and store d in accordance with 
Directive 92/65/EEC before 1 Sept ember 2010; 
(g) POR -GP-STORA GE-INTRA drawn up in accordance with the model set out in Chapt er 44 of Annex I, for consignments 
of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product storag e centre: 
— semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of porcine animals collect ed, processed and store d in accordance with Council Directive 
90/429/EEC before 21 Apr il 2021; 
— oocytes and embr yos of porcine animals collect ed or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of porcine animals collected or produced, processed and store d in accordance with 
Directive 92/65/EEC after 31 August 2010 and before 21 Apr il 2021; 
— stoc ks of oocyte s and embr yos of porcine animals collected or produced, processed and store d in accordance with 
Directive 92/65/EEC before 1 Sept ember 2010. 
Article 11 
Model animal health certificates for the movements betw een Member States of certain types of germinal 
products of equine animals 
The animal health certificates referred to in Article 1(2)(a) to be used for the move ments between Member State s of certain 
types of germinal products of equine animals shall correspond to one of the followi ng models, depending on type of 
products concer ned: 
(a) EQUI-SEM-A-INTRA drawn up in accordance with the model set out in Chapt er 45 of Annex I, for consignments of 
semen of equine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and Deleg ated 
Regulation (EU) 2020/686 after 20 Apr il 2021, dispatch ed from the semen collection centre where the semen was 
collected; EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                         L 113/13   
(b) EQUI-SEM-B-INTRA drawn up in accordance with the model set out in Chapt er 46 of Annex I, for consignments of 
stoc ks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 
30 Sept ember 2014 and before 21 Apr il 2021, dispatched after 20 Apr il 2021 from the semen collection centre 
where the semen was collected; 
(c) EQUI-SEM-C-INTRA drawn up in accordance with the model set out in Chapt er 47 of Annex I, for consignments of 
stoc ks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 
31 August 2010 and before 1 October 2014, dispatc hed after 20 Apr il 2021 from the semen collection centre where 
the semen was collect ed; 
(d) EQUI-SEM-D-INTRA drawn up in accordance with the model set out in Chapt er 48 of Annex I, for consignments of 
stoc ks of semen of equine animals collect ed, processed and store d in accordance with Directive 92/65/EEC before 
1 Sept ember 2010, dispatched after 20 Apr il 2021 from the semen collection centre where the semen was collect ed; 
(e) EQUI-OOCY TES-EMB-A-INTRA drawn up in accordance with the model set out in Chapt er 49 of Annex I, for 
consignments of oocytes and embr yos of equine animals collected or produced, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021, dispatch ed by the 
embr yo collection or production team by which the oocyte s or embr yos were collect ed or produced; 
(f) EQUI-OOCY TES-EMB-B-INTRA drawn up in accordance with the model set out in Chapt er 50 of Annex I, for 
consignments of stoc ks of oocytes and embr yos of equine animals collect ed or produced, processed and stored in 
accordance with Directive 92/65/EEC after 30 Sept ember 2014 and before 21 Apr il 2021, dispatch ed after 20 Apr il 
2021 by the embr yo collection or production team by whic h the oocyt es or embr yos were collect ed or produced; 
(g) EQUI-OOCY TES-EMB-C-INTRA drawn up in accordance with the model set out in Chapt er 51 of Annex I, for 
consignments of stoc ks of oocytes and embr yos of equine animals collect ed or produced, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014, dispatche d after 20 Apr il 
2021 by the embr yo collection or production team by whic h the oocyt es or embr yos were collect ed or produced; 
(h) EQUI-OOCY TES-EMB-D-INTRA drawn up in accordance with the model set out in Chapt er 52 of Annex I, for 
consignments of stoc ks of oocytes and embr yos of equine animals collect ed or produced, processed and stored in 
accordance with Directive 92/65/EEC before 1 Sept ember 2010, dispatched after 20 Apr il 2021 by the embr yo 
collection or production team by which the oocyte s or embr yos were collect ed or produced; 
(i) EQUI-GP -PROCESSING-INTRA drawn up in accordance with the model set out in Chapt er 53 of Annex I, for 
consignments of germinal products liste d below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of equine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
31 August 2010 and before 1 October 2014; 
— stoc ks of semen of equine animals collect ed, processed and store d in accordance with Directive 92/65/EEC before 
1 Sept ember 2010; 
— oocytes and embr yos of equine animals collected or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of equine animals collect ed or produced, processed and stored in accordance with 
Directive 92/65/EEC after 30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of oocyt es and embr yos of equine animals collected, processed and store d in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014; 
— stoc ks of oocyt es and embr yos of equine animals collected, processed and store d in accordance with Directive 
92/65/EEC before 1 Sept ember 2010; EN Offi cial Jour nal of the European Union L 113/14                                                                                                                                         31.3.2021   
(j) EQUI-GP -STORA GE-INTRA drawn up in accordance with the model set out in Chapt er 54 of Annex I, for 
consignments of germinal products liste d below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of equine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
31 August 2010 and before 1 October 2014; 
— stoc ks of semen of equine animals collect ed, processed and store d in accordance with Directive 92/65/EEC before 
1 Sept ember 2010; 
— oocytes and embr yos of equine animals collected or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/686 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of equine animals collect ed or produced, processed and stored in accordance with 
Directive 92/65/EEC after 30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of oocyt es and embr yos of equine animals collected, processed and store d in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014; 
— stoc ks of oocyt es and embr yos of equine animals collected, processed and store d in accordance with Directive 
92/65/EEC before 1 Sept ember 2010. 
Article 12 
Model animal health certificates for the movements betw een Member States of certain categor ies of bees 
The animal health certificates referred to in Article 1(2)(a) to be used for movements between Member States of certain 
catego ries of bees shall correspond to one of the follo wing models, depending on the species concer ned: 
(a) HBEE-INTRA drawn up in accordance with the model set out in Chapt er 55 of Annex I, for hone ybees; 
(b) QUE-INTRA drawn up in accordance with the model set out in Chapt er 56 of Annex I, for queen hone ybees under 
derogation; 
(c) BBEE-INTRA drawn up in accordance with the model set out in Chapt er 57 of Annex I, for bumble bees. 
Article 13 
Model animal health certificates and declarations for the movements betw een Member States of certain 
categor ies of terrestr ial animals and certain germinal products 
The animal health certificates refer red to in Article 1(2)(a) and declarations refer red to in Article 1(3) to be used for the 
mov ements between Member States of certain cate gories of terrestr ial animals and certain germinal products thereof shall 
correspond to one of the followi ng models, depending on the species and cate gories of products concer ned: 
(a) CONFINED-LIVE-INTRA drawn up in accordance with the model set out in Chapt er 58 of Annex I for terrestrial 
animals moved between confined establishments; 
(b) CONFINED-PRIMA TE-INTRA drawn up in accordance with the model set out in Chapt er 59 of Annex I, for primat es 
move d into a conf ined establishment ; 
(c) GP-CONFINED-INTRA drawn up in accordance with the model set out in Chapt er 60 of Annex I, for consignment of 
semen, oocyte s and embr yos of terrestrial animals kept at confined establishment whic h were collected or produced, 
processed and store d in accordance with Regulation (EU) 2016/429 and Deleg ated Regulation (EU) 2020/686; EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                         L 113/15   
(d) CANIS-FELIS-FERRETS-INTRA drawn up in accordance with the model set out in Chapt er 61 of Annex I, for dogs, cats 
and ferrets; 
(e) GP-CANIS-FELIS-INTRA drawn up in accordance with the model set out in Chapt er 62 of Annex I, for consignment of 
semen, oocytes and embr yos of dogs (Canis lupus familiar is) and cats (Felis silvestr is catus) which were collect ed or 
produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 
2020/686; 
(f) OTHCARN -INTRA drawn up in accordance with the model set out in Chapt er 63 of Annex I, for other carnivores; 
(g) WILD-ANIMALS-INTRA drawn up in accordance with the model set out in Chapt er 64 of Annex I, for wild terrestrial 
animals; 
(h) GP-CAM-CER -INTRA drawn up in accordance with the model set out in Chapt er 65 of Annex I, for consignments of 
semen, oocyte s and embr yos of animals of the families Camelidae and Cervidae whic h were collected or produced, 
processed and store d in accordance with Regulation (EU) 2016/429 and Deleg ated Regulation (EU) 2020/686. 
Article 14 
Model animal health certificates and animal health/off icial certificates for the entr y into the Union of certain 
categor ies of ungulates 
The animal health certificates and animal health/official certificates referred to in Article 1(2)(b) to be used for the entr y into 
the Union of certain categor ies of ungulates shall correspond to one of the follo wing models, depending on the species 
concer ned: 
(a) BOV-X drawn up in accordance with the model set out in Chapt er 1 of Annex II, for bovine animals; 
(b) BOV-Y drawn up in accordance with the model set out in Chapt er 2 of Annex II, for bovine animals intende d for 
slaughter; 
(c) BOV-X-TRANSIT -RU drawn up in accordance with the model set out in Chapt er 3 of Annex II, for bovine animals 
intended for transit from the region of Kaliningrad to other regions of Russia via the territory of Lithuania; 
(d) OV/CAP-X drawn up in accordance with the model set out in Chapt er 4 of Annex II, for ovine and capr ine animals; 
(e) OV/CAP- Y drawn up in accordance with the model set out in Chapt er 5 of Annex II, for ovine and capr ine animals 
intended for slaughter; 
(f) SUI-X drawn up in accordance with the model set out in Chapt er 6 of Annex II, for porcine animals and animals of the 
family Tayassuidae; 
(g) SUI- Y drawn up in accordance with the model set out in Chapt er 7 of Annex II, for porcine animals intended for 
slaughter; 
(h) RUM drawn up in accordance with the model set out in Chapt er 8 of Annex II for animals of the families 
Antilocapr idae, Bovidae (other than bovine, ovine and capr ine animals), Giraffidae, Moschi dae and Tragulidae; 
(i) RHINO drawn up in accordance with the model set out in Chapt er 9 of Annex II, for animals of the families Tapir idae, 
Rhinocerotidae and Elephantidae; 
(j) HIPPO drawn up in accordance with the model set out in Chapt er 10 of Annex II, for animals of the family 
Hippopotamidae; 
(k) CAM-CER drawn up in accordance with the model set out in Chapt er 11 of Annex II, for camelid and cervid animals. EN Offi cial Jour nal of the European Union L 113/16                                                                                                                                         31.3.2021   
Article 15 
Model animal health certificates, animal health/off icial certificates and declarations for the entr y into the Union 
of certain categor ies of equine animals 
The animal health certificates and animal health/official certificates referred to in Article 1(2)(b) and declarations 
accompan ying animal health certificates or animal health/official certificates refer red to in Article 1(3) to be used for the 
entr y into the Union or transit through the Union of certain cate gories of equine animals shall correspond to one of the 
follo wing models, depending on movements concer ned: 
(a) EQUI-X drawn up in accordance with the model set out in Chapt er 12 of Annex II, for the entr y into the Union of 
equine animals not intende d for slaughter; 
(b) EQUI- Y drawn up in accordance with the model set out in Chapt er 13 of Annex II, for the entr y into the Union of 
equine animals intended for slaughter; 
(c) EQUI- TRANSIT -X drawn up in accordance with the model set out in Chapt er 14 of Annex II, for transit through the 
Union of equine animals not intended for slaughter; 
(d) EQUI- TRANSIT -Y drawn up in accordance with the model set out in Chapt er 15 of Annex II, for transit through the 
Union of equine animals intended for slaughter; 
(e) EQUI-RE-ENTR Y-30 drawn up in accordance with the model set out in Chapt er 16 of Annex II, for the re-entr y into the 
Union of registered horses for racing, compe tition and cultural events after temporar y expor t for a period of not more 
than 30 days; 
(f) EQUI-RE-ENTR Y-90-C OMP drawn up in accordance with the model set out in Chapt er 17 of Annex II, for the re-entr y 
into the Union of register ed horses for competition after temporar y expor t for a period of not more than 90 days to 
participate in equestr ian events organised under the auspices of the Fédération Equestre Internationale (FEI); 
(g) EQUI-RE-ENTR Y-90-RA CE drawn up in accordance with the model set out in Chapt er 18 of Annex II, for the re-entr y 
into the Union of register ed horses for racing after temporar y expor t for a period of not more than 90 days to 
participate in specifi c race events in Australia, Canada, the Unit ed State s of Amer ica, Hong Kong, Japan, Singapore, the 
Unit ed Arab Emirates or Qatar . 
Article 16 
Model animal health certificates for the entr y into the Union of ungulates intended for conf ined an establishment 
The animal health certificates refer red to in Article 1(2)(b) to be used for the entr y into the Union of ungulate s intended for 
a confined establishment shall correspond to one of the follo wing models, depending on the species concer ned: 
(a) CONFINED-R UM drawn up in accordance with the model set out in Section 2 of Chapt er 19 of Annex II, for animals 
listed in Section 1 of that Chapt er that are originating from and intende d for a conf ined establishment ; 
(b) CONFINED-SUI drawn up in accordance with the model set out in Section 2 of Chapt er 20 of Annex II, for animals 
listed in Section 1 of that Chapt er that are originating from and intende d for a conf ined establishment ; 
(c) CONFINED- TRE drawn up in accordance with the model set out in Section 2 of Chapt er 21 of Annex II, for animals 
listed in Section 1 of that Chapt er that are originating from and intende d for a conf ined establishment ; 
(d) CONFINED-HIPPO drawn up in accordance with the model set out in Chapt er 22 of Annex II, for animals of the family 
of Hippopotamidae that are originating from and intended for a conf ined establishment. EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                         L 113/17   
Article 17 
Model animal health certificates and animal health/off icial certificates for the entr y into the Union of certain 
categor ies of birds and germinal products thereof 
The animal health certificates and animal health/official certificates referred to in Article 1(2)(b) to be used for the entr y into 
the Union of certain categor ies of birds and germinal products thereof shall correspond to one of the followi ng models, 
depending on categor ies of birds and germinal products concer ned thereof : 
(a) BPP drawn up in accordance with the model set out in Chapt er 23 of Annex II, for breeding poultr y other than ratit es 
and productive poultr y other than ratites; 
(b) BPR drawn up in accordance with the model set out in Chapt er 24 of Annex II, for breeding ratite s or productive 
ratites; 
(c) DOC drawn up in accordance with the model set out in Chapt er 25 of Annex II, for day-old chicks other than ratites; 
(d) DOR drawn up in accordance with the model set out in Chapt er 26 of Annex II, for day-old chicks of ratites; 
(e) HEP drawn up in accordance with the model set out in Chapt er 27 of Annex II, for hatching eggs of poultr y other than 
ratites; 
(f) HER drawn up in accordance with the model set out in Chapt er 28 of Annex II, for hatching eggs of ratites; 
(g) SPF drawn up in accordance with the model set out in Chapt er 29 of Annex II, for specified pathogen-free eggs; 
(h) SP drawn up in accordance with the model set out in Chapt er 30 of Annex II, for poultr y intended for slaughte r other 
than ratite s; 
(i) SR drawn up in accordance with the model set out in Chapt er 31 of Annex II, for ratites intended for slaughter; 
(j) POU-L T20 drawn up in accordance with the model set out in Chapt er 32 of Annex II, for less than 20 heads of poultr y 
other than ratite s; 
(k) HE-L T20 drawn up in accordance with the model set out in Chapt er 33 of Annex II, for less than 20 hatch ing eggs of 
poultr y other than ratites; 
(l) CAPTIVE-BIRDS drawn up in accordance with the model set out in Chapt er 34 of Annex II, for captive birds; 
(m) HE-C APTIVE-BIRDS drawn up in accordance with the model set out in Chapt er 35 of Annex II, for hatching eggs of 
captive birds. 
Article 18 
Model animal health certificates for the entr y into the Union of certain categor ies of bees 
The animal health certificates referred to in Article 1(2)(b) to be used for the entr y into the Union of certain catego ries of 
bees shall correspond to one of the following models, depending on the species concer ned: 
(a) QUE drawn up in accordance with the model set out in Chapt er 36 of Annex II, for queen honeybees; 
(b) BBEE drawn up in accordance with the model set out in Chapt er 37 of Annex II, for bumble bees. 
Article 19 
Model animal health certificate for the entr y into the Union of dogs, cats and ferrets 
The animal health certificate refer red to in Article 1(2)(b) to be used for the entr y into the Union of dogs, cats and ferrets 
shall correspond to the model CAN IS-FELIS-FERRETS drawn up in accordance with the model set out in Chapt er 38 of 
Annex II. EN Offi cial Jour nal of the European Union L 113/18                                                                                                                                         31.3.2021   
Article 20 
Model animal health certificates for the entr y into the Union of certain types of germinal products of bovine 
animals 
The animal health certificates refer red to in Article 1(2)(b) to be used for the entr y into the Union of certain types of 
germinal products of bovine animals shall correspond to one of the following models, depending on type of products 
concer ned: 
(a) BOV-SEM-A-ENTR Y drawn up in accordance with the model set out in Chapt er 39 of Annex II, for consignments of 
semen of bovine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and Delega ted 
Regulation (EU) 2020/692 after 20 Apr il 2021, dispatch ed from the semen collection centre where the semen was 
collected; 
(b) BOV-SEM-B-ENTR Y drawn up in accordance with the model set out in Chapt er 40 of Annex II, for consignments of 
stoc ks of semen of bovin e animals collect ed, processed and stored after 31 December 2004 and before 20 Apr il 2021 
in accordance with Directive 88/407/EEC, as amended by Directive 2003/43/EC, dispatche d after 20 Apr il 2021 from 
the semen collection centre where the semen was collected; 
(c) BOV-SEM-C-ENTR Y drawn up in accordance with the model set out in Chapt er 41 of Annex II, for consignments of 
stoc ks of semen of bovin e animals collect ed, processed and stored before 1 Januar y 2005 in accordance with Council 
Directive 88/407/EEC as amended by Council Directive 93/60/EEC, dispatched after 20 Apr il 2021 from the semen 
collection centre where the semen was collected; 
(d) BOV-OOCY TES-EMB-A-ENTR Y drawn up in accordance with the model set out in Chapt er 42 of Annex II, for 
consignments of oocyt es and embr yos of bovine animals collected or produced, processed and store d in accordance 
with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021, dispatch ed by the 
embr yo collection or production team by which the oocyte s or embr yos were collect ed or produced; 
(e) BOV-in vivo-EMB-B-ENTR Y drawn up in accordance with the model set out in Chapt er 43 of Annex II, for 
consignments of stoc ks of in vivo derived embr yos of bovine animals collect ed, processed and stored before 21 Apr il 
2021 in accordance with Council Directive 89/556/EEC, dispatched after 20 Apr il 2021 by the embr yo collection 
team by which the embr yos were collect ed; 
(f) BOV-in vitro-EMB-C-ENTR Y drawn up in accordance with the model set out in Chapt er 44 of Annex II, for 
consignments of stoc ks in vitro produced embr yos of bovin e animals produced, processed and stored before 21 Apr il 
2021 in accordance with Council Directive 89/556/EEC, conceived using semen compl ying with requirements of 
Council Directive 88/407/EEC, dispatched after 20 Apr il 2021 by the embr yo production team by which the embr yos 
were produced; 
(g) BOV-in vitro-EMB-D-ENTR Y drawn up in accordance with the model set out in Chapt er 45 of Annex II, for 
consignments of stoc ks of in vitro produced embr yos of bovine animals produced, processed and store d before 
21 Apr il 2021 in accordance with Council Directive 89/556/EEC, conceived using semen coming from semen 
collection or storage centres approved by the compet ent author ity of the expor ting countr y, dispatche d after 20 Apr il 
2021 by the embr yo production team by which the embr yos were produced; 
(h) BOV-GP-PROCESSING-ENTR Y drawn up in accordance with the model set out in Chapt er 46 of Annex II, for 
consignments of germinal products liste d below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of bovine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of bovine animals collect ed, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 Apr il 2021; 
— stoc ks of semen of bovine animals collected, processed and stored before 1 Januar y 2005 in accordance with 
Council Directive 88/407/EEC as amended by Directive 93/60/EEC; 
— oocytes and embr yos of bovine animals collect ed or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                         L 113/19   
— stoc ks of in vivo derived embr yos of bovine animals collect ed, processed and stored in accordance with Directive 
89/556/EEC before 21 Apr il 2021; 
— stoc ks of in vitro produced embr yos of bovine animals produced, processed and store d in accordance with Directive 
89/556/EEC before 21 Apr il 2021 and conceived using semen compl ying with requirements of Directive 
88/407/EEC; 
— stoc ks of in vitro produced embr yos of bovine animals collect ed, processed and stored in accordance with Directive 
89/556/EEC before 21 Apr il 2021 and conceived using semen coming from semen collection or stora ge centres 
approved by the compet ent author ity of the expor ting countr y; 
(i) BOV-GP-STORA GE-ENTR Y drawn up in accordance with the model set out in Chapt er 47 of Annex II, for 
consignments of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product stora ge 
centre: 
— semen of bovine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of bovine animals collect ed, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 Apr il 2021; 
— stoc ks of semen of bovine animals collected, processed and stored before 1 Januar y 2005 in accordance with 
Council Directive 88/407/EEC as amended by Council Directive 93/60/EEC; 
— oocytes and embr yos of bovine animals collect ed or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of in vivo derived embr yos of bovine animals collect ed, processed and stored in accordance with Directive 
89/556/EEC before 21 Apr il 2021; 
— stoc ks of in vitro produced embr yos of bovine animals produced, processed and store d in accordance with Directive 
89/556/EEC before 21 Apr il 2021 and conceived using semen compl ying with requirements of Directive 
88/407/EEC; 
— stoc ks of in vitro produced embr yos of bovine animals produced, processed and store d in accordance with Directive 
89/556/EEC before 21 Apr il 2021 and conceived using semen coming from semen collection or stora ge centres 
approved by the compet ent author ity of the expor ting countr y. 
Article 21 
Model animal health certificates for the entr y into the Union of certain types of germinal products of ovine and 
capr ine animals 
The animal health certificates refer red to in Article 1(2)(b) to be used for the entr y into the Union of certain types of 
germinal products of ovine and capr ine animals shall correspond to one of the follo wing models, depending on type of 
products concer ned: 
(a) OV/CAP-SEM-A -ENTR Y drawn up in accordance with the model set out in Chapt er 48 of Annex II, for consignments of 
semen of ovine and capr ine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021, dispatc hed from the semen collection centre where the 
semen was collect ed; 
(b) OV/CAP-SEM-B-ENT RY drawn up in accordance with the model set out in Chapt er 49 of Annex II, for consignments of 
stoc ks of semen of ovine and capr ine animals collect ed, processed and store d in accordance with Directive 92/65/EEC 
before 21 Apr il 2021, dispatch ed after 20 Apr il 2021 from the semen collection centre where the semen was collect ed; 
(c) OV/CAP-OOC YTES-EMB-A-ENTR Y drawn up in accordance with the model set out in Chapt er 50 of Annex II, for 
consignments of oocytes and embr yos of ovine and capr ine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021, dispatche d 
by the embr yo collection or production team by which the oocytes or embr yos were collect ed or produced; EN Offi cial Jour nal of the European Union L 113/20                                                                                                                                         31.3.2021   
(d) OV/CAP-OOC YTES-EMB-B-ENTR Y drawn up in accordance with the model set out in Chapt er 51 of Annex II, for 
consignments of oocytes and embr yos of ovine and capr ine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC before 21 Apr il 2021, dispatched after 20 Apr il 2021 by the embr yo collection 
or production team by which the oocytes or embr yos were collect ed or produced; 
(e) OV/CAP-GP -PROCESSING-ENTR Y drawn up in accordance with the model set out in Chapt er 52 of Annex II, for 
consignments of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of ovine and capr ine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of ovine and capr ine animals collected, processed and stored in accordance with Council Directive 
92/65/EEC before 21 Apr il 2021; 
— oocytes and embr yos of ovine and capr ine animals collect ed or produced, processed and store d in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of ovine and capr ine animals collect ed or produced, processed and stored in 
accordance with Council Directive 92/65/EEC before 21 Apr il 2021; 
(f) OV/CAP-GP -STORA GE-ENTR Y drawn up in accordance with the model set out in Chapt er 53 of Annex II, for 
consignments of germinal products listed below , dispatch ed after 20 Apr il 2021 from the germinal product storage 
centre: 
— semen of ovine and capr ine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of ovine and capr ine animals collected, processed and stored in accordance with Council Directive 
92/65/EEC before 21 Apr il 2021; 
— oocytes and embr yos of ovine and capr ine animals collect ed or produced, processed and store d in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of ovine and capr ine animals collect ed or produced, processed and stored in 
accordance with Council Directive 92/65/EEC before 21 Apr il 2021. 
Article 22 
Model animal health certificates for the entr y into the Union of certain types of germinal products of porcine 
animals 
The animal health certificates refer red to in Article 1(2)(b) to be used for the entr y into the Union of certain types of 
germinal products of porcine animals shall correspond to one of the followi ng models, depending on type of products 
concer ned: 
(a) POR -SEM-A-ENTR Y drawn up in accordance with the model set out in Chapt er 54 of Annex II, for consignments of 
semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021, dispatc hed from the semen collection centre where the 
semen was collect ed; 
(b) POR -SEM-B-ENTR Y drawn up in accordance with the model set out in Chapt er 55 of Annex II, for consignments of 
stoc ks of semen of porcine animals collected, processed and store d in accordance with Directive 90/429/EEC before 
21 Apr il 2021, dispatched after 20 Apr il 2021 from the semen collection centre where the semen was collect ed; 
(c) POR -OOCY TES-EMB-ENTR Y drawn up in accordance with the model set out in Chapt er 56 of Annex II, for 
consignments of oocyt es and embr yos of porcine animals collect ed or produced, processed and store d in accordance 
with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021, dispatc hed by the 
embr yo collection or production team by which the oocytes or embr yos were collect ed or produced; EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                         L 113/21   
(d) POR -GP-PROCESSING-ENTR Y drawn up in accordance with the model set out in Chapt er 57 of Annex II, for 
consignments of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of porcine animals collect ed, processed and store d in accordance with Council Directive 
90/429/EEC before 21 Apr il 2021; 
— oocytes and embr yos of porcine animals collect ed or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
(e) POR -GP-STORA GE-ENTR Y drawn up in accordance with the model set out in Chapt er 58 of Annex II, for 
consignments of germinal products listed below , dispatch ed after 20 Apr il 2021 from the germinal product storage 
centre: 
— semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of porcine animals collect ed, processed and store d in accordance with Council Directive 
90/429/EEC before 21 Apr il 2021; 
— oocytes and embr yos of porcine animals collect ed or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021. 
Article 23 
Model animal health certificates for the entr y into the Union of certain types of germinal products of equine 
animals 
The animal health certificates refer red to in Article 1(2)(b) to be used for the entr y into the Union of certain types of 
germinal products of equine animals shall correspond to one of the follo wing models, depending on type of products 
concer ned: 
(a) EQUI-SEM-A-ENTR Y drawn up in accordance with the model set out in Chapt er 59 of Annex II, for consignments of 
semen of equine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and Deleg ated 
Regulation (EU) 2020/692 after 20 Apr il 2021, dispatch ed from the semen collection centre where the semen was 
collected; 
(b) EQUI-SEM-B-ENTR Y drawn up in accordance with the model set out in Chapt er 60 of Annex II, for consignments of 
stoc ks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 
30 Sept ember 2014 and before 21 Apr il 2021, dispatched after 20 Apr il 2021 from the semen collection centre 
where the semen was collected; 
(c) EQUI-SEM-C-ENTR Y drawn up in accordance with the model set out in Chapt er 61 of Annex II, for consignments of 
stoc ks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 
31 August 2010 and before 1 October 2014, dispatc hed after 20 Apr il 2021 from the semen collection centre where 
the semen was collect ed; 
(d) EQUI-SEM-D-ENTR Y drawn up in accordance with the model set out in Chapt er 62 of Annex II, for consignments of 
stoc ks of semen of equine animals collect ed, processed and store d in accordance with Directive 92/65/EEC before 
1 Sept ember 2010, dispatched after 20 Apr il 2021 from the semen collection centre where the semen was collect ed; 
(e) EQUI-OOCY TES-EMB-A-ENTR Y drawn up in accordance with the model set out in Chapt er 63 of Annex II, for 
consignments of oocytes and embr yos of equine animals collected or produced, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021, dispatch ed by the 
embr yo collection or production team by which the oocyte s or embr yos were collect ed or produced; 
(f) EQUI-OOCY TES-EMB-B-ENTR Y drawn up in accordance with the model set out in Chapt er 64 of Annex II, for 
consignments of stoc ks of oocytes and embr yos of equine animals collect ed or produced, processed and stored in 
accordance with Directive 92/65/EEC after 30 Sept ember 2014 and before 21 Apr il 2021, dispatch ed after 20 Apr il 
2021 by the embr yo collection or production team by whic h the oocyt es or embr yos were collect ed or produced; EN Offi cial Jour nal of the European Union L 113/22                                                                                                                                         31.3.2021   
(g) EQUI-OOCY TES-EMB-C-ENTR Y drawn up in accordance with the model set out in Chapt er 65 of Annex II, for 
consignments of stoc ks of oocytes and embr yos of equine animals collect ed or produced, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014, dispatche d after 20 Apr il 
2021 by the embr yo collection or production team by whic h the oocyt es or embr yos were collect ed or produced; 
(h) EQUI-GP -PROCESSING-ENTR Y drawn up in accordance with the model set out in Chapt er 66 of Annex II, for 
consignments of germinal products liste d below , dispatched after 20 Apr il 2021 from the germinal product 
processing establishment: 
— semen of equine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
31 August 2010 and before 1 October 2014; 
— stoc ks of semen of equine animals collect ed, processed and store d in accordance with Directive 92/65/EEC before 
1 Sept ember 2010; 
— oocytes and embr yos of equine animals collected or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of equine animals collect ed or produced, processed and stored in accordance with 
Directive 92/65/EEC after 30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of oocyt es and embr yos of equine animals collected, processed and store d in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014; 
(i) EQUI-GP -STORA GE-ENTR Y drawn up in accordance with the model set out in Chapt er 67 of Annex II, for 
consignments of germinal products listed below , dispatched after 20 Apr il 2021 from the germinal product stora ge 
centre: 
— semen of equine animals collect ed, processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of semen of equine animals collect ed, processed and stored in accordance with Directive 92/65/EEC after 
31 August 2010 and before 1 October 2014; 
— stoc ks of semen of equine animals collect ed, processed and store d in accordance with Directive 92/65/EEC before 
1 Sept ember 2010; 
— oocytes and embr yos of equine animals collected or produced, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 after 20 Apr il 2021; 
— stoc ks of oocyte s and embr yos of equine animals collect ed or produced, processed and stored in accordance with 
Directive 92/65/EEC after 30 Sept ember 2014 and before 21 Apr il 2021; 
— stoc ks of oocyt es and embr yos of equine animals collected, processed and store d in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014. 
Article 24 
Model animal health certificate for the entr y into the Union of germinal products of certain categor ies of 
terrestr ial animals 
The animal health certificate referred to in Article 1(2)(b) to be used for the entr y into the Union of consignments of semen, 
oocyte s and embr yos of terrestrial animals kept at conf ined establishment whic h were collect ed or produced, processed and 
store d in accordance with Regulation (EU) 2016/429 and Delegat ed Regulation (EU) 2020/692 shall correspond to the 
model GP-CONFINED-ENTR Y drawn up in accordance with the model set out in Chapt er 68 of Annex II. EN Offi cial Jour nal of the European Union 31.3.2021                                                                                                                                         L 113/23   
Article 25 
Model official declarations for the entr y into the Union of certain categor ies of terrest rial animals 
1. The declaration referred to in Article 1(3) to be used for the transpor t of terrestrial animals enter ing the Union by sea 
shall correspond to the model addendum AT-TERRE-SEA drawn up in accordance with the model set out in Chapt er 1 of 
Annex III and shall be compl eted by the maste r of the vessel. 
2. The declaration refer red to in Article 1(3) to be used for the transhipment of equidae to meet the requirements laid 
down in Articles 9(2) and 10(2) of Imple menting Regulation (EU) 2018/659 shall correspond to the model EQUI- TRANS 
drawn up in accordance with the model set out in Chapt er 2 of Annex III to this Regulation. 
3. Declarations refer red to in paragraphs 1 and 2 shall be attac hed to the relevant animal health certificates or animal 
health/official certificates. 
Article 26 
Repeals 
1. Decision 2010/470/EU is repealed with effect from 21 Apr il 2021. 
2. References to this Decision shall be constr ued as referen ces to this Regulation and shall be read in accordance with the 
correlation table in Annex IV. 
Article 27 
Transitional provisions 
Consignments of terrestrial animals and germinal products thereof accompan ied by the appropr iate certificate issued in 
accordance with Commission Regulations (EC) No 798/2008 and (EU) No 206/2010, Commission Implementing 
Regulations (EU) No 139/2013 and (EU) 2018/659, Commission Decisions 2006/168/EC and 2010/472/EU as well as 
those issued in accordance with Commission Imple menting Decisions 2011/630/EU, 2012/137/EU and (EU) 2019/294, 
before the date of application of this Regulation, shall be accept ed for the entr y into the Union until 20 October 2021 
provid ed that the certificate was signed by the person author ised to sign the certificate in accordance with those 
Regulations and Decisions before 21 August 2021. 
Article 28 
Entr y into force and application 
This Regulation shall enter into force on the twentieth day followi ng that of its publication in the Official Journal of the 
European Union. 
It shall apply from 21 Apr il 2021. 
This Regulation shall be binding in its entirety and directly applicable in all Member States. 
Done at Brussels, 24 Marc h 2021.  
For the Commission 
The President 
Ursula VON DER LEYEN     EN Offi cial Jour nal of the European Union L 113/24                                                                                                                                         31.3.2021   
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /25
ANNEX I
Annex I contains the following model animal health certificates and animal health/ official 
certificates for the movement between Member States
Model
Ungulates
BOV -INTRA -X Chapter 1: Model animal health certificate for the movement between Member 
States of bovine animals not intended for slaughter
BOV -INTRA -Y Chapter 2: Model animal health certificate for the movement between Member 
States of bovine animals intended for slaughter
POR -INTRA -X Chapter 3: Model animal health certificate for the movement between Member 
States of porcine animals not intended for slaughter
POR -INTRA -Y Chapter 4: Model animal health certificate for the movement between Member 
States of porcine animals intended for slaughter
OV/CAP -INTRA -X Chapter 5: Model animal health certificate for the movement between Member 
States of ovine and caprine animals not intended for slaughter
OV/CAP -INTRA -Y Chapter 6: Model animal health certificate for the movement between Member 
States of ovine and caprine animals intended for slaughter
EQUI -INTRA -IND Chapter 7: Model animal health certificate for the movement between Member 
States of an individual equine animal not intended for slaughter
EQUI -INTRA -CON Chapter 8: Model animal health certificate for the movement between Member 
States of a consignment of equine animals
CAM -INTRA -X Chapter 9: Model animal health certificate for the movement between Member 
States of camelid animals not intended for slaughter
CAM -INTRA -Y Chapter 10: Model animal health certificate for the movement between Member 
States of camelid animals intended for slaughter
CER- INTRA -X Chapter 11: Model animal health certificate for the movement between Member 
States of cervid animals not intended for slaughter
CER- INTRA -Y Chapter 12: Model animal health certificate for the movement between Member 
States of cervid animals intended for slaughter
OTHER -UNGULATES -
INTRA -XChapter 1 3: Model animal health certificate for the movement between Member 
States of kept ungulates other than bovine, ovine, caprine, porcine, equine, 
camelid and cervid animals not intended for slaughter
OTHER -UNGULATES -
INTRA -YChapter 14: Model animal health certificate for the movement between Member 
States of kept ungulates other than bovine, ovine, caprine, porcine, equine, camelid and cervid animals intended for slaughter
L 113 /26 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Birds and germinal products thereof
POU -INTRA -HEP Chapter 15: Model animal health/ official certificate for the movement between 
Member States of hatching eggs of poultry
POU -INTRA -DOC Chapter 16: Model animal health/ official certificate for the movement between 
Member States of day -old chicks
POU -INTRA -X Chapter 17: Model animal health/official certificate for the movement between 
Member States of breeding poultry and productive poultry
POU -INTRA -LT20 Chapter 18: Model animal health/ official certificate for the movement between 
Member States of less than 20 heads of poultry other than ratites or less than 20 
hatching eggs of poultry other than ratites
POU -INTRA -Y Chapter 19: Model animal health/ official certificate for the movement between 
Member States of poultry intended for slaughter
POU -INTRA -SPF Chapter 20: Model animal hea lth certificate for the movement between Member 
States of specified pathogen -free eggs
CAPTIVE -BIRDS -INTRA Chapter 21: Model animal health certificate for the movement between Member 
States of captive birds
HE-CAPTIVE -BIRDS -
INTRAChapter 22: Model animal health certificate for the movement between Member 
States of hatching eggs of captive birds
Germinal products of bovine animals
BOV -SEM -A-INTRA Chapter 23: Model animal health certificate for the movement between Member 
States of consignments of semen of bovine animals collected, processed and 
stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021, dispatched from the
semen collection 
centre where the semen was collected
BOV -SEM -B-INTRA Chapter 24: Model animal health certificate for the movement between Member 
States of consignments of stocks of semen of bovine animals collected, 
processed and stored after 31 December 2004 and before 21 April 2021, in 
accordance with Council Directive 88 /407/EEC, as amended by Council 
Directive 2003/43/EC, dispatched after 20 April 2021 from the semen 
collection centre where the semen was collected
BOV -SEM -C-INTRA Chapter 25: Model animal health certificate for the movement between Member 
States of consignments of stocks of semen of bovine animals collected, 
processed and stored before 1 January 2005, in accordance with Council 
Directive 88/407/EEC as amended by Council Directive 93/60/EEC ,dispatched 
after 20 April 2021 from thesemen collection centre w here the semen was 
collected
BOV -OOCYTES -EMB -A-
INTRAChapter 26: Model animal health certificate for the movement between Member 
States of consignment s of oocytes and embryos of bovine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021, dispatched by 
theembryo collection or production team by which the oocytes or embryos 
were collected or produced
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /27
BOV -EMB -B-INTRA Chapter 27: Model animal health certificate for the movement between Member 
States of consignments of stocks of embryos of bovine animals collected or 
produced, processed and stored before 21 April 2021 in accordance with 
Council Directive 89/556/EEC, dispatched after 20 April 2021 by the embryo 
collection or production team by which the embryos were colle cted or produced
BOV -GP-PROCESSING -
INTRAChapter 28: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product processing establishment :
-semen of bovine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/686 after 20 April 2021;
-stocks of semen of bovine animals collected, processed and stored in 
accordance w ith Council Directive 88/407/EEC, as amended by 
Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021;
-
stocks of semen of bovine animals collected, processed and stored 
before 1 January 2005, in accordance with Council Directive 
88/407/EEC as amended by Council Directive 93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, 
processed and s tored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of embryos of bovine animals collected or produced, processed 
and stored in accordance with Directive 89/556/EEC before 21 April 
2021
BOV -GP-STORAGE -INTRA Chapter 29: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product storage centre:
-semen of bovine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/686 after 20 April 2021;
-stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC, as amended by 
Council Directive 2003/43/EC, after 31 December 2004 and before 21 
April 2021;
-stocks of semen of bovine animals collected, processed and stored 
before 1 January 2005 in accordance with Council Directive 
88/407/EEC as amended by Council Directiv e93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of embryos of bovine animals collected or produced , processed 
and stored in accordance with Directive 89/556/EEC before 21 April 2021
L 113 /28 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Germinal products of ovine and caprine animals
OV/CAP -SEM -A-INTRA Chapter 30: Model animal health certificate for the movement between Member 
States of consignments of semen of ovine and caprine animals collected, 
processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020/686 after 20 April 2021, dispatched from the
semen collection centre where the semen was collected
OV/CAP -SEM -B-INTRA Chapter 31: Model animal health certificate for the movement between Member 
States of consignments of stocks of semen of ovine and caprine animals 
collected, processed and stored in accord ance with Directive 92/65/EEC after 
31 August 2010 and before 21 April 2021, dispatched after 20 April 2021 from 
thesemen collection centre where the semen was collected
OV/CAP -SEM -C-INTRA Chapter 32: Model animal health certificate for the movement between Member 
States of consignments of stocks of semen of ovine and caprine animals 
collected, processed and stored in accordance with Directive 92/65/EEC before 
1 September 2010, dispatched after 20 April 2021 from the semen collection
centre where the semen was collected
OV/CAP -OOCYTES -EMB -
A-INTRAChapter 33: Model animal health certificate for the movement between Member 
States of consignments of oocytes and embryos of ovine and caprine animals 
collected or produced, processed and st ored in accordance with Regulation 
(EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021, 
dispatched by theembryo collection or production team by which the oocytes 
or embryos were collected or produced
OV/CAP -OOCYTES -EMB -
B-INTRAChapt er 34: Model animal health certificate for the movement between Member 
States of consignments of stocks of oocytes and embryos of ovine and caprine 
animals collected or produced, processed and stored in accordance with 
Directive 92/65/EEC after 31 August 2 010 and before 21 April 2021,
dispatched after 20 April 2021 by the embryo collection or production team by 
which the oocytes or embryos were collected or produced
OV/CAP -OOCYTES -EMB -
C-INTRAChapter 35: Model animal health certificate for the movement between Member 
States of consignments of stocks of oocytes and embryos of ovine a nd caprine 
animals collected or produced, processed and stored in accordance with 
Directive 92/65/EEC before 1 September 2010, dispatched after 20 April 2021
by theembryo collection or production team by which the oocytes or embryos 
were collected or produced
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /29
OV/CAP -GP-PROCESSING -
INTRAChapter 36: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product processing establishment :
-semen of ovine and caprine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/686 after 20 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC after 31 
August 2010 and before 21 April 2021;
-stocks of semen of ovine and caprine animals collected , processed and 
stored in accordance with Council Directive 92/65/EEC before 1 
September 2010;
-oocytes and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 
2021;
-stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC after 31 August 2010 and before 21 April 2021; 
-stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC before 1 September 2010
OV/CAP -GP-STORAGE -
INTRAChapter 37: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product storage centre:
-semen of ovine and caprine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/686 after 20 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC after 31 
August 2010 and before 21 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC before 1 
September 2010;
-oocytes and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with R egulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 
2021;
-stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC after 31 August 2010 a nd before 21 April 2021; 
-stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC before 1 September 2010
L 113 /30 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Germinal products of porcine animals
POR -SEM -A-INTRA Chapter 38: Model animal health certificate for the movement between Member 
States of consignments of semen of porcine animals collected, processed and 
stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/686 after 20 April 2021, dispatched from thesemen collection 
centre where the semen was collected
POR -SEM -B-INTRA Chapter 39: Model animal health certificate for the movement betwe en Member 
States of consignments of stocks of semen of porcine animals collected, 
processed and stored in accordance with Directive 90/429/EEC before 21 April 
2021, dispatched after 20 April 2021 from thesemen collection centre where 
the semen was collected
POR -OOCYTES- EMB -A-
INTRAChapter 40: Model animal health certificate for the movement between Member 
States of consignments of oocytes and embryos of porcine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 2016/429
and Delegated Regulation (EU) 2020/686 after 20 April 2021, dispatched by 
theembryo collection or production team by which the oocytes or embryos 
were collected or produced
POR -OOCYTES- EMB -B-
INTRAChapter 41: Model animal health certificate for the movemen t between Member 
States of consignments of stocks of oocytes and embryos of porcine animals 
collected or produced, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 21 April 2021, dispatched after 2 0
April 2021 by the embryo collection or production team by which the oocytes 
or embryos were collected or produced
POR -OOCYTES- EMB -C-
INTRAChapter 42: Model animal health certificate for the movement between Member 
States of consignments of stocks of ooc ytes and embryos of porcine animals 
collected or produced, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010, dispatched after 20 April 2021 by the
embryo collection or production team by which the oocytes or embryos were 
collected or produced
POR -GP-PROCESSING -
INTRAChapter 43: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product processing establishment :
-semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/686 after 20 April 2021;
-stocks of semen of porcine animals collected, processed and stored in 
accordance with Council Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of oo cytes and embryos of porcine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 21 April 2021;
-stocks of oocytes and embryos of porcine animals collected or 
produced, processed and sto red in accordance with Directive 
92/65/EEC before 1 September 2010
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /31
POR -GP-STORAGE -INTRA Chapter 44: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product storage centre:
-semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/686 after 20 April 2021;
-stocks of semen of porcine animals collected, processe d and stored in 
accordance with Council Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 2 0 April 2021;
-stocks of oocytes and embryos of porcine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 21 April 2021;
-stocks of oocytes and embryos of porcine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010
Germinal products of equine animals
EQUI -SEM -A-INTRA Chapter 45: Model animal health certificate for the movement between Member 
States of consignments of semen of equine animals collected, processed and 
stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/686 after 20 April 2021, dispatched from thesemen collection 
centre where the semen was collected
EQUI -SEM -B-INTRA Chapter 46: Model animal health certificate for the movement between Member 
States of consignments of stocks of semen of equine animals collected, 
processed and stored in accordance with Directive 92/65/EEC after 
30September 2014 and before 21 April 2021, dispatched after 20 April 2021 
from thesemen collection centre where the semen was collected
EQUI -SEM -C-INTRA Chapter 47: Model animal health certificate for the movement between Member 
States of consignments of stocks of semen of equine animals collected, 
processed and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014, dispatched after 20 April 2021 from the
semen collection centre where the semen was collected
EQUI -SEM -D-INTRA Chapter 48: Model animal health certificate for the movement between Member
States of consignments of stocks of semen of equine animals collected, 
processed and stored in accordance with Directive 92/65/EEC before 1 
September 2010 ,dispatched after 20 April 2021 from the semen collection 
centre where the semen was collected
EQUI -OOCYTES -EMB -A-
INTRAChapter 49: Model animal health certificate for the movement between Member 
States of consignments of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 2016/429 
andDelegated Regulation (EU) 2020/686 after 20 April 2021, dispatched by 
theembryo collection or production team by which the oocytes or embryos 
were collected or produced
L 113 /32 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EQUI -OOCYTES -EMB -B-
INTRAChapter 50: Model animal health certificate for the movemen t between Member 
States of consignments of stocks of oocytes and embryos of equine animals 
collected or produced, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021, dispatched after 
20 April 2021 b ytheembryo collection or production team by which the 
oocytes or embryos were collected or produced
EQUI -OOCYTES -EMB -C-
INTRAChapter 51: Model animal health certificate for the movement between Member 
States of consignments of stocks of oocytes and embr yos of equine animals 
collected or produced, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014, dispatched after 
20 April 2021 by the embryo collection or production team by which the 
oocytes or embryos were collected or produced
EQUI -OOCYTES -EMB -D-
INTRAChapter 52: Model animal health certificate for the movement between Member 
States of consignments of stocks of oocytes and embryos of equine animals 
collected or produced, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010, dispatched after 20 April 2021 by the 
embryo collection or production team by which the oocytes or embryos were collected or produced
EQUI -GP-PROCESSING -
INTRAChapter 53: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product processing establishment :
-semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/686 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and 
before 21 April 2021;
-stocks of se men of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 
1 October 2014;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC before 1 S eptember 2010 ;
-oocytes and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC afte r 31 August 
2010 and before 1 October 2014;
-stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC before 1 
September 2010
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /33
EQUI -GP-STORAGE -
INTRAChapter 54: Model animal health certificate for the movement between Member 
States of consignments of germinal products listed below ,dispatched after 20 
April 2021 from thegerminal product storage centre:
-semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 201 6/429 and Delegated Regulation (EU) 
2020/686 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and 
before 21 April 2021;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 
1 October 2014;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;
-oocytes
and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-
stocks of oocytes and embryos of equine animals collected or 
produced, proces sed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014;
-stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC before 1 
September 2010
Bees
HBEE -INTRA Chapter 55: Model animal health certificate for the movement between Member 
States of honeybees 
QUE -INTRA Chapter 56: Model animal health certificate for the movement between Member 
States of queen honeybees under derogation
BBEE -INTRA Chapter 57: Model animal health certificate for the movement between Member 
States of bumble bees
Certain categories of terrestrial animals and certain germinal products
CONFINED -LIVE -INTRA Chapter 58: Model animal health certificate for the movement between Member 
States of terrestrial animals between confined establishments
CONFINED -PRIMATE -
INTRAChapter 59: Model animal health certificate for the movement between Member 
States of primates into a confined establishment
GP-CONFINED -INTRA Chapter 60: Model animal health certificate for the movement between Member 
States of consignments of semen, oocytes and embryos of terrestrial animals 
kept at confined establishment which were collected or produced, processed 
and stored in accordance with Regulation (EU) 2016/429 and Delegated 
Regulation (EU) 2020/686
L 113 /34 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CANIS- FELIS -FERRETS -
INTRAChapter 61: Model animal health certificate and model declaration for the 
movement between Member States of dogs, cats and ferrets
GP-CANIS -FELIS -INTRA Chapter 62: Model animal health certificate for the movement between Member 
States of consignments of semen, oocytes and embryos of dogs ( Canis lupus 
familiaris ) and cats ( Felis silvestris catus ) which were collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020/686 
OTHCARN -INTRA Chapter 63: Model animal health certificate for the movement between Member 
States of other carnivores
WILD -ANIMALS -INTRA Chapter 64: Model animal health certificate for the movement between Member 
States of wild terrestrial animals
GP-CAM -CER -INTRA Chapter 65: Model animal health certificate for the movement between Member 
States of consignments of semen, oocytes and embryos of animals of the 
families Camelidae and Cervidae which were collected or produced, processed 
and stored in accordance with Regulation (EU) 2016/429 and Delegated 
Regulat ion (EU) 2020/686 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /35
CHAPTER 1
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF BOVINE ANIMALS NOT INTE NDED FOR SLAUGHTER 
(MODEL ‘BOV- INTRA- X’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country 
codeI.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
CountryISO country 
codeCountry ISO country code
I.7 Country of originISO country 
codeI.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /36 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subs pecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of 
originCold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /37
EUROPEAN UNION Certificate model BOV -INTRA- XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The bovine animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 38 of Commission Delegated Regulation (EU) 
2019/2035.
II.1.2. They, for at least the 30 day period prior to the departure of the consignment, or since birth, if 
they are younger than 30 days of age,
II.1.2.1. have been continuously resident in the establishment of origin;
II.1.2.2. have not been in contact with kept bovine animals of a lower health status or 
subject to movement res trictions for animal health reasons;
II.1.2.3. have not been in direct or indirect contact with kept animals that have entered the 
Union from a third country or territory during the 30 day period prior to the 
departure of the animals.
II.1.3. They have not shown clinical signs or symptoms of diseases listed for bovine animals during 
the clinical examination which was carried out, within the 24 hour period prior to departure of 
the consignment ,on ………………. ( insert date dd/mm/yyyy).
II.2. According to officia l information, the animals described in Part I meet the following health requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the species 
or situated in a restricted zone established for reasons of diseases listed for bovine animals.
II.2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and 
B. suis without vaccination regarding bovine animals, and 
(2)either [the establishments of origin are situated in a Member State or zone thereof with the status 
free from infection with Brucella abortus, B. melitensis and B. suis regarding the bovine 
population;]
(2)and/or [they have been subjected to a test for infection with Brucella abortu s, B. melitensis and B. 
suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission 
Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken 
during the 30 day period prior to departure, and in the case of post -parturient females taken at 
least 30 days after parturition;]
(2)and/or [they are less than 12 months old;]
(2)and/or [they are castrated.]
II.2.3. They come from establishments free from infection with Mycobacterium tuberculosis
complex ( M.bovis, M. caprae and M. tuberculosis ), and 
(2)either [the establishments of origin are situated in a Member State or zone thereof with the status 
free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis );]
(2)and/or [they have been subjected to a test for infection with Mycobacterium tuberculosis complex 
(M. bovis, M. caprae and M. tuberculosis ) with one of the diagnostic methods provided for in 
Part 2 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, 
during the 30 day period prior to departure;]
(2)and/or [they are less than 6 weeks old.]
L 113 /38 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -INTRA- X
II.2.4. They come from establishments in which infection with rabies virus in kept terrestrial animals 
has not been reported during the 30 day period prior to departure.
II.2.5. They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in kept animals of listed spe cies for that disease during the last 2 years prior to 
departure.
II.2.6. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 days period prior to departure.
II.2.7. They come from establishments in which surra ( Trypanosoma evansi ) has not been reported 
during the 30 days period prior to departure, and 
(2)either [surra has not been reported in the establishments during the last 2 years prior to their 
departure.]
(2)or [surra has been reported during the last 2 years prior to departure, following the last outbreak 
the affected establishments have remained under movement restrictions until:
– the infected animals have been removed from the establishments, and
– the remaining animals on the establishments have been subjected to a test for surra (Trypanosoma evansi ) with one of the diagnostic methods provided for in part 3 of 
Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the 
establishments.]
(2)either [II.2.8. They originate from a Member State or a zone free from infection with bluetongue virus 
(serotypes 1 -24), where no case of infection with bluetongue virus (serotypes 1 -24) has been 
confirmed d uring the last 24 months in the targeted animal population and have not been 
vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1 -24) in the 
60 day period before the date of movement and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]
(2)and/or [II.2.8. They originate from a Member State or a zone covered by the eradication programme for 
infection with bluetongue virus (serotypes 1- 24) and the req uirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they
(2)either [II.2.8.1. have been kept in a Member State or zone seasonally free from infection with bluetongue virus (serotypes 1-
24) in accordance with Article 40(3) of 
Commission Delegated Regulation (EU) 2020/689
(2)either [II.2.8.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.8.1.2. for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free from infection 
with bluetongue virus (serotypes 1- 24)]]
(2)and/or [II.2.8.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the entry date of the animal into 
the Member State or zone seasonally f ree from infection with 
bluetongue virus (serotypes 1 -24);]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /39
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)and/or [II.2.8.2. have been protected against attacks by  vectors during transportation to the place 
of destination and have been kept protected against attacks by vectors in a vector 
protected establishment
(2)either [II.2.8.2.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.8.2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.8.2.3. for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors;]]]
(2)and/or [II.2.8.3. have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and 
(2)either [II.2.8.3.1. have been vaccinated more than 60 days before the date of 
movement]]
(2)and/or [II.2.8.3.2. have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity set in the specifications of the 
vaccine;]]]
(2)and/or [II.2.8.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and
(2)either [II.2.8.4.1. the serological test has been carried out on samples collected at least 
60 days before the date of movement.]]]
(2)and/or [II.2.8.4.2. the serological test has been carr ied out on samples collected at least 
30 days before the date of the movement and the animal has been 
subjected to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of movement.]]]
(2)and/or [II.2.8 . They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotypes 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotypes 1- 24) and the requirements laid down in Article 32(1)( a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they
(2)either [II.2.8.1. have been protected against attacks by  vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector 
protected establishment
(2)either [II.2.8.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.8.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.8.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors;]]]
L 113 /40 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)and/or [II.2.8.2. have been kept for the 60 day period prior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out in 
Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated Regulation 
(EU) 2020/689 has been carried out during that period, and
(2)either [II.2.8.2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept and are within the immunity period 
guaranteed in the specifications of the vaccine and 
(2)either [II.2.8.2.1.1. have been vaccinated more than 60 days before the 
date of movement]]]
(2)and/or [II.2.8.2.1.2. have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the 
immunity set in the specifications of the vaccine;]]]]
(2)and/or [II.2.8.2.2. the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept, and
(2)either [II.2.8.2.2.1. the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 60 days before the date of movement]]]
(2)and/or [II.2.8.2.2.2. the animals have been subjected with positive results to a serological test carried out on samples collected at 
least 30 days before the date of the movement and to a 
PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of 
movement.]]]]
(2)and/or [II.2.8. They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Member State 
or zone thereof
(2)either [II.2.8.1. with the status free from infection with bluetongue virus (serotypes 1 -24) and the 
Member State of destination has informed the Commission and the other 
Member States that such movement is a uthorised subject to the conditions 
referred to in Article 43(2)(a), (b) and (c) of Delegated Regulation (EU) 
2020/689, and
(2)either [II.2.8.1.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.1 .2.point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /41
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)and/or [II.2.8.1.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.1.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation ar e fulfilled.]]]
(2)and/or [II.2.8.2. with an approved eradication program for infection with bluetongue virus 
(serotypes 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authorised 
subject to the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated 
Regulation (EU) 2020/689 and
(2)either [II.2.8.2.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.2.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.2.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.2.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled.] ]]
(2)and/or [II.2.8.3. neither free from infection with bluetongue virus (serotypes 1- 24) nor covered by 
the eradication programme for infection with bluetongue virus (serotypes 1 -24) 
and the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised
(2)either [II.2.8.3.1. without any conditions, and
(2)and/or [II.2.8.3.2. subject to the conditions referred to in point 5 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.8.3.3. subject to the conditions referred to in point 6 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.8.3.4. subject to the conditions referred to in point 7 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.8.3.5. subject to the conditions referred to in point 8 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
the r equirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled.]]]
L 113 /42 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)[(2)either [II.2.9. They are moved to a Member State or zone thereof with the status free from enzootic 
bovine leukosis, and
(2)either [II.2.9.1. they come from establishments free from enzootic bovine leukosis.]]
(2)or [II.2.9.1. they come from establishments not free from enzootic bovine leukosis, a nd
enzootic bovine leukosis has not been reported in those establishments during the 
24 month period prior to departure, and
(2)either [II.2.9.1.1. they are over 24 months of age and they have been subjected to a serological test for enzootic bovine 
leukosis with one of the 
diagnostic methods provided for in Part 4 of Annex I to Delegated 
Regulation (EU) 2020/688, carried out with negative results
(2)either [II.2.9.1.1.1. on samples taken on two occasions at an interval of at 
least four months while k ept in isolation from the 
other bovine animals of the establishment]]]
(2)and/or [II.2.9.1.1.2. on a sample taken during the 30 day period prior to the departure of the consignment, and all bovine animals over 24 months of age kept in the establishment have 
been subjected to a serological test for enzootic bovine 
leukosis with one of the diagnostic methods provided 
for in Part 4 of Annex I to Delegated Regulation (EU) 
2020/688, carried out, with negative results, on 
samples taken on two occasions at an i nterval of not 
less than four months during the 12 month period prior 
to the departure of the consignment;]]]]
(2)and/or [II.2.9.1.2. they are less than 24 months of age and they were born to dam 
subjected to a serological test for enzootic bovine leukosi s with one 
of the diagnostic methods provided for in Part 4 of Annex I to 
Delegated Regulation (EU) 2020/688, carried out, with negative 
results, on samples taken on two occasions at an interval of not less 
than four months during the 12 month period prior to the departure 
of the consignment.]]]
(2)or[II.2.9. They are moved to a Member State or zone thereof with an approved eradication programme 
for enzootic bovine leukosis, and
(2)either [II.2.9.1. they come from establishments free from enzootic bovine leukosis.]]
(2)or [II.2.9.1. they come from establishments not free from enzootic bovine leukosis, and
enzootic bovine leukosis has not been reported in those establishments during the 
24 month period prior to departure, and
(2)either [II.2.9.1.1. they are o ver 24 months of age and they have been subjected to a 
serological test for enzootic bovine leukosis with one of the 
diagnostic methods provided for in Part 4 of Annex I to Delegated 
Regulation (EU) 2020/688, carried out with negative results
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /43
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)either [II.2.9.1.1.1. on samples taken on two occasions at an interval of at 
least four months while kept in isolation from the 
other bovine animals of the establishment]]]
(2)and/or [II.2.9.1.1.2. on a sample taken during the 30 day period prior to the 
departure of the consignment, and all bovine animals 
over 24 months of age kept in the establishment have 
been subjected to a serological test for enzootic bovine 
leukosis with one of the diagnostic methods provided 
for in Part 4 of Annex I to Delegated Regulation (EU) 
2020/688, carried out, with negative results, on 
samples taken on two occasions at an interval of not 
less than four months during the 12 month period prior 
to the departure of the consignment;]]]]
(2)and/or [II.2.9.1.2. they are less than 24 months of age and they were born to dam, 
which has been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 o f
Annex I to Delegated Regulation (EU) 2020/688, carried out, with 
negative results, on samples taken on two occasions at an interval of 
not less than four months during the 12 month period prior to the 
departure of the consignment.]]] ]
(2)[(2)either [II.2.10. They are moved to a Member State or zone thereof with the status free from 
infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have not been 
vaccinated against infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and
(2)either [II.2.10.1. they come from establishments free from infectio us bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and
(2)either [II.2.10.1.1. the establishments of origin are situated in a Member State or zone 
thereof with the status free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis]]
(2)and/or [II.2.10.1.2 the animals have been subjected to quarantine for at least 30 days 
prior to departure and have been subjected to a serological test for the detection of antibodies against whole bovine herpes virus -1
(BoHV -1) with one of the diagnostic methods provided for in Part 5 
of Annex I to Delegated Regulation (EU) 2020/688, with a negative 
result, carried out on a sample taken during the 15 day period prior to 
the departure of the consignment.]]]
(2)or [II.2.10.1. they come from establishments not free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis and they have been kept in an 
approved quarantine establishment for at least 30 days prior to departure and 
have been subjected to a serological test for the detection of antibodies against 
whole BoHV -1, with one of the diagnostic methods provided for in Part 5 of 
Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried 
out on a sample taken not less than 21 days after commencement of the 
quarantine.]]
L 113 /44 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)or [II.2.10. They are moved to a Member State or zone thereof with an approved eradication 
programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and 
(2)either [II.2.10.1. they come from establishments free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and 
(2)either [II.2.10.1.1. the establishments of origin are situated in a Member State or zone 
thereof with the status free from infectious bovi ne 
rhinotracheitis/infectious pustular vulvovaginitis]]
(2)and/or [II.2.10.1.2. the establishments of origin are situated in a Member State or zone 
thereof with an approved eradication programme for infectious 
bovine rhinotracheitis/infectious pustular vu lvovaginitis]]
(2)and/or [II.2.10.1.3. the animals have been subjected to quarantine for at least 30 days 
prior to departure and have been subjected to a serological test for 
the detection of antibodies against whole bovine herpes virus -1
(BoHV -1) with one of the diagnostic methods provided for in Part 5 
of Annex I to Delegated Regulation (EU) 2020/688 with a negative 
result, carried out on a sample taken during the 15 day period prior to 
the departure of the consignment]]
(2)and/or [II.2.10.1.4. the animals are destined for an establishment which keeps bovine 
animals for meat production without contact to bovine animals of 
other establishments, and from which they are directly moved to the slaughterhouse.]]]
(2)or [II.2.10.1. they come from establishm ents not free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and
– they have been kept in an approved quarantine establishment for at least 30 days prior to departure, and
– they have been subjected to a serological test for the detection of antibodies 
against whole BoHV -1, with one of the diagnostic methods provided for in 
Part 5 of Annex I to Delegated Regulation (EU) 2020/688, with a negative 
result, carried out on a sample taken not less than 21 days after 
commencement of the quarantine.]]]
(2)[(2)either [II.2.11. They are moved to a Member State or zone thereof with the status free from 
bovine viral diarrhoea and they have not been vaccinated against bovine viral diarrhoea, and
(2)either [II.2.11.1. they come from establishments free from bovine viral diarrhoea, and
(2)either [II.2.11.1.1. the establishments of origin are situated in a Member State or zone thereof with the status free from bovine viral diarrhoea]]
(2)and/or [II.2.11.1.2. the establishments of origin have been subjected to a testing regime 
as referred in point 1(c)(ii) or (iii) of Section 2 of Chapter 1 of Part 
VI of Annex IV to Delegated Regulation (EU) 2020/689, carried out, 
with negative results, within the four months period prior to the 
departure of the con signment]]
(2)and/or [II.2.11.1.3. the animals have been tested individually to exclude the presence of 
bovine viral diarrhoea virus prior to the departure of the 
consignment.]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /45
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)or [II.2.11.1. they come from establishments not free from bovine viral diarrhoea and they 
have been subjected to a test for bovine viral diarrhoea virus antigen or genome 
with one of the diagnostic methods provided for in Part 6 of Annex I to 
Delegated Regulation (EU) 2020/688, carried out with negative results, and
(2)either [II.2.11.1.1. they have been kept in an approved quarantine establishment for a 
period of at least 21 days prior to the departure of the consignment 
(2)[and in case of pregnant dams, they have been subjected to a 
serological test for the detection of ant ibodies against bovine viral 
diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried 
out, with negative results, on samples taken not less than 21 days after commencement of the qu arantine]]]
(2)and/or [II.2.11.1.2. they have been subjected to a serological test for the detection of 
antibodies against bovine viral diarrhoea virus with one of the 
diagnostic methods provided for in Part 6 of Annex I to Delegated 
Regulation (EU) 2020/688, with positive results,
(2)either [II.2.11.1.2.1. in case of non -pregnant animals, carried out on 
samples taken prior to departure of the consignment]]]
(2)and/or [II.2.11.1.2.1. in case of pregnant dams, carried out on samples taken 
before insemination preceding the current 
gestation.]]]]
(2)or[II.2.11. They are moved to a Member State or zone thereof with an approved eradication programme 
for bovine viral diarrhoea, and
(2)either [II.2.11.1. they come from establishments free from bovine viral diarrhoe a, and
(2)either [II.2.11.1.1. the establishments of origin are situated in a Member State or zone 
thereof with the status free from bovine viral diarrhoea]]
(2)and/or [II.2.11.1.2. the establishments of origin are situated in a Member State or zone 
thereof with an approved eradication programme for bovine viral 
diarrhoea]] 
(2)and/or [II.2.11.1.3. the establishments of origin have been subjected to a testing regime as referred in point 1(c)(ii) or (iii) of Section 2 of Chapter 1 of Part 
VI of Annex IV to Delegated Regulation (EU) 2020/689, carried out, 
with negative results, within the last 4 months prior to the departure 
of the consignment]]
(2)and/or [II.2.11.1.4. the animals hav e been tested individually to exclude the presence of 
bovine viral diarrhoea virus prior to the departure of the 
consignment]]
(2)and/or [II.2.11.1.5. the animals are destined for an establishment which keeps bovine 
animals for meat production separate fro m bovine animals of other 
establishments, and from which they are directly moved to the 
slaughterhouse]]
L 113 /46 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -INTRA- X
(2)and/or [II.2.11.2. they come from establishments not free from bovine viral diarrhoea and they 
have been subjected to a test for bovine viral diar rhoea virus antigen or genome 
with one of the diagnostic methods provided for in Part 6 of Annex I to 
Delegated Regulation (EU) 2020/688, carried out with negative results, and
(2)either [II.2.11.2.1. they have been kept in an approved quarantine establish ment for a 
period of at least 21 days prior to the departure of the consignment 
(2)[and in case of pregnant dams, they have been subjected to a 
serological test for the detection of antibodies against bovine viral 
diarrhoea virus with one of the diagnostic methods provided for in 
Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried 
out, with negative results, on samples taken not less than 21 days after commencement of the quarantine]]]
(2)and/or [II.2.11.2.2. they have been subjected to a serological test for the detection of 
antibodies against bovine viral diarrhoea virus with one of the 
diagnostic methods provided for in Part 6 of Annex I to Delegated 
Regulation (EU) 2020/688, with positive results,
(2)either [II.2.11.2.2.1. in case of non -pregnant animals, carried out on 
samples taken prior to departure of the consignment]]]
(2)and/or [II.2.11.2.2.1. in case of pregnant dams, carried out on samples taken 
before insemination preceding the current 
gestation.]]]]]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
2)[II.4. According to official information and as declared by the operator, they are semen donor animal s, and 
II.4.1. they come from a semen collection centre and will be transported directly to another semen 
collection centre in accordance with Article 19 of Commission Delegated Regulation (EU) 
2020/686; and
(2)either [II.4.2. they were continuously resident since the date of their admission at the semen collection 
centre and were subjected, with negative results, to all compulsory routine tests referred to in 
point 2 of Chapter I of Part 1 of Annex II to Delegated Regulation (EU) 2020/686 in the period of the preceding 12 months prior to date of that movement; and]
(2)or [II.4.2. they were subjected, with negative results, to all tests referred to in point 1(b) and (c) of 
Chapter I of Part 1 of Annex II to Delegated Regulation (EU) 2020/686, required before 
admission to a semen collection centre carried out during the period immediately preceding quarantine and during the quarantine period; and]
II.4.3. the prior consent of the centre veterinarian of the semen collection centre of destination has 
been obtained by the operator; and
II.4.4. the means of transport used have been cleansed and disinfected before use.]
II.5.
Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /47
EUROPEAN UNION Certificate model BOV -INTRA- X
II.6. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.7. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
Animal wel fare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date)(4)(5).
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429 of the European Parliament and of the Council.
Box reference I .12: “Place of destination”:
Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying doc uments” :In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issu
ed in this establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based o n which the animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment ide ntified in accordance with Article 38 of Delegated Regulation (EU) 
2019/2035.
L 113 /48 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -INTRA- X
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
(4)In the case where a consignment is grouped in an establishment approved for assembly operations and 
comprises animals that were loaded on different dates, the date which the journey commenced for the 
whole consignment is considered to be the earliest date when any part of the consignment left the 
establishment of origin.
(5)This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /49
CHAPTER 2
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF BOVINE ANIMALS INTENDED FOR SLAUGHTER 
(MODEL ‘BO V-INTRA- Y’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country 
codeI.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
CountryISO country 
codeCountry ISO country code
I.7 Country of originISO country 
codeI.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /50 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /51
EUROPEAN UNION Certificate model BOV- INTRA- YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The bovine animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 38 of Commission Delegated Regulation (EU) 
2019/2035.
II.1.2. They have not shown clinical signs or symptoms of diseases listed for bovine animals during 
the clinical examination which was carried out, within the24 hour period prior to departure of 
the consignment, on ………………. ( insert date dd/mm/yyyy).
(2)[II.1.3. They are intended to be slaughtered for disease eradication purposes as part of an eradication 
programme, as provided for in Article 31(1) or (2) of Reg ulation (EU) 2016/429, and the 
Member State of destination and, where applicable, the Member State of passage authorised 
the movement in advance.]
II.2. According to official information, the animals described in Part I meet the following health requireme nts:
II.2.1. They do not come from establishments subject to movement restrictions affecting the species 
or situated in a restricted zone established for reasons of diseases listed for bovine animals.
(2)either [II.2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and 
B. suis with or without vaccination regarding bovine animals.]
(2)and/or [II.2.2. They are castrated.]
(2)and/or [II.2.2. They are less than 12 months old.]
(2)and/or [II.2.2. They are entire bovine animals older than 12 months of age and have been subjected to a test 
for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic 
methods provided for in Part 1 of Annex I to Commission Delegated Regulat ion (EU) 
2020/688, carried out, with negative results, on a sample taken during the 30 day period prior 
to departure, and in the case of post -parturient females taken at least 30 days after parturition.]
(2)either [II.2.3. They come from establishments free from infection with Mycobacterium tuberculosis
complex ( M. bovis, M. caprae and M. tuberculosis ).]
(2)and/or [II.2.3. They have been subjected to a test for infection with Mycobacterium tuberculosis complex 
(M. bovis, M. caprae and M. tuberculosis ) with one of the diagnostic methods provided for in 
Part 2 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, 
during the 30 day period prior to departure.]
II.2.4. They come from establishments in which infection with rabies vi rus in kept terrestrial animals 
has not been reported during the 30 day period prior to departure.
II.2.5. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
II.2.6. They come from establishments in which infection with bluetongue virus (serotypes 1 -24) has 
not been reported during the 30 day period prior to departure.
(2)[II.2.7. The requirements as regards infection with bluetongue virus (serotypes 1- 24) laid down in 
Article 33 of Delegated Regulation (EU) 2020/688 are fulfilled.]
L 113 /52 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- INTRA- Y
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the cert ificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on approved establishments.]]
Animal welfare attestation
At the tim e of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date)(4)(5).
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with A nnex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an estab lishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched fr om an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified in accordance with Article 38 of Delegated Regulation (EU) 
2019/2035.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /53
EUROPEAN UNION Certificate model BOV- INTRA- Y
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
(4)In the case where a consignment is grouped in an establishment approved for assembly operations and 
comprises animals that were loaded on different dates, the date which the journey commenced for the 
whole consignment is considered to be the earliest date when an y part of the consignment left the 
establishment of origin.
(5)This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /54 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 3
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF PORCINE ANIMALS NOT INT ENDED FOR SLAUG HTER 
(MODEL ‘POR -INTRA- X’) 
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country 
codeI.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
CountryISO country 
codeCountry ISO country code
I.7 Country of originISO country 
codeI.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /55
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /56 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -INTRA -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The porcine animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 52 or 54(2) of Commission Delegated 
Regulation (EU) 2019/2035.
II.1.2. They, for at least the 30 day perio d prior to the departure of the consignment, or since birth, if 
they are younger than 30 days of age,
II.1.2.1. have been continuously resident in the establishment of origin;
II.1.2.2. have not been in contact with kept porcine animals of a lower health status or 
subject to movement restrictions for animal health reasons;
II.1.2.3. have not been in direct or indirect contact with kept animals that have entered the 
Union from a third country or territory during the 30 day period prior to the 
departure of t he animals.
II.1.3. They have not shown clinical signs or symptoms of diseases listed for porcine animals during the clinical examination which was carried out, within the 24 hour period prior to departure of 
consignment, on ………………. ( insert date dd/mm/yyyy ).
(2)[II.1.4. They come from one or more holdings officially recognised as applying controlled housing conditions in accordance with Article 8 of Commission Implementing Regulation (EU) 
2015/1375 and have not passed through an establishment approved for a ssembly operations in 
accordance with Article 99(3) of Regulation (EU) 2016/429 that does not meet the 
requirements set out in Chapter I(A)(j) of Annex IV of Implementing Regulation (EU) 
2015/1375.]
II.2. According to official information, the animals described in Part I meet the following health requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the species 
or situated in a restricted zone established for reasons of diseases listed for porcine animals.
II.2.2. They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the 30 day period prior to departure.
II.2.3. They come from establishments in which anthrax in ungulates has not been repo rted during 
the 15 day period prior to departure.
II.2.4. They come from establishments in which infection with Brucella abortus, B. melitensis and 
B. suis in porcine animals has not been reported during the last 42 days prior to departure, and 
in which during at least the 12 month period prior to departure 
(2)either [II.2.4.1. biosecurity and risk mitigating measures set out in Article 19(1)(f)(i) of 
Commission Delegated Regulation (EU) 2020/688 have been introduced;]
(2)and/or [II.2.4.2. surveillance for infection with Brucella abortus, B. melitensis and B. suis has 
been carried out on the porcine animals kept on the establishments in accordance 
with Article 19(1)(f)(ii) of Delegated Regulation (EU) 2020/688.] 
II.2.5. They come from establishments in whi ch infection with Aujeszky’s disease virus has not been 
reported during the 30 day period prior to departure of the consignment.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /57
EUROPEAN UNION Certificate model POR -INTRA -X
(2)[II.2.6. They are moved to a Member State or zone thereof with the status free from infection with 
Aujeszky’s disease virus and have not been vaccinated against infection with Aujeszky’s 
disease virus, and
(2)either [II.2.6.1. come from establishments free from infection with Aujeszky’s disease virus, and
(2)either [II.2.6.1.1. the establishments of origin are situated i n a Member State or zone 
with the status free from infection with Aujeszky’s disease virus;]]
(2)and/or [II.2.6.1.2. the animals in the consignment have been subjected to a serological 
test for the detection of antibodies against whole Aujeszky’s disease 
virus with one of the diagnostic methods provided for in Part 7 of 
Annex I to Delegated Regulation (EU) 2020/688(3)(4), with a negative 
result, on a sample taken during the 15 day period prior to 
departure;]]]
(2)and/or [II.2.6.2. come from establishments not free from infection with Aujeszky’s disease virus, 
and
– have been kept in an approved quarantine establishment for a period of at 
least 30 days; and
– have been subjected to a serological test for the detection of antibodies 
against whole Aujeszky’s disea se virus with the diagnostic method 
provided for in Part 7 of Annex I to Delegated Regulation (EU) 2020/688, 
with a negative result, carried out on samples taken on two occasions at an 
interval of not less than 30 days, the last sample taken during the 15 day 
period prior to departure.]]
(2)[II.2.6. They are moved to a Member State or zone thereof with an approved eradication programme 
for infection with Aujeszky’s disease virus, and
(2)either [II.2.6.1. come from establishments free from infection with Au jeszky’s disease virus, and 
(2)either [II.2.6.1.1. the establishments of origin are situated in a Member State or zone 
thereof with the status free from infection with Aujeszky’s disease virus;]]
(2)and/or [II.2.6.1.2. the establishments of origin are sit uated in a Member State or zone 
thereof with an approved eradication programme for infection with Aujeszky’s disease virus;]]
(2)and/or [II.2.6.1.3. the animals in the consignment have been subjected to a serological 
test for the detection of antibodies ag ainst whole Aujeszky’s disease 
virus or antibodies against Aujeszky’s disease virus -gE protein, 
where applicable, with one of the diagnostic methods provided for in Part 7 of Annex I to Delegated Regulation (EU) 2020/688
(4), with a 
negative result, on a sa mple taken during the 15 day period prior to 
departure;]]]
L 113 /58 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -INTRA -X
(2)and/or [II.2.6.2. come from an establishment not free from infection with Aujeszky’s disease 
virus, and 
– have been kept in an approved quarantine establishment for a period of at 
least 30 days; and
– have been subjected to a serological test for the detection of antibodies 
against whole Aujeszky’s disease virus with the diagnostic method 
provided for in Part 7 of Annex I to Delegated Regulation (EU) 2020/688, 
with a negative result, carried o ut on samples taken on two occasions at an 
interval of not less than 30 days, the last sample taken during the last 15 
days prior to departure.]]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
(2)[II.4. According to official information and as declared by the operator, they are semen donor animals, and 
II.4.1. they come from a semen collection centre and will be transported direct ly to another semen 
collection centre in accordance with Article 19 of Commission Delegated Regulation (EU) 
2020/686; and
(2)either [II.4.2. they were continuously resident since the date of their admission at the semen collection 
centre and were subjected , with negative results, to all compulsory routine tests referred to in 
point 2 of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020/686 in the 
period of the preceding 12 months prior to date of that movement; and]
(2)or [II.4.2. they were subjected, with negative results, to all tests referred to in point 1(b) and (c) of 
Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020/686, required before 
admission to a semen collection centre carried out during the period immediately prec eding 
quarantine and during the quarantine period; and]
II.4.3. the prior consent of the centre veterinarian of the semen collection centre of destination has 
been obtained by the operator; and
II.4.4. the means of transport used have been cleansed and dis infected before use.]
II.5. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.6. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(5)[II.7. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on approved establishments.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /59
EUROPEAN UNION Certificate model POR -INTRA -X
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date)(6)(7).
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in thi
s establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which t he animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified i n accordance with Article 52 or 54(2) of Delegated Regulation 
(EU) 2019/2035.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)For porcine animals less than four months old born to dams vaccinated with a gE- deleted vaccine, the 
diagnostic method for the detection of antibodies against Aujeszky’s disease virus gE protein provided for in Part 7 of Annex I to Delegated Regulation (EU) 2020/688 may be used. 
(4)The number of porcine animals tested must allow at least for the detection of 10% seroprevalence of the 
consignment with 95% confidence.
L 113 /60 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -INTRA -X
(5)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
(6)In the case where a consignment is grouped in an establishment approved for assembly operations and 
comprises animals that were loaded on different dates, the date which the journey commenced for the 
whole consignment is considered to be the earliest date when any part of the consignment left the 
establishment of origin.
(7)This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /61
CHAPTER 4
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF PORCINE ANIMALS INTENDED FOR SLAUGHTER 
(MODEL ‘POR -INTRA- Y’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /62 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of 
originCold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing plant Approval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /63
EUROPEAN UNION Certificate model POR -INTRA -YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The porcine animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 52 or 54(2) of Commission Delegated 
Regulation (EU) 2019/2035.
II.1.2. They have not shown clinical signs or symptoms of disease s listed for porcine animals during 
the clinical examination which was carried out, within the 24 hour period prior to departure of 
consignment, on ………………. ( insert date dd/mm/yyyy ).
(2)[II.1.3. They are intended to be slaughtered for disease eradication pu rposes as part of an eradication 
programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, and the 
Member State of destination and, where applicable, the Member State of passage authorised 
the movement in advance.]
(2)[II.1.4. They ar e
(2)either [II.1.4.1. not weaned and less than 5 weeks of age.]] 
(2)or [II.1.4.1. coming from one or more holdings officially recognised as applying controlled 
housing conditions in accordance with Article 8(1) of Commission Implementing 
Regulation (EU) 2015/1375 
(2)either [II.1.4.1.1 of which the carcases of all sows and boars are examined for 
Trichinella ]]
(2)and/or [II.1.4.1 .1.of which 10% of the carcases of the animals sent for slaughter are 
examined for Trichinella .]]]
(2)or [II.1.4.1.1. situated in a Member State in which no autochthonous Trichinella 
infestations in domestic swine kept on holdings officially recognised 
as applying controlled housing conditions have been detected during 
the past 3 years, during which time continuous testin g has been 
conducted in accordance with Article 2 of Implementing Regulation 
(EU) 2015/1375.]]]
(2)or [II.1.4.1.1. situated in a Member State for which historical data on continuous testing carried out on slaughtered swine population of those holdings or c
ompartment to which they belong provide at least 95% 
confidence that the prevalence of Trichinella does not exceed 1 per 
million in that population.]]]
(2)or [II.1.4.1. comingfrom one or more holdings officially recognised as applying controlled 
housing c onditions in accordance with Article 8(2) of Implementing Regulation 
(EU) 2015/1375 and situated in Belgium or Denmark.]]
II.2. According to official information, the animals described in Part I meet the following health requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the species 
or situated in a restricted zone established for reasons of diseases listed for porcine animals.
II.2.2. They come from establishments in which infection with rabies virus in k ept terrestrial animals 
has not been reported during the 30 day period prior to departure.
L 113 /64 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -INTRA -Y
II.2.3. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
(2)[II.2.4. They are moved to a Member State or zone thereof with the status free from infection with 
Aujeszky’s disease virus or with an approved eradication programme for infection with 
Aujeszky’s disease virus, and
− come from establishments in which infection with Aujeszky’s disea se virus has 
not been reported during the 30 day period prior to departure;
− are transported directly to the slaughterhouse in the Member State of destination 
without undergoing any assembly operations in that Member State or zone 
thereof, or any Member Sta te or zone thereof of passage, which is free from 
infection with Aujeszky’s disease virus.]
II.3. To the best of my knowledge, and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Commission 
Delegated Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly op erations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date)(4)(5).
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Br itain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this cer tificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /65
EUROPEAN UNION Certificate model POR -INTRA -Y
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for 
this con signment is issued in this establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certifi cate(s), based on which the animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the
consignment identified in accordance with Article 52 or 54(2) of Delegated Regulation 
(EU) 2019/2035.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched fr om the establishment approved for assembly 
operations.
(4)This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.
(5)To be completed in case of consignment grouped in an establishment approved for assembly operations 
located in the Member State of transit.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /66 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 5
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF OVI NE AND CAPRINE ANIMALS NOT INTENDED FOR 
SLAUGHTER (MODEL ‘OV/CAP -INTRA- X’) 
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /67
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying 
area/purification centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar establishment
□Products for human consumption □Pollination □Live aquatic animals 
for human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23 □For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of 
originCold store Identification 
markType of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /68 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -INTRA -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The ovine/caprine animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 45(2) or (4) or Article 46(1) of Commission 
Delegated Regulation (EU) 2019/2035.
II.1.2. They, for at least the 30 day period pr ior to the departure of the consignment, or since birth, if 
they are younger than 30 days of age,
II.1.2.1. have been continuously resident in the establishment of origin;
II.1.2.2. have not been in contact with kept ovine or caprine animals of a lower hea lth 
status or subject to movement restrictions for animal health reasons;
II.1.2.3. have not been in direct or indirect contact with kept animals that have entered the 
Union from a third country or territory during the 30 day period prior to the 
departure of the animals.
II.1.3. They have not shown clinical signs or symptoms of diseases listed for ovine/caprine animals 
during the clinical examination which was carried out, within the 24 hour period prior to 
departure of the consignment, on ………………. (insert d atedd/mm/yyyy ).
II.2. According to official information, the animals described in Part I meet the following health requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the species 
or situated in a restricted zone established for reasons of diseases listed for ovine/caprine 
animals.
(2)either [II.2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and 
B. suis without vaccination regarding ovine and caprine animals, and 
(2)either [the establishments of origin are situated in a Member State or zone thereof with the status 
free from infection with Brucella abortus, B. melitensis and B. suis regarding the ovine a nd
caprine population;]
(2)and/or [they have been subjected to a test for infection with Brucella abortus, B. melitensis and B. 
suis with one of the diagnostic methods provided for in Part 1 of Annex I toCommission 
Delegated Regulation (EU) 2020/688, carr ied out, with negative results, on a sample taken 
during the 30 day period prior to departure, and in the case of post -parturient females taken at 
least 30 days after parturition;]
(2)and/or [they are less than 6 months old;]
(2)and/or [they are castrated. ]
(2)or[II.2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and 
B. suis with vaccination regarding ovine and caprine animals and they are moved to a 
Member State or zone thereof without the status free from infect ion with Brucella abortus, B. 
melitensis and B. suis regarding ovine and caprine animals.]
(2)either [II.2.3. They are kept ovine animals and come from establishments in which infection with 
Mycobacterium tuberculosis complex ( M. bovis, M. caprae and M. tub erculosis ) has not been 
reported during the last 42 days prior to departure.]
(2)and/or [II.2.3. They are kept caprine animals and come from establishments in which surveillance for 
infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis) has been carried out on the caprine animals kept on the establishments during at 
least the 12 month period prior to departure, as referred to in Article 15(3) of Delegated 
Regulation (EU) 2020/688.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /69
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
II.2.4. They come from establishments in which infection with rabies virus in kept terrestrial animals 
has not been reported during the 30 day period prior to departure.
II.2.5. They come from establishments situated in an area of at least 150 km radius around those 
establishments in which in fection with epizootic haemorrhagic disease virus has not been 
reported in kept animals of listed species for that disease during the last 2 years prior to 
departure.
II.2.6. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
II.2.7. They come from establishments in which surra ( Trypanosoma evansi ) has not been reported 
during the 30 day period prior to departure, and 
(2)either [surra has not been reported in the establishments during the last 2 years prior to their 
departure.]
(2)or [surra has been reported during the last 2 years prior to departure, following the last outbreak 
the affected establishments have remained under movement restrictions until:
– the infected animals have been removed from the establishments, and
– the remaining animals on the establishments have been subjected to a test for surra 
(Trypanosoma evansi) with one of the diagnostic methods provided for in part 3 of 
Annex I to Delegated Regulation (EU) 2020/688, c arried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the 
establishments.]
(2)[II.2.8. They are kept uncastrated male ovine animals, and 
– come from establishments in which ovine epididymiti s (Brucella ovis ) has not been 
reported during the 12 month period prior to departure, and
– have been subjected to a serological test for ovine epididymitis ( Brucella ovis ), carried 
out, with negative results, on a sample taken during the 30 day period prior to 
departure.]
(2)either [II.2.9. They originate from a Member State or a zone free from infection with bluetongue virus 
(serotypes 1 -24), where no case of infection with bluetongue virus (serotypes 1 -24) has been 
confirmed during the last 24 months in the targeted animal population and have not been 
vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1 -24) in the 
60 day period before the date of movement and the requirements laid down in Article 
32(1)(a), (b) or (c) or A rticle 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]
(2)and/or [II.2.9. They originate from a Member State or a zone covered by the eradication programme for infection with bluetongue virus (serotypes 1- 24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they
(2)either [II.2.9.1. have been kept in a Member State or zone seasonally free from infection with 
bluetongue virus (serotypes 1 -24) in accordance with Article 40(3) of 
Commission Delegated Regulation (EU) 2020/689
(2)either [II.2.9.1.1. for at least 60 days prior to the date of movement]]
L 113 /70 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
(2)and/or [II.2.9.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free from infection 
with bluetongue virus (serotypes 1- 24)]]
(2)and/or [II.2.9.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the entry date of the animal into 
the Member State or zone seasonally free from infe ction with 
bluetongue virus (serotypes 1 -24);]]]
(2)and/or [II.2.9.2. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establi shment
(2)either [II.2.9.2.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.9.2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.9.2.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative result s, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors;]]]
(2)and/or [II.2.9.3. have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and 
(2)either [II.2.9.3.1. have been vaccinated more than 60 days before the date of 
movement]]
(2)and/or [II.2.9.3.2. have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity set in the specifications of the 
vaccine;]]]
(2)and/or [II.2.9.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and
(2)either [II.2.9.4.1. the serological test has been carried out on samples collected at least 
60 days before the date of movement]]
(2)and/or [II.2.9.4.2. the serological test has been carried out on samples collected at least 
30 days before the date of the movement and the animal has been 
subjected to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of movement;]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /71
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
(2)and/or [II.2.9. They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotypes 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotypes 1- 24) and the requirements laid down in Article 32(1)(a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they
(2)either [II.2.9.1. have been protected against attacks by the vectors during transportation to the place of destination and have been kept protected agai nst attacks by vectors in a 
vector protected establishment
(2)either [II.2.9.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.9.1.2. for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.9.1.3. for at least 14 days prior to the date of movement and have been
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors;]]]
(2)and/or [II.2.9.2. have been kept for the 60 day period p rior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out in 
Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated Regulation 
(EU) 2020/689 has been carried out during that period, and
(2)either [II.2.9.2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept and are within the immunity period 
guaranteed in the specifications of the vaccine and 
(2)either [II.2.9.2.1.1. have been vaccinated more than 60 days before the 
date of movement]]]
(2)and/or [II.2.9.2.1.2. have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the 
immunity set in the specifications of the vaccine;]]]]
(2)and/or [II.2.9.2.2. the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept, and
(2)either [II.2.9.2.2.1. the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 60 days before the date of movement]]]
(2)and/or [II.2.9.2.2.2. the animals have been subjected with positive results 
to a serological test carried out on samples collected at least 30 days before the date of the movement and to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of 
movement;]]]]
L 113 /72 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
(2)and/or [II.2.9. They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Member State 
or zone thereof
(2)either [II.2.9.1. with the status free from infection with bluetongue virus (serotypes 1 -24) and the 
Member State of destination has informed the Commission and the other 
Member States that such movement is aut horised subject to the conditions 
referred to in Article 43(2)(a), (b) and (c) of Delegated Regulation (EU) 
2020/689, and
(2)either [II.2.9.1.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regula tion are fulfilled.]]]
(2)and/or [II.2.9.2. with an approved eradication program for infection with bluetongue virus 
(serotypes 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authori sed 
under the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated 
Regulation (EU) 2020/689, and
(2)either [II.2.9.2.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled.] ]]
(2)and/or [II.2.9.3. neither free from infection with bluetongue virus (serotypes 1- 24) nor covered by 
the eradication programme for infection with bluetongue virus (serotypes 1 -24) 
and the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised
(2)either [II.2.9.3.1. without any conditions, and
(2)and/or [II.2.9.3.2. subject to the conditions referred to in point 5 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /73
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
(2)and/or [II.2.9.3.3. under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated Regulation (EU) 2020/689, and
(2)and/or [II.2.9.3.4. under the conditions referred to in point 7 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated Regulation (EU) 2020/689, and
(2)and/or [II.2.9.3.5. under the conditions referred to in point 8 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled.]]] 
(2)either [II.2.10. The animals are intended for a Member State or zone of a Member State listed in point 
2.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001 of the 
European Parliament and of the Council as having a negligible risk status for classical 
scrapie or for a Member Stat e listed in point 3.2. of that Section as having an approved 
national scrapie control programme, and 
(2)either [come from a holding situated in a Member State or zone of a Member State listed in 
point 2.3. of Section A of Chapter A of Annex VIII to Regula tion (EC) No 999/2001 
as having a negligible risk status for classical scrapie.]
(2)and/or [come from a holding recognised as having a negligible risk of classical scrapie in 
accordance with point 1.2. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001 and listed as such by the competent authority of the Member State 
in accordance with point 1.1. of that Section.]
(2)and/or [come from a holding not subject to the measures laid down in points 3 and 4 of 
Chapter B of Annex VII to Regulatio n (EC) No 999/2001 and the animals are of the 
ovine species and are of the ARR/ARR prion protein genotype, or the animals are of 
the caprine species and carry at least one of the K222, D146 or S146 alleles.]
(2)and/or [come from and are destined for an app roved body, institute or centre as defined in 
Article 2(1)(c) of Council Directive 92/65/EEC.]
(2)or [comply with the conditions set out in point 4.1.(d) of Section A of Chapter A of 
Annex VIII to Regulation (EC) No 999/2001.]]
(2)or [II.2.10. The animals are for breeding and are intended for a Member State or zone of a Member State 
other than those listed in point 2.3. of Section A of Chapter A of Annex VIII to Regulation 
(EC) No 999/2001 as having a negligible risk status for classical scrapie or other than those 
listed in point 3.2. of that Section as having an approved national scrapie control programme, 
and 
(2)either [come from a holding situated in a Member State or zone of a Member State listed in 
point 2.3. of Section A of Chapter A of A nnex VIII to Regulation (EC) No 999/2001 
as having a negligible risk status for classical scrapie.]
L 113 /74 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
(2)and/or [come from a holding recognised as having a negligible risk of classical scrapie in 
accordance with point 1.2. of Section A of Chapter A of Annex VIII to Regulation 
(EC) No 999/2001 and listed as such by the competent authority of the Member State 
in accordance with point 1.1. of that Section.]
(2)and/or [come from a holding recognised as having a controlled risk of classical scrapie in 
accord ance with point 1.3. of Section A of Chapter A of Annex VIII to Regulation 
(EC) No 999/2001 and listed as such by the competent authority of the Member State 
in accordance with point 1.1. of that Section.]
(2)and/or [come from a holding not subject to the measures laid down in points 3 and 4 of 
Chapter B of Annex VII to Regulation (EC) No 999/2001 and the animals are of the 
ovine species and are of the ARR/ARR prion protein genotype, or the animals are of 
the caprine species and carry at least one of the K2 22, D146 or S146 alleles.]
(2)and/or [come from and are destined for an approved body, institute or centre as defined in Article 2(1)(c) of Directive 92/65/EEC.]
(2)or [comply with the conditions set out in point 4.1.(d) of Section A of Chapter A of 
Annex VIII to Regulation (EC) No 999/2001.]]
(2)or [II.2.10. The animals are not for breeding and are intended for a Member State or zone of a Member 
State other than those listed in point 2.3. of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/20 01 as having a negligible risk status for classical scrapie or other 
than those listed in point 3.2. of that Section as having an approved national scrapie control 
programme.]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
(2)[II.4. According to official information and as declared by the operator, they are semen donor animals, and 
II.4.1. they come from a semen collection centre and will be transported directly to another semen 
collection centre in accordance with Article 19 of Commission Delegated Regulation (EU) 
2020/686; and
(2)either [II.4.2. they were continuously present since the date of their admission at the semen collecti on 
centre and were subjected, with negative results, to all compulsory routine tests referred to in 
point 2 of Chapter I of Part 3 of Annex II to Delegated Regulation (EU) 2020/686 in the 
period of the preceding 12 months prior to date of that movement; and]
(2)or [II.4.2. they were subjected, with negative results, to all tests referred to in point 1(c) and (d) of 
Chapter I of Part 3 of Annex II to Delegated Regulation (EU) 2020/686, required before admission to a semen collection centre carried out during the period immediately preceding 
quarantine and during the quarantine period; and]
II.4.3. the prior consent of the centre veterinarian of the semen collection centre of destination has 
been obtained by the operator; and
II.4.4. the means of transport use d have been cleansed and disinfected before use.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /75
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
II.5. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.6. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3 )[II.7. Since leaving their establishments of origin and before arriving to this establishment appr oved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date )(4)(5).
Notes:In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to Europea n Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”:
Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429 of the European Parliament and of the 
Council.
Box reference I .12: “Place of destination”: Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is i
ssued in this establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), base d on which the animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified in accordance with Article 45(2) or (4) or Article 46(1) of 
Delegated Regulation (EU) 2019/2035.
L 113 /76 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -INTRA -X
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
(4)This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.
(5)To be completed in case of consignment grouped in an establishment approved for assembly operations 
located in the Member State of transit.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /77
CHAPTER 6
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF OVI NE AND CAPRINE ANIMALS INTENDED FOR 
SLAUGHTER (MODEL ‘OV/CAP -INTRA- Y’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
CountryISO country 
codeCountry ISO country code
I.7 Country of originISO country 
codeI.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
L 113 /78 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /79
EUROPEAN UNION Certificate model OV/CAP -INTRA -YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The ovine/caprine animals(1)of the consignment described in Part I meet the following requirements:
(2)either [II.1.1. All of the animals are individually identified in accordance with Article 45(2) of 
Commission Delegated Regulation (EU) 2019/2035.]
(2)or [II.1.1. They are identified in accordance with Article 45 of Delegated Regulation (EU) 2019/2035 
and they have been continuously resident in the establishment for at least 21 days prior to 
departure, or since birth, if they are younger than 21 days of age.]
II.1.2. They ha ve not shown clinical signs or symptoms of diseases listed for ovine/caprine animals 
during the clinical examination which was carried out, within the 24 hour period prior to 
departure of the consignment, on ………………. (insert date dd/mm/yyyy ).
(2)[II.1.3. They are intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, 
and the Member State of destination and, where applicable, the Member State of pass age 
authorised the movement in advance.]
II.2. According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the 
species or situated in a restricted zone established for reasons of diseases listed for 
ovine/caprine animals.
(2)either [II.2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and 
B. suis with or without vaccination regarding ovine and caprine animals;]
(2)and/or [II.2.2. They are older than 6 months of age and have been subjected to a test for infection with 
Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods pr ovided for 
in Part 1 of Annex I toCommission Delegated Regulation (EU) 2020/688, carried out, with 
negative results, on a sample taken during the 30 day period prior to departure, and in the 
case of post -parturient females taken at least 30 days after par turition;]
(2)and/or [II.2.2. They are castrated.]
II.2.3. They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the 30 day period prior to departure.
II.2.4. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
II.2.5. They come from establishments in which infection with bluetongue virus (serotypes 1- 24) 
has not been reported during the 30 day period p rior to departure.
(2)[II.2.6. The requirements as regards infection with bluetongue virus (serotypes 1- 24) laid down in 
Article 33 of Delegated Regulation (EU) 2020/688 are fulfilled.]
L 113 /80 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -INTRA -Y
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of o rigin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on approved establishments.]]
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date)(4).
Notes:In accordance wi th the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction wit h Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
forin Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”:
Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an estab lishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched fr om an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified in accordance with Article 45 of Delegated Regulation (EU) 
2019/2035.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /81
EUROPEAN UNION Certificate model OV/CAP -INTRA -Y
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
(4)This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /82 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 7
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF AN INDIVIDUAL EQUINE AN IMAL NOT INTENDED FO R
SLAUGHTER (MODEL ‘EQ UI-INTRA- IND’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
CountryISO country 
codeCountry ISO country code
I.7 Country of originISO country 
codeI.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /83
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Desc ription of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /84 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI -INTRA- INDPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animal described in Part I meets the following requirements:
II.1.1. The animal is accompanied by its single lifetime identification document as provided 
for in Article 65, 67 or 68 of Commission Delegated Regulation (EU) 2019/2035, or 
by a temporary document issued in accordance with Article 61(2) the reof.
(1)[The single lifetime identification document was issued in accordance with Article 
65(2) or 67(1) of Delegated Regulation (EU) 2019/2035, or the temporary document was issued in accordance with Article 61(2) of that Regulation, for a registered 
equine animal as defined in Article 2(30) of that Delegated Regulation.]
(1)[The single lifetime identification document includes a valid validation mark in 
accordance with Article 65(1)(i)(i) of Delegated Regulation (EU) 2019/2035.]
(1)[The single lifetime identification document includes a valid license in accordance 
with Article 65(1)(i)(ii) of Delegated Regulation (EU) 2019/2035.]
II.1.2. The animal has not shown signs or symptoms of diseases listed for equine animals 
during the clinical examination, whic h was carried out within the 48 hour period 
prior to its departure, or on the last working day prior to its departure(2), from the 
registered establishment, on ………………. ( insert date dd/mm/yyyy).
II.2. According to official information, the animal described in Part I meets the following health 
requirements:
II.2.1. The animal does not come from an establishment subject to movement restrictions or 
situated in a restricted zone established for reasons of diseases listed for equine 
animals, including African hor se sickness and infection with Burkholderia mallei
(glanders).
II.2.2. The animal comes from an establishment in which surra ( Trypanosoma evansi) has 
not been reported during the 30 day period prior to its departure, and 
(1)either [surra has not been repo rted in the establishment during the 2 year period prior to 
departure.]
(1)or [surra has been reported in the establishment during the 2 year period prior to its 
departure and following the last outbreak the establishment has remained under 
movement restriction s
(1)either [until the remaining animals in the establishment have been subjected to a 
test for surra with one of the diagnostic methods provided for in Part 3 of 
Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, 
with negative results, on samples taken at least 6 months after the last 
infected animal has been removed from the establishment.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /85
EUROPEAN UNION Certificate model EQUI -INTRA- IND
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last animal of listed species on the establishment 
was either killed and destroyed or slaughtered.]]
II.2.3. The animal comes from an establishment in which dourine has not been reported 
during the last 6 months prior to its departure, and
(1)either [dourine has not been reported in t he establishment during the 2 year period prior to its 
departure.]
(1)or [dourine has been reported in the establishment during the 2 year period prior to its 
departure and following the last outbreak, the establishment has remained under 
movement restriction s
(1)either [until theremaining equine animals in the establishment, except castrated 
male equine animals, have been subjected to a test for dourine with the 
diagnostic method provided for in Part 8 of Annex I to Delegated 
Regulation (EU) 2020/688, carried out, with negative results, on samples 
taken at least 6 months after the infected animals have been killed and 
destroyed or slaughtered, or the infected entire male equine animals have 
been castrated.]]
(1)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was either killed and destroyed or 
slaughtered.]]
II.2.4. The animal comes from an establishment in which equine infectious anaemia has not 
been reported during the 90 day period prior to its departure, and
(1)either [equine infectious anaemia has not been reported on the establishment during the 12 
month period prior to its departure.]
(1)or [equine infectious anaemia has been reported on the establishment during the 12 
month peri od prior to its departure and following the last outbreak the establishment 
has remained under movement restriction s
(1)either [until the remaining equine animals in the establishment have been 
subjected to a test for equine infectious anaemia with the dia gnostic 
method provided for in Part 9 of Annex I to Delegated Regulation (EU) 
2020/688, carried out, with negative results, on samples taken on two 
occasions with a minimum interval of 90 days following cleaning and 
disinfection of the establishment after the infected animals have been 
killed and destroyed or slaughtered.]]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was either 
killed and destroyed or slaughte red.]]
II.2.5. The animal comes from an establishment in which Venezuelan equine 
encephalomyelitis has not been reported during the 6 month period prior to its 
departure, and
(1)either [during the 2 year period prior to its departure, Venezuelan equine enc ephalomyelitis 
has not been reported in the Member State or zone thereof in which the establishment is situated.]
L 113 /86 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI -INTRA- IND
(1)or [during the 2 year period prior to its departure, Venezuelan equine encephalomyelitis 
has been reported in the Member State or zone thereof in which the establishment is 
situated, and during the 21 day period prior to departure of the animal referred to in
point II.1 all equine animals in the establishment have remained clinically healthy, and 
(1)either [the animal referred to in point II.1 was kept protected from attacks by 
insect vectors in a quarantine station, in which any equine animal that showed a r ise in daily taken body temperature has been subjected with 
negative result to a diagnostic test for Venezuelan equine 
encephalomyelitis with the diagnostic method provided for in Part 
10(1)(a) of Annex I to Delegated Regulation (EU) 2020/688, and the 
anim al referred to in point II.1 has been 
(1)either [vaccinated against Venezuelan equine encephalomyelitis 
with a complete primary course and revaccinated according to 
manufacturer's recommendations not less than 60 days and 
not more than 12 months prior to the date of its departure.]]]
(1)or [subjected to a serological test for Venezuelan equine 
encephalomyelitis with the diagnostic method provided for in 
Part 10(1)(b) of Annex I to Delegated Regulation (EU) 
2020/688, carried out, with negative results, on a sample 
taken not less than 14 days after the date of its entry into the 
quarantine station.]]]
(1)or [the body temperature of the animal referred to in point II.1 has been taken daily, either without a rise or the animal has been subjected to a 
diagnostic
test for Venezuelan equine encephalomyelitis with the 
diagnostic method provided for in Part 10(1)(a) of Annex I to Delegated 
Regulation (EU) 2020/688, with negative results, and the animal referred 
to in point II.1 has been subjected to tests for Venezue lan equine 
encephalomyelitis with the diagnostic methods provided for in:
− Part 10(1)(b) of Annex I to Delegated Regulation (EU) 2020/688, 
without an increase in antibody titre, carried out on paired samples 
taken on two occasions with an interval of 21 day s, the second of 
which was taken during the 10 day period prior to the date of its 
departure, and
− Part 10(2) of Annex I to Delegated Regulation (EU) 2020/688, 
with negative result, carried out on a sample taken within the 48 
hour period prior to its depart ure, and the animal has been 
protected from attacks by insect vectors after sampling until its 
departure.]]
II.2.6. The animal comes from an establishment in which infection with rabies virus in kept 
terrestrial animals has not been reported during the 30 day period prior to its 
departure.
II.2.7. The animal comes from an establishment in which anthrax in ungulates has not been 
reported during the 15 day period prior to its departure.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /87
EUROPEAN UNION Certificate model EQUI -INTRA- IND
II.3. To the best of my knowledge, after due inquiry, and as declared by the operator, the animal comes 
from an establishment where there were no abnormal mortalities with an undetermined cause and 
the animal has not been in contact with kept animals of listed species which did not comply with 
the requirements referred to in points II.2.1. to II.2.6. during the 30 day period prior to its 
departure, and with the requirement referred to in point II.2.7. during the 15 day period prior to its 
departure.
(1)[II.4. According to official information and as declared by the operator, it is a semen donor animal 
subjected to the testing programme as referred to in point 1(b)(i) of Chapter I of Part 4 of Annex 
II to Commission Delegated Regulation (EU) 2020/686, and 
II.4.1. it comesfrom a semen collection centre and will be transported directly to another 
semen collection centre in accordance with Article 19 of Delegated Regulation (EU) 
2020/686; and
II.4.2. since the date of its admission, it was continuously resident at the seme ncollection
centre and was subjected, with negative results, to all compulsory routine tests 
referred to in point 1(a) of Chapter I of Part 4 of Annex II to Delegated Regulation 
(EU) 2020/686 during the 12 month period prior to the date of its departure; and
II.4.3. the prior consent of the centre veterinarian of the semen collection centre of 
destination has been obtained by the operator; and
II.4.4. the means of transport used have been cleansed and disinfected before use.]
II.5. Arrangements are made to
(1)either [transport the animal in accordance with Article 4 of Delegated Regulation (EU) 
2020/688.]
(1)or [move the animal on foot.]
II.6. This animal health certificate is valid for 
(1)either [10 days from the date of issuing, and]
(1)or [30 days from the date of issuing, and a valid validation mark or license is attested in 
point II.1.1, and]
in the case of transport by waterway/sea of the animal, the period of validity of the animal health 
certificate may be extended by the duration of the journey by waterway/sea.
Animal welfare attestation
At the time of inspection, the animal covered by this health certificate wasfit to be transported in accordance with 
the provisions of Council Regulation (EC) No 1/2005 on the intended journey due t o start on ……………(insert 
date) .
L 113 /88 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI -INTRA- IND
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”:
Indicate a registered establishment of dispatch of the equine 
animal or, provided the animal is transported, an establishment approved for assembly 
operations in accordance with Articles 97 and 99 of Regulation (EU) 201 6/429.
Box reference I.12: “Place of destination”: Indicate a registered establishment of destination or, provided 
the animal is transported, an establishment approved for assembly operations in 
accordance with Articles 97 and 99 of Regulation (EU) 201 6/429.
Box reference I.30: “Identificati on number” : Indicate the unique code of the equine animal referred to in 
Article 65(1)(b) of Delegated Regulation (EU) 2019/2035, or the code displayed by the 
means of identification defined in point (a), (c) or (e) of Annex III to Delegated 
Regulation (EU ) 2019/2035, if the animal is unweaned and accompanies its dam or 
foster mare.
Part II:
(1)Delete if not applicable.
(2)Option only available in case of equine animals moved in accordance with Article 92(2) of Delegated 
Regulation (EU) 2020/688.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /89
CHAPTER 8
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF A CONSIGNMENT OF EQUINE ANIMALS (MODEL 
‘EQUI -INTRA- CON’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /90 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description o f consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /91
EUROPEAN UNION Certificate model EQUI- INTRA- CONPart II: CertificationII. Hea lth informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are accompanied by their single lifetime identification documents as provided for in
(2)either [Article 65, 67 or 68 of Commission Delegated Regulation (EU) 2019/2035, and are not 
intended for slaughter for human consumption.]
(2)or [Article 65 or 67(1) of Delegated Regulation (EU) 2019/2035, and are intended for 
slaughter for human consumption.] 
(2)[Their single lifetime identification documents were issued in accordance with Article 65(2) 
or 67(1) of Delegated Regulation (EU) 2019/2035 for registered e quine animals as defined 
in Article 2(30) of that Delegated Regulation.]
(2)[Their single lifetime identification documents include a valid validation mark in 
accordance with Article 65(1)(i)(i) of Delegated Regulation (EU) 2019/2035.]
II.1.2. They have no t shown signs or symptoms of diseases listed for equine animals during the 
clinical examination, which was carried out within the 48 hour period prior to departure of 
the consignment, or on the last working day prior to departure(3)of the consignment, from 
the registered establishment, on ………………. ( insert date dd/mm/yyyy ).
(2)[II.1.3. They are intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, 
and the Member State of destination and, where applicable, the Member State of passage 
authorised the movement in advance.]
II.2. According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the 
species or situated in a restricted zone established for reasons of diseases listed for equine 
animals, including African horse sickness and infection with Burkholderia mallei (glande rs).
II.2.2. They come from establishments in which surra ( Trypanosoma evansi) has not been reported 
during the 30 day period prior to their departure, and 
(2)either [surra has not been reported in the establishments during the 2 year period prior to their departure.]
(2)or [surra has been reported in the establishments during the 2 year period prior to their 
departure and following the last outbreak the establishments have remained under 
movement restriction s
(2)either [until the remaining animals in the establishment have been subjected to a test for 
surra with one of the diagnostic methods provided for in Part 3 of Annex I to 
Commission Delegated Regulation (EU) 2020/688, carried out, with negative 
results, on samples taken at least 6 months after th e last infected animal has been 
removed from the establishment.]]
L 113 /92 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- INTRA- CON
(2)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the establishment was 
either killed and destroyed, or slaughtered.]]
II.2.3. They come from establishments in which dourine has not been reported during the 6 month 
period prior to their departure, and
(2)either [dourine has not been reported in the establishments during the 2 year period prior to their 
departure.]
(2)or [dourine has been reported in the establishments during the 2 year period prior to their 
departure and following the last outbreak, the establishments have remained under movement restriction s
(2)either [until the remaining equine animals in the establishment, except castrated male 
equine animals, have been subjected to a test for dourine with the diagnostic 
method provided for in Part 8 of Annex I to Delegated Regulation (EU) 
2020/688, carried out, with negative results, on samples taken a t least 6 months 
after the infected animals have been killed and destroyed or slaughtered, or the 
infected entire male equine animals have been castrated.]]
(2)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the establishment was 
either killed and destroyed, or slaughtered.]]
II.2.4. They come from establishments in which equine infectious anaemia has not been reported 
during the 90 day period prior to their departure, and
(2)either [equine infectious anaemia has not been reported on the establishments during the 12 month period prior to their departure.]
(2)or [equine infectious anaemia has been reported on the establishments during the 12 month 
period prior to their depart ure and following the last outbreak the establishments has 
remained under movement restrictions
(2)either [until the remaining equine animals in the establishment have been subjected to a 
test for equine infectious anaemia with the diagnostic method provi ded for in Part 
9 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days 
following cleaning and disinfection of the establishment after the infected 
animals have been killed and destroyed, or slaughtered.]]
(2)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the establishment was 
either killed and destroyed, or slaughtered.]]
II.2.5. They come from establishments in which Venezuelan equine encephalomyelitis has not been 
reported during the 6 month period prior to their departure, and
(2)either [during the 2 year period prior to their departure, Venezuelan equine encephalomyelitis has 
not been reported in the Member State or zone thereof in which the establishments are 
situated.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /93
EUROPEAN UNION Certificate model EQUI- INTRA- CON
(2)or [during the 2 year period prior to their departure, Venezuelan equine encephalomyelitis has 
been reported in the Member State or zone thereof in which the establishments are situated, 
and during the 21 day period prior to departure of the animals referred to in point II.1 all 
equine animals in the establishments have remained clinically healthy, and 
(2)either [the animals referred to in point II.1 were kept protected from attacks by insect 
vectors in a quarantine station , in which any equine animal that sh owed a rise in 
daily taken body temperature has been subjected with negative result to a 
diagnostic test for Venezuelan equine encephalomyelitis with the diagnostic 
method provided for in Part 10(1)(a) of Annex I to Delegated Regulation (EU) 
2020/688, and the animals referred to in point II.1 have been 
(2)either [vaccinated against Venezuelan equine encephalomyelitis with a 
complete primary course and revaccinated according to 
manufacturer's recommendations not less than 60 days and not more than 12 months prior to the date of their departure.]]]
(2)or [subjected to a serological test for Venezuelan equine 
encephalomyelitis with the diagnostic method provided for in Part 10(1)(b) of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken not less than 14 days 
after the date of their entry into quarantine.]]]
(2)or [the body temperature of the animals referred to in point II.1 has been taken 
daily, either without a rise or the animals have been subjected to a diagn ostic test 
for Venezuelan equine encephalomyelitis with the diagnostic method provided 
for in Part 10(1)(a) of Annex I to Delegated Regulation (EU) 2020/688, with negative results, and the animals referred to in point II.1 have been subjected to 
tests for 
Venezuelan equine encephalomyelitis with the diagnostic methods 
provided for in:
− Part 10(1)(b) of Annex I to Delegated Regulation (EU) 2020/688, without an increase in antibody titre, carried out on paired samples taken on two 
occasions with an interval of 21 days, the second of which was taken 
during the 10 day period prior to the date of their departure, and
−
Part 10(2) of Annex I to Delegated Regulation (EU) 2020/688, with 
negative result, carried out on a sample taken within the 48 hour period 
prior to t heir departure, and the animals have been protected from attacks 
by insect vectors after sampling until their departure.]]
II.2.6. They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during t he 30 day period prior to their departure.
II.2.7. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to their departure.
L 113 /94 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- INTRA- CON
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause and they have not been in contact 
with kept animals of listed species which did not comply with the requirements referred to in points 
II.2.1. to II.2.6. during the 30 day period prior to their departure, and with the requirement referred to in 
point II.2.7. during the 15 day period prior to their departure.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(4)[II.6. Since leaving their registered establishments of dispatch and before arriving to this establishment 
approved for assembly operations, none of the animals of the consignment has undergone more than 
two assembly operations, and 
(2)either [they come from registered establishments of dispatch.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate a registered establishment of dispatch of the equine 
animals or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.
Box reference I.12: “Place of destination”: Indicate a registered establishment of destination or an 
establishment approved for assembly operations in accordance with Articles 97 and 99 
of Regulation (EU) 201 6/429.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /95
EUROPEAN UNION Certificate model EQUI- INTRA- CON
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for 
this consignment is issued in thi s establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which t he animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate for each animal of the consignment the unique code 
referred to in A rticle 65(1)(b) of Delegated Regulation (EU) 2019/2035, or the code 
displayed by the means of identification defined in point (a), (c) or (e) of Annex III to 
Delegated Regulation (EU) 2019/2035, if the animal is unweaned and accompanies its 
dam or foster m are.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Option only available in case of equine animals moved in accordance with Article 92(2) of Delegated 
Regulation (EU) 2020/688.
(4)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /96 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 9
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CAM ELID ANIMALS NOT INTENDED FOR SLAUGHTER 
(MODEL ‘CAM -INTRA- X’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /97
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /98 EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CAM- INTRA -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The camelid animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 73 of Commission Delegated Regulation (EU) 
2019/2035.
II.1.2. They, for at least the 30 day period prior to the departure of the consignment, or since birth, 
if they are younger than 30 days of age,
II.1.2.1. have been continuously resident in the establishment of origin;
II.1.2.2. have not been in contact with kept camelid animals of a lower health status or 
subject to movement restrictions for animal health reasons;
II.1.2.3. have not been in direct or indirect contact with kept animals that have entered 
the Union from a third country or territory during the 30 day period prior to the 
departure of the animals.
II.1.3. They have not shown clinical signs or symptoms of diseases listed for camelid animals 
during the clinical examination which was carr ied out, within the 24 hour period prior to 
departure of the consignment, on ………………. ( insert date dd/mm/yyyy ).
II.2. According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from es tablishments subject to movement restrictions affecting the 
species or situated in a restricted zone established for reasons of diseases listed for camelid 
animals.
II.2.2. They come from establishments in which infection with Brucella abortus, B. melitens isand 
B. suis in camelid animals has not been reported during the last 42 days prior to departure, 
and the animals in the consignment have been subjected to a test for infection with Brucella 
abortus, B. melitensis and B. suis with one of the diagnostic m ethods provided for in Part 1 
of Annex I toCommission Delegated Regulation (EU) 2020/688, carried out, with negative 
results, on a sample taken during the 30 day period prior to departure, and in the case of 
post-parturient females taken at least 30 days after parturition.
II.2.3. They come from establishments in which surveillance for infection with Mycobacterium 
tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the 
camelid animals kept on the establishments during at least the 12 month period prior to 
departure, as referred to in Article 23(1)(e) of Delegated Regulation (EU) 2020/688.
II.2.4. They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the 30 day period prior to departure.
(2)[II.2.5. They are moved to a Member State or zone thereof with the status free from infectious 
bovine rhinotracheitis/infectious pustular vulvovaginitis or with an approved eradication 
programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine 
animals and they come from an establishment in which infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis in camelid animals has not been reported 
during the 30 day period prior to departure.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /99
EUROPEAN UNION Certificate model CAM- INTRA -X
II.2.6. They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in any establishment during the last 2 years prior to departure.
II.2.7. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
II.2.8. They come from establishments in which surra ( Trypanosoma evansi) has not been reported 
during the 30 day period prior to departure, and 
(2)either [surra has not been reported in the establishments during the last 2 years prior to their 
departure.]
(2)or [surra has been reported during the last 2 years prior to departure, following the last 
outbreak the affected establishments have remained under movement restrictions until:
– the infected animals have been removed from the establishments, and
– the remaining animals on the establishments have been subjected to a test for surra 
(Trypanosoma evansi) w ith one of the diagnostic methods provided for in part 3 of 
Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the 
establishments.]
(2)either [II.2.9. They originate from a Member State or a zone free from infection with bluetongue virus 
(serotype s1-24), where no case of infection with bluetongue virus (serotype s 1-24) has been 
confirmed during the last 24 months in the targeted animal population and have not been 
vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1- 24) in 
the 60 day period before the date of movement and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegat ed Regulation (EU) 2020/688 are fulfilled.]
(2)and/or [II.2.9. They originate from a Member State or a zone covered by the eradication programme for 
infection with bluetongue virus (serotypes 1- 24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they
(2)either [II.2.9.1. have been kept in a Member State or zone seasonally free from infection with 
bluetongue virus (serotypes 1- 24) in accordance with Article 40(3) of 
Commission Delegated Regulation (EU) 2020/689
(2)either [II.2.9.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.9.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative re sults, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free from 
infection with bluetongue virus (serotypes 1 -24)]]
L 113 /100  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CAM- INTRA -X
(2)and/or [II.2.9.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the entry date of the 
animal into the Member State or zone seasonally free from 
infection with bluetongue virus (ser otypes 1 -24);]]]
(2)and/or [II.2.9.2. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment
(2)either [II.2.9.2.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.9.2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.9.2.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors;]]]
(2)and/or [II.2.9.3. have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the 
specifications of the vaccine and 
(2)either [II.2.9.3.1. have been vaccinated more than 60 days before the date of 
movement]]
(2)and/or [II.2.9.3.2. have be en vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 
days after the onset of the immunity set in the specifications of the 
vaccine;]]]
(2)and/or [II.2.9.4. have been subjected with positive results to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and
(2)either [II.2.9.4.1. the serological test has been car ried out on samples collected at 
least 60 days before the date of movement]]
(2)and/or [II.2.9.4.2. the serological test has been carried out on samples collected at 
least 30 days before the date of the movement and the animal has 
been subjected to a PCR t est, with negative results, carried out on 
samples collected not earlier than 14 days before the date of 
movement;]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /101
EUROPEAN UNION Certificate model CAM- INTRA -X
(2)and/or [II.2.9. They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotypes 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotypes 1 -24) and the requirements laid down in Article 32(1)(a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they
(2)either [II.2.9.1. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment
(2)either [II.2.9.1.1. for at least 60 days prior to the date of m ovement]]
(2)and/or [II.2.9.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.9.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors;]]]
(2)and/or [II.2.9.2. have been kept for the 60 day period prior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the estab lishment, where surveillance in compliance with the requirements set out 
in Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and
(2)either [II.2.9.2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept and are within the immunity 
period guarante ed in the specifications of the vaccine and 
(2)either [II.2.9.2.1.1. have been vaccinated more than 60 days before the date of movement]]]
(2)and/or [II.2.9.2.1.2. have been vaccinated with an inactivated vaccine 
and subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of 
the immunity set in the specifications of the 
vaccine;]]]]
(2)and/or [II.2.9.2.2. the animals have been immunised against those serotypes from 1 to 24 of infection with bluetongue virus whic h were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept, and
(2)either [II.2.9.2.2.1. the animals have been subjected with positive results 
to a serological test carried out on samples collected 
at least 60 days before the date of movement]]]
L 113 /102  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CAM- INTRA -X
(2)and/or [II.2.9.2.2.2. the animals have been subjected with positive results 
to a serological test carried out on samples collected 
at least 30 days before the date of the movement and 
to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the 
date of movement;]]]]
(2)and/or [II.2.9. They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Member State 
or zone thereof
(2)either [II.2.9.1. with the status free from infection with bluetongue virus (serotypes 1-24) and 
the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised subject the conditions 
referred to in Article 43(2)(a), (b) and (c) of Delegated Regulation (EU) 
2020/689, and
(2)either [II.2.9.1.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled]]]
(2)and/or [II.2.9.2. with an approved eradication program for infection with bluetongue virus 
(serotypes 1 -24) and the M ember State of destination has informed the 
Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated 
Regulation (EU) 2020/689 and
(2)either [II.2.9.2.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /103
EUROPEAN UNION Certificate model CAM- INTRA -X
(2)and/or [II.2.9.2.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled]]]
(2)and/or [II.2.9.2. neither free from infection with bluetongue virus (serotypes 1- 24) nor covered 
by the eradication programme for infection with bluetongue virus (serotypes 1-
24) and the Member State of destination has informed the Commission and the 
other Member States that such movement is authorised
(2)either [II.2.9.2.1. without any conditions, and
(2)and/or [II.2.9.2.2. subject to the conditions referred to in point 5 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.9.2.3. subject to under the conditions referred to in point 6 of Section 1 of Chapter 2 of Part II of An
nex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.9.2.4. subject to the conditions referred to in point 7 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.9.2.5. subject to the condit ions referred to in point 8 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are 
fulfilled.]]]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.
II.4.
Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
L 113 /104  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CAM- INTRA -X
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Cha pter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 9 7 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in thi
s establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which t he animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified i n accordance with Article 73 of Delegated Regulation (EU) 
2019/2035.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /105
CHAPTER 10
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CAM ELID ANIMALS INTENDED FOR SLAUGHTER 
(MODEL ‘CAM -INTRA- Y’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /106  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /107
EUROPEAN UNION Certificate model CAM- INTRA -YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The camelid animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 73 of Commission Delegated Regulation (EU) 
2019/2035.
II.1.2. They have not shown clinical signs or symptoms of diseases listed for camelid animals 
during the clinical examination which was carried out, within the 24 hour period prior to 
departure of the consignment, on …… …………. ( insert date dd/mm/yyyy ).
(2)[II.1.3. They are intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, and the Member State of destination and, where applicable, the Member State of passage 
authorised the movement in advance.]
II.2.
According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the 
species or situated in a restricted zone established for reasons of diseases listed for camelid 
animals.
II.2.2. They come from establishments in which infection with rabies virus in kept terrestrial animals has not bee n reported during the 30 day period prior to departure.
II.2.3. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
II.2.4. They come from establishments in which infection with bluetongue virus (serotypes 1- 24) 
has not been reported during the 30 day period prior to departure.
(2)[II.2.5. The requirements as regards infection with bluetongue virus (serotypes 1- 24) laid down in 
Article 33 of Commission Delegated Regulation (EU) 20 20/688 are fulfilled.]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the dur ation of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operatio ns, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
L 113 /108  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CAM- INTRA -Y
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicat e an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an establishment
of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an es tablishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operati ons, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the animal health certificate for this consign ment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified in accordance with Article 73 of Delegated Regulation (EU) 
2019/2035.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /109
CHAPTER 11
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CER VID ANIMALS NOT INTE NDED FOR SLAUGHTER 
(MODEL ‘CER- INTRA -X’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /110  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certi fied as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /111
EUROPEAN UNION Certificate model CER- INTRA -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The cervid animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 73 or Article 74 of Commission Delegated 
Regulation (EU) 2019/2035.
II.1.2. They, for at least the 30 day period prior to the departure of the consignment, or since birth, 
if they are younger than 30 days of age,
II.1.2.1. have been continuously resident in the establishment of origin;
II.1.2.2. have not been in contact with kept cervid animals of a lower health status or subject to movement restrictions for animal health reasons;
II.1.2.3. have not been in direct or indirect contact with kept animals that have entered 
the Uni on from a third country or territory during the 30 day period prior to the 
departure of the animals.
II.1.3. They have not shown clinical signs or symptoms of diseases listed for cervid animals during 
the clinical examination which was carried out, within the 24 hour period prior to departure 
of the consignment, on ………………. (insert date dd/mm/yyyy).
II.2.
According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from establishments sub ject to movement restrictions affecting the 
species or situated in a restricted zone established for reasons of diseases listed for cervid 
animals.
II.2.2. They come from establishments in which infection with Brucella abortus, B. melitensis and 
B. suis incervid animals has not been reported during the last 42 days prior to departure.
II.2.3. They come from establishments in which surveillance for infection with Mycobacterium 
tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried o ut on the 
cervid animals kept on the establishments during at least the 12 month period prior to 
departure, as referred to in Article 26(1)(e) of Commission Delegated Regulation (EU) 
2020/688.
II.2.4. They come from establishments in which infection with r abies virus in kept terrestrial 
animals has not been reported during the 30 day period prior to departure.
(2)[II.2.5. They are moved to a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis or with an approved eradication 
programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine 
animals and they come from an establishment in which infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis in cervid animals has not been reported 
during the 30 day period prior to departure.]
II.2.6. They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in any establishment during the last 2 years prior to departure.
L 113 /112  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CER- INTRA -X
II.2.7. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
II.2.8. They come from establis hments in which surra ( Trypanosoma evansi) has not been reported 
during the 30 day period prior to departure, and 
(2)either [surra has not been reported in the establishments during the last 2 years prior to their 
departure.]
(2)or [surra has been report ed during the last 2 years prior to departure, following the last 
outbreak the affected establishments have remained under movement restrictions until:
– the infected animals have been removed from the establishments, and
– the remaining animals on the establishments have been subjected to a test for surra 
(Trypanosoma evansi ) with one of the diagnostic methods provided for in part 3 of 
Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the 
establishments.]
(2)either [II.2.9. They originate from a Member State or a zone free from infection with bluetongue virus 
(serotypes 1 -24), where no case of infection with bluetongue virus (serotypes 1 -24) has been 
confirmed during the last 24 months in the targeted animal population and have not been 
vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1- 24) in 
the 60 day period before the date of movement and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]
(2)and/or [II.2.9. They originate from a Member State or a zone covered by the eradication programme for 
infection with bluetongue virus (s erotypes 1- 24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they 
(2)either [II.2.9.1. have been kept in a Member State or zone seasonally free from infection with 
bluetongue virus (serotypes 1- 24) in accordance with Article 40(3) of 
Commission Delegated Regulation (EU) 2020/689
(2)either [II.2.9.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.9.1.2. for at least 28 days prior to the date o f movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free from 
infection with bluetongue virus (se rotypes 1 -24)]]
(2)and/or [II.2.9.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the entry date of the 
animal into the Membe r State or zone seasonally free from 
infection with bluetongue virus (serotypes 1 -24);]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /113
EUROPEAN UNION Certificate model CER- INTRA -X
(2)and/or [II.2.9.2. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment
(2)either [II.2.9.2.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.9.2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.9.2.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors;]]]
(2)and/or [II.2.9.3. have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the 
specifications of the vaccine and 
(2)either [II.2.9.3.1. have been vaccinated more than 60 days before the date of 
movement]]
(2)and/or [II.2.9.3.2. have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 
days after the onset of the immunity set in the specifications of the 
vaccine;]]]
(2)and/or [II.2.9.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and
(2)either [II.2.9.4.1. the serological test has been carried out on samples collected at least 60 days before the date of movement]]
(2)and/or [II.2.9.4.2. the serological test has been carr ied out on samples collected at 
least 30 days before the date of the movement and the animal has 
been subjected to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the date of 
movement;]]]
(2)and/or [II.2.9. They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotypes 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotypes 1 -24) and the requirements laid down in Article 32(1) (a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they
(2)either [II.2.9.1. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against at tacks by vectors in a 
vector protected establishment
L 113 /114  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CER- INTRA -X
(2)either [II.2.9.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.9.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.9.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors;]]]
(2)and/or [II.2.9.2. have been kept for the 60 day period prior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out 
in Sections 1 and 2 of Chapter 1 of Part II of Annex V to Dele gated Regulation 
(EU) 2020/689 has been carried out during that period, and
(2)either [II.2.9.2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during 
the past 2 years in an ar ea of at least 150 km radius centred on the 
place where the animals were kept and are within the immunity 
period guaranteed in the specifications of the vaccine and 
(2)either [II.2.9.2.1.1. have been vaccinated more than 60 days before the 
date of movemen t]]]
(2)and/or [II.2.9.2.1.2. have been vaccinated with an inactivated vaccine 
and subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of 
the immunity set in the specifications of the 
vaccine;]]]]
(2)and/or [II.2.9.2.2. the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept, and
(2)either [II.2.9.2.2.1. the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days before the date of movement]]]
(2)and/or [II.2.9.2.2.2. the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days before the date of the movement and 
to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the date of movement.]]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /115
EUROPEAN UNION Certificate model CER- INTRA -X
(2)and/or [II.2.9. They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of 
the Member State of origin authorised movement of those anim als to another Member State 
or zone thereof
(2)either [II.2.9.1. with the status free from infection with bluetongue virus (serotypes 1- 24) and 
the Member State of destination has informed the Commission and the other 
Member States that such movement is au thorised subject to the conditions 
referred to in Article 43(2)(a), (b) and (c) of Delegated Regulation (EU) 
2020/689, and
(2)either [II.2.9.1.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.1.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are 
fulfilled;]]]
(2)and/or [II.2.9.2. with an approved eradication program for infection with bluetongue virus 
(serotypes 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authorised 
subject to the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated 
Regulation (EU) 2020/689 and
(2)either [II.2.9.2.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.9.2.4. point 8 of Section 1 of Chapter 2 of P art II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are 
fulfilled;]] ]
(2)and/or [II.2.9.3. neither free from infection with bluetongue virus (serotypes 1- 24) nor covered 
by the eradication programme for infection with bluetongue virus (serotypes 1-
24) and the Member State of destination has informed the Commission and the
other Member States that such movement is authorised
(2)either [II.2.9.3.1. without any conditions, and
L 113 /116  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CER- INTRA -X
(2)and/or [II.2.9.3.2. subject to the conditions referred to in point 5 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.9.3.3. subject to the conditions referred to in point 6 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.9.3.4. subject to the conditions referred to in point 7 of Sect ion 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.9.3.5. subject to the conditions referred to in point 8 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
the requi rements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are 
fulfilled.]]]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This cert ificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establish ments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
Animal welfare attes tation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in co njunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /117
EUROPEAN UNION Certificate model CER- INTRA -X
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an estab lishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched fr om an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for 
this consignment is issued in this establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified in accordance with Article 73 or Artic le 74 of Delegated 
Regulation (EU) 2019/2035.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /118  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 12
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CER VID ANIMALS INTENDED FOR SLAUGHTER 
(MODEL ‘CER- INTRA -Y’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /119
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /120  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CER- INTRA -YPart II: CertificationII. Health i nformationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The cervid animals(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified as provided for in Article 73 or Article 74 of Commission Delegated 
Regulation (EU) 2019/2035.
II.1.2. They have not shown clinical signs or symptoms of diseases listed for cervid animals during 
the clinical examination which was carried out, within the 24 hour period prior to departure 
of the consignm ent, on ………………. ( insert date dd/mm/yyyy).
(2)[II.1.3. They are intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, and the Member State of des tination and, where applicable, the Member State of passage 
authorised the movement in advance.]
II.2.
According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from establishments s ubject to movement restrictions affecting the 
species or situated in a restricted zone established for reasons of diseases listed for cervid 
animals.
II.2.2. They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the 30 day period prior to departure.
II.2.3. They come from establishments in which anthrax in ungulates has not been reported during 
the last 15 day period prior to departure.
II.2.4. They come from establishments in which infec tion with bluetongue virus (serotypes 1- 24) 
has not been reported during the 30 day period prior to departure.
(2)[II.2.5. The requirements as regards infection with bluetongue virus (serotypes 1- 24) laid down in 
Article 33 of Delegated Regulation (EU) 2020/688 are fulfilled.]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment i n accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the d uration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /121
EUROPEAN UNION Certificate model CER- INTRA -Y
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the A greement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chap ter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accor dance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in thi
s establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which t he animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment identified in accordance with Article 73 or Article 74 of Delegated 
Regulation (EU) 2019/2035.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishmen t approved for assembly 
operations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
CHAPTER 13
L 113 /122  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF KEP T UNGULATES OTHER TH AN BOVINE, OVINE, 
CAPRINE, PORCINE, EQ UINE, CAMELID AND CE RVID ANIMALS NOT 
INTENDED FOR SLAUGHTER (MODEL ‘OTHER- UNGULATES -INTRA- X’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /123
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated j ourney time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date o f
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /124  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The animals(1)of the consignment described in Part I are kept ungulates other than bovine, ovine, 
caprine, porcine, equine, camelid and cervid animals and meet the following requirements:
II.1.1. They are identified as provided for in Article 117 of Regulation (EU) 2016/429.
II.1.2. They, for at least the last 30 day period prior to the departure of the consignment, or since 
birth, if they are younger than 30 days of age,
II.1.2.1. have been continuously resident in the establishment of origin;
II.1.2.2. have not been in contact with other kept ungulates of a lower health status or 
subject to movement restrictions for animal health reasons;
II.1.2.3. have not been in direct or indirect contact with kept animals that have entered 
the Union from a third country or territory during the last 30 day period prior to the de parture of the animals.
II.1.3. They have not shown clinical signs or symptoms of diseases listed for ungulates of the species concerned during the clinical examination which was carried out, within the 24 hour 
period prior to departure of the consignment, on ………………. ( insert date dd/mm/yyyy ).
II.2.
According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from establishments subject to movement restrictions affecting the 
species or si tuated in a restricted zone established for reasons of diseases listed for ungulates 
of the species concerned.
(2)[II.2.2. They come from establishments in which infection with Brucella abortus, B. melitensis and 
B. suis in kept animals of listed species h as not been reported during the last 42 days prior to 
departure.]
(2)[II.2.3. They come from establishments in which infection with Mycobacterium tuberculosis 
complex (M. bovis, M. caprae and M. tuberculosis) in kept animals of listed species has not 
been reported during the last 42 days prior to departure.]
(2)[II.2.4. They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the 30 day period prior to departure.]
(2)[II.2.5. They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in any establishment during the last 2 years prior to departure.]
II.2.6. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period days prior to departure.
(2)[II.2.7. They come from establishments in which surra ( Trypanosoma evansi) has not been reported 
during the 30 day period prior to departure, and 
(2)either [surra has not been reported in the establishments during the last 2 years prior to their 
departure.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /125
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -X
(2or [surra has been reported during the last 2 years prior to depa rture, following the last 
outbreak the affected establishments have remained under movement restrictions until:
– the infected animals have been removed from the establishments, and
– the remaining animals on the establishments have been subjected to a test for surra 
(Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of 
Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed f rom the 
establishments.]]
(2)[(2)either [II.2.8. They originate from a Member State or a zone free from infection with bluetongue virus 
(serotypes 1 -24), where no case of infection with bluetongue virus (serotypes 1 -24) has been 
confirmed during the last 24 months in the targeted animal population and have not been 
vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1- 24) in 
the 60 day period before the date of movement and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]
(2)and/or [II.2.8. They originate from a Member State or a zone covered by the eradication programme for 
infection with bluetongue virus (serotypes 1- 24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they 
(2)either [II.2.8.1. have been kept in a Member State or zone seasonally free from infection with 
bluetongue virus (serotypes 1- 24) in accord ance with Article 40(3) of 
Commission Delegated Regulation (EU) 2020/689
(2)either [II.2.8.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.8.1.2. for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free from 
infection with bluetongue virus (serotypes 1 -24)]]
(2)and/or [II.2.8.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the entry date of the 
animal into the Member State or zone seasonally free from 
infection with bluetongue virus (serotypes 1 -24);]]]
(2)and/or [II.2.8.2. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a vector protected establi shment
L 113 /126  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -X
(2)either [II.2.8.2.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.8.2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on samples 
collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.8.2.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative result s, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors;]]]
(2)and/or [II.2.8.3. have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetong ue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the 
specifications of the vaccine and 
(2)either [II.2.8.3.1. have been vaccinated more than 60 days before the date of 
movement]]
(2)and/or [II.2.8.3.2. have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 
days after the onset of the immunity set in the specifications of the vaccine;]]]
(2)and/or[II.2.8.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and
(2)either [II.2.8.4.1. the serological test has been carried out on samples collected at least 60 days before the date of movement]]
(2)and/or [II.2.8.4.2. the serological test has been carried out on samples collected at 
least 30 days before the date of the movement and the animal has 
been subjected to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the date of 
movement;]]]
(2)and/or [II.2.8. They originate from a Member State or a zone neither free from infection w ith bluetongue 
virus (serotypes 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotypes 1 -24) and the requirements laid down in Article 32(1)(a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fu lfilled, and they
(2)either [II.2.8.1. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a vector protected establishment
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /127
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -X
(2)either [II.2.8.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.8.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on samples collected at least 28 days followin
g the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.8.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors;]]]
(2)and/or [II.2.8.2 have been kept for the 60 day period prior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out 
in Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated Regulation 
(EU) 2020/689 has been carried out during that period, and
(2)either [II.2.8.2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine and 
(2)either [II.2.8.2.1.1. have been vaccinated more than 60 days before the 
date of movement]]]
(2)and/or [II.2.8.2.1.2. have been vaccinated with an inactivated vaccine
and subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of 
the immunity set in the specifications of the 
vaccine;]]]]
(2)and/or [II.2.8.3.2. the animals have been immunised against those serotypes from 1 to
24 of infection with bluetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept, and
(2)either [II.2.8.3.2.1. the animals have been subjected with positive results toa serological test carried out on samples collected 
at least 60 days before the date of movement]]]
(2)and/or [II.2.8.3.2.2. the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days befo re the date of the movement and 
to a PCR test, with negative results, carried out on samples collected not earlier than 14 days before the 
date of movement;]]]]
L 113 /128  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -X
(2)and/or [II.2.8. They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Member State 
or zone thereof
(2)either [II.2.8.1. with the status free from infection with bluetongue virus (serotypes 1- 24) and 
the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised subject to the conditions 
referred to in Article 43(2)(a), (b) and (c) of Delegate d Regulation (EU) 
2020/689, and
(2)either [II.2.8.1.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.2.8.1.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.2.8.1.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.2.8.1.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are 
fulfilled;]]]
(2)and/or [II.2.8.2. with an approved eradication program for infection with bluetongue virus 
(serotypes 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authorised 
subject to the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated 
Regulation (EU) 2020/689, and
(2)either [II.2.8.2.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.2.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.2.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.8.2.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are 
fulfilled;]]]
(2)and/or [II.2.8.3. neither free from infection with bluetongue virus (serotypes 1- 24) nor covered 
by the eradication programme for infection with bluetongue virus (serotypes 1-
24) and the Member State of destination has informed the Commission and the 
other Member States that such movement is authorised
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /129
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -X
(2)either [II.2.8.3.1. without any conditions, and
(2)and/or [II.2.8.3.2. subject to the conditions referred to in point 5 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.8.3.3. subject to the conditions referred to in point 6 of Section 1 of 
Chapter 2 of Pa rt II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.8.3.4. subject to the conditions referred to in point 7 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.8.3.5. subject to the conditions referred to in point 8 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the 
requirements laid down in Article 33 of that Delegated Regulation 
are fulfilled.]]]]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the peri od of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of t he consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on approved establishments.]]
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
NotesThis animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /130  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -X
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an estab lishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched fr om an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for 
this consignment is issued in this establishment approved for assembly operations, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the animal health certificate for this consignment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification number of each animal.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /131
CHAPTER 14
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF KEP T UNGULATES OTHER TH AN BOVINE, OVINE, 
CAPRINE, PORCINE, EQ UINE, CAMELID AND CE RVID ANIMALS INTENDE D
FOR SLAUGHTER (MODEL ‘OTHER -UNGULATES -INTRA- Y’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /132  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of cons ignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /133
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -YPart II: CertificationII. H ealth informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The animals(1)of the consignment described in Part I are kept ungulates other than bovine, ovine, 
caprine, porcine, equine, camelid and cervid animals and meet the following requirements:
II.1.1. They are identified as provided for in Article 117 of Regulation (EU) 201 6/429.
II.1.2. They have not shown clinical signs or symptoms of diseases listed for ungulates of the 
species concerned during the clinical examination which was carried out, within the 24 hour 
period prior to departure of the consignment, on ………………. ( insert date dd/mm/yyyy ).
(2)[II.1.3. They are intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, 
and the Member State of destination and, whe re applicable, the Member State of passage 
authorised the movement in advance.]
II.2. According to official information, the animals described in Part I meet the following health 
requirements:
II.2.1. They do not come from establishments subject to movemen t restrictions affecting the 
species or situated in a restricted zone established for reasons of diseases listed for ungulates 
of the species concerned.
II.2.2. They come from establishments in which anthrax in ungulates has not been reported during 
the 15 day period prior to departure.
(2)[II.2.3. They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the 30 day period prior to departure.]
(2)[II.2.4. They come from establishments in whi ch infection with bluetongue virus (serotypes 1- 24) 
has not been reported during the 30 day period prior to departure.]
(2)[II.2.5. The requirements as regards infection with bluetongue virus (serotypes 1- 24) laid down in 
Article 33 of Commission Delegated Regulation (EU) 2020/688 are fulfilled.]
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.5. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(2)(3)[II.6. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two assembly 
operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
L 113 /134  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OTHER -UNGULATES- INTRA -Y
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicat e an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.12: “Place of destination”: Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.
Box reference I.17: “Accompanying documents” :In case the animals are dispatched from an es tablishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operati ons, 
may be indicated. 
In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the animal health certificate for this consign ment is 
issued in this establishment approved for assembly operations, must be indicated.
Box reference I.30: “Identification number” : Indicate identification number of each animal.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /135
CHAPTER 15
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATES OF HATCHING EGGS O F POULTRY (MODEL 
‘POU -INTRA- HEP’) 
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /136  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of 
originCold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing plant Approval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /137
EUROPEAN UNION Certificate model POU -INTRA -HEPPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. the hatching eggs(1)of poultry described in Part I of this certificate come from
(2)either [an establishment approved in accordance with Article 8 of Commission Delegated Regulation 
(EU) 2019/2035, which is not subject to movement restrictions or situated in a restricted zone
established for reasons of listed diseases relevant for avian species;]
(2)or [a hatchery approved in accordance with Article 7 of Delegated Regulation (EU) 2019/2035, 
which is not subject to movement restrictions or situated in a restricted zone establi shed for 
reasons of listed diseases relevant for avian species;]
II.1.2. the hatching eggs described in Part I come from flocks:
(a) in which infection with Salmonella Pullorum, Salmonella Gallinarum and 
Salmonella arizonae has not been reported;
(b) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) has 
not been reported;
(c) which have been continuously resident in one or more establishments approved in 
accordance with Article 8 of Delegated Regulation (EU) 2019/2035 since hatchi ng 
or for at least the last 42 days prior to the collection of the hatching eggs, and:
(2)either [(i) in which infection with Salmonella Pullorum, S. Gallinarum or S. arizonae
was not confirmed during the last 12 months prior to the collection of the 
hatching eggs;]
(2)or [(i) in which infection with Salmonella Pullorum, S. Gallinarum or S. arizonae
was confirmed during the last 12 months prior to the collection of the 
hatching eggs and the measures provided for in Article 34(1)(b) of 
Commission Delegated Regulation (EU) 2020/688 have been applied;]
(2)either [(ii) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. 
meleagridis) was not confirmed during the last 12 months prior to the 
collection of the hatching eggs;]
(2)or [(ii) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. 
meleagridis) was confirmed during the last 12 months prior to the 
collection of the hatching eggs and the measures provided for in Article 
34(1)(c) of Delegated Regulation (EU) 2020/688 have been applied;]
(d) which, on the basis of 
(2)either [a clinical inspection within the last 72 hours before departure of the consignment 
and the health and production records kept on the establish ment, checked within the 
last 72 hours before departure of the consignment, show no clinical signs or 
suspicion of listed diseases relevant for the species;]
L 113 /138  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -HEP
(2)or [monthly health inspection visits, the most recent being within the last 31 days 
before departure of the consignment, and the health and production records kept on 
the establishment, checked within the last 72 hours before departure of the 
consignment, show no clinical signs or suspicion of listed diseases relevant for the 
species;]
(2)(3)either [(e) which have not been vaccinated against infection with Newcastle disease virus;]
(2)(3)or [(e) which have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2)[live attenuated vaccines that comply with the c riteria of 
Annex VI to Delegated Regulation (EU) 2020/688](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
II.1.3. the hatching eggs described in Part I:
(a) are individually marked with the approva l number of the establishment of the flock 
of origin;
(b) have been disinfected;
(2)(3)either [(c) have not been vaccinated against infection with Newcastle disease virus;]
(2)(3)or [(c) have been vaccinated against infection with Newcastle disease virus with
[inactivated vaccines](2)[live attenuated vaccines that comply with the criteria of 
Annex VI to Delegated Regulation (EU) 2020/688](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
II.1.4. arrangements have been made to transport the consignment in containers that comply with 
Article 5 of Delegated Regulation (EU) 2020/688 and in means of transport that comply with 
Article 4 of Delegated Regulation (EU) 2020/688;
(4)[II.1.5. the hatching eggs described in Part I are intended for a Member State or zone which has been 
granted the status free from infection with Newcastle disease virus without vaccination, and 
they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from flocks which
(2)either [have not been vaccinated against infection with Newcastle disease virus.]
(2)or [have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2)[live attenuated vaccines that comply with the criteria of 
Annex VI to Delegated Regulation (EU) 2020/688 and vaccination has taken place at 
least 30 days before the collection of the hatching eggs](2)]
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /139
EUROPEAN UNION Certificate model POU -INTRA -HEP
II.2. Public health attestation
(5)[II.2.1. The Salmonella control programme referred to in Article 5 of Regulation (EC) No 2160/2003 and the 
specific requirements for the use of antimicrobials and vaccines in Commission Regulation (EC) 
No1177/2006, have been applied to the parent flock of origin and this parent flock has been tested for 
Salmonella serotypes of public health significance:
Identification of 
the flockAge of the 
birdsDate of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]Result of all testing in the 
flock(6)
Positive Negative
(5)[II.2.2. Neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control programme 
referred to in point II.2.1.]
(7)[II.2.3. If the Member State of destination is Finland or Sweden, the hatching eggs come from flocks which 
have tested negative for Salmonella in accordance with the rules laid down in Commission Decision 
2003/644/EC .]
Notes:
This animal health/official certificate is valid for 10 days from the date of issuing.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this c ertificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 2 of Annex I to Commission Implementing Regul ation (EU) 2020/2235.
Part I:
Box I.30: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.“Category” : select one of the following: Pure line/grandparents/parents/laying pullet s/others.
“Age” : provide the date of collection.
Part II:
(1)‘Hatching eggs’ as defined in Article 4 of Regulation (EU) 2016/429.
(2)Keep as appropriate.
(3)Delete when the consignment is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without 
vaccination, in which case the consignment sho uld comply with II.1.5.
(4)This guarantee is required for consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member State or zone thereof which has been granted the status free from infection with Newcastle 
disease virus without vaccination. Delete reference if not applicable to the consignment.
(5)This guarantee applies only for hatching eggs belonging to the species of Gallus gallus and turkeys.
(6)If any of the results were positive for the following serotypes during the life of the parent flock, indicate 
as positive: Salmonella Hadar , Salmonella Virchow and Salmonella Infantis .
(7)Delete if consignment is not intended for Finland or Sw eden.
L 113 /140  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -HEP
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /141
CHAPTER 16
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATES OF DAY- OLD CHICKS (MODEL ‘P OU-INTRA-
DOC’) 
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /142  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /143
EUROPEAN UNION Certificate model POU -INTRA -DOCPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. the day -old chicks(1)described in Part I of this certificate have hatched on and come from a 
hatchery approved in accordance with Article 7 of Commission Delegated Regulation (EU) 
2019/2035, which is not subject to movement restrictions or situated in a restricted zone 
establ ished for reasons of listed diseases relevant for avian species;
II.1.2. to the best of my knowledge, and as declared by the operator, the day -old chicks described in 
Part I come from a hatchery where there were no abnormal mortalities with an undetermined
cause;
(2)either [II.1.3. the day -old chicks described in Part I have hatched from eggs coming from flocks:
(a) in which infection with Salmonella Pullorum, Salmonella Gallinarum and 
Salmonella arizonae has not been reported;
(b) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) has 
not been reported;
(c) which have been continuously resident in one or more establishments approved in 
accordance with Article 8 of Delegated Regulation (EU) 2019/2035 since hatching 
or for at least the last 42 days prior to the collection of the eggs from which the day-
old chicks have hatched and:
(2)either [(i) in which infection with Salmonella Pullorum, S. Gallinarum or S. arizonae
was not confirmed during the last 12 months prior to the collection of the 
hatching eggs;]
(2)or [(i) in which infection with Salmonella Pullorum, S. Gallinarum or S. arizonae
was confirmed during the last 12 months prior to the collection of the 
hatching eggs and the measures provided for in Article 34(1)(b) of 
Commission Delegated Regulation (EU) 2020/688 have been applied;]
(2)either [(ii) in which avian mycoplasmosis (Mycop lasma gallisepticum and M. 
meleagridis) was not confirmed during the last 12 months prior to the 
collection of the hatching eggs;]
(2)or [(ii) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. 
meleagridis) was confirmed during the last 12 month s prior to the 
collection of the hatching eggs and the measures provided for in Article 
34(1)(c) of Delegated Regulation (EU) 2020/688 have been applied;]
(d) which according to the health and production records kept on the establishment, 
checked within the last 24 hours before departure of the consignment, show no 
clinical signs or suspicion of listed diseases relevant for the species;
(2)(3)either [(e) which have not been vaccinated against infection with Newcastle disease virus;]
L 113 /144  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -DOC
(2)(3)or [(e) which have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2)[live attenuated vaccines that comply with the criteria of 
Annex VI to Commission Delegated Regulation (EU) 2020/688](2)
…………………………………………………..
(name of str ain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
(2)(4)or[II.1.3. the day -old chicks described in Part I have hatched from eggs which have entered the Union 
from a third country or territory or zone thereof in accordance with the pr ovisions of 
Commission Delegated Regulation (EU) 2020/692;]
II.1.4. the day -old chicks described in Part I:
(a) show no clinical signs or suspicion of listed diseases relevant for the species;
(2)(3)either [(b) have not been vaccinated against infection with Newcastle disease virus;]
(2)(3)or [(b) have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2)[live attenuated vaccines that comply with the criteria of 
Annex VI to Delegated Regulation (EU) 2020/688](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
II.1.5. arrangements have been made to transport the consignment in containers that comply with 
Article 5 of Delegated Regulation (EU) 2020/688 and in m eans of transport that comply with 
Article 4 of Delegated Regulation (EU) 2020/688;
(5)[II.1.6. the day -old chicks described in Part I are intended for a Member State or zone thereof which 
has been granted the status free from infection with Newcastle dise ase virus without 
vaccination, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from hatching eggs which:
(i) are not vaccinated against infection with Newcastle disease virus;
(ii) come from flocks which
(2)either [have not been vaccinated against infection with Newcastle disease virus;]
(2)or [have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2)[live attenuated vaccines that comply with the 
criteria of Annex VI t o Delegated Regulation (EU) 2020/688 and 
vaccination has taken place at least 30 days before the collection of the 
hatching eggs](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /145
EUROPEAN UNION Certificate model POU -INTRA -DOC
(c) come from a hatchery where working practice ensures that the hatching eggs are 
incubated at completely separate times and locations from hatching eggs not 
satisfying the conditions in point (b).]
II.2. Public health attestation
(6)[II.2.1. The Salmonella control programme referred to in Article 5 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Commission Regulation 
(EC) No 1177/2006, have been applied to the parent flock of origin and this parent flock has been 
tested for Salmonella serotypes of public health significance:
Identification of 
the flockAge of the 
birdsDate of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]Result of all testing in the 
flock(7)
positive negative
The specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No 1177/2006 
have been applied to the day -old chicks. 
For reasons other than the Salmonella control programme:
(2)either [antimicrobials were not administered to the day -old chicks (including in- ovo
injection);]
(2)(8)or[the following antimicrobials were administered to the day -old chicks (including in- ovo
injection)…………………………………………………………..;]]
(6)[II.2.2. If the day -old chicks are intended for breeding, neither Salmonella Enteritidis nor Salmonella
Typhimurium were detected within the control programme referred to in point II.2.1.]
(9)[II.2.3. If the Member State of destination is Finland or Sweden, the day -old chicks for introduction into 
flocks of breeding poultry or flocks of productive poultry come from flocks which have tested 
negative for Salmonella in accordance with the rules laid down in Commission Decision 
2003/644/EC .]
Notes:
This animal health/ official certificate is valid for 10 days from the date of issuing. In the case of transport by 
waterway/sea of animals, the period of validity of the animal health/ official certificate may be extended by the 
duration of the journey by waterway/sea.
In acc ordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conju nction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certif icates 
provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.30: Description of consignment:
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05 or 01.06.39.
“Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.
“Age” : provide the date the animals have hatched.
L 113 /146  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -DOC
Part II:
(1)‘Day -old chicks’ means all poultry less than 72 hours old, as defined in Article 3 of Delegated 
Regulation (EU) 2020/688.
(2)Keep as appropriate.
(3)Delete when the consignment is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Membe r State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without 
vaccination, in which case the consignment should comply with II.1.6.
(4)Where the day -old chicks have hatched from eggs which have entered the Union from a third country or 
territory or zone thereof, the specific animal health requirements for movement and handling of those animals in the establishment of destination, laid down in Chapter 5 of Title 2 of Part III of Delegated 
Regulation (EU) 2020/692, must be respected.
(5)This guarantee is required for consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member State or zone thereo f which has been granted the status free from infection with Newcastle 
disease virus without vaccination. Delete reference if not applicable to the consignment.
(6)This guarantee applies only for day -old chicks belonging to the species of Gallus gallus an d turkeys.
(7)If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:
-flocks of breeding poultry: Salmonella Hada r, Salmonella Virchow and Salmonella Infantis ;
-flocks of productive poultry: Salmo nella Enteritidis and Salmonella Typhimurium .
(8)Keep if appropriate: indicate the name and active substance of antimicrobials used.
(9)Delete if consignment is not intended for Finland or Sweden.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /147
CHAPTER 17
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATES OF BREEDING POULTRY AND PRODUCTIVE 
POULTRY (MODEL ‘POU- INTRA- X’) 
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /148  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/producti onManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /149
EUROPEAN UNION Certificate model POU -INTRA -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. the [breeding poultry(1)](2)[productive poultry(3)](2)described in Part I of this certificate have been 
continuously resident in one or more establishments approved in accordance with Article 8 of 
Commission Delegated Regulation (EU) 2019/2035 
(2)(4)either [since hatching or for at least the last 42 days pr ior to the departure of the consignment;]
(2)(5)or [since hatching or for at least the last 21 days prior to the departure of the consignment, during 
which time they had no contact with birds of lower health status;]
II.1.2. the poultry described in Part I come from an establishment:
(a) which is not subject to movement restrictions or situated in a restricted zone established for 
reasons of listed diseases relevant for avian species;
(2)either [(b) in which infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was not 
confirmed during the last 12 months prior to the departure of the consignment;]
(2)or [(b) in which infection with Salmonella Pullorum, S. Gallinarum or S . arizonae was confirmed 
during the last 12 months prior to the departure of the consignment and the measures 
provided for in Article 34(1)(b) of Commission Delegated Regulation (EU) 2020/688 have 
been applied;]
(2)either [(c) in which avian mycoplasmosis (Mycoplasm a gallisepticum and M. meleagridis) was not 
confirmed during the last 12 months prior to the departure of the consignment;]
(2)or [(c) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was 
confirmed during the last 12 months prior to the departure of the consignment and the 
measures provided for in Article 34(1)(c) of Delegated Regulation (EU) 2020/688 have 
been applied;]
II.1.3. to the best of my knowledge, and as declared by the operator, the poultry described in Part I come 
from an establishment where there were no abnormal mortalities with an undetermined cause;
II.1.4. the poultry described in Part I come from a flock in which:
(a) infection with Salmonella Pullorum, Salmonella Gallinarum and Salmonella arizonae has 
not been rep orted;
(b) avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) has not been 
reported;
(c) no confirmed case of low pathogenic avian influenza was detected during the last 21 days 
prior to departure of the consignment, in accordance with the s urveillance provided for in 
Article 3(1) of Commission Delegated Regulation (EU) 2020/689;
L 113 /150  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -X
II.1.5. the poultry described in Part I:
(2)(6)either [(a) have not been vaccinated against infection with Newcastle disease virus;]
(2)(6)or [(a) have been vaccinated against infection with Newcastle disease virus with [inactivated 
vaccines](2)[live attenuated vaccines that comply with the criteria of Annex VI to Delegated 
Regulation (EU) 2020/688](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
(2)(7)or [(a) are intended for a Member State or zone thereof which has been granted the status free from 
infection with Newcastle disease virus without vaccination, and they:
(i) have not been vaccinated a gainst infection with Newcastle disease virus;
(ii) were kept in isolation for at least 14 days prior to departure of the consignment in 
the establishment of origin under the supervision of an official veterinarian or in an 
approved quarantine establishment, where:
- no poultry was vaccinated against infection with Newcastle disease virus 
during the period of at least 21 days prior to departure;
- no other birds have entered into the establishment during that time; 
- no vaccination has been carried out in the quarantine establishment;
(iii) have tested negative to serological tests to detect antibodies against Newcastle 
disease virus, performed on blood samples at a level which gives 95% confidence of 
detecting infection at 5% prevalence and which were taken during the period of at 
least 14 days prior to departure;]
(8)[(b) are ducks or geese and have tested negative to a virological examination for highly 
pathogenic avian influenza, in accordance with the requirements of Annex IV to Delegated 
Regulatio n (EU) 2020/688, during the week prior to the time of loading for dispatch;]
II.1.6. the flock of origin and the animals of the consignment have been subjected to a clinical inspection 
within the 48 hours prior to loading for dispatch to the Union, and sho wed no clinical signs or 
suspicion of listed diseases relevant for the species;
II.1.7. arrangements have been made to transport the consignment in containers that comply with Article 
5 of Delegated Regulation (EU) 2020/688 and in means of transport that c omply with Article 4 of 
Delegated Regulation (EU) 2020/688;
(9)[II.1.8. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two 
assembly operations, and 
(2)either [they come from their establishments of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /151
EUROPEAN UNION Certificate model POU -INTRA -X
II.2. Public health attestation
(10)[II.2.1. The Salmonella control programme referred to in Article 5 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Commission Regulation 
(EC) No 1177/2006, have been applied to the flock of origin and the flock has been tested for 
Salmonella serotypes of public health significance:
Identification of the 
flockAge of the 
birdsDate of last sampling of the 
flock from which the testing 
result is known 
[dd/mm/yyyy]Result of all testing in 
the flock(11)
positive negative
For reasons other than the Salmonella control programme, w ithin the last three weeks prior to entry into 
the Union:
(2)either [antimicrobials were not administered to the breeding and productive poultry other than 
ratites;]
(2)(12)or [the following antimicrobials were administered to the breeding and productive poultry other 
than ratites: ……………………………………;]]
(10)[II.2.2. If breeding poultry, neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within 
the control programme referred t o in point II.2.1.]
(13)[II.2.3. If the Member State of d estination is Finland or Sweden:
(2) either [the breeding poultry has tested negative for Salmonella in accordance with the rules laid down in 
Commission Decision 2003/644/EC;]
(2) or [the laying hens (productive poultry reared in view to producing eggs for consumption) have tested 
negative for Salmonella in accordance with the rules laid down in Commission Decision 
2004/235/EC.]]
Notes:
This animal health/ official certificate is valid for 10 days from the date of issuing. In the case of transport by 
waterway/sea of animals, the period of validity of the animal health/ official certificate may be extended by the 
duration of the journey by waterway/sea.
In acc ordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conju nction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certif icates 
provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.17:     In case the animals are dispatched from an establishment approved for assembly operations in the 
Member State of origin, the reference number(s) of the official document(s), based on which the 
animal health/ official certificate for this consignment is issued in this establishment approved for 
assembly operations, may be indicated. In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the animal health/ official certificate for this consignment is issued in 
this establishment approved for assembly operations, must be indicated.
L 113 /152  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -X
Box I.30: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05 or 01.06.39.
“Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.
Part II:
(1)‘Breeding poultry’ means poultry 72 hours old or more, intended for the production of hatching eggs, as 
defined in Article 3 of Delegated Regulation (EU) 2020/688.
(2)Keep as appropriate.
(3)‘Productive poultry’ means poultry 72 hours old or more, reared for the production of meat, eggs for 
consumption or other products or for restocking supplies of game birds, as defined in Article 3 of 
Delegated Regulation (EU) 2020/688.
(4)Applicable for breeding poultry and product ive poultry for the production of meat, eggs for 
consumption or other products. 
(5)Applicable for productive poultry for restocking supplies of game birds.
(6)Delete when the consignment is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without 
vaccination.
(7)This guarantee is required for consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member State or zone thereof which has been granted the status free from infection with Ne wcastle 
disease virus without vaccination. Delete reference if not applicable to consignment.
(8)Applicable for ducks and geese. Delete reference if not applicable to the consignment.
(9)Applicable in case the consignment is dispatched from an establishm ent approved for assembly 
operations. The animal in the consignment which has undergone the highest number of assembly 
operation determines the number of remaining allowed assembly operations for this consignment. 
Delete reference if not applicable to the consignment.
(10)This guarantee applies only for poultry belonging to the species of Gallus gallus and turkeys . 
(11)If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:
-flocks of breeding poul try: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis;
-flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium.
(12)Complete if appropriate: indicate the name and active substance of antimicrobials used.
(13)Delete if consignment is not intended for Finland or Sweden.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /153
CHAPTER 18
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATES OF LESS THAN 20 HEADS OF POULTRY OTHER
THAN RATITES OR LESS THAN 20 HATCHING EGG S OF POULTRY OTHER 
THAN RATITES (MODEL ‘POU -INTRA- LT20’) 
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /154  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country co de Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /155
EUROPEAN UNION Certificate model POU -INTRA -LT20Part II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. the [poultry other than ratites](1)[hatching eggs of poultry other than ratites](1)described in Part I of 
this certificate come from a [registered](1)[approved](1)establishment, which is not subject to 
movement restrictions or situated in a restricted zone established for reasons of list ed diseases 
relevant for avian species;
II.1.2. to the best of my knowledge, and as declared by the operator, the [poultry other than ratites](1) 
[hatching eggs of poultry other than ratites](1)described in Part I come from an establishment 
where there were no abnormal mortalities with an undetermined cause;
II.1.3. the [poultry other than ratites](1)[hatching eggs of poultry other than ratites](1)described in Part I 
come from a flock which ha s been continuously resident in the establishment of origin since 
hatching or for at least the last 21 days prior to 
(1)(2)(3)(4)either [departure of the consignment;]
(1)(5)or [the collection of the eggs;]
II.1.4. [the poultry other than ratites describe d in Part I](2)(3)
or [the [day -old chicks other than ratites](1)[hatching eggs of poultry other than ratites](1)described in 
Part I come from a flock which](4)(5)
tested negative, within 21 days preceding the time of loading for dispatch, in serological and/or 
bacteriological tests(6)for:
(1)either [Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus 
gallus );]
(1)or [Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, 
Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);] 
(1)or [Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris , Coturnix 
coturnix , Phasianus colchicus , Perdix perdix and Anas spp );]
(1)(2)(3)(4)[II.1.5. the poultry other than ratites described in Part I 
II.1.5.1. have had no contact with newly -arrived poultry or with birds of lower health status 
during the last 21 days prior to the departure of the consignment;
II.1.5.2. they come from a flock i n which no confirmed case of low pathogenic avian influenza 
was detected during the last 21 days prior to departure of the consignment, in 
accordance with the surveillance provided for in Article 3(1) of Commission Delegated 
Regulation (EU) 2020/689;
II.1.5.3. they 
(1)(7)either [(a) have not been vaccinated against infection with Newcastle disease virus;]
L 113 /156  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -LT20
(1)(7)or [(a) have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](1)[live attenuated vaccines that comply with the criteria 
of Annex VI to Commission Delegated Regulation (EU) 2020/688](1)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
(1)(8)or [(a) are intended for a Member State or zone thereof which has been granted the 
status free from infection with Newcastle disease virus without vaccination, 
and they:
(1)(2)either [(i) have not been vaccinated against infection with Newcastle disease 
virus;
(ii) were kept i n isolation for at least 14 days prior to departure of the 
consignment in the establishment of origin under the supervision of 
an official veterinarian or in an approved quarantine establishment, 
where:
- no poultry was vaccinated against infection with Ne wcastle 
disease virus during the period of at least 21 days prior to 
departure;
- no other birds have entered into the establishment during that 
time; 
- no vaccination has been carried out in the quarantine 
establishment;
(iii) have tested negative to ser ological tests to detect antibodies against 
Newcastle disease virus, performed on blood samples at a level 
which gives 95% confidence of detecting infection at 5% 
prevalence and which were taken during the period of at least 14 
days prior to departure;]
(1)(3)or [come from a flock which:
(1)either [is not vaccinated against infection with Newcastle disease virus and 
tested negative, during the last 14 days prior to departure of the 
consignment, in serological tests to detect antibodies against 
Newcastle dis ease virus performed on blood samples at a level which 
gives 95% confidence of detecting infection at 5% prevalence;]
(1)or [is vaccinated against infection with Newcastle disease virus and tested 
negative, during the last 14 days prior to departure of the consignment, 
in a test to detect the presence of Newcastle disease virus, performed at 
a level which gives 95% confidence of detecting infection at 5% 
prevalence;]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /157
EUROPEAN UNION Certificate model POU -INTRA -LT20
(1)(4)or [(i) have not been vaccinated against infection with Newcastle disease 
virus;
(ii) come from hatching eggs which:
- are not vaccinated against infection with Newcastle disease 
virus;
- come from flocks which
(1)either [have not been vaccinated against infection with 
Newcastle disease virus;]
(1)or [have been vaccinated against infection with 
Newcastle disease virus with [inactivated 
vaccines](1)[live attenuated vaccines that comply 
with the criteria of Annex VI to Delegated 
Regulation (EU) 2020/688 and vaccination has 
taken place at least 30 days before the collection of 
the ha tching eggs](1)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of 
……………. weeks;]
(iii) come from a hatchery where working practice ensures that the 
hatching eggs are incubated at completely separate times and 
locati ons from hatching eggs not satisfying the conditions in point 
(ii);]]
(9)[(b) are ducks or geese and have tested negative to a virological examination for 
highly pathogenic avian influenza, in accordance with the requirements of 
Annex IV to Delegated Regu lation (EU) 2020/688, during the week prior to 
the time of loading for dispatch;]
II.1.5.4. the flock of origin and the animals of the consignment have been subjected to a clinical 
inspection within the 48 hours prior to loading for dispatch to the Union, and showed no 
clinical signs or suspicion of listed diseases relevant for the species;]
(1)(5)[II.1.5. the hatching eggs described in Part I 
II.1.5.1. come from a flock which on the basis of 
(1)either [a clinical inspection within the last 72 hours before departure of the consignment and 
the health and production records kept on the establishment, checked within the last 72 
hours before departure of the consignment, shows no clinical signs or suspicion of listed diseases relevant for the species;]
(1)or [monthly health inspection visits, the most recent being within the last 31 days before 
departure of the consignment, and the health and production records kept on the 
establishment, checked within the last 72 hours before departure of the consignment,
shows no clinical signs or suspicion of listed diseases relevant for the species;]
L 113 /158  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -LT20
(1)(7)either [II.1.5.2. come from a flock which has not been vaccinated against infection with Newcastle 
disease virus;]
(1)(7)or [II.1.5.2. come from a flock which has been vaccinated against infection with Newcastle disease 
virus with [inactivated vaccines](1)[live attenuated vaccines that comply with the criteria 
of Annex VI to Delegated Regulation (EU) 2020/688](1)
…………………………………………………..
(name of strain used in the vaccine)on ………………. (date) at the age of ……………. weeks;]
(1)(8)or[II.1.5.2. are intended for a Member State which has been granted the status free from infection 
with Newcastle disease virus without vaccination, and they:(a) have not been vaccinated agains t infection with Newcastle disease virus;
(b) come from a flock which
(1)either [has not been vaccinated against infection with Newcastle disease virus;]
(1)or [has been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](1)[live attenuated vaccines that comply with the 
criteria of Annex VI to Delegated Regulation (EU) 2020/688 and the 
vaccination has taken place at least 30 days before the collection of the hatching eggs]
(1)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]]]
II.1.6. arrangements have been made to transport the consignment in containers that comply with Article 
5 of Delegated Regulation (EU) 2020/688 and in means of transport that comply with Article 4 of 
Delegated Regulation (EU) 2020/688.
II.2. Public health attestation
II.2.1. I, the undersigned official veterinarian, hereby certify the following as regards the [breeding 
poultry other than ratites](1)[productive poultry other than ratites](1)[poultry intended for 
slaughter other than ratites](1)[day-old chicks other than ratites](1)described in this certificate:
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /159
EUROPEAN UNION Certificate model POU -INTRA -LT20
(10)[II.2.1.1. The Salmonella control programme referred to in Article 5 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Commission Regulation (EC) No 1177/2006, have been applied to the flock of origin 
and the flock has been tested for Salmonella serotypes of public health significance:
Identification of the 
flockAge of the 
birdsDate of last sampling of the 
flock from which the testing 
result is known 
[dd/mm/yyyy]Result of all testing in 
the flock(11)
positive negative
For reasons other than the Salmonella control programme, within the last three weeks 
prior to entry into the Union:
(1)either [antimicrobials were not administered to the breeding and productive 
poultry other than ratites;]
(1)(12)or [the following antimicrobials were administered to the breeding and 
productive poultry other than ratites: ……………………………………;]]
(10)[II.2.1.2. If breeding poultry, neither Salmonella Enteritidis nor Salmonella Typhimurium 
were detected within the control programme referred to in point II.2.1.1.]
(13)[II.2.1.3. If the Member State of d estination is Finland or Sweden:
(1) either [the breeding poultry has tested negative for Salmonella in accordance 
with the rules laid down in Commission Decision 2003/644/EC;]
(1) or [the laying hens (productive poultry reared in view to producing eggs for 
consumption) have tested negative in accordance with the rules laid down 
in Commission Decision 2004/235/EC.]]
Notes:
This animal health/official certificate is valid for 10 days fr om the date of issuing. 
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Irel and / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the not es for the completion of certificates 
provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.30: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05, 01.06.39, 04.07.
“Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.
L 113 /160  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -LT20
Part II:
(1)Keep as appropriate.
(2)Applicable for breeding poultry and productive poultry. Delete reference if not applicable to the 
consignment.
(3)Applicable for poultry intended for slaughter. Delete reference if not applicable to the consignment.
(4)Applicable for day -old chicks. Delete reference if not applicable to the consignment.
(5)Applicable for hatching e ggs. Delete reference if not applicable to the consignment.
(6)If the animals have been vaccinated against infection with any serotype of Salmonella or Mycoplasma, 
only bacteriological testing must be used. The confirmation method must be capable of differentiating 
between live vaccinal strains and field strains.
(7)Delete when the consignment is dispatched from a Member State or zone thereof which d oes not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without 
vaccination.
(8)This guarantee is required for consignments dispatched from a Member State or zone thereof which does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member State or zone thereof which has been granted the status free from infectio n with Newcastle 
disease virus without vaccination. Delete reference if not applicable to the consignment.
(9)Applicable for ducks and geese, except those intended for slaughter. Delete reference if not applicable 
to the consignment.
(10)This guarantee a pplies only for poultry belonging to the species of Gallus gallus and turkeys .
(11)If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:
-flocks of breeding poultry: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis;
-flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium.
(12)Complete if appropriate: indicate the name and active substance of antimicrobials used.
(13)Delete if consignment is not intended for F inland or Sweden.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /161
CHAPTER 19
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATES OF POULTRY INTENDED FOR SLAUGHTER 
(MODEL ‘POU -INTRA- Y’) 
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /162  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /163
EUROPEAN UNION Certificate model POU -INTRA -YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. the poultry intended for slaughter(1)described in Part I of this certificate have been continuously 
resident in the establishment of origin since hatching or for at least the last 21 days prior to 
departure of the consignment;
II.1.2. the poultry described in Part I come from an establishmen t which is not subject to movement 
restrictions or situated in a restricted zone established for reasons of listed diseases relevant for 
avian species;
II.1.3. to the best of my knowledge, and as declared by the operator, the poultry described in Part I come 
from an establishment where there were no abnormal mortalities with an undetermined cause;
II.1.4. the poultry described in Part I : 
(2)(3)either [have not been vaccinated against infection with Newcastle disease virus;]
(2)(3)or [have been vaccinated against infection with Newcastle disease virus with [inactivated vaccines](2)
[live attenuated vaccines that comply with the criteria of Annex VI to Commission Delegated 
Regulation (EU) 2020/688](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
(2)(4)or [are intended for a Member State or zone thereof which has been granted the status free from 
infection with Newcastle disease virus without vaccination, and they come from flocks which:
(2)either [are not vaccinated against infection with Newcastle disease virus and have tested 
negative, during the last 14 days prior to departure of the consignment, in serological tests 
to detect antibodies against Newcastle disease virus performed on blood sa mples at a level 
which gives 95% confidence of detecting infection at 5% prevalence;]
(2)or [are vaccinated against infection with Newcastle disease virus and have tested negative, 
during the last 14 days prior to departure of the consignment, in a test to detect the 
presence of Newcastle disease virus, performed at a level which gives 95% confidence of detecting infection at 5% prevalence;]]
II.1.5. the flock of origin and the animals of the consignment have been subjected to a clinical inspection 
within 
the last 5 days before departure of the consignment and showed no clinical signs or 
suspicion of listed diseases relevant for the species;
II.1.6. arrangements have been made to transport the consignment in containers that comply with Article 
5 of Delegate d Regulation (EU) 2020/688 and in means of transport that comply with Article 4 of 
Delegated Regulation (EU) 2020/688;
L 113 /164  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -Y
(5)[II.1.7. Since leaving their establishments of origin and before arriving to this establishment approved for 
assembly operations, none of the animals of the consignment has undergone more than two 
assembly operations, and 
(2)either [they come from their establishm ents of origin.]]
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment.]]
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishme nts.]]
II.2. Public health attestation
(6)[II.2.1. The Salmonella control programme referred to in Article 5 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Commission Regulation (EC) No 1177/2006, have been applied to the flock of origin and 
this flock has been tested for Salmonella serotypes of public health significance:
Identification of 
the flockAge of the 
birdsDate of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/ yyyy]Result of all testing in the 
flock(7)
positive negative
For reasons other than the Salmonella control programme:
(2)either [antimicrobials were not administered to the slaughter poultry;]
(2)(8)or[the following antimicrobials were administered to the slaughter poultry: 
…………………………………………………………..;]]
(9)[II.2.2. If the Member State of destination is Finland or Sweden, the poultry underwent a 
microbiological test by sampling on the holding of origin and tested Salmonella negative in 
accordance with the procedures in Decision 95/410/EC pursuant to Article 9(3) of 
Regulation (EC) No 2160/2003 .]
Notes:
This animal health/ official certificate is valid for 10 days from the date of issuing. In the case of transport by 
waterway/sea of animals, the period of validity of the animal health/ official certificate may be extended by the 
duration of the journey by waterway/sea.
In acc ordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conju nction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certif icates 
provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /165
EUROPEAN UNION Certificate model POU -INTRA -Y
Part I:
Box I.17:     In case the animals are dispatched from an establishment approved for assembly operations in the 
Member State of origin, the reference number(s) of the official document(s), based on which the 
animal health/ official certificate for this consi gnment is issued in this establishment approved for 
assembly operations, may be indicated. In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of passage, the reference number(s) of the 
certificate( s), based on which the animal health/ official certificate for this consignment is issued in 
this establishment approved for assembly operations, must be indicated.
Box I.30: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05 or 01.06.39.
Part II:
(1)‘Poultry intended for slaughter’ means poultry to be transported directly or after undergoing an 
assembly operation to a slaughterhouse, as defined in Article 3 of Delegated Regulation (EU) 2020/688.
(2)Keep as appropriate.
(3)Delete when the consignment is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without 
vaccination.
(4)This guarantee is required for consignments dispatched from a Member State or zone thereof which 
does not have the status free from infec tion with Newcastle disease virus without vaccination to a 
Member State or zone thereof which has been granted the status free from infection with Newcastle 
disease virus without vaccination. Delete reference if not applicable to the consignment.
(5)Appli cable in case the consignment is dispatched from an establishment approved for assembly 
operations. The animal in the consignment which has undergone the highest number of assembly 
operation determines the number of remaining allowed assembly operations fo r this consignment. 
Delete reference if not applicable to the consignment.
(6)This guarantee applies only to poultry belonging to the species of Gallus gallus and turkeys. 
(7)If any of the results were positive for the following serotypes during the lif e of the flock, indicate as 
positive: Salmonella Enteritidis and Salmonella Typhimurium .
(8)Complete if appropriate: indicate the name and active substance of antimicrobials used.
(9)Delete if consignment is not intended for Finland or Sweden.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /166  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 20
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF SPECIFIED PATHOGEN- FREE EGGS (MODEL ‘PO U-
INTRA- SPF’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /167
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /168  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POU -INTRA -SPFPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1. the specified pathogen -free eggs(1)described in Part I of this certificate have been dispatched 
from an establishment approved in accordance with Article 8 of Commission Delegated 
Regulation (EU) 2019/2035, which is not subject to movement restrictions or situated in a 
restricted zone established for reasons of listed diseases relevant for avian species;
II.2. to the best of my knowledge, and a s declared by the operator, the specified pathogen -free eggs 
described in Part I come from an establishment where there were no abnormal mortalities with 
an undetermined cause;
II.3. thespecified pathogen -free eggs described in Part I come from flocks whi ch are free from 
specified pathogens as described in the European Pharmacopoeia and the results of all tests and 
clinical examinations required for this specific status have been favourable;
II.4. the specified pathogen- free eggs described in Part I are marked individually with the approval 
number of the establishment of origin;
II.5. arrangements have been made to transport the consignment in containers that comply with 
Article 5 of Commission Delegated Regulation (EU) 2020/688 and in means of transport th at 
comply with Article 4 of Delegated Regulation (EU) 2020/688 .
Notes:
This animal health certificate is valid for 10 days from the date of issuing. 
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include th e United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.30: Description of consignment
“Age” : provide the date of collection.
Part II:
(1)‘Specified pathogen -free eggs’, means hatching eggs derived from “chicken flocks free from specified 
pathogens”, as described in the European Pharmacopoeia and which are intended solely for diagnostic 
research or pharmaceutical use, as defined in Article 3 of Delegated Regulation (EU) 2020/688.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /169
CHAPTER 21
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CAP TIVE BIRDS (MODEL ‘C APTIVE- BIRDS -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /170  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /171
EUROPEAN UNION Certificate model CAPTIVE -BIRDS- INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. the captive birds described in Part I of this certificate have been continuously resident in the 
establishment of origin since hatching or for at least the last 21 days prior to departure of the 
consignment;
II.1.2. the captive birds described in Part I come from a [registered](1)[confined](1)establishment which is 
not subject to movement restrictions or situated in a restricted zone established for reasons of listed 
diseases relevant for avian species;
II.1.3. to the best of my knowledge, and as declared by the operator, the captive birds described in Part I 
come from an establishment where there were no abnormal mortalities with an undetermined 
cause;
II.1.4. the captive birds described in Part I : 
(1)(2)either [(a) have not been vaccinated against infection with Newcastle dise ase virus;]
(1)(2)(3)or [(a) have been vaccinated against infection with Newcastle disease virus with [inactivated vaccines]
(1)[live attenuated vaccines that comply with the criteria of Annex VI to 
Commission Delegated Regulation (EU) 2020/688](1)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
(1)(4)or [(a) are captive birds of the galliformes species intended for a Member State or zone thereof 
which has been granted the status free from inf ection with Newcastle disease virus 
without vaccination, and they:
(i) have not been vaccinated against infection with Newcastle disease virus;
(ii) were kept in isolation for at least 14 days prior to departure of the consignment 
in the establishment of origin under the supervision of an official veterinarian or in an approved quarantine establishment, where:
-
no bird was vaccinated against infection with Newcastle disease virus 
during the period of at least 21 days prior to departure;
-no other birds ha ve entered into the establishment during that time; 
-no vaccination has been carried out in the quarantine establishment;
(iii) have tested negative to serological tests to detect antibodies against Newcastle 
disease virus, performed on blood samples at a level which gives 95% 
confidence of detecting infection at 5% prevalence and which were taken 
during the period of at least 14 days prior to departure;]
L 113 /172  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CAPTIVE -BIRDS- INTRA
(5)[(b) are psittacidae and they 
(i) have been individually identified in accordance with Article 76 of Commission 
Delegated Regulation (EU) 2019/2035;
(ii) come from an establishment on which 
(1)either [avian chlamydiosis has not been confirmed for a period of at least 6 months 
prior to departure of the consignment;]
(1)or [avian chlamydiosis has been confirmed during the last 6 months prior to 
departure of the consignment, but not during the last 60 days, and the measures provided for in Article 59(2)b) of Delegated Regulation (EU) 2020/688 have been applied;]
(iii) have
(1)either [not been in contact with captive birds from establishments on which avian 
chlamydiosis has been diagnosed during the last 60 days prior to departure;]
(1)or [been in contact with captive birds from establishments on which avian 
chlamydiosis has been diagnosed during the last 60 days prior to departure and 
were found negative to laboratory testing for avian chlamydiosis performed at 
least 14 days after contact;]
II.1.5. the flock of origin and the animals of the consignment have been subjected to a clinical inspection 
within th e last 48 hours before departure of the consignment and showed no clinical signs or 
suspicion of listed diseases relevant for the species;
II.1.6. arrangements have been made to transport the consignment in containers that comply with Article 
5 of Delegate d Regulation (EU) 2020/688 and in means of transport that comply with Article 4 of 
Delegated Regulation (EU) 2020/688;
(6)[II.1.7. the captive birds described in Part I of have entered the Union from a third country or territory or zone thereof and have been quarantined in the approved quarantine establishment of destination in 
the Union in accordance with the provisions of Section 2 of Chapter 2 of Title 3 of Part II of 
Commission Delegated Regulation (EU) 2020/692.]
Notes:
This animal health certificat e is valid for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of validity of the animal health certificate may be extended by the duration of the journey by 
waterway/sea.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box I.30: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.36.31, 01.06.32 or 01.06.39.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /173
EUROPEAN UNION Certificate model CAPTIVE -BIRDS- INTRA
Part II:
(1)Keep as appropriate.
(2)Delete in case of consignments of captive birds of the galliformes species dispatched from a Member 
State or zone thereof which does not have the status free from infection with Newcastle disease virus 
without vaccination to a Member St ate or zone thereof which has been granted the status free from 
infection with Newcastle disease virus without vaccination.
(3)This guarantee is required for consignments of pigeons. 
(4)This guarantee is required for consignments of captive birds of the galliformes species dispatched from 
a Member State or zone thereof which does not have the status free from infection with Newcastle 
disease virus without vaccination to a Member State or zone thereof which has been granted the status 
free from infection with Newcastle disease virus without vaccination. Delete reference if not applicable 
to the consignment.
(5)This guarantee is required only for consignments of psittacidae. Delete reference if not applicable to the 
consignment.
(6)This guarantee is requi red for consignments of captive birds which have entered the Union from a third 
country or territory or zone thereof. Delete reference if not applicable to the consignment.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /174  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 22
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF HATCHING EGGS OF CAPTIVE BIRDS (MODEL ‘HE-
CAPTIVE- BIRDS -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /175
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /176  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model HE -CAPTIVE -BIRDS- INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. the hatching eggs(1)of captive birds described in Part I of this certificate come from a [registered](2)
[confined](2)establishment which is not subject to movement restrictions or situated in a restricted 
zone established for reasons of listed diseases relevant for avian s pecies;
(2)(3)either [II.1.2. the hatching eggs described in Part I: 
(2)either [(a) have not been vaccinated against infection with Newcastle disease virus;]
(2)or [(a) have been vaccinated against infection with Newcastle disease virus with [inactivated
vaccines](2)[live attenuated vaccines that comply with the criteria of Annex VI to 
Commission Delegated Regulation (EU) 2020/688](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]
(2)either [(b) come from flocks which have not been vaccinated against infection with Newcastle 
disease virus;]
(2)or [(b) come from flocks which have been vaccinated against infection with Newcastle 
disease virus with [inactivated vaccines](2)[live attenuated vaccines that comply with 
the criteria of Annex VI to Commission Delegated Regulation (EU) 2020/688](2)
…………………………………………………..
(name of strain used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]]
(2)(4)or[II.1.2. the hatc hing eggs described in Part I are hatching eggs of captive birds of the galliformes 
species intended for a Member State or zone which has been granted the status free from 
infection with Newcastle disease virus without vaccination, and they:
(a) are not va ccinated against infection with Newcastle disease virus;
(b) come from flocks which
(2)either [have not been vaccinated against infection with Newcastle disease virus;]
(2)or [have been vaccinated against infection with Newcastle disease virus with [inacti vated 
vaccines](2)[live attenuated vaccines that comply with the criteria of Annex VI to 
Delegated Regulation (EU) 2020/688 and vaccination has taken place at least 30 days 
before the collection of the hatching eggs](2)
…………………………………………………..
(name of stra in used in the vaccine)
on ………………. (date) at the age of ……………. weeks;]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /177
EUROPEAN UNION Certificate model HE -CAPTIVE -BIRDS- INTRA
II.1.3. the hatching eggs of captive birds described in Part I come from flocks which have been subjected 
to a clinical inspection within the last 48 hours before departure of the consignment and showed no 
clinical signs or suspicion of listed diseases relevant for the species;
II.1.4. arrangements have been made to transport the consignment in containers that comply with Article 
5 of Delegated Regulation (EU) 2020/688 and in means of transport that comply with Article 4 of 
Delegated Regulation (EU) 2020/688.
Notes:
This animal health certificate is valid for 10 days from the date of issuing.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certifica te include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2 235.
Part I:
Box I.30: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.
“Age” : provide the date of collection.
Part II:
(1)‘Hatching eggs’ as defined in point (44) of Article 4 of Regulation (EU) 2016/429.
(2)Keep as appropriate.
(3)Delete when the consignment is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination.
(4)This guarantee is required for consignments of hatching eggs of captive birds of the galliformes species 
dispatched fro m a Member State or zone thereof which does not have the status free from infection with 
Newcastle disease virus without vaccination to a Member State or zone thereof which has been granted 
the status free from infection with Newcastle disease virus withou t vaccination. Delete reference if not 
applicable to the consignment.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /178  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 23
MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF SEMEN OF BOVINE ANIM ALS 
COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED REGULATION (EU) 2020/ 686
AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED (MO DEL ‘BOV- SEM -A-
INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QRCODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transpor tI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /179
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act□Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilize rs and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /180  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- SEM -A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen of bovine animals described in Part I has been collected, processed and stored, and dispatched 
from the semen collection centre(1)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 
2020/686.
II.2. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals 
which
II.2.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
II.2.2. come, before the commencement of the quarantine referred to in point II.2.6., from 
establishments in a Member State or zone thereof, or from establishments under official 
control by the competent authority in a third country or territory, or a zone the reof 
II.2.2.1. situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the establishment for a period of at least 30 days and 
in which foot -and-mouth disease has not been reported during a period of at 
least 3 months, and 
(2)either [they were not vaccinated against foot -and-mouth disease;]
(2)or[they were vaccinated against foot- and-mouth disease during the period of 12 
months prior to the date of collection of the semen but not during the period of the la st 30 days immediately prior to the date of collection of the semen, and 5 
% (with a minimum of five straws) of each quantity of semen taken from a 
donor animal at any time is submitted to a virus isolation test for foot -and-
mouth disease with negative res ults;]
II.2.2.2. free from infection with Mycobacterium tuberculosis complex ( M. bovis, M. 
caprae and M. tuberculosis ), and they have never been kept previously in any 
establishment of a lower health status;
II.2.2.3. free from infection with Brucella abor tus, B. melitensis and B. suis, and they 
have never been kept previously in any establishment of a lower health status;
(2)either [II.2.2.4. free from enzootic bovine leukosis, and they have never been kept previously 
in any establishment of a lower health status;]
(2)or[II.2.2.4. not free from enzootic bovine leukosis and the donor animals are younger than 2 years of age and have been produced by dams which have been subjected, with negative results, to a serological test for enzootic bovine leukosis afte r
removal of the animal from the dam;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /181
EUROPEAN UNION Certificate model BOV- SEM -A-INTRA
(2)or[II.2.2.4. not free from enzootic bovine leukosis and the donor animals have reached the 
age of 2 years and have been subjected, with a negative result, to a serological 
test for enzootic bovine leukosis;]
(2)either [II.2.2.5. free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, 
and they have never been kept previously in any establishment of a lower 
health status;]
(2)or[II.2.2.5. not free from infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis and the donor animals have been subjected, with a negative 
result, to a serological test (whole virus) on a blood sample;]
II.2.2.6. in which surra (Trypanosoma evansi) has not been reported during the 30 day 
period, and
(2)either [surra has not been reported in the establishments during the last 2 years.]
(2)or [surra has been reported in the establishments during the last 2 years and 
following the last outbreak the establishments have remained under movem ent 
restrictions until
−the infected animals have been removed from the establishment, and
−the remaining animals on the establishment have been subjected to a test for 
surra ( Trypanosoma evansi) with one of the diagnostic methods provided 
for in Part 3 of A nnex I to Commission Delegated Regulation (EU) 
2020/688, carried out, with negative results, on samples taken at least 6 
months after the infected animals have been removed from the 
establishment.]
II.2.3. did not show symptoms or clinical signs of transmi ssible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen; 
II.2.4. are individually identified as provided for in Article 38 of Commission Delegated 
Regulation (EU) 2019/2035;
II.2.5. for a period of at least 30 days prior to the date of first collection of the semen and during 
the collection period 
II.2.5.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot- and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, contagious bovine pleuropneumonia or
lumpy skin disease ,or of an emerging disease relevant for bovine animals;
II.2.5.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis andB. suis, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax, surra (Trypanosoma 
evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic 
haemorrhagic disease virus, infection with bluetongue virus (serotypes 1- 24), 
bovine genital campylobacteriosis and trichomonosis have not been reported;
II.2.5.3. were not in contact with animals from establishments situated in a restricted 
zone due to the occurrence of diseases referred to in point II.2.5.1. or from 
establishments which do not meet the conditions referred to in point II.2.5.2.;
II.2.5.4. were not used for natural bre eding;
L 113 /182  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- SEM -A-INTRA
II.2.6. have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health 
status were present, which on the day of their admission to the semen collection centre 
complied with the following conditions:
II.2.6.1. it was not situated in a restricted zone established due to diseases referred to in 
point II.2.5.1.;
II.2.6.2. none of the diseases referred to in point II.2.5.2. has been reported for a p eriod 
of at least 30 days;
II.2.6.3. it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;
II.2.6.4. has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;
II.2.7. were kept in the semen collection centre
II.2.7.1. which was not situated in a restricted zone established due to diseases referred 
to in point II.2.5.1.;
II.2.7.2. where none of the diseases referred to in point II.2.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and
(2)(3)[at least 30 days following the date of the collection;]
(2)(4)[until the date of dispatch of the consignment of semen to another Member 
State;]
II.2.7.3. situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and
II.2.8. comply with at least one of the following conditions as regards infection with bluetongue 
virus (serotypes 1 -24):
(2)either [II.2.8.1. they have been kept for a period of at least 60 days prior to and during collection 
of the semen in a Member State or zone thereof free from infection with 
bluetongue virus (serotypes 1 -24) where no case of infection with bluetongue virus 
(serotypes 1 -24) has been confirmed during the last 24 months in the targeted 
animal population;]
(2)and/or [II.2.8.2. they have been kept in a seasonally disease- free zone, during the seasonally 
disease- free period, for a period of at least 60 days prior to and during collection of 
the semen, in a Member State or zone thereof with an approved eradica tion 
programme against infection with bluetongue virus (serotype s1-24);]
(2)and/or [II.2.8.3. they have been kept in a seasonally disease- free zone, during the seasonally 
disease- free period, for a period of at least 60 days prior to and during collection of 
the semen, in a Member State or zone thereof where the competent authority of the 
place of origin of the consignment of semen has obtained the prior written consent of the competent authority of the Member State of destination to the conditions for 
establishment of that seasonally disease -free zone and to accept the consignment of 
semen;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /183
EUROPEAN UNION Certificate model BOV- SEM -A-INTRA
(2)and/or [II.2.8.4. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(2)and/or [II.2.8.5. they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1- 24, with negative results, between 28 and 60 days from the date 
of each collection of the semen;]
(2)and/or [II.2.8.6. they have been subjec ted to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood samples taken at commencement 
and final collection of the semen and during collection of the semen at intervals of 
at least every 7 days, in the case of the virus isolation test, or of at least every 28 
days, in the case of PCR;]
II.2.9. comply with at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7):
(2)either [II.2.9.1. they have been kept for a period of at least 60 days prior to and during collection 
of the semen in a Member State or zone thereof where EHDV 1 -7 has not been 
reported for a period of at least the preceding 2 years within a radius of 150 km of 
the establishm ent;]
(2)and/or [II.2.9.2. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(2)and/or [II.2.9.3. were resident in the Member State in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to the following tests carried out in an 
official laboratory:
(2)either [II.2.9.3.1. a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days throughout the collection period and between 28 and 60 days from the date of the final collection of the 
semen;]]
(2)and/or [II.2.9.3.2. an agent identification test for EHDV 1 -7, with 
negative results, on blood sample s taken at the commencement and 
final collection of the semen and during the collection of the semen at 
intervals of at least every 7 days, in the case of virus isolation test, or 
of at least every 28 days, in the case of PCR.]]
II.2.10. have been subjecte d to the following tests, carried out on blood samples taken within the 
period of 30 days prior to the commencement of the quarantine referred to in point II.2.6., 
with negative results, except for the bovine viral diarrhoea antibody test referred to in point 
II.2.10.5.2., required in accordance with point 1(b) of Chapter I of Part 1 of Annex II to 
Delegated Regulation (EU) 2020/686:
II.2.10.1. for infection with Mycobacterium tuberculosis complex ( M. bovis, M. caprae 
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated Regulation (EU) 2020/688;
L 113 /184  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- SEM -A-INTRA
II.2.10.2. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(2)(5)[II.2.10.3. for enzootic bovine leukosis, a serological test referred to in point (a) of Part 4 
of Annex I to Delegated Regulation (EU) 2020/688;]
II.2.10.4. for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample if the animals do not come 
from an establishment free from infectious bovine rhinotracheitis/infectious 
pustular vulvova ginitis;
II.2.10.5. for bovine viral diarrhoea:
II.2.10.5.1. a virus isolation test, a test for virus genome or a test for virus 
antigen, and 
II.2.10.5.2. a serological test to determine the presence or absence of 
antibodies;
II.2.11. have been subjected to the following tests, carried out on blood samples taken within a 
period of at least 21 days, or 7 days in the case of the tests referred to in points II.2.11.4. and 
II.2.11.5., after the commencement of the quarantine referred to in point II.2.6., with 
negative results, except for the bovine viral diarrhoea antibody test referred to in point 
II.2.11.3.2., required in accordance with point 1(c) of Chapter I of Part 1 of Annex II to 
Delegated Regulation (EU) 2020/686:
II.2.11.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
II.2.11.2. for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample;
II.2.11.3. for bovine viral diarrhoea:
II.2.11.3.1. a virus isolation test, a test for virus genome or a test for virus 
antigen, and 
II.2.11.3.2. a serological test to determine the presence or absence of 
antibodies;
II.2.11.4. for bovine genital campylobacteriosis (Campylobacter fetus ssp. venerealis ): 
(2)either [II.2.11.4.1. a single test carried out on a sample of artificial vagina washings or preputial specimen, in the case of animals less than 6 months 
old or kept since that ag e in a single sex group without contact 
with females prior to the quarantine referred to in point II.2.6.;]
(2)or [II.2.11.4.2. tests carried out on samples of artificial vagina washings or 
preputial specimens taken on three occasions at intervals of at least 
7 days;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /185
EUROPEAN UNION Certificate model BOV- SEM -A-INTRA
II.2.11.5. for trichomonosis ( Trichomonas foetus ):
(2)either [II.2.11.5.1. a single test carried out on a sample of preputial specimen, in the 
case of animals less than 6 months old or kept since that age in a single sex group without 
contact with females prior to the 
quarantine referred to in point II.2.6.;]
(2)or [II.2.11.5.2. tests carried out on preputial specimens taken on three occasions at 
intervals of at least 7 days;]
II.2.12. have been subjected at semen collection centre, at least once a year, to the following 
compulsory routine tests, required in accordance with point 2 of Chapter I of Part 1 of 
Annex II to Delegated Regulation (EU) 2020/686:
II.2.12.1. for infection with Mycobacterium tuberculosis complex ( M. bovis, M. capra e
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated Regulation (EU) 2020/688;
II.2.12.2. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 o f Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
II.2.12.3. for enzootic bovine leukosis, a serological test referred to in point (a) of Part 4 of Annex I to Delegated Regulation (EU) 2020/688;
II.2.12.4. for infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample;
(2)(6)[II.2.12.5. for bovine viral diarrhoea, a serological test for detection of an antibody;]
(2)(7)[II.2.12.6. for bovine genital campylobacteriosis ( Campylobacter fetus ssp. venerealis ), a 
test on a sample of preputial specimen;]
(2)(7)[II.2.12.7. for trichomonosis ( Trichomonas foetus ), a test on a sample of preputial 
specimen;]
II.3. The semen described in Part I
II.3.1. has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/686;
II.3.2. isplaced in straws or other packages on which the mark is applied in accordance with 
requirements pro vided for in Article 10 of Delegated Regulation (EU) 2020/686 and that 
mark is indicated in Box I.30;
II.3.3. is transported in a container which:
II.3.3.1. was sealed and numbered prior to the dispatch from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, 
and the seal bears the number as indicated in Box I.19;
II.3.3.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container;
(2)(3)[II.3.3.3. has been filled in with the cryogenic agent which not have been previously 
used for other products.]
L 113 /186  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- SEM -A-INTRA
II.4. The semen is preserved by the addition of antibiotics as follows:
II.4.1. The following antibiotic or mixture of antibiotics, effective in particular against campylobacters, 
leptospires and mycoplasmas, has been added to the semen after final dilution, or is contained in the used semen diluents, to reach the indicated concentration per ml of semen:
(2)either [a mixture of gentamicin (250 μg), tylosin (50 μg) an d lincomycin -spectinomycin (150/300 μg);]
(2)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]
(2)or [a mixture of amikacin (75 μg) and divekacin (25 μg);]
(2)or [an antibiotic or a mixture of antibiot ics(8)…………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg), tylosin (50 μg) and lincomycin- spectinomycin (150/300 μg);
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.4.2. Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature of at least 5°C for a period of not less than 45 minutes, or under 
a time -temperature regime with a documented equivalent bactericidal activity.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commi ssion Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen.
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: semen.
“Species” : select amongst “ Bos taurus ”, “Bison ” or “ Bubalus bubalis ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : indicate mark on the straw or other packages where semen of 
the consignment is placed. 
“Date of collection/production”: indicate the date on which semen of the consignment 
was collected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.“Quantity” : Indicate number of straws or other packages with the same mark.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /187
EUROPEAN UNION Certificate model BOV- SEM -A-INTRA
Part II:
(1)Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
(2)Delete if not applicable.
(3)Applicable fo r frozen semen.
(4)Applicable for fresh and chilled semen.
(5)Not applicable to animals which come from an establishment not free from enzootic bovine leukosis and 
which are less tha n2 years of age as referred to in Article 20(2)(a) of Delegated Regulation (EU) 2020/686.
(6)Applicable only to seronegative animals.
(7)Applicable only to bulls in semen production or having contact with bulls in semen production. Bulls 
returning to col lection after a lay -off period of more than 6 months shall be tested during a period of 30 days 
prior to resuming production.
(8)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the semen diluent containing antibiotics.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /188  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 24
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF B OVINE 
ANIMALS COLLECTED, P ROCESSED AND STORED AFTER 31 DECEMBER 20 04
AND BEFORE 21 APRIL 2021 IN ACCORDANCE W ITH COUNCIL DIRECTIVE
88/407/EEC, AS AMEND ED BY COUNCIL DIRECTIVE 2003/43/EC, DISPATCHED
AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE 
SEMEN WAS COLLECTED (MODEL ‘BOV -SEM -B-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /189
I.20 Certi fied as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /190  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- SEM -B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the semen described in Part I:
II.1.1. was collected, processed and stored in a semen collection centre(1)approved and 
supervised by the competent authority in accordance with Chapter I(1) and Chapter 
II(1) of Annex A to Directive 88/407/EEC;
II.1.2. was collected from bulls, which:
II.1.2.1. meet the requirements of Chapters I and II of Annex B to Directive 
88/407/EEC,
(2)either II.1.2.2. [have not been vaccinated against foot -and-mouth disease within 12 months 
prior to collection;]
(2)orII.1.2.2. [have been vaccinated against foot- and-mouth disease less than 12 months and 
more than 30 days prior to the coll ection, and 5% of doses of semen of each 
collection, with a minimum of 5 straws, have been submitted to a virus 
isolation test for foot -an-mouth disease, carried out with negative results in the 
laboratory (………………………… )(3)situated in or designated by the 
Member State of destination;]
II.1.3. was collected, processed, stored and transported under conditions which comply with 
the standards laid down in Annex C to Directive 88/407/EEC;
II.1.4. was stored in approved conditions for a minimum period of 30 days immediately 
following collection(4).
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the semen collection centre (as defined in Article 2(b) first indent 
of Directive 88/407/EEC) where the semen was collected.
Box I.12: Place of destination shall correspond to the semen collection or storage cent re (as defined in Article 
2(b) of Directive 88/407/EEC), or to the holding of semen destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: Donor identity shall correspond to the official identification of the anima l.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the centre shall correspond to the approval number of the semen centre indicated 
in Box I.12. where the semen was collected.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /191
EUROPEAN UNION Certificate model BOV- SEM -B-INTRA
Part II:
(1)Only semen collection centres approved by the competent authority and listed in accordance with 
Article 5(2) of Council Directive 88/407/EEC.
(2)Delete as appropriate.
(3)Name of the laboratory.
(4)May be deleted for fresh semen.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /192  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 25
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF B OVINE 
ANIMALS COLLECTED, P ROCESSED AND STORED BEFORE 1 JANUARY 200 5
IN ACCORDANCE WITH COUNCIL DIRECTIVE 88/ 407/EEC AS AMENDED B Y
COUNCIL DIRECTIVE 93/60/EEC , DISPATCHED AFTER 2 0 APRIL 2021 FROM 
THE SEMEN COLLECTION CENTRE WHERE THE SEM EN WAS COLLECTED 
(MODEL ‘BOV- SEM -C-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /193
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /194  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- SEM -C-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1.1. The semen described in Part I was collected before the date of 31 December 2004 on a semen 
collection centre(1)which:
(a) was approved under conditions laid down in Chapter I of Annex A to Council Directive 
88/40 7/EEC;
(b) was operated and supervised under conditions laid down in Chapter II of Annex A to 
Directive 88/407/EEC.
II.1.2. At the time the semen described in Part I was collected, all bovine animals at the semen 
collection centre:
(a) came from herds and/ or were born to dams which satisfy the conditions of points 1(b) 
and (c) in Chapter I of Annex B to Directive 88/407/EEC;
(b) have, within the 30 days preceding the quarantine isolation period, undergone, with 
negative results:
- the tests referred to in points 1(d)(i), (ii) and (iii) of Chapter I of Annex B to Directive 88/407/EEC, and 
-
a serum neutralization test or ELISA test for infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and 
- a virus isolation test (fluorescent antibody te st or immunoperoxidase test) for 
bovine viral diarrhoea, which in the case of an animal less than six months of age 
has been deferred until that age was reached;
(c) have satisfied the quarantine isolation period of 30 days and have been subjected with 
therequired negative results to the following health tests:
- a serological test for brucellosis carried out in accordance with the procedure 
described in Annex C to Directive 64/432/EEC;
- either an immunofluorescent antibody test or a culture test for Camp ylobacter 
fetus infection on a sample of preputial material or artificial vagina washings, or, 
in the case of a female animal, a vaginal mucus agglutination test;
- a microscopic examination and culture test for Trichomonas foetus on a sample 
of preputial material or artificial vagina washings, or in case of a female animal a 
vaginal mucus agglutination test;
(d) have undergone, at least once a year, with negative results, the routine tests referred to 
in points 1(a), (b) and (c) in Chapter II of Annex B to Directive 88/407/EEC.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /195
EUROPEAN UNION Certificate model BOV- SEM -C-INTRA
II.1.3. At the time the semen described in Part I was collected,
(a) all female bovine animals in the centre have undergone, at least once a year, a vaginal 
mucus agglutination test for Campylobacter fetus infection with negative results, and
(b) all bulls used for semen production have undergone with negative result either an 
immunofluorescent antibody test or a culture test for Campylobacter fetus infection on a 
sample of preputial material or artificial vagina washings carried out within 12 months 
prior to collection.
II.1.4. The semen described in Part I was collected from bulls standing in a semen collection centre in 
which:
(2)either [all bovine animals have not been vaccinated against infectious bovine rhinotracheitis and have 
undergone at least once a year with negative result a serum neutralisation test or an ELISA test 
for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]
(2)or [bovine animals not vaccinated against infectious b ovine rhinotracheitis have undergone, at 
least once a year, with negative result a serum neutralisation test or ELISA test for infectious 
bovine rhinotracheitis/infectious pustular vulvovaginitis, and testing for infectious bovine 
rhinotracheitis is not ca rried out on bulls which have received a first vaccination against 
infectious bovine rhinotracheitis at the insemination centre after they have been tested with 
negative result in a serum neutralisation test or ELISA test for infectious bovine 
rhinotrachei tis/infectious pustular vulvovaginitis and which since the first vaccination have 
been regularly re -vaccinated with an interval of not more than six months;].
II.1.5. The semen described in Part I was collected from bulls which:
II.1.5.1.
(2)either [have not been vaccinated against foot- and-mouth disease within 12 months prior to 
collection;]
(2)or [have been vaccinated against foot -and-mouth disease less than 12 months and more 
than 30 days prior to collection, and 5% of doses of the semen from each collection, 
with a minimum of five straws, have been submitted to a virus isolation test for foot -
and-mouth disease, carried out with negative results in the laboratory 
(…………………………………)(3), situated in or designated by the Member State of 
destination;]
II.1.5.2.
(2)either [have not been vaccinated against infectious bovine rhinotracheitis,]
(2)or [have been vaccinated against infectious bovine rhinotracheitis in accordance with 
point II.1.4,].
II.1.6. The semen described in Part I was stored in approved conditions for a minimum period of 30 
days immediately following collection(4).
II.1.7. The semen described in Part I was sent to the place of loading in a sealed container and bearing 
the number detailed in Box I.19.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /196  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- SEM -C-INTRA
Part I:
Box I.11: Place of dispatch shall correspond to the semen collection centre (as defined in Article 2(b) first indent 
of Directive 88/407/EEC) where the semen was collected.
Box I.12: Place of destination shall correspond to the semen collection or storage centre (as defined in 
Article 2(b) of Directive 88/407/EEC), or to the holding o f semen destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: Donor identity shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyy y and shall be earlier than 31 
December 2004.
Approval number of the centre shall correspond to the approval number of the semen centre indicated 
in Box I.11. where the semen was collected.
Part II: 
(1)Only semen collection centres approved by the competent authority and listed in accordance with 
Article 5(2) of Council Directive 88/407/EEC.
(2)Delete as appropriate.
(3)Name of the laboratory.
(4)May be deleted for fresh semen.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /197
CHAPTER 26
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF 
BOVINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH REGULATION (EU) 2016/429 AND DELEGATED 
REGULATION (EU) 2020 /686 AFTER 20 APRIL 2021, DISPATCHED BY THE
EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (M ODEL ‘BOV- OOCYT ES-
EMB- A-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country 
codeI.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
CountryISO country 
codeCountry ISO country code
I.7 Country of originISO country 
codeI.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /198  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /199
EUROPEAN UNION Certificate model BOV- OOCYTES -EMB- A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)[II.1. The in vivo derived embryos of bovine animals described in Part I have been collected, processed 
and stored, and dispatched by the embryo collection team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Commission Delegated 
Regulation (EU) 2020/686.]
(1)[II.1. The oocytes(1)/ in vitro produced embryos(1)/micromanipulate d embryos(1)of bovine animals 
described in Part I have been collected or produced, processed and stored, and dispatched by the 
embryo production team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with req uirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020/686.]
II.2. The oocytes(1)/ embryos(1)described in Part I are intended for artificial reproduction and were 
obtained from donor animals which
II.2.1. have been born and remained since birth in the Union, or have entered the Union in accordance with the requirements for entry into the Union;
II.2.2. come from establishments in a Member State or zone thereof, or from establishments under official control by the competent authority in a third country or territory, or a 
zone thereof 
II.2.2.1. free from infection with Mycobacterium tuberculosis complex ( M. bovis, 
M. caprae and M. tuberculosis
), and they have never been kept 
previously in any establishment of a lower health status;
II.2.2.2. free from infection with Brucella abortus, B. melitensis and B. suis and 
they have never been kept previously in any establishment of a lower health status;
(1)either [II.2.2.3. free from enzootic bovine leukosis and they have never been kept 
previously in any establishment of a lower health status;]
(1)or[II.2.2.3. not f ree from enzootic bovine leukosis and the official veterinarian 
responsible for the establishment of origin has certified that there has 
been no clinical case of enzootic bovine leukosis during a period of at 
least the preceding 3 years;]
(1)either [II.2.2 .4. free from infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis and they have never been kept previously in any 
establishment of a lower health status;]
L 113 /200  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- OOCYTES -EMB- A-INTRA
(1)or[II.2.2.4. not free from infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis and the official veterinarian responsible for the 
establishment of origin has certified that there has been no clinical case 
of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis 
during a period of at least the pre ceding 12 months;]
II.2.2.5. in which surra (Trypanosoma evansi) has not been reported during the 
30 day period prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1), and
(1)either [surra has not been reported in the establishments during the last 2 years 
prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)or [surra has been reported in the establishments during the last 2 years 
prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1)and 
following the last outb reak the establishments have remained under 
movement restrictions until
−the infected animals have been removed from the establishment, and
−the remaining animals on the establishment have been subjected to a test for surra (Trypanosoma evansi ) with one of t
he diagnostic 
methods provided for in Part 3 of Annex I to Commission Delegated 
Regulation (EU) 2020/688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the establishment;]
II.2.3. were examined by the team veterinarian or a
team member and did not show 
symptoms or clinical signs of transmissible animal diseases on the day of 
collection(1)/ production(1)of the oocytes(1)/ embryos(1); 
II.2.4. are individually identified as provided for in Article 38 of Commission Delegated 
Regulation (EU) 2019/2035;
II.2.5. for a period of at least 30 days prior to the date of first collection(1)/ production(1)of 
the oocytes(1)/ embryos(1)and during the collection period 
II.2.5.1. were kept on establishments not situated in a restricted zone established 
due to the occurrence of foot -and-mouth disease, infection with 
rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia orlumpy skin disease ,or of an emerging 
disease relevant for ovine and caprine animals;
II.2.5.2. were kept on a single establishment where infection with Brucella 
abortus, B. melitensis and B. suis, infection with Mycobacterium 
tuberculosis complex (M. bovis, M. caprae and M. tuberculosis ), rabies, 
anthrax, surra (Trypanosoma evansi), enzootic bovine leukosis, 
infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, 
bovine viral diarrhoea, infection with epizootic haemorrhagic disease 
virus and infection with bluetong ue virus (serotypes 1- 24) have not been 
reported;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /201
EUROPEAN UNION Certificate model BOV- OOCYTES -EMB- A-INTRA
II.2.5.3. were not in contact with animals from establishments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.2.5.1. or from establishments which do not meet the c onditions 
referred to in point II.2.5.2.;
II.2.5.4. were not used for natural breeding;
II.2.6. comply with the following conditions as regards foot -and-mouth disease 
II.2.6.1. they come from establishments 
−situated in an area where foot -and-mouth disease has not been 
reported within a 10- km radius centred on the establishment for a 
period of at least 30 days immediately prior to the date of collection 
of the oocytes(1)/ embryos(1);
−in which foot -and-mouth disease has not been reported during a 
period of at least 3 months immediately prior to the date of collection 
of the oocytes(1)/ embryos(1);
(1)either [II.2.6.2. they were not vaccinated against foot -and-mouth disease;]
(1)(3)or[II.2.6.2. they were vaccinated against foot- and-mouth disease during the period 
of 12 months prior to the date of collection or production of the embryos
and
II.2.6.2.1. have not been vaccinated against foot -and-mouth disease 
within the period of at least 30 days immediately prior to the 
date of collection of the emb ryos;
II.2.6.2.2. the semen used for fertilisation was collected from a male 
donor that complies with the conditions set out in point 1(b) 
or the semen complies with the conditions set out in point 2 
of Chapter I of Part 5 of Annex II to Delegated Regulati on 
(EU) 2020/686;
II.2.6.2.3. prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the 
recommendations of the IETS Manual(4);
II.2.6.2.4. the embryos were stored deep frozen for a period of at least 
30 days from the date of collection, and during this period the donor animal has not shown clinical signs of foot -and-
mouth disease;]
(1)(5)[II.2.7. comply with at least one of the following conditions as regards infection with 
bluetongue virus (serotypes 1 -24):
(1)either [II.2.7.1. they have been kept for a period of at least 60 days prior to and during 
collection of the oocytes in a third country, territory or zone thereof free 
from infection with bluetongue virus (serotypes 1- 24)where no case of 
infection with b luetongue virus (serotypes 1 -24) has been confirmed during 
the last 24 months in the targeted animal population;]
L 113 /202  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- OOCYTES -EMB- A-INTRA
(1)and/or [II.2.7.2. they have been kept in a seasonally disease -free zone, during the seasonally 
disease- free period, for a period of at least 60 days prior to and during 
collection of the oocytes, in a third country, territory or zone thereof with an 
approved eradication programme against infection with bluetongue virus 
(serotype s1-24);]
(1)and/or [II.2.7.3. they have been kept in a seasonally disease -free zone, during the seasonally 
disease- free period, for a period of at least 60 days prior to and during 
collection of the oocytes, in a third country, territory or zone thereof where 
the competent authority of the place of origin of the co nsignment of 
oocytes(1)/ in vitro produced embryos(1)has obtained the prior written 
consent of the competent authority of the Member State of destination to the conditions for establishment of that seasonally disease -
free zone and to 
accept the consignmen t of oocytes(1)/ in vitro produced embryos(1);]
(1)and/or [II.2.7.4. they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes;]
(1)and/or [II.2.7.5. they have been subjected to a serological test to detect antibodies to the 
bluetongue virus serogroup 1 -24, with negative results, between 28 and 60 
days from the date of each collection of the oocytes;]
(1)and/or [II.2.7.6. they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood sample taken on the day of 
collection of the oocytes;]]
(1)(5)[II.2.8. comply with at least one of the following conditions as regards infection with 
epizootic haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7):
(1)either [II.2.8.1. they have been kept for a period of at least 60 days prior to and during 
collection of the oocytes in a third country, territory or zone thereof where 
EHDV 1 -7 has not been reported for a period of at least the preceding 2 
years within a radius of 150 km of the establishment;]
(1)and/or [II.2.8.2. they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes;]
(1)and/or [II.2.8.3. were resident in the exporting country in which according to official 
findings the following serotypes of EHDV exist: ………………………… and have been subjected with negative results in each case to the following 
tests carried out in an official laboratory:
(1)either [II.2.8.3.1. a serological test to detect antibodies to EHDV 1 -7, 
with negative results, on blood sample taken between 28 and 60 days from the date of the 
collection of the oocytes;]]
(1)and/or [II.2.8.3.2. an agent identification test for EHDV 1 -7, with 
negative results, on blood sample taken on the day
of collection of the oocytes.]]]
(1)(5)[II.2.9. comply with animal health requirements laid down in Chapter III of Part 1 of Annex 
II to Delegated Regulation (EU) 2020/686.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /203
EUROPEAN UNION Certificate model BOV- OOCYTES -EMB- A-INTRA
II.3. The oocytes(1)/ embryos(1)described in Part I
II.3.1. has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to 
Delegated Regulation (EU) 2020/686;
II.3.2. areplaced in s traws or other packages on which the mark is applied in accordance 
with requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 
and that mark is indicated in Box I.30;
II.3.3. are transported in a container which:
II.3.3.1. was sealed and numbered prior to the dispatch by the embryo collection 
or production team under responsibility of the team veterinarian, or by 
an official veterinarian, and the seal bears the number as indicated in 
Box I.19;
II.3.3.2. has been cleaned and either dis infected or sterilised before use, or is 
single -use container; 
(1)(6)[II.3.3.3. has been filled in with the cryogenic agent which not have been 
previously used for other products;]
(1)(7)[II.3.4. are placed in straws or other packages which are securely a nd hermetically sealed;
II.3.5. are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
(1)(8)[II.4. The in vivo derived embryos(1)/ in vitro produced embryos(1)/micromanipulated embryos(1)
described in Part I were conceived by artificial insemination using semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre 
approved for the collection, processing and/or storage of semen by the competent authority of a 
Member State or by the competent authority of a third country, territory or zone thereof listed in 
Annex IX to Commission Implementing Regulation (EU) 2021/404.]
(1)(9)[II.5. The following antibiotic or mixture of antibiotics(10)has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicat e the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. 
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.
L 113 /204  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- OOCYTES -EMB- A-INTRA
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Species” : select amongst “ Bos taurus ”, “Bison bison ” or “ Bubalus bubalis ” as 
appropriate.
“Type”: specify if oocytes, in vivo derived embryos, in vitro produced embryos or 
micromanipulated embryos.“Species” : select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : indicate mark on the straw or other packages where oocytes or 
embryos of th e consignment are placed. 
“Date of collection/production”: indicate the date on which oocytes or embryos of the 
consignment was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only embryo collection or producti on teams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(3)Option available only for the consignment of in vivo derived embryos.
(4)Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society ,1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA (http://www.iets.org/).
(5)Applicable for the consignment of oocytes and in vitro produced embryos.
(6)Applicable for frozen oocytes or embryos.
(7)Applicable for the consignment where in one container oocytes, in vivo derived embryos, in vitro produced 
embryos and micromanipulated embryos of bovine animals are placed and transported.
(8)Does not apply to oocytes.
(9)Mandatory attestation in case antibiotics were added.
(10)Insert the name(s) of the antibiotic(s) added and its(their) concentration.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /205
CHAPTER 27
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF EMBRYOS OF BOVINE 
ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED BEFORE 
21 APRIL 2021 IN ACCORDANCE WITH COUNCIL DIRECTIVE 89/556/EEC,
DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO CO LLECTION OR 
PRODUCTION TEAM BY W HICH THE EMBRYOS WERE COLLECTED OR 
PRODUCED (MODEL ‘BOV- EMB- B-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /206  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /207
EUROPEAN UNION Certificate model BOV- EMB- B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the embryos described in this certificate:
II.1. were collected, processed and stored in compliance with Annex A to Council Directive 
89/556/EEC;
II.2. were sent to the place of loading in sealed containers in compliance with Annex A to Directive 
89/556/EEC;
II.3. come from donors of the bovine species which comply with Annex B to Directive 89/556/EEC;
II.4. were conceived either by artificial insemination or by in vitro fertilisa tion (1) using semen 
coming from semen collection or storage centres approved in accordance with Council Directive 
88/407/EEC and loaded in a Member State of the European Community or in a third country 
listed in Annex I to Commission Decision 2004/639/EC (1)(2).
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box referenc e I.17: In the case of imported embryos, insert the number of the import certificate.
Box reference I.30: “Identification mark ”: corresponding to the details identifying the donor cows and the 
date of collection on the straw.
“Type ”: specify whether ther e is (a) penetration or (b) non -penetration of zona 
pellucida .
Part II:
(1)Delete as necessary.
(2)OJ L 292, 15.9.2004, p.21.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /208  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 28
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIG NMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT PROCESSING ESTABLISHMENT:
-semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 
April 2021;
-stocks of semen of bovine animals collected, processed and stored before 1 January 2005 in accordance 
with Council Directive 88/407/EEC as amended by Cou ncil Directive 93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of embryos of bovine animals collecte d or produced, processed and stored in accordance with 
Directive 89/556/EEC before 21 April 2021
(MODEL ‘BOV- GP-PROCESSING -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /209
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /210  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- GP-PROCESSING -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ 
oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)
was/were processed and stored:
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities 
and equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 
2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ 
micromanipulated embryos(2)described in Part I is/are intended for arti ficial reproduction and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or 
processed and stored in a germinal product processing establishment(2)(3),and/or stored in 
a germinal product storage centre(2)(3)situated in the Member State of its/their collection 
or production and complying with requirements as regards responsibilities, operational 
procedures, facilit ies and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Annex I to Delegated Regulation (EU) 2020/686, and was/were moved to the germinal 
product processing establishment indicated in Box I.11. situated in the Member State of 
its/their collection or production under animal health certification requirements at least as 
strict as those provided for in:
(2)either [Model BOV -SEM -A-INTRA(4);]
(2)and/or [Model BOV -SEM -B-INTRA(4);]
(2)and/or [Model BOV -SEM -C-INTRA(4);]
(2)and/or [Model B OV-OOC YTES-EMB -A-INTRA(4);]
(2)and/or [Model BOV -EMB -B-INTRA(4);]
(2)and/or [Model BOV -GP-PROCESSING -INTRA(4);]
(2)and/or [Model BOV -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or 
processed and stored in a germinal product processing establishment(2)(3),and/or stored in 
a germinal product storage centre(2)(3)situated in the Member State of its/their collection 
or production and complying with requirements as regards responsibilities, operational 
procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Annex I to Delegated Regulation (EU) 2020/686, and was/were moved to the germinal 
product processing establishment indicated in Box I.11. situated in another Member State 
accompanied by certificate(s) in accordance with:
(2)either [Model BOV -SEM -A-INTRA(4);]
(2)and/or [Model BOV -SEM -B-INTRA(4);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /211
EUROPEAN UNION Certificate model BOV- GP-PROCESSING -INTRA
(2)and/or [Model BOV -SEM -C-INTRA(4);]
(2)and/or [Model BOV -OOC YTES-EMB -A-INTRA4);]
(2)and/or [Model BOV -EMB -B-INTRA(4);]
(2)and/or [Model BOV -GP-PROCESSING -INTRA(4);]
(2)and/or [Model BOV -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or 
processed and stored in a germinal product processing establishment(2)(3),and/or stored in 
a germinal product storage centre(2)(3)situated in a third country, territory or zone thereof 
listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 and
complying with requirements as regards responsibilities, operational procedures, facilities 
and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to 
Delegated Regulation (EU) 2020/686, and entered the Union accompanied by 
certificate(s) in accordance with:
(2)either [Model BOV -SEM -A-ENTRY(4);]
(2)and/or [Model BOV -SEM -B-ENTRY (4);]
(2)and/or [Model BOV -SEM -C-ENTRY (4);]
(2)and/or [Model BOV -OOCYTES -EMB -A-ENTRY (4);]
(2)and/or [Model BOV -in-vivo-EMB -B-ENTRY(4);]
(2)and/or [Model BOV -in-vitro -EMB -C-ENTRY(4);]
(2)and/or [Model BOV -in-vitro -EMB -D-ENTRY(4);]
(2)and/or [Model BOV -GP-PROCESSING -ENTRY(4);]
(2)and/or [Model BOV -GP-STORAGE -ENTRY(4);]]
II.2.2. has/have been collected, processed and stored in accordance with animal health 
requirements set out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/areplaced i n straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and/or 
Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in Box 
I.30;
II.2.4.is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from the germinal product 
processing establishment under responsibility of the centre veterinarian, or by 
an official veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before u se, or is single -use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for other products;]
L 113 /212  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV- GP-PROCESSING -INTRA
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishments 
approved by the competent autho rity and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s ) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo collection and/or production team by which the oocytes and/or embryos were c ollected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.26 : Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as 
appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consig nment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same ma rk.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /213
EUROPEAN UNION Certificate model BOV- GP-PROCESSING -INTRA
Part II:
(1)Only germinal product processing establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020/686.
(2)Delete if not applicable.
(3)Only germinal product establishments approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(4)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo coll ection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where t he semen, oocytes 
or embryos were stored to the germinal product processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of bovine animals are placed and transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /214  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 29
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIG NMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT STORAGE CENTRE:
-semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 
April 2021;
-stocks of semen of bovine animals collected, processed and stored before 1 January 2005 in accordance 
with Council Directive 88/407/EEC as amended by Council Directive 93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulat ion (EU) 2020/686 after 20 April 2021;
-stocks of embryos of bovine animals collected or produced, processed and stored in accordance with 
Directive 89/556/EEC before 21 April 2021
(MODEL ‘BOV- GP-STORAGE- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /215
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /216  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -GP-STORAGE -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in
vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)was/were 
stored:
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with r equirements as regards responsibilities, operational procedures, facilities 
and equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 
2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ 
micromanipulated embryos(2)described in Part I is/are intended for artificial reproduction and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or 
processed and stored in a germinal product processing establishment(2)(3),and/or stored in 
a germinal product storage centre(2)(3)situated in the Member State of its/their collection 
or production and complying with r equirements as regards responsibilities, operational 
procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Annex I to Delegated Regulation (EU) 2020/686, and was/were moved to the germinal 
product storage cent re indicated in Box I.11. situated in the Member State of its/their 
collection or production under animal health certification requirements at least as strict as 
those provided for in:
(2)either [Model BOV -SEM -A-INTRA(4);]
(2)and/or [Model BOV -SEM -B-INTRA(4);]
(2)and/or [Model BOV -SEM -C-INTRA(4);]
(2)and/or [Model in Annex D1 to Directive 88/407/EEC(4);]
(2)and/or [Model in Annex D2 to Directive 88/407/EEC(4);]
(2)and/or [Model in Annex D3 to Directive 88/407/EEC(4);]
(2)and/or [Model BOV -OOCYTES -EMB -A-INTRA(4);]
(2)and/or [Model BOV -EMB -B-INTRA(4);]
(2)and/or [Model BOV -GP-PROCESSING -INTRA(4);]
(2)and/or [Model BOV -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or 
processed and stored in a germinal product processing establishment(2)(3),and/or stored in 
a germinal product storage centre(2)(3)situated in the Member State of its/t heir collection 
or production and complying with requirements as regards responsibilities, operational 
procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Annex I to Delegated Regulation (EU) 2020/686, and w as/were moved to the germinal 
product storage centre indicated in Box I.11. situated in another Member State 
accompanied by certificate(s) in accordance with:
(2)either [Model BOV -SEM -A-INTRA(4);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /217
EUROPEAN UNION Certificate model BOV -GP-STORAGE -INTRA
(2)and/or [Model BOV -SEM -B-INTRA4);]
(2)and/or [Model BOV -SEM -C-INTRA(4);]
(2)and/or [Model in Annex D1 to Directive 88/407/EEC(4);]
(2)and/or [Model in Annex D2 to Directive 88/407/EEC(4);]
(2)and/or [Model in Annex D3 to Directive 88/407/EEC(4);]
(2)and/or [Model BOV -OOCYTES -EMB -A-INTRA(4);]
(2)and/or [Model BOV -EMB -B-INTRA(4);]
(2)and/or [Model BOV -GP-PROCESSING -INTRA(4);]
(2)and/or [Model BOV -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or 
processed and stored in a germinal product processing establishment(2)(3),and/or stored in 
a germinal product storage centre(2)(3)situated in a third country, territory or zone thereof 
listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 and
complying with requirements as regards responsibilities, operational procedures, facilities 
and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to 
Delegated Regulation (EU) 2020/686, and entered the Union accompanied by 
certificate(s) in accordance with:
(2)either [Model BOV -SEM -A-ENTRY(4);]
(2)and/or [Model BOV -SEM -B-ENTRY(4);]
(2)and/or [Model BOV -SEM -C-ENTRY(4);]
(2)and/or [Model 1 in Section A of Part 1of Annex II to Decision 2011/630/EU(4);]
(2)and/or [Model 2 in Section B of Part 1of Annex II to Decision 2011/630/EU(4);]
(2)and/or [Model 3 in Section C of Part 1of Annex II to Decision 2011/630/EU(4);]
(2)and/or [Model BOV -OOCYTES -EMB -A-ENTRY(4);]
(2)and/or [Model BOV -in-vivo-EMB -B-ENTRY(4);]
(2)and/or [Model BOV -in-vitro -EMB -C-ENTRY(4);]
(2)and/or [Model BOV -in-vitro -EMB -D-ENTRY(4);]
(2)and/or [Model BOV -GP-PROCESSING -ENTRY(4);]
(2)and/or [Model BOV -GP-STORAGE -ENTRY(4);]]
II.2.2. has/have been collected, processed and stored in accordance with animal health 
requirements set out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and/or 
Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in Box 
I.30;
L 113 /218  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model BOV -GP-STORAGE -INTRA
II.2.4. is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from the germinal product 
storage centre under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single- use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for other products;]
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent authority and included in the register referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
Box reference I.12: “Place of destination”:
Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I .19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as 
appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /219
EUROPEAN UNION Certificate model BOV -GP-STORAGE -INTRA
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : in Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produce d.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product storage centres approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(2)Delete if not applicable.
(3)Only germinal product establishments approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(4)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch described in Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of bovine animals are placed an d transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /220  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 30
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF SEMEN O F OVINE AND CAPRINE 
ANIMALS COLLECTED, PROC ESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED REGULATION (EU) 2020/ 686
AFTER 20 APRIL 2021, DISPATCH ED FROM THE SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED (MO DEL ‘OV/CAP -SEM -A-
INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /221
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act□Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /222  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)[II.1. The semen of ovine(1)/ caprine(1)animals described in Part I has been collected, processed and stored, and 
dispatched from the semen collection centre(2)which
II.1.1. isapproved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
(1)[II.1. The semen of ovine(1)/ caprine(1)animals described in Part I has been collected, processed and stored, and 
dispatched from the establishment where thedonor animals are kept as referred to in Article 13 of 
Delegated Regulation (EU) 2020/686, and
II.1.1. the operator obtained the prior consent of the competent authority of the Member State of 
destination to accept the consignment;
II.1.2. the donor animals have been clinically examined by a veterinarian prior to semen collection;
II.1.3. the operato r keeps records at the establishment which include at least the information 
provided for in Article 8(1)(a) of Delegated Regulation (EU) 2020/686.]
(1)either [II.1.4. was collected from animals which have been kept continuously since birth on a holding or 
holdings recognised as having a negligible or controlled risk of classical scrapie according to 
point 1 of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001, except 
during the period when they were kept at a semen collection centre that c omplied during that 
period with the conditions set out in the four indents of point 1.3.(c)(iv) of that Section;]
(1)or [II.1.4. was collected from animals which have been kept continuously for the last three years before 
the collection on a holding or hol dings which has/have complied for the last three years 
before the collection with the requirements laid down in points 1.3. (a) to (f) of Section A of 
Chapter A of Annex VIII to Regulation (EC) No 999/2001, except during the period when 
they were kept at a semen collection centre that complied during that period with the 
conditions set out in the four indents of point 1.3.(c)(iv) of that Section;]
(1)or [II.1.4. was collected from animals which have been kept continuously since birth in a Member State 
or zone of a Member State listed in point 2.3. of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie;]
(1)or [II.1.4. was collected from ovine animals of the ARR/ARR prion protein genot ype;]
II.2. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals 
which
II.2.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /223
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRA
II.2.2. come, before the commencement of the quarantine referred to in point II.2.6., from 
establishments in a Member State or zone thereof, or from establishments under official 
control by the competent authority in a third country or territory, or a zone thereof 
II.2.2.1. situated in an area where foot- and-mouth disease has not been reported within a 
10-km radius centred on the establishment for a period of at least 30 days and in 
which foot -and-mouth disease has not been reported during a period of at least 3 
months, and 
(1)either [they were not vaccinated against foot -and-mouth disease;]
(1)or[they were vaccinated against foot -and-mouth disease during the period of 12 
months prior to the date of collection of the semen but not during the period of 
the last 30 days immed iately prior to the date of collection of the semen, and 5 % 
(with a minimum of five straws) of each quantity of semen taken from a donor 
animal at any time is submitted to a virus isolation test for foot -and-mouth 
disease with negative results;]
II.2.2.2. free from infection with Brucella abortus, B. melitensis and B. suis and have 
never been kept previously in any establishment of a lower health status;
(1)(3)[II.2.2.3. in which infection with Mycobacterium tuberculosis complex ( M. bovis, M. 
caprae and M. tuberculosis ) has not been reported during the last 42 days;]
(1)(4)[II.2.2.3. in which surveillance for infection with Mycobacterium tuberculosis complex
(M. bovis, M. caprae and M. tuberculosis) has been carried out on the caprine 
animals kept on the establishments during at least the 12 month period, as 
referred to in Article 15(3) of Commission Delegated Regulation (EU) 2020/688, 
and in case, during this period, infection with Mycobacterium tuberculosis 
complex (M. bovis, M. caprae and M. tuberculosi s) has been reported in caprine 
animals kept on the establishment, measures were taken in accordance with Part 
1(3) of Annex II to that Delegated Regulation;]
II.2.2.4. in which surra (Trypanosoma evansi ) has not been reported during the 30 day 
period, and
(1)either [surra has not been reported in the establishments during the last 2 years;]
(1)or [surra has been reported in the establishments during the last 2 years and 
following the last outbreak the establishments have remained under movement 
restriction s until
−the infected animals have been removed from the establishment, and
−the remaining animals on the establishment have been subjected to a test for surra (Trypanosoma evansi) with one of the diagnostic methods provided for 
in Part 3 of Annex I to Deleg ated Regulation (EU) 2020/688, carried out, 
with negative results, on samples taken at least 6 months after the infected 
animals have been removed from the establishment;]
L 113 /224  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRA
(1)(3)[II.2.2.5. in which ovine epididymitis ( Brucella ovis ) has not been reported during the 12 
month period;]
(1)(8)[II.2.2.6. where, during the period of 60 days prior to their stay in the quarantine 
accommodation referred to in point II.2.6., they have been subjected, with 
negative results, to a serological test for ovine epididymitis ( Brucella ovis ), or 
any other test for ovine epididymitis ( Brucella ovis ) of an equivalent documented 
sensitivity and specificity, as required in accordance with point 1(b) of Chapter I 
of Part 3 of Annex II to Delegated Regulation (EU) 2020/686;]
II.2.3. did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen; 
II.2.4. are individually identified as provided for in Article 45(2 ) or (4), or Article 46(1) of 
Commission Delegated Regulation (EU) 2019/2035;
II.2.5. for a period of at least 30 days prior to the date of first collection of the semen and during the collection period 
II.2.5.1. were kept on establishments not situated i n a restricted zone established due to 
the occurrence of foot -and-
mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants 
virus, sheep pox and goat pox orcontagious caprine pleuropneumonia ,or of an 
emerging disease relevant for ovine and caprine animals;
II.2.5.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis andB. suis, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax, surra (Trypanosoma 
evansi), infection with epizootic haemorrhagic disease virus, infection with 
bluetongue virus (serotypes 1 -24) and, in case of ovine animals and those caprine 
animals which are kept together with ovine animals, ovine epididymitis 
(Brucella ovis ) have not been reported;
II.2.5.3. were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.2.5.1. or from 
establishme nts which do not meet the conditions referred to in point II.2.5.2.;
II.2.5.4. were not used for natural breeding;
II.2.6. have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven- hoofed anim als with at least the same health status 
were present, which on the day of their admission to the semen collection centre complied 
with the following conditions:
II.2.6.1. it was not situated in a restricted zone established due to diseases referred to in 
point II.2.5.1.;
II.2.6.2. none of the diseases referred to in point II.2.5.2. has been reported for a period of 
at least 30 days;
II.2.6.3. it was situated in an area where foot- and-mouth disease has not been reported 
within a 10- km radius centred on the quarantine accommodation for a period of 
at least 30 days;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /225
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRA
II.2.6.4. has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;
II.2.7. were kept in the semen collection centre
II.2.7.1. which was not situated in a restricted zone established due to diseases referred to 
in point II.2.5.1.;
II.2.7.2. where none of the diseases referred to in point II.2.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and
(1)(3)[at least 30 days following the date of the collection;]
(1)(4)[until the date of dispatch of the consignment of semen to another Member 
State;]
II.2.7.3. situated in an area where foot- and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and
(1)(3)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the seme n and 30 days from the date of collection;]
(1)(4)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment of semen to another Member State and the do nor animals have been kept at that 
semen collection centre for a continuous period of at least 30 days immediately 
prior to the date of collection of the semen;]
II.2.8. comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1 -24):
(1)either [II.2.8.1. they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a Member State or zone thereof free from infection with bluetongue 
virus (serotypes 1- 24) where no case of infection with bluetongue virus (serotypes 
1-24) has been confirmed during the last 24 months in the targeted animal 
population;]
(1)and/or [II.2.8.2. they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a p eriod of at least 60 days prior to and during collection of the 
semen, in a Member State or zone thereof with an approved eradication programme against infection with bluetongue virus (serotype s1-24);]
(1)and/or [II.2.8.3. they have been kept in a seasona lly disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a Member State or zone thereof where the competent authority of the 
place of origin of the consignment of sem en has obtained the prior written consent 
of the competent authority of the Member State of destination to the conditions for 
establishment of that seasonally disease -free zone and to accept the consignment of 
semen;]
L 113 /226  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRA
(1)and/or [II.2.8.4. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(1)and/or [II.2.8.5. they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1 -24, with ne gative results, between 28 and 60 days from the date of 
each collection of the semen;]
(1)and/or [II.2.8.6. they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood samples taken at com mencement 
and final collection of the semen and during collection of the semen at intervals of at 
least every 7 days, in the case of the virus isolation test, or of at least every 28 days, 
in the case of PCR;]
II.2.9. comply with at least one of the follow ing conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7):
(1)either [II.2.9.1. they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a Member State or zone thereof where EHDV 1 -7 has not been 
reported for a period of at least the preceding 2 years within a radius of 150 km of 
the establishment;]
(1)and/or [II.2.9.2. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(1)and/or [II.2.9.3. were resident in the Member State in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to the foll owing tests carried out in an 
official laboratory:
(1)either [II.2.9.3.1. a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days throughout the collection period and 
between 28 and 60 days from the date of the final collection of the 
semen;]]
(1)and/or [II.2.9.3.2. an agent identification test for EHDV 1 -7, with negative results, on 
blood samples taken at the commencement and final collection of the semen and during the collection of the semen at intervals of at least 
every 7 days, in the case of virus isolation test, or of at least every 28 
days, in the case of PCR.]]
(1)(5)[II.2.10. have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to the commencem ent of the quarantine referred to in point II.2.6., 
with negative results, required in accordance with point 1(c) of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/686:
II.2.10.1. for infection with Brucella abortus, B. melitensis and B.suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(1)(8)[II.2.10.2. for ovine epididymitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /227
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRA
II.2.11. have been subjected to the following tests, carried out on blood samples taken within a period 
of at least 21 days after the commencement of the quarantine referred to in point II.2.6., with 
negative results, required in accordance with point 1(d) of Chapter I of Part 3 of Annex II to 
Delegated Regulation (EU) 2020/686:
II.2.11.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU )
2020/688;
(1)(8)[II.2.11.2. for ovine epididymitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]
II.2.12. have been subjected at semen collection centre, at least once a year, to the fol lowing 
compulsory routine tests, required in accordance with point 2 of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/686:
II.2.12.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in poin t 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(1)(8)[II.2.12.2. for ovine epididymitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity.]]
(1)(9)[II.2.13. have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to collection of the semen, with negative results:
II.2.13.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in po int 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(1)(8)[II.2.13.2. for ovine epididymitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]]
II.3. The semen described in Part I
(1)(5)[II.3.1. has been collected, processed and stored in accordance with animal health requirements set out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/686;]
II.3.2. isplaced in straws or other packages on which the mark
is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and that 
mark is indicated in Box I.30;
II.3.3. is transported in a container which:
II.3.3.1. was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;
II.3.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use
container; 
(1)(6)[II.3.3.3. has been filled in with the cryogenic agent which not have been previously used for other products.]
L 113 /228  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRA
(1)(10)[II.4. The semen is preserved by the addition of antibiotics as follows:
II.4.1. The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, 
or is contained in the used semen diluents, to reach the indicated concentration per ml of semen:
(1)either [gentamicin (250 μg);]
(1)or [a mixture of penicillin (500 IU) and streptom ycin (500 μg);]
(1)or [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]
(1)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]
(1)or [a mixture of amikacin (75 μg) and divekacin (25 μg);]
(1)or [an antibiotic or a mixture of antibiotics(11)…………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg); 
-penicillin (500 IU) and streptomycin (500 μg);
-gentamicin (250 μg), tylosin (50 μg) and lincomycin- spectinomycin (150/300 μg);
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.4.2. Immediately after the additio n of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature of at least 5°C for a period of not less than 45 minutes, or under a 
time-temperature regime with a documented equivalent bactericidal activity.]
Notes:
Inaccordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in c onjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificate s provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the semen collection centre or, in case of an establishment as referred in Article 13 of 
Delegated Regulation (EU) 2020/686, the unique registration number and address of 
the establishment of dispatch of the consignment of semen. 
Box reference I.12: “Place of destination”: Indicate the address and uniq ue registration or approval 
number of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /229
EUROPEAN UNION Certificate model OV/CAP -SEM -A-INTRA
Box reference I.30: “Type”: semen.
“Species” : select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
Identification mark : indicate mark on the straw or other packages where semen of the 
consignment is placed. 
“Date of collection/production”: indicate the date on which semen of the consignment 
was collected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre or, in case of an establishment as 
referred in Article 13 of Delegated Regulation (EU) 2020/686, the unique registration 
number of the establishment where the semen was collected.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regul ation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
(3)Applicable for ovine animals.
(4)Applicable for caprine animals.
(5)Applicable for semen collected at a semen collection centre.
(6)Applicable for frozen semen.
(7)Applicable for fresh and chilled semen.
(8)Applicable for ovine animals and for those caprine animals which are kept together with ovine animals.
(9)Applicable for semen collected at an establishment w here the donor animals are kept as referred to in Article 
13 of Delegated Regulation (EU) 2020/686.
(10)Mandatory attestation in case antibiotics were added.
(11)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /230  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 31
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF OVINE AND
CAPRINE ANIMALS COLLECTED, PROCESSED AND STORED IN 
ACCORDANCE WITH DIRECTIVE 92/65/EEC AFTE R 31 AUGUST 2010 AND
BEFORE 21 APRIL 2021 , DISPATCHED AFTER 2 0 APRIL 2021 FRO MTHE
SEMEN COLLECTION CEN TRE WHERE THE SEMEN WAS COLLECTED 
(MODEL ‘OV/CAP -SEM -B-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /231
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /232  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -SEM -B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen described in Part I: 
II.1.1. was collected, processed and stored in a semen collection centre(1)approved and supervised by 
the competent authority in accordance with Chapter I(I)(1) and Chapter I(II)(1) of Annex D to 
Directive 92/65/EEC;
II.1.2. comes from donor animals which meet the requirements of Chapter II(II) of Annex D to 
Directive 92/65/EEC;
II.1.3. was collected, processed, stored and transported under conditions which comply with the 
requirements of Chapters II(II) and III(I) of Annex D to Directive 92/65/EEC;
(2)either [II.1.4. was collected from animals which have been kept continuously since birth on a holding or 
holdings recognised as having a negligible or controlled risk of classical scrapie according to point 1 of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;]
(2)or [II.1.4. was collected from animals which hav e been kept continuously for the last three years before 
the collection on a holding or holdings which has/have complied for the last three years 
before the collection with the requirements laid down in points 1.3. (a) to (f) of Section A of 
Chapter A of A nnex VIII to Regulation (EC) No 999/2001;]
(2)or [II.1.4. was collected from animals which have been kept continuously since birth in a Member State 
or zone of a Member State with a negligible risk status for classical scrapie approved in 
accordance with p oint 2.2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 
999/2001.;] 
(2)or [II.1.4. was collected from ovine animals of the ARR/ARR prion protein genotype;]
II.1.5. was sent to the place of loading in a sealed container in accordance with p oint 1.4. of 
Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number detailed in 
Box I.23.
(2)either [II.2. No antibiotics or no mixture of antibiotics were added to the semen.]
(2)or [II.2. The following antibiotic or combination of antibiotics was added to produce a concentration 
in the final diluted semen of not less than(3):
…………………………………………………………………………………….. .]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the semen collection centre of origin of the semen.
Box I.12: Place of destination shall correspond to the semen collection centre, germinal product processing 
establishment, germinal product storage centre or to the establishment of semen destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: Identification number shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the centre shall correspond to the approval number of the semen centre indicated 
in Box I.11. where the semen was collected.
Part II:
(1)Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Directive 92/65/EEC. 
(2)Delete as appropriate.
(3)Insert names and concentrations.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /233
EUROPEAN UNION Certificate model OV/CAP -SEM -B-INTRA
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /234  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 32
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF OVINE AND
CAPRINE ANIMALS COLLECTED, PROCESSED AND STORED IN 
ACCORDANCE WITH DIRECTIVE 92/65/EEC BEFO RE 1 SEPTEMBER 2010,
DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION
CENTRE WHERE THE SEME N WAS COLLECTED (MODEL ‘OV/CAP -SEM -C-
INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /235
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /236  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -SEM -C-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the semen described in Part I:
II.1. was collected, processed and stored in a semen collection centre(1)approved and supervised 
by the competent authority in accordance with Chapter I(I) and Chapter I(II) of Annex D to 
Directive 92/65/EEC;
II.2. comes from the donor animals which meet the requirements of Chapter II(II) of Annex D to 
Directive 92/65/EEC;
II.3. was collected, processed, stored and transported under conditions which comply with the 
requirements of Chapters II(II) and III of Annex D to Directive 92/65/EEC;
(2)either [II.4. meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001, as 
applicable on 31 August 2010;]
(2)or [II.4. meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001, as 
applicable on 31 August 2010, and is destined for a Member State which benefits, for all or 
part of its terr itory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex 
VIII to Regulation (EC) No 999/2001, as applicable on 31 August 2010, and the donor 
animals comply regarding scrapie with the guarantees provided for by the programmes 
referred to in that point and with the guarantees(3)requested by the Member State of 
destination.]
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European At omic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the semen collection centre of origin of the semen.
Box I.12: Place of destination shall correspond to the semen collection centre, germinal product processing 
establishment, germinal product storage centre or to the establishment of semen destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: Identification number shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval numb er of the centre shall correspond to the approval number of the semen centre indicated 
in Box I.11. where the semen was collected.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /237
EUROPEAN UNION Certificate model OV/CAP -SEM -C-INTRA
Part II:
(1) Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.
(2) Delete as appropriate.
(3) Additional guarantees as laid down in Article 2 of Regulation (EC) No 546/2006 (OJ L 94, 1.4.2006, 
p.28).
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /238  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 33
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF 
OVINE AND CAPRINE ANIMALS COLLECTED OR P RODUCED, PROCESSED 
AND STORED IN ACCORD ANCE WITH REGULATION (EU) 2016/429 AND 
DELEGATED REGULATION (EU) 2020/686 AFTER 20 APRIL 2021 D ISPATCHED 
BYTHE EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE 
OOCYTES OR EMBRYOS W ERE COLLECTED OR PRODUCED (MODEL 
‘OV/CAP -OOCYTES -EMB- A-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /239
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /240  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)[II.1. The in vivo derived embryos of ovine(1)/ caprine(1)animals described in Part I have been collected, 
processed and stored, and dispatched by the embryo collection team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilit ies, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Commission Delegated 
Regulation (EU) 2020/686.]
(1)[II.1. The oocytes(1)/ in vitro produced embryos(1)/micromanipulated embryos(1)of ovine(1)/ caprine(1)
animals descri bed in Part I have been collected or produced, processed and stored, and dispatched 
by the embryo production team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities , operational procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020/686.]
II.2. The consignment consists of embryos of the ovine or caprine species which comply with the 
following conditions as regards classical scrapie:
(1)either [they were collected from animals which have been kept continuously since birth on a 
holding or holdings recognised as having a negligible or a controlled risk of classical 
scrapie in accordance with point 1 of Section A of Cha pter A of Annex VIII to 
Regulation (EC) No 999/2001, except during the period when they were kept at a semen collection centre that complied during that period with the conditions set out in the four 
indents of point 1.3.(c)(iv) of that Section;]
(1)or [they were collected from animals which have been kept continuously for the last three 
years before the collection on a holding or holdings which have complied for the last 
three years before collection with the requirements laid down in points (a) to (f) of point 
1.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001, except 
during the period when they were kept at a semen collection centre that complied during 
that period with the conditions set out in the four indents of point 1.3.(c)(i v) of that 
Section;]
(1)or [they were collected from animals which have been kept continuously since birth in a 
Member State or zone of a Member State listed in point 2.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for 
classical scrapie;]
(1)or [they were collected from ovine animals and
(1)either [are of the ARR/ARR prion protein genotype;]
(1)or [carry at least one ARR allele;]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /241
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- A-INTRA
II.3. The oocytes(1)/ embryos(1)described in Part I are intended for artificial reproduction and were 
obtained from donor animals which
II.3.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
II.3.2. come from establishments in a Member State or zone thereof, or from establishments 
under official control by the competent authority in a third country or territory, or a 
zone thereof 
II.3.2.1. free from infection with Brucella abortus, B. melitensis and B. suis and 
have never been kept previously in any establishment of a lower health status;
(1)(3)[II.3.2.2. in which infection with Mycobacterium tuberculosis complex (M. bovis, 
M. caprae and M. tuberculosis ) has not been reported during the last 42 
days prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)(4)[II.3.2.2. in which surveillance for infection with Mycobacterium tuberculosis 
complex (M. bovis, M. caprae and M. tuberculosis) has been carried out 
on the caprine a nimals kept on the establishments during at least the 12 
month period prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1), as referred to in Article 15(3) of Commission Delegated 
Regulation (EU) 2020/688, and in case, during this period, in fection 
with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis) has been reported in caprine animals kept on the 
establishment, measures were taken in accordance with Part 1(3) of 
Annex II to that Delegated Regulation;]
II.3.2.3. in which surra (Trypanosoma evansi) has not been reported during the 
30 days period prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1), and
(1)either [surra has not been reported in the establishments during the last 2 years prior to collection
(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)or [surra has been reported in the establishments during the last 2 years 
prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1)and 
following the last outbreak the establishments have remained under 
movement restrictions until
−the infected animals have been removed from the establishment, and
−the remaining animals on the establishment have been subjected to a test for surra (Trypanosoma evansi
) with one of the diagnostic 
methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from 
the establishment;]
II.3.3. were examined by the team veterinar ian or a
team member and did not show 
symptoms or clinical signs of transmissible animal diseases on the day of 
collection(1)/ production(1)of the oocytes(1)/ embryos(1); 
L 113 /242  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- A-INTRA
II.3.4. are individually identified as provided for in Article 45(2) or (4), or Article 46(1) or 
(3) of Commission Delegated Regulation (EU) 2019/2035;
II.3.5. for a period of at least 30 days prior to the date of first collection(1)/ production(1)of 
the oocytes(1)/ embryos(1)and during the collection period 
II.3.5.1. were kept on establishments not situated in a restricted zone established 
due to the occurrence of foot -and-mouth disease, infection with 
rinderpest virus, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox orcontagious 
caprine pleuropneumonia ,or of an emerging disease relevant for ovine 
and caprine animals;
II.3.5.2. were kept on a single establishment where infection with Brucella 
abortus, B. melitensis and B. suis, infection with Mycobacterium 
tuberculosi scomplex (M. bovis, M. caprae and M. tuberculosis ), rabies, 
anthrax, surra (Trypanosoma evansi), infection with epizootic 
haemorrhagic disease virus, infection with bluetongue virus (serotypes 
1-24) and, in case of ovine animals and those caprine animals which are 
kept together with ovine animals, ovine epididymitis ( Brucella ovis )
have not been reported;
II.3.5.3. were not in contact with animals from establishments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.3.5.1. or from establishments which do not meet the conditions 
referred to in point II.3.5.2.;
II.3.5.4. were not used for natural breeding;
II.3.6. comply with the following conditions as regards foot -and-mouth disease 
II.3.6.1. they come from establishmen ts 
−situated in an area where foot -and-mouth disease has not been 
reported within a 10- km radius centred on the establishment for a 
period of at least 30 days immediately prior to the date of collection of the oocytes
(1)/ embryos(1);
−in which foot -and-mouth disease has not been reported during a 
period of at least 3 months immediately prior to the date of collection of the oocytes
(1)/ embryos(1);
(1)either [II.3.6.2. they were not vaccinated against foot -and-mouth disease;]
(1)(5)or[II.3.6.2. they were vaccinated against foot- and-mouth disease during the period 
of 12 months prior to the date of collection or production of the embryos
and
II.3.6.2.1. have not been vaccinated against foot -and-mouth disease 
within the period of at least 30 days i mmediately prior to the 
date of collection of the embryos;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /243
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- A-INTRA
II.3.6.2.2. the semen used for fertilisation was collected from a male 
donor that complies with the conditions set out in point 1(b) 
or the semen complies with the conditions set out in point 2 
of Chapter I of Part 5 of Annex II to Delegated Regulation 
(EU) 2020/686;
II.3.6.2.3. prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the 
recommendations of the IETS Manual(6);
II.3.6.2.4. the embryos we re stored deep frozen for a period of at least 
30 days from the date of collection, and during this period the donor animal has not shown clinical signs of foot -and-
mouth disease;]
II.3.7. comply with at least one of the following conditions as regards inf
ection with 
bluetongue virus (serotypes 1 -24):
(1)either [II.3.7.1. they have been kept for a period of at least 60 days prior to and during 
collection of the oocytes(1)/ embryos(1)in a Member State or zone thereof 
free from infection with bluetongue virus (serotypes 1 -24)where no 
case of infection with bluetongue virus (serotypes 1- 24) has been 
confirmed during the last 24 months in the targeted animal population;]
(1)and/or [II.3.7.2. they have been kept in a seasonally disease- free zone, during the
seasonally disease- free period, for a period of at least 60 days prior to 
and during collection of the oocytes(1)/ embryos(1), in a Member State or 
zone thereof with an approved eradication programme against infection 
with bluetongue virus (serotype s1-24);]
(1)and/or [II.3.7.3. they have been kept in a seasonally disease- free zone, during the 
seasonally disease- free period, for a period of at least 60 days prior to 
and during collection of the oocytes(1)/ embryos(1), in a Member State or 
zone thereof wher e the competent authority of the place of origin of the 
consignment of oocytes(1)/ embryos(1)has obtained the prior written 
consent of the competent authority of the Member State of destination to 
the conditions for establishment of that seasonally diseas e-free zone and 
to accept the consignment of oocytes(1)/ embryos(1);]
(1)and/or [II.3.7.4. they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes(1)/ embryos(1);]
(1)and/or [II.3.7.5. they have been subjected to a serological test to detect antibodies to the bluetongue virus serogroup 1 -24, with negative results, between 28 and 
60 days from the date of each collection of the oocytes
(1)/ embryos(1);]
L 113 /244  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- A-INTRA
(1)and/or [II.3.7.6. they have been subjected to an agent identification test for bluetongue 
virus (serotypes 1 -24), with negative results, on blood sample taken on 
the dayof collection of the oocytes(1)/ embryos(1);]
II.3.8. comply with at least one of the following conditio ns as regards infection with 
epizootic haemorrhagic disease virus (serotypes 1- 7) (EHDV 1 -7):
(1)either [II.3.8.1. they have been kept for a period of at least 60 days prior to and during 
collection of the oocytes(1)/ embryos(1)in a Member State or zone t hereof 
where EHDV 1 -7 has not been reported for a period of at least the 
preceding 2 years within a radius of 150 km of the establishment;]
(1)and/or [II.3.8.2. they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes(1)/ embryos(1);]
(1)and/or [II.3.8.3. were resident in a Member State or zone thereof in which according to 
official findings the following serotypes of EHDV exist: 
………………………… and have been subjected with negative results 
in each case to the following tests carried out in an official laboratory:
(1)either [II.3.8.3.1. a serological test to detect antibodies to EHDV 1 -7, with 
negative results, on blood sample taken between 28 and 60 days from the date of the collection of the oocytes
(1)/ 
embryos(1);]]
(1)and/or [II.3.8.3.2. an agent identification test for EHDV 1 -7, with negative 
results, on blood sample taken on the dayof collection of the 
oocytes(1)/ embryos(1).]]
II.4. The oocytes(1)/ embryos(1)described in Part I
II.4.1. has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to 
Delegated Regulation (EU) 2020/686;
II.4.2. areplaced in straws or other packages on which the mark is applied in accordance 
with requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 
and that mark is indicated in Box I.30;
II.4.3. are transported in a container which:
II.4.3.1. was sealed and numbered prior to the dispatch by the embryo collection or production team under responsibility of the team veterinarian, or by 
an official veterinarian, and the seal bears the number as indicated in 
Box I.19;
II.4.3.2. has been cleaned and either disinfected or sterilised 
before use, or is 
single -use container; 
(1)(7)[II.4.3.3. has been filled in with the cryogenic agent which not have been 
previously used for other products;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /245
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- A-INTRA
(1)(8)[II.4.4. are placed in straws or other packages which are securely and hermetically sealed;
II.4.5. are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
(1)(9)[II.5. The in vivo derived embryos(1)/ in vitro produced embryos(1)/micromanipulated e mbryos(1)
described in Part I were conceived by artificial insemination using semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing and/or storage o f semen by the competent authority of a 
Member State or by the competent authority of a third country, territory or zone thereof listed in 
Annex X to Commission Implementing Regulation (EU) 2021/404.]
(1)(10)[II.6. The following antibiotic or mixture of antibiotics(11)has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European U nion and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. 
Box reference I.12: “Place of destination”: Indicate the address and unique regis
tration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced 
embryos or micromanipulated embryos.
“Species” : select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate.
“Identification number” : Indicate identif ication number of each donor animal.
“Identification mark” : indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed. 
“Date of collection/production”: indicate the date on which oocytes or embryos of the 
consignm ent was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
L 113 /246  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- A-INTRA
Part II:
(1)Delete if not applicable.
(2)Only embryo collection or production teams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(3)Applicable for ovine animals.
(4)Applicable for caprine animals.
(5)Option available only for the consignment of in vivo derived embryos.
(6)Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society ,1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA ( http://www.iets.org/ ).
(7)Applicable for frozen oocytes or embryos.(8)Applicable for the consignment where in one container 
oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of ov ine or 
caprine animals are placed and transported.
(9)Does not apply to oocytes.
(10)Mandatory attestation in case antibiotics were added.
(11)Insert the name(s) of the antibiotic(s) added and its(their) concentration.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /247
CHAPTER 34
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF OOCYTES AND 
EMBRYOS OF OVINE AND CAPRINE ANIMALS COLLECTED OR PRODUCED, 
PROCESSED AND STORED IN ACCORDANCE WITH DIRECTIVE 92/65/EEC 
AFTER 31 AUGUST 2010 AND BEFORE 21 APRIL 2021, DISPATCH ED AFTER 20 
APRIL 2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY 
WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED 
(MODEL ‘OV/CAP -OOCYTES -EMB -B-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /248  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /249
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)either [II.1. the in vivo derived embryos(1)/in vivo derived ova(1)described in Part I were collected, 
processed and stored by an embryo collection team(2)approved and supervised in 
accordance with Chapter I(III)(1) of Annex D to Directive 92/65/EEC;]
(1)or [II.1. the in vitro produced embryos(1)/micromanipulated embryos(1)described in Part I were 
produced, processed and stored by an embryo production team(2)approved and 
supervised in accordance with Chapter I(III)(1) and (2) of Annex D to Directive 
92/65/EEC;]
(1)either [II.2. the in vivo derived embryos described in Part I meet the requirements of Chapter 
III(II)(1) of Annex D to Directive 92/65/EEC;]
(1)or [II.2. the in vivo derived ova described in Part I meet the requirements of Chapter III(II)(2) of 
Annex D to Directive 92/65/EEC;]
(1)or [II.2. the in vitro produced embryos described in Part I meet the requirements of Chapter 
III(II)(3) of Annex D to Directive 92/65/EEC;]
(1)or [II.2. the micromanipulated embryos described in Part I meet the requirements of Chapter 
III(II)(4) of Annex D to Directive 92/65/EE C;]
[II.3. the consignment consists of embryos of the ovine or caprine species which comply with 
the following conditions as regards classical scrapie:
(1)either [they were collected from animals which have been kept continuously since birth on a holding or holdings recognised as having a negligible or a controlled risk of classical 
scrapie in accordance with point 1 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001;]
(1)or [they were collected from animals which have been kept conti nuously for the last three 
years before the collection on a holding or holdings which have complied for the last three years before collection with the requirements laid down in points (a) to (f) of point 1.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;]
(1)or [they were collected from animals which have been kept continuously since birth in a Member State or zone of a Member State with a negligible risk status for classical 
scrapie approved in accordance with the first subparag raph of point 2.2. of Section A of 
Chapter A of Annex VIII to Regulation (EC) No 999/2001;]
(1)or [they were collected from ovine animals and
(1)either [are of the ARR/ARR prion protein genotype;]
(1)or [carry at least one ARR allele and were collected after the date of 1 January 
2015;]]
II.4. the ova or embryos described in Part I come from female donors of the ovine(1)/caprine 
species(1)which meet the requirements of Chapter IV(3) of Annex D to Directive 
92/65/EEC;
L 113 /250  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- B-INTRA
(1)either [II.5. the embryos described in Part I were conceived as a result of artificial insemination of 
the donor females with semen which was collected, processed, stored and transported 
under conditions which comply with the requirements of Chapters I(I), II(I) and III(I) of 
Annex D to Directive 92/65/EEC;]
(1)or [II.5. the embryos described in Part I were conceived as a result of in vitro fertilisation of ova 
complying with the conditions in Chapter III(II)(2) of Annex D to Directive 92/65/EEC 
with semen which was collected, proce ssed, stored and transported under conditions 
which comply with the requirements of Chapters I(I), II(I) and III(I) of Annex D to Directive 92/65/EEC;]
(1)or [II.5. the ova have not been in contact with semen of the ovine and caprine species;]
II.6. the ova or embryos described in Part I were sent to the place of loading in a sealed 
container in accordance with point 6 of Chapter III(II) of Annex D to Directive 
92/65/EEC and bearing the number detailed in Box I.19.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the embryo collection team or embryo production team of 
embryos collection/production.
Box I.12: Place of destination shall correspond to the embryo collection team, embryo production team, 
germinal product processing establishment, germinal product storage centre or to the establishment 
of ova/embryos destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: “Type” : specify if: in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or 
micromanipul ated embryos.
Identification number shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the team shall correspond to the embryo collection team or e mbryo production 
team of ova/embryos collection/production.
Part II:
(1)Delete as appropriate.
(2)Only embryo collection or production teams approved by the competent authority and listed in accordance 
with Article 11(4) of Directive 92/65/EEC.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /251
CHAPTER 35
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF OOCYTES AND 
EMBRYOS OF OVINE AND CAPRINE ANIMALS COLLECTED OR PRODUCED, 
PROCESSED AND STORED IN ACCORDANCE WITH DIRECTIVE 92/65/EEC 
BEFORE 1 SEPTEMBER 2 010, DISPATCHED AFTER 20 APRIL 2021 BYTHE
EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (M ODEL ‘OV/CAP -
OOCYTES -EMB- C-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /252  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of 
originCold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing plant Approval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /253
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- C-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the ova/embryos(1)described in Part I:
II.1. were collected, processed and stored under conditions which meet the requirements of Directive 
92/65/EEC;
II.2. come from female donors of the ovine/caprine species(1)which meet the requirements of Chapter IV of 
Annex D to Directive 92/65/EEC;
II.3. are embryos of the ovine or caprine species which comply with the following conditions as regards 
classical scrapie:
(1)either [II.3.1. they meet the requirements of Chapter III of Annex D to Directive 92/65/EEC and of Chapter A(I) 
of Annex VIII to Regulation (EC) No 999/2001, as applicable on 31 August 2010;]
(1)or[II.3.1. they meet the requirements of Chapter III of Annex D to Directive 92/65/EEC and of Chapter A(I) 
of Annex VIII to Regulation (EC) No 999/2001, as applicable on 31 August 2010, and are destined 
for a Member State which benefits, for all or part of its territory, from the provisions laid down in 
point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001, as applicable on 
31 August 2010 and the donor animals comply regarding scrapie with the guarantees provided for 
by the programmes referred to in that point and with the guarantees(2)requested by the Member 
State of destination;]
(1)either [II.3.2. the semen used for fertilisation meets the requirements of Directive 92/65/EEC and the requirements 
of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001, as applicable on 31 August 2010;]
(1)or [II.3.2. the semen used for fertilisation meets the requirements of Directive 92/65/EEC and the 
requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001, as applicable on 
31 August 2010, and is dest ined for a Member State which benefits, for all or part of its territory, 
from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001, as applicable on 31 August 2010, and the donor animals comply regarding
scrapie with the guarantees provided for by the programmes referred to in that point and with the 
guarantees
(2)requested by the Member State of destination.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the embryo collection team of ova/embryos collection.
Box I.12: Place of destination shall correspond to the embryo collection team, embryo production team, 
germinal product processing establishment, germinal product s torage centre or to the establishment of 
ova/embryos destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: ”Type”: specify if: in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or 
micromanipulated embryos.
Identification number shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the team shall correspond t o the embryo collection team of ova/embryos 
collection indicated in Box I.11.
Part II:
(1)Delete as appropriate.
(2)Additional guarantees as laid down in Article 2 of Regulation (EC) No 546/2006 [OJ L 94, 1.4.2006, 
p.28].
Official veterinarian
L 113 /254  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -OOCYTES -EMB- C-INTRA
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /255
CHAPTER 36
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT PROCESSING ESTABLISHMENT :
-semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC after 31 August 2010 and before 21 April 2021;
-stocks of semen of ovine and caprine animals collected , processed and stored in accordance with 
Council Directive 92/65/EEC before 1 September 2010;
-oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 
2021
-stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Council Directive 92/65/EEC after 31 August 2010 and before 21 April 2021; 
-stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 1 September 2010
(MODEL ‘OV/CAP -GP-PROCESSING -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
L 113 /256  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /257
EUROPEAN UNION Certificate model OV/CAP -GP-PROCESSING -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)was/were 
processed and stored:II.1.1. is approved and kept in a register by the competent authority;
II.1.2.
complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated 
embryos(2)described in Part I is/are intended for artificial reproduction and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection tea m(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal produ ct processing establishment indicated in Box I.11. situated 
in the Member State of its/their collection or production under animal health certification 
requirements at least as strict as those provided for in:
(2)either [Model OV/CAP- SEM -A-INTRA(4);]
(2)and/or [Model OV/CAP- SEM -B-INTRA(4);]
(2)and/or [Model OV/CAP- SEM -C-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -A-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -B-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -C-INTRA(4);]
(2)and/or [Model OV/CAP- GP-PROCESSING -INTRA(4);]
(2)and/or [Model OV/CAP- GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards respons ibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal product processing establishment indicated in Box I.11. situated 
in another Member State accompanied by certificate(s) in accordance with:
(2)either [Model OV/CAP- SEM -A-INTRA(4);]
(2)and/or [Model OV/CAP- SEM -B-INTRA(4);]
(2)and/or [Model OV/CAP- SEM -C-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -A-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -B-INTRA(4);]
L 113 /258  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -GP-PROCESSING -INTRA
(2)and/or [Model OV/CAP- OOCY TES-EMB -C-INTRA(4);]
(2)and/or [Model OV/CAP- GP-PROCESSING -INTRA(4);]
(2)and/or [Model OV/CAP- GP-STORAGE -INTRA (4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in a third country, territory or zone thereof listed in Annex X to Commission 
Implementing Regulation (EU) 2021/404 and complying with requirements as regards 
responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 
3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and entered the Union 
accompanied by certificate(s) in accordance with:
(2)either [Model OV/CAP- SEM -A-ENTRY(4);]
(2)and/or [Model OV/CAP- SEM -B-ENTRY(4);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -A-ENTRY(4);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -B-ENTRY(4);]
(2)and/or [Model OV/CAP- GP-PROCESSING -ENTRY(4);]
(2)and/or [Model OV/CAP- GP-STORAGE -ENTRY(4);]]
II.2.2. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of De legated Regulation (EU) 2020/686 and/or Article 
83(a) of Commission Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.30;
II.2.4. is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before u se, or is single -use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;]
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6.is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /259
EUROPEAN UNION Certificate model OV/CAP -GP-PROCESSING -INTRA
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishments 
approved by the competent autho rity and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
Box reference I.12: “Place of destination: Indicate the address and unique registration or approval number 
of the establishment of destination of the consignment of semen, oocytes, and/or 
embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : indicate “Ovis aries ” and/or “ Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
L 113 /260  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -GP-PROCESSING -INTRA
Part II:
(1)Only germinal product processing establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020/686.
(2)Delete if not applicable .
(3)Only germinal product establishments approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(4)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or emb
ryos were stored to the germinal product processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /261
CHAPTER 37
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT STORAGE CENTRE:
-semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC after 31 August 2010 and before 21 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and stored in accordance with
Council Directive 92/65/EEC before 1 September 2010;
-oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 
2021
-stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC after 31 August 2010 and before 21 April 2021; 
-stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 1 September 2010
(MODEL ‘OV/CAP -GP-STORAGE- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
L 113 /262  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /263
EUROPEAN UNION Certificate model OV/CAP -GP-STORAGE -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo
derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)was/were stored:
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated 
embryos(2)described in Part I is/are intended for artificial re production and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product proce ssing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equip ment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal product storage centre indicated in Box I.11. situated in the 
Member State of its/their collection or production under animal health certification requirements 
at least as strict as those provided for in:
(2)either [Model OV/CAP- SEM -A-INTRA(4);]
(2)and/or [Model OV/CAP- SEM -B-INTRA(4);]
(2)and/or [Model OV/CAP- SEM -C-INTRA(4);]
(2)and/or [Model in Part A of Annex III to Commission Decision 2010/470/EU(4);]
(2)and/or [Model in Part B of Annex III to Decision 2010/470/EU(4);]
(2)and/or [Model in Part C of Annex III to Decision 2010/470/EU(4);]
(2)and/or [Model in Commission Decision 95/388/EC(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -A-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -B-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -C-INTRA(4);]
(2)and/or [Model OV/CAP- GP-PROCESSING -INTRA(4);]
(2)and/or [Model OV/CAP- GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal product storage centre indicated in Box I.11. situated in another 
Member State accompanied by certificate(s) in accordance with:
(2)either [Model OV/CAP- SEM -A-INTRA(4);]
L 113 /264  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -GP-STORAGE -INTRA
(2)and/or [Model OV/CAP- SEM -B-INTRA(4);]
(2)and/or [Model OV/CAP- SEM -C-INTRA(4);]
(2)and/or [Model in Part A of Annex III to Decision 2010/470/EU(4);]
(2)and/or [Model in Part B of Annex III to Decision 2010/470/EU(4);]
(2)and/or [Model in Part C of Annex III to Decision 2010/470/EU(4);]
(2)and/or [Model in Decision 95/388/EC(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -A-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -B-INTRA(4);]
(2)and/or [Model OV/CAP- OOCY TES-EMB -C-INTRA(4);]
(2)and/or [Model OV/CAP- GP-PROCESSING -INTRA(4);]
(2)and/or [Model OV/CAP- GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in a third country, territory or zone thereof listed in Annex X to Commissi on
Implementing Regulation (EU) 2021/404 and complying with requirements as regards 
responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 
3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and entered the Union 
accompanied by certificate(s) in accordance with:
(2)either [Model OV/CAP- SEM -A-ENTRY(4);]
(2)and/or [Model OV/CAP- SEM -B-ENTRY(4);]
(2)and/or [Model 1 in Section A of Part 2 of Annex II to Commission Decision 2010/472/EU(4);]
(2)and/or [Model 2 in Section B of Part 2 of Annex II to Decision 2010/472/EU(4);]
(2)and/or [Model in Annex II to Decision 2008/635/EC(4);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -A-ENTRY(4);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -B-ENTRY(4);]
(2)and/or [Model OV/CAP- GP-PROCESSING -ENTRY(4);]
(2)and/or [Model OV/CAP- GP-STORAGE -ENTRY(4);]]
II.2.2. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and/or Article 
83(a) of Commission Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.30;
II.2.4. is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /265
EUROPEAN UNION Certificate model OV/CAP -GP-STORAGE -INTRA
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent 
author ity and included in the register referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number o f the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total num ber of packages shall correspond to the number of containers.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : indicate “Ovis aries ” and/or “ Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
L 113 /266  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OV/CAP -GP-STORAGE -INTRA
Part II:
(1)Only germinal product storage centres approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(2)Delete if not applicable.
(3)Only germ inal product establishments approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(4)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which t he oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were st ored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one conta iner semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /267
CHAPTER 38
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF SEMEN O F PORCINE ANIMALS 
COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED REGULATION (EU) 2020/ 686
AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION
CENTRE WHERE THE SEM EN WAS COLLECTED (MO DEL ‘POR- SEM -A-
INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /268  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /269
EUROPEAN UNION Certificate model POR -SEM -A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen of porcine animals described in Part I has been collected, processed and stored, and dispatched 
from the semen collection centre(1)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 
2020/686.
II.2. The semen d escribed in Part I is intended for artificial reproduction and was obtained from donor animals 
which
II.2.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
II.2.2. come, before the commencement of the quarantine referred to in point II.2.8., from 
establishments in a Member State or zone thereof, or from establishments under official 
control by the competent authority in a third country or territory, or a zone ther eof 
II.2.2.1. situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the establishment for a period of at least 30 days and 
in which foot -and-mouth disease has not been reported during a period of at 
least 3 months, and 
(2)either [they were not vaccinated against foot -and-mouth disease;]
(2)or[they were vaccinated against foot- and-mouth disease during the period of 12 
months prior to the date of collection of the semen but not during the period of 
the las t 30 days immediately prior to the date of collection of the semen, and 5 
% (with a minimum of five straws) of each quantity of semen taken from a 
donor animal at any time is submitted to a virus isolation test for foot -and-
mouth disease with negative results;]
II.2.2.2. free from infection with Brucella abortus, B. melitensis and B. suis in 
accordance with the requirements laid down in Chapter IV of Part 5 of Annex 
II to Delegated Regulation (EU) 2020/686;
II.2.2.3. where no clinical, serological, virological or pathological evidence of infection 
with Aujeszky’s disease virus had been detected during the period of at least 12 
months;
II.2.2.4. where, during the period of at least 3 months, no animal was vaccinated against infection with porcine repr
oductive and respiratory syndrome virus and no 
infection with porcine reproductive and respiratory syndrome virus was 
detected;
II.2.3. did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen; 
II.2.4. are identified as provided for in Article 52 or 54(2) of Commission Delegated Regulation 
(EU) 2019/2035;
II.2.5. for a period of at least 30 days prior to the date of first collection of the s emen and during 
the collection period 
II.2.5.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot- and-mouth disease, infection with rinderpest virus, 
classical swine fever orAfrican swine fever ,or of an emerging disease relevant 
for porcine animals;
L 113 /270  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -SEM -A-INTRA
II.2.5.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis and B. suis , infection with rabies virus, anthrax, infection with 
Aujeszky’s disease virus and infection with porcine reproductive and 
respiratory syndrome virus have not been reported;
II.2.5.3. were not in contact with animals from establishments situated in a restricted 
zone due to the occurrence of diseases referred to in point II.2.5.1. or from
establishments which do not meet the conditions referred to in point II.2.5.2.;
II.2.5.4. were not used for natural breeding;
II.2.6. have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health 
status were present, which on the day of their admission to the semen collection centre 
complied with the following conditions:
II.2.6.1. it was not situated in a restricted zone established due to diseases ref erred to in 
point II.2.5.1.;
II.2.6.2. none of the diseases referred to in point II.2.5.2. has been reported for a period 
of at least 30 days;
II.2.6.3. it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius cen tred on the quarantine accommodation for a period of 
at least 30 days;
II.2.6.4. has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;
II.2.6.5. it was free from infection with Brucella abortus, Brucella melitensis and 
Brucella suis for the period of at least the preceding 3 months;
II.2.7. were kept in the semen collection centre
II.2.7.1. which was not situated in a restricted zone establ ished due to diseases referred 
to in point II.2.5.1.;
II.2.7.2. where none of the diseases referred to in point II.2.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and
(2)(3)[at least 30 days following the date of the collection;]
(2)(4)[until the date of dispatch of the consignment of semen to another Member 
State;]
II.2.7.3. situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and
(2)(3)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and 30 days from the date of collection;]
(2)(4)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the 
consignment of semen to another Member State and the donor animals have 
been kept at that semen collection centre for a continuous period of at least 30
days immediately prior to the date of collection of the semen;]
II.2.7.4. where no clinical, serological, virological or pathological evidence of infection 
with Aujeszky’s disease virus had been reported for a period comprising at 
least 30 days prior to t he date of admission and at least 30 days immediately 
prior to the date of collection of the semen;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /271
EUROPEAN UNION Certificate model POR -SEM -A-INTRA
II.2.8. have been subjected to the following tests, carried out within the period of 30 days prior to 
the commencement of the quarantine referred to in point II.2.6., with negative results, 
required in accordance with point 1(b) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020/686:
II.2.8.1. as regards infection with Brucella abortus, B. melitensis and B. suis, a buffered 
Brucella anti gen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella species;
II.2.8.2. as regards infection with Aujeszky’s disease virus 
(2)[in the case of non -vaccinated animals, an ELISA to detect an tibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]
(2)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to 
detect antibodies to glycopro tein E (ADV -gE) of Aujeszky’s disease virus;]
(2)[II.2.8.3. as regards classical swine fever, an antibody ELISA or serum neutralisation test, in case of animals coming from a Member State or zone thereof where 
classical swine fever has been reported or vaccination against this disease has 
been practiced for the period of the preceding 12 months;]
II.2.8.4. as regards infection with porcine reproductive and respiratory syndrome virus, 
a serological test (the immunoperoxidase monolayer assay (IPMA), 
immunofluorescence assay (IFA), or ELISA);
II.2.9. have been subjected to the following tests, carried out on samples taken within a period of at 
least 21 days after the commencement of the quarantine referred to in point II.2.6., with negative results, required in accordance with point 1(c) of Chapter I of Part 2 of Annex II to 
Delegated Regulation (EU) 2020/686:
II.2.9.1. as regards infection with Brucella abortus, B. melitensis and B. suis, a buffered 
Brucella antigen test (rose Bengal test), a competitive ELI SA or an indirect 
ELISA for the detection of antibodies to smooth Brucella species;
II.2.9.2. as regards infection with Aujeszky’s disease virus 
(2)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]
(2)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to 
detect antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]
(2)[II.2.9.3. as regards classical swine fever, an antibody ELISA or serum neutralisation test, in case of animals coming from a Member State or zone thereof where 
classical swine fever has not been reported and vaccination against this disease 
has not bee n practiced for the period of the preceding 12 months;]
II.2.9.4. as regards infection with porcine reproductive and respiratory syndrome virus, 
a serological test (IPMA, IFA, or ELISA) and a test for virus genome (reverse-
transcription polymerase chain re action (RT -PCR), nested set RT -PCR, real -
time RT -PCR);
L 113 /272  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -SEM -A-INTRA
II.2.10. have been subjected, at semen collection centre, to the following compulsory routine tests, 
required in accordance with point 2(a) of Chapter I of Part 2 of Annex II to Delegated 
Regulation (EU) 2020/686:
II.2.10.1. as regards infection with Brucella abortus, B. melitensis and B. suis, a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella species;
II.2.10.2. as regards infection with Aujeszky’s disease virus 
(2)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutra lisation test;]
(2)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to 
detect antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]
II.2.10.3. as regards classical swine fever, an antibody ELISA or serum neutralisation 
test;
II.2.10.4. as regards infection with porcine reproductive and respiratory syndrome virus, a serological test (IPMA, IFA, or ELISA);
II.2.11. have been subjected to the tests referred to in point II.2.10. carried out, in accordance with 
point 2(b) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020/686, on 
samples taken from:
(2)either [all animals immediately prior to leaving the semen collection centre, or upon arrival at the 
slaughterhouse, and in no case later than 12 months from the date of admission to the semen 
collection centre.]
(2)or[at least 25 % of the animals in the semen collection centre every 3 months to test for 
infection with Brucella abortus, Brucella melitensis and Brucella suis , infection with 
Aujeszky’s disease v irus and classical swine fever and from at least 10 % of the animals in 
the semen collection centre every month to test for infection with porcine reproductive and 
respiratory syndrome virus.]
(2)or[at least 10 % of the animals in the semen collection cen tre every month to test for infection 
with Brucella abortus, Brucella melitensis and Brucella suis , infection with Aujeszky’s 
disease virus, classical swine fever and infection with porcine reproductive and respiratory 
syndrome virus.]
II.3. The semen described in Part I
II.3.1. has been collected, processed and stored in accordance with animal health requirements set out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/686;
II.3.2. isplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and that mark is indicated in Box I.30;
II.3.3. is transported in a container which:
II.3.3.1. was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in Box I.19;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /273
EUROPEAN UNION Certificate model POR -SEM -A-INTRA
II.3.3.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(3)[II.3.3.3. has been filled in with the cryogenic agent which not have been previously 
used for other products.]
II.4. The semen is preserved by the addition of antibiotics as follows:
II.4.1. The following antibiotic or mixture of antibiotics, effective in particular against leptospires, has 
been added to the semen after final dilution, or is contained in the used semen diluents, to reach 
the indicated concentration per ml of semen:
(2)either [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]
(2)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]
(2)or [a mix ture of amikacin (75 μg) and divekacin (25 μg);]
(2)or [an antibiotic or a mixture of antibiotics(5)…………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg), tylosin (50 μg) and lincomyc in-spectinomycin (150/300 μg);
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.4.2. Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature of at least 5°C or 15°C for a period of not less than 45 minutes, 
or under a time -temperature regime with a documented equivalent bactericidal activity.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicat e the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. 
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: semen.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : indicate mark on the straw or other packages where semen of 
the consignment is placed. 
“Date of collection/production”: indicate the date on which semen of the consignment 
was col lected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.
“Quantity” : Indicate number of straws or other packages with the same mark.
L 113 /274  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -SEM -A-INTRA
Part II:
(1)Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
(2)Delete if not applicable.
(3)Applicable for frozen semen.
(4)Applicable for fresh and chilled semen.
(5)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /275
CHAPTER 39
MODEL ANIMAL H EALTH CERTIFICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF PORCINE 
ANIMALS COLLECTED, P ROCESSED AND STORED IN ACCORDANCE WITH 
DIRECTIVE 90/429/EEC BEFORE 21 APRIL 2021 , DISPATCHED AFTER 2 0 APRIL 
2021 FROM THE SEMEN COLLECTION CEN TRE WHERE THE SEMEN WAS 
COLLECTED (MODEL ‘PO R-SEM -B-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISOcountry code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /276  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /277
EUROPEAN UNION Certificate model POR -SEM -B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the semen described in Part I was:
II.1. collected, processed and stored in a semen collection centre(1)approved and supervised by 
the competent authority in accordance with Chapter I and Chapter II of Annex A to 
Directive 90/429/EEC;
(2)either [II.2. collected in a semen collection centre which only contains animals that have not been 
vaccinated against Aujeszky's disease and meet the requirements of Annex B to Directive 
90/429/EEC;]
(2)(3)and/or [II.2. collected in a semen collection centre in which some or all of the animals have been 
vaccinated against Aujeszky's disease using a gE deleted vaccine and meet the requirements 
of Annex B to Directive 90/429/EEC;]
II.3. collected, processed, stored and transported under conditi ons which comply with the 
standards laid down in Annex C to Directive 90/429/EEC.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implemen ting Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the semen collection centre of the semen dispatch.
Box I.12: Place of destination shall correspond to the semen collection centre, germinal product processing 
establishment, germinal product storage centre or to the establishment of semen destination.
Box I.19: Identification of container andSeal number shall be indicated.
Box I.30: Identification number shall include the official identification mark of the animal in accordance with 
Council Directive 2008/71/EC of 15 July 2008 on the identification and registration of pigs (OJ L 213, 
8.8.2008, p. 31.)
Date of collection shall be indi cated in the following format: dd/mm/yyyy.
Approval number of the centre shall correspond to the approval number of the semen centre where the 
semen was collected.
Part II:
(1)Only semen collection centres approved by the competent authority and listed in accordance with Article 
5(2) of Council Directive 90/429/EEC.
(2)Delete as appropriate.
(3)This option must be deleted in case the Member State, or a region thereof, of destination is free of 
Aujeszky’s disease in accordance with Article 10 of Directive 64/432/EEC, has informed the Commission 
in accordance with point 4 of Annex C to Directive 90/429/EEC and is listed on the following website: http://ec.europa.eu/food/ani mal/semen_ova/porcine/index_en.htm .
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /278  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 40
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF 
PORCINE ANIMALS COLLECTED OR PRODUCED, P ROCESSED AND STORED 
IN ACCORDANCE WITH REGULATION (EU) 2016/ 429 AND DELEGATED 
REGULATION (EU) 2020 /686 AFTER 20 APRIL 2021, DISPATCHED BYTHE
EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (M ODEL ‘POR -OOCYTES -
EMB- A-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /279
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of 
originCold store Identification mark Type of packaging Net weight
Slaughterhous
eTreatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /280  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)[II.1. The in vivo derived embryos of porcine animals described in Part I have been collected, processed 
and stored, and dispatched by the embryo collection team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requiremen ts as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Commission Delegated 
Regulation (EU) 2020/686.]
(1)[II.1. The oocytes(1)/ in vitro produced embryos(1)/micromanipulated embryos(1)of porcine animals 
described in Part I have been collected or produced, processed and stored, and dispatched by the 
embryo production team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020/686.]
II.2. The oocytes(1)/ embryos(1)described in Part I are intended for artificial reproduction and were 
obtained f rom donor animals which
II.2.1. have been born and remained since birth in the Union, or have entered the Union in accordance with the requirements for entry into the Union;
(1)(3)[II.2.2. come from a Member State or zone thereof which is free from infecti on with 
Aujeszky’s disease virus or where an approved eradication programme for infection 
with Aujeszky’s disease virus is carried out;]
II.2.3. come from establishments in a Member State or zone thereof, or from establishments 
under official control by the competent authority in a third country or territory, or a 
zone thereof 
II.2.3.1. in which infection with Brucella abortus, B. melitensis and B. suis in 
porcine animals has not been reported during the last 42 days prior to 
collection of the oocytes(1)/ embryos(1), and in which during at least the 
12 month period prior to collection of the oocytes(1)/ embryos(1)
(1)either [II.2.3.2.1. biosecurity and risk mitigating measures set out in Article 
19(1)(f)(i) of Commission Delegated Regulation (EU) 
2020/688 have been introduced;
(1)and/or [II.2.3.2.2. surveillance for infection with Brucella abortus, B. melitensis 
andB. suis has been carried out on the porcine animals kept 
on the establishments in accordance with Article 19(1)(f)(ii) 
of Delegated Regulation (EU) 2020/688;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /281
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- A-INTRA
II.2.3.2. where no clinical, serological, virological or pathological evidence of 
infection with Aujeszky’s disease virus had been detected during the 
period of at least 12 months prior to collection of the oocytes(1)/ 
embryos(1).
II.2.4. were examined by the team veterinarian or a team member and did not show 
symptoms or clinical signs of transmissible animal diseases on the day of collection 
of the oocytes(1)/ embryos(1); 
II.2.5. are identified as provided for in Article 52 or 54(2) of Commission Delegated 
Regulation (EU) 2019/2035;
II.2.6. for a period of at least 30 days prior to the date of first collection of the oocytes(1)/ 
embryos(1)and during the collection period; 
II.2.6.1. were kept on establishments not situated in a restricted zone established 
due to the occurrence of foot -and-mouth disease, infection with 
rinderpest virus, classical swine fever or African swine fever ,or of an 
emerging disease relevant for porcine animals ;
II.2.6.2. were kept on a single establishment where infection with Brucella 
abortus, B. melitensis and B. suis , infection with rabies virus, anthrax, 
infection with Aujeszky’s disease virus and infection with porcine 
reproductive and respiratory syndrome virus have not been reported;
II.2.6.3. were not in contact with animals from establishments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.2.6.1. or from establishments which do not meet the conditions 
referred to in point II.2.6.2.;
II.2.6.4. were not used for natural breeding;
II.2.7. comply with the following conditions as regards foot -and-mouth disease 
II.2.7.1. they come from establishments 
−situated in an area where foot -and-mouth disease has not been 
report ed within a 10- km radius centred on the establishment for a 
period of at least 30 days immediately prior to the date of collection of the oocytes
(1)/ embryos(1);
−in which foot -and-mouth disease has not been reported during a 
period of at least 3 months immediately prior to the date of collection 
of the oocytes(1)/ embryos(1);
(1)either [II.2.7.2. they were not vaccinated against foot -and-mouth disease;]
(1)(4)or[II.2.7.2. they were vaccinated against foot- and-mouth disease during the period 
of 12 months prior to the date of collection or production of the embryos
and
II.2.7.2.1. have not been vaccinated against foot -and-mouth disease 
within the period of at least 30 days immediately prior to the 
date of collection of the embryos;
L 113 /282  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- A-INTRA
II.2.7.2.2. the semen used for fertilisation was collected from a male 
donor that complies with the conditions set out in point 1(b) 
or the semen complies with the conditions set out in point 2 
of Chapter I of Part 5 of Annex II to Delegated Regulation 
(EU) 2020/686;
II.2.7.2.3. prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the 
recommendations of the IETS Manual(5);
II.2.7.2.4. the embryos were stored deep frozen for a period of at least 
30 days from the date of collection, and during this period 
the donor animal has not shown clinical signs of foot -and-
mouth disease;]
(1)(6)[II.2.8. were subjected to a serological test for infection with porcine reproductive and 
respiratory syndrome virus, with negative results, on two occa sions, at an interval of 
not less than 21 days, the second test being performed within a period of 15 days 
prior to embryo collection.]
II.3. The oocytes(1)/ embryos(1)described in Part I
II.3.1. has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to 
Delegated Regulation (EU) 2020/686;
II.3.2. areplaced in straws or other packages on which the mark is applied in accordance 
with requirements provid ed for in Article 10 of Delegated Regulation (EU) 2020/686 
and that mark is indicated in Box I.30;
II.3.3. are transported in a container which:
II.3.3.1. was sealed and numbered prior to the dispatch by the embryo collection 
or production team under respo nsibility of the team veterinarian, or by 
an official veterinarian, and the seal bears the number as indicated in 
Box I.19;
II.3.3.2. has been cleaned and either disinfected or sterilised before use, or is 
single -use container; 
(1)(7)[II.3.3.3. has been f illed in with the cryogenic agent which not have been 
previously used for other products;]
(1)(8)[II.3.4. are placed in straws or other packages which are securely and hermetically sealed;
II.3.5. are transported in a container where they are separated fro m each other by physical 
compartments or by being placed in secondary protective bags.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /283
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- A-INTRA
(1)(9)[II.4. The in vivo derived embryos(1)/ in vitro produced embryos(1)/micromanipulated embryos(1) 
described in Part I were conceived by artificial insemination using semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre 
approved for the collection, processing and/or storage of semen by the competent authority of a 
Member State or by the competent authority of a third country, territory or zone thereof listed in 
Annex XI to Commission Implementing Regulation (EU) 2021/404.]
(1)(10)[II.5. The following antibiotic or mixture of antibiotics(11)has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. 
Box reference I.12: “Place of destination”: Indicate the address and unique registration or app roval 
number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced 
embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : indicate mark on the straw or o ther packages where oocytes or 
embryos of the consignment are placed. 
“Date of collection/production”: indicate the date on which oocytes or embryos of the 
consignment was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only embryo collection or production teams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
(3)Not applicable for in vivo derived embryos subject to trypsin treatment.
(4)Option available only for the consignment of in vivo derived embryos.
(5)Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo Transfer Society ,1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA (http://www.iets.org/).
(6)Applicable for in vivo derived embryos.
(7)Applica ble for frozen oocytes or embryos.(8)Applicable for the consignment where in one container 
oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of porcine 
animals are placed and transported.
(9)Does not apply to oocyte s.
(10)Mandatory attestation in case antibiotics were added.
(11)Insert the name(s) of the antibiotic(s) added and its(their) concentration.
L 113 /284  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- A-INTRA
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /285
CHAPTER 41
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF OOCYTES AND 
EMBRYOS OF PORCINE A NIMALS COLLECTED OR PRODUCED, PROCESSED 
AND STORED IN ACCORD ANCE WITH DIRECTIVE 92/65/EEC AFTER 31 
AUGUST 2010 AND BEFO RE 21 APRIL 2021, DI SPATCHED AFTER 2 0 APRIL 2021 
BYTHE EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE 
OOCYTES OR EMBRYOS W ERE COLLECTED OR PRO DUCED (MODEL ‘POR-
OOCYTES -EMB- B-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /286  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /287
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the ova/embryos(1)described in Part I:
II.1. were produced/collected(1), processed and stored by an embryo collection/production(1)
team(2)approved and supervised in accordance with Chapter I(III) of Annex D to 
Directive 92/65/EEC;
II.2. meet the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC;
II.3. come from donor females of the porcine species which meet the requirements of 
Chapter IV(2) of Annex D to Directive 92/65/EEC;
(1)either [II.4. are in vivo derived embryos which:
II.4.1. were conceived as a result of artificial insemination with semen meeting the 
requirements of Directive 90/429/EEC,
II.4.2. originat e from a Member State or region thereof:
(1)either [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC;]
(1)or [listed in Annex I to Decision 2008/185/EC and are destine d for a Member 
State or region thereof not listed in Annex I or II to Decision 2008/185/EC;]
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC and have 
been was hed with trypsin;]
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member State or region thereof listed in Annex II to Decision 2008/185/EC;]
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a Member
State or region thereof listed in Annex I or II to Decision 
2008/185/EC and have been washed with trypsin;]
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a Member State or region thereof not listed in Annex I or II to Dec ision 
2008/185/EC;];]
(1)or [II.4. are in vitro produced/micromanipulated(1)embryos which:
II.4.1. were conceived as a result of in vitro fertilisation with semen meeting the 
requirements of Directive 90/429/EEC,
II.4.2. originate from a Member State or region thereof: 
(1)either [listed in Annex I to Decision 2008/185/EC and are destined for a Member State or region thereof listed in Annex I to Decision 2008/185/EC;]
L 113 /288  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- B-INTRA
(1)or [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof not listed in Annex I or II to Decision 2008/185/EC;]
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC and the
donor females of the ova used for their production comply with the conditions 
of Article 1 of Decision 2008/185/EC;]
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex II to Decision 20 08/185/EC;]
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof listed in Annex I or II to Decision 
2008/185/EC and the donor females of the ova used for their production 
comply with the conditions of Article 1 of Decision 2008/185/EC;]
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof not listed in Annex I or II to Decision 
2008/185/EC;]]
(1)or [II.4. are in vivo derived ova w hich originate from a Member State or region thereof:
(1)either [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC;]
(1)or [listed in Annex I to Decision 2008/185/EC an d are destined for a Member 
State or region thereof not listed in Annex I or II to Decision 2008/185/EC;]
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC and which 
come from donor females complying with the conditions of Article 1 of 
Decision 2008/185/EC;]
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex II to Decision 2008/185/EC;]
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof listed in Annex I or II to Decision 
2008/185/EC and which come from donor females complying with the 
conditions of Article 1 of Decision 2008/185/EC;]
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof not listed in Annex I or II to Decision 
2008/185/EC;]]
II.5. were sent to the place of loading in a sealed container under conditions complying
with point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the 
number detailed in Box I.23.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /289
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- B-INTRA
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the embryo collection team or embryo production team of 
ova/embryos collection/production.
Box I.12: Place of destination shall correspond to the embryo collection team, embryo production team, 
germinal product processing establishment, germinal product storage centre or to the establishment 
of ova/embryos destination.
Box I.19: Identification of containe r and Seal number shall be indicated.
Box I.30: “Type”: specify if: in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or 
micromanipulated embryos.
Identification number shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the team shall correspond to the embryo collection team or embryo production 
team of ova/embryos collection/production indicated in Box I.11.
Part II:
(1)Delete as appropriate.
(2)Only embryo collection or production teams approved by the competent authority and listed in 
accordance with Article 11(4) of Council Directive 92/65/EEC.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /290  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 42
MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF OOCYTES AND 
EMBRYOS OF PORCINE A NIMALS COLLECTED OR PRODUCED, PROCESSED 
AND STORED IN ACCORD ANCE WITH DIRECTIVE 92/65/EEC BEFORE 1 
SEPTEMBER 2010 ,DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO 
COLLECTION OR PRODUC TION TEAM BY WHICH THE OOCYTES OR 
EMBRYOS WERE COLLECTED OR PRODUCED (MODEL ‘POR -OOCYTES -EMB-
C-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /291
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /292  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- C-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The ova/embryos(1)described in Part I: 
II.1.1. were collected, processed and stored under conditions which meet the requirements of 
Directive 92/65/EEC;
II.1.2. come from donor female swine which meet the requirements of Chapter IV of Annex D to Directive 92/65/EEC;
II.1.3. meet the requirements of Chapter III of Annex D to Directive 92/65/EEC.
(1)either [II.2. In the case of embryos, 
II.2.1. the semen used for fertilisation meets the requirements of Directive 90/429/EEC;
II.2.2. the embryos have been washed with trypsin(2).]
(1)or [II.2. In the case of ova, the ova comes from a donor female swine which meets the conditions 
of Article 1 of Decision 2008/185/EC(2).]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the embryo collection team of ova/embryos collection.
Box I.12: Place of destination shall correspond to the embryo collection team, embryo production team, 
germinal product processing establishment, germinal product s torage centre or to the establishment of 
ova/embryos destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: “Type”: specify if: in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or 
micromanipulated embryos.
Identification number shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the team shall correspond t o the embryo collection team of ova/embryos 
collection indicated in Box I.11.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /293
EUROPEAN UNION Certificate model POR -OOCYTES- EMB- C-INTRA
Part II:
(1)Delete as appropriate.
(2)This condition applies only to ova and embryos which originate in the Member States or regions thereof 
not listed in Annexes I and II to Decision 2008/185/EC (OJ L 59, 4.3.2008, p. 19) and destined to the 
Member States or regions thereof so listed. It shall also apply to movements from Member States or 
regions thereof listed in Annex II of Decision 2008/185/EC to Member States or regions thereof listed in 
Annex I of Decision 2008/185/EC.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /294  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 43
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT PROCESSING ESTABLISHMENT:
-semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of porcine animals collected, processed and stored in accordance with Council 
Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine ani mals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of oocytes and embryos of porcine animals collected or produced, processed and stored in 
accorda nce with Directive 92/65/EEC after 31 August 2010 and before 21 April 2021;
-stocks of oocytes and embryos of porcine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010
(MODEL ‘POR -GP-PROCESSIN G-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /295
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /296  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -GP-PROCESSING -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)was/were 
processed and stored:
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated 
embryos(2)described in Part I is/are intended for artificial reproduction and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a sem en collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal product processing establishment indicated in Box I.11. situated 
in the Member State of its/their collection or production under animal health certification 
requirements at least as strict as those provide d for in:
(2)either [Model POR -SEM -A-INTRA(4);]
(2)and/or [Model POR -SEM -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -A-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -C-INTRA(4);]
(2)and/or [Model POR -GP-PROCESSING -INTRA(4);]
(2)and/or [Model POR -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards respo nsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal product processing establishment indicated in Bo x I.11. situated 
in another Member State accompanied by certificate(s) in accordance with:
(2)either [Model POR -SEM -A-INTRA(4);]
(2)and/or [Model POR -SEM -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -A-INTRA(4);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /297
EUROPEAN UNION Certificate model POR -GP-PROCESSING -INTRA
(2)and/or [Model POR -OOCYTES -EMB -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -C-INTRA(4);]
(2)and/or [Model POR -GP-PROCESSING -INTRA(4);]
(2)and/or [Model POR -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in a third country, territory or zo ne thereof listed in Annex XI to Commission 
Implementing Regulation (EU) 2021/404 and complying with requirements as regards 
responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 
3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and entered the Union 
accompanied by certificate(s) in accordance with:
(2)either [Model POR -SEM -A-ENTRY(4);]
(2)and/or [Model POR -SEM -B-ENTRY(4);]
(2)and/or [Model POR -OOCYTES -EMB -ENTRY(4);]
(2)and/or [Model POR -GP-PROCESSING -ENTRY(4);]
(2)and/or [Model POR -GP-STORAGE -ENTRY(4);]]
II.2.2. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and/or Article 83(a) of Commission Delegated Regulation (EU) 2020/692 and that mark is indicated in Bo x I.30;
II.2.4. is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;]
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /298  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -GP-PROCESSING -INTRA
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishments 
approved by the competent authority and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes an d/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the g erminal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate t he date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product processing establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020/686.
(2)Delete if not applicable.
(3)Only germinal product establishments approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /299
EUROPEAN UNION Certificate model POR -GP-PROCESSING -INTRA
(4)The original(s) of the document(s) or the health certifi cate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the ge
rminal product processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of porcine animals are placed and transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /300  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 44
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT STORAGE CENTRE:
-semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of porcine animals collected, processed and stored in accordance with Council Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of oocytes and embry os of porcine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 21 April 2021;
-stocks of oocytes and embryos of porcine animals collected or produced, processed and stored in 
accordan ce with Directive 92/65/EEC before 1 September 2010
(MODEL ‘POR -GP-STORAGE- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /301
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act□Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /302  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -GP-STORAGE -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo
derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)was/were stored:
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated 
embryos(2)described in Part I is/are intended for artificial reproduction and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal product storage centre indicated in Box I.11. situated in the 
Member State of its/their collection or production under animal health certification requ irements 
at least as strict as those provided for in:
(2)either [Model POR -SEM -A-INTRA(4);]
(2)and/or [Model POR -SEM -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -A-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -C-INTRA(4);]
(2)and/or [Model POR -GP-PROCESSING -INTRA(4);]
(2)and/or [Model POR -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying wit h
requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1
(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and 
was/were moved to the germinal product storage c entre indicated in Box I.11. situated in another 
Member State accompanied by certificate(s) in accordance with:
(2)either [Model POR -SEM -A-INTRA(4);]
(2)and/or [Model POR -SEM -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -A-INTRA(4);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /303
EUROPEAN UNION Certificate model POR -GP-STORAGE -INTRA
(2)and/or [Model POR -OOCYTES -EMB -B-INTRA(4);]
(2)and/or [Model POR -OOCYTES -EMB -C-INTRA(4);]
(2)and/or [Model POR -GP-PROCESSING -INTRA(4);]
(2)and/or [Model POR -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in a third country, territory or zone thereof listed in Annex XI to Commission 
Implementing Regulation (EU) 2021/404 and complying with requirements as regards 
responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 
3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and entered the Union 
accompanied by certificate(s) in accordance with:
(2)either [Model POR -SEM -A-ENTRY(4);]
(2)and/or [Model POR -SEM -B-ENTRY(4);]
(2)and/or [Model POR -OOCYTES -EMB -ENTRY(4);]
(2)and/or [Model POR -GP-PROCESSING -ENTRY(4);]
(2)and/or [Model POR -GP-STORAGE -ENTRY(4);]]
II.2.2. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and/or Article 
83(a) of Commission Delegated Regulatio n (EU) 2020/692 and that mark is indicated in Box I.30;
II.2.4. is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which n ot have been previously used for 
other products;]
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /304  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model POR -GP-STORAGE -INTRA
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent 
authority and included in the register referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certific ate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre describe d in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number o f each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the co nsignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product storage centres approved by the competent authority and included in the register
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(2)Delete if not applicable.
(3)Only germinal product establishments approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /305
EUROPEAN UNION Certificate model POR -GP-STORAGE -INTRA
(4)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
descr ibed in Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated em bryos of porcine animals are placed and transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /306  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 45
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF SEMEN O F EQUINE ANIMALS 
COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED REGULATION (EU) 2020/ 686
AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED (MO DEL ‘EQUI -SEM -A-
INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /307
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing plant Approval or registration 
number of 
plant/establishment/centreTest
L 113 /308  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen of equine animals described in Part I has been collected, processed and stored, and dispatched 
from the semen collection centre(1)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686.
II.2. The semen descr ibed in Part I is intended for artificial reproduction and was obtained from donor animals 
which
II.2.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
II.2.2. come, before entering the semen collection centre, from establishments in a Member State or 
zone thereof, or from establishments under official control by the competent authority in a 
third country or territory, or a zone thereof 
II.2.2.1. in which surra ( Trypanosoma evansi ) has not been reported during the period of the 
preceding 30 days prior to collection of the semen, and 
(2)either [surra has not been reported in the establishment during the period of the preceding 2 
years prior to collection of the se men;]
(2)or [surra has been reported in the establishment during the period of the preceding 2 
years prior to collection of the semen and following the last outbreak the 
establishment has remained under movement restriction s
(2)either [until the remaining animals in the establishment have been subjected to a 
test for surra with one of the diagnostic methods provided for in Part 3 of 
Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, 
with negative results, on samples taken at least 6 mont hs after the last 
infected animal has been removed from the establishment;]]
(2)or [for at least 30 days from the date of cleaning and disinfection after the last 
animal of listed species on the establishment was either killed and destroyed 
or slaughtered .]]
II.2.2.2. in which dourine has not been reported during the period of the preceding 6 months 
prior to collection of the semen, and
(2)either [dourine has not been reported in the establishment during the period of the 
preceding 2 years prior to collect ion of the semen;]
(2)or [dourine has been reported in the establishment during the period of the preceding 2 
years prior to collection of the semen and following the last outbreak, the 
establishment has remained under movement restriction s
(2)either [until the remaining equine animals in the establishment, except castrated 
male equine animals, have been subjected to a test for dourine with the diagnostic method provided for in Part 8 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negat ive results, on samples taken at least 
6 months after the infected animals have been killed and destroyed or 
slaughtered, or the infected entire male equine animals have been 
castrated;]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /309
EUROPEAN UNION Certificate model EQUI- SEM -A-INTRA
(2)or [for at least 30 days after the last equine animal on the establishment was 
either killed and destroyed or slaughtered, and the premises were cleaned 
and disinfected;]]
II.2.2.3. in which equine infectious anaemia has not been reported during the period of the 
preceding 90 days prior to collection of the semen, a nd
(2)either [equine infectious anaemia has not been reported on the establishment during the period of the preceding 12 months prior to collection of the semen;]
(2)or [equine infectious anaemia has been reported on the establishment during the period 
of the preceding 12 months prior to collection of the semen and following the last 
outbreak the establishment has remained under movement restrictions
(2)either [until the remaining equine animals in the establishment have been subjected 
to a test for equine infectious anaemia with the diagnostic method provided 
for in Part 9 of Annex I to Delegated Regulation (EU) 2020/688, carried out, 
with negative results, on samples taken on two occasions with a minimum 
interval of 3 months after the infected animals have been killed and 
destroyed or slaughtered and the establishment was cleaned and 
disinfected;]]
(2)or [for at least 30 days after the last equine animal on the establishment was 
either killed and destroyed or slaughtered, and the premises were cleaned 
and d isinfected;]]
II.2.2.4. in which during the period of 30 days prior to the date of collection of the semen no 
equine animal has shown signs of infection with equine arteritis virus and of 
contagious equine metritis ( Taylorella equigenitalis );
II.2.3. did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen; 
II.2.4. are identified as provided for in Article 58(1), 59(1) or 62(1) of Commission Delegated 
Regulation (EU) 2019/2035;
II.2.5. for a period of at least 30 days prior to the date of first collection of the semen and during the 
collection period 
II.2.5.1. were kept on establishments not situated in a restricted zone established due to t he 
occurrence of African horse sickness, infection with Burkholderia mallei (glanders) 
or of an emerging disease relevant for equine animals;
II.2.5.2. were kept on a single establishment where Venezuelan equine encephalomyelitis, 
dourine, surra (Trypanosoma evansi ), equine infections anaemia, infection with 
equine arteritis virus, contagious equine metritis ( Taylorella equigenitalis ), infection 
with rabies virus and anthrax have not been reported;
II.2.5.3. were not in contact with animals from es tablishments situated in a restricted zone due 
to the occurrence of diseases referred to in point II.2.5.1. or from establishments 
which do not meet the conditions referred to in point II.2.5.2.;
II.2.6. were not used for natural breeding during a period o f at least 30 days prior to the date of first 
semen collection and between the dates of the first sample referred to in points II.2.7.1., 
II.2.7.2. and/or II.2.7.3. and until the end of the collection period;
II.2.7. have been subjected to the following te sts, referred to in point 1(a) of Chapter I of Part 4 of 
Annex II to Delegated Regulation (EU) 2020/686, as follows:
II.2.7.1. for infection with equine infectious anaemia (EIA), an agar -gel immuno -diffusion 
test (AGID or Coggins test) or an enzyme- linked immunosorbent assay (ELISA) with 
a negative result;
II.2.7.2. for infection with equine arteritis virus (EVA),
L 113 /310  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -A-INTRA
(2)either [II.2.7.2.1.a serum neutralisation test with a negative result at a serum dilution of one 
in four;]
(2)and/or [II.2.7.2.2.a virus isolation test, polymerase chain reaction (PCR) or real -time PCR 
with a negative result on an aliquot of the entire semen of the donor 
stallion;]
II.2.7.3. for contagious equine metritis ( Taylorella equigenitalis ) (CEM), an agent 
identification test carrie d out on three specimens (swabs) taken from the donor 
stallion on two occasions with an interval of not less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis;
The samples were in no case taken earlier than 7 days (sy stemic treatment) or 21 
days (local treatment) after antimicrobial treatment of the donor stallion and were 
placed in transport medium with activated charcoal, such as Amies medium, before 
dispatch to the laboratory where they were subjected with a negativ e result to a test 
for:
(2)either [II.2.7.3.1.the isolation of Taylorella equigenitalis after cultivation under 
microaerophilic conditions for a period of at least 7 days, set up within the 
24 hour period after taking the specimens from the donor animal, or the 48 
hour period where the specimens are kept cool during transport;]
(2)and/or [II.2.7.3.2.the detection of genome of Taylorella equigenitalis by PCR or real -time 
PCR, carried out within the 48 hour period after taking the specimens 
from the donor a nimal;]
II.2.8. were subjected with the results specified in point II.2.7. in each case to at least one of the 
following testing programmes detailed respectively in points 1(b)(i), (ii) and (iii) of Chapter I 
of Part 4 of Annex II to Delegated Regulation ( EU) 2020/686:
(3)[II.2.8.1. The donor stallion was continuously resident at the semen collection centre for a 
period of at least 30 days prior to the date of the first collection and during the 
period of collection of the semen described in Part I, and no equine animals in 
the semen collection centre came during that time into direct contact with equine 
animals of lower health status than the donor stallion. The tests described in 
point II.2.7. were carried out on samples taken(4)from the donor stallion at least 
once a year at the beginning of the breeding season or prior to the first collection 
of semen intended for movement to another Member State as fresh, chilled or 
frozen semen and not less than 14 days following the date of the commencement 
of the residence period of at least 30 days prior to the first semen collection.]
(3)[II.2.8.2. The donor stallion was resident on the semen collection centre for a period of at 
least 30 days prior to the date of the first collection and during the period of 
collection of the semen described in Part I, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous perio d of less 
than 14 days during the collection period, or other equine animals in the semen 
collection centre came into direct contact with equine animals of a lower health 
status. The tests described in point II.2.7. were carried out on samples taken
(4)
from the donor stallion at least once a year at the beginning of the breeding 
season or prior to the date of the first collection of semen intended for movement 
to another Member State as fresh, chilled or frozen semen and not less than 14 
days following the date of the commencement of the residence period of at least 
30 days prior to the first semen collection, and during the period of collection of 
the semen intended for movement to another Member State as fresh, chilled or 
frozen semen the donor stallion wa s subjected to the tests described in point 
II.2.7., as follows:
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /311
EUROPEAN UNION Certificate model EQUI- SEM -A-INTRA
(a) for equine infectious anaemia, one of the tests described in point II.2.7.1. 
was last carried out on a sample of blood taken(4)not more than 90 days 
prior to the collection of the semen described in Part I;
(b) for infection with equine arteritis virus, one of the tests described
(2)either [in point II.2.7.2. was last carried out on a sample taken(4)not more than 
30 days prior t o the date of the collection of the semen described in Part 
I;]
(2)or [in point II.2.7.2.2., in case the non- shedder state of a donor stallion 
seropositive for infection with equine arteritis virus is confirmed, was 
carried out on an aliquot of the entire semen of the donor stallion taken(4)
not more than 6 months prior to the date of the collection of the semen 
described in Part I and a blood sample taken(4)from the donor stallion 
during the 6 months period reacted with a positive result in a serum 
neutra lisation test for infection with equine arteritis virus at a serum 
dilution of more than one in four;] 
(c) for contagious equine metritis, the test described in point II.2.7.3. was last carried out on three specimens (swabs) taken
(4)not more than 60 days
prior to the date of the collection of semen described in Part I
(2)either [on two occasions;]
(2)or [on a single occasion and subjected to a PCR or real -time PCR.]]
(3)[II.2.8.3. The donor stallion does not meet the conditions set out in points 1(b)(i) and (ii) 
of Chapter I of Part 4 of Annex II to Delegated Regulation (EU) 2020/686 and the semen is collected for movement to another Member State as frozen semen.
The tests described in points II.2.7.1, II.2.7.2 and II.2.7.3 were carried out on samples 
taken
(4)from the donor stallion at least once a year at the beginning of the breeding 
season, and the tests described in points II.2.7.1 and II.2.7.3. were carried out on 
samples taken(4)from the donor stallion during the storage period of the semen of a 
minimum period of 30 days from the date of the collection of the semen and before 
the semen is removed from the semen collection centre, not less than 14 days and not 
more than 90 days after the collection of the semen described in Part I, and
(2)either [the tests for infection with equine arteritis virus described in point II.2.7.2. 
were carried out on samples taken(4)during the storage period of the semen of 
a minimum period of 30 days from the date of the collection of the semen and 
before the semen is r emoved from the semen collection centre or used, not 
less than 14 days and not more than 90 days after the date of the collection of 
the semen described in Part I.]
(2)or [the non- shedder state of a donor stallion seropositive for infection with 
equine art eritis virus was confirmed by virus isolation test, PCR or real -time 
PCR carried out with a negative result on samples of an aliquot of the entire 
semen of the donor stallion taken(4)twice a year at an interval of at least 4 
months and the donor stallion has reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for infection with 
equine arteritis virus.]
L 113 /312  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -A-INTRA
II.2.9. underwent the testing provided for in point II.2.8. on samples taken on the following dates:Identification 
of semen
Test 
programmeStart date(4)Date of sampling for health tests(4)
Donor 
residenceSemen 
collectionEIA II.2.7.1.EVA II.
2.7.2.CEM
II.2.7.3.
Blood 
sampleSemen 
sample1. sample 2. sample
II.3. The semen described in Part I
II.3.1. has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/686;
II.3.2. areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and that mark 
is indicated in Box I.30;
II.3.3. is transported in a container which:
II.3.3.1. was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;
II.3.3.2. hasbeen cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(5)[II.3.3.3. has been filled in with the cryogenic agent which not have been previously used for other products.]
(2)(6)[II.4. The semen is preserved by the add ition of antibiotics as follows:
II.4.1. The following antibiotic or mixture of antibiotics has been added to the semen after final 
dilution, or is contained in the used semen diluents, to reach the indicated concentration per ml of semen:
(2)either [a mix ture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 
μg);]
(2)or [a mixture of lincomycin- spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin 
(500 μg);]
(2)or [a mixture of amikacin (75 μg) and divekacin (25 μg); ]
(2)or [an antibiotic or a mixture of antibiotics(7)…………………………………………………, 
with a bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg), tylosin (50 μg) and lincomycin- spectinomycin (150/300 μg);
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.4.2. Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature of at least 5°C for a period of not less than 45 minutes, or 
under a time -temperature regime with a documented equivalent bactericidal activity.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /313
EUROPEAN UNION Certificate model EQUI- SEM -A-INTRA
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicat e the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. 
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval number 
of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: semen.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen of the 
consignment is placed. 
“Date of collection/production”: Indicate the date on which semen of the consignment 
was col lected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
Guidance for the completion of the table in point II.2.9.Abbreviations:
EIA-1 Equine infectious anaemia (EIA) testing first occasion
EIA-2 EIA testing second occasion
EVA -B1 Equine arteritis virus (EVA) testing on blood sample first occasion
EVA -B2 EVA testing on blood sample second occasion
EVA -S1 EVA testing on semen sample first occasion
EVA -S2 EVA testing on semen sample second occasion
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11
CEM -21 CEM testing second occasion first sample
CEM -22 CEM testing second occasion second sample taken 7 days after CEM- 21
Instructions:
For each semen identified in column A in correspondence with Box I.30, the test programme (points II.2.8.1., 
II.2.8.2. and/or II.2.8.3.) shall be specified in column B, and columns C and D shall be completed with the dates 
required.
The dates when samples were taken for laboratory testing prior to the first collection of the semen de scribed in 
Part I as required in points II.2.8.1., II.2.8.2. and II.2.8.3., shall be entered in the upper line of columns 5 to 9 of 
the table, this being the boxes marked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM- 12 in the 
example below.
The dates wh en samples were taken for repeat laboratory testing as required in accordance with point II.2.8.2. 
or II.2.8.3. shall be entered in the lower line of columns 5 to 9 in table, this being the boxes EIA -2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM- 22 in the example below.
L 113 /314  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -A-INTRAIdentification 
of semen
Test 
programmeStart date Date of sampling for health tests
Donor 
residenceSemen 
collectionEIA II.2.7.1.EVA
II.2.7.2.CEM
II.2.7.3.
Blood 
sampleSemen 
sample1.sample 2.sample
A B C DEIA-1 EVA-B1 EVA-S1 CEM -11 CEM -12
EIA-2 EVA-B2 EVA-S2 CEM -21 CEM -22
(1)Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
(2)Delete if not applicable.
(3)Cross out the programmes that do not apply to the consignment.
(4)Insert date in table in point II.2.9. (follow Guidance in Part II of the Notes).
(5)Applicable for frozen semen.
(6)Mandatory attestation in case antibiotics were added.
(7)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the semen 
diluent containing antibiotics.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /315
CHAPTER 46
MODEL ANIMAL HEALTH CERTIF ICATE THE MOVEMENT BETWEEN
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE 
ANIMALS COLLECTED, P ROCESSED AND STORED IN ACCORDANCE WITH 
DIRECTIVE 92/65/EEC AFTER 30 SEPTEMBER 2014 AND BEFORE 21 APRIL 
2021, DISPATCHED AFTER 20 APRIL 2021 FRO MTHE SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED (MO DEL ‘EQUI -SEM -B-
INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /316  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /317
EUROPEAN UNION Certificate model EQUI- SEM -B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen collection centre(1), in which the semen described in Part I was collected, processed and 
stored, for trade was approved and supervised by the competent authority in accordance with 
Chapters I(I)(1) and I(II)(1) of Annex D to Directive 92/65/EEC(2);
II.1.1. during the period commencing 30 days prior to the date of first collection of the semen 
described in Part I until the date the fresh or chilled semen was dispatche d or until the 30 
days minimum storage period for frozen semen elapsed, the semen collection centre:
II.1.1.1. was situated on the territory or in the case of regionalisation in a part of the 
territory(3)of a Member State which was not considered to be infected with 
African horse sickness in accordance with Article 5(2)(a) and(b) of Directive 
2009/156/EC(4);
II.1.1.2. fulfilled the conditions for a holding laid down in Article 4(5) of Directive 
2009/156/EC;
II.1.1.3. contained only equidae which were free of clinical signs of equine viral 
arteritis and contagious equine metritis;
II.2. Only equidae satisfying the conditions laid down in Articles 4 and 5 or Articles 12 to 16 of 
Directive 2009/156/EC have been admitted onto the centre.
II.3. The semen describ ed in Part I was collected from donor stallions, which:
II.3.1. did not show any clinical sign of an infectious or contagious disease at the time of admission onto the semen collection centre and on the day the semen was collected;
II.3.2. were kept for a period of 30 days prior to the date of semen collection in holdings where 
no equine showed any clinical sign of equine viral arteritis or contagious equine metritis during that period;
II.3.3. were not used for natural mating during a period of at least 30 days prior to the date of 
first semen collection and from the dates of the first sample referred to in point II.3.5.1., II.3.5.2. or II.3.5.3. until the end of the collection period;
II.3.4. underwent the tests, which meet at least the requirements of the relevant Chapter of the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out 
in a laboratory which is recognised by the competent authority and has the tests referred to 
hereinafter included in its accreditation in accor dance with Article 12 of Regulation (EC) 
No 882/2004
(5), as follows:
II.3.4.1. for equine infectious anaemia (EIA), an agar -gel immuno- diffusion test 
(AGID or Coggins test) or an enzyme -linked immunosorbent assay (ELISA) 
for equine infectious anaemia with a negative result;
II.3.4.2. for equine viral arteritis (EVA),
(3)either [II.3.4.2.1. a serum neutralisation test with a negative result at a serum dilution 
of one in four;]
L 113 /318  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -B-INTRA
(3)and/or [II.3.4.2.2. a virus isolation test, polymerase chain reaction (PCR) or real -time 
PCR with a negative result on an aliquot of the entire semen of the 
donor stallion;]
II.3.4.3. for contagious equine metritis (CEM), an agent identification test carried out 
on three specimens (swabs) taken from the donor stallion on two occas ions 
with an interval of not less than 7 days at least from the penile sheath 
(prepuce), the urethra and the fossa glandis;
The samples were in no case taken earlier than 7 days (systemic treatment) or 
21 days (local treatment) after antimicrobial treatment of the donor stallion 
and were placed in transport medium with activated charcoal, such as Amies 
medium, before dispatch to the laboratory where they were subjected with 
negative result to a test for:
(3)either [II.3.4.3.1. the isolation of Taylo rella equigenitalis after cultivation under 
microaerophilic conditions for at least 7 days, set up within the 24 
hour period after taking the specimens from the donor animal, or 
the 48 hour period where the specimens are kept cool during 
transport;]
(3)and/or [II.3.4.3.2. the detection of genome of Taylorella equigenitalis by PCR or 
real-time PCR, carried out within the 48 hour period after taking 
the specimens from the donor animal;]
II.3.5. were subjected with the results specified in point II.3.4. in each case to at least one of the 
test programmes detailed in points II.3.5.1., II.3.5.2. and II.3.5.3., as follows:
(6)[II.3.5.1. The donor stallion was continuously resident on the semen collection centre 
for a period of at least 30 days prior to the date of the first collection and 
during the period of collection of the semen described above and no equidae 
on the semen collection centre came into direct contact with equidae of lower 
health status than the donor stallion.
The tests described in point II.3.4. were carried out on samples taken(7)from 
the donor stallion at least once a year at the beginning of the breeding season 
or prior to the first collection of semen intended for trade in fresh, chilled or 
frozen semen and not less than 14 days following the date of the 
commencement of the residence period of at least 30 days prior to the date of first semen collection.]
(6)[II.3.5.2. The donor stallion was resident on the semen collection centre for a period of 
at least 30 days prior to the date of the first collection and during the period of 
collection of the semen described in Part I, but has left the centre under the responsibility of the centre veterinarian for a continuous period of less than 14 
days, and/or other equidae on the semen collection centre came into direct 
contact with equidae of lower health status.
The tests described in point II.3.4. were carried out on samples taken
(7)from 
the donor stallion at least once a year at the beginning of the breeding season 
or prior to the first collection of semen intended for trade in fresh, chilled or 
frozen semen and not less than 14 days following the date of the 
commencement of the residence period of at least 30 days prior to the date of 
first semen collection,
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /319
EUROPEAN UNION Certificate model EQUI- SEM -B-INTRA
and during the period of collection of the semen intended for trade in fresh, 
chilled or frozen semen the donor stallion was subjected to the tests described 
in point II.3.4., as follows:
(a) for equine infectious anaemia, one of the tests described in point II.3.4.1. 
was last carried out on a sample of blood taken(7)not more than 90 days 
prior to the date of the collection of the semen described in Part I;
(b) for equine viral arteritis:
(3)either [one of the tests described in point II.3.4.2. was last carried out on a 
sample taken(7)not more than 30 days prior to the date of the collection 
of the semen described in Part I;]
(3)or [one of the tests described in point II.3.4.2.2 was carried out on an 
aliquot of the entire semen of the donor stallion taken(7)not more than 
six months prior to the date of the collection of the semen described in 
Part I and a blood sample taken(7)from the donor stallion during the six 
months period reacted with a positive result in a serum neutralisation 
test for equine viral arteritis at a serum dilution of more than one in 
four;]
(c) for contagious equine metritis, one of the tests described in point 
II.3.4.3. was last carried out on three specimens (swabs) taken(7)not 
more than 60 days prior to the date of the collection of the semen 
described in Part I
(3)either [on two occasions at least 7 days apart;]
(3)or [on a single occasion and subjected to a PCR or real -time PCR.]]
(6)[II.3.5.3. The donor stallion does not meet the conditions set out in points 1.6(a) and (b) 
of Chapter II of Annex D to Directive 92/ 65/EEC and the semen is collected 
for trade in frozen semen.
The tests described in points II.3.4.1, II.3.4.2. and II.3.4.3. were carried out on samples taken
(7)from the donor stallion at least once a year at the beginning 
of the breeding season,
and the tests described in points II.3.4.1 and II.3.4.3. were carried out on samples 
taken(7)from the donor stallion during the storage period of the semen of a 
minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre, not less than 
14 days and not more than 90 days after the collection of the semen described 
in Part I,
and
(3)either [the tests for equine viral arteritis described in point II.3.4.2. were 
carried out on samples taken(7)during the storage period of the 
semen of a minimum period of 30 days from the date of the 
collection of the semen and before the semen is removed from the semen collection centre or used, not less than 14 days and not more 
than 90 days after the collectio n of the semen described in Part I.]
L 113 /320  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -B-INTRA
(3)or [the non -shedder state of a donor stallion seropositive for equine 
viral arteritis was confirmed by virus isolation test, PCR or real -
time PCR carried out with a negative result on samples of an 
aliquot of the entire semen of the donor stallion taken(7)twice a 
year at an interval of at least four months and the donor stallion 
reacted with a positive result at a serum dilution of at least one in 
four in a serum neutralisation test for equine viral arteritis.]]
II.3.6. underwent the testing provided for in point II.3.5. on samples taken on the following 
dates.Identification of 
semen
Test programmeStart date(7)Date of sampling for health tests(7)
Donor 
residenceSemen 
collectionEIA 
II.3.4.1.EVA
II.3.4.2.CEM
II.3.4.3.
Blood 
sampleSemen 
sample1.sample 2.sample
(3)either [II.4. No antibiotics were added to the semen;]
(3)or[II.4. The following antibiotic or combination of antibiotics was added to produce a concentration in 
the final diluted semen of not less than(8): …………………………………………...
…………………………………………………………………………………….. ;]
II.5. The semen described in Part I was:
II.5.1. collected, pr ocessed, stored and transported under conditions which comply with the 
requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;
II.5.2. in the case of frozen semen, stored for a minimum period of 30 days from the date of 
collection o f the semen;
II.5.3. sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.19.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /321
EUROPEAN UNION Certificate model EQUI- SEM -B-INTRA
Part I:
Box I.11: The place of dispatch shall correspond to the semen collection centre of origin of the semen.
Box I.12: The place of destination shall correspond to the semen collection or storage centre or to the holding of 
semen destination.
Box I.19: The identification of container and seal number shall be indicated.
Box I.30: The donor identity shall co rrespond to the official identification of the animal.
The date of collection shall be indicated in the following format: dd/mm/yyyy.
Part II:
Guidance for the completion of the table in point II.3.6.:
Abbreviations:
EIA-1 Equine infectious anaemia (EIA) testing first occasion
EIA-2 EIA testing second occasion
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion
EVA -B2 EVA testing on blood sample second occasion
EVA -S1 EVA testing on semen sample first occasion
EVA -S2 EVA testing on semen sample second occasion
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11
CEM -21 CEM testing second occasion first sample
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21
Instructions:
For each semen identification in column A in the example below, the test programme (points II.3.5.1., II.3.5.2. 
and/or II.3.5.3.) shall be described in column B and columns C and D shall be com pleted with the dates required.
The dates when samples were taken for laboratory testing prior to the first collection of the semen described in 
Part I, as required in points II.3.5.1., II.3.5.2. and II.3.5.3., shall be entered in the upper line of columns 5 to 9 of 
the table, this being the boxes marked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM -12 in the 
example below.
The dates when samples were taken for repeat laboratory testing as required in accordance with point II.3.5.2. or 
II.3.5.3. shall be entered in the lower line of columns 5 to 9 in table, this being the boxes EIA -2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM- 22 in the example below.Identification 
of semen
Test 
programmeStart date(7)Date of sampling for health tests(7)
Donor 
residenceSemen 
collectionEIA 
II.3.4.1.EVA 
II.3.4.2.CEM 
II.3.4.3.
Blood 
sampleSemen 
sample1.sample 2.sample
A B C DEIA-1 EVA-B1 EVA-S1 CEM -11 CEM -12
EIA-2 EVA-B2 EVA-S2 CEM -21 CEM -22
(1)Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Directive 92/65/EEC.
(2)OJ L 268, 14.9.1992, p. 54.
(3)Delete as appropriate.
(4)OJ L 192, 23.7.2010, p. 1.
(5)OJ L 165, 30.4.2004, p. 1.
(6)Cross out the programme(s) that do(es) not apply to the consignment.
(7)Insert date in table in point II.3.6 (follow Guidance in Part II of the Notes).
(8)Insert names and concentrations.
L 113 /322  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -B-INTRA
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /323
CHAPTER 47
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE 
ANIMALS COLLECTED, P ROCESSED AND STORED IN ACCORDANCE WITH 
DIRECTIVE 92/65/EEC AFTER 31 AUGUST 2010 AND BEFORE 1 OCTOBER 2014,
DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED (MO DEL ‘EQUI -SEM -C-
INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QRCODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /324  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act□Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /325
EUROPEAN UNION Certificate model EQUI- SEM -C-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen collection centre(1), in which the semen described in Part I was collected, processed and 
stored, for trade was approved and supervised by the competent authority in accordance with 
Chapter I(I)(1) and Chapter I(II)(1) of Annex D to Directive 92/65/EEC;
II.1.1. during the period commencing 30 days prior to the date of first collection of the semen 
described in Part I until the date the fresh or chilled semen was dispatched or until the 30 
days storage period for frozen semen elapsed, the semen collection centre:
II.1.1.1. was situated on the territory or in the case of regionalisation in a part of the territory
(2)of a Member State which was not considered to be infect ed with 
African horse sickness in accordance with Article 5(2)(a) and(b) of Directive 
2009/156/EC(3);
II.1.1.2. fulfilled the conditions for a holding laid down in Article 4(5) of Directive 
2009/156/EC(3);
II.1.1.3. contained only equidae which were free o f clinical signs of equine viral arteritis 
and contagious equine metritis;
II.2. Only equidae satisfying the conditions laid down in Articles 4 and 5 or Articles 12 to 16 of 
Directive 2009/156/EC(3)have been admitted onto the centre.
II.3. The semen descr ibed in Part I was collected from donor stallions, which:
II.3.1. have not shown any clinical sign of an infectious or contagious disease at the time of 
admission onto the centre and on the day the semen was collected;
II.3.2. have been kept for 30 days prior to the date of semen collection in holdings where no 
equine has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period;
II.3.3. have not been used for natural mating during at least 30 days prior to the date of first semen collection and from the dates of the first sample referred to in points II.3.5.1., 
II.3.5.2. or II.3.5.3. until the end of the collection period;
II.3.4. have undergone the following tests, which meet at least the requirements of the relevan t 
Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the 
OIE, carried out on samples taken in accordance with one of the programmes specified in 
point II.3.5 in a laboratory recognised by the competent authority:
(2)either [II.3.4.1. an agar -gel immuno- diffusion test (Coggins test) for equine infectious anaemia 
(EIA) with negative result;]
(2)or [II.3.4.1. an ELISA for equine infectious anaemia (EIA) with negative result;]
and (2)either [II.3.4.2. a serum neutralisation test for equine viral arteritis (EVA) with negative result at a serum dilution of one in four;]
(2)or [II.3.4.2. a virus isolation test for equine viral arteritis (EVA) carried out with negative 
result on an aliquot of the entire semen of the donor stalli on;]
L 113 /326  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -C-INTRA
and II.3.4.3. an agent identification test for contagious equine metritis (CEM) carried out on 
two occasions on samples taken with an interval of seven days by isolation of 
Taylorella equigenitalis after a cultivation of 7 to 14 days from pre -ejaculatory 
fluid or a semen sample and from genital swabs taken at least from the penile 
sheath, urethra and urethral fossa with negative result in each case;
II.3.5. have been subjected with the results speci fied in II.3.4. in each case to at least one of the 
test programmes(4)detailed in points II.3.5.1., II.3.5.2. and II.3.5.3. as follows:
II.3.5.1. The donor stallion was continuously resident on the semen collection centre for 
at least 30 days prior to the date of the first collection and during the period of 
collection of the semen described in Part I and no equidae on the semen 
collection centre came into direct contact with equidae of lower health status 
than the donor stallion.
The tests described in p oint II.3.4. have been carried out on samples taken(5)
prior to the first semen collection and at least 14 days following the date of the 
commencement of the residence period of at least 30 days.
II.3.5.2. The donor stallion was resident on the semen colle ction centre for at least 30 
days prior to the date of the first collection and during the period of collection 
of the semen described in Part I, but has left the centre under the responsibility 
of the centre veterinarian for a continuous period of less th an 14 days, and/or 
other equidae on the collection centre came into direct contact with equidae of 
lower health status.
The tests described in point II.3.4. have been carried out on samples taken(5)
prior to the first semen collection of the breeding seas on or collection period in 
the year the semen described in Part I was collected and at least 14 days 
following the date of the commencement of the residence period of at least 30 
days, 
and the test described in point II.3.4.1. for equine infectious anaemi a was last 
carried out on a sample of blood taken(5)not more than 90 days before the 
semen described in Part I was collected, 
and(2)either [one of the tests described in point II.3.4.2. for equine viral arteritis 
was last carried out on a sample taken(5)not more than 30 days before 
the semen described above was collected,]
(2)or [a virus isolation test for equine viral arteritis was carried out with negative result on an aliquot of the entire semen of the donor stallion 
taken
(5)not more than six months before the semen described in Part I 
was collected and a blood sample taken on the same date(5)reacted 
positive in a serum neutralisation test for equine viral arteritis at a 
serum dilution of more than one in four,]
and the test described in point II .3.4.3. for contagious equine metritis was last 
carried out on samples taken(5)not more than 60 days before the semen 
described in Part I was collected.
II.3.5.3. The tests described in point II.3.4. have been carried out on samples taken(5)
prior to the f irst semen collection of the breeding season or collection period in 
the year the semen described in Part I was collected, 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /327
EUROPEAN UNION Certificate model EQUI- SEM -C-INTRA
and the tests described in point II.3.4. were last carried out on samples taken(5)not
less than 14 days and not more than 90 days after the collection of the semen 
described in Part I.
II.3.6. have undergone the testing provided for in point II.3.5. on samples taken on the following 
dates:Identifica tion of 
semen
Test programmeStart date(5)Date of sampling for health tests(5)
Donor 
residenceSemen 
collectionEIA 
II.3.4.1.EVA
II.3.4.2.CEM 
II.3.4.3.
Blood 
sampleSemen 
sample1.sample 2.sample
(2)either [II.4. No antibiotics were added to the semen;]
(2)or[II.4. The following antibiotic or combination of antibiotics was added to produce a concentration in 
the final diluted semen of not less than(6): ……………………………………….
…………………………………………………………………………………….. ;]
II.5. The semen described in Part I was:
II.5.1. collected, processed, stored and transported under conditions which comply with the 
requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;
II.5.2. sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter 
III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.19.
Notes
This animal health certificate shall be completed a ccording to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:Box I.11: Place of dispatch shall correspond to the semen collection centre of origin of the semen.
Box I.12: Place of destination shall correspond to the semen collection or storage centre or to the holding of semen 
destination.
Box I.19: Identification of container and seal number shall be indicated.
Box I.30: Donor identity shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the centre shall correspond to the approval number of the semen centre indicated in 
B  I 11 h  th    ll t d
L 113 /328  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -C-INTRA
Part II:
Guidance for the completion of Table in II.3.6:
Abbreviations:
EIA-1 Equine infectious anaemia (EIA) testing first occasion
EIA-2 EIA testing second occasion
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion
EVA -B2 EVA testing on blood sample second occasion
EVA -S1 EVA testing on semen sample first occasion
EVA -S2 EVA testing on semen sample second occasion
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample
CEM -12 CEM testing first occasion s econd sample taken 7 days after CEM -11
CEM -21 CEM testing second occasion first sample
CEM -22 CEM testing second occasion second sample taken 7 days after CEM- 21
Instructions:
For each semen identification in column A in the example below, the test program me (II.3.5.1., II.3.5.2. and/or 
II.3.5.3.) must be described in column B and columns C and D must be completed with the dates required.The dates when samples were taken for laboratory testing prior to the first collection of the semen described in 
Part I as required in II.3.5.1., II.3.5.2. and II.3.5.3., are entered in the upper line of columns 5 to 9 of the table, 
this being the boxes marked with EIA- 1, EVA -B1 or EVA- S1 and CEM -11 and CEM- 12 in the example below.
The dates when samples were taken for repe at laboratory testing as required in accordance with II.3.5.2. or 
II.3.5.3. are entered in the lower line of columns 5 to 9 in table, this being the boxes EIA -2, EVA -B2 or EVA -S2 
and CEM- 21 and CEM- 22 in the example below.Identifica tion 
of semen
Test 
programmeStart date(5)Date of sampling for health tests(5)
Donor 
residenceSemen 
collectionEIA 
II.3.4.1.EVA 
II.3.4.2.CEM 
II.3.4.3.
Blood 
sampleSemen 
sample1.sample 2.sample
A B C DEIA-1 EVA-B1 EVA-S1 CEM -11 CEM -12
EIA-2 EVA-B2 EVA-S2 CEM -21 CEM -22
(1)Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.
(2)Delete as appropriate. 
(3)OJ L 192, 23.7.2010, p. 1.
(4)Cross out the programme(s) that do(es) not apply to the consignment.
(5)Insert date in table in point II.3.6 (follow Guidance in Part II of the Notes).
(6)Insert names and concentrations.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /329
CHAPTER 48
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE 
ANIMALS COLLECTED, P ROCESSED AND STORED IN ACCORDANCE WITH 
DIRECTIVE 92/65/EEC BEFORE 1 SEPTEMBER 2 010, DISPATCHED AFTER 20 
APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN 
WAS COLLECTED (MODEL ‘EQUI -SEM -D-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /330  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /331
EUROPEAN UNION Certificate model EQUI- SEM -D-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen collection centre(1), in which the semen described in Part I was collected, processed 
and stored for trade:
II.1.1. was approved and supervised by the competent authority according to the conditions of 
Chapter I of Annex D to Directive 92/65/EEC;
II.1.2. was situated on the territory or in the case of regionalisation in a part of the territory(2)of 
a Member State which was on the day semen was collected until the date the semen was 
dispatched as fresh/chilled(2)semen or until the 30 days mandatory storage period for 
frozen semen elapsed(2)not considered to be infected with African horse sickness in 
accordance with Article 5(2)(a) and(b) of Directive 2009/156/EC(3);
II.1.3. fulfilled during the period commencing 30 days prior to the date of semen collection 
until the date the semen was dispatched as fresh/chilled(2)semen or until the 30 days 
mandatory storage period for frozen semen elapsed(2), the conditions of Article 4 of 
Directive 2009/156/EC;
II.1.4. contained during the period commencing 30 days prior to the date of semen collection 
until the date the semen was dispatched as fresh/chilled(2)semen or until the 30 days 
mandatory storage period for frozen seme n elapsed(2)only equidae which were free of 
clinical signs of equine viral arteritis and contagious equine metritis;
II.2. All equidae have been admitted onto the centre under the provisions of Article 4 and 5 of 
Directive 2009/156/EC(3);
II.3. The semen described in Part I was collected from donor stallions, which:
II.3.1. on the day the semen was collected have not shown clinical signs of an infectious or 
contagious disease,
II.3.2. during at least 30 days prior to collection of the semen have not been u sed for natural 
service,
II.3.3. during the 30 day period prior to collection of the semen have been kept on holdings where no equidae showed clinical signs of equine viral arteritis,
II.3.4. during the 60 days period prior to collection of the semen have been kept on holdings 
where no equidae showed clinical signs of contagious equine metritis,
II.3.5. to the best of my knowledge and as far as I could ascertain, have not been in contact 
with equidae suffering from an infectious or contagious disease during
15 days 
immediately preceding collection of the semen,
II.3.6. have undergone the following animal health tests, carried out in a laboratory recognised 
by the competent authority, in accordance with a test programme as specified in point 
II.3.7.
II.3.6.1. an agar -gel immuno -diffusion test (Coggins test) for equine infectious 
anaemia with negative result;
L 113 /332  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- SEM -D-INTRA
and(2)either [II.3.6.2. a serum neutralisation test for equine viral arteritis with negative result at a 
serum dilution of one in four; and]
(2)or [II.3.6.2. a virus isolation test for equine viral arteritis carried out with negative result 
on an aliquot of the entire semen of the donor stallion;]
and II.3.6.3. an agent identification test for contagious equine metritis carried out on two 
occasions on samples collected from the donor stallion with an interval of 
seven days by isolation of Taylorella equigenitalis from pre -ejaculatory fluid 
or a semen sample and from genital swabs taken at least from the penile sheath, urethra and urethral fossa with negative result in each case;
II.3.7. have been subject to the one of the following test programmes
(4):
II.3.7.1. The donor stallion was continuously resident on the collection centre for at 
least 30 days prior to the semen collection, and during the collection period, 
and no equidae on the collection centre came during that time into direct 
contact with equidae of lower health status than the donor stallions.
The tests described in point II.3.6. have been carried out on samples taken on 
………………………..(5)and in the case of contagious equine metritis on a 
second sample taken on ………………………..(5), being at least 14 days after 
the commencement of the above residence period and at least at the beginning of the breeding season;
II.3.7.2. The donor stallion was n ot continuously resident on the collection centre or 
other equidae on the collection centre came into contact with equidae of 
lower health status than the donor stallion.
The tests described in point II.3.6. have been carried out on samples taken on ………………………..
(5)and in the case of contagious equine metritis on a 
second sample taken on ………………………..(5), being within the 14 days 
period before the first semen collection and at least at the beginning of the breeding season, 
and the test described in point II.3.6.1. for equine infectious anaemia was 
last carried out on a sample of blood taken on ………………………..
(5), 
being not more than 120 days before the semen described in Part I was 
collected; 
and(2)either [one of the tests described in point II.3.6.2. for eq uine viral arteritis was 
last carried out on a sample collected on …………………..(5), being not 
more than 30 days before the semen described in Part I was collected,]
(2)or [the non -shedder state of the seropositive stallion for equine viral 
arteritis was conf irmed by a virus isolation test which was carried out on 
an aliquot of the entire semen of the donor stallion collected on 
………………………..(5), being not more than one year before the 
semen described in Part I was collected;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /333
EUROPEAN UNION Certificate model EQUI- SEM -D-INTRA
II.3.7.3. The tests described in point II.3.6. have been carried out during the 30 days 
mandatory storage period of frozen semen and not less than 14 days after the 
collection of the semen on samples taken on ……………………(5)and in the 
case of contagious equine metritis on a second sample tak en 
on…………………….(5);
II.4. The semen described in Part I was collected, processed, stored and transported under 
conditions which comply with the requirements of Chapters II and III of Annex D to Directive 
92/65/EEC.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: place of dispatch shall correspond to the semen collection centre of origin of the semen.
Box I.12: place of destination shall correspond to the semen collection or storage centre or to the holding of 
semen destination.
Box I.19: identification of container and Seal number shall be indicated.
Box I.30: donor identity shall correspond to the official identification of the animal.
date of collection shall be indicated in the following format: dd/mm/yyyy.
approval number of the centre shall correspond to the approval number of the semen centre 
indicated in Box I.11. where the semen was collected.
Part II:
(1)Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.
(2)Delete as appropriate.
(3)OJ L 192, 23.7.20 10, p. 1.
(4)Cross out the programme(s) that do(es) not apply to the consignment.
(5)Insert date.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /334  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 49
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF 
EQUINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED I N
ACCORDANCE WITH REGULATION (EU) 2016/429 AND DELEGATED 
REGULATION (EU) 2020 /686 AFTER 20 APRIL 2021, DISPATCHED BY THE
EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (M ODEL ‘EQUI -OOCYTES -
EMB- A-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /335
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /336  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- A-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)[II.1. The in vivo derived embryos of equine animals described in Part I have been collected, processed 
and stored, and dispatched by the embryo collection team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirement s as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Commission Delegated 
Regulation (EU) 2020/686.]
(1)[II.1. The oocytes(1)/ in vitro produced embryos(1)/micromanipulated embryos(1)of equine animals 
described in Part I have been collected or produced, processed and stored, and dispatched by the 
embryo production team(2)which
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020/686.]
II.2. The oocytes(1)/ embryos(1)described in Part I are intended for artificial reproduction and were 
obtained from donor animals which
II.2.1. have been born and remained since birth in the Union, or have entered the Union in accordance with the requirements for entry into the Union;
II.2.2. come from establishments in a Member State or zone thereof, or fr om establishments 
under official control by the competent authority in a third country or territory, or a 
zone thereof 
II.2.2.1. in which surra ( Trypanosoma evansi
) has not been reported during the 
period of the preceding 30 days prior to collection(1)/ production(1)of the 
oocytes(1)/ embryos(1), and 
(1)either [surra has not been reported in the establishment during the period of the 
preceding 2 years prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1);]
(1)or [surra has been reported in the establishment during the period of the 
preceding 2 years prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1)and following the last outbreak the establishment has remained 
under movement restrictions
(1)either [until the remaining animals in the establishment have been 
subjected to a test for surra with one of the diagnostic methods 
provided for in Part 3 of Annex I to Commission Delegated 
Regulation (EU) 2020/688, carried out, with negative results, on 
samples taken at least 6 mont hs after the last infected animal has 
been removed from the establishment;]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /337
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- A-INTRA
(1)or [for at least 30 days from the date of cleaning and disinfection 
after the last animal of listed species on the establishment was 
either killed and destroyed or slaughtered;]]
II.2.2.2. in which dourine has not been reported during the period of the preceding 
6 months prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1), 
and
(1)either [dourine has not been reported in the establishment during the period of 
the preceding 2 years prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1);]
(1)or [dourine has been reported in the establishment during the period of the preceding 2 years prior to collection
(1)/ production(1)of the oocytes(1)/ 
embryos(1)and following the last outbreak, the establishment has remained 
under movement restrictions
(1)either [until the remaining equine animals in the establishment, except 
castrated male equine animals have been subjected to a test for 
dourine with the diagnos tic method provided for in Part 8 of 
Annex I to Delegated Regulation (EU) 2020/688, carried out, 
with negative results, on samples taken at least 6 months after the 
infected animals have been killed and destroyed or slaughtered, 
or the infected entire male equine animals have been castrated;]]
(1)or [for at least 30 days after the last equine animal on the 
establishment was either killed and destroyed or slaughtered, and 
the premises were cleaned and disinfected;]]
II.2.2.3. in which equine infectious anaem ia has not been reported during the 
period of the preceding 90 days prior to collection(1)/ production(1)of the 
oocytes(1)/ embryos(1), and
(1)either [equine infectious anaemia has not been reported on the establishment 
during the period of the preceding 12 months prior to collection(1)/ 
production(1)of the oocytes(1)/ embryos(1);]
(1)or [equine infectious anaemia has been reported on the establishment during 
the period of the preceding 12 months prior to collection(1)/ production(1)
of the oocytes(1)/ em bryos(1)and following the last outbreak the 
establishment has remained under movement restriction s
(1)either [until the remaining equine animals in the establishment have 
been subjected to a test for equine infectious anaemia with the 
diagnostic method provided for in Part 9 of Annex I to Delegated 
Regulation (EU) 2020/688, carried out, with negative results, on 
samples taken on two occasions with a minimum interval of 3 
months after the infected animals have been killed and destroyed 
or slaughtered and the establishment was cleaned and 
disinfected;]]
L 113 /338  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- A-INTRA
(1)or [for at least 30 days after the last equine animal on the 
establishment was either killed and destroyed or slaughtered, and 
the premises were cleaned and disinfected;]]
II.2.3. were examined by the team veterinarian or a team member and did not show 
symptoms or clinical signs of transmissible animal diseases on the day of collection 
of the oocytes(1)/ embryos(1); 
II.2.4. are identified as provided for in Article 58(1), 59(1) or 62(1) of Commission 
Delegated Regulation (EU) 2019/2035;
II.2.5. for a period of at least 30 days prior to the date of first collection of the oocytes(1)/ 
embryos(1)and during the collection period 
II.2.5.1. were kept on establishments not situated in a restricted zone established 
due to the occurrence of African horse sickness, infection with 
Burkholderia mallei (glanders) or of an emerging disease relevant for 
equine animals;
II.2.5.2. were kept on a single establishment where Venezuelan equine 
encephal omyelitis, dourine, surra ( Trypanosoma evansi), equine infections 
anaemia, contagious equine metritis ( Taylorella equigenitalis ), infection 
with rabies virus and anthrax have not been reported;
II.2.5.3. were not in contact with animals from establishments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.2.5.1. or from establishments which do not meet the conditions referred 
to in point II.2.5.2.;
II.2.6. were not used for natural breeding during a period of at least 30 days prior to the date 
of the collection of the oocytes(1)/ embryos(1)and between the date of the first 
samples referred to in points II.2.7.1. and II.2.7.2. and the date of the collection of the 
oocytes(1)/ embryos(1);
II.2.7. have been subjected to t he following tests, referred to in points 2(b) and (c) of 
Chapter II of Part 4 of Annex II to Delegated Regulation (EU) 2020/686, as follows:
II.2.7.1. for equine infectious anaemia (EIA), an agar -gel immuno -diffusion test 
(AGID or Coggins test) or an enzy me-linked immunosorbent assay 
(ELISA) with a negative result carried out on a blood sample taken on ……………….
(3), being not less than 14 days following the date of 
commencement of the period referred to in point II.2.6, and the test was last carried out on a blood sample taken on …………………….
(3),being 
not more than 90 days prior to the date of the collection of the 
oocytes(1)/embryos(1)intended for movement to another Member State;]
II.2.7.2. for contagious equine metritis (CEM), an agent identification test c arried 
out with a negative result on at least two specimens (swabs) taken during 
the period referred to in point II.2.6. from at least the mucosal surfaces of 
the clitoral fossa and the clitoral sinuses of the donor mare
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /339
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- A-INTRA
(1)either [II.2.7.2.1. on two occasions with an interval of not less than 7 days 
on…………(3)and on………………..(3), in the case of isolation 
of Taylorella equigenitalis after cultivation under 
microaerophilic conditions for a period of at least 7 days, set up 
within 24 hours after taking the specimens from the donor 
animal, or 48 hours where the specimens are kept cool during 
transport.]
(1)and/or [II.2.7.2.2. on one occasion on………………..(3), in the case of detection 
of genome of Taylorella equigenitalis by a polymerase chain 
reaction (PCR) or real -time PCR, carried out within 48 hours 
after taking the specimens from the donor animal.]
The samples referred to in points II.2.7.2.1. and II.2.7.2.2. were in no case 
taken earlier than 7 days (systemic treatment) or 21 days (local treatment) 
after antimicrobial treatment of the donor mare and were placed in 
transport medium with activated charcoal, such as Amies medium, before 
dispatch to the laboratory.
II.3. The oocytes(1)/ embryos(1)described in Part I
II.3.1. has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to 
Delegated Regulation (EU) 2020/686;
II.3.2. areplaced in straws or other packages on which the mark is applied in accordance 
with requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 
and that mark is indicated in Box I.30;
II.3.3. are transported in a container which:
II.3.3.1. was sealed and numbered prior to t he dispatch by the embryo collection 
or production team under responsibility of the team veterinarian, or by an official veterinarian, and the seal bears the number as indicated in 
Box I.19;
II.3.3.2. has been cleaned and either disinfected or sterilised b efore use, or is 
single -use container; 
(1)(4)[II.3.3.3. has been filled in with the cryogenic agent which not have been 
previously used for other products;]
(1)(5)[II.3.4. are placed in straws or other packages which are securely and hermetically sealed;
II.3.5. are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
L 113 /340  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- A-INTRA
(1)(6)[II.4. The in vivo derived embryos(1)/ in vitro produced embryos(1)/micromanipulated embryos(1)
described in Part I were conceived by artificial insemination using semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre 
approved for the collection, processing and/or storage of seme n by the competent authority of a 
Member State or by the competent authority of a third country, territory or zone thereof listed in 
Annex XII to Commission Implementing Regulation (EU) 2021/404 .]
(1)(7)[II.5. The following antibiotic or mixture of antibio tics(7)has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicat e the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. 
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced 
embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed. 
“Date of collection/production”: indicate the date on which oocytes or embryos of the 
consignment was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /341
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- A-INTRA
Part II:
(1)Delete if not applicable.
(2)Only embryo collection or production teams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU)
2020/686.
(3)Insert date in the following format: dd.mm.yyyy.
(4)Applicable for frozen oocytes or embryos.(5)Applicable for the consignment where in one container 
oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of equine 
animals are placed and transported.
(6)Does not apply to oocytes.
(7)Mandatory attestation in case antibiotics were added.
(8)Insert the name(s) of the antibiotic(s) added and its(their) concentra tion.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /342  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 50
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF OOCYTES AND 
EMBRYOS OF EQUINE ANIMALS COLLECTED OR P RODUCED, PROCESSED 
AND STORED IN ACCORD ANCE WITH DIRECTIVE 92/65/EEC AFTER 30 
SEPTEMBER 2014 AND B EFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 
2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE 
OOCYTES OR EMBRYOS W ERE COLLECTED OR PRO DUCED (MODEL ‘EQUI -
OOCYTES -EMB- B-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /343
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing plant Approval or registration 
number of 
plant/establishment/centreTest
L 113 /344  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- B-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)either [II.1. the in vivo derived embryos/ in vivo derived ova(1)described in Part I were collected, processed 
and stored by an embryo collection team(2)approved and supervised in accordance with 
Chapter I(III)(1) of Annex D to Directive 92/65/EEC(3);]
(1)or [II.1. the in vitro produced embryos/micromanipulated embryo s(1)described in Part I were produced, 
processed and stored by an embryo production team(2),approved and supervised in accordance 
with Chapter I(III) (1) and (2) of Annex D to Directive 92/65/EEC;]
(1)either [II.2. the in vivo derived embryos described in Part I meet the requirements of Chapter III(II)(1) of 
Annex D to Directive 92/65/EEC;]
(1)or [II.2. the in vivo derived ova described in Part I meet the requirements of Chapter III(II)(2) of Annex D 
to Directive 92/65/EEC;]
(1)or [II.2. the in vitro produced embryos described in Part I meet the requirements of Chapter III(II)(3) of 
Annex D to Directive 92/65/EEC;]
(1)or [II.2. the micromanipulated embryos described in Part I meet the requirements of Chapter III(II)(4) of 
Annex D to Directive 92/65/EEC;]
II.3. the ova or embryos described in Part I come from donor mares which:
II.3.1. come from holdings fulfilling the conditions laid down in Article 4(5) of Directive 
2009/156/EC(4)onto which only equidae satisfying the conditions laid down in Articles 
4 and 5 or Articles 12 to 16 of Directive 2009/156/EC were admitted;
II.3.2. meet the requirements of Chapter IV(4) of Annex D to Directive 92/65/EEC;
II.3.3. were not used for natural breeding during a period of at least 30 days pr ior to the date of 
collection of the ova or embryos and between the date of the first sample referred to in 
points II.3.4.1 and II.3.4.2. and the date of the collection of the ova or embryos;
II.3.4. underwent the tests, which meet at least the requirement s of the relevant Chapter of the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out 
in a laboratory which is recognised by the competent authority and has the tests referred 
to hereinafter included in its accreditation in accordance with Article 12 of Regulation 
(EC) No 882/2004(5), as follows:
II.3.4.1. for equine infectious anaemia (EIA), an agar -gel immuno- diffusion test (AGID 
or Coggins test) or an enzyme -linked immunosorbent assay (ELISA) with a 
negative result carr ied out on a blood samples taken on ……………….(6), being 
not less than 14 days following the date of commencement of the period 
referred to in point II.3.3, and the test was last carried out on a sample of blood 
taken on …………………….(6); being not more than 90 days prior to the date 
of the collection of the ova or embryos intended for trade;
II.3.4.2. for contagious equine metritis (CEM), an agent identification test carried out 
with a negative result on at least two specimens (swabs) taken during the period referred to in point II.3.3 from at least the mucosal surfaces of the clitoral fossa 
and the clitoral sinuses of the donor mare;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /345
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- B-INTRA
(1)either [II.3.4.2.1. on two occasions with an interval of not less than 7 days 
on…………(6)and on………………..(6), in the case of isolation of 
Taylorella equigenitalis after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within the 24 hour 
period after taking the specimens from the donor animal, or the 48 
hour period where the sp ecimens are kept cool during transport;]
(1)and/or [II.3.4.2.2. on one occasion on………………..(6), in the case of the detection 
of genome of Taylorella equigenitalis by a polymerase chain 
reaction (PCR) or real -time PCR test, carried out within the 48 
hour per iod after taking the specimens from the donor animal.]
The samples referred to in points II.3.4.2.1. and II.3.4.2.2. were in no case taken earlier than 7 days (systemic treatment) or 21 days 
(local treatment) after antimicrobial treatment of the donor mare
and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory;
(1)either [II.4. the embryos described in Part I were conceived as a result of artificial insemination of the donor 
mares with semen whic h was collected, processed, stored and transported under conditions which 
comply with the requirements of Chapters I(I), II(I) and III(I) of Annex D to Directive 
92/65/EEC;]
(1)or [II.4. the embryos described in Part I were conceived as a result of in vitr ofertilisation of ova 
complying with the conditions set out in point 2 of Chapter III(II) of Annex D to Directive 
92/65/EEC with semen which was collected, processed, stored and transported under conditions which comply with the requirements of Chapters I (I), II(I) and III(I) of Annex D to Directive 
92/65/EEC;]
(1)or [II.4. the ova have not been in contact with semen of the equine species;]
II.5. the ova or embryos described in Part I were sent to the place of loading in a sealed container in accordance with point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the 
number detailed in Box I.19.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of A nnex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: The place of dispatch shall correspond to the embryo collection team or embryo production team 
of ova/embryos collection/production.
Box I.12: The place of destination shall co rrespond to the embryo collection team, embryo production team 
or to the holding of ova/embryos destination.
Box I.19: The identification of container and Seal number shall be indicated.
Box I.30: “Type”: specify if: in vivo derived embryos, in vivo derive d oocytes, in vitro produced embryos or 
micromanipulated embryos.
The donor identity shall correspond to the official identification of the animal.
The date of collection shall be indicated in the following format: dd/mm/yyyy.
Part II:
(1)Delete as appropriate.
(2)Only embryo collection or production teams approved by the competent authority and listed in accordance 
with Article 11(4) of Directive 92/65/EEC.
(3)OJ L 268, 14.9.1992, p. 54.
(4)OJ L 192, 23.7.2010, p. 1.
(5)OJ L 165, 30.4.2004, p. 1 .
(6)Insert date.
L 113 /346  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- B-INTRA
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /347
CHAPTER 51
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF OOCYTES AND 
EMBRYOS OF EQUINE ANIMALS COLLECTED OR PRODUCED, PR OCESSED 
AND STORED IN ACCORD ANCE WITH DIRECTIVE 92/65/EEC AFTER 
31AUGUST 2010 AND BEFO RE 1 OCTOBER 2014, D ISPATCHED AFTER 2 0
APRIL 2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY 
WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED 
(MODEL ‘EQUI -OOCYTES -EMB -C-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /348  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /349
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- C-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
(1)either [II.1. the in vivo derived embryos/ in vivo derived ova(1)described in Part I were collected, processed and 
stored by an embryo collection team(2)approved and supervised in accordance with 
Chapter I(III)(1) of Annex D to Directive 92/65/EEC;]
(1)or [II.1. the in vitro produced embryos/micromanipulated embryos(1)described in Part I were produced, 
processed and stored by an embryo production team(2),approved and supervised in accordance 
with Chapter I(III) (1) and (2) of Annex D to Directive 92/65/EEC;]
(1)either [II.2. the in vivo derived embryos described in Part I meet the requirements of Chapter III(II)(1) of 
Annex D to Directive 92/65/EEC;]
(1)or [II.2. the in vivo derived ova described in Part I meet the requirements of Chapter III(II)(2) of Annex D 
to Directive 92/65/EEC;]
(1)or [II.2. the in vitro produced embryos described in Part I meet the requirements of Chapter III(II)(3) of 
Annex D to Directive 92/65/EEC;]
(1)or [II.2. the micromanipulated embryos described in Part I meet the requirements of Chapter III(II)(4) of 
Annex D to Directive 92/65/EEC;]
II.3. the ova or embryos described in Part I come from donor mares which:
II.3.1. coming from holdings fulfilling the conditions laid down in Article 4(5) of Directive 
2009/156/EC(4)onto which only equidae satisfying the conditi ons laid down in Articles 4 
and 5 or Articles 12 to 16 of Directive 2009/156/EC have been admitted;
II.3.2. meet the additional requirements of Chapter IV(4) of Annex D to Directive 92/65/EEC;
II.3.3. have not been used for natural breeding during at least 30 days prior to the date of 
collection of ova or embryos and between the date of the first sample referred to in points 
II.3.4. and II.3.5. and the date of the collection of ova and embryos; 
II.3.4. have been subjected with negative result to an agar -gel immuno -diffusion test (Coggins 
test) or an ELISA for equine infectious anaemia carried out on a blood samples taken on ……………….
(3), being during the past 30 days prior to the date of the first collection of 
ova or embryos and the last test was carried out on a sample of blood taken on 
…………………….(3); being not more than 90 days before the ova and embryos were 
collected;
II.3.5. have been subjected to an agent identification test for contagious equine metritis by 
isolation of Taylorella equigenitalis after a cultivation of 7 to 14 days carried out with 
negative results in each case on samples taken during the past 30 days prior to the date of 
the first collection of ova or embryos from mucosal surfaces of the clitoral fossa and 
clitoral sinuses on two consecutives oestrus periods on…………(3)and 
on………………..(3), and on an additional culture specimen taken during one of the 
oestrus periods from the endometrial cervix on……………….(3);
L 113 /350  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- C-INTRA
(1)either [II.4. the embryos described in Part I were conceived as a result of artificial insemination of the donor 
mares with semen which was collected, processed, stored and transported under conditions which 
comply with the requirements of Chapters I(I), II(I) and III(I) of Annex D to Directive 
92/65/EEC;]
(1) or [II.4. the em bryos described in Part I were conceived as a result of in vitro fertilisation of ova complying 
with the conditions in point 2 of Chapter III(II) of Annex D to Directive 92/65/EEC with semen 
which was collected, processed, stored and transported under conditions which comply with the 
requirements of Chapters I(I), II(I) and III(I) of Annex D to Directive 92/65/EEC;]
(1) or [II.4. the ova have not been in contact with semen of the equine species;]
II.5. the ova or embryos described in Part I were sent to the place of loading in a sealed container in 
accordance with point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the 
number detailed in Box I.19.
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the embryo collection team or embryo production team of 
ova/embryos collection/production.
Box I.12: Place of destination shall correspond to the embryo collection team, embryo production team or to 
the holding of ova/embryos destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: “Type”: Specify if: in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or 
micromanipulated embryos.
Donor identity shall corr espond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the team shall correspond to the embryo collection team or embryo 
production team of ova/embryos collection /production.
Part II:
(1)Delete as appropriate.
(2)Only embryo collection or production teams approved by the competent authority and listed in accordance 
with Article 11(4) of Council Directive 92/65/EEC.
(3)Insert date.
(4)OJ L 192, 23.7.2010, p. 1.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /351
CHAPTER 52
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOCKS OF OOCYTES AND 
EMBRYOS OF EQUINE ANIMALS COLLECTED OR PRODUCED, PROCESSED 
AND STORED IN ACCORD ANCE WITH DIRECTIVE 92/65/EEC BEFORE 1 
SEPTEMBER 2010 ,DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO 
COLLECTION OR PRODUC TION TEAM BY WHICH THE OOCYTES OR 
EMBRYOS WERE COLLECTED OR PRODUCE D (MODEL ‘EQUI -OOCYTES -
EMB- D-INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of 
an establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation
No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /352  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /353
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- D-INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. Ova/embryos(1)described in Part I were collected by a collection team(2)approved by the competent 
authority and processed in an appropriate laboratory;
II.2. Ova/embryos(1)were collected from donor mares which:
II.2.1. on the day of collection have been located in premises situated on the territory or in the case of 
regional isation in a part of the territory of a Member State which is not considered to be infected 
with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 
2009/156/EC(3),
II.2.2. have been located in holdings under veterinary supervisi on which on the day of collection 
fulfilled the conditions of Article 4 of Directive 2009/156/EC,
II.2.3. have been kept prior to the collection in holdings free from clinical signs of contagious equine 
metritis for 60 days,
II.2.4. have not been used for natural breeding during the period of 30 days prior to the collection of 
ova/embryos(1),
II.2.5. to the best of my knowledge and as far as I could ascertain, have not been in contact with equidae 
suffering from an infectious or contagious disease during th e 15 days immediately preceding the 
collection of ova/embryos(1),
II.2.6. have on the day of collection not shown clinical signs of an infectious or contagious disease;
II.3. Ova/embryos(1)were collected, processed, stored and transported under conditions which comply with the 
requirements of Annex D of Directive 92/65/EEC;
II.4. The semen used for the artificial insemination of the donor mares complies with the requirements of 
Directive 92 /65/EEC(4)(1);
II.5. The ova used for the in vitro production of embryos comply with the requirements of Directive 
92/65/EEC(1).
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
forin Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.11: Place of dispatch shall correspond to the embryo collection team of ova/embryos collection.
Box I.12: Place of destination shall correspond to the embryo collection team, embryo production team or to 
the holding of ova/embryos destination.
Box I.19: Identification of container and Seal number shall be indicated.
Box I.30: “Type”: Specify if: in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or 
micromanipulated embryos.
Donor identity shall correspond to the official identification of the animal.
Date of collection shall be indicated in the following format: dd/mm/yyyy.
Approval number of the team shall correspond to the embryo collection team of ova /embryos 
collection.
L 113 /354  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- OOCYTES- EMB- D-INTRA
Part II:
(1)Delete as appropriate.
(2)Only embryo collection teams approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.
(3)OJ L 192, 23.7.2010, p. 1.
(4)Does not apply to ova.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /355
CHAPTER 53
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIG NMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT PROCESSING ESTABLISHMENT:
-semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 Ap ril 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014;
-stocks of semen of equine animals collected, processed and stored in accordance with Directiv e
92/65/EEC before 1 September 2010;
-oocytes and embryos of equine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;
-stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010
(MODEL ‘EQUI -GP-PROCESSING -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
L 113 /356  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /357
EUROPEAN UNION Certificate model EQUI- GP-PROCESSING -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)was/were 
processed and stored:
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embr yos(2)/ in vitro produced embryos(2)/ micromanipulated 
embryos(2)described in Part I is/are intended for artificial reproduction and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collectio n or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out 
in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/686, 
and was/were moved to the germinal product processing establishment indicated in Box I.11. 
situated in the Member State of its/their collection or production under animal health certification requirements at least as strict as those provided for in:
(2)either [Model EQUI -SEM -A-INTRA(4);]
(2)and/or [Model EQUI -SEM -B-INTRA(4);]
(2)and/or [Model EQUI -SEM -C-INTRA(4);]
(2)and/or [Model EQUI -SEM -D-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -A-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -B-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -C-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -D-INTRA(4);]
(2)and/or [Model EQUI -GP-PROCESSING -INTRA(4);]
(2)and/or [Model EQUI -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Memb er State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1
(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU ) 2020/686, 
and was/were moved to the germinal product processing establishment indicated in Box I.11. 
situated in another Member State accompanied by certificate(s) in accordance with:
(2)either [Model EQUI -SEM -A-INTRA(4);]
(2)and/or [Model EQUI -SEM -B-INTRA(4);]
(2)and/or [Model EQUI -SEM -C-INTRA(4);]
L 113 /358  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- GP-PROCESSING -INTRA
(2)and/or [Model EQUI -SEM -D-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -A-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -B-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -C-INTRA(4);]
(2)and/or [Model EQUI -OOC YTES-EMB -D-INTRA(4);]
(2)and/or [Model EQUI -GP-PROCESSING -INTRA(4);]
(2)and/or [Model EQUI -GP-STORAGE -INTRA(4);]]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in a third country, territory or zone thereof lis ted in Annex XII to Commission 
Implementing Regulation (EU) 2021/404 and complying with requirements as regards 
responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 
3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and entered the Union 
accompanied by certificate(s) in accordance with: 
(2)either [Model EQUI -SEM -A-ENTRY(4);]
(2)and/or [Model EQUI -SEM -B-ENTRY(4);]
(2)and/or [Model EQUI -SEM -C-ENTRY(4);]
(2)and/or [Mode l EQUI -SEM -D-ENTRY(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -A-ENTRY(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -B-ENTRY(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -C-ENTRY(4);]
(2)and/or [Model EQUI -GP-PROCESSING -ENTRY(4);]
(2)and/or [Model EQUI -GP-STORAGE -ENTRY(4);]
II.2.2. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/are placed in straws or other packages on which the mark is applied in accordance wit h
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and/or Article 
83(a) of Commission Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.30;
II.2.4. is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from
the germinal product storage 
centre under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is a single -use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for other products;]
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /359
EUROPEAN UNION Certificate model EQUI- GP-PROCESSING -INTRA
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishments 
approved by the competent autho rity and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s ) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo collection and/or production team by which the oocytes and/or embryos were c ollected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.26 : Total number of packages shall correspond to the number of containers.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indic ate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
L 113 /360  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- GP-PROCESSING -INTRA
Part II:
(1)Only germinal product processing establishments approved by the compet ent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020/686.
(2)Delete if not applicable.
(3)Only germinal product establishments approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(4)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, an d/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of equine animals are placed and transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /361
CHAPTER 54
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIG NMENTS OF GERMINAL PRODUCTS LI STED 
BELOW ,DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL 
PRODUCT STORAGE CENTRE:
-semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010;
-oocytes and embryos of equine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021;
-stocks of oocytes and embryos of equine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Direc tive 92/65/EEC after 31 August 2010 and before 1 October 2014;
-stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010
(MODEL ‘EQUI -GP-STORAGE -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
L 113 /362  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /363
EUROPEAN UNION Certificate model EQUI- GP-STORAGE -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo
derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)was/were stored:
II.1.1. is approved and kept in a register by the competent authority;
II.1.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated 
embryos(2)described in Part I is/are intended for artificial reproduction and 
(2)either [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1
(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/686, 
and was/were moved to the germinal product storage centre indicated in Box I.11. situated in the 
Member State of its/their collection or production under animal health certification requirements 
at least as strict as those provided for in:
(2)either [Model EQUI -SEM -A-INTRA(4);]
(2)and/or [Model EQUI -SEM -B-INTRA(4);]
(2)and/or [Model EQUI -SEM -C-INTRA(4);]
(2)and/or [Model EQUI -SEM -D-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -A-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -B-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -C-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -D-INTRA(4);]
(2)and/or [Model EQUI -GP-PROCESSING -INTRA(4);]
(2)and/or [Model EQUI -GP-STORAGE -INTRA(4);]]
(2)and/or [Model IA in Part A of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model IB in Part B of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model IC in Part C of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model ID in Part D of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model in Commission Decision 95/307/EC(4);]
(2)and/or [II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out 
in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/686, 
and was/were moved to the germinal product storage centre indicated in Box I.11. situated in 
another Member State accompanied by certificate(s) in accordance with:
(2)either [Model EQUI -SEM -A-INTRA(4);]
(2)and/or [Model EQUI -SEM -B-INTRA(4);]
L 113 /364  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- GP-STORAGE -INTRA
(2)and/or [Model EQUI -SEM -C-INTRA(4);]
(2)and/or [Model EQUI -SEM -D-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -A-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -B-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -C-INTRA(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -D-INTRA(4);]
(2)and/or [Model EQUI -GP-PROCESSING -INTRA(4);]
(2)and/or [Model EQUI -GP-STORAGE -INTRA(4);]]
(2)and/or [Model IA in Part A of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model IB in Part B of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model IC in Part C of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model ID in Part D of Annex I to Decision 2010/470/EU(4);]
(2)and/or [Model in Annex to Commission Decision 95/307/EC(4);]
(2)and/or [II.2.1. has/ha ve been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)situated in a third country, territory or zone thereof listed in Annex XII to Commission 
Implementing Regulation (EU) 2021/404 and complying with requirements as regards 
responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 
3(2)/Part 4(2)/Part 5(2)of Annex I to Delegated Regulation (EU) 2020/686, and entered the Union 
accompanied by certificate(s) in accordance with:
(2)either [Model EQUI -SEM -A-ENTRY(4);]
(2)and/or [Model EQUI -SEM -B-ENTRY(4);]
(2)and/or [Model EQUI -SEM -C-ENTRY(4);]
(2)and/or [Model EQUI -SEM -D-ENTRY(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -A-ENTRY(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -B-ENTRY(4);]
(2)and/or [Model EQUI -OOCYTES -EMB -C-ENTRY(4);]
(2)and/or [Model EQUI -GP-PROCESSING -ENTRY(4);]
(2)and/or [Model EQUI -GP-STORAGE -ENTRY(4);]
(2)and/or [Model 1 in Section A of Part 1 of Annex III to Regulation (EU) 2018/659(4);]
(2)and/or [Model 2 in Section B of Part 1 of Annex III to Regulation (EU) 2018/ 659(4);]
(2)and/or [Model 3 in Section C of Part 1 of Annex III to Regulation (EU) 2018/659(4);]
(2)and/or [Model 4 in Section D of Part 1 of Annex III to Regulation (EU) 2018/659(4);]
(2)and/or [Model 1 in Section A of Part 2 of Annex II to Decision 2010/471/EU(4);]
(2)and/or [Model 2 in Section B of Part 2 of Annex II to Decision 2010/471/EU(4);]
(2)and/or [Model 3 in Section C of Part 2 of Annex II to Decision 2010/471/EU(4);]
(2)and/or [Model in Annex to Commission Decision 96/539/EC(4);]
II.2.2. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.3. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and/or Article 
83(a) of Commission Delegated Regulation (EU) 2020/692 and that mark is indicated in Box 
I.30;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /365
EUROPEAN UNION Certificate model EQUI- GP-STORAGE -INTRA
II.2.4. is/are transported in a container which:
II.2.4.1. was sealed and numbered prior to the dispatch from the germinal product storage 
centre under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(5)[II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;]
(2)(6)[II.2.5. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.6. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent 
authority and included in the regi ster referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/686.
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of desti nation of the consignment of semen, oocytes, 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) th at accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.26: Total number of packages shall corres pond to the number of containers.
L 113 /366  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model EQUI- GP-STORAGE -INTRA
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: indicate the date on which semen, oocytes and/or 
embryos of the consignme nt was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product storage centres approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(2)Delete if not applicable.
(3)Only germinal product establishments approved by the competent authority and included in the register 
refer red to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/686.
(4)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocyte s or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
described i n Box I.11 must be attached to this certificate.
(5)Applicable for frozen semen, oocytes or embryos.
(6)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of equine animals are placed and transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /367
CHAPTER 55
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF HONEYBEES (MODEL ‘HBEE- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISOcountry code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /368  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /369
EUROPEAN UNION Certificate model HBEE- INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. The animals in the consignment described in Part I meet the following requirements in any stage 
of their lifecycle, including honeybee brood:
II.1.1. The animals have not shown signs of occurrence of American foulbrood, Aethina 
tumida (Small hive beetle) and Tropilaelaps spp . during the visual examination 
carried out within the 48 hour period prior to departure.
II.1.2. Their packaging and any accompany ing feed or other material have not shown signs 
of presence of American foulbrood, Aethina tumida (Small hive beetle) and 
Tropilaelaps spp . during the visual examination carried out within the 48 hour period 
prior to departure.
II.2. According to official information, the animals meet the following animal health requirements:
II.2.1. The animals come from an apiary situated in the centre of a circle of at least 3 km radius where American foulbrood has not been reported during the 30 day period 
prior to depa
rture and which is not restricted due to an outbreak of American 
foulbrood .
II.2.2. The animals come from an apiary situated in the centre of a circle of at least 100 km 
radius, where infestation with Aethina tumida (Small hive beetle) and Tropilaelaps 
spp. has not been reported and which is not restricted due to a suspected case or the 
confirmed occurrence of infestation with Aethina tumida (Small hive beetle) or 
Tropilaelaps spp.
(1)II.2.3. [The animals come from a Member State or zone the reof with the status free from 
infestation with Varroa spp. and arrangements have been made to ensure that they 
are protected from infestation with Varroa spp . during transport. ]
II.3. To the best of my knowledge and as declared by the operator, the animal s in the consignment come 
from an establishment where there were no abnormal mortalities with an undetermined cause and 
they have not been in contact with honeybees, which did not comply with the requirements referred 
to in point II.2.
II.4. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of 10 days for the validity of the certificate may be extended by the duration of 
the journey by waterway/sea.
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /370  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model HBEE- INTRA
Part I:
Box reference I.11: “Place of dispatch”: Indicate a registered establishment.
Box reference I.12: “Place of destination”: Indicate a registered establishment.
Box reference I.30: “Category”: Indicate: queen honeybees with maximum 20 attendants, colonies with 
brood or other.
Part II:
(1)Delete if not applicable.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /371
CHAPTER 56
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF QUEEN HONEYBEES UNDER DEROGATION (MODEL 
‘QUE -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /372  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /373
EUROPEAN UNION Certificate model QUE- INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. The animals(1)in the consignment described in Part I meet the following requirements:
II.1.1. The animals have not shown signs of occurrence of American foulbrood, Aethina 
tumida (Small hive beetle) and Tropilaelaps spp . during the visual examination 
carried out within the 24 hour period prior to departure.
II.1.2. Their packaging and any accompanying feed or other material have not shown signs of presence of American foulbrood, Aethina tumida
(Small hive beetle) and 
Tropilaelaps spp . during the visual examination carried out within the 24 hour period 
prior to depart ure.
II.1.3. The documentary check verified that the establishment of origin has been inspected 
every month during the production season by the competent authority with negative 
results to provide a confidence level of at least 95% of detecting infestation with 
small hive beetle if at least 2% of the hives were infested.
II.1.4. The animals are caged individually with a maximum of 20 accompanying attendants.
II.1.5. Arrangements have been made to ensure that the cages, containers or the entire 
consignment a re covered with fine mesh of not more than 2 mm in pore size 
immediately after the visual examination for the health certification.
II.2. According to official information, the animals meet the following animal health requirements:
II.2.1. The animals come from an apiary situated in the centre of a circle of at least 3 km 
radius where American foulbrood has not been reported during the 30 day period 
prior to departure and which is not restricted due to an outbreak of American 
foulbrood.
II.2.2. The animals come from an apiary situated in the centre of a circle of at least 100 km 
radius, where infestation with Tropilaelaps spp. has not been reported and which is 
not restricted due to a suspected case or the confirmed occurrence of infestation with 
Tropilaelap s spp.
II.2.3. In the apiary infestation with small hive beetle has not been reported and the apiary is situated at a distance of at least 30 km from the limits of a protection zone of at least 20 km in radius established by the competent authority around 
a confirmed 
occurrence of infestation with small hive beetle.
II.2.4. the apiary is not located in a zone restricted by emergency measures established by 
the Union due to the confirmed occurrence of infestation with small hive beetle .
II.2.5. the apiary of origin is situated in an area where annual surveillance for the detection 
of infestation with small hive beetle by the competent authority is ongoing to provide 
a confidence level of at least 95% of detecting infestation with small hive beetle if at 
least 2% of the apiaries were infested .
L 113 /374  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model QUE- INTRA
(2)II.2.6. [The animals come from a Member State or zone thereof with the status free from 
infestation with Varroa spp. and arrangements have been made to ensure that they 
are protected from infestation with Varroa spp .during transport. ]
II.3. To the best of my knowledge and as declared by the operator, the animals in the consignment 
come from an establishment where there were no abnormal mortalities with an undetermined 
cause and they have not been in contact with hone ybees which did not comply with the 
requirements referred to in point II.2.
II.4. This certificate is valid for 10 days from the date of issuing. In the case of transport by 
waterway/sea of animals, the period of 10 days for the validity of the certificate may be extended 
by the duration of the journey by waterway/sea.
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate a registered establishment.
Box reference I.12: “Place of destination”: Indicate a registered establishment.
Box reference I.30: “Nature of commodity”: indicate: queen honeybees with maximum 20 attendants.
Part II:
(1)Animals can only be queen honeybees with maximum 20 attendants.
(2)Delete if not applicable.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /375
CHAPTER 57
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF BUM BLE BEES (MODEL ‘BBEE -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /376  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the co nsignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /377
EUROPEAN UNION Certificate model BBEE- INTRAart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. The animals in the consignment described in Part I meet the following requirements:
II.1.1. The animals have not shown signs of occurrence of Aethina tumida (Small hive 
beetle) during the visual examination carried out within the 48 hour period prior to 
departure.
II.1.2. Their packaging and any accompanying feed or other material have not shown signs 
of presence of small hive beetle during the visual examina tion carried out within the 
48 hour period prior to departure.
II.2. According to official information, the animals come from an establishment situated in the centre of a 
circle of at least 100 km radius, where infestation with small hive beetle has not been reported and 
which is not restricted due to a suspected case or the confirmed occurrence of infestation with small 
hive beetle .
II.3. To the best of my knowledge and as declared by the operator, the animals in the consignment come 
from an establishmen t where there are no abnormal mortalities with an undetermined cause and they 
have not been in contact with bumble bees which did not comply with the requirements referred to in 
point II.2.
II.4. This certificate is valid for 10 days from the date of issui ng. In the case of transport by waterway/sea 
of animals, the period of 10 days for the validity of the certificate may be extended by the duration of 
the journey by waterway/sea.
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to Europea n Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate a registered establishment.
Box reference I.12: “Place of destination”: Indicate a registered or approved establishment.
Box reference I.30: “Category ”:Indicate either of the following: queens with maximum 20 attendants, 
colonies with brood or other.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /378  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 58
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF TER RESTRIAL ANIMALS BETWEEN CONFINED 
ESTABLISHMENTS (MODEL ‘CONFINED- LIVE- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /379
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /380  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CONFINED -LIVE- INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. The a nimals(1)in the consignment described in Part I meet the following requirements:
II.1.1. Their confined establishment of dispatch is approved in accordance with Articles 97 and 99 of 
Regulation (EU) 201 6/429.
II.1.2. They have not shown clinical signs or symptoms of diseases, in particular relevant diseases 
listed in Annex of Commission Implementing Regulation (EU) 2018/1882, during the clinical 
examination, or where this is not possible, a clinical inspection, which was carried out within 
the 48 hour period prior to departure of the consignment, on ………………. (insert date
dd/mm/yyyy ).
II.2. According to official information, animals in the consignment described in Part I meet the following 
health requirements:
II.2.1. They come from a confined establishment that is not subject to movement restrictions 
affecting the animals to be moved.
(2)(3)either [II.2.2. They originate from a Member State or a zone free from infection with bluetongue virus 
(serotypes 1 -24), where no case of infection with bluetongue virus (serotypes 1- 24) has been 
confirmed during the last 24 months in the targeted animal population and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1 -24) in the 
60 day period before the date of movement and the requi
rements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Commission Delegated Regulation (EU) 2020/688 are fulfilled.]
(2)(3)and/or [II.2.2. They originate from a Member State or a zone covered by the eradication programme for infection with b luetongue virus (serotypes 1- 24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they
(2)either [II.2.2.1. have been kept in a Member State or zone seasonally free fro m infection with 
bluetongue virus (serotypes 1 -24) in accordance with Article 40(3) of 
Commission Delegated Regulation (EU) 2020/689
(2)either [II.2.2.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.2.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the animal into the Member State or zone seasonally free from infection 
with b luetongue virus (serotypes 1- 24)]]
(2)and/or [II.2.2.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the entry date of the ani mal into 
the Member State or zone seasonally free from infection with 
bluetongue virus (serotypes 1 -24);]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /381
EUROPEAN UNION Certificate model CONFINED -LIVE- INTRA
(2)and/or [II.2.2.2. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment and
(2)either [II.2.2.2.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.2.2.2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.2.2.3. for at least 14 days prior to the date of move ment and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors;]]]
(2)and/or [II.2.2.3. have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and 
(2)either [II.2.2.3.1. have been vaccinated more than 60 days before the date of 
movement]]
(2)and/or [II.2.2.3.2. have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the im munity set in the specifications of the 
vaccine;]]]
(2)and/or [II.2.2.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and
(2)either [II.2.2.4.1. the serological test has been carried out on samples collected at least 60 days before the date of movement]]
(2)and/or [II.2.2.4.2. the serological test has been carried out on samples collected at least 
30 days before the date of the movement and the animal has been 
subjected to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of movement;]]]
(2)(3)and/or [II.2.2. They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotypes 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotypes 1- 24) and the requirements laid down in Article 32(1)(a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they
(2)either [II.2.2.1. have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors i n a 
vector protected establishment and 
(2)either [II.2.2.1.1. for at least 60 days prior to the date of movement]]
L 113 /382  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CONFINED -LIVE- INTRA
(2)and/or [II.2.2.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors]]
(2)and/or [II.2.2.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors;]]]
(2)and/or [II.2.2.2. have been kept at least for the 60 day period prior to departure in an 
establishment situated in a Member State or in an area of at least 150 km radius 
centred on the establishment, where surveillance in compliance with the 
requirements laid down in Sectio ns 1 and 2 of Chapter 1 of Part II of Annex V to 
Delegated Regulation (EU) 2020/689 has been carried out during that period and
(2)either [II.2.2.2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept and are within the immunity period 
guaranteed in the specifications of the vaccine and 
(2)either [II.2.2.2.1.1. have been vaccinated more than 60 days before the 
date of movement]]]
(2)and/or [II.2.2.2.1.2. have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the immunity s et in the specifications of the vaccine;]]]]
(2)and/or [II.2.2.2.2. the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius cen tred on the place 
where the animals were kept, and
(2)either [II.2.2.2.2.1. the animals have been subjected with positive results to a serological test carried out on samples collected at 
least 60 days before the date of movement]]]
(2)or [II.2.2.2.2.2. the animals have been subjected with positive results 
to a serological test carried out on samples collected at least 30 days before the date of the movement and to a 
PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of 
movement;]]]]
(2)(3)and/or [II.2.2. They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to Regulation (EU) 2020/689 and the competent authority of the Member 
State of origin authorised movement of those animals to another Member State or zone 
thereof
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /383
EUROPEAN UNION Certificate model CONFINED -LIVE- INTRA
(2)either [II.2.2.1. with the status free from infection with bluetongue virus (serotypes 1 -24) and the 
Member State of destination has informed the Commission and the other 
Member States that such movement is authorised subject to the conditions 
referred to in Article 43(2)(a), (b) and (c) of Delegated Regulation (EU) 
2020/689 and
(2)either [II.2.2.1.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.2.1.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.2.1.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.2.1.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled;]]]
(2)and/or [II.2.2.2. with an approved eradication program for infection with bluetongue virus 
(serotypes 1 -24) and the Member State of destination has informed the 
Commission and the other Member States th at such movement is authorised 
subject to the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated 
Regulation (EU) 2020/689 and
(2)either [II.2.2.2.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.2.2.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.2.2.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
(2)and/or [II.2.2.2.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Delegated Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Deleg ated Regulation are fulfilled;]]]
(2)and/or [II.2.2.3. neither free from infection with bluetongue virus (serotypes 1- 24) nor covered by 
the eradication programme for infection with bluetongue virus (serotypes 1 -24) 
and the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised
(2)either [II.2.2.3.1. without any conditions, and
L 113 /384  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CONFINED -LIVE- INTRA
(2)and/or [II.2.2.3.2. subject to the conditions referred to in point 5 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.2.3.3. subject to the conditions referred to in point 6 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.2.3.4. subject to the conditions referred to in point 7 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.2.2.3.5. subject to the conditions referred to in point 8 of Section 1 of 
Chapter 2 of Part II of Anne x V to Delegated Regulation (EU) 
2020/689, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled.]]]
II.3. To the best of my knowledge and as declared by the operator:
II.3.1. In the confined establishment of dispatch there are no abnormal mortalities with an 
undetermined cause affecting the animals to be moved.
II.3.2. The animals have not been in contac t with animals which are subject to movement restrictions 
referred to in Point II.2.1., or with animals of a lower health status.
II.3.3. Based on the results of the surveillance plan of the confined establishment, the animals do not 
pose a significant ris k at the confined establishment of destination for the spread of diseases 
for which they are listed.
II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 20 20/688.
II.5. This certificate is vali d for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of 10 days for the validity of the certificate may be extended by the duration of the journey by waterway/sea.
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date ).
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Cha pter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /385
EUROPEAN UNION Certificate model CONFINED -LIVE- INTRA
Part I:
Box reference I.11: “Place of dispatch”: Indicate a confined establishment approved in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.
Box reference I.12: “Place of destination”: Indicate a confined establishment approved in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Only in case of animal s belonging to the families Antilocapridae, Bovidae , Camelidae, Cervidae , 
Giraffidae , Moschidae or Tragulidae.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /386  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 59
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF PRI MATES INTO A CONFINE D ESTABLISHMENT 
(MODEL ‘CONFINED- PRIMATE- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /387
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /388  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CONFINED -PRIMATE -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. Animals(1)in the consignment described in Part I meet the following requirements:
II.1.1. They have shown no clinical signs or symptoms of diseases, in particular relevant 
diseases listed in Annex of Commission Implementing Regulation (EU) 2018/1882 
during the clin ical examination or where this is not possible, a clinical inspection, 
which was carried out within the 48 hour period prior to departure of the 
consignment, on ………………. ( insert date dd/mm/yyyy ).
II.1.2. Their movement has been authorised by an agreement of the competent authority of 
Member State of origin and the competent authority of Member State of destination 
pursuant to, and in compliance with, Article 63(2)(b) of Commission Delegated 
Regulation (EU) 2020/688.
II.2. To the best of my knowledge and as declared by the operator:
II.2.1. The animals come from an establishment where there are no abnormal mortalities 
with an undetermined cause.
II.2.2. The animals are consigned directly to the confined establishment of destination.
II.3. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.4. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of 10 days for the validity of the certificate may be extended by the 
duration of the journey by waterway/sea.
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date).
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate an establishment.
Box reference I.12: “Place of destination”: Indicate a confined establishment approved in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.
Part II:
(1)There can be one or more animals in the consignment.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /389
EUROPEAN UNION Certificate model CONFINED -PRIMATE -INTRA
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /390  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 60
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF SEMEN, OOCYTES AND E MBRYOS 
OF TERRESTRIAL ANIMALS KEPT AT CONFINED ESTABLISHMENT WHICH 
WERE COLLECTED OR PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH REGULATION (EU) 2016/429 AND DELEGATED 
REGULATION (EU) 2020 /686 (MODEL ‘GP -CONFINED- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /391
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /392  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model GP -CONFINED- INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. The semen(1)/ in vivo derived embryos(1)/ oocytes(1)/ in vitro produced embryos(1)/
micromanipulated embryos(1)described in Part I has/have been collected or produced, processed 
and stored, and dispatched from the confined establishment(2)which
II.1.1. is approved, assigned with a unique approval number and kept in a register by the 
competent authority;
II.1.2. complies with requirements  as regards quarantine, isolation and other biosecurity 
measures, surveillance and control measures, facilities and equipment referred to in 
Article 16 of Commission Delegated Regulation (EU) 2019/2035.
II.2. The semen(1)/ oocytes(1)/ embryos(1)described in Part I is/are intended for artificial reproduction 
and was/were obtained from donor animals which
II.2.1. have been born and remained sinc e birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
II.2.2. have remained in a single confined establishment of origin for a period of at least 30 
days prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1);
(1)[II.2.3. are bovine animals and they are identified as provided for in Article 38 of Delegated 
Regulation (EU) 2019/2035.]
(1)[II.2.3. are porcine animals and they are identified as provided for in Article 52(1) or 54(2) 
of Delegated Regulation (EU) 2019/2035.]
(1)[II.2.3. are ovine or caprine animals and they are identified as provided for in Article 45(2) or (4), or Article 46(1), (2) or (3) of Delegated Regulation (EU) 2019/2035.]
(1)[II.2.3. are equine animals and they ar e identified as provided for in Article 58(1) or 59(1) or 
62(1) of Delegated Regulation (EU) 2019/2035.]
(1)[II.2.3. are terrestrial animals other than bovine, porcine, ovine, caprine and equine animals 
and they are identified and registered in accordance with the rules of the confined 
establishment.]
II.3. The semen(1)/ oocytes(1)/ embryos(1)described in Part I comes/come from the confined 
establishment indicated in Box I.11. and is/are destined to another confined establishment.
II.4. According to official information, the semen(1)/ oocytes(1)/ embryos(1)described in Part I 
was/were obtained from donor animals which
II.4.1. do not come from a confined establishment, nor have been in contact with animals 
from a confined establishment, situated in a restricted zone established due to the 
occurrence of a category A disease, referred to in the Annex to Commission 
Implementing Regulation (EU) 2018/1882, or of an emerging disease relevant for 
species in those donor animals;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /393
EUROPEAN UNION Certificate model GP -CONFINED- INTRA
II.4.2. come from a confined establishment where no category D disease relevant for that 
species as referred to in the Annex to Implementing Regulation (EU) 2018/1882 has 
been reported for a period of at least 30 days prior to the date of collection of the 
semen(1)/ oocytes(1)/ embry os(1).
II.5. To the best of my knowledge and as declared by the operator, the semen(1)/ oocytes(1)/ embryos(1)
described in Part I was/were obtained from donor animals which
II.5.1. have been clinically examined by the establishment veterinarian responsible for the 
activities carried out at the confined establishment and showed no disease symptoms 
on the day of collection of the semen(1)/ oocytes(1)/ embryos(1);
II.5.2. as much as possible, were not used for natural breeding during a period of at least 30 
days prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1)and during 
the collection period.
II.6. To the best of my knowledge and based on the documentary check of the data submitted by the 
establishment veterinarian responsibl e for the activities carried out at the confined establishment, 
the semen(1)/ oocytes(1)/ embryos(1)described in Part I is/are placed in straws or other packages on 
which the mark is applied in accordance with requirements provided for in
(1)(2)[Article 10of Commission Delegated Regulation (EU) 2020/686 and that mark is indicated in 
Box I.30.]
(1)(3)[Article 11 of Delegated Regulation (EU) 2020/686 and that mark is indicated in Box I.30.]
II.7. The semen(1)/oocytes(1)/ embryos(1)described in Part I
II.7.1. is/are transported in a container which:
II.7.1.1. was sealed and numbered prior to the dispatch by the establishment 
veterinarian responsible for the activities carried out at the confined 
establishment, or by an official veterinarian, and the seal b ears the 
number as indicated in Box I.19;
II.7.1.2. has been cleaned and either disinfected or sterilised before use, or is 
single -use container; 
(1)(4)[II.7. 1.3. has been filled in with the cryogenic agent which not have been 
previously used for other products;]
(1)(2)(5)[II.7. 2. is/are placed in straws or other packages which are securely and hermetically sealed;
II.7.3. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary p rotective bags.]
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /394  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model GP -CONFINED- INTRA
Part I:
Box reference I.11: “Place of dispatch”: Indicate the address and the unique approval number of the 
confined establishment of dispatch of the consignment of semen, oocytes or embryos.
Box reference I.12: “Place of destination”: Indicate the address and the unique approval number of the 
confined establishment of destination of the consignment of semen, oocytes or 
embryos.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Ident ification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes or embryos of the consignment are placed.
“Date of collection/production”: Indicate the date on which semen, oocytes or 
embryos of the consignment were collected or produced.
“Approval or registration number of plant/establishment”: Indicate the unique 
approval number of the confined establishment of the collection or production of 
semen, oocytes or embryos of the consignment.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Applicable for the consignment of semen, oocytes or embryos of bovine, porcine, ovine, caprine or equine 
animals.
(3)Applicable for the consignment of semen, oocytes or embryos of terrestrial animals other than bovine, 
porcine, ovine, caprine or equine animals.
(4)Applicable for frozen semen, oocytes or embryos.
(5)Applicable for the consignment where in one container oocytes, in vivo derived embryos, in vitro produced 
embryos and micromanipulated embryos of bovine, porcine, ovine, caprine or equine animals are placed and transported.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /395
CHAPTER 61
MODEL ANIMAL HEALTH CERTIF ICATE AND MODEL DE CLARATION FOR 
THE MOVEMENT BETWEEN MEMBER STATES OF DOG S, CATS AND 
FERRETS (MODEL ‘CANI S-FELIS -FERRETS -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /396  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /397
EUROPEAN UNION Certificate model CANIS- FELIS -FERRETS -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. The dogs, cats and ferrets(1)of the consignment described in Part I meet the following requirements:
II.1.1. They are individually identified:
(2)either [in accordance with Article 70 of Commission Delegated Regulation (EU) 2019/2035.]
(2)and/or [by a clearly readable tattoo applied before 3 July 2011.] 
II.1.2. They are accompanied by their individual identification document as provided for in Article 
71 of Delegated Regulation (EU) 2019/2035.
II.1.3. They have undergone a clinical examination or a clinical inspection on ………………. 
(insert date dd/mm/yyyy) within the 48 hour period prior to departure and have not shown 
symptoms or clinical signs of diseases. 
(3)[II.1.4. They come from registered or approved establishments in which according to offic ial 
information, infection with rabies virus in kept terrestrial animals has not been reported 
during the 30 day period prior to departure and in which to the best of my knowledge and as 
declared by the operator, there were no abnormal mortalities with an undetermined cause.]
II.2. The dogs, cats and ferrets(1)of the consignment described in Part I meet the following requirements:
(2)either [II.2.1. The animals were at least 12 weeks old at the time of vaccination against rabies 
and at least 21 days have elapsed since the completion of the primary anti -rabies 
vaccination carried out in accordance with the validity requirements set out in Part 1 of 
Annex VII to Commission Delegated Regulation (EU) 2020/688, and any subsequent 
revaccination was carried out within the period of validity of the preceding vaccination.]
(2)or [II.2.1. The animals are intended for direct transport in accordance with Article 5 4(2) of Delegated 
Regulation (EU) 2020/688 to the confined establishment indicated in Box I.12 of Part I.]
(2)or [II.2.1. The animals are less than 12 weeks old and have not received an anti -rabies vaccination, or 
are between 12 and 16 weeks old and have r eceived a complete primary course of anti -
rabies vaccination in accordance with the validity requirements set out in Part I of Annex VII to Delegated Regulation (EU) 2020/688 less than 21 days prior to departure, and the 
Member State of destination has inf
ormed the public in accordance with Article 57 of 
Delegated Regulation (EU) 2020/688 that it authorises the movement of such animals into 
its territory; and 
(2)either [they are accompanied by a declaration of the operator or the pet keeper(4), attached to this 
certificate, stating that from birth until the time of dispatch the animals have had no contact 
with kept terrestrial animals under suspicion of infection with rabies virus or wild animals 
of listed species for infection with rabies virus;]
(2)or [the female on whom they still depend is their mother, and from the individual identification 
document of this female, it can be established that it received before their birth an anti -
rabies vaccination which complied with the validity requirements set out i n Part I of Annex 
VII to Delegated Regulation (EU) 2020/688;]
L 113 /398  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model CANIS- FELIS -FERRETS -INTRA
[II.2.2. The dogs, due to their intended destination(5)indicated in Box I.10, or in Box I.11 where 
regionalisation is applied:
(2)either [have been treated against Echinococcus multilocularis in accordance with Article 6 of 
Commission Delegated Regulation (EU) 2018/772.]
(2)or [have not been treated against(6)Echinococcus multilocularis .]]
(2)or [II.2.2. The animals are intended for direct transport in accordance with Article 54(2) of Delegated 
Regulation (EU) 2020/688 to the confined establishment indicated in Box I.12 of Part I.]
(3)[II.3. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.4. This certificate is va lid for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.
(3)Animal welfare attestation
At the time of inspectio n, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protoc ol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate a registered establishment of dispatch, an approved 
shelter of dogs, cats and ferrets, an establishment approved for assembly operations or 
a household (in case of movements of dogs, cats or ferrets other than non- commercial 
movements carried out in accordance with Article 55, and where applicable Article 56, 
of Delegated Regulation (EU) 2020/688).
Box reference I.12: “Place of destination”: Indicate a registered establishment of destination, an approved 
shelter of dogs, cats and ferrets, an estab lishment approved for assembly operations, a 
household (in case of movements of dogs, cats or ferrets other than non- commercial 
movements carried out in accordance with Article 55, and where applicable Article 56, 
of Delegated Regulation (EU) 2020/688) or a confined establishment.
Box reference I.30: “Identification number” : Indicate for each animal of the consignment their 
alphanumeric code.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /399
EUROPEAN UNION Certificate model CANIS- FELIS -FERRETS -INTRA
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
(3)Not applicable in case of movements of dogs, cats or ferrets other than non- commercial movements 
carried out in accordance with Article 55, and where applicable Article 56, of Regulation (EU) 2020/688.
(4)The declaration referred to in point II.2.1. to be attached to the certificate is laid down in Chapter 61 of 
Annex I to Implementing Regulation (EU) 2021/403 (after the model animal health certificate).
(5)Member States or parts thereof listed in the Anne x to Commission Implementing Regulation (EU) 
2018/878.
(6)Treatments against Echinococcus multilocularis , if administered after the date this certificate was signed 
must be completed and documented in accordance with Article 6 of Commission Delegated Regulation 
(EU) 2018/772.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /400  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Model declaration referred to in, and to be attached to the certificate pursuant to Article 
54(1)(b)(i) or Article 56(b)(i) of Delegated Regulation (EU) 2020/688
I, the undersigned,
…………………………………………………………………………………………………………...1
[operator or pet keeper making movement of dogs, cats or ferrets other than non- commercial movements as 
provided for to in Article 55 of Delegated Regulation (EU) 2020/688]
declare that from birth until the time of departure the animals have had no contac t with kept 
terrestrial animals under suspicion of infection with rabies virus or wild animals of listed 
species for infection with rabies virus.
Transponder/tattoo2Passport/animal health certificate2number 
1To be completed in block letters
2Delete as appropriate 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /401
CHAPTER 62
MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF SEMEN, OOCYTES AN D EMBRYOS 
OF DOGS ( CANIS LUPUS FAMILIARIS )AND CATS ( FELIS SILVESTRIS CAT US)
WHICH WERE COLLECTED O R PRODUCED, PROCESSE D AND STORED IN 
ACCORDANCE WITH REGULATION (EU) 2016 /429 AND DELEGATED 
REGULATION (EU) 2020 /686 (MODEL ‘ GP-CANIS -FELIS -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country 
codeI.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
CountryISO country 
codeCountry ISO country code
I.7 Country of originISO country 
codeI.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /402  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human consumption □Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22 □For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /403
EUROPEAN UNION Certificate model GP -CANIS -FELIS -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen(1)/ oocytes(1)/ embryos(1)of dogs(1)/ cats(1)described in Part I are intended for artificial 
reproduction and were obtained from donor animals which
II.1.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
II.1.2. are 
(1)either [marked by the implantation of a transponder in accordance with Article 17(1) of 
Regulation (EU) No 576/2013;]
(1)or [marked by a clearly readable tattoo in accordance with Article 17(1) of Regulation 
(EU) No 576/2013;]
(1)or [identified in accordance with Article 70 of Commission Delegated Regulation (EU) 
2019/2035;]
II.1.3. have received an anti- rabies vaccination that complies with the validity requirements 
set out in Part 1 of Annex VII to Commission Delegated Regulation (EU) 2020/688.
II.2. The semen(1)/ oocytes(1)/ embryos(1)described in Part I comes/ come from a registered 
establishment assigne d by the competent authority with a unique registration number as indicated 
in Box I.11.
II.3. According to official information, the semen(1)/ oocytes(1)/ embryos(1)described in Part I 
was/were obtained from donor animals which
II.3.1. come from establis hments in which infection with rabies virus has not been 
confirmed for a period of at least 30 days prior to the date of collection of the 
semen(1)/ oocytes(1)/ embryos(1);
II.3.2. comply with any preventive health measure for diseases or infections other than 
rabies set out in Part 2 of Annex VII to Delegated Regulation (EU) 2020/688.
II.4. To the best of my knowledge and as declared by the operator, the semen(1)/ oocytes(1)/ embryos(1)
was/were obtained from donor animals which
II.4.1. showed no disease s ymptoms on the day of collection of the semen(1)/ oocytes(1)/ 
embryos(1);
II.4.2. were not used for natural breeding during a period of at least 30 days prior to the date 
of collection of the semen(1)/ oocytes(1)/ embryos(1)and during the collection perio d.
II.5. The semen(1)/ oocytes(1)/ embryos(1)described in Part I is/ are placed in a sealed transport container 
and the seal bears the number as indicated in Box I.19.
II.6. To the best of my knowledge and based on the documentary check of the data submitted by the 
operator, the semen(1)/ oocytes(1)/ embryos(1)described in Part I is/are placed in straws or other 
packages on which the mark is applied in accordance with requirements provided for in Article 11 of Commission Delegated Regulation (EU) 2020/686 and that mark is indicated in Box I.30. 
L 113 /404  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model GP -CANIS -FELIS -INTRA
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: indicate the address and the unique registration number of the 
establishment of dispatch of the consignment of semen, oocytes or embryos.
Box reference I.12: “Place of destination”: Indicate the address and the unique registration number, if 
assigned by the competent authority, of the establishment of destination of the 
consignment of semen, oocytes or embryos.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, invivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : Indicate “Canis lupus familiaris ” or “ Felis silvestris catus ” as appropriate.
“Identification number” : Indicate individual identification number of each donor 
anim al.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes or embryos of the consignment are placed.
“Date of collection/production”: Indicate the date on which semen, oocytes or 
embryos of the consignment were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
registration number of the establishment of the collection or production of semen, 
oocytes or embryos of the consignment.
“Quantity” : Indicate number of straw s or other packages with the same mark.
Part II:
(1)Delete if not applicable.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /405
CHAPTER 63
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF OTH ER CARNIVORES (MODEL ‘OTHCARN- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
L 113 /406  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /407
EUROPEAN UNION Certificate model OTHCARN -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify:
II.1. The other carnivores(1)(2)of the consignment described in Part I meet the following requirements:
II.1.1. They are identified:
(3)either [individually;]
(3)and/or [as a group of animals of the same species kept together during the movement to 
destination;] 
II.1.2. They have undergone a clinical examination or a clinical inspection on ………………. 
(insert date dd/mm/yyyy) within the 48 hour period prior to departure and have not shown 
symptoms or clinical signs of diseases.
II.1.3. They come from a registered or approved establishment in which infection with rabies virus 
in kept terrestrial animals has not been reported during the 30 day period prior to departure 
and in w hich to the best of my knowledge and as declared by the operator, there were no 
abnormal mortalities with an undetermined cause.
II.2. The other carnivores(1)of the consignment described in Part I meet the following requirements:
(3)either [II.2.1. They ha ve received a complete primary course of anti -rabies vaccination and at least 21 
days have elapsed since the completion of the primary anti -rabies vaccination carried out in 
accordance with the validity requirements set out in Part 1 of Annex VII to Commis ion
Delegated Regulation (EU) 2020/688, and any subsequent revaccination was carried out 
within the period of validity of the preceding vaccination.]
(3)or [II.2.1. [They are intended for direct transport in accordance with Article 58(2) of Delegated 
Regul ation (EU) 2020/688 to:
(3)either [the confined establishment indicated in Box I.20 of Part I;]
(3)or [the establishment indicated in Box I.20 of Part I where these animals are kept as fur 
animals as defined in point 1 of Annex I to Commission Regulation (EU) No 142/2011.]]
[II.2.2. The canidae, other than dogs, due to their scheduled destination(4)indicated in Box I.10, or 
in Box I.11 where regionalisation is applied:
(3)either [have been treated against Echinococcus multilocularis in accordance with Par t 2(2) of 
Annex VII to Delegated Regulation (EU) 2020/688;]]
(3)or [have not been treated against(5)Echinococcus multilocularis;]]
L 113 /408  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model OTHCARN -INTRA
Identification Anti-echinococcus treatment Administering veterinarian
Name and 
manufacturer of the 
productDate [dd/mm/yyyy] 
and time [00:00]of 
treatment Name in capitals, stamp 
and signature
(3)or[are intended for direct transport in accordance with Article 58(2) of Delegated Regulation (EU) 
2020/688 to:
(3)either [the confined establishment indicated in Box I.20 of Part I.]]]
(3)or [the establishment indicated in Box I.20 of Part I.] where these animals are kept as fur 
animals as defined in point (1) of Annex I to Regulation (EU) No 142/2011.]]]
II.3. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/688.
II.4. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certifica te may be extended by the duration of the journey by 
waterway/sea.
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC ) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate a registered or an approved establishment of dispatch.
Box reference I.12: “Place of destination”: Indicate a registered or an approved establishment of 
destination.
Box reference I.30: “Identification number” : Indicate for each animal of the con signment its identification.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /409
EUROPEAN UNION Certificate model OTHCARN -INTRA
Part II:
(1)There can be one or more animals in the consignment.
(2)Other carnivores means animals of the species belonging to the order Carnivora other than dogs, cats and 
ferrets as defined in Article 3(32) of Delegated Regulation (EU) 2020/688.
(3)Delete if not applicable.
(4)Member States or parts thereof listed in the Annex to Commission Implementing Regulation (EU) 
2018/878.
(5)The table referred to in point II.2.2. must be used to document the details of the treatment against 
Echinococcus multilocularis, in accordance with Part 2(2) of Annex VII to Delegated Regulation (EU) 
2020/688, if administered after the date the certificat e was signed and prior to the scheduled entry into 
Member States or parts thereof listed in the Annex to Commission Implementing Regulation (EU) 
2018/878.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /410  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 64
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF WILD TERRESTRIAL ANIMALS (MODEL ‘ WILD-
ANIMALS -INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /411
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /412  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model WILD -ANIMALS- INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The animals(1)of the consignment described in Part I are wild terrestrial animals and meet the following 
requirements:
II.1.1. The majority of the animals of the consignment, for at least the 30 day period prior to the 
departure of the consignment, or since birth, if they are younger than 30 days of age,
II.1.1.1. have been resident in the habitat of origin; 
II.1.1.2. have not been in contact with kept animals of a lower health status or subject to 
movement restrictions for animal health reasons; 
II.1.1.3. have not been in direct or indirect contact with kept animals that have entered the 
Union from a third country or territory during the 30 day period prior to the 
departure of the animal.
II.1.2. They have not shown clinical signs or symptoms of listed diseases for animals of the species 
concerned or emerging diseas es during the clinical examination, or where this is not possible, 
the clinical inspection, which was carried out ,within the 24 hour period prior to departure of 
the consignment, on ………………. (insert date dd/mm/yyyy).
II.2. According to official information , the wild terrestrial animals described in Part I do not come from a 
habitat subject to movement restrictions or situated in a restricted zone established for reasons of listed 
diseases for animals of the species concerned.
(2)[II.3. According to official information, the wild terrestrial animals described in Part I are ungulates and meet 
the following health requirements:
(2)[II.3.1. They come from a habitat in which infection with Brucella abortus, B. melitensis and B. suis
in wild terrestrial animals of listed species for that disease has not been reported during the 
last 42 days prior to departure.]
(2)[II.3.2. They come from a habitat in which infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis) in wild terrestrial animals of listed species for that 
disease has not been reported during the last 42 days prior to departure.]
(2)[II.3.3. They come from a habitat in which infection with rabies virus has not been reported during 
the 30 day period prior to depa rture.]
(2)[II.3.4. They come from a habitat in which infection with epizootic haemorrhagic disease virus within 
a radius of 150 km has not been reported in wild terrestrial animals of listed species of that 
disease during the last 2 years prior to departu re.]
(2)[II.3.5. They come from a habitat in which anthrax in ungulates has not been reported during the 15 
day period prior to departure.]
(2)[II.3.6. They come from a habitat in which surra (Trypanosoma evansi ) has not been reported during 
the last 30 da ys prior to departure.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /413
EUROPEAN UNION Certificate model WILD -ANIMALS- INTRA
(2)[II.4. According to official information the wild terrestrial animals described in Part I belong to the families 
Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae or Tragulidae and meet the 
following health requirements:
(2)either [II.4.1. They originate from ahabitat in a Member State or a zone free from infection with 
bluetongue virus (serotypes 1- 24), where no case of infection with bluetongue virus 
(serotypes 1 -24) has been confirmed during the last 24 m onths in the targeted animal 
population and have not been vaccinated with a live vaccine against infection with bluetongue 
virus (serotypes 1- 24) in the 60 day period before the date of movement and the requirements 
laid down in Article 32(1)(a), (b) or (c ) or Article 32(2) of Commission Delegated Regulation 
(EU) 2020/688 are fulfilled.]
(2)and/or [II.4.2. They originate from a habitat in a Member State or a zone covered by the eradication 
programme for infection with bluetongue virus (serotypes 1 -24) and the requirements laid 
down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 
are fulfilled, and they
(2)either [II.4.2.1. have been resident in a Member State or zone seasonally free from infection with 
bluetongue virus (serotypes 1 -24) in accordance with Article 40(3) of 
Commission Delegated Regulation (EU) 2020/689
(2)either [II.4.2.1.1. for at least 60 days prior to the date of movement]]
(2)and/or [II.4.2.1.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free from infection 
with bluetongue virus (serotypes 1- 24)]]
(2)and/or [II.4.2.1.3. for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples
collected at least 14 days following the entry date of the animal into 
the Member State or zone seasonally free from infection with 
bluetongue virus (serotypes 1 -24);]]]
(2)and/or [II.4.2.2. have been vaccinated against those serotypes from 1 to 24 of i nfection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and 
(2)either [II.4.2.2.1. have been vaccinated more than 60 days be fore the date of 
movement]]
(2)and/or [II.4.2.2.2. have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity set in the specifications of the 
vaccine;]]]
L 113 /414  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model WILD -ANIMALS- INTRA
(2)and/or [II.4.2.3. have been subjected with positive results to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and
(2)either [II.4.2.3.1. the serological test has been carried out on samples collected at least 
60 days before the date of movement]]
(2)and/or [II.4.2.3.2. the serological test has been carried out on samples collected at least 
30 days before the date of the movement and the animal has been 
subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days before the date of movement;]]]
(2)and/or [II.4.3. They originate from a habitat in a Member State or a zone neither free from infection with 
bluetongue virus (serotypes 1- 24) nor covered by the eradication programme for infection 
with bluetongue virus (serotypes 1- 24) and the requirements laid down in Article 32(1)(a), (b) 
or (c) or Article 32(2) of Delegated Regu lation (EU) 2020/688 are fulfilled, and they
[II.4.3.1. have been resident at least for the 60 day period prior to departure in a habitat 
situated in a Member State or in an area of at least 150 km radius centred on the 
habitat, where surveillance in compliance with the requirements laid down in 
Sections 1 and 2 of Chapter 1 of Part II of Annex V to Regulation (EU) 2020/689 
has been carried out during that period and
(2)either [II.4.3.1.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the 
habitat where the animals were resident and are within the immunity 
period guaranteed in the specifications of the vaccine and 
(2)either [II.4.3.1.1.1. have been vaccinated more than 60 days before the 
date of movement]]]
(2)and/or [II.4.3.1.1.2. have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]]]
(2)and/or [II.4.3.1.2. the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the 
habitat where the animals were resident, and
(2)either [II.4.3.1.2.1. the animals have been subjected with positive results to a serological test carried out on samples collected at 
least 60 days before the date of movement]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /415
EUROPEAN UNION Certificate model WILD -ANIMALS- INTRA
(2)or [II.4.3.1.2.2. the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 30 days before the date of the movement and to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of 
movement;]]]]
(2)and/or [II.4.4. They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Member State 
or zone thereof
(2)either [II.4.4.1. with the status free from infection with bluetongue virus (serotypes 1 -24) and the 
Member State of destina tion has informed the Commission and the other 
Member States that such movement is authorised subject to the conditions 
referred to in Article 43(2)(a), (b) and (c) of Delegated Regulation (EU) 
2020/689 and
(2)either [II.4.4.1.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.4.4.1.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.4.4.1.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.4.4.1.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled]]
(2)and/or [II.4.4.2. with an approved eradication programme for infection with bluetongue virus 
(serotypes 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authorised 
subject to the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated 
Regulation (EU) 2020/689 and
(2)either [II.4.4.2.1. point 5 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.4.4.2.2. point 6 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.4.4.2.3. point 7 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
(2)and/or [II.4.4.2.4. point 8 of Section 1 of Chapter 2 of Part II of Annex V to that 
Regulation, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are f ulfilled;]]]
L 113 /416  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model WILD -ANIMALS- INTRA
(2)and/or [II.4.4.3. neither free from infection with bluetongue virus (serotypes 1- 24) nor covered by 
the eradication programme for infection with bluetongue virus (serotypes 1 -24) 
and the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised
(2)either [II.4.4.3.1. without any conditions, and
(2)and/or [II.4.4.3.2. subject to the conditions referred to in point 5 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.4.4.3.3. subject to the conditions referred to in point 6 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.4.4.3.4. subject to the conditions referred to in point 7 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/689, and
(2)and/or [II.4.4.3.5. subject to the conditions referred to in point 8 of Section 1 of 
Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 
2020/68 9, and
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 and the requirements 
laid down in Article 33 of that Delegated Regulation are fulfilled.]]]
II.5. To the best of my knowledge and as declared by the operator, the wild terrestrial animals come from a 
habitat where there were no abnormal mortalities with an undetermined cause.
II.6. Arrangements are made to transport the consignment in accordance with Article 101(1), (2) and (3) of 
Deleg ated Regulation (EU) 2020/688.
II.7. This certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/s ea.
Animal welfare attestation
At the time of inspection, the animals covered by this health certificate were fit to be transported in accordance 
with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start 
on……………(insert date) .
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Nort hern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /417
EUROPEAN UNION Certificate model WILD -ANIMALS- INTRA
Part I:
Box reference I.11: “Place of dispatch”: Indicate a habitat of the origin of the animals in the consignment.
Box reference I.12: “Place of destination”: Indicate a habitat or an establishment of the final destination of 
the consignment.
Box reference I.30: “Identification number” : Indicate identification codes of the animals in the 
consignment.
Part II:
(1)There can be one or more animals in the consignment.
(2)Delete if not applicable.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /418  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 65
MODEL ANIMAL HEALTH CERTIF ICATE FOR THE MOVEMENT BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF SEMEN, OOCYTES AND E MBRYOS 
OF ANIMALS OF THE FAMILIES CAMELIDAE AND CERVIDAE WHICH WERE 
COLLECTED OR PRODUCED, PROCESS ED AND STORED IN ACCORDANCE 
WITH REGULATION (EU) 2016/429 AND DELEGAT ED REGULATION (EU) 
2020/686 (MODEL ‘GP -CAM -CER- INTRA’)
EUROPEAN UNION INTRAPart I: Description of consignmentI.1 Consignor I.2 IMSOC reference 
Name I.2a Local reference
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee I.6 Operator conducting assembly operations independently of an 
establishment
Name Name Registration No
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15Means of 
transportI.16 Transporter
□Vessel □AircraftName Registration/Authorisation No
Address
□Railway □Road vehicleCountry ISO country code
I.17 Accompanying documents
Identification □Other Type Code
DocumentCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /419
I.20 Certified as or for
□Further keeping □Slaughter □Confined establishment □Germinal products
□Registered equine animal □Travelling circus/animal act □Exhibition □Event or activity near borders
□Release into the wild □Dispatch centre □Relaying area/purification 
centre□Ornamental aquaculture 
establishment
□Further processing □Organic fertilizers and soil 
improvers□Technical use □Quarantine or similar 
establishment
□Products for human 
consumption□Pollination □Live aquatic animals for 
human consumption□Other
I.21 □For transit through a third country
Third country ISO country code
Exit point BCP code
Entry point BCP code
I.22□For transit through Member State(s) I.23□For export
Member State ISO country code Third country ISO country code
Member State ISO country code Exit point BCP code
Member State ISO country code
I.24 Estimated journey time I.25 Journey log □yes □no
I.26 Total number of packages I.27 Total quantity
I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment
I.30 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Type
Region of origin Cold store Identification mark Type of packaging Net weight
Slaughterhouse Treatment type Nature of 
commodityNumber of packages Batch No
Date of 
collection/productionManufacturing 
plantApproval or registration 
number of 
plant/establishment/centreTest
L 113 /420  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model GP -CAMELID -CER -INTRAPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen(1)/ oocytes(1)/ embryos(1)described in Part I are intended for artificial reproduction and 
were obtained from donor animals which
II.1.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;
II.1.2. have remained in a single establishment of origin for a period of at least 30 days prior 
to the date of collection of the semen(1)/ oocytes(1)/ embryos(1);
(1)[II.1.3. are animals of the family Camelidae and are identified in accordance with Article
73(1) of Commission Delegated Regulation (EU) 2019/2035.] 
(1)[II.1.3. are animals of the family Cervidae and are identified in accordance with Article 73 (2) or Article 74 of Delegated Regulation (EU) 2019/2035.] 
II.2. The semen
(1)/ oocytes(1)/ embryos(1)described in Part I comes/ come from a registered 
establishment assigned by the competent authority with a unique registration number as indicated 
in Box I.11.
II.3. According to official information, the semen(1)/ oocytes(1)/ embryos(1)was/were obtain ed from 
donor animals which
II.3.1. do not come from an establishment, nor have been in contact with animals from an establishment, situated in a restricted zone established due to the occurrence of foot -
and-mouth disease, infection with rinderpest virus, infection with Rift Valley fever 
virus, infection with peste des petits ruminants virus or of an emerging disease 
relevant for species of those kept terrestrial animals;
II.3.2. come from an establishment where during a period of at least the preceding 12 
months prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1)
II.3.2.1. a surveillance programme to detect infection with Mycobacterium 
tuberculosis complex (M. bovis, M. caprae and M. tuberculosis ) has 
been carried out in accordance with Part 2 or 3 of Annex II to 
Commission Delegated Regulation (EU) 2020/688;
II.3.2.2. no animals of the family Camelidae or Cervidae which do not fulfil the requirements referred to in point II.3.2.1. has been introduced;
II.3.2.3. in case of suspicion of infection with 
Mycobacterium tuberculosis 
complex (M. bovis, M. caprae and M. tuberculosis ), investigations were 
carried out and the disease was ruled out;
II.3.3. come from an establishment where infection with Brucella abortus, Brucella 
melitensis and Brucella suis has not been reported during the period of at least the 
preceding 42 days prior to the date of collection of the semen(1)/ oocytes(1)/ 
embryos(1);
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /421
EUROPEAN UNION Certificate model GP -CAMELID -CER -INTRA
(1)[II.3.4. are animals of the family Camelidae and come from an esta blishment where all 
animals present have been subjected to a test for infection with Brucella abortus, 
Brucella melitensis and Brucella suis as referred to in Part 1 of Annex I to Delegated 
Regulation (EU) 2020/688 with negative results carried out on samples taken during 
the period of the preceding 30 days prior to the date of collection of the semen(1)/ 
oocytes(1)/ embryos(1);]
II.3.5. come from an establishment where infectious bovine rhinotracheitis/ infectious 
pustular vulvovaginitis has not been repor ted during the period of at least the 
preceding 30 days prior to the date of collection of the semen(1)/ oocytes(1)/ 
embryos(1);
II.3.6. come from an establishment where infection with epizootic haemorrhagic disease 
virus has not been reported during a period of at least the preceding 2 years prior to 
the date of collection of the semen(1)/ oocytes(1)/ embryos(1)within a radius of 150 km 
around the establishment;
II.3.7. come from an establishment where infection with rabies virus has not been confirmed
during the period of at least the preceding 30 days prior to the date of collection of 
the semen(1)/ oocytes(1)/ embryos(1);
II.3.8. come from an establishment where anthrax has not been reported during the period of 
at least the preceding 15 days prior t o the date of collection of the semen(1)/ 
oocytes(1)/ embryos(1);
II.3.9. come from an establishment where surra ( Trypanosoma evansi ) has not been reported 
during a period of at least the preceding 30 days prior to the date of collection of the 
semen(1)/ oocytes(1)/ embryos(1), and
(1)either [surra has not been confirmed during the preceding 2 years;]
(1)or [surra has been confirmed during the preceding 2 years and following the last 
outbreak of that disease the establishment has remained under movement re strictions 
until
–the infected animals were removed from the establishment; and 
–the remaining animals on the establishment were subjected to a test for surra 
(Trypanosoma evansi ) referred to in Part 3 of Annex I to Delegated Regulation 
(EU) 2020/688, with negative result, carried out on samples taken at least 6 
months after the infected animals were removed from the establishment;]
II.3.10. comply with at least one of the following conditions as regards infection with 
bluetongue virus (serotypes 1 -24):
(1)either [II.3.10.1. they have been kept for a period of at least 60 days prior to and during 
collection of the semen(1)/ oocytes(1)/ embryos(1)in a Member State or zone 
thereof free from infection with bluetongue virus (serotypes 1- 24)where 
no case of inf ection with bluetongue virus (serotypes 1 -24) has been 
confirmed during the last 24 months in the targeted animal population;]
(1)and/or [II.3.10.2. they have been kept in a seasonally disease- free zone, during the 
seasonally disease- free period, for a per iod of at least 60 days prior to and 
during collection of the semen(1)/ oocytes(1)/ embryos(1), in a Member State 
or zone thereof with an approved eradication programme against infection 
with bluetongue virus (serotype s1-24);]
L 113 /422  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
EUROPEAN UNION Certificate model GP -CAMELID -CER -INTRA
(1)and/or [II.3.10.3. they have been kept in a seasonally disease- free zone, during the 
seasonally disease- free period, for a period of at least 60 days prior to and 
during collection of the semen(1)/ oocytes(1)/ embryos(1), in a Member State 
or zone thereof where the competent aut hority of the place of origin of the 
consignment of semen(1)/ oocytes(1)/ embryos(1)has obtained the prior 
written consent of the competent authority of the Member State of 
destination to the conditions for establishment of that seasonally disease -
free zo ne and to accept the consignment of semen(1)/ oocytes(1)/ 
embryos(1);]
(1)and/or [II.3.10.4. they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the semen(1)/ oocytes(1)/ 
embryos(1);]
(1)and/or [II.3.10.5. they have been subjected to a serological test to detect antibodies to the 
bluetongue virus serogroup 1 -24, with negative results, between 28 and 60 
days from the date of each collection of the semen(1)/ oocytes(1)/ 
embryos(1);]
(1)and/or [II.3.10.6. they have been subjected to an agent identification test for bluetongue 
virus (serotypes 1 -24), with negative results, on blood samples taken at 
commencement and final collection of the semen and during collection of 
the semen at intervals of at least every 7 days, in the case of the virus 
isolation test, or of at least every 28 days, in the case of PCR;]
(1)and/or [II.3.10.7. they have been subjected to an agent identification test for bluetongue 
virus (serotypes 1 -24), with negative resul ts, on blood sample taken on the 
dayof collection of the oocytes(1)/ embryos(1).]
II.4. To the best of my knowledge and as declared by the operator, the semen(1)/ oocytes(1)/ embryos(1)
described in Part I was/were obtained from donor animals which
II.4.1. have been clinically examined by a veterinarian and showed no disease symptoms on 
the day of collection of the semen(1)/ oocytes(1)/ embryos(1);
II.4.2. have not been in contact with animals which did not comply with the requirements 
set out in poi nt II.1.1. and in points II.3.1. to II.3.10. during the residenc eperiod of at 
least 30 days set out in point II.1.2.;
II.4.3. were not used for natural breeding during a period of at least 30 days prior to the date 
of collection of the semen(1)/ oocytes(1)/ embryos(1)and during the collection period.
II.5. The semen(1)/ oocytes(1)/ embryos(1)described in Part I is/ are placed in a sealed transport container 
and the seal bears the number as indicated in Box I.19.
II.6. To the best of my knowledge and based on the documentary check of the data submitted by the 
operator, the semen(1)/ oocytes(1)/ embryos(1)described in Part I is/are placed in straws or other 
packages on which the mark is applied in accordance with requirements provided for in Article 
11of Commission Delegated Regulation (EU) 2020/686 and that mark is indicated in Box I.30. 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /423
EUROPEAN UNION Certificate model GP -CAMELID -CER -INTRA
Notes
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the address and the unique registration number of the 
establishment of dispatch of the consignment of semen, oocytes or embryos.
Box reference I.12: “Place of destination”: Indicate the address and the unique registration number of the 
establishment of destination of the consignment of semen, oocytes or embryos.
Box reference I.30: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : Indicate “Camelidae ” or “ Cervidae ” as appropriate.
“Identification number” : Indicate individual identification number of each donor 
animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes or embryos of the consignment are placed. 
“Date of collection/production: Indicate the date on which semen, oocytes or embryos 
of the consignment were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
registration number of the establishment of the collection or production of semen, 
oocytes or embryos of the consignment.
“Quantity” : Indicate number of straws or other packages with t he same mark.
Part II:
(1)Delete if not applicable.
Official veterinarian
Name (in capital letters) Qualification and title
Local Control Unit name Local Control Unit code
Date
Stamp Signature
L 113 /424  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
ANNEX II
Annex II contains the following model animal health certificates and animal health/ official 
certificates and declarations for entry into the Union and transit t hrough the Union:
Model
Ungulates
BOV -X Chapter 1: Model animal health/ official certificate for entry into the Union of 
bovine animals 
BOV -Y Chapter 2: Model animal health/ official certificate for entry into the Union of 
bovine animals intended for slaughter
BOV -X-TRANSIT -RU Chapter 3: Model animal health certificate for entry into the Union of bovine 
animals intended for transit from the region of Kaliningrad to other regions of 
Russia via the territory of Lithuania
OV/CAP -X Chapter 4: Model animal health/ official certificate for entry into the Union of 
ovine and caprine animals
OV/CAP -Y Chapter 5: Model animal health/ official certificate for entry into the Union of 
ovine and caprine animals intended for slaughter
SUI-X Chapter 6: Model animal health/ official certificate for entry into the Union of 
porcine animals and animals of the family Tayassuidae
SUI-Y Chapter 7: Model animal health/ official certificat e for entry into the Union of 
porcine animals intended for slaughter
RUM Chapter 8: Model animal health/ official certificate for entry into the Union of 
animals of the families Antilocapridae, Bovidae (other than bovine, ovine and 
caprine animals), Giraffidae, Moschidae and Tragulidae
RHINO Chapter 9: Model animal health certificate for entry into the Union of animals 
of the families Tapiridae, Rhinocerotidae and Elephantidae
HIPPO Chapter 10: Model animal health certificate for entry into the Unio n of animals 
of the family Hippopotamidae
CAM -CER Chapter 11: Model animal health/ official certificate for ent ry into the Union of 
camelid and cervid animals
Equine animals
EQUI -X Chapter 12: Model animal health/ official certificate and model declaration for 
entry into the Union of eq uine animals not intended for slaughter
EQUI -Y Chapter 13: Model animal health/official certificate and model declaration for 
entry into the Union of equine animals intended for slaughter
EQUI -TRANSIT -X Chapter 14: Model animal health certificate and model declaration for transit 
through the Union of equine animals not intended for slaughter
EQUI -TRANSIT -Y Chapter 15: Model animal health certificate and model declaration for transit 
through the Union of equine animals intended for slaughter
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /425
EQUI -RE-ENTRY -30 Chapter 16: Model animal health certificate and model declaration for the re -
entry into the Union of registered horses for racing, competition and cultural 
events after temporary export for a period of not more than 30 days
EQUI -RE-ENTRY -90-COMP Chapter 17: Model animal health certificate and model declaration for the re -
entry into the Union of registered horses for competition after temporary export 
for a period of not more than 90 days to participate in equestrian events 
organised under the auspices of the Fédération Equestre Internationale (FEI)
EQUI -RE-ENTRY -90-
RACEChapter 18: Model animal health certificate and model declaration for the re-
entry into the Union of registered horses for racing after temporary export for a 
period of not more than 90 days to participate in specific race events in 
Australia, Canada, the United States of America, Hong Kong, Japan, Singapore, 
the United Arab Em irates or Qatar
Ungulates intended for a confined establishment
CONFINED -RUM Chapter 19: Model animal health certificate for entry into the Union of animals 
listed in Section 1 of Chapter 19 of Annex II to Commission Implementing 
Regulation (EU) 2021/403 that are originating from and intended for a confined 
establishment 
CONFINED -SUI Chapter 20: Model animal health certificate for entry into the Union of animals 
listed in Section 1 of Chapter 20 of Annex II to Commission Implementing 
Regulation (EU) 2021/403 that are originating from and intended for a confined 
establishment
CONFINED -TRE Chapter 21: Model animal health certificate for the entry into the Union of 
animals listed in Section 1 of Chapter 21 of Annex II to Commission 
Implementing Regulation (EU) 2021/403 that are originating from and intended 
for a confined establishment
CONFINED -HIPPO Chapter 22: Model animal health certificate for entry into the Union of animals 
of the family of Hippopotamidae that are originating from and intended for a 
confined establishment
Birds and germinal products thereof
BPP Chapter 23: Model animal health/ official certificate for entry into the Union of 
breeding poultry other than ratites and productive poultry other than ratites
BPR Chapter 24: Model animal health certificate for entry into the Union of breeding 
ratites and productive ratites
DOC Chapter 25: Model animal health/ official certificate for entry into the Union of 
day-old chicks other than ratites
DOR Chapter 26: Model animal health certificate for entry into the Union of day -old 
chicks of ratites
HEP Chapter 27: Model animal health/ official certificate for entry into the Union of 
hatching eggs of poultry other than ratites
HER Chapter 28: Model animal health certificate for entry into the Union of hatching 
eggs of ratites
SPF Chapter 29: Model animal health certificate for entry into the Union of 
specified pathogen -free eggs
L 113 /426  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
SP Chapter 30: Model animal health/ official certificate for entry into the Union of 
poultry intended for slaughter other than ratites
SR Chapter 31: Model animal health/ official certificate for en try into the Union of 
ratites intended for slaughter
POU -LT20 Chapter 32: Model animal health/ official certificate for entry into the Union of 
less than 20 heads of poultry other than ratites
HE-LT20 Chapter 33: Model animal health/ official certificate for entry into the Union of 
less than 20 hatching eggs of poultry other than ratites
CAPTIVE -BIRDS Chapter 34: Model animal health certificate for entry into the Union of captive 
birds
HE-CAPTIVE -BIRDS Chapter 35: Model animal health certificate for en try into the Union of hatching 
eggs of captive birds
Bees
QUE Chapter 36: Model animal health certificate for entry into the Union of queen 
honeybees
BBEE Chapter 37: Model animal health certificate for entry into the Union of bumble 
bees
Dogs, cats and ferrets
CANIS- FELIS -FERRETS Chapter 38: Model animal health certificate for entry into the Union of dogs, 
cats and ferrets
Germinal products of bovine animals
BOV -SEM -A-ENTRY Chapter 39: Model animal health certificate for entry into the Union of 
consignments of semen of bovine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 after 20 April 2021, dispatched from thesemen collection centre 
where the semen was collected
BOV -SEM -B-ENTRY Chapter 40: Model animal health certificate for entry into the Union of 
consignments of stocks of semen of bovine animals collected, processed and 
stored after 31 December 2004 and before 21 April 2021, in accordance with Council Directive 88/407 /EEC, as amended by Council Directive 2003/43/EC, 
dispatched after 20 April 2021 from the
semen collection centre where the 
semen was collected
BOV -SEM -C-ENTRY Chapter 41: Model animal health certificate for entry into the Union of 
consignments of s tocks of semen of bovine animals collected, processed and 
stored before 1 January 2005 in accordance with Council Directive 
88/407/EEC , as amended by Council Directive 93/60/EEC ,dispatched after 20 
April 2021 from thesemen collection centre where the sem en was collected
BOV -OOCYTES -EMB -A-
ENTRYChapter 42: Model animal health certificate for entry into the Union of 
consignments of oocytes and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched by the
embryo collection or production team by which the oocytes or embryos were 
collected or produced
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /427
BOV -in-vivo-EMB -B-
ENTRYChapter 43: Model animal health certificate for entry into the Union of 
consignments of stocks of in vivo derived embryos of bovine animals collected, 
processed and stored before 21 April 2021 in accordance with Council 
Directive 89/556/EEC, dispatched after 20 April 2021 by theembryo collection 
team by which the embryos were collected
BOV -in-vitro -EMB -C-
ENTRYChapter 44: Model animal health certificate for entry into the Union of 
consignments of stocks of in vitro produced embryos of bovine animals 
produced, processed and stored before 21 April 2021 in accordance with 
Council Directive 89/556/EEC, conceived using semen complying with 
requirements of Council Directive 88/407/EEC, dispatched after 20 April 2021 
by theembryo production team by which the embryos were produced
BOV -in-vitro -EMB -D-
ENTRYChapter 45: Model animal health certificate for entry into the Union of 
consignments of stocks of in vitro produced embryos of bovine animals 
produced, processed and st ored before 21 April 2021 in accordance with 
Council Directive 89/556/EEC, conceived using semen coming from semen 
collection or storage centres approved by the competent authority of the 
exporting country, dispatched after 20 April 2021 by theembryo prod uction 
team by which the embryos were produced
BOV -GP-PROCESSING -
ENTRYChapter 46: Model animal health certificate for entry into the Union of 
consignments of germinal products listed below ,dispatched after 20 April 2021 
from thegerminal product processing establishment :
-semen of bovine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 after 20 April 2021;
-stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC, as amended by 
Council Directive 2003/43/EC, after 31 December 2004 and before 21 
April 2021;
-stocks of semen of bovine animals collected, processed and stored 
before 1 January 2005 in accordance with Council Dir ective 
88/407/EEC, as amended by Council Directive 93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of in vivo derived embryos of bovine animals collected, 
processed and stored in accordance with Directive 89/556/EEC before 21 April 2021;
-stocks of in vitro
produced embryos of bovine animals produced, 
processed and stored in accordance with Direct ive 89/556/EEC before 
21 April 2021 and conceived using semen complying with 
requirements of Council Directive 88/407/EEC;
-stocks of in vitro produced embryos of bovine animals produced, 
processed and stored in accordance with Directive 89/556/EEC before 2
1 April 2021 and conceived using semen coming from semen 
collection or storage centres approved by the competent authority of the exporting country
L 113 /428  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
BOV -GP-STORAGE -
ENTRYChapter 47: Model animal health certificate for entry into the Union of 
consignments ofgerminal products listed below ,dispatched after 20 April 2021 
from thegerminal product storage centre:
-semen of bovine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 after 20 April 2021;
-stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC, as amended by 
Council Directive 2003/43/EC, after 31 December 2004 and before 21 
April 2021 and ;
-stocks of semen of bovine anima ls collected, processed and stored 
before 1 January 2005 in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regula tion (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of in vivo derived embryos of bovine animals collected, 
processed and stored in accordance with Directive 89/556/EEC before 
21 April 2021;
-stocks of in vitro produced emb ryos of bovine animals produced, 
processed and stored in accordance with Directive 89/556/EEC before 
21 April 2021 and conceived using semen complying with 
requirements of Council Directive 88/407/EEC;
-stocks of in vitro produced embryos of bovine animals produced, 
processed and stored in accordance with Directive 89/556/EEC before 
21 April 2021 and conceived using semen coming from semen 
collection or storage centres approved by the competent authority of the exporting country
Germinal products of ovine and caprine animals
OV/CAP -SEM -A-ENTRY Chapter 48: Model animal health certificate for entry into the Union of 
consignments of semen of ovine and caprine animals collected, processed and 
stored in accordance with Regulation (EU) 2016/429 and Delegated Reg ulation 
(EU) 2020/692 after 20 April 2021, dispatched from thesemen collection 
centre where the semen was collected
OV/CAP -SEM -B-ENTRY Chapter 49: Model animal health certificate for entry into the Union of 
consignments of stocks of semen of ovine and caprine animals collected, 
processed and stored in accordance with Directive 92/65/EEC before 21 April 
2021, dispatched after 20 April 2021 from thesemen collection centre where 
the semen was collected
OV/CAP -OOCYTES -EMB -
A-ENTRYChapter 50: Model animal health certificate for entry into the Union of 
consignments of oocytes and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021 ,dispatched by 
theembryo collection or production team by which the oocytes or embryos 
were collected or produced
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /429
OV/CAP -OOCYTES -EMB -
B-ENTRYChapter 51: Model animal health certificate for entry into the Union of
consign ments of oocytes and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Directive 92/65/EEC before 
21 April 2021, dispatched after 20 April 2021 by theembryo collection or 
production team by which the oocyt es or embryos were collected or produced
OV/CAP -GP-PROCESSING -
ENTRYChapter 52: Model animal health certificate for entry into the Union of 
consign ments ofgerminal products listed below ,dispatched after 20 April 2021 
from thegerminal product processing establishment :
-semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/692 after 20 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and
stored in accordance with Council Directive 92/65/EEC before 21 
April 2021;
-oocytes and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/692 aft er 20 April 
2021
-stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC before 21 April 2021
OV/CAP -GP-STORAGE -
ENTRYChapter 53: Model animal health certificat efor entry into the Union of 
consignments ofgerminal products listed below ,dispatched after 20 April 2021 
from thegerminal product storage centre:
-semen of ovine and caprine animals collected, processed and stored in 
accordance with Regulation (EU) 201 6/429 and Delegated Regulation 
(EU) 2020/692 after 20 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 
April 2021;
-oocytes and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 
2021
-stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and store d in accordance with Council 
Directive 92/65/EEC before 21 April 2021
Germinal products of porcine animals
POR -SEM -A-ENTRY Chapter 54: Model animal health certificate for entry into the Union of 
consignments of semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 after 20 April 2021, dispatched from thesemen c ollection centre 
where the semen was collected
L 113 /430  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
POR -SEM -B-ENTRY Chapter 55: Model animal health certificate for entry into the Union of 
consignments of stocks of semen of porcine animals collected, processed and 
stored in accordance with Directive 90/429/EEC before 21 April 2021, 
dispatched after 20 April 2021 from thesemen collection centre where the 
semen was collected
POR -OOCYTES- EMB -
ENTRYChapter 56: Model animal health certificate for entry into the Union of 
consignments of oocytes and embryos of porcine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 2016/429 
and De legated Regulation (EU) 2020/692 after 20 April 2021 ,dispatched by 
theembryo collection or production team by which the oocytes or embryos 
were collected or produced
POR -GP-PROCESSING -
ENTRYChapter 57: Model animal health certificate for entry into the Uni on of 
consignments ofgerminal products listed below ,dispatched after 20 April 2021 
from thegerminal product processing establishment :
-semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/692 after 20 April 2021;
-stocks of semen of porcine animals collected, processed and stored in 
accordance with Council Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine animals collected or produced, 
processed a nd stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021
POR -GP-STORAGE -ENTRY Chapter 58: Model animal health certificate for entry into the Union of 
consignments ofgerminal products listed below ,dispatched after 20 April 2021 
from thegerminal product storage centre:
-semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/692 after 20 April 2021;
-stocks of semen of porcine animals collected, processed and stored in 
accordance with Council Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021
Germinal products of equine animals
EQUI -SEM -A-ENTRY Chapter 59: Model animal health certificate for entry into the Union of 
consignments of semen of equine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 after 20 April 2021, dispatched from thesemen collection centre 
where t he semen was collected
EQUI -SEM -B-ENTRYChapter 60: Model animal health certificate for entry into the Union of 
consignments of stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 30 September 201 4and 
before 21 April 2021, dispatched after 20 April 2021 from thesemen collection 
centre where the semen was collected
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /431
EQUI -SEM -C-ENTRYChapter 61: Model animal health certificate for entry into the Union of 
consignments of stocks of semen of equine animals collected, processed and 
stored in accordance with Directive 92/65/EEC after 31 August 2010 and 
before 1 October 2014, dispatched after 20 April 2021 from thesemen 
collection c entre where the semen was collected
EQUI -SEM -D-ENTRYChapter 62: Model animal health certificate for entry into the Union of 
consignments of stocks of semen of equine animals collected, processed and 
stored in accordance with Directive 92/65/EEC before 1 Se ptember 2010, 
dispatched after 20 April 2021 from thesemen collection centre where the 
semen was collected
EQUI -OOCYTES -EMB -A-
ENTRYChapter 63: Model animal health certificate for entry into the Union of 
consignments of oocytes and embryos of equine animal s collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched by the
embryo collection or production team by which the oocytes or embryos were 
collected or produced
EQUI -OOCYTES -EMB -B-
ENTRYChapter 64: Model animal health certificate for entry into the Union of 
consignments of stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 92/65/EEC afte r
30 September 2014 and before 21 April 2021, dispatched after 20 Ap ril 2021
by theembryo collection or production team by which the oocytes or embryos 
were collected or produced
EQUI -OOCYTES -EMB -C-
ENTRYChapter 65: Model animal health certificate for entry into the Union of 
consignments of stocks of oocytes and embryos of equine animals collected or 
produced , processed and stored in accordance with Directive 92/65/EEC after 
31August 2010 and before 1 October 2014, dispatched after 20 April 2021 by 
theembryo collection or production team by which the oocytes or embryos 
were col lected or produced
EQUI -GP-PROCESSING -
ENTRYChapter 66: Model animal health certificate for entry into the Union of 
consignments ofgerminal products listed below ,dispatched after 20 April 2021 
from thegerminal product processing establishment :
-semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and 
before 21 April 2021;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 
1 October 2014;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010;
-
oocytes and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
L 113 /432  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
-stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014
EQUI -GP-STORAGE -
ENTRYChapter 67: Model animal health certificate for entry into the Union of 
consignments ofgerminal products listed below ,dispatched after 20 April 2021 
from thegerminal product storage centre:
-semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and 
before 21 April 2021;
-stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 20 10 and before 
1 October 2014;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;
-
oocytes and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014
Germinal products of certain categories of terrestrial animals
GP-CONFINED -ENTRY Chapter 68: Model animal health certificate for entry into the Union of 
consignments of semen, oocytes and embryos of terrestrial animals kept at 
confined establishment which were collected or produced, processed and stored in accord ance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /433
CHAPTER 1
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF BOVINE ANIM ALS (MODEL ‘BOV- X’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Travelling circus/animal acts
□Quarantine establishment □Exhibition
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /434  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /435
COUNTRY Certificate model BOV- XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:
II.1.1. have not received:
− any stilbene or thyrostatic substances, 
− oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);
II.1.2. fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are listed in Commission Decision 2011/163/EU for the concerned country of origin;
II.1.3. with regard to bovine spongiform encephalopathy (BSE):
(a) the animals are identified by a permanent identification system enabling them to be traced 
back to the dam and herd of origin, and they are not:
(i) BSE cases;
(ii) bovine animals which, during their first year of life, were reared with BSE cases 
during their first year of life, and which an investigation has shown that they have 
consumed the same potentially contaminated feed during that period, or
(iii) if the results of the investigation referred to in indent (ii) are inconclusive, bovine 
animals which, during their first year of life, were reared with BSE cases during 
their first year of life, or were born in the same herd as, and within 12 months 
preceding or following the date of the birth of, the BSE cases;
and
(1)either [(b) (i) the animals were born and continuously reared in a country or region or countries or 
regions classified in accordance with Commission Decision 2007/453/EC as 
countries or regions posing a negligible BSE risk;
(ii) if there have been BSE indigenous cases in the count ry concerned, the animals were 
born after the date from which the ban on the feeding of ruminants with meat -and-
bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively 
enforced, or they were born after the date of birth of the last BSE indigenous case if 
born after the date of the feed ban.]
L 113 /436  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- X
(1)or [(b) (i) the country or region of origin of the animals is classified in accordance with 
Decision 2007/453/EC as a country or region posing a controlled BSE risk;
(ii) the animals were born after the date from which the ban on the feeding of ruminants 
with meat- and-bone meal and greaves derived from ruminants, as defined in the 
Terrestrial Animal Health Code of the World Organisation for Animal Health, was 
effectively enforced, or they were born after the date of birth of the last BSE 
indigenous case if born after the date of the feed ban.]
(1)or [(b) (i) the country or region of origin of the animals is classif ied in accordance with 
Decision 2007/453/EC as a country or region posing an undetermined BSE risk;
(ii) the feeding of ruminants with meat -and-bone meal and greaves from ruminants, as 
defined in the Terrestrial Animal Health Code of the World Organisati on for 
Animal Health, has been banned and the ban has been effectively enforced in the 
country or region of origin;
(iii) the animals were born at least two years after the date from which the ban on the 
feeding of ruminants with meat -and-bone meal and g reaves derived from ruminants, 
as defined in the Terrestrial Animal Health Code of the World Organisation for 
Animal Health, was effectively enforced, or they were born after the date of birth of 
the last BSE indigenous case if born after the date of the f eed ban.]
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.2.1. come from the zone with code: __ __ - __(2)which, at the date of issue of this certificate is 
authorised for entry into the Union of bovine animals and listed in Part 1 of Annex I to 
Commission Implementing Regulation (EU) 2021/404 .
II.2.2. have remained continuously: 
(i)in the zone referred to in point II.2.1. since birth or for a period of time of at least 6 months prior to the date of their dispatch to the Union, and
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to the date 
of their dispatch to the Union, in towhich during this period no bovine animals and no ani mals of 
other species listed for the same diseases as bovine animals have been introduced. 
II.2.3. had no contact with animals of a lower health status since birth or at least for 30 days prior to the 
date of their dispatch to the Union. 
II.2.4. are not 
to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 
and emerging diseases.
(1)either [II.2.5. have been dispatched directl y from their establishment of origin to the Union without passing 
through any other establishment].
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /437
COUNTRY Certificate model BOV- X
(1)or [II.2.5. have undergone one single assembly operation in the zone of origin fulfilling the following 
requirements:
(a)the assembly operation took place in an establishment: 
(i)approved for conducting assembly operations of ungulates by the competent authority in 
the third country or territory in accordance with Article 5 of Delegated Regulation (EU) 
2019/2035; 
(ii)which has a n unique approval number assigned by the competent authority of the third 
country or territory;
(iii)listed for that purpose by the competent authority of the third country or territory of 
dispatch with the information set out in Article 21 of Delegated Regulat ion (EU) 
2019/2035;
(iv)fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 
2020/692.
(b)the assembly operation in the assembly centre took no longer than 6 days.]
II.2.6. have not been unloaded in any place that does not comply wi th the requirements laid down in 
point II.2.11. since they were dispatched from their establishment of origin until they are loaded 
for dispatch to the Union and during that period they have not been in contact with animals of a lower health status.
II.2.7. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)
(3)in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority of the third country or territory and construc ted in such a way that: 
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.2.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for 
dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, who did not detect signs indicative of the occurrence of diseases, including the relevant 
listed dise
ases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging 
diseases.
II.2.9. have not been vaccinated against:
(i)foot and mouth disease, infection with Rift Valley fever virus, infection with 
Mycoplasma mycoides subsp. mycoides SC(Conta gious bovine pleuropneumonia), 
Mycobacterium tuberculosis complex (M.bovis, M.caprae and M.tuberculosis ) and 
infection with Brucella abortus, B. melitensis andB. suis , and 
(ii)infection with bluetongue virus (serotypes 1- 24) with a live vaccine during 60 day s
prior to their dispatch to the Union.
II.2.10. come from a zone :
II.2.10.1. in which: 
(i)foot and mouth disease has not been reported for: 
either [at least 24 months prior to the date of dispatch of the animals to the 
Union](1)
or [since __/__/____ (dd/mm/yyyy)](1)(4)
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch of the animals to the Union, and no animals 
vaccinated against foot and mouth disease have been introduced during that period.
L 113 /438  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- X
II.2.10.2. in which infection with lumpy skin disease virus has not been reported for at least 12 
months prior to the date of dispatch of the animals to the Union.
II.2.10.3. in which infection with rinderpest virus, infection with Rift Valley fever virus and 
infection with Mycoplasma mycoides subsp . mycoides SC(Contagious bovine 
pleuropneumonia) has not been reported for at least 12 months prior to the date of 
dispatch of the animals to the Union and during that period:
(i)vaccination against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introduced.
either [II.2.10.4. which is free from infection with bluetongue virus (serotypes 1 -24)](1)(5)
or [II.2.10.4. which is seasonally free from infection with bluetongue virus (serotypes 1 -24): 
either [II.2.10.4.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6)
or[II.2.10.4.1. for at least 28 days prior to the date of dispatch of the animals to the 
Union and the animals have been subjected to a serological test in 
accordance with Article 9(b) of Delegated Regulation (EU) 2020/692, 
with negative results, carried out on samples collected at least 28 days 
following the date of entry of the animal into the seasonally free 
zone.](1)(6)
or[II.2.10.4.1. for at least 14 days prior to the date of dispatch of the animals to the 
Union and have been subjected to a PCR test, with negative results, 
carried out on samples collected at least 14 days following the date of entry of the animal in the seasonally free zone.]
(1)(6)
or [II.2.10.4. is not free from infection with bluetongue virus (serotypes 1- 24) and the 
animals have been vaccinated against a ll the serotypes (1 to 24) of bluetongue virus reported 
during the past 2 years in that zone and are still within the immunity period of time guaranteed 
in the specifications of the vaccine and 
either [II.2.10.4.1. have been vaccinated more than 60 days prior to the date of dispatch of 
the animals to the Union.]](1)
or[II.2.10.4.1. have been vaccinated with an inactivated vaccine and were subjected to 
a PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity p rotection set in the specifications of the 
vaccine.]](1)
or[II.2.10.4. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals 
have been subjected with positive results to a serological test able to detect specific 
antibodies ag ainst all serotypes (1 to 24) of bluetongue virus reported during the past 
2 years in that zone and:
either [II.2.10.4.1. the serological test has been carried out on samples collected at least 
60 days prior to the date of dispatch of the animals to the Union.]](1)
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /439
COUNTRY Certificate model BOV- X
or [II.2.10.4.1. the serological test has been carried out on samples collected at least 30 
days prior to the date of dispatch of the animals to the Union and the 
animals were subjected to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days prior to the date of dispatch of 
the animals to the Union.]](1)
either [II.2.10.5. is free from enzootic bovine leukosis](1)(7)
or [II.2.10.5. is not free from enzootic bovine leukosis and the disease has not been reported 
in the establishment of origin of the animals during at least the 24 months prior to the date of 
dispatch of the animals to the Union, and 
[II.2.10.5.1. the animals of the consignment over 24 months of age:
either [II.2.10.5.1.1. have been kept in isolation from the other bovine 
animals kept in the same establishment prior to dispatch to the 
Union and during the period of isolation have been subjected to a laboratory examination for enzootic bovine leukosis using one of the diagnostic method
s referred to in Article 9(b)(i) of Delegated 
Regulation (EU) 2020/692, with negative results, carried out on 
samples taken on two occasions at an interval of at least 4 
months.]](1)
or [II.2.10.5.1.1. have been subjected to a laboratory examination for e
nzootic bovine leukosis using one of the diagnostic methods 
referred to in Article 9(b)(i) of Delegated Regulation (EU) 
2020/692, with negative results, carried out on a sample taken 
during the 30 day period prior to the date of their dispatch to the Union
and all bovine animals over 24 months of age kept in the 
establishment of origin have been subjected to a laboratory 
examination for enzootic bovine leukosis with one of the diagnostic methods referred to in Article 9(b)(i) of Delegated Regulation (EU) 
20
20/692, carried out, with negative results, on samples taken on 
two occasions at an interval of not less than 4 months during the 12 
month period prior to the date of dispatch of the animals to the 
Union.]](1)
[II.2.10.5.2. the animals of the consignment younger than 24 months of age were born 
to dams which have been subjected to a laboratory examination for 
enzootic bovine leukosis with one of the diagnostic methods referred to in 
Article 9(b)(i) of Delegated Regulation (EU) 2020/692, with negative 
result s, carried out on samples taken on two occasions at an interval of not 
less than 4 months during the 12 month period prior to the date of dispatch 
of the animals to the Union.]](1)
II.2.11. come from an establishment :
II.2.11.1. which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 
years up- to-date records containing information regarding:
(i)the species, categories, number and identification of animals on the 
establishment;
(ii)movements of animals into and out of the establishment;
(iii)mortality in the establishment.
L 113 /440  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- X
II.2.11.2. which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at a frequency that is proportional to the risk 
posed by the establishment. 
II.2.11.3. which was not subject to national restriction measures for animal health reasons, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at the time of dispatch of the animals to the 
Union. 
II.2.11.4. in and around which, in an area of 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has 
been reported for at least 30 days prior to the date of dispatch of the animals to 
the Union: foot and mouth disease, infection with rinderpest virus, infection with 
Rift valley fever virus, infection with Mycoplas ma mycoides subsp. mycoides SC 
(Contagious bovine pleuropneumonia) and infection with lumpy skin disease 
virus.
either [II.2.11.5. in and around which, in an area with a 150 km radius, including where 
appropriate the territory of a neighbouring country, ep izootic haemorrhagic 
disease has not been reported for at least 2 years before the date of dispatch of 
the animals to the Union.](1)
or[II.2.11.5. which is located in a zone seasonally free of epizootic haemorrhagic 
disease.](1)(8)
II.2.11.6. free from infection with Mycobacterium tuberculosis complex (M. bovis , M. 
caprae and M. tuberculosis ) as regards bovine animals (9),and 
either [II.2.11.6.1. located in a zone free from the disease where vaccination against 
that disease is not practiced.](1)(10)
or     [II.2.11.6.1. the animals have been tested with one of the diagnostic methods 
provided for in Article 9(b)(i) of Delegated Regulation (EU) 
2020/692 for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis) , with negative results, 
during the 30 day period prior to the date of dispatch of the animals 
to the Union;]
(1)
or    [II.2.11.6.1. the animals are less than six weeks old.](1)
II.2.11.7. free from infection with Brucella abortus, B. melitensis and B. suis as regards 
bovine animals(9), and
either [II.2.11.7.1. locayed in a zone free from the disease where vaccination against 
that disease is not practiced.](1)(11)
or[II.2.11.7.1. the animals have been tested with one of the diagnostic methods 
provided fo r in Article 9(b)(i) of Delegated Regulation (EU) 
2020/692 for infection with Brucella abortus, B. melitensis and B. 
suis, with negative results, on a sample taken during the 30 day 
period prior to the date of dispatch of the animals to the Union, and 
in the case of post -parturient females, the test is carried out on a 
sample taken at least 30 days after parturition.](1)
or[II.2.11.7.1. the animals are less than 12 months old.](1)
or[II.2.11.7.1. the animals are castrated.](1)
II.2.11.8. in which infection with rabies virus has not been reported for at least 30 days prior 
to dispatch of the animals to the Union.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /441
COUNTRY Certificate model BOV- X
II.2.11.9. in which anthrax has not been reported for at least 15 days prior to the date of 
dispatch of the animals to the Union.
either [II.2.11.10. in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior 
to the date of dispat ch of the animals to the Union.](1)
or[II.2.11.10. in which surra ( Trypanosoma evansi) has not been reported for at least 30 days prior 
to the date of dispatch of the animals to the Union and when the disease was 
reported in the establishment of origin du ring the 2 years prior to the date of dispatch 
of the animals to the Union, the establishment remained under restriction until the 
infected animals were removed from the establishment and the remaining animals on 
the establishment were subjected with negat ive result to a test for surra 
(Trypanosoma evansi) as described in Article 9(b)(i) of Delegated Regulation (EU) 
2020/692 carried out on samples taken at least 6 months after the infected animals 
were removed from the establishment.](1)
(1)(12)[[II.2.12. the animals have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis, and
either [II.2.12.1. originate from a third country or territory or zone thereof free from Infectious 
bovine rhinotracheitis/ infectious pustular vulvovaginitis.]](1)(13)
or[II.2.12.1. have been kept in quarantine for at least 30 days prior to the date of dispatch of the 
animals to the Union and have undergone a serological test for the detection of 
antibodies against whole bovine herpes virus -1 (BoHV -1) with one of the diagnostic 
methods referred to in Article 9(b)(i) of Delegated Regulation (EU) 2020/692, with negative results, on a sample taken within 15 days prior to the date of dispatch of 
the animals to the Union.]]
(1)
(1)(12)[II.2.13. the animals have not been vaccinated against bovine viral diarrhoea, and:
either [II.2.13.1. originate from a third country or territory or zone thereof free from bovine viral 
diarrhoea.]](1)(14)
or[II.2.13.1. have been tested for bovine viral diarrhoea virus antigen or genome using one of the 
diagnostic methods provided for in Part 6 of Annex I to Commission Delegated 
Regulation (EU) 2020/688 with negative results, and 
either [II.2.13.1.1. have been kept in a quarantine establishment for a per iod of at least 
21 days prior to their dispatch to the Union.]]](1)
or[II.2.13.1.1. the animals are pregnant dams and have been kept in a quarantine 
establishment for a period of at least 21 days prior to their dispatch to 
the Union and have been subjecte d to a serological test for the 
detection of antibodies against bovine viral diarrhoea virus using one 
of the diagnostic methods provided for in Part 6 of Annex I to 
Delegated Regulation (EU) 2020/688 with negative results carried 
out on samples taken not less than 21 days after the commencement 
of the quarantine.]]](1)
L 113 /442  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- X
or[II.2.13.1.1. have been subjected to serological test for the detection of antibodies 
against bovine viral diarrhoea virus using one of the diagnostic 
methods provided for in Part 6 of Annex I to Delegated Regulation 
(EU) 2020/688, with positive results, carried out on samples taken 
prior to their dispatch to the Union.]]](1)
or[II.2.13.1.1. the animals are pregnant dams that have been subjected to 
serological test for the detection of antibodies against bovine viral 
diarrhoea virus using one of the diagnostic methods provided for in 
Part 6 of Annex I to Delegated Regulation (EU) 2020/688 with 
positive results, carried out on samples taken before insemination 
preceding the current gestat ion.]]](1)
Notes:
This certificate is intended for entry into the Union of bovine animals, including when the Union is not the final 
destination of the animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual id entification codes of the animals in accordance 
with Article 21(1) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(3)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.
(4)Only for zones with openin g date in accordance with column 8 in part 1 of Annex II to Implementing 
Regulation (EU) 2021/404 .
(5)For zones with entry BTV in column 7 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404 .
(6)For zones with entry SF -BTV in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(7)For zones with entry EBL in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(8)For zones with entry SF -EHD in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(9)In accordance with Article 10 of Delegated Regulation (EU) 2020/692.
(10)For zones with entry TB  for bovine animals in column 7 of Part 1 of Annex II to Implementing Regulation 
(EU) 2021/404.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /443
COUNTRY Certificate model BOV- X
(11)For zones with entry BRU for bovine animals in column 7 of Part 1 of Annex II to Implementing Regulation 
(EU) 2021/404.
(12)Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement 
between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 
30.4.2002), either has disease -free status or an approved eradication programme for the diseases mentioned in 
point II.2.12 and II.2.13 (infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and bovine viral 
diarrhoea) .
(13)For zones with e ntry IBR in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(14)For zones with entry BVD in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /444  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 2
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF BOVINE ANIM ALS INTENDED FOR SLAUGHTER (MODEL ‘BOV- Y’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Slaughter
I.21I.22□For internal market
I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /445
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
L 113 /446  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation
I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:
II.1.1. have not received:
− any stilbene or thyrostatic substances, 
− oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);
II.1.2. fulfil the guarantees covering live an imals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are listed in Commission Decision 2011/163/EU for the concerned country of origin;
II.1.3. with regard to bovine spongiform encephalopathy (BSE):
(a) the animals are identified by a permanent identification system enabling them to be traced 
back to the dam and herd of origin, and they are not:
(i) BSE cases;
(ii) bovine animals which, during their first yea r of life, were reared with BSE cases 
during their first year of life, and which an investigation has shown that they have 
consumed the same potentially contaminated feed during that period, or
(iii) if the results of the investigation referred to in inden t (ii) are inconclusive, bovine 
animals which, during their first year of life, were reared with BSE cases during 
their first year of life, or were born in the same herd as, and within 12 months preceding or following the date of the birth of, the BSE case s;
and
(1)either [(b) (i) the animals were born and continuously reared in a country or region or countries or 
regions classified in accordance with Commission Decision 2007/453/EC as 
countries or regions posing a negligible BSE risk;
(ii) if there have been BSE indigenous cases in the country concerned, the animals were 
born after the date from which the ban on the feeding of ruminants with meat -and-
bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the Wor
ld Organisation for Animal Health, was effectively 
enforced, or they were born after the date of birth of the last BSE indigenous case if 
born after the date of the feed ban.]
(1)or [(b) (i) the country or region of origin of the animals is classified in accordance with 
Decision 2007/453/EC as a country or region posing a controlled BSE risk;
(ii) the animals were born after the date from which the ban on the feeding of ruminants 
with meat- and-bone meal and greaves derived from ruminants, as defined in t he 
Terrestrial Animal Health Code of the World Organisation for Animal Health, was 
effectively enforced, or they were born after the date of birth of the last BSE 
indigenous case if born after the date of the feed ban.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /447
COUNTRY Certificate model BOV- Y
(1)or [(b) (i) the country or region of origin of the animals is classified in accordance with 
Decision 2007/453/EC as a country or region posing an undetermined BSE risk;
(ii) the feeding of ruminants with meat -and-bone meal and greaves from ruminants, as 
defined in the Terrestrial Animal Health Code of the World Organisation for 
Animal Health, has been banned and the ban has been effectively enforced in the 
country or region of origin;
(iii) the animals were born at least two years after the date from which the ban on the 
feeding of ruminants with meat -and-bone meal and greaves derived from ruminants, 
as defined in the Terrestrial Animal Health Code of the World Organisation for 
Animal Health, was effectively enforced, or they were born after the date of birth of 
the last BSE indig enous case if born after the date of the feed ban.]
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.2.1. come from the zone with code: __ __ - __(2)which, at the date of is sue of this certificate is 
authorised for entry into the Union of bovine animals intended for slaughter and is listed in Part 1 
of Annex II to Commission Implementing Regulation (EU) 2021/404 .
II.2.2. are intended for slaughter in the Union.
II.2.3. have remained continuously:
(i)in the zone referred to in point II.2.1. since birth or for a period of time of at least 3 months prior 
to the date of their dispatch to the Union, and 
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to the 
date of their dispatch to the Union, into which during this period no bovine animals and no 
animals of other species listed for the same diseases as bovine animals have been introduced.
II.2.4. had no contact with animals of a lower he alth status since birth or at least for 30 days prior to the 
date of their dispatch to the Union. 
II.2.5. are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Com mission Delegated Regulation (EU) 
2020/692 and emerging diseases.
(1)either [II.2.6. have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment].
(1)or [II.2.6. have undergone one single as sembly operation in the zone of origin fulfilling the following 
requirements:
(a)the assembly operation took place in an establishment: 
(i)approved for conducting assembly operations of ungulates by the competent authority in 
the third country or territory in a ccordance with Article 5 of Commission Delegated 
Regulation (EU) 2019/2035; 
(ii)which has an unique approval number assigned by the competent authority of the third 
country or territory;
L 113 /448  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- Y
(iii)listed for that purpose by the competent authority of the third country or territory of 
dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 
2019/2035;
(iv)fulfilling the requirements provided for in Article 8 of Commission Delegated Regulation 
(EU) 2020/692;
(b) the assembly operation in the assembly centre took no longer than 6 days.]
II.2.7. have not been unloaded in any place that does not comply with the requirements laid down in 
point II.2.12. since they were dispatched from their establishment of origin until they are loaded 
for dispatch to the Union and during that period they have not been in contact with animals of a 
lower health status. 
II.2.8. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of transport 
which was cleaned and disinfected prior to loadi ng with a disinfectant authorised by the 
competent authority of the third country or territory and constructed in such a way that: 
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter or feed is prevented or minimized.
II.2.9. have been subjected to a clinical inspection within the 24 hour period prior to loading for 
dispatch to the Union, carried out by an official veterinarian in the third country or territory of 
origin, who did not detect signs indicative of the occurrence of diseases, including the relevant 
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging 
diseases. 
II.2.10. have not been vaccinated against:
(i)foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma 
mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia), Mycobacterium 
tuberculosis complex (M.bovis, M.caprae and M.tuberculosis ) and infection with Brucella 
abortus, B. mel itensis and B. suis , and 
(ii)infection with bluetongue virus (serotypes 1 -24) with a live vaccine during 60 days prior to their 
dispatch to the Union.
II.2.11. come from a zone :
II.2.11.1. in which:
(i) foot and mouth disease has not been reported for: 
either [at least 24 months prior to the date of dispatch of the animals to the Union](1)
or [since __/__/____ (dd/mm/yyyy)](1)(4) 
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the anim
als to the Union, and no animals 
vaccinated against foot and mouth disease have been introduced during that period.
II.2.11.2. in which infection with lumpy skin disease virus has not been reported for at least 12 
months prior to the date of dispatch of the animals to the Union.
II.2.11.3. in which infection with rinderpest virus, infection with Rift Valley fever virus and 
infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine 
pleuropneumonia) has not been reported for at least 12 months p rior to the date of dispatch 
of the animals to the Union and during that period:
(i)vaccination against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introduced.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /449
COUNTRY Certificate model BOV- Y
either [II.2.11.4. which is free from infection with bluetongue virus (serotypes 1 -24).](1)(5)
or [II.2.11.4. which is seasonally free from infection with bluetongue virus (serotypes 1- 24): 
either [II.2.11.4.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6)
or [II.2.11.4.1. for at least 28 days prior to the date of dispatch of the animals to the Union 
and the animals have been subjected to a serological test in accordance with Article 
9(b) of Delegated Regulation (EU) 2020/692, with negative results, c arried out on 
samples collected at least 28 days following the date of entry of the animal into the seasonally free zone.]
(1)(6)
or [II.2.11.4.1. for at least 14 days prior to the date of dispatch of the animals to the Union 
and have been subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of entry of the animal in the seasonally free 
zone.](1)(6)
or [II.2.11.4. is not free from infection with bluetongue virus (serotypes 1- 24) and the animal s have been 
vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years in 
that zone and are still within the immunity period of time guaranteed in the specifications of the 
vaccine, and 
either [II.2.11.4.1. have be en vaccinated more than 60 days prior to the date of dispatch of the 
animals to the Union.]](1)
or [II.2.11.4.1. have been vaccinated with an inactivated vaccine and were subjected to a 
PCR test, with negative results on samples collected at least 14 days after the onset of 
the immunity protection set in the specifications of the vaccine.]](1)
or [II.2.11.4. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals have been 
subjected with positive results to a serological test able to detect specific antibodies against all serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone, and
either [II.2.11.4.1 the serological test has been carried out on samples collected at least 60 
days prior to the date of di spatch of the animals to the Union.]]
(1)
or [II.2.11.4.1. the serological test has been carried out on samples collected at least 30 
days prior to the date of dispatch of the animals to the Union and the animals were subjected to a PCR test, with negative results, carried out on samples collected not 
earlier than 14 days prior to the date of dispatch of the animals to the Union.]]
(1)
either [II.2.11.5. is free from enzootic bovine leukosis.](1)(7)
or [II.2.11.5. is not free from enzootic bovine leukosis and the disease has not been reported in the 
establishment of origin of the animals during at least the 24 months prior to the date of dispatch of the 
animals to the Union, and 
[II.2.11.5.1. the animals of the consignment over 24 months:
either [II.2.11.5.1.1. have been kept in isolation from the other bovine animals kept in the 
same establishment prior to dispatch to the Union and during the period of isolation 
have been subjected to a laboratory examination for enzootic bovine leukosis using one 
of the diag nostic methods referred to in Article 9(b)(i) of Delegated Regulation (EU) 
2020/692, with negative results, carried out on samples taken on two occasions at an 
interval of at least 4 months.]](1)
L 113 /450  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- Y
or [II.2.11.5.1.1. have been subjected to a laboratory examination for enzootic bovine 
leukosis using one of the diagnostic methods referred to in Article 9(b)(i) of Delegated 
Regulation (EU) 2020/692, with negative results, carried out on a sample taken during the 30 day period prior to the date of their dispatch to the Union and all bovine animals 
over 24 months kept in the establishment of origin have been subjected to a laboratory 
examination for enzootic bovine leukosis with one of the diagnostic methods referred to 
in Article 9(b)(i) of Delegated Regulation (EU) 2020/692, carried out, with negative 
results, on samples taken on two occasions at an interval of not less than 4 months 
during the 12 month period prior to the date of dispatch of the animals to the Union.]]
(1)
[II.2.11.5.2. the animals of the con signment younger than 24 months of age were born to dams 
which have been subjected to a laboratory examination for enzootic bovine leukosis with one of the diagnostic methods referred to in Article 9(b)(i) of Delegated Regulation (EU) 2020/692, 
with negative results, carried out on samples taken on two occasions at an interval of not less 
than 4 months during the 12 month period prior to the date of dispatch of the animals to the Union.]]
(1)
II.2.12. come from an establishment : 
II.2.12.1. which is register ed by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years up-
to-date records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animals into and out of the establishment;
(iii)mortality in the establishment.
II.2.12.2. which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the relevant listed diseases referred to 
in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases, at a frequency 
that is proportional to the risk posed by the establishment.
II.2.12.3. which was not subject to national restriction measures for animal health reasons, including 
the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
and emerging diseases, at the time of dispatch of the animals to the Union.
II.2.12.4. in and arou nd which, in an area of 10 km radius, including where appropriate the territory 
of a neighbouring country, none of the following listed diseases has been reported for at 
least 30 days prior to the date of dispatch of the animals to the Union: foot and mout h
disease, infection with rinderpest virus, infection with Rift valley fever virus, infection 
with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) 
and infection with lumpy skin disease virus.
either [II.2.12.5. in and around whic h, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 2 
years before the date of dispatch of the animals to the Union.](1)
or [II.2.12.5. w hich is located in a zone seasonally free of epizootic haemorrhagic disease.](1)(8)
[II.2.12.6. free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis ) as regards bovine animals.](1)(9)
[II.2.12.7. free from in fection with Brucella abortus, B. melitensis and B. suis as regards bovine 
animals.](1)(9)
II.2.12.8. in which infection with rabies virus has not been reported for at least 30 days prior to 
dispatch of the animals to the Union.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /451
COUNTRY Certificate model BOV- Y
II.2.12.9. in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the 
animals to the Union.
either [II.2.12.10. in which surra (Trypanosoma evansi ) has not been reported for at least 2 years prior to the 
date of dispatch of the animals to the Union.](1)
or [II.2.12.10. in which surra ( Trypanosoma evansi ) has not been reported for at least 30 days prior to the 
date of dispatch of the animals to the Union and when the disease was reported in the establishment of 
origin during the 2 years pri or to the date of dispatch of the animals to the Union, the establishment 
remained under restriction until the infected animals were removed from the establishment and the 
remaining animals on the establishment were subjected with negative result to a test for surra 
(Trypanosoma evansi ) as described in Article 9(b)(i) of Delegated Regulation (EU) 2020/692 carried 
out on samples taken at least 6 months after the infected animals were removed from the 
establishment.](1)
(1)(10)[II.2.13. the animals have not b een vaccinated against infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis, and 
either [II.2.13.1. originate from a third country or territory or zone thereof free from Infectious bovine 
rhinotracheitis/ infectious pustular vulvovaginitis.]](1)(11)
or [II.2.13.1. have been kept in quarantine for at least 30 days prior to the date of dispatch of the 
animals to the Union and have undergone a serological test for the detection of antibodies against 
whole bovine herpes virus -1 (BoHV -1) with one of the diagnostic methods referred to in Article 
9(b)(i) of Delegated Regulation (EU) 2020/692, with negative results, on a sample taken within 15 
days prior to the date of dispatch of the animals to the Union.]](1)
(1)(10)[II.2.14. the ani mals have not been vaccinated against bovine viral diarrhoea, and:
either [II.2.14.1. originate from a third country or territory or zone thereof free from bovine viral 
diarrhoea.]](1)(12)
or [II.2.14.1. have been tested for bovine viral diarrhoea virus antigen or genome using one of the diagnostic methods provided for in Part 6 of Annex I to Commission Delegated Regulation (EU) 2020/688 with negative results, and 
either [II.2.14.1.1. have bee n kept in a quarantine establishment for a period of at least 21 
days prior to their dispatch to the Union.]]]
(1)
or [II.2.14.1.1. the animals are pregnant dams and have been kept in a quarantine 
establishment for a period of at least 21 days prior to thei r dispatch to the Union and 
have been subjected to a serological test for the detection of antibodies against bovine 
viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of 
Annex I to Delegated Regulation (EU) 2020/688 with nega tive results carried out on 
samples taken not less than 21 days after the commencement of the quarantine.]]](1)
or [II.2.14.1.1. have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in 
Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results, carried 
out on samples taken prior to their dispatch to the Union.]]]
(1)
or [II.2.14.1.1. the animals are pregnant dams that have been subje cted to serological test 
for the detection of antibodies against bovine viral diarrhoea virus using one of the 
diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 
2020/688, with positive results, carried out on samples taken b efore insemination 
preceding the current gestation.]](1)
L 113 /452  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- Y
Notes:
This certificate is intended for entry of bovine animals that will be slaughtered in the Union.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(3)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.
(4)Only for zones with opening date in accordance with column 8 in part 1 of Annex II to Implementing 
Regulation (EU) 2021/ 404.
(5)For zones with entry BTV in column 7 of Part 1 of Annex I to Implementing Regulation (EU) 2021/404.
(6)For zones with entry SF -BTV in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(7)For zones with entry EBL in column 7 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404 .
(8)For zones with entry SF -EHD in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(9)In accordance with Article 10 of Delegated Regulation (EU) 2020/692.
(10)Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 
30.4.2002), either have disease -free status or an approved eradication programme for the diseases mentioned 
in point II.2.12 and II.2.13 (infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and bovine viral diarrhoea) .
(11)For zones with entry IBR in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(12)For zones with entry BVD in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /453
CHAPTER 3
MODEL ANIMAL HEALTH CERTIFICATE FOR ENTR Y INTO THE UNION OF 
BOVINE ANIMALS INTENDED FOR TRANSIT FROM THE REG ION OF 
KALININGRAD TO OTHER REGIONS OF RUSSIA VI A THE TERRITORY OF 
LITHUANIA (MODEL ‘BO V-X-TRANSIT- RU’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
I.21□For transit I.22
Third country ISO country code I.23
L 113 /454  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /455
COUNTRY Certificate model BOV- X-TRANSIT -RUPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.1.1. come from the zone with code RU -2(2) which, at the date of issuing this certificate is listed in Part 1 of 
Annex XXII to Commission Implementing Regulation (EU) 2021/404 for transit of bovine animals through 
the Union under specific conditions. 
(1)either [II.1.2. they originate from the Uni on and they were introduced from the Union into the zone with code 
RU-2 on ………. (dd/mm/yyyy) and, since that date, they have been kept in facilities where 
only animals that originate from the Union are kept.]
(1)or [II.1.2. they have remained in the zone with code RU -2 since birth, or for at least the last six months 
before the date of dispatch to Russia via the Union and without contact with imported animals 
for the last 30 days.]
II.1.3. had no contact with animals not complying with the animal health re quirements as described in this 
certificate.
II.1.4. are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 and emergin g
diseases.
II.1.5. have not been unloaded in any place that does not comply with the requirements laid down in point II.1.10. since they were dispatched from their establishment of origin until their dispatch to Russia via 
the Union and during that period they have not been in contact with animals of a lower health status.
II.1.6. have been loaded for dispatch to Russia via the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority of the third country or territory and constructed in such a way that:
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.1.7. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch to 
Russia via the Union, carried out by an official veterinarian, who did not detect signs indicative of the 
occurrence of diseases, including the relevant listed diseases referred to in Annex I to Delegated 
Regulation (EU) 2020/692 and emerging diseases.
II.1.8. have not been vaccinated against:
(i)foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma 
mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) s, and 
(ii)infection with bluetongue virus (serotypes 1- 24) with a live vaccine during 60 days prior to 
their dispatch to Russia via the Union.
II.1.9. come from the zone described in point II.1.1.:
L 113 /456  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- X-TRANSIT -RU
II.1.9.1. in which:
(iii)foot and mouth disease has not been reported for:
either [at least 24 months prior to the date of dispatch to Russia via the Union](1)
or [since __/__/____ (dd/mm/yyyy)](1)(4)
(iv)vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch of the animals to the Union, and no animals 
vaccinated against foot and mouth disease have been i ntroduced during that period.
II.1.9.2. in which infection with lumpy skin disease virus has not been reported for at least 12 months 
prior to the date of dispatch to Russia via the Union.
II.1.9.3. in which infection with rinderpest virus, infection with Rift Valley fever virus and infection 
with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) has 
not been reported for at least 12 months prior to the date of dispatch to Russia via the Union 
and during that period:
(i)vaccination against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introduced. 
either [II.1.9.4. which is free from infection with bluetongue virus (serotypes 1 -24)](1)(5)
or [II.1.9.4. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals have 
been vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years 
in that zone and are still within the immunity period of time guaranteed in the specificati ons of the 
vaccine and have been vaccinated more than 60 days prior to the date of dispatch of the animals to 
Russia via the Union.](1)
II.1.10. come from the establishment described under box reference I.11 [where they have remained 
since birth or at leas t 40 days before the date of dispatch to Russia via the Union and](6):
II.1.10.1. which was not subject to national restriction measures for animal health reasons, including 
the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
and emerging diseases, at the time of dispatch of the animals to the Union. 
II.1.10.2. in and around which, in an area of 10 km radius none of the following listed diseases has 
been reported for at least 30 days prior to the date of dispatch of the animals to the Union: 
foot and mouth disease, infection with rinderpest virus, i nfection with Rift valley fever 
virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine 
pleuropneumonia) and infection with lumpy skin disease virus.
II.1.10.3. in and around which, in an area with a 150 km radius, including where a ppropriate the 
territory of a neighbouring country, epizootic haemorrhagic disease has not been reported 
for at least 60 days before the date of dispatch of the animals to Russia via the Union.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /457
COUNTRY Certificate model BOV- X-TRANSIT -RU
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commiss ion Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21(1) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex XXII to Implementing Regulation (EU) 
2021/404.
(3)Date of loading: it cannot be a date prior to the date of authorisation for transit to Russia via the Union of the 
zone referred to in point II.1.1., or a date in a period when restriction measures have been ado pted by the 
Union against transit of these animals from this zone.
(4)Only for zones with opening date in accordance with column 8 in part 1 of Annex XXII to Implementing 
Regulation (EU) 2021/404 .
(5)For zones with entry BTV in column 7 of Part 1 of Annex XXII to Implementing Regulation (EU) 2021/404.
(6)Delete the text in square brackets if the second option for point II.1.2. is deleted. 
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /458  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 4
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF OVINE AND C APRINE ANIMALS (MODEL ‘OV/CAP -X’)
COUNTRY Animal health/o fficial certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Travelling circus/animal acts
□Quarantine establishment □Exhibition
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /459
I.24 Total number of packages I.25 Total quantity I.26Total net weight/gross weight 
(kg)
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
L 113 /460  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:
II.1.1. have not received:
− any stilbene or thyrostatic substances, 
− oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);
II.1.2. fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC, and the concerned 
animals are listed in Commission Decision 2011/163/EU for the concerned country of origin.
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.2.1. come from the zone with code: __ __ - __(2)which, at the date of issue of this certificate is authorised 
for entry into the Union of ovine and caprine animals and listed in Part 1 of Annex I to Commission 
Implementing Regulation (EU) 2021/404 .
II.2.2. have remained continuously: 
(i) in the zone referred to in point II.1 since birth or for a period of time of at least 6 months prior 
to the date of their dispatch to the Union, and
(ii) in the establishment of origin since birth or for a period of time of at least 40 days prior to the 
date of their dispatch to the Union, into  which during this period no ovine and caprine 
animals and no animals of other species listed for t he same diseases as ovine and caprine 
animals have been introduced.
II.2.3. had no contact with animals of a lower health status since birth or at least for 30 days prior to the date 
of their dispatch to the Union.
II.2.4.are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex I of Commission Delegated Regulation (EU) 2020/692 and 
emerging diseases.
(1)either [II.2.5. have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment].
(1)or [II.2.5. have undergone one single assembly operation in the zone of origin fulfilling the following 
requirements:
(a)the assembly operation took place in an establishment: 
(i)approved for conducting assembly operations of ungulates by the competent authority in the 
third country or territory in accordance with Article 5 of Commission Delegated Regulation 
(EU) 2019/2035;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /461
COUNTRY Certificate model OV/CAP -X
(ii)which has an unique approval number assigned by the competent authority of the third 
country or territory;
(iii)listed for that purpose by the competent authority of the third country or territory of 
dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 
2019/2035;
(iv) fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 
2020/692.
(b)the assembly operation in the assembly centre took no longer than 6 days.]
II.2.6. have not been unloaded in any place that does not comply with the requirements laid down in point 
II.2.11. since they were dispatched from their establishment of origin until they are loaded for 
dispatch to the Union and during that period have not been in contact with animals of a lower health 
status.
II.2.7. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of transport which 
was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter or feed is prevented or minimized.
II.2.8. been subjected to a clinical inspection within the 24 hour period prior to loading for dis patch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred to 
in Annex 1 to Delegated Regulatio n (EU) 2020/692 and emerging diseases.
II.2.9. have not been vaccinated against:
(i) foot and mouth disease, infection with Rift Valley fever virus, infection with peste des 
petits ruminants virus , sheep pox and goat pox, contagious caprine pleuropneumonia, 
Mycobacterium tuberculosis complex (M.bovis , M.caprae and M.tuberculosis
) and 
infection with Brucella abortus , B. melitensis and B. suis , and 
(ii) infection with bluetongue virus (serotypes 1 -24) with a live vaccine during the 60 days 
prior to their dispatch to the Union.
II.2.10. come from a zone :
II.2.10.1. in which:
(i) foot and mouth disease has not been reported for: 
either [at least 24 months prior to the date of dispatch to the Union](1)
or [since __/__/____ (dd/mm/yyyy)](1)(4)
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 months 
prior to the date of dispatch of the animals to the Union, and no animals vaccinated against 
foot and mouth disease have been introduced during that period.
II.2.10.2. in which infection with rinderpest virus , infection with Rift Valley fever virus, infection 
with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia has not been reported for at least 12 months prior to the date of dispatch 
of the animals to the Union and during that period:
(i)vaccination against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introduced.
L 113 /462  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -X
either [II.2.10.3. is free from infection with bluetongue virus (serotypes 1-24)](1)(5)
or [II.2.10.3. is seasonally free from infection with bluetongue virus (serotypes 1- 24):
either [II.2.10.3.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6)
or [II.2.10.3.1. for at least 28 days prior to the date of dispatch of the animals to the Union and 
the animals have been subjected to a serological test in accordance with Article 9(b) of 
Commission Delegated Regulation (EU) 2020/692, with negative results, carried out on 
samples collected at least 2 8 days following the date of entry of the animal into the 
seasonally free zone.] (1)(6)
or [II.2.10.3.1. for at least 14 days prior to the date of dispatch of the animals to the Union and 
have been subjected to a PCR test, with negative results, carried ou t on samples collected at 
least 14 days following the date of entry of the animal in the seasonally free zone.](1)(6)
or [II.2.10.3. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals have 
been vaccinated against all the ser otypes (1 to 24) of bluetongue virus reported during the past 2 years 
in that zone and are still within the immunity period of time guaranteed in the specifications of the 
vaccine and 
either [II.2.10.3.1. have been vaccinated more than 60 days prior to the date of dispatch of the 
animals to the Union.]](1)
or [II.2.10.3.1. have been vaccinated with an inactivated vaccine and were subjected to a PCR 
test, with negative results on samples collected at least 14 days after the onset of the 
immunity protectio n set in the specifications of the vaccine.]](1)
or [II.2.10.3. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals have 
been subjected with positive results to a serological test able to detect specific antibodies against all
serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone and:
either [II.2.10.3.1. the serological test has been carried out on samples collected at least 60 
days prior to the date of dispatch of the animals to the Union.]](1)
or [II.2.10.3.1. the serological test has been carried out on samples collected at least 30 days 
prior to the date of dispatch of the animals to the Union and the animals were subjected to a 
PCR test, with negative results, carried out on samples collected not earlier than 14 days 
prior to the date of dispatch of the animals to the Union.]](1)
II.2.11. come from an establishment : 
II.2.11.1. which is registered by and under the control of the competent authority of the third country 
or territory of origin and has a system in place to maintain for at least 3 years up -to-date 
records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animals into and out of the establishment;
(iii)mortality in the establishment.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /463
COUNTRY Certificate model OV/CAP -X
II.2.11.2. which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, including the 
relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and 
emerging diseases, at a frequency that is proportional to the risk posed by the establishment.
II.2.11.3. which was not subject to national restriction measures for animal health reasons, inc luding 
the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
and emerging diseases, at the time of dispatch to the Union.
II.2.11.4. in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been reported 
for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth 
disease, infection with rinderpest virus, infection with Rift valley f ever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia.
either [II.2.11.5. in and around which, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 
2 years prior to the date of dispatch of the animals to the Union](1)
or [II.2.11.5 . which is located in a zone seasonally free of epizootic haemorrhagic disease.](1)(7)
either [II.2.11.6. in which infection with Mycobacterium tuberculosis complex (M.bovis, M.caprae and
M.tuberculosis ) has not been reported during 42 days prior to the date of dispatch of the animals to the 
Union](1)(8)
or [II.2.11.6. subjected to surveillance to detect infection with Mycobacterium tuberculosis complex 
(M.bovis, M.caprae andM.tuberculosis ) in accordance with the procedures in points (1) and (2) of part 
1 of Annex II to Commission Delegated Regulation (EU) 2 020/688 during at least 12 months prior to 
the date of dispatch to the Union and during this period:
(i)only caprine animals from establishments applying the measures provided in the paragraph above 
have been introduced in the establishment; 
(ii)in case infectio n with Mycobacterium tuberculosis complex (M.bovis , M.caprae and 
M.tuberculosis ) has been reported in caprine animals kept on the establishment, measures were 
taken in accordance with point (3) of part 1 of Annex II to Delegated Regulation (EU) 
2020/688].(1)(9)
II.2.11.7. free from infection with Brucella abortus, B. melitensis and B. suis as regards ovine and caprine 
animals(10); and
either [II.2.11.7.1. in a zone free from the disease as regards ovine and caprine animals where 
vaccination against that d isease is not practiced](1)(11);
or [II.2.11.7.1. the animals have been tested with one of the diagnostic methods provided for in 
Article 9(b)(i) of Delegated Regulation (EU) 2020/692 for infection with Brucella abortus, B. 
melitensis andB. suis, with negative results, on a sample taken during the 30 day period prior 
to the date of dispatch to the Union, and in the case of post -parturient females, the test is 
carried out on a sample taken at least 30 days after parturition](1)
or [II.2.11.7.1. the anima ls are less than 6 months old;](1)
or [II.2.11.7.1. the animals are castrated](1).
L 113 /464  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -X
II.2.11.8. in which rabies has not been reported for at least 30 days prior to dispatch of the animals to the 
Union;
II.2.11.9. in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the 
animals to the Union;
either [II.2.11.9. in which surra ( Trypanosoma evansi) has not been reported for at least 2 years prior 
to the date of dispatch of the animals to the Union.](1)
or [II.2.11.9. in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior 
to the date of dispatch of the animals to the Union and when the disease was reported in the 
establishment of origin during the 2 years prior to the date of dispatch of the a nimals to the 
Union, the establishment remained under restriction until the infected animals were removed 
from the establishment and the remaining animals on the establishment were subjected with 
negative result to a test for surra ( Trypanosoma evansi) as described in Article 9(b)(i) of 
Regulation (EU) 2019/692 carried out on samples taken at least 6 months after the infected 
animals were removed from the establishment.](1)
[II.2.11.10. in which Burholderia mallei (glanders) has not been reported for at least 6 months prior to the 
date of dispatch of the animals to the Union.](9)
[II.2.12. include uncastrated males of ovine animals, which have remained for a continuous period of at 
least 60 days prior to their dispatch to the Union in an establishment whe re infection with 
Brucella ovis (contagious epididymitis) has not been reported during the period of 12 months 
prior to the date of their dispatch to the Union and have been subjected to a serological test for the detection of Brucella ovis , with negative results, during the 30 days prior to the date of their 
dispatch to the Union.]
(1)
II.2.13. comply with the following conditions as regards classical scrapie:
II.2.13.1. they have been kept continuously since birth in a country where the following 
conditio ns are fulfilled:
(a) classical scrapie is compulsorily notifiable;
(b) an awareness, surveillance and monitoring system is in place;
(c) ovine and caprine animals affected with classical scrapie are killed and 
completely destroyed;
(d) the feeding to ovine and caprine animals of meat -and-bone meal or greaves 
of ruminant origin, as defined in the Terrestrial Animal Health Code of the 
World Organisation for Animal Health, has been banned and effectively 
enforced in the whole country for a period of at least the last seven y ears, 
and
(1)either [II.2.13.2. they are animals intended for production and they are destined for a Member 
State other than those with a negligible risk status for classical scrapie approved in accordance 
with point 2.2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001, or 
other than those which are listed in point 3.2 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 as having an approved national scrapie control programme;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /465
COUNTRY Certificate model OV/CAP -X
(1)or [II.2.13.2. they are animals intended for breeding and they are destined for a Member 
State other than those with a negligible risk status for classical scrapie approved in accordance 
with point 2.2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001, or 
other than those which are listed in point 3.2 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 as having an approved national scrapie control programme and:
(1)either [they come from a holding or holdings that have complied with the 
requirement s laid down in point 1.3 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001;]
(1)or [they are ovine animals of the ARR/ARR prion protein genotype and they come 
from a holding or holdings where no official movement restriction has been 
imposed due to BSE or classical scrapie during the last two years;]]
(1)or [II.2.13.2. they are destined for a Member State with a negligible risk status for classical 
scrapie approved in accordance with point 2.2 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001, or for a Member State listed in point 3.2 of Section A of Chapter 
A of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control 
programme and:
(1)either [they come from a holding or holdings that have complied with the 
requirements laid down in point 1.2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;]
(1)or [they are ovine animals of the ARR/ARR prion protein genotype and they come 
from a holding or holdings where no offic ial movement restriction has been 
imposed due to BSE or classical scrapie during the last two years;]]
Notes:
This certificate is intended for entry into the Union of ovine and caprine animals, including when the Union is not 
the final destination of the animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern I reland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the compl etion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system 
(such as ear tag, tattoo, tra nsponder etc., from the list in Annex III to Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the animals in 
accordance with Article 21 (1) of Commission Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(3)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a date in a 
period when restriction measures have been adopted by the Union against entries of these animals from this zone.
(4)For zones with opening date in accordance with column 8 in part 1 of Annex II to Implementing Regulation (EU) 2021/404
(5)For zones with entry BTV in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(6)For zones with entry SF -BTV in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(7)For zones with entry SF -EHD in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(8)Only for ovine animals.
(9)Only for caprine animals.
(10)In accordance with Article 10 of Delegated Regulation (EU) 2020/692.
(11)Zones with entry BRU for ovine and caprine animals in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 
2021/404.
L 113 /466  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -X
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /467
CHAPTER 5
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF OVINE AND C APRINE ANIMALS INTENDED FOR SLAUGHTER
(MODEL ‘OV/CAP -Y’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Slaughter
I.21 I.22□For internal market
I.23
L 113 /468  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /469
COUNTRY Certificate model OV/CAP -YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:
II.1.1. have not received:
− any stilbene or thyrostatic substances, 
− oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
II.1.2. fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are listed in Commission Decision 2011/163/EU for the concerned country of origin.
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.2.1. come from the zone with code: __ __ -__(2)which, at the date of issuing this certificate is authorised for 
entry into the Union of ovine and caprine animals and is listed in Part 1 of Annex I to Commission 
Implementing Regulation (EU) 2021/404 .
II.2.2. are intended for slaughter in the Union.
II.2.3. have remained continuously:
(i)in the zone referred to in point II.2.1. since birth or for a period of time of at least 3 months prior to the 
date of their dispatch to the Union, and
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to the date of 
their dispatch to the Union, into which during this period no ovine and caprine animals and no animals of 
other species listed for the same diseases as ovine and caprine animals have been introduced.
II.2.4. had no contact with animals of a lower health status since birth or at least for 30 days prior to the date of 
their dispatch t o the Union.
II.2.5. are not to be killed under a national programme for the eradication of diseases, including the relevant listed 
diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 and emerging diseases.
(1)either [II.2.6. have been dispatched directly from the establishment of origin to the Union without 
passing through any other establishment].
(1)or[II.2.6. have undergone one single assembly operation in the zone of origin fulfilling the 
following requirements:
(a)the assembly operation took place in an establishment:
(i)approved for conducting assembly operations of ungulates by the competent authority in 
the third country or territory in accordance with Article 5 of Commission Delegated 
Regulation (EU) 2019/2035; 
(ii)which has an unique approval number assigned by the competent authority of the third 
country or territory;
L 113 /470  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -Y
(iii)listed for that purpose by the competent authority of the third country or territory of 
dispatch, including the information set out in Article 21 of Dele gated Regulation (EU) 
2019/2035;
(iv) fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 
2020/692.
(b)the assembly operation in the assembly centre took no longer than 6 days.]
II.2.7. have not been unloaded in any place that does not comply with the requirements laid down in point II.2.12. 
since they were dispatched from their establishment of origin until their dispatch to the Union and during 
that period have not been in contact with animals of a lower health status.
II.2.8. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of transport which 
was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.2.9. been subjected to a clinical inspection within t he 24 hour period prior to loading for dispatch to the Union, 
carried out by an official veterinarian in the third country or territory of origin, who did not detect signs indicative of the occurrence of diseases, including the relevant listed diseases ref erred to in Annex I to 
Delegated Regulation (EU) 2020/692 and emerging diseases.
II.2.10. have not been vaccinated against:
(i)foot and mouth disease, infection with Rift Valley fever virus, infection with 
peste des petits 
ruminants virus , sheep pox and goat pox, contagious caprine pleuropneumonia, Mycobacterium 
tuberculosis complex (M.bovis , M.caprae and M.tuberculosis ) and infection with Brucella abortus, B. 
melitensis and B. suis , and 
(ii)infection with bluetongue virus (serotypes 1 -24) with a live vaccine during the 60 days prior to their 
dispatch to the Union.
II.2.11. come from a zone :
II.2.11.1. in which:
(i)foot and mouth disease has not been reported for:
either [at least 24 months prior to the date of dispatch to the Union](1)
or [since __/__/____ (dd/mm/yyyy)](1)(4)
(ii)vaccination against foot and mouth disease has not been carried out for at least 12 months prior to 
the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth 
disease have been introduced durin g that period.
II.2.11.2. in which infection with rinderpest virus , infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that 
period:
(i)vaccination against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introduced.
either [II.2.11.3. is free from infection with bluetongue virus (serotypes 1- 24)]
(1)(5)
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /471
COUNTRY Certificate model OV/CAP -Y
or [II.2.11.3. is seasonally free from infection with bluetongue virus (serotypes 1 -24):
either [II.2.11.3.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6)
or [II.2.11.3.1. for at least 28 days prior to the date of dispatch of the animals to the Union 
and the animals have been subjected to a serological test in accordance with Article 
9(b) of Delegated Regulation (EU) 2020/692, with negative results, c arried out on 
samples collected at least 28 days following the date of entry of the animal into the 
seasonally free zone.](1)(6)
or [II.2.11.3.1. for at least 14 days prior to the date of dispatch of the animals to the Union 
and have been subjected to a PC R test, with negative results, carried out on samples 
collected at least 14 days following the date of entry of the animal in the seasonally 
free zone.](1)(6)
or [II.2.11.3. is not free from infection with bluetongue virus (serotypes 1 -24) and the animals have been 
vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that 
zone and are still within the immunity period of time guaranteed in the specifications of the vaccine and 
either [II.2.11.3.1. have been vaccinated more than 60 days prior to the date of dispatch of the 
animals to the Union.]](1)
or [II.2.11.3.1. have been vaccinated with an inactivated vaccine and were subjected to a PCR test, with 
negative results on samples collected at least 14 days after the onset of the immunity protection set 
in the specifications of the vaccine.]](1)
or [II.2.11.3. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals have been 
subjected with positive results to a serological test able to detect specific antibodies against all serotypes (1 to 
24) of bluetongue virus reported during the past 2 years in that zone and:
either [II.2.11.3.1. the serological test has been carried out on samples collected at least 60 days 
prior to the date of dispatch of the animals to the Union.]] (1)
or [II.2.11.3.1. the serological test has been carried out on samples collected at least 30 days 
prior to the date of dispatch of the animals to the Union and the animals were subjected to a 
PCR test, with negative results, carried out on samples collected not earlier than 14 days 
prior to the date of dispatch of the animals to the Union.]](1)
II.2.12. come from an establishment :
II.2.12.1. which is registered by and under the control of the competent authority o f the third country or 
territory of origin and has a system in place to maintain for at least 3 years up -to-date records 
containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of anim als into and out of the establishment;
(iii)mortality in the establishment.
II.2.12.2. which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative of the occurrence diseases, including of the relevant 
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging 
diseases, at a frequency that is proportional to the risk posed by the establishment.
L 113 /472  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -Y
II.2.12.3. which was not subject to national restriction measures for animal health reasons, including the 
relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and 
emerging diseases, at the time of dispatch to the Union.
II.2.12.4. in and around which, in an area with a 10 km radius, including where appropriate the territory 
of a neighbouring country, none of the following listed diseases has been reported for at least 30 
days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection 
with rinderp est virus, infection with Rift valley fever virus, infection with peste des petits 
ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia.
either [II.2.12.5. in and around which, in an area with a 150 km radius, including where appr opriate the territory 
of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 2 
years prior to the date of dispatch of the animals to the Union](1)
or [II.2.12.5. which is located in a zone seasonally free of epizootic haemorrhagic disease.](1)(7)
either [II.2.12.6. in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and
M. tuberculosis ) has not been reported during 42 days prior to the date of dispatch of the animals 
to the Union] (1)(8)
or[II.2.12.6. subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, 
M. caprae and M. tuberculosis ) in accordance with the procedures in points (1) and (2) of part 1 of 
Annex II to Commission Delegated Regu lation (EU) 2020/688 during at least 12 months prior to 
the date of dispatch to the Union and during this period:
(iii)only caprine animals from establishments applying the measures provided in the paragraph 
above have been introduced in the establishment; 
(iv)in case infection with Mycobacterium tuberculosis complex (M. bovis , M. caprae and M. 
tuberculosis ) has been reported in caprine animals kept on the establishment, measures were 
taken in accordance with point (3) of part 1 of Annex II to Delegated Regulation (EU) 
2020/688]. (1)(9)
II.2.12.7. free from infection with Brucella abortus, B. melitensis and B. suis as regards ovine and caprine 
animals(10).
II.2.12.8. in which rabies has not been reported for at least 30 days prior to dispatch of the animals to the 
Union.
II.2.12.9. in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the 
animals to the Union.
either [II.2.12.10. in which surra ( Trypanosoma evansi ) has not been reported for at least 2 years prior to 
the date of dispatch of the animals to the Union.](1)
or [II.2.12.10. in which surra (Trypanosoma evansi ) has not been reported for at least 30 days prior to 
the date of dispatch of the animals to the Union and when the disease was reported in the 
establishment of origin during the 2 years prior to the date of dispatch of the animals to the Union, 
the establishment remained under restriction until the infected animals were removed from the 
establishment and the remaining animals on the establishment were subjected w ith negative result 
to a test for surra ( Trypanosoma evansi) as described in Article 9(b)(i) of Regulation (EU) 
2020/692 carried out on samples taken at least 6 months after the infected animals were removed 
from the establishment.](1)
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /473
COUNTRY Certificate model OV/CAP -Y
[II.2.12.11. in which Burholderia mallei (glanders) has not been reported for at least 6 months prior to the 
date of dispatch of the animals to the Union.](9)
[II.2.13. include uncastrated males of ovine animals, which have remained for a continuous period of 
at least 60 d ays prior to their dispatch to the Union in an establishment where infection with 
Brucella ovis (contagious epididymitis) has not been reported during the period of 12 months 
prior to the date of their dispatch to the Union and have been subjected to a serological test 
for the detection of Brucella ovis , with negative results, during the 30 days pri or to the date of 
their dispatch to the Union.](1)
II.2.14. have been kept continuously since birth in a country where the following conditions as 
regards classical scrapie are fulfilled:
(a) classical scrapie is compulsorily notifiable;
(b) an awareness, surveillance and monitoring system is in place;
(c) ovine and caprine animals affected with classical scrapie are killed and completely 
destroyed;
(d) the feeding to ovine and caprine animals of meat -and-bone meal or greaves of ruminant 
origin, as defined in the T errestrial Animal Health Code of the World Organisation for 
Animal Health, has been banned and effectively enforced in the whole country for a 
period of at least the last seven years.
Notes:
This certificate is intended for entry of ovine animals that wil l be slaughtered in the Union.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol o n Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to t he notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21(1) of Delegated Regulatio n (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404.
(3)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.
(4)For zones with opening date in accordance with column 8 in part 1 of Annex I Ito Implementing Regulation 
(EU) 2021/404 .
(5)For zones with entry BTV in column 7 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404 .
L 113 /474  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -Y
(6)For zones with entry SF -BTV in column 7 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404 .
(7)For zones with entry SF -EHD in column 7 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404 .
(8)Only for ovine animals.
(9)Only for caprine animals.
(10)In accordance with Article 10 of Delegated Regulation (EU) 2020/692.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /475
CHAPTER 6
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF PORCINE ANI MALS AND ANIMALS OF THE FAMILY 
TAYASSUIDAE (MODEL ‘ SUI-X’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Travelling circus/animal acts
□Quarantine establishment □Exhibition
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /476  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /477
COUNTRY Certificate model SUI -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:
II.1.1. have not received:
− any stilbene or thyrostatic substances, 
− oestrogenic, androgenic, gestagenic o r beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
II.1.2. fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are listed in Decision 2011/163/EU for the concerned country of origin.
(1)(2)(10)[II.1.3. are domestic porcine animals either coming from a holding officially recognised as 
applying controlled housing conditions in accordance with Article 8 of Commission 
Implementing Regulation (EU) 2015/1375 or are not weaned and less than 5 weeks of 
age.]
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.2.1. come from the zone with code: __ __ - __(2)which, at the date of issue of this certificate is 
authorised for entry into the Union of animals of the families Suidae and Tayassuidae and listed in 
Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404.
II.2.2. have remained continuously:
(i)in the zone referred to in point II.2.1. since birth or for a period of ti me of at least 6 
months immediately prior to the date of their dispatch to the Union, and
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to 
the date of their dispatch to the Union, into which during this period no animals of the 
families Suidae and Tayassuidae and no animals of other species listed for the same 
diseases as animals of the families Suidae and Tayassuidae have been introduced. 
II.2.3. had no contact with animals of a lower health status since bir th or at least for 30 days prior to the 
date of their dispatch to the Union.
II.2.4. are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 
and emerging diseases.
L 113 /478  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SUI -X
(1)either [II.2.5. have been dispatched directly from the establishment of origin to the Union 
without passing through any other establishment].
(1)(3)or [II.2.5. have undergone one single assembly operation in the zone of origin fulfilling 
the following requirements:
(a)the assembly operation took place in an establishment:
(i)approved for conducting assembly operations of ungulates by the competent 
authority in the third country or territory in accordance with Ar ticle 5 of 
Commission Delegated Regulation (EU) 2019/2035; 
(ii)which has an unique approval number assigned by the competent authority of the 
third country or territory;
(iii)listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation 
(EU) 2019/2035;
(iv) fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 
2020/692.
(b)the assembly operation in the assembly centre took no longer than 6 days.]
II.2.6. have not been unloaded in any place that does not comply with the requirements laid down in point II.2.11. since they were dispatched from their establishment of origin until their dispatch to 
the Union and during that period they have not been in contact with animals of a lower health 
status.
II.2.7. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)
(4)in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.2.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch 
to the Union, carried out by an official veterinarian in the third country or territory of origin, who 
did not detect signs indicative of the oc currence of diseases, including the relevant listed diseases 
referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.2.9. have not been vaccinated against foot and mouth disease and classical swine fever.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /479
COUNTRY Certificate model SUI -X
II.2.10. come from a zone in which:
II.2.10.1. foot and mouth disease has not been reported for:
either [at least 24 months prior to the date of dispatch of the animals to the Union.](1)
or [since …………… (dd/mm/yyyy).](1)(5)
and in which vaccination against foot and mouth disease has not been carried out for at 
least 12 months prior to the date of dispatch of the animals to the Union and no animals 
vaccinated against the disease have been introduced during that period.
II.2.10.2. infection with rinderpest virus has not been reported for at least 12 months prior to the 
date of dispatch of the animals to the Union and in which vaccination against this 
disease has not been carried out for at least the 12 month period and no animals 
vaccinated against the disea se have been introduced during that period.
II.2.10.3. classical swine fever has not been reported: 
either [for at least 24 months prior to the date of dispatch of the animals to the 
Union.](1)
or [since …………… (dd/mm/yyyy) and the animals of the consignment have 
been subjected to a test for the detection of classical swine fever, with a 
negative result, carried out within a period of 30 days prior to the date of 
dispatch of the animals to the Union;](1)(6)
and in which vaccination against classical swine fever has not been carried out for at least 
12 months prior to the date of dispatch of the animals to the Union and no animals 
vaccinated against the disease have been introduced during that period.
[II.2.10.4. African swine fever has not been rep orted for the 12 month period prior to the date of 
dispatch of the animals to the Union](1)(7).
II.2.11. come from an establishment :
II.2.11.1. which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animals into and out of the establishment;
(iii)mortality in the establishment.
L 113 /480  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SUI -X
II.2.11.2. which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, 
including the relevant listed diseases r eferred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at a frequency that is proportional to the risk 
posed by the establishment.
II.2.11.3. which was not subject to national restriction measures for animal health reasons, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at the time of dispatch to the Union.
II.2.11.4. in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch of the animals to the Union: foot and 
mouth disease, infection with rinderpest virus, classical swine fever and African swin e
fever.
II.2.11.5. [in which infection with Brucella abortus , B. melitensis and B. suis has not been 
reported during the last 42 days prior to dispatch to the Union and in which during the 
last 12 month period prior to dispatch to the Union 
either[biosecurity and risk mitigating measures, including housing conditions and 
feeding systems, have been applied as necessary to prevent transmission of infection 
with Brucella abortus , B. melitensis and B. suis from wild animals of listed species to 
porcin e animals kept on the establishment and only porcine animals from 
establishments applying equivalent biosecurity measures have been introduced;]](1)
or[surveillance for infection with Brucella abortus , B. melitensis and B. suis has been 
carried out on the porcine animals kept on the establishment in accordance with Annex 
III to Commission Delegated Regulation (EU) 20 20/688, and during this period:
-only porcine animals from establishments applying the biosecurity 
measures or the surveillance measures provid ed for above have been 
introduced in the establishment, and
-in case infection with Brucella abortus , B. melitensis and B. suis has 
been reported in porcine animals kept on the establishment, measures 
were taken in accordance with Part 1(3) of Annex II to Delegated 
Regulation (EU) 2020 /688]].(1)
II.2.11.6. in which infection with Aujeszky’s disease virus has not been reported for at least the 
30 days prior to dispatch of the animals to the Union;
[II.2.11.7. in which rabies has not been reported for at least the 30 days prior to dispatch of the 
animals to the Union](1)(7);
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /481
COUNTRY Certificate model SUI -X
II.2.11.8. in which anthrax has not been reported for at least the 15 days prior to dispatch of the 
animals to the Union.
II.2.12. Additional guarantees as regards category C diseases(1)(8)
[II.2.12.1. the animals
either [II.12.1.1 originate from a third country or territory or zone thereof free from 
infection with Aujeszky’s disease virus](1)(9); 
or[II.12.1.1. have undergone a serological test for the detection of antibodies 
against whole Aujeszky’s disease virus or antibodies against ADV -gE 
protein, if necessary, using one of the diagnostic methods provided for 
in Part 7 of Annex Ito Delegated Regulation (EU) 2020/688, with a 
negative result on a sample taken during the period of 15 days prior to 
the date of their dispatch to the Union.]](1)(7)
Notes:
This certificate is intended for entry into the Union of porcine animals and animals of the family Tayassuidae, 
including when the Union is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21(1) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(3)Only possible for porcine animals.
(4)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.
(5)Only for countries with the opening date in column 8 in Part 1 of Annex II to Implementing Regulation (EU) 
2021/404.
(6)For countries with entry CSF in column 6 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404
(7)Only applicable to ungulates of the family Suidae .
(8)When required by the Member State of destination.
(9)For countries with entry ADV in column 7 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404
recognised free from infection with Aujeszky’s disease virus or with an approved eradication programme and 
fulfilling the requirements in Regulation (EU) 2020/688.
(10)Only for third countries listed in Article 13 (2)of Implementing Regulation (EU) 2015/1375.
L 113 /482  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SUI -X
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /483
CHAPTER 7
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF PORCINE ANI MALS INTENDED FOR SL AUGHTER (MODEL ‘SUI -Y’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Slaughter
I.21 I.22□For internal market
I.23
L 113 /484  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /485
COUNTRY Certificate model SUI -YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:
II.1.1. have not received:
-any stilbene or thyrostatic substances, 
-oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
II.1.2. fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are listed in Decision 2011/163/EU for the concerned country of origin.
(1)(2)(10)[II.1.3. are domestic porcine animals either coming from a holding officially recognised as 
applying controlled housing conditions in accordance with Article 8 of Commission Implementing Regulation (EU) 2015/1375 or are not weaned and less than 5 weeks of 
age.]
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.2.1. come from the zone with code: __ __ -__
(2)which, at the date of issue of this certificate is 
authorised for the entry i nto the Union of porcine animals intended for slaughter and listed in Part 1 of 
Annex II to Commission Implementing Regulation (EU) 2021/404.
II.2.2. are intended for slaughter in the Union.
II.2.3. have remained continuously:
(i)in the zone referred to in po int II.2.1. since birth or for a period of time of at least 3 months prior to 
the date of their dispatch to the Union, and
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to the date 
of their dispatch to the Uni on, into which during this period no porcine animals and no animals of 
other species listed for the same diseases as porcine animals  have been introduced. 
II.2.4. had no contact with animals of a lower health status since birth or at least for 30 days pr ior to the 
date of their dispatch to the Union.
II.2.5. are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 and 
emer ging diseases.
(1)either [II.2.6. have been dispatched directly from the establishment of origin to the Union without 
passing through any other establishment].
L 113 /486  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SUI -Y
(1)(3)or[II.2.6. have undergone one single assembly operation in the zone of origin fulfilling the 
following requirements:
(a)the assembly operation took place in an establishment: 
(i)approved for conducting assembly operations of ungulates by the competent 
authority in the third country or territory in accordance with Article 5 of 
Commission Delegated Regulation (EU) 2019/2035;
(ii)which has an unique approval number assigned by the competent authority of the 
third country or territory;
(iii)listed for that purpose by the competent authority of the third country or territory 
of dispatch, including the information set out in Article 21 of Delegated 
Regulation (EU) 2019/2035;
(iv) fulfilling the requirements provided for in Article 8 of Delegated Regulation 
(EU) 2020/692.
(b)the assembly operation in the assembly centre took no longer than 6 days.]
II.2.7. have not been unloaded in any place that does not comply with the requirements laid down in point 
II.2.12. since they were dispatched from their establishment of origin until their dispatch to the 
Union and during that period they have not been in contact with animals of a lower health status. 
II.2.8. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(4)in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that: 
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.2.9. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch 
to the Union, carried out by an official veterinarian in the third country or territory of origin, who 
did not detect signs indicative of the occurrence o f diseases, including the relevant listed diseases 
referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.2.10. have not been vaccinated against foot and mouth disease and classical swine fever.
II.2.11. come from a zone in which:
II.2.11.1. foot and mouth disease has not been reported for: 
either [at least 24 months prior to the date of dispatch of the animals to the Union.](1)
or [since …………… (dd/mm/yyyy).](1)(5)
and in which vaccination against foot and mouth disease has not been carried out for at least 
12 months prior to the date of dispatch of the animals to the Union and no animals 
vaccinated against the disease have been introduced during that period.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /487
COUNTRY Certificate model SUI -Y
II.2.11.2. infection with rinderpest virus has not been repor ted for at least 12 months prior to the 
date of dispatch of the animals to the Union and in which vaccination against this disease 
has not been carried out for at least the last the 12 month period prior to the date of 
dispatch of the animals to the Union and no animals vaccinated against the disease have 
been introduced during that period.
II.2.11.3. classical swine fever has not been reported: 
either [for at least 24 months prior to the date of dispatch of the animals to the Union.](1)
or[since …………… (d d/mm/yyyy) and the animals of the consignment have been 
subjected to a test for the detection of classical swine fever, with a negative result, carried 
out within a period of 30 days prior to the date of dispatch of the animals to the Union;](1)(6)
and in which vaccination against classical swine fever has not been carried out for at least 
12 months prior to the date of dispatch of the animals to the Union and no animals 
vaccinated against the disease have been introduced during that period.
[II.2.11.4. African swine fever has not been reported for the 12 month period prior to the date of 
dispatch of the animals to the Union](1)(7).
II.2.12. come from an establishment :
II.2.12.1. which is registered by and under the control of the competent authority of the third country or territory of origin and has a system in place to maintain for at least 3 years up-
to-date records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animal s into and out of the establishment;
(iii)mortality in the establishment.
II.2.12.2. which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, including 
the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 
2020/692 and emerging diseases, at a frequency that is proportional to the risk posed by 
the establishment.
II.2.12.3. which was not subject to national restriction measur es for animal health reasons, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at the time of dispatch to the Union.
II.2.12.4. in and around which, in an area with a 10 km radius, i ncluding where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, classic al swine fever and African swine fever.
II.2.12.5. [in which infection with Brucella abortus , B. melitensis and B. suis has not been reported 
during the last 42 days prior to dispatch to the Union and in which during the 12 month period prior to dispatch t o the Union 
L 113 /488  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SUI -Y
either [biosecurity and risk mitigating measures, including housing conditions and 
feeding systems, have been applied as necessary to prevent transmission of 
infection with Brucella abortus , B. melitensis and B. suis from wild animals of 
listed species to porcine animals kept on the establishment and only porcine 
animals from establishments applying equivalent biosecurity measures have been 
introduced;]](1)
or [surveillance for infection with Brucella abortus , B. melitensis and B. suis has
been carried out on the porcine animals kept on the establishment in accordance 
with Annex III to Commission Delgated Regulation (EU) 2020 /688, and during 
this period:
-only porcine animals from establishments applying the biosecurity measures 
or the surv eillance measures provided for above have been introduced in the 
establishment, and
-in case infection with Brucella abortus , B. melitensis and B. suis has been 
reported in porcine animals kept on the establishment, measures were taken in accordance with Pa rt 1(3) of Annex II to Delegated Regulation (EU) 
2020 /688].
(1)
II.2.12.6. in which infection with Aujeszky’s disease virus has not been reported for at least the 30 days prior to dispatch of the animals to the Union;
[II.2.12.7. in which rabies has not been reported for at least the 30 days prior to dispatch of the 
animals to the Union]
(1)(7);
II.2.12.8. in which anthrax has not been reported for at least the 15 days prior to dispatch of the animals to the Union.
[either [II.2.13. originate from a third
country or territory or zone thereof free from infection with 
Aujeszky’s disease virus](1)(9); 
or[II.2.13. have undergone a serological test for the detection of antibodies against whole Aujeszky’s disease virus or antibodies against ADV -gE protein, if 
necessary, using one of the 
diagnostic methods provided for in Part 7 of Annex I to Delegated Regulation (EU) 
2020/688, with a negative result on a sample taken during the period of 15 days prior to the date of their dispatch to the Union.]
(1)(7)](1)(8)
Notes:
This certificate is intended for porcine animals and animals of the family Tayassuidae that will be slaughtered in 
the Union.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the Euro pean Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in r espect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /489
COUNTRY Certificate model SUI -Y
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of t he animals in accordance 
with Article 21(1) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex II to Commission Implementing Regulation 
(EU) 2021/404.
(3)Only possible for porcine animals.
(4)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals from this zone.
(5)Only for countries with the opening date in column 8 in Part 1 of Annex II to Implementing Regulation (EU) 
2021/404.
(6)For countries with entry CSF in column 6 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(7)Only applicable to ungulates of the family Suidae.
(8)Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement 
between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 
30.4.2002), either have disease -free stat us for the relevant category C disease or an approved eradication 
programme.
(9)For countries with entry ADV in column 7 of Part 1 of Annex II to Regulation (EU) 2021/404 recognised free 
from infection with Aujeszky’s disease virus or with an approved eradica tion programme and fulfilling the 
requirements in Delegated Regulation (EU) 2020/688.
(10)Only for third countries listed in Article 13 (2)of Implementing Regulation (EU) 2015/1375.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /490  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 8
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF ANIMALS OF THE FAMILIES ANTILOCAPRIDAE, BOVIDAE 
(OTHER THAN BOVINE, OVINE AND CAPRINE AN IMALS), GIRAFFIDAE, 
MOSCHIDAE AND TRAGULIDAE (MODEL ‘RUM’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Travelling circus/animal acts
□Quarantine establishment □Exhibition
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /491
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
L 113 /492  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model RUMPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1 Public health attestation [*to delete when the Union is not the final destination of the animals]
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:
II.1.1. have not received:
− any stilbene or thyrostatic substances, 
− oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
II.1.2. fulfil the guarantees covering live an imals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are listed in Commission Decision 2011/163/EU for the concerned country of origin.
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.2.1. come from the zone with code: __ __ - __(2)which, at the date of issue of this certificate is 
authorised for the entry into the Union of ungulates of the families Antilocapridae, Bovidae, 
Giraffidae, Moschidae, Tragulidae and listed in Part 1 of Annex II to Commission Implementing 
Regulation (EU) 2021/404 .
II.2.2. have remained continuously:
(i)in the zone referred to in point II.2.1. since birth or for a period of time of at least 6 months 
prior to the date of dispatch to the Union, and
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to the 
date of dispatch to the Union, into which during this per iod no ungulates of the families of 
Antilocapridae, Bovidae, Giraffidae, Moschidae, Tragulidae and no animals of other species listed for the same diseases as ungulates of the families Antilocapridae, Bovidae, Giraffidae, 
Moschidae, Tragulidae have been in troduced. 
II.2.3. had no contact with animals of a lower health status since birth or at least for 6 months prior to the 
date of dispatch to the Union.
II.2.4. are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 and 
emerging diseases.
II.2.5. have been dispatched directly from the establishment of origin to the Union without passing through 
any other establishment.
II.2.6. have not been unloaded in any place that does not comply with the requirements laid down in point 
II.2.11 since they were dispatched from their establishment of origin until their dispatch to the Union 
and during that period they have not been in cont act with animals of a lower health status.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /493
COUNTRY Certificate model RUM
II.2.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent 
authority in the third country or territory and constructed in such a way that: 
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.2.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch to 
the Union, carried out by an official veterinarian in the third country or territory of origin, who did 
not detect signs indicative of the occurrence of diseases, including the relevant listed diseases 
referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.2.9. have not been vaccinated against:
(i)foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, 
infection with Mycoplasma mycoides subsp . mycoides SC (contagious bovine pleuropneumonia), 
contagious caprine pleuropneumonia, Mycobacterium tuberculosis complex (M.bovis, M.caprae 
andM.tuberculosis) , infection with Brucella abortus, B. melitensis andB. suis, and
(ii)infection with bluetongue virus (serotype s 1-24) with a live vaccine during the 60 days prior to 
their dispatch to the Union.
II.2.10. come from a zone :
II.2.10.1. in which:
(i)foot and mouth disease has not been reported for: 
either [at least 24 months prior to the date of dispatch to the Union](1)
or [since __/__/____ (dd/mm/yyyy)](1)(4)
(ii)vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch to the Union, and no animals vaccinated against 
foot and mouth disease have been introduced during that period.
II.2.10.2. infection with rinderpest virus, [infection with Rift Valley fever virus](1)(5), [infection 
with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia)](1)(6)
[and contagious caprine pleuropneum onia](1)(7) has not been reported for the 12 month period 
prior to dispatch to the Union and during that period:
(i)vaccination against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introduced.
either [II.2.10.3. which is free from infection with bluetongue virus (serotypes 1 -24)](1)(8)
or [II.2.10.3. which is seasonally free from infection with bluetongue virus (serotypes 1 -24): 
either [II.2.10.3.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(9)
L 113 /494  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model RUM
or [II.2.10.3.1. for at least 28 days prior to the date of dispatch of the animals to the 
Union and the animals have been subjected to a serological test in accordance with 
Article 9(b) of Delegated Regulation (EU) 2020/692, with negative results, carried out
on samples collected at least 28 days following the date of entry of the animal into the 
seasonally free zone.] (1)(9)
or [II.10.3.1. for at least 14 days prior to the date of dispatch of the animals to the Union 
and have been subjected to a PCR test, wit h negative results, carried out on samples 
collected at least 14 days following the date of entry of the animal in the seasonally free zone.]
(1)(9)
or[II.2.10.3. is not free from infection with bluetongue virus (serotypes 1 -24) and the animals have been
vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone and are still within the immunity period of time guaranteed in the specifications of 
the vaccine and 
either [II.2.10.3.1.have been vaccinated more than 60 days prior to the date of dispatch of the 
animals to the Union.]]
(1)
or [II.2.10.3.1. have been vaccinated with an inactivated vaccine and were subjected to a PCR 
test, with negative results on samples collected at least 14 days aft er the onset of the immunity 
protection set in the specifications of the vaccine.]](1)
or [II.2.10.3. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals have been 
subjected with positive results to a serological test able to detect specific antibodies against all 
serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone and:
either [II.2.10.3.1. the serological test has been carried out on samples collected at least 60 days 
prior to the date of dis patch of the animals to the Union.]](1)
or [II.2.10.3.1. the serological test has been carried out on samples collected at least 30 days 
prior to the date of dispatch of the animals to the Union and the animals were subjected to a 
PCR test, with negative results, carried out on samples collected not earlier than 14 days 
prior to the date of dispatch to the Union. ]](1)
II.2.11. come from an establishment :
II.2.11.1. which is registered by and under the control of the competent authority of the third country 
or territory of origin and has a system in place to maintain for at least 3 years up- to-date 
records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animals into and out of the establishment;
(iii)mortality in the establishment.
II.2.11.2 which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of occurrence of diseases, including the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and 
emerging diseases, at a frequency that is proportional to the risk posed by the 
establishment.
II.2.11.3. which was not subject to national restriction measures for animal he alth reasons, including 
the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
and emerging diseases, at the time of dispatch to the Union.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /495
COUNTRY Certificate model RUM
II.2.11.4. in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been reported 
for at least 30 days prior to dispatch to the Union: 
−foot and mouth disease, 
−infection with rinderpest virus,
−[infection with Rift Valley fever virus](1)(5), 
−[infection with Mycoplasma mycoides subsp . mycoides SC (contagious bovine 
pleuropneumonia)](1)(6)
−[contagious caprine pleuropneumonia](1)(7)
either [II.2.11.5. in and around which, including where appropriate the territory of a neighbouring country, 
epizootic haemorrhagic disease has not been reported for at least 2 years before the date of dispatch to the Union in an area with a 150 km radius]
(1)
or [II.2.11.5. which is located in a zone seasonally free of epizootic haemorrhagic disease.](1)(10)
II.2.11.6. in which infection with Mycobacterium tuberculosis complex (M. bovis , M. caprae and 
M. tuberculosis ) has not been reported in kept animals of listed species during the 42 days 
prior to dispatch to the Union 
II.2.11.7. in whic h infection with Brucella abortus, B. melitensis and B. suis has not been reported 
in kept animals of listed species during the 42 days prior to dispatch to the Union.
[II.2.11.8. in which rabies has not been reported for at least the 30 days prior to dispatch to the 
Union].(1)(11)
II.2.11.9. in which anthrax has not been reported for at least the 15 days prior to dispatch to the 
Union.
II.2.11.10. in which surra ( Trypanosoma evansi) has not been reported for at least the 30 days prior 
to dispatch to the Union and if the disease was reported in the establishment of origin 
during the last 2 years prior to dispatch to the Union, the affected establishment 
remained under restriction until the infected animals were removed from the 
establishment and the remain ing animals on the establishment were subjected with 
negative result to a test for surra ( Trypanosoma evansi ) as described in Part 3 of Annex 
I to Commission Delegated Regulation (EU) 2020/688 carried out on samples taken at 
least 6 months after the infect ed animals were removed from the establishment.
Notes:
This certificate is intended for entry into the Union of animals of the families Antilocapridae, Bovidae (other than 
bovine, ovine and caprine animals), Giraffidae, Moschidae and Tragulidae, including when the Union is not the 
final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particula r Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate s hall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /496  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model RUM
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the animals in 
accordance with Article 21(1) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in point II.2.1., or during a period where restriction measures have been adopted by 
the Union against entries of these animals from this third country, territory or zone thereof.
(4)Only for countries with the opening date in column 8 in Part 1 of Annex I Ito Impleme nting Regulation (EU) 
2021/404.
(5)Not applicable to ungulates of the family Tragulidae .
(6)Only applicable to ungulates of the species Syncerus cafer.
(7)Only applicable to ungulates of the species Gazella spp.
(8)For countries with entry BTV in Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404
(9)For countries with entry SF -BTV in Part 1 of Annex I I to Implementing Regulation (EU) 2021/404 .
(10)For countries with entry SF -EHD in Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(11)Only applicable to ungulates of the family Bovidae.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /497
CHAPTER 9
MODEL ANIMAL HEALTH CERTIFICATE FOR ENTRY INTO THE UNION OF 
ANIMALS OF THE FAMILIES TAPIRIDAE, RHINO CEROTIDAE AND 
ELEPHANTIDAE (MODEL ‘RHINO’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Travelling circus/animal acts
□Quarantine establishment □Exhibition
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /498  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /499
COUNTRY Certificate model RHINOPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:
II.1.1. come from the zone with code: __ __ - __(2)which, at the date of issue of this certificate is 
authorised for entry into the Union of animals of the families Tapiridae, Rh inocerotidae and 
Elephantidae and listed in Part 1 of Annex II to Commission Implemen ting Regulation (EU) 
2021/404.
II.1.2. have remained continuously:
(i)in the zone referred to in point II.1.1. since birth or for a period of time of at least 6 months prior 
to the date of dispatch to the Union, and
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to the 
date of dispatch to the Union, in which no animals have been introduced during that period of 
time.
II.1.3. had no contact with animals of a lower health status since birth or at least for 6 months p rior to the 
date of dispatch to the Union.
II.1.4. are not to be killed under a national programme for the eradication of diseases, including listed 
diseases and emerging diseases.
II.1.5. have been dispatched directly from the establishment of origin to t he Union without passing 
through any other establishment.
II.1.6. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that: 
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.1.7. have been subjected with negative result to a clinical inspection, carried out by an official 
veterinarian in the third country or territory of origin or zone thereof within the 24 hour period 
prior to loading for dispatch to the Union for the purpose of detection of signs indicative of the occurrence of diseases, including the relevant listed diseases referred to in Annex 
1 to 
Commission Delegated Regulation (EU) 2020/692 and emerging diseases.
II.1.8. have not been vaccinated against [foot and mouth disease and](1)(4)infection with Rift Valley fever 
virus.
II.1.9. come from a zone :
[II.1.9.1. in which: 
(i)foot and mouth dis ease has not been reported for: 
either [at least 24 months prior to the date of dispatch to the Union](1)
or       [since __/__/____ (dd/mm/yyyy)](1)(5)
(ii)vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch to the Union, and no animals vaccinated against 
foot and mouth disease have been introduced during that period.](1)(4)
L 113 /500  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model RHINO
II.1.9.2. infection with Rift Valley fever virus has not been reported for the 12 month period prior 
to dispatch to the Union and during that period: 
(i)vaccination against the disease has not been carried out, and 
(ii)animals vaccinated against the disease have not been introduced.
II.1.10. come from an establishment : 
II.1.10.1. which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animals into and out of the establishment;
(iii)mortality in the establishment.
II.1.10.2. which receives regular animal health vi sits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at a frequency that is proportional to the risk 
posed by the establishment.
II.1.10.3. which was not subject to national restriction measures for animal health reasons, 
including listed diseases and emerging diseases, at the time of dispatch to the Union.
II.1.10.4. in and around which, including where appropriate the territory of a neighbouring 
country, none of the following listed diseases has been reported for at least 30 days 
prior to dispatch to the Union in an area with a 10 km radius: [foot and mouth disease 
and](1)(4)infection with Rift Valley fever virus.
II.1.10.5. in which anthrax has not been reported for at least the 15 days prior to dispatch to the Union.
Notes:
This certificate is intended for entry into the Union of animals of the families Tapiridae, Rhinocerotidae and 
Elephantidae, including when the Union is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and t he European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northe rn Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the animals in 
accorda nce with Article 21(1) of Delegated Regulation (EU) 2020/692.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /501
COUNTRY Certificate model RHINO
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or zone thereof referred to in point II.2.1., or during a period where restriction measures have been adopted by 
the Union against entries of these animals from this third country, territory or zone thereof. 
(4)Only applicable to ungulates of the family Elephantidae.
(5)Only for countries with the opening date in column 8 in Part 1 of Annex II to Implementing Regulation (EU) 
2021/404.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /502  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 10
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
ANIMALS OF THE FAMILY HIPPOPOTAMIDAE (MO DEL ‘HIPPO’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Travelling circus/animal acts
□Quarantine establishment □Exhibition
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /503
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
L 113 /504  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HIPPOPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:
II.1.1. come from the zone with code: __ __ - __(2)which, at the date of issue of this certificate is 
authorised for entry into the Union of animals of the family Hippopotamidae and listed in Part 1 of 
Annex II to Commission Implementing Regulation (EU) 2021/404.
II.1.2. have remained continu ously:
(i) in the zone referred to in point II.1.1. since birth or for a period of time of at least 6 months 
prior to the date of dispatch of the animals to the Union, and
(ii) in the establishment of origin since birth or for a period of time of at least 40 days prior to the 
date of dispatch of the animals to the Union, into which during this period no animals of the 
family Hippopotamidae and no animals of other species listed for the same diseases as 
animals of the family Hippopotamidae have been introduced.
II.1.3.had no contact with animals of a lower health status since birth or at least for 6 months prior to the 
date of dispatch of the animals to the Union.
II.1.4. are not to be killed under a national programme for the eradication of diseases, including therelevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 
and emerging diseases.
II.1.5.
have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment.
II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in point 
II.1.11. since they were dispatched from their establishment of origin until their dispatch to the 
Union and during that period they have not been in co ntact with animals of a lower health status.
II.1.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent autho rity in the third country or territory and constructed in such a way that: 
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.1.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch 
to the Union, carried out by an official veterinarian in the third country or territory of origin, who did not detect signs indicative of the occur rence of diseases, including the relevant listed diseases 
referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.1.9. have not been vaccinated against foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, Mycobacterium tuberculosis complex (M.bovis, M.caprae and
M.tuberculosis) and infection with Brucella abortus, B. melitensis andB. suis.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /505
COUNTRY Certificate model HIPPO
II.1.10. come from a zone :
II.1.10.1.in which:
(i)foot and mouth disease has not been reported for: 
either [at least 24 months prior to the date of dispatch of the animals to the 
Union](1)
or      [since __/__/____ (dd/mm/yyyy)](1)(4)
(ii)vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch of the animals to the Union, and no animals 
vaccinated against foot and mouth disease have been introduced during that 
period.
II.1.10.2. infection with rinderpest virus and infection with Rift Valley f ever virus has not been 
reported for the 12 month period prior to dispatch of the animals to the Union and 
during that period: 
(i)vaccination against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introd uced.
II.1.11. come from an establishment : 
II.1.11.1. which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animals into and out of the establishment;
(iii)mortality in the establishment.
II.1.11.2. which receives regular animal health vi sits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at a frequency that is proportional to the risk 
posed by the establishment.
II.1.11.3. which was not subject to national restriction measures for animal health reasons, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at the time of dispatch of the animals to the 
Union.
II.1.11.4. in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch of the animals to the Union: foot and 
mouth disease, infection with rinderpest virus and infection with Rift Valley fever 
virus.
II.1.11.5. in which infection with Mycobacterium tuberculosis complex (M. bovis , M. caprae and 
M. tuberculosis ) has not been reported in kept animals of listed species during the 42 
days prior to dispatch of the animals to the Union.
II.1.11.6. in which infection with Brucella abortus, B. melitensis and B. suis has not been
reported in kept animals of listed species during the 42 days prior to dispatch of the 
animals to the Union.
II.1.11.7. in which anthrax has not been reported for at least the 15 days prior to dispatch of the 
animals to the Union.
either[II.1.11.8. in wh ich surra (Trypanosoma evansi) has not been reported for at least 2 years prior 
to the date of dispatch of the animals to the Union.](1)
L 113 /506  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HIPPO
or[II.1.11.8. in which surra ( Trypanosoma evansi) has not been reported for at least 30 days prior 
to the date of dispatch of the animals to the Union and when the disease was 
reported in the establishment of origin during the 2 years prior to the date of dispatch 
of the animals to the Union, the establishment remained under restriction until the infected animals were removed from the establishment and the remaining animals on 
the establishment were subjected with negative result to a test for surra 
(Trypanosoma evansi ) as described in Article 9(b)(i) of Regulation (EU) 2020/692 
carried out on samples taken at least 6 months after the infected animals were 
removed from the establishment.](1)
Notes:
This certificate is intended for entry into the Union of animals of the family Hippopotamidae, including when the 
Union is not the final destination of those animals.
In ac cordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conj unction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the animals in 
accordance with Ar ticle 21(1) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of these animals shall not be permitted wh en the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in point II.2.1., or during a period where restriction measures have been adopted by 
the Union against entries of these animals from this third country, territory or zone thereof.
(4)Only for countries with the opening date in column 8 in Part 1 of Annex I Ito Implementing Regulation (EU) 
2021/404.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /507
CHAPTER 11
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF CAMELID AND CERVID ANIMALS (MODEL ‘CAM -CER’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Travelling circus/animal acts
□Quarantine establishment □Exhibition
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /508  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /509
COUNTRY Certificate model CAM- CERPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:
II.1.1. have not received:
-any stilbene or thyrostatic substances, 
-oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
II.1.2. fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are listed in Commision Decision 2011/163/EU for the concerned country of origin.
II.2. Animal healt h attestation
I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:
II.2.1. come from the zone with code: __ __ - __(2)which, at the date of issuing this certificate is 
authorised for entry into the Union of camel id and cervid animals and listed in Part 1 of Annex II 
to Commission Implementing Regulation (EU) 2021/404 . 
II.2 .2. have remained continuously: 
(i)in the zone referred to in point II.2.1. since birth or for a period of time of at least 6 months 
prior to the date of their dispatch to the Union, and
(ii)in the establishment of origin since birth or for a period of time of at least 40 days prior to the date of their dispatch to the Union, in which no animals have been introduced during that 
period of time. 
II.2.3. had no contact with animals of a lower health status since birth or at least for 6 months prior to the 
date of their dispatch to the Union.
II.2.4.
are not to be killed under a national programme for the eradication of diseases, including the 
relev ant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 
and emerging diseases.
II.2.5. have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment.
II.2.6. have not been unloaded in any place that does not comply with the requirements laid down in point 
II.11 since they were dispatched from their establishment of origin until their dispatch to the Union 
and during that period they have not been in contact wit h animals of a lower health status.
II.2.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in t he third country or territory and constructed in such a way that:
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
L 113 /510  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CAM- CER
II.2.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch 
to the Union, carried out by an official veterinarian in the third country or territory of origin, who 
did not detect signs indicative of the occurrence of diseases, including the relevant listed diseases 
referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.2.9. have not been vaccinated against: 
(i)foot and mouth disease, infection with rinderpest virus, infection with Rift Va lley fever 
virus, infection with peste des petits ruminants virus, Mycobacterium tuberculosis 
complex (M.bovis, M.caprae andM.tuberculosis) , infection with Brucella abortus, B. 
melitensis andB. suis, and
(ii)infection with bluetongue virus (serotypes 1 -24) w ith a live vaccine during the 60 days 
prior to their dispatch to the Union.
II.2.10. come from a zone :
II.2.10.1. in which: 
(i)foot and mouth disease has not been reported for: 
either [at least 24 months prior to the date of dispatch to the Union](1)
or [since __/__/____ (dd/mm/yyyy)](1)(4)
(ii)vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch to the Union, and no animals vaccinated 
against foot and mouth disease have been introduced dur ing that period.
II.2.10.2. infection with rinderpest virus, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus has not been reported for the 12 month period prior to 
dispatch to the Union and during that period: 
(i)vacci nation against these diseases has not been carried out, and 
(ii)animals vaccinated against these diseases have not been introduced.
either [II.2.10.3. which is free from infection with bluetongue virus (serotypes 1 -24)](1)(5)
or [II.2.10.3. which is seasonally free from infection with bluetongue virus (serotypes 1- 24):
either [II.2.10.3.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6)
or[II.2.10.3.1. for at least 28 days prior to the date of dispatch of the animals to the 
Union and the animals have been subjected to a serological test in 
accordance with Article 9(b) of Delegated Regulation (EU) 2020/692, 
with negative results, carried out on samples collected at least 28 days 
following the date of entry of the animal into the seasonally free 
zone.] (1)(6)
or[II.2.10.3.1. for at least 14 days prior to the date of dispatch of the animals to the 
Union and have been subjected to a PCR test, with negative r esults, 
carried out on samples collected at least 14 days following the date of 
entry of the animal in the seasonally free zone.](1)(6)
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /511
COUNTRY Certificate model CAM- CER
or [II.2.10.3.is not free from infection with bluetongue virus (serotypes 1 -24) and the animals have 
been vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 
years in that zone and are still within the immunity period of time guaranteed in the 
specifications of the vaccine and 
either [II.2.10.3.1. have been vaccinated more than 60 days prior to the date of dispatch 
to the Union.]](1)
or [II.2.10.3.1. have been vaccinated with an inactivated vaccine and were subjected 
to a PCR test, with negative results on samples collected at least 14 days after the onset of 
the immunity protection set in the specifications of the vaccine.]](1)
or [II.2.10.3. is not free from infection with bluetongue virus (serotypes 1- 24) and the animals have 
been subjected with positive results to a serological test able to detect specific antibodies against all 
serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone and:
either [II.2.10.3.1. the serological test has been carried out on samples collected at least 
60 days prior to the date of dispatch of the animals to the Union.]](1)
or [II.2.10.3.1. the serological test has been carried out on samples collected at least 
30 days prior to the date of dispatch of the animals to the Union and the animals were 
subjected to a PCR test, with negative results, carried out on sampl es collected not earlier 
than 14 days prior to the date of dispatch of the animals to the Union.]](1)
II.2.11. come from an establishment : 
II.2.11.1. which is registered by and under the control of the competent authority of the third country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:
(i)the species, categories, number and identification of animals on the establishment;
(ii)movements of animals into and out of the establis hment;
(iii)mortality in the establishment.
II.2.11.2. which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, 
including the relevant listed disease s referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at a frequency that is proportional to the risk posed by the establishment.
II.2.11.3.
which was not subject to national restriction measures for animal health reasons, 
including listed diseases and emerging diseases, at the time of dispatch to the Union.
II.2.11.4. in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch to the Union: foot and mouth disease, 
infection with Rift Valley fever virus and infection with peste des petits ruminants 
virus.
either [II.2.11.5. in and around which, in an area with a 150 km radius, including where 
appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not 
been reported for at least 2 years before the date of dispatch to the Union.](1)
L 113 /512  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CAM- CER
or [II.2.11.5. which is located in a zone seasonally free of epizootic haemorrhagic 
disease.](1)(7)
II.2.11.6. subjected to surveillance to detect infection with Mycobacterium tuberculosis complex 
(M.bovis, M.caprae and M.tuberculosis ) in animals of the same species of animals as 
the animals of the consignment i n accordance with the procedures in points (1) and (2) 
of part 2 of Annex II to Commission Delegated Regulation (EU) 2020/688 during at 
least the 12 month period prior to dispatch to the Union and during this period:
(i)only animals from establishments applying the measures provided in the paragraph 
above have been introduced in the establishment;
(ii)[infection with Mycobacterium tuberculosis complex (M.bovis, M.caprae and
M.tuberculosis ) has been reported in animals of the same species of animals as the 
animals of the consignment kept on the establishment and measures were taken in 
accordance with point (3) of part 2 of Annex II to Delegated Regulation (EU) 
2020 /688]].(1)
II.2.11.7. in which infection with Brucella abortus, B. melitensis and B. sui s in anim als of the 
same species of animals as the animals of the consignment has not been reported during 
the last 42 days prior to dispatch to the Union, and the animals of the consignment have 
been subjected to a test for the detection of infection with Brucella abortus, B. 
melitensis and B. sui s with one of the diagnostic methods provided for in Part 1 of 
Annex I to Delegated Regulation (EU) 2020 /688, with negative results, carried out on a 
sample taken during the 30 day period prior to dispatch to the Union, and in the case of 
post-parturient females, taken at least 30 days after parturition.
II.2.11.8. in which rabies has not been reported for at least the 30 days prior to dispatch to the 
Union.
II.2.11.9. in which anthrax has not been reported for at least the 15 days prior to dispatch to the 
Union.
II.2.11.10. in which surra ( Trypanosoma evansi) has not been reported for at least the 30 days prior 
to dispatch to the Union and if the disease was reported in the establishment of origin during the last 2 years pr ior to dispatch to the Union, the affected establishment 
remained under restriction until the infected animals were removed from the 
establishment and the remaining animals on the establishment were subjected with 
negative result to a test for surra ( Trypanosoma evansi) as described in Part 3 of Annex I 
to Delegated Regulation (EU) 2020/688 carried out on samples taken at least 6 months after the infected animals were removed from the establishment.
[II.2.11.11. in which, if an infection with Burkholderia m allei (glanders) has been reported during 
the period of 3 years prior to the date of dispatch to the Union, following the last 
outbreak the establishment remained under movement restrictions by the competent 
authority until:
(i)the infected animals have been killed and destroyed; and
(ii)the remaining animals were subjected to a test carried out as described in point 3.1 
of Chapter 3.5.11 of the OIE Terrestrial Manual (Version adopted 2015) with 
negative results on samples taken at least 6 months after the date on which the 
infected animals were killed and destroyed and the establishment cleaned and 
disinfected](1)(8)
[II.2.12. originate from an establishment in which infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis has not been reported on came lid animals in the 30 day period 
prior to dispatch to the Union.](1)(9)
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /513
COUNTRY Certificate model CAM- CER
Notes:
This certificate is intended for entry into the Union of camelid and cervid animals, including when the Union is not 
the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the animals in 
accordance with Article 21(1) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in point II.2.1., or during a period where restriction measures have been adopted by 
the Union agai nst entries of these animals from this third country, territory or zone thereof.
(4)Only for countries with the opening date in column 8 in Part 1 of Annex II to Implementing Regulation (EU) 2021/404
(5)For countries with entry BTV in Part 1 of Annex I Ito Implementing Regulation (EU) 2021/404.
(6)For countries with entry SF -BTV in Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(7)For countries with entry SF -EHD in Part 1 of Annex II to Implementing Regulation (EU) 2021/404 .
(8)Only applicable for ungul ates of the family Camelidae.
(9)Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement 
between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002), either have disease-
free status for infectious bovine rhinotracheitis /infectious pustular 
vulvovaginitis in bovine animals or an approved eradication programme.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /514  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 12
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFI CATE AND MODEL 
DECLARATION FOR ENTRY INTO THE UNION OF EQUINE ANIMALS NOT 
INTENDED FOR SLAUGHTER (MODEL ‘ EQUI -X’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □ □Registered horse
□ □
□
I.21 I.22□For internal market
I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /515
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age
L 113 /516  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animal described in Part I:
II.1.1. is not intended for slaughter for human consumption and not intended for slaughter in the 
framework of the eradication of a disease communicable to equine animals, and
(1)either [is a registered equine animal, as defined in Article 2(30) of Commission Delegated 
Regulation (EU ) 2019/2035.]
(1)or [is a registered horse as defined in Article 2(30) of Delegated Regulation (EU) 2019/2035.]
(1)or [is an equine animal other than a registered equine animal or a registered horse.]
II.1.2. has not shown signs or symptoms of diseases lis ted for equine animals in Commission 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date dd/mm/yyyy )(2), this being within the 48 hour period, or in the 
case of a registered horse within the 48 hour pe riod or on the last working day, prior to 
departure from the registered establishment.
II.1.3. meets the requirements attested in points II.2. to II.5., and where applicable in point II.6., of 
this certificate;
II.1.4. is accompanied by a written declarati on, signed by the operator of the animal, which forms 
part of this certificate.
II.2. Attestation on third country, territory or zone thereof and on establishment of dispatch
II.2.1. The equine animal described in Part I is dispatched from …………………... ( insert name 
of country, territory or zone thereof ), a country, territory or zone thereof, which on the date 
of issuing this certificate has the Code: ………..…(3)and is assigned to Sanitary Group 
……(3).
II.2.2. In the country or territory of dispatch the fol lowing diseases are compulsorily notifiable: 
African horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia 
mallei (glanders), surra (Trypanosoma evansi ), dourine (Trypanosoma equiperdum ), equine 
infectious anaemia, rabies and ant hrax.
II.2.3. The equine animal described in Part I comes from a country, territory or zone thereof in 
which there has been no clinical, serological (in unvaccinated equine animals) or 
epidemiological evidence of African horse sickness during the 24 month period prior to the 
date of departure of the animal and there have been no systematic vaccinations against 
African horse sickness during the 12 month period prior to the date of departure.
II.2.4. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(1)either [infection with Burkholderia mallei (glanders) has not been reported during the 36 month 
period prior to the date of departure of the animal.]
(1)or [a surveillance and eradi cation programme for infection with Burkholderia mallei
(glanders) recognised by the European Union(2)has been carried out during the 36 month 
period prior to the date of departure, and
(1)either [infection with Burkholderia mallei (glanders) has not been reported in the 
establishment of dispatch during the 36 month period prior to the date of departure 
of the animal.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /517
COUNTRY Certificate model EQUI -X
(1)or [infection with Burkholderia mallei (glanders) has been reported in the 
establishment during the 36 month period prior to the date of departure of the 
animal and following the last outbreak, the establishment has remained under 
movement restriction s
(1)either [until the remaining equine an imals in the establishment have been 
subjected to a complement fixation test for infection with Burkholderia 
mallei (glanders)(4), carried out, with negative results at a serum dilution 
of 1 in 5, on samples taken at least 6 months after the infected anima ls 
have been killed and destroyed.]]]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the establishment 
was killed and destroyed.]]]
II.2.5. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(1)either [surra has not been reported during the 24 month period prior to the date of departure.]
(1)or [a surveillance and eradication programme for surra recognised by the European Union(2) 
has been carried out during the 24 month period prior to the date of departure of the animal, 
and 
(1)either [surra has not been reported in the establishment during the 24 month period prior to the date of departure of th e animal.]]
(1)or [surra has been reported in the establishment during the 24 month period prior to 
the date of departure of the animal, and following the last outbreak the 
establishment has remained under movement restriction s
(1)either [until the remaining animals in the establishment have been subjected to an enzyme- linked immunosorbent assay (ELISA) for trypanosomosis or 
card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4
(4)carried out, with negative results, on samples take n at least 6 
months after the last infected animal has been removed from the 
establishment.]]]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the establishment 
was ei ther killed and destroyed or slaughtered.]]]
II.2.6. The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which
(1)either [dourine has not been reported during the 24 month period prior to the date of departure of 
the animal.]
(1)or [a surveillance and eradication programme for dourine recognised by the European Union(2)
has been carried out during the 24 month period prior to the date of departure of the animal, 
and
(1)either [dourine has not been reported in the establishment during the 24 month period 
prior to the date of departure of the animal.]]
(1)or [dourine has been reported in the establishment during the 24 month period prior 
to the date of departure of the animal, and following the last outbreak, the 
establishment has remained under movement restriction s
L 113 /518  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -X
(1)either [until the remaining equine animals in the establishment, except castrated 
male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5
(4)on
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been castrated.]]]
(1)or [for at least 3 0 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the establishment was 
either killed and destroyed or slaughtered.]]]
II.2.7. The equine animal described in Part I comes from an establishment in which 
(1)either [equine infectious anaemia has not been reported during the 12 month period prior to the 
date of departure of the animal.]
(1)or [equine infectious anaemia has been reported during the 12 month period prior to the date of departure of the animal and following the last outbreak the establishment has remained 
under movement restrictions
(1)either [until the remaining equine animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID or Coggins test) or EL ISA(4)for equine 
infectious anaemia carried out, with negative results, on samples taken on two 
occasions with a minimum interval of 90 days following cleaning and disinfection 
of the establishment after the infected animals have been killed and destroyed , or 
slaughtered.]]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the establishment was 
either killed and destroyed or slaughtered.]]
II.2.8. The equine animal described in Part I comes from an establishment in which 
II.2.8.1. infection with rabies virus in kept terrestrial animals has not been reported during 
the 30 day period prior to the date of departure of the animal;
II.2.8.2. anthrax in ungulates has not been reported during the 15 day period prior to the 
date of departure of the animal.
II.2.9. To the best of my knowledge and as declared by the operator, the equine animal described 
in Part I has not been in contact with kept animals of l isted species which did not comply 
with the requirements referred to in points II.2.3. to II.2.8.1 during the 30 day period prior to the date of departure of the animal, and with the requirement referred to in point II.2.8.2. 
during the 15 day period prior to the date of departure of the animal.
II.3. Attestation of residence and pre -export isolation
(1)either [II.3.1. During the 40 day period prior to the date of its departure, or since birth if it is less than 40 
days of age, the equine animal described in Part I has been continuously resident in the 
country, territory or zone thereof of dispatch or entered the country , territory or zone 
thereof of dispatch from a Member State of the European Union or Norway.] 
(1)or [II.3.1. During the 40 day period prior to the date of its departure, or since birth if it is less than 40 
days of age, the registered horse described in P art I 
(1)either [has been continuously resident in the country, territory or zone thereof of dispatch;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /519
COUNTRY Certificate model EQUI -X
(1)or [entered the country, territory or zone thereof of dispatch on one or more occasions from
(1)either [a Member State of the European Union or Norway;]]]
(1)and/or [a country, territory or zone thereof authorised for entry into the Union of 
registered horses, and from which it was imported into the country, territory or 
zone thereof of dispatch under conditions at least as strict as those require d in 
accordance with Union legislation for the entry of registered horses from this 
country, territory or zone thereof directly to the Union, and which is:
(1)either [assigned to the same Sanitary Group ……….. (3)as the country, territory 
or zone thereof o f dispatch;]]]]
(1)and/or[assigned to Sanitary Group A, B or C;]]]]
(1)and/or[China(5)(6), Hong Kong, Japan, Korea Republic, Macao, Singapore, or the 
United Arab Emirates.]]]]
(1)either [II.3.2. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group A, B, C, D or G, and 
(1)either [during the 30 day period prior to the date of its departure, or since birth if it is less than 30 days of age or since entry from a Member State of the Union or Norway, 
(1)either [it has been kept apart from other equine animals, except in case of a foal at foot of his mother, in an establishment situated in a country, territory or zone thereof 
assigned to Sanitary Group A.]]]
(1)or [it has been kept in pre -export isolation from other equine animals, except in case 
of a foal at foot of his mother, in an establishment situated in a country, territory or zone thereof assigned to Sanitary Group B, C, D or G.]]]
(1)or [it is a registered horse which has been kept in establishments under veterinary supervision 
during the 30 day period prior to the date of its departure, or since birth if it is less than 30 
days of age, or since entry in accordance with point II.3.1 from a Member State of the 
European Union, Norway or a country, territory or zone thereof which is assigned to 
Sanitary Group A, B, C, D, E or G,.]]
(1)(7)or [II.3.2. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, and 
(1)either [during the 40 day period prior to the date of its departure, or since birth if it is less than 40 
days of age, or since entry in accordance with point II.3.1 from a Member State of the 
European Union, Norway or a country, territory or zone thereof whi ch is assigned to 
Sanitary Group A, B, C, D, E or G, it has been kept 
(1)either [in isolation in an establishment protected from insect vectors.]]]
(1)or [in an establishment under veterinary supervision, and the country, territory or 
zone thereof of disp atch is recognised by the World Organisation for Animal 
Health (OIE) as officially free of African horse sickness.]]]
L 113 /520  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -X
(1)or [is a registered horse which has been kept during the 30 day period prior to the date of its 
departure, or since birth if it is less than 30 days of age, or since entry in accordance with point II.3.1 from a Member State of the European Union, Norway or a country, territory or 
zone thereof which is assigned to Sanitary Group A, B, C, D, E or G, in establishments 
under veterinary su
pervision, and the country, territory or zone thereof of dispatch is 
recognised by the OIE as officially free of African horse sickness.]]
(1)(7)or [II.3.2. The registered horse described in Part I is dispatched from a country, territory or zone 
thereof a ssigned to Sanitary Group F, and: 
(1)either [during the 40 day period prior to the date of departure it has been kept in the approved 
quarantine station of …………………………. ( insert name of quarantine station ), 
confined to the vector -protected premises at least from two hours prior to sunset until two 
hours after sunrise and exercise was provided under official veterinary supervision, 
following the application of insect repellents in combination with an insecticide effective 
against Culicoides prior to the removal from the quarantine stables, and in strict isolation 
from equine animals not being prepared for export under conditions at least as strict as 
required for entry into the Union.]]
(1)or [during the 14 day period prior to the date of departure it has been permanently confined in 
the approved vector -proof quarantine station of …………………………. ( insert name of 
quarantine station ) and constant monitoring of the vector protection has proven absence of 
insect vectors inside the vector -proof part of the quarantine st ation.]]
II.4. Attestation of vaccination and health tests
(1)either [II.4.1. The equine animal described in Part I was not vaccinated against African horse sickness in 
the country, territory or zone thereof of dispatch and there is no information suggesting previous vaccination.]
(1)or [II.4.1. The equine animal described in Part I was vaccinated against African horse sickness more than 12 months prior to the date of its departure.]
(1)(7)or [II.4.1. The registered horse described in Part I was vac cinated against African horse sickness not 
more than 24 months and at least 40 days prior to the date of entry in the vector -protected 
or vector –proof quarantine station situated in a country, territory or zone thereof assigned to 
Sanitary Group F, and thi s vaccination consisted of a complete primary course of 
vaccination against African horse sickness, or a revaccination within the period of validity 
of the previous vaccination, by administration according to manufacturer's instructions of a 
registered vaccine which is protective against the circulating serotypes of the African horse 
sickness virus, and the last vaccination was applied on …………….. (insert date) .]
II.4.2. The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the 60 day period prior to the date of its departure, and 
(1)either [it comes from an establishment situated in a country or territory in which Venezuelan equine encephalomyelitis has not been reported during the 24 month period p rior to the date 
of its departure.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /521
COUNTRY Certificate model EQUI -X
(1)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not 
been reported during the 6 month period prior to the date of its departure and which is situated in a country, territory or 
zone thereof in which a surveillance and eradication 
programme for Venezuelan equine encephalomyelitis recognised by the European Union(2)
has been carried out during the 24 month period prior to the date of its departure, and 
during the 21 day period prior to the date of departure of the animal described in Part I, all 
equine animals in the establishment have remained clinically healthy, and 
(1)either [the equine animal described in Part I has been kept protected from attacks by 
insect vectors in a quaran tine station, in which any equine animal that showed a 
rise in daily taken body temperature has been subjected with negative result to a 
virus isolation test for Venezuelan equine encephalomyelitis(4); and the equine 
animal described in Part I 
(1)either [was vaccinated against Venezuelan equine encephalomyelitis with a 
complete primary course and revaccinated according to manufacturer's 
recommendations not less than 60 days and not more than 12 months 
prior to the date of departure;]]]
(1)or [was subjecte d to a haemagglutination inhibition test for Venezuelan 
equine encephalomyelitis(4), carried out, with negative result, on a sample 
taken not less than 14 days after the date of its entry into the quarantine 
station.]]]
(1)or [the body temperature of the e quine animal described in Part I has been taken 
daily, either without a rise or the animal has been subjected to a virus isolation test 
for Venezuelan equine encephalomyelitis with negative result, and the equine 
animal described in Part I has been subject ed to 
− a haemagglutination inhibition test for Venezuelan equine 
encephalomyelitis(4), without an increase in antibody titre, carried out on 
paired samples taken on two occasions with an interval of 21 days, the 
second of which was taken during the 10 day period prior to the date of its departure, and
− a reverse transcription -polymerase chain reaction (RT -
PCR) for the 
detection of Venezuelan equine encephalomyelitis virus genome(4), with 
negative result, carried out on a sample taken within the 48 hour perio d
prior to its departure, and
− protection from vector attacks during the period after sampling until 
loading for dispatch, by combined use of approved insect repellents and 
insecticides on the animal and disinsectization of the stable and the means in which it is transported.]]
(1)(7)either [II.4.3. The equine animal described in Part I is dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, where it was continuously resident since 
birth, and did not come into contac t with equine animals which have entered Iceland from 
other countries.]
(1)or [II.4.3. The equine animal described in Part I was subjected with negative result to an agar gel 
immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infectious 
anaemia(4)carried out on a blood sample taken on …………… (insert date), this being
within
(1)either [the 30 day period prior to the date of its departure.]]
(1)(7)or [the 90 day period prior to the date of its departure from a country, territory or zone thereof 
assigned to Sanitary Group A .]]
L 113 /522  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -X
(1)[II.4.4. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group B, D or E or from China, or from a country or territory in which infection with Burkholderia mallei (glanders) has been reported during the 36 month period 
prior to the date of departure, and was subjected to a complement fixation test for infection 
with Burkholderia mallei (glanders)
(4)carried out with negative result at a serum dilu tion of 
1 in 5 on a blood sample taken on ……………………. ( insert date), within the 30 day 
period prior to the date of departure.]
(1)[II.4.5. The equine animal described in Part I is an uncastrated male or female equine animal older 
than 270 days dispatched fro m a country, territory or zone thereof assigned to Sanitary 
Group B, D, E or F, or from China, or from a country in which dourine has been reported 
during the 24 month period prior to the date of departure, and was subjected to a 
complement fixation test f or dourine(4)carried out with negative result at a serum dilution 
of 1 in 5 on a blood sample taken on ……………………. ( insert date), within the 30 day 
period prior to the date of departure, and the equine animal described in Part I has not been 
used for breedi ng during the 30 day period prior to and after the date the sample was taken.]
(1)[II.4.6. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, from Brazil, Bolivia, Uruguay, Malaysia (Peninsula) or from 
a country or territory in which surra was reported during the 24 month period prior to the 
date of departure, and was subjected to a card agglutination test for trypanosomosis 
(CATT)(4), carried out with negative result at a serum dilut ion of 1 in 4 on a blood sample 
taken on ……………………. ( insert date ), within the 30 day period prior to the date of 
departure.]
(1)(7)[II.4.7. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
which is assigned to Sanitary Group E and 
(3)either [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8), 
which was carried o ut by the same laboratory on the same day on blood samples taken on 
two occasions with an interval of between 21 and 30 days, on …………………… (insert 
date) and on ………………… (insert date) , the second of which was taken within the 10 
day period prior to the date of departure,
(3)either [with negative results in each case.]]]
(3)or [with a positive result in the first sample, and 
(3)either [the second sample was subsequently tested with negative result in a Real-time RT -PCR
(8).]]]]
(3)or [the two samples were tested without more than a two -fold increase in 
antibody titre in a virus neutralisation test as described in point 2.4 of 
Chapter 2.5.1. of the OIE Terrestrial Manual for Diagnostic Tests and 
Vaccines.]]]]
(1)or [it was subjected to an indirect ELISA or a bloc king ELISA for African horse sickness(8)
with negative result on a blood sample taken on ……………… (insert date), within the 21 
day period prior to the date of departure, and the country or territory of dispatch is 
recognised by the OIE as officially free of African horse sickness.]]
(1)or [it is a registered horse not vaccinated against African horse sickness and dispatched from a 
country, territory or zone thereof which is recognised by the OIE as officially free of 
African horse sickness.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /523
COUNTRY Certificate model EQUI -X
(1)(7)[II.4.8. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group F and 
(1)either [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8)
carried out by the same labo ratory on the same day on blood samples taken on two 
occasions with an interval of between 21 and 30 days, on …………………… (insert date) 
and on ………………… (insert date) , the first sample not taken less than 7 days after 
introduction into the vector -protected quar antine station, the second sample taken within 
the 10 day period prior to the date of departure,
(1)either [with negative results in each case.]]]
(1)or [with a positive result in the first sample, and
(1)either [the second sample was subsequently tested with negative result in a 
Real-time RT -PCR(8).]]]]
(1)or [the two samples were tested without more than a two- fold increase in 
antibody titre in a virus neutralisation test as described in point 2.4 of Chapter 2.5.1. of the OIE Terrestrial Manual for Diagn ostic Tests and 
Vaccines.]]]]
(1)or [it was subjected to an indirect ELISA or a blocking ELISA and a Real -time RT -PCR for 
African horse sickness(8)carried out with negative result in each case on a blood sample 
taken on ………………… ( insert date ) not less than 28 days after the date of introduction 
into the vector -protected quarantine station and within the 10 day period prior to the date of 
departure.]]
(1)or [it was subjected to a Real- time RT -PCR for African horse sickness(8), carried out with 
negative resul t on a blood sample taken on ………………… (insert date ) not less than 14 
days after the date of introduction into the vector -proof quarantine station and not more 
than 72 hours before departure.]]
II.5. Attestation of thetransport conditions
(1)(7)either [II.5.1. The equine animal described in Part I is dispatched from a country, territory o rzone thereof 
assigned to Sanitary Group A, B, C, D, E or G and arrangements have been made to 
transport it directly to the Union, without subjecting the animal to any assembly operation 
and without coming into contact with other equine animals not complying with at least the 
same health requirements as described in this health certificate.]
(1)(7)or [II.5.1. The animal is dispatched from a country, territory or zone thereof which is assigned to 
Sanitary Group F and arrangements have been made to transport it directly from the vector -
protected or vector –proof quarantine station without coming into contact with other equine 
animals not complying with at least the same hea lth requirements as described in this health 
certificate
(1)either [to the airport under vector- protected conditions and arrangements have been made for the 
aircraft to be cleansed and disinfected in advance with a disinfectant officially recognised in 
thethird country of dispatch, and sprayed against insect vectors just prior to take off.]]
(1)or [to a sea port in that country, territory or zone thereof under vector -protected conditions and 
arrangements have been made to transport it on a vessel which is scheduled directly to a 
port in the European Union without calling into a port situated in a country, territory or 
zone thereof not approved for the entry into the Union of equine animals, in stalls which 
were cleansed and disinfected in advance with a dis infectant officially recognised in the 
third country of dispatch and sprayed against insect vectors just prior to departure.]]
L 113 /524  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -X
II.5.2. Arrangements have been made and verified to prevent any contact with other equine 
animals not complying with at least t he same health requirements as described in this health 
certificate during the period from certification until dispatch to the European Union.
II.5.3. The transport vehicles or containers in which the animal is going to be loaded were cleaned 
and disinfect ed before loading with a disinfectant officially recognised in the country or the 
territory of dispatch and they are so constructed that faeces, urine, litter or fodder cannot 
escape during transportation.
(1)(9)[II.6. Public health attestation
I, the undersigned official veterinarian, hereby certify, that the equine animal described in this certificate:
II.6.1. in the country or territory of dispatch has not received:
-any stilbene or thyrostatic substances;
-oestrogenic, androgenic, gestagenic or be ta-agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);
II.6.2. fulfils the guarantees covering live equine animals provided by the residue plan submitted 
and approved in accordance wi th Article 29 of Council Directive 96/23/EC and it has been 
dispatched from a country or territory listed for equine animals in the Annex to 
Commission Decision 2011/163/EU.]
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I :
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27: “Identification system” : The animal must be individually identified with one of the means 
of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation 
(EU) 2019/2035, or be identified by an alternative method in accordance w ith Article 62 of 
that Regulation (e.g. brand) provided it is recorded in its identification document (passport). 
Specify the identification system and the anatomic place used on the animal. If a passport accompanies the animal, its number should be stated
and the name of the competent 
authority which validated it.
“Age” : Date of birth (dd/mm/yyyy).
“Sex”: M = male, F = female, C = castrated.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /525
COUNTRY Certificate model EQUI -X
Part II:
(1)Delete as appropriate.
(2)The certificate must be issued on the day of loading or on the last working day before loading of the animal 
for dispatch to the Member State of destination in the Union.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restrictive measures have been adopted by the Union against the entry of equine animals from this country, territory or zone thereof. Check against columns 8 a nd 9 of 
Part1 of Annex IV to Implementing Regulation (EU) 2021/404.
(3)Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 respectively in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
(4)Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop
(5)Zone of country or territory authorised for entry into the Union as appearing in columns 2 and 5 
respectively of Part 1 of Annex IV to Implementing Regulation (EU) 2021/404 .
(6)Only authorised if country of dispatch is assigned to Sanitary Group G.
(7)Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to 
which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that the 
numbering of the subsequent statements is maintained.
(8)Tests for African horse sickness described by the European Union Reference Laboratory for African horse 
sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -diagnostico.aspx
(9)By deleting this point, the equine animal, if intended for free circulation in accordance with the customs 
procedures laid down in Regulation (EU) No 952/2013 of the European Parliament and of the Council (OJL 
269, 10.10.2013, p.1), will be excluded from slaughter for human consumption in the identification 
document issued in accordance with Union animal health rules.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /526  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Declaration by the operator responsible for entry into the Union of the consignment of equine 
animal not intended for slaughter
Identification of the animal(1)
Species (Scientific name) Identification system
……………………….Identification number
……………………….Age
……………….Sex
…………
I, the undersigned operator of the equine animal described above, hereby declare, that:
- the equine animal 
(2)either [has remained in …………………... ( insert name of country, territory or zone thereof of dispatch ) during a period 
of at least 40 days prior to the date of dispatch, or since birth, or since entry from the European Union or
Norway;]
(2)or [entered …………………... ( insert name of country, territory or zone thereof of dispatch ) during the required 
residence period of at least 40 days prior to the date of dispatch:(a) on……….(insert date ) from………….………. (insert name of country or territory from where the 
horse entered the country, territory or zone thereof of dispatch)
(b) on……….(insert date) from………….………. (insert name of country or territory from where the 
horse entered thecountry, territory or zone thereof of dispatch)
(c) on……….(insert date ) from………….………. (insert name of country or territory from where the 
horse entered the country, territory or zone thereof of dispatch);]
- during the period of 15 days prior to the date of departure the equine animal has not been in contact with animals 
suffering from infectious or contagious diseases transmissible to equine animals;
- the conditions for residence and pre -export isolation as applicable in accordance with point II. 3. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled;
- the conditions for the transport as applicable in accordance with point II. 5. of the accompanying health certificate for the 
country or part of the territory of the country of dispat ch are fulfilled;
- I am aware of the animal health and veterinary certification requirements for the movement of equine animals from one EU Member State to another laid down in Commission Delegated Regulation (EU) 2020/688;
- the equine animal is scheduled to leave the European Union on ………………………….…… (date ) at the border post 
of ……………………………… (insert name and place of border post of exit ) or otherwise will be subject to the 
identification and registration rules applicable in acc ordance with Commission Delegated Regulation (EU) 2019/ 2035.
Name and address of the operator: ……………………………………………………..
Date: …………………………(dd/mm/yyyy )
…………………………………………………………………………………………………………………..
(Signature )
(1)Identification system : The animal must be individually identified with one of the means of identification defined in point (a), (c), (e) or (g) of Annex III to 
Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Regulati on provided it is recorded in 
its identification document (passport) . Specify the identification system (such as ear tag, tattoo, brand, transponder) and the anatomic place used on the 
animal.
If a passport accompanies the animal, its number should be stated and the name of the competent authority which validated it.
Age: Date of birth (dd/mm/yyyy).
Sex(M = male, F = female, C = castrated).
(2)Delete as appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /527
CHAPTER 13
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE AND MODEL 
DECLARATION FOR ENTRY INTO THE UNION OF EQUINE ANIM ALS 
INTENDED FOR SLAUGHTER (MODEL ‘EQUI -Y’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISOcountry code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Slaughter
I.21 I.22□For internal market
I.23
L 113 /528  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification 
systemIdentification number Quantity
Slaughterhouse
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /529
COUNTRY EQUI -Y
Entry –equine animals intended for slaughter
II.a Certificate reference II.b IMSOC referencePart II: CertificationII. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animals(1)of the consignment described in Part I:
II.1.1. are intended for slaughter for human consumption and are not intended for slaughter in 
the framework of the eradication of a disease communicable to equine animals;
II.1.2. have not shown signs or symptoms of diseases listed for equine animals in Commission 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on ………………. ( insert date dd/mm/yyyy )
(2), this being within th e 48 hour period prior to 
departure 
(3)either [from the registered establishment of origin in the country, territory or zone thereof of dispatch;]
(3)or [from the establishment approved for conducting assembly operations of equine animals 
by the competent authority in the country or territory of dispatch in accordance with 
requirements at least as stringent as those laid down in Article 5 of Commission 
Delegated Regulation (EU) 2019/2035; ]
II.1.3. meet the requirements attested in points II.2. to II.6. of this certificate, including in case 
of dispatch from an establishment approved for assembly operations;
II.1.4. are accompanied by a written declaration, signed by the operator of the consignment of 
animals, which forms part of this certificate.
II.2. Attestation on third country, territory or zone thereof and on establishment of dispatch
II.2.1. The equine animals described in Part I are dispatched from …………………... ( insert 
name of country, territory or zone thereof ), a country, territory or zone thereof, which on 
the date of issuing this certificate has the Code: ………..…(4)and is assigned to Sanitary 
Group ……(4).
II.2.2. In the country or territory of dispatch the following diseases are compulsorily notifiable: 
African horse sickness, Venezuelan equine e ncephalomyelitis, infection with 
Burkholderia mallei (glanders), surra ( Trypanosoma evansi ), dourine (Trypanosoma 
equiperdum), equine infectious anaemia, infection with rabies virus and anthrax.
II.2.3. The equine animals described in Part I are dispatched from a country, territory or zone 
thereof in which there has been no clinical, serological (in unvaccinated equine animals) 
or epidemiological evidence of African horse sickness during the 24 month period prior 
to the date of departure of the animals, and there have been no systematic vaccinations 
against African horse sickness during the 12 month period prior to the date of departure.
II.2.4. The equine animals described in Part I come from an establishment of origin situated in a 
country, territory or zo ne thereof in which
(3)either [infection with Burkholderia mallei (glanders) has not been reported during the 36 month 
period prior to the date of departure of the animals.]
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei
(glanders) recognised by the European Union(2)has been carried out during the 36 month 
period prior to the date of departure, and
(3)either [infection with Burkholderia mallei (glanders) has not been reported in the 
L 113 /530  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY EQUI -Y
Entry –equine animals intended for slaughter
II.a Certificate reference II.b IMSOC reference
establishment of origin during the 36 month period prior to the date of 
departure of the animals.]
(3)or [infection with Burkholderia mallei (glanders) has been reported in the 
establishment of origin during the 36 month period prior to the date of 
departure of the animals and following the last outbreak, the establishment has 
remained under movement restrictions
(3)either [until the remaining equine animals in the establishment have been 
subjected to a complement f ixation test for infection with 
Burkholderia mallei (glanders)(5), carried out, with negative results at 
a serum dilution of 1 in 5, on samples taken at least 6 months after the 
infected animals have been killed and destroyed.]]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was 
killed and destroyed.]]]
II.2.5. The equine animals described in Part I come from an establishment of origin situated in a 
country, territory or zone thereof in which
(3)either [surra has not been reported during the 24 month period prior to the date of departure.]
(3)or [a surveillance and eradication programme for surra recognised by the European Union(2)
has been carried out during the 24 month period prior to the date of departure of the 
animals, and
(4)either [surra has not been reported in the establishment of origin during the 24 month 
period prior to the date of departure of the animals.]
(3)or [surra has been reported in the es tablishment of origin during the 24 month 
period prior to the date of departure of the animals, and following the last 
outbreak the establishment has remained under movement restrictions
(3)either [until the remaining animals in the establishment have been subjected 
to an enzyme- linked immunosorbent assay (ELISA) for 
trypanosomosis or card agglutination test for trypanosomosis (CATT) 
at a serum dilution of 1 in 4(5)carried out, with negative results, on 
samples taken at least 6 months after the last infect ed animal has been 
removed from the establishment.]]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last animal of listed species on the 
establishment was either killed and destroyed or slaughtered. ]]]
II.2.6. The equine animals described in Part I come from an establishment of origin situated in a country, territory or zone thereof in which
(3)either [dourine has not been reported during the 24 month period prior to the date of departure 
of the anim als.]
(3)or [a surveillance and eradication programme for dourine recognised by the European 
Union(2)has been carried out during the 24 month period prior to the date of departure of 
the animals, and
(3)either [dourine has not been reported in the establishment of origin during the 24 
month period prior to the date of departure of the animals.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /531
COUNTRY EQUI -Y
Entry –equine animals intended for slaughter
II.a Certificate reference II.b IMSOC reference
(3)or [dourine has been reported in the establishment of origin during the 24 month 
period prior to the date of departure of the animals, and following the last 
outbreak, the establishment has remained under movement restrictions
(3)either [until the remaining equine animals in the establishment, except 
castrated male equine animals, have been subjected to a complement 
fixation test for dourine , carried out with negative results at a serum 
dilution of 1 in 5(5)on samples taken at least 6 months after the 
infected animals have been killed and destroyed or slaughtered, or the 
infected entire male equine animals have been castrated.]]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was 
either killed and destroyed or slaughtered.]]]
II.2.7. The equine animals described in Part I come from an establishment of origin in which 
(3)either [equine infectious anaemia has not been reported during the 12 month period prior to the 
date of departure of the animals.]
(3)or [equine infectious anaemia has been reported during the 12 month period prior to the date 
of departure of the animals and following the last outbreak the establishment has 
remained under movement restrictions
(3)either [until the remaining equine animals in the establishment have been subjected to 
an agar gel immuno- diffusion test (AGID or Coggins test) or ELISA(5)for 
equine infectious anaemia carried out, with negative results, on samples taken 
on two occasions with a minimum interval of 90 days following cleaning and disinfection of the establishment after the infected animals have been killed 
and destroyed or slaughtered.]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last equine animal on the establishment was either 
killed and destroyed or slaughtered.]]
II.2.8. The equine animals described in Part I come from an establishment of origin in which 
II.2.8.1. infection with rabies virus in kept terrestrial animals has not been reported 
during the 30 day period prior to the date of departure of the animals;
II.2.8.2. anthrax in ungulates has not been reported during the last 15 days prior to the 
date of departure of the animals.
II.2.9. To the best of my knowledge and as declared by the operator of the consignment, the equine animals described in Part I have not been in contact with kept animals of listed 
species which did not comply with the requirements referred to in points II.2.3. to II.2.8.1 during the 30 day period prior to the date of departure of the animals, and with t he 
requirement referred to in point II.2.8.2. during the 15 day period prior to the date of 
departure of the animals.
L 113 /532  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY EQUI -Y
Entry –equine animals intended for slaughter
II.a Certificate reference II.b IMSOC reference
II.3. Attestation of residence and pre -export isolation
II.3.1. The equine animals described in Part I have been resident in the country, territory or zone 
thereof of dispatch during the 90 day period prior to the date of departure.
(3)either [II.3.2. The equine animals described in Part I are dispatched from a country, territory or zone 
thereof assigned to Sanitary Group A, B, C, D , or G, and during the 30 day period prior to 
the date of departure from the establishment of origin have been kept in pre -export 
isolation.]
(3)(6)or [II.3.2. The equine animals described in Part I are dispatched from a country, territory or zone thereof assigned to Sanitary Group E, and during the 40 day period prior to the date of 
departure from the establishment of origin, have been kept
(3)either [in isolation in an establishment of origin protected from insect vectors.]]
(3)or [in an establishment of origin under veterinary supervision, and the country, territory or 
zone thereof of dispatch is recognised by the World Organisation for Animal Health 
(OIE) as officially free of African horse sickness.]]
(3)[II.3.3. Immediately prior to their dispatch from the country, territory or zone thereof of dispatch, 
the equine animals of the consignment described in Part I have been kept in the 
establishment approved for assembly operations referred to in point II.1.2. for a period of not more than 6 days after leav
ing their respective establishments of origin. In the 
approved establishment, which complies with the requirements for establishments in 
point II.2., the animals have been kept under conditions that effectively protect their 
health status and without comin g into contact with equine animals not complying with the 
requirements in points II.2., II.3.1., II.3.2. and II.4. of this certificate.]
II.4. Attestation of vaccination and health tests
II.4.1. The equine animals described in Part I were not vaccinated against African horse 
sickness in the country, territory or zone thereof of dispatch and there is no information 
suggesting previous vaccination.
II.4.2. The equine animals described in Part I have not been vaccinated against Venezuelan equine encephalomye litis during the 60 day period prior to the date of departure, and 
come from an establishment situated in a country, territory or zone thereof in which Venezuelan equine encephalomyelitis has not been reported during the 24 month period 
prior to the date o f departure.
(3)either [II.4.3. The equine animals described in Part I are dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, where they have been continuously 
resident since birth, and did not come into contact with equine which have entered 
Iceland from other countries.]
(3)or [II.4.3. The equine animals described in Part I were subjected with negative result in each case 
to an agar gel immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infect ious anaemia
(5)carried out on a blood sample taken on …………… (insert date), 
within the 30 day period prior to the date of departure.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /533
COUNTRY EQUI -Y
Entry –equine animals intended for slaughter
II.a Certificate reference II.b IMSOC reference
(3)[II.4.4. The equine animals described in Part I are dispatched from a country, territory or zone 
thereof assigned to S anitary Group B, D or E, or from a country or territory in which 
infection with Burkholderia mallei (glanders) has been reported during the 36 month 
period prior to the date of departure, and were subjected to a complement fixation test 
for infection with Burkholderia mallei (glanders)(5)carried out with negative result in 
each case at a serum dilution of 1 in 5 on a blood sample taken on ……………………. 
(insert date), within the 30 day period prior to the date of departure.
(3)[II.4.5. The equine animals descri bed in Part I are uncastrated male or female equine animals 
older than 270 days dispatched from a country, territory or zone thereof assigned to 
Sanitary Group B, D or E, or from a country in which dourine has been reported during 
the 24 month period prior to the date of departure, and were subjected to a complement 
fixation test for dourine(5)carried out with negative result in each case at a serum 
dilution of 1 in 5 on a blood sample taken on ……………………. ( insert date), within 
the 30 day period prior to the date of departure.]
(3)[II.4.6. The equine animals described in Part I are dispatched from a country, territory or zone 
thereof which is assigned to Sanitary Group E, from Brazil, Bolivia, Uruguay, or from a country or territory in which surra was reported during the 24 month period prior to the 
date of departure, and were subjected to a card agglutination test for trypanosomosis 
(CATT)
(5), carried out with negative result in each case at a serum dilution of 1 in 4 on a 
blood sample taken on ………………… …. (insert date ), within the 30 day period prior 
to the date of departure.]
(3)(6)[II.4.7. The equine animals described in Part I are dispatched from a country, territory or zone thereof which is assigned to Sanitary Group E, and 
(3)either [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7), 
which was carried out with negative results in each case by the same laboratory on the 
same day on blood samples taken on two occasions with an interval of between 21 and 30 days, on …………………… (insert date) and on ………………… (insert date) , the 
second of which was taken within the 10 day period prior to the date of departure.] ]
(3)or [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7)
with negative result on a blood sample taken on ……………… (insert date), within the 
21 day period prior to the date of departure, and the country or territory of dispatch is recognised by the OIE as officially free of African horse sickness.]]
II.5. Attestation of the transport c onditions
II.5.1. Arrangements have been made to transport this consignment of animals directly to the 
Union, without subjecting the animals after certification to any further assembly 
operation outside the European Union and without coming into contact wi th other 
equine animals not complying with at least the same health requirements as described in 
this health certificate.
L 113 /534  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY EQUI -Y
Entry –equine animals intended for slaughter
II.a Certificate reference II.b IMSOC reference
II.5.2. Arrangements have been made and verified to prevent any contact with other equine 
animals not complying with at least the same health requirements as described in this 
health certificate during the period from certification until dispatch to the European Union.
II.5.3. The transport vehicles or containers in which the animals are going to be loaded were 
cleaned and disinfecte d before loading with a disinfectant officially recognised in the 
country or territory of dispatch and they are so constructed that faeces, urine, litter or 
fodder cannot escape during transportation.
II.6. Public health attestation
I, the undersigned official veterinarian, hereby certify, that the equine animals described in Part I:
II.6.1. in the country or territory of dispatch have not received:
-any stilbene or thyrostatic substances;
-oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other 
than therapeutic or zootechnical treatment (as defined in Council Directive 
96/22/EC);
II.6.2. fulfil the guarantees covering live equine animals provided by the residue plan
submitted and approved in accordance with Article 29 of Council Directive 96/23/EC 
thereof and have been dispatched from a country or territory listed for equine animals in 
the Annex to Commission Decision 2011/163/EU.
Notes :
In accordance with the Agreem ent on the withdrawal of the United Kingdom of Great Britain and Northern 
Ireland from the European Union and the European Atomic Energy Community, and in particular Article 
5(4) of the Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references 
to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of 
certificates provided for in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 
2020/2235.
Part I:
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as 
appearing in column 2 of Annex IV to Commission Implementing Regulation 
(EU) 2021/404.
Box reference I.27: “Identification system” : The animals must be individually identified with one 
of the means of identification defined in point (a), (c), (e) or (g) of Annex III to 
Delegated Regulation (EU) 2019/2035 which permits to link the a nimals to the 
animal health/official certificate. Specify the identification system and the 
anatomic place used on the animals.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /535
COUNTRY EQUI -Y
Entry –equine animals intended for slaughter
II.a Certificate reference II.b IMSOC reference
Part II:
(1)There can be one or more equine animals in the consignment.
(2)The certificate must be issued within the 48 hour period prior to loading of the animals for dispatch 
to the Member State of destination in the Union.
The entry into the Union shall not be allowed when the animals were loaded either prior to the date 
of authorisation for entry into the Union from the res pective country, territory or zone thereof 
referred to in point II.1.1., or during a period where restrictive measures have been adopted by the 
Union against the entry of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of Part 1 of Annex IV to Implementing Regulation (EU) 2021/404 .
(3)Delete as appropriate.
(4)Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 
3 respectively in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
(5)Tests for glanders, surra, dourine, equine infectious anaemia and Venezue lan equine 
encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop
(6)Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group 
to which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that 
the numbering of the subsequent statements is maintained.
(7)Tests for African horse sickness described by the European Union Reference Laboratory for African 
horse sickness: http s://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -
diagnostico.aspx
Official veterinarian
Name (in capital letters): Qualification and title:
Date: Signature:
Stamp:
L 113 /536  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Declaration by the operator responsible for entry into the Union of the consignment of equine 
animals intended for slaughter
Identification of the animals(1)
Total number Species (Scientific 
name)
……………………….Identification system
……………………….Identification number(s)
……………….Quantity
…………
I, the undersigned operator of the consignment of equine animals intended for slaughter described above, hereby declare, that :
- the animals have remained in the country, territory or zone thereof of dispatch for at least 90 days prior to the date of 
dispatch;
- during the period of 15 days prior to the date of dispatch the animals have not been in contact with animals suffering from infectious or contagious diseases transmissible to equine animals;
- the conditions for residence and pre -export isolation as applicable in accordance with point II. 3. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled;
- the conditions for the transport as applicable in accordance with point II. 5. of the accompanying health certificate for the 
country, territory or zone thereof of dispatch are fulfilled;
- the transportation will be effected in such a way that health and welfare of the animals can be protected effectively at all 
stages of the journey;
- the animals will be sent 
(2)either [directly from the establishment of origin to the slaughterhouse of destination without coming into contact with other equine animals not of the same health status;]
(2)or [from the establishment approved for assembly operations on equine animals to the slaughterhouse of 
destination without coming into contact with other equine animals not of the same health status;]
Name and address of the operator: ……………………………………………………..
Date: …………………………(dd/mm/yyyy )
…………………………………………………………………………………………………………………..
(Signature )
(1)Identification system : The animals must be individually identified with one of the means of identification defined in point (a), (c), (e) or (g) of Annex III to 
Delegated Regulation (EU) 2019/2035 which permits to link the animals to the animal health/official certificate. Specify the identification system (such as 
ear tag, tattoo, brand, transponder) and the anatomic place used on the animals .
(2)Delete as appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /537
CHAPTER 14
MODEL ANIMAL HEALTH CERTIF ICATE AND MODEL DECLARATIO N FOR 
TRANSIT THROUGH THE UNION OF EQUINE ANIM ALS NOT INTENDED FOR
SLAUGHTER (MODEL ‘ EQUI -TRANSIT- X’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Registered horse
I.21□For transit I.22
Third country ISO country code I.23
L 113 /538  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /539
COUNTRY Certificate model EQUI -TRANSIT -XPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animal described in Part I:
II.1.1. is not intended for slaughter for human consumption and not intended for slaughter in the 
framework of the eradication of a disease communicable to equine animals, and
(1)either [is a registered equine animal, as defined in Article 2(30) of Commission Delegated 
Regulation (EU) 2019/2035.]
(1)or [is a registered horse as defined in Article 2(30) of Delegated Regulation (EU) 2019/2035.]
(1)or [is an equine animal other than a registered equine animal or a registered horse.]
II.1.2. has not shown signs or symptoms of diseases listed for equine anima ls in Commission 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date dd/mm/yyyy)(2), this being within the 48 hour period, or in the 
case of a registered horse within the 48 hour period or on the last working day, prior to 
departure from the registered establishment.
II.1.3. meets the requirements attested in points II.2. to II.5. of this certificate;
II.1.4. is accompanied by a written declaration, signed by the operator of the animal, which forms 
partof this certificate.
II.2. Attestation on third country, territory or zone thereof and on establishment of dispatch
II.2.1. The equine animal described in Part I is dispatched from …………………... ( insert name 
of country, territory or zone thereof ), a country, territory or zone thereof, which on the date 
of issuing this certificate has the Code: ………..…(3)and is assigned to Sanitary Group 
……(3).
II.2.2. In the country or territory of dispatch the following diseases are compulsorily notifiable: 
African horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia 
mallei (glanders), surra (Trypanosoma evansi), dourine ( Trypanosoma equiper dum), equine 
infectious anaemia, infection with rabies virus and anthrax.
II.2.3. The equine animal described in Part I comes from a country, territory or zone thereof in 
which there has been no clinical, serological (in unvaccinated equine animals) or 
epidemiological evidence of African horse sickness during the 24 month period prior to the 
date of departure of the animal and there have been no systematic vaccinations against 
African horse sickness during the 12 month period prior to the date of departure.
II.2.4. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(1)either [infection with Burkholderia mallei (glanders) has not been reported during the 36 month 
period prior to the date of departure of the animal.]
L 113 /540  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -X
(1)or [a surveillance and eradication programme for infection with Burkholderia mallei
(glanders) recognised by the European Union(2)has been carried out during the 36 month 
period prior to the date of departure, and
(1)either [infection with Burkholderia mallei (glanders) has not been reported in the 
establishment of dispatch during the 36 month period prior to the date of departure 
of the animal.]
(1)or [infection with Burkholderia mallei (glanders) has been reported in the 
establishment during the 36 month period prior to the date of departure of the 
animal and following the last outbreak, the establishment has remained under 
movement restriction s
(1)either [until the remaining equine animals in the establishment have been 
subjected to a complement fixation test for infection with Burkholderia mallei (glanders)
(4), carried out, with negative results at a serum dilution of 
1 in 5, on samples taken at least 6 m onths after the infected animals have 
been killed and destroyed.]]]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was killed 
and destroyed.]]]
II.2.5. The equi ne animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(1)either [surra has not been reported during the 24 month period prior to the date of departure.]
(1)or [a surveillance and eradication pro gramme for surra recognised by the European Union(2) 
has been carried out during the 24 month period prior to the date of departure of the animal, 
and
(1)either [surra has not been reported in the establishment during the 24 month period prior to the date of departure of the animal.] ]
(1)or [surra has been reported in the establishment during the 24 month period prior to 
the date of departure of the animal, and following the last outbreak the 
establishment has remained under movement restriction s
(1)either [until the remaining animals in the establishment have been subjected to an 
enzyme- linked immunosorbent assay (ELISA) for trypanosomosis or card 
agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4
(4)carried out, with negative results, on samples taken at least 6 months 
after the last infected animal has been removed from the establishment.]]]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment , after the last animal of listed species on the es tablishment 
was either killed and destroyed or slaughtered.]]]
II.2.6. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(1)either [dourine has not been reported during the 24 month period prior to the date of departure of 
the animal.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /541
COUNTRY Certificate model EQUI -TRANSIT -X
(1)or [a surveillance and eradication programme for dourine recognised by the European Union(2) 
has been carried out during the 24 month period prior to the date of departure of the animal, 
and
(1)either [dourine has not been reported in the establishment during the 24 month period prior to the date of departure of the animal.] ]
(1)or [dourine has been reported in the establishment during the 24 month period prior to the date of departure of the ani
mal, and following the last outbreak, the 
establishment has remained under movement restriction s
(1)either [until the remaining equine animals in the establishment, except castrated 
male equine animals, have been subjected to a complement fixation test fo r
dourine, carried out with negative results at a serum dilution of 1 in 5(4)on
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals 
have been castrated.]] ]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was either 
killed and destroyed or slaughtered.]] ]
II.2.7. The equine animal described in Part I comes from an esta blishment in which 
(1)either [equine infectious anaemia has not been reported during the 12 month period prior to the date of departure of the animal.]
(1)or [equine infectious anaemia has been reported during the 12 month period prior to the date of departure of the animal and following the last outbreak the establishment has remained 
under movement restrictions
(1)either [until the remaining equine animals in the establishment have been subjected to an agar gel immuno -diffusion test (AGID or Coggins test) or ELISA
(4)for equine 
infectious anaemia carried out, with negative results, on samples taken on two 
occasions with a minimum interval of 90 days following cleaning and disinfection 
of the establishment after the infected animals have been killed a nd destroyed or 
slaughtered.]]
(1)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was either killed 
and destroyed or slaughtered.]]
II.2.8. The equine animal described in Part I comes from an establishment in which 
II.2.8.1. infection with rabies virus in kept terrestrial animals has not been reported during 
the 30 day period prior to the date of departure of the animal;
II.2.8.2. anthrax in ungulates has not been reported during the 15 day period prior to the 
date of departure of the animal.
II.2.9. To the best of my knowledge and as declared by the operator, the equine animal described 
in Part I has not been in contact with kept animals of l isted species which did not comply 
with the requirements referred to in points II.2.3. to II.2.8.1 during the 30 day period prior 
to the date of departure of the animal, and with the requirement referred to in point II.2.8.2. 
during the 15 day period prior to the date of departure of the animal.
L 113 /542  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -X
II.3. Attestation of residence and pre -export isolation
II.3.1. During the 40 day period prior to the date of its departure, or since birth if it is less than 40 
days of age, the equine animal described in Part I
(1)either [has been continuously resident in the country, territory or zone thereof of dispatch;]
(1)or [entered the country, territory or zone thereof of dispatch on one or more occasions from
(1)either [a Member State of the European Union or Norway;]]
(1)and/or [a country, territory or zone thereof that is authorised for entry into the Union of 
registered horses, and from which it was imported into the country, territory or 
zone thereof of dispatch under conditions at least as strict as those required i n
accordance with Union legislation for the entry of registered horses from this 
country, territory or zone thereof directly to the Union, and which is:
(1)either [assigned to the same Sanitary Group ……….. (3)as the country, territory 
or zone thereof of dispatch;]]]
(1)and/or[assigned to Sanitary Group A, B or C;]]]
(1)and/or[China(5)(6), Hong Kong, Japan, Korea Republic, Macao, Singapore or the 
United Arab Emirates.]]]
(1)either [II.3.2. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group A, B, C, D or G, and 
(1)either [during the 30 day period prior to the date of its departure, or since birth if it is less than 30 
days of age or since entry from a Member State of the European Union or Norway, 
(1)either [it has been kept apart from other equine animals, except in case of a foal at foot of his mother, in an establishment situated in a country, territory or zone thereof 
assigned to Sanitary Group A.]]]
(1)or [it has been kept in pre -export isolation from other equine animals, except in case 
of a foal at foot of his mother, in an establishment situated in a country, territory or 
zone thereof assigned to Sanitary Group B, C, D or G.]]]
(1)or [it is a registered horse which has been kept in establishments under veterinary supervision 
during the 30 day period prior to the date of its departure, or since entry in accordance with point II.3.1 from a Member State of the European U nion or Norway or a country, territory 
or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G.]]
(1)(7)or [II.3.2. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, a nd 
(1)either [during the 40 day period prior to the date of its departure, or since birth if it is less than 40 
days of age, or since entry in accordance with point II.3.1 from a Member State of the European Union or Norway, or a country, territory or zon e thereof which is assigned to 
Sanitary Group A, B, C, D, E or G, it has been kept 
(1)either [in isolation in an establishment protected from insect vectors.]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /543
COUNTRY Certificate model EQUI -TRANSIT -X
(1)or [in an establishment under veterinary supervision, and the country, territory or 
zone thereof of dispatch is recognised by the World Organisation for Animal 
Health (OIE) as officially free of African horse sickness.]]]
(1)or [is a registered horse which has been kept during the 30 day period prior to the date of its 
departure, or since entr y in accordance with point II.3.1 from a Member State of the 
European Union or Norway or a country, territory or zone thereof which is assigned to 
Sanitary Group A, B, C, D, E or G, in establishments under veterinary supervision, and the 
country, territory or zone thereof of dispatch is recognised by the OIE as officially free of 
African horse sickness.]]
(1)(7)or [II.3.2. The registered horse described in Part I is dispatched from a country, territory or zone 
thereof assigned to Sanitary Group F, and: 
(1)either [during at the 40 day period prior to the date of departure it has been kept in the approved 
quarantine station of …………………………. ( insert name of quarantine station ), 
confined to the vector -protected premises at least from two hours prior to sunset until two 
hours after sunrise and exercise was provided under official veterinary supervision, 
following the application of insect repellents in combination with an insecticide effective 
against Culicoides prior to the removal from the quarantine stables, and in strict isolation 
from equine animals not being prepared for export under conditions at least as strict as 
required for entry into the Union.]]
(1)or [during the 14 day period prior to the date of its departure has been permanently confined in 
the ap proved vector- proof quarantine station of …………………………. ( insert name of 
quarantine station ) and constant monitoring of the vector protection has proven absence of 
insect vectors inside the vector -proof part of the quarantine station.]]
II.4. Attestation of v accination and health tests
(1)either [II.4.1. The equine animal described in Part I was not vaccinated against African horse sickness in 
the country, territory or zone thereof of dispatch and there is no information suggesting 
previous vaccination.]
(1)or [II.4.1. The equine animal described in Part I was vaccinated against African horse sickness more than 12 months prior to the date of its departure.]
(1)(7)or [II.4.1. The registered horse described in Part I was vaccinated against African horse sickness not 
more than 24 months and at least 40 days prior to the date of entry in the vector -protected 
or vector –proof quarantine station situated in a country, territory or zone thereof assigned to 
Sanitary Group F, and this vaccination consisted of a complete p rimary course of 
vaccination against African horse sickness, or a revaccination within the period of validity 
of the previous vaccination, by administration according to manufacturer's instructions of a 
registered vaccine which is protective against the ci rculating serotypes of the African horse 
sickness virus, and the last vaccination was applied on …………….. (insert date) .]
II.4.2. The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the 60 day period prior to the date of its departure, and 
(1)either [it comes from an establishment situated in a country or territory in which Venezuelan 
equine encephalomyelitis has not been reported during the 24 month period prior to the date 
of its departure.]
L 113 /544  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -X
(1)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not 
been reported during the last 6 months prior to the date of its departure and which is 
situated in a country, territory or zone thereof in which a surveillance and e radication 
programme for Venezuelan equine encephalomyelitis recognised by the European Union(2)
has been carried out during the 24 month period prior to the date of its departure, and 
during the 21 day period prior to the date of departure of the animal described in Part I, all 
equine animals in the establishment have remained clinically healthy, and 
(1)either [the equine animal described in Part I has been kept protected from attacks by 
insect vectors in a quarantine station, in which any equine animal t hat showed a 
rise in daily taken body temperature has been subjected with negative result to a 
virus isolation test for Venezuelan equine encephalomyelitis(4); and the equine 
animal described in Part I 
(1)either [was vaccinated against Venezuelan equine encephalomyelitis with a 
complete primary course and revaccinated according to manufacturer's 
recommendations not less than 60 days and not more than 12 months prior 
to the date of departure;]]]
(1)or [was subjected to a haemagglutination inhibition test f or Venezuelan 
equine encephalomyelitis(4), carried out, with negative result, on a sample 
taken not less than 14 days after the date of its entry into the quarantine station.]]]
(1)or [the body temperature of the equine animal described in Part I has been taken 
daily, either without a rise or the animal has been subjected to a virus isolation test 
for Venezuelan equine encephalomyelitis with negative result, and the equine 
animal described in Part I has been subjected to
− a haemagglutination inhibition test for Venezuelan equine 
encephalomyelitis(4), without an increase in antibody titre, carried out on 
paired samples taken on two occasions with an interval of 21 days, the 
second of which was taken within the 10 day period prior to the date of its 
departure, and
− a reverse transcription -polymerase chain reaction (RT -PCR) for the 
detection of Venezuelan equine encephalomyelitis virus genome(4), with 
negative result, carried out on a sample taken within the 48 hour period prior to its departure, and
− protection fr om attacks by insect vectors during the period after sampling 
until loading for dispatch, by combined use of approved insect repellents 
and insecticides on the animal and disinsectization of the stable and the 
means in which it is transported.]]
(1)(7)either [II.4.3. The equine animal described in Part I is dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, where it was continuously resident since 
birth, and did not come into contact with equine animals which have entered Iceland from 
other countries.]
(1)or [II.4.3. The equine animal described in Part I was subjected with negative result to an agar gel 
immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infectious 
anaemia(4)carried out on a bloo d sample taken on …………… (insert date), this being
within
(1)either [the 30 day period prior to the date of its departure.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /545
COUNTRY Certificate model EQUI -TRANSIT -X
(1)(7)or [the 90 day period prior to the date of its departure from a country, territory or zone thereof 
assigned to Sanitary Group A.]]
(1)[II.4.4. The equine animal described in Part I is dispatched from a country, territory or zone thereof assigned to Sanitary Group B, D or E, or from China, or from a country or territory in 
which infection with Burkholderia mallei (glanders) has been reported during the 36 month 
period prior to the date of departure, and was subjected to a complement fixation test for 
infection with Burkholderia mallei (glanders)
(4)carried out with negative result at a serum 
dilution of 1 in 5 on a blood sample taken on ……………………. ( insert date), within the 
30 day period prior to the date of departure.]
(1)[II.4.5. The equine animal described in Part I is an uncastrated male or female equine animal older 
than 270 days dispatched from a country, territory or zone thereof assigned to Sanitary 
Group B, D, E or F, or from China, or from a country in which dourine has been reported 
during the 24 month period prior to the date of departure, and was subjected to a 
complement fixation test for dourine(4)carried out with negative result at a serum dilution 
of 1 in 5 on a blood sample taken on ……………………. ( insert date), within the 30 day 
period prior to the date of departure, and the equine animal described in Part I has not been 
used for breeding during the 30 day period pr ior to and after the date the sample was taken.]
(1)[II.4.6. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, from Brazil, Bolivia, Uruguay or from a country or territory in which surra was reported during the 24 month period prior to the date of departure, and 
was subjected to a card agglutination test for trypanosomosis (CATT)
(4), carried out with 
negative result at a serum dilution of 1 in 4 on a blood sample taken on 
……………………. ( insert date ), within the 30 day period prior to the date of departure.]
(1)(7)[II.4.7. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
which is assigned to Sanitary Group E, and 
(3)either [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8)
carried out by the same laboratory on the same day on blood samples taken on two 
occasions with an interval of between 21 and 30 days, on …………………… (insert date) and on ………………… (insert date ), the second of which was taken within the 10 day 
period prior to the date of departure,
(3)either [with negative results in each case.]]]
(3)or [with a positive result in the first sample, and 
(3)either [the second sample was subsequently tested with ne gative result in a 
Real-time RT -PCR(8).]]]]
(3)or [the two samples were tested without more than a two -fold increase in 
antibody titre in a virus neutralisation test as described in point 2.4 of 
Chapter 2.5.1. of the OIE Terrestrial Manual for Diagnostic T ests and 
Vaccines.]]]]
(1)or [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8)
with negative result on a blood sample taken on ……………… (insert date), within a 
period of 21 days prior to the date of departure, and the c ountry or territory of dispatch is 
recognised by the OIE as officially free of African horse sickness.]]
L 113 /546  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -X
(1)or [it is a registered horse not vaccinated against African horse sickness and dispatched from a 
country, territory or zone thereof which is recognised by the World Organisation for 
Animal Health (OIE) as officially free of African horse sickness.]]
(1)(7)[II.4.8. The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group F, and 
(1)either [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8)
carried out by the same laboratory on the same day on blood samples taken on two 
occasions with an interval of between 21 and 30 days, on …………………… (insert date)
and on ………………… (insert date) , the first sample not taken less than 7 days after 
introduction into the vector -protected quarantine station, the second sample taken within 
the 10 day period prior to the date of departure,
(1)either [with negative results in each case.]]]
(1)or [with a positive result in the first sample, and
(1)either [the second sample was subsequently tested with negative result in a 
Real-time RT -PCR(8).]]]]
(1)or [the two samples were tested without more than a two -fold increase in 
antibo dy titre in a virus neutralisation test as described in point 2.4 of 
Chapter 2.5.1. of the OIE Terrestrial Manual for Diagnostic Tests and 
Vaccines.]]]]
(1)or [it was subjected to an indirect ELISA or a blocking ELISA and a Real -time RT -PCR for 
African hor se sickness(8)carried out with negative result in each case on a blood sample 
taken on ………………… ( insert date ) not less than 28 days after the date of introduction 
into the vector -protected quarantine station and within the 10 day period prior to the date o f
departure.]]
(1)or [it was subjected to a Real -time RT -PCR for African horse sickness(8), carried out with 
negative result on a blood sample taken on ………………… ( insert date ) not less than 14 
days after the date of introduction into the vector -proof quarant ine station and not more 
than 72 hours before departure.]]
II.5. Attestation of the transport conditions
(1)(7)either [II.5.1. The equine animal described in Part I is dispatched from a country, territory o rzone thereof 
assigned to Sanitary Group A, B, C, D, E or G and arrangements have been made to 
transport it directly to the Union, without subjecting the animal to any assembly operation 
and without coming into contact with other equine animals not complying with at least the same health requirements as described in this health certificate.]
(1)(7)or [II.5.1. The animal is dispatched from a country, territory or zone thereof which is assigned to Sanitary Group F and arrangements have been made to transport it directly from the vector -
protected or vector –proof quarantine station without coming into contact with other equine 
animals not complying with at least the same health requirements as described in this health 
certificate
(1)either [to the airport under vector- protected conditions and arrangements have been made for the 
aircraft to be cleansed and disinfected in advance with a disinfectant officially recognised in 
the third country of dispatch, and sprayed against insect vectors just prior to take off.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /547
COUNTRY Certificate model EQUI -TRANSIT -X
(1)or [to a sea port in that country, territory or zone thereof under vector -protected conditions and 
arrangements have been made to transport it on a vessel which is scheduled directly to a 
port in the Union without calling into a port situated in a country, territory, or zone thereof 
not approved for the entry into the Union of equine animals, in stalls which were cleansed 
and disinfected in advance with a disinfectant officially recognised in the third country of 
dispatch and sprayed against insect vectors just prior to departure.]]
II.5.2. Arrangeme nts have been made and verified to prevent any contact with other equine 
animals not complying with at least the same health requirements as described in this health 
certificate during the period from certification until dispatch to the Union.
II.5.3. The transport vehicles or containers in which the animal is going to be loaded were cleaned 
and disinfected before loading with a disinfectant officially recognised in the third country of dispatch and they are so constructed that faeces, urine, litter or fodd er cannot escape 
during transportation.
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the count ry, territory or zone thereof of dispatch as appearing in 
column 2 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27: “Identification system” : The animal must be individually identified with one of the 
means of identificat ion defined in point (a), (c), (e), or (g) of Annex III to Delegated 
Regulation (EU) 2019/2035, or be identified by an alternative method in accordance 
with Article 62 of that Regulation (e.g. brand) 
provided it is recorded in its 
identification document ( passport). Specify the identification system and the anatomic 
place used on the animal. If a passport accompanies the animal, its number should be 
stated and the name of the competent authority which validated it.
“Age” : Date of birth (dd/mm/yyyy).
“Sex”: M = male, F = female, C = castrated.
L 113 /548  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -X
Part II:
(1)Delete as appropriate.
(2)The certificate must be issued within the 48 hour period prior to loading or on the last working day before 
loading of the animal for dispatch to the Member State of destination in the Union.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.1.1., or du ring a period where restrictive measures have been adopted by the Union against the 
entry of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of 
Part1 of Annex IV to Implementing Regulation (EU) 2021/404.
(3)Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
(4)Tests for glanders, surra, dourine, equine infectious anaemia and Venezue lan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop
(5)Zone of country or territory authorised for entry into the Union as appearing in columns 2 and 5 
respectively of Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
(6)Only authorised if country of dispatch is assigned to Sanitary Group G.
(7)Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to 
which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that the 
numbering of the subsequent statements is maintained.
(8)Tests for African horse sickness described by the European Union Reference Laboratory for African horse 
sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -diagnostico.aspx
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /549
Declaration by the operator responsible for the transit through the Union of the consignment of 
equine animal not intended for slaughter
Identification of the animal(1)
Species (Scientific name) Identification system
……………………….Identification number
……………………….Age
……………….Sex
…………
I, the undersigned operator of the equine animal described above, hereby declare, that:
- the equine animal 
(2)either [has remained in …………………... ( insert name of country, territory or zone thereof of dispatch ) during a period 
of at least 40 days prior to the date of dispatch;]
(2)or [entered …………………... ( insert name of country, territory or zone thereof of dispatch ) during the required 
residence period of at least 40 days prior to the date of dispatch:
(a) on……….(insert date) from………….………. (insert name of country or territory from where the 
horse entered the country, territory or zone thereof of dispatch)
(b) on……….(insert date) from………….………. (insert name of country or territory from where the
horse entered the country, t erritory or zone thereof of dispatch)
(c) on……….(insert date ) from………….………. (insert name of country or territory from where the 
horse entered the country, territory or zone thereof of dispatch);]
- during the period of 15 days prior to the date of departur e the equine animal has not been in contact with animals 
suffering from infectious or contagious diseases transmissible to equine animals;
- the transportation will be effected in such a way that health and welfare of the equine animal can be protected eff ectively 
at all stages of the journey;
- the conditions for residence and pre -export isolation as applicable in accordance with point II. 3. of the accompanying 
health certificate for the country, terri tory or zone thereof of dispatch are fulfilled;
- the conditions for the transport as applicable in accordance with point II.5. of the accompanying health certificate for the 
country or part of the territory of the country of dispatch are fulfilled;
- the equine animal is scheduled to leave the Union on ………………………….…… (date ) at the border post of 
……………………………… ( insert name and place of border post of exit );
Name and address of the operator: ……………………………………………………..
Date: …………………………(dd/mm/yyyy )
…………………………………………………………………………………………………………………..
(Signature )
(1)Identification system : The animal must be individually identified with one of the means of identification defined in point (a), (c), (e) or (g) of A nnex III to 
Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance wit h Article 62 of that Regulation provided it is recorded in 
its identification document (passport) . Specify the identification system (such as ear tag, tattoo, brand, transponder) and the anatomic place used on the 
animal.
If a passport accompanies the animal, its number should be stated and the name of the competent authority which validated it.
Age: Date of birth (dd/mm/yyyy).
Sex(M = male, F = female, C = castrated).
(2)Delete as appropriate.
L 113 /550  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 15
MODEL ANIMAL HEALTH CERTIF ICATE AND MODEL DECLARATIO N FOR 
TRANSIT THROUGH THE UNION OF EQUINE ANIM ALS INTENDED FOR 
SLAUGHTER (MODEL ‘ EQUI -TRANSIT- Y’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Slaughter
I.21□For transit I.22
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /551
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
L 113 /552  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -YPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animals(1)of the consignment described in Part I:
II.1.1. are intended for slaughter for human consumption and are not intended for slaughter in the 
framework of the eradication of a disease communicable to equine animals;
II.1.2. have not shown signs or symptoms of diseases listed for equine animals in Commission 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date dd/mm/yyyy )(2), this being within the 48 hour period prior to 
departure 
(3)either [from the registered establishment of origin in the country, territory or zone thereof of dispatch;]
(3)or [from the establis hment approved for conducting assembly operations of equine animals by the 
competent authority in the country, territory or zone thereof of dispatch in accordance with 
requirements at least as stringent as those laid down in Article 5 of Commission Delegat ed 
Regulation (EU) 2019/2035;
II.1.3. meet the requirements attested in points II.2. to II.5. of this certificate, including in case of 
dispatch from an establishment approved for assembly operations;
II.1.4. are accompanied by a written declaration, signe d by the operator of the consignment of animals, 
which forms part of this certificate.
II.2. Attestation on third country, territory or zone thereof and on establishment of dispatch
II.2.1. The equine animals described in Part I are dispatched from ………………… ... (insert name of 
country, territory or zone thereof ), a country, territory or zone thereof, which on the date of 
issuing this certificate has the Code: ………..…(4)and is assigned to Sanitary Group ……(4).
II.2.2. In the country or territory of dispatch the following diseases are compulsorily notifiable: African horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia mallei(glanders), surra (Trypanosoma evansi), dourine ( Trypanosoma equiperdum ), equine infectious 
anaemia, infection with rabies virus and anthrax.
II.2.3. The equine animals described in Part I are dispatched from a country, territory or zone thereof in 
which there has been no clinical, serological (in unvaccinated equine animals) or 
epidemiological evidence of African horse sickness during the 24 month period prior to the date 
of departure of the animal sand there have been no systematic vaccinations against African horse 
sickness during the 12 month period prior to the date of departure.
II.2.4. The equine animals des cribed in Part I come from an establishment of origin situated in a 
country, territory or zone thereof in which
(3)either [infection with Burkholderia mallei (glanders) has not been reported during the 36 month period 
prior to the date of departure of the animals.]
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei (glanders) 
recognised by the European Union(2)has been carried out during the 36 month period prior to the 
date of departure, and
(3)either [infection with Burkholderia mallei (glanders) has not been reported in the 
establishment of origin during the 36 month period prior to the date of departure of the 
animals.] ]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /553
COUNTRY Certificate model EQUI -TRANSIT -Y
(3)or [infection with Burkholderia mallei (glanders) has been reported in the establishment 
of origin during the 36 month period prior to the date of departure of the animals and 
following the last outbreak, the establishment has remained under movement 
restriction s
(3)either [until the remainin g equine animals in the establishment have been subjected 
to a complement fixation test for infection with Burkholderia mallei
(glanders)(5), carried out, with negative results at a serum dilution of 1 in 5, 
on samples taken at least 6 months after the infected animals have been killed 
and destroyed.]]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was killed 
and destroyed.]]]
II.2.5. The equine animals descr ibed in Part I come from an establishment of origin situated in a 
country, territory or zone thereof in which
(3)either [surra has not been reported during the 24 month period prior to the date of departure.]
(3)or [a surveillance and eradication programme for surra recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animals, and
(4)either [surra has not been reported in the establishment of origin during the 24 month period 
prior to the date of departure of the animals.] ]
(3)or [surra has been reported in the establishment of origin during the 24 month period 
prior to the date of departure of the animals, and following the last outbreak the 
establishment has remained under movement restri ction s
(3)either [until the remaining animals in the establishment have been subjected to an enzyme-
linked immunosorbent assay (ELISA) for trypanosomosis or card 
agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4(5)
carried out, wit h negative results, on samples taken at least 6 months after the 
last infected animal has been removed from the establishment.]]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last animal of listed species on the establishment was 
either killed and destroyed or slaughtered.]]]
II.2.6. The equine animals described in Part I come from an establishment of origin situated in a 
country, territory or zone thereof in which
(3)either [dourine has not been reported during the 24 month period prior to the date of departure of the 
animals.]
(3)or [a surveillance and eradication programme for dourine recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animals, and
(3)either [dourine has not been reported in the establishment of origin during the 24 month 
period prior to the date of departure of the animals.] ]
(3)or [dourine has been reported in the establishment of origin during the 24 month period 
prior to the date of departure of the animals, and following the last outbreak, the 
establishment has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment, except castrated 
male equine animal s, have been subjected to a complement fixation test for 
dourine, carried out with negative results at a serum dilution of 1 in 5(5)on
samples taken at least 6 months after the infected animals have been killed and destroyed or slaughtered, or the infecte d entire male equine animals have 
been castrated.]]]
L 113 /554  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -Y
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was either 
killed and destroyed or slaughtered.]]]
II.2.7. The equine animals described in Part I come from an establishment of origin in which 
(3)either [equine infectious anaemia has not been reported during the 12 month period prior to the date of 
departure of the animals.]
(3)or [equine infectious anaemia has been reported during the 12 month period prior to the date of 
departure of the animals and following the last outbreak the establishment has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID or Coggins test) or ELISA(5)for equine 
infectious anaemia carried out, with negative results, on samples taken on two 
occasions with a minimum interval of 90 days following cleaning and disinfection of 
the establishment after the infected animals have been killed and destroyed or 
slaughtered.]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the establishment, 
after the last equine animal on the establishment was either kill ed and destroyed or 
slaughtered.]]
II.2.8. The equine animals described in Part I come from an establishment of origin in which 
II.2.8.1. infection with rabies virus in kept terrestrial animals has not been reported during the 30 
day period prior to the date of departure of the animals;
II.2.8.2. anthrax in ungulates has not been reported during the 15 day period prior to the date of 
departure of the animals.
II.2.9. To the best of my knowledge and as declared by the operator of the consignment, the equine
animals described in Part I have not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.3. to II.2.8.1 during the 30 day period 
prior to the date of departure of the animals, and with 
the requirement referred to in point 
II.2.8.2. during the 15 day period prior to the date of departure of the animals.
II.3. Attestation of residence and pre -export isolation
II.3.1. The equine animals described in Part I have been resident in the country, territory or zone thereof 
of dispatch during the 90 day period prior to the date of departure.
(3)either [II.3.2. The equine animals described in Part I are dispatched from a country, territory or zone thereof 
assigned to Sanitary Group A, B, C, D or G, and during the 30 day period prior to the date of 
departure from the establishment of origin have been kept in pre -export isolation.]
(3)(6)or [II.3.2. The equine animals described in Part I are dispatched from a country, territory or zone thereof assigned to Sanitary Group E, and during the 40 day period prior to the date of departure from 
the establishment of origin, have been kept
(3)either [in isolation in an establishment of origin protected from insect vectors.]]
(3)or [in an establishment of origin u nder veterinary supervision, and the country, territory or zone 
thereof of dispatch is recognised by the World Organisation for Animal Health (OIE) as 
officially free of African horse sickness.]]
(3)[II.3.3. Immediately prior to their dispatch from the cou ntry, territory or zone thereof of dispatch, the 
equine animals of the consignment described in Part I have been kept in the establishment 
approved for assembly operations referred to in point II.1.2. for a period of not more than 6 days 
after leaving thei r respective establishments of origin. In the approved establishment, which 
complies with the requirements for establishments in point II.2., the animals have been kept 
under conditions that effectively protect their health status and without coming into c ontact with 
equine animals not complying with the requirements in points II.2., II.3.1., II.3.2. and II.4. of this 
certificate.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /555
COUNTRY Certificate model EQUI -TRANSIT -Y
II.4. Attestation of vaccination and health tests
II.4.1. The equine animals described in Part I were not vaccinated against African horse sickness in 
the country, territory or zone thereof of dispatch and there is no information suggesting 
previous vaccination.
II.4.2. The equine animals described in Part I have not been vaccinated against Venezuelan equine 
encephalomyelitis du ring the 60 day period prior to the date of departure, and come from an 
establishment situated in a country or territory or zone thereof in which Venezuelan equine 
encephalomyelitis has not been reported during the 24 month period prior to the date of 
depa rture.
(3)either [II.4.3. The equine animals described in Part I are dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, where they have been continuously resident 
since birth, and did not come into contact with e quine animals which have entered Iceland from 
other countries.]
(3)or [II.4.3. The equine animals described in Part I were subjected with negative result in each case to an agar gel immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infectious anaemia
(5)carried out on a blood sample taken on …………… (insert date), within the 30 day 
period prior to the date of departure.]
(3)[II.4.4. The equine animals described in Part I are dispatched from a country, territory or zone thereof 
assigned to Sanitary Group B, D or E, or from a country or territory in which infection with 
Burkholderia mallei (glanders) has been reported during the 36 month period prior to the date 
of departure, and were subjected to a complement fixation test for infection with Burkholderia 
mallei (glanders)(5)carried out with negative result in each case at a serum dilution of 1 in 5 on 
a blood sample taken on ……………………. ( insert date), within the 30 day period prior to the 
date of departure.
(3)[II.4.5. The equine animals described in Part I are uncastrated male or female equine animals older than 
270 days dispatched from a country, territory or zone thereof assigned to Sanitary Group B, D 
or E, or from a country in which dourine has been reported during the 24 month period prior to 
the date of departure, and were subjected to a complement fixation test for dourine(5)carried out 
with negative result in each case at a serum dilution of 1 in 5 on a blood sample taken on ……………………. ( insert date), within the 30 day period prior t o the date of departure.]
(3)[II.4.6. The equine animals described in Part I are dispatched from a country, territory or zone thereof 
which is assigned to Sanitary Group E, from Brazil, Bolivia, Uruguay, or from a country or 
territory in which surra was reported during the 24 month period prior to the date of departure, 
and were subjected to a card agglutination test for trypanosomosis (CATT)(5), carried out with 
negative result in each case at a serum dilution of 1 in 4 on a blood sample taken on 
……………………. (insert date ), within the 30 day period prior to the date of departure.]
(3)(6)[II.4.7. The equine animals described in Part I are dispatched from a country, territory or zone thereof which is assigned to Sanitary Group E, and 
(3)either [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7)carried 
out with negative results in each case by the same laboratory on the same day on blood samples taken on two occasions with an interval of between 21 and 30 days, on …………………… 
(insert date) and on ………………… (insert date) , the second of which was taken within the 10 
day period prior to the date of departure.]]
L 113 /556  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -TRANSIT -Y
(3)or [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7)with 
negative result on a blood sample taken on ……………… (insert date), within the 21 day period 
prior to the date of departure, and the country or territory of dispatch is recognised by the World 
Organisation for Animal Health (OIE) as officially free of A frican horse sickness.]]
II.5. Attestation of the transport conditions
II.5.1. Arrangements have been made to transport this consignment of animals directly to the Union, 
without subjecting the animals after certification to any further assembly operation outside the 
European Union and without coming into contact with other equine animals not complying with 
at least the same health requirements as described in this health certificate.
II.5.2. Arrangements have been made and verified to prevent any contact w ith other equine animals 
not complying with at least the same health requirements as described in this health certificate 
during the period from certification until dispatch to the Union.
II.5.3. The transport vehicles or containers in which the animals ar e going to be loaded were cleaned 
and disinfected before loading with a disinfectant officially recognised in the third country of 
dispatch and they are so constructed that faeces, urine, litter or fodder cannot escape during 
transportation.
Notes:
In acc ordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conju nction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates pr ovided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27: “Identification system” : The animals must be individually identified with o ne of the 
means of identification defined in point (a), (c), (e) or (g) of Annex III to Delegated 
Regulation (EU) 2019/2035 which permits to link the animals to the animal 
health/official certificate. Specify the identification system and the anatomic plac e
used on the animal.
Part II:
(1)There can be one or more equine animals in the consignment.
(2)The certificate must be issued within the 48 hour period prior to loading of the animals for dispatch to the 
Member State of destination in the Union.
The en try into the Union shall not be allowed when the animals were loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.1.1., or during a period where restrictiv e measures have been adopted by the Union against the 
entry of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of 
Part1 of Annex IV to Implementing Regulation (EU) 2021/404 .
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /557
COUNTRY Certificate model EQUI -TRANSIT -Y
(3)Delete as appropriate.
(4)Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
(5)Tests for glanders, surra, dourine, equine infectious anaemia and Venezue lan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop
(6)Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to 
which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that the 
numbering of the subsequent statements is maintained.
(7)Tests for African horse sickness described by the European Union Reference Laboratory for African horse 
sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -diagnostico.aspx
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /558  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Declaration by the operator responsible for the transit through the Union of the consignment of 
equine animals intended for slaughter
Identification of the animals(1)
Total number Species (Scientific 
name)
……………………….Identification system
……………………….Identification number
……………….Quantity
…………
I, the undersigned operator of the consignment of equine animals intended for slaughter described above, hereby declare, that :
- the animals have remained in the country, territory or zone thereof of dispatch for at least 90 days prior to the date of 
dispatch;
- during the period of 15 days prior to the date of dispatch the animals have not been in contact with animals suffering 
from infectious or contagious diseases transmissible to equine animals;
- the conditions for residence and pre -export isolation as applicable in accordance with point II. 3. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled;
- the conditions for the transport as applicable in accordance with point II. 5. of the accompanying health certificate for the 
country, territory or zone thereof of dispatch are fulfilled;
- the transportation will be effected in such a way that health and welfare of the animals can be protected effectively at all 
stages of the journey to the European Union;
- the animals will be sent 
(2)either [directly from the establishment of origin to the slaughterhouse of destination without coming into contact with other equine animals not of the same health status;]
(2)or [from the establishment approved for assembly operations on equine animals to the slaughterhouse of 
destination without coming into contact with other equine animals not of the same health status;]
- arrangements have been made to transport the animals on the territory of the European Union in accordance with 
Regulation (EC) No 1/2005;
- the animals are scheduled to leave the European Union on ………………….. (insert date dd/mm/yyyy ) at the border 
control post of ………………………………. (insert name and place of the border control post of exit ).
Name and address of the operator: ……………………………………………………..
Date: …………………………(dd/mm/yyyy )
…………………………………………………………………………………………………………………..
(Signature )
(1)Identification system : The animals must be individually identified with one of the means of identification defined in point (a), (c), (e) or (g) of Annex III to 
Delegated Regulation (EU) 2019/2035, which permits to link the animal sto the animal health/official certificate . Spec ify the identification system (such as 
ear tag, tattoo, brand, transponder) and the anatomic place used on the animal.
(2)Delete as appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /559
CHAPTER 16
MODEL ANIMAL HEALTH CERTIF ICATE AND MODEL DECLARATIO N FOR 
THE RE- ENTRY INTO THE UNION OF REGISTERED HORSES FOR RACING, 
COMPETITION AND CULTURAL EVENTS AFTER TEMPORARY EXPORT FOR 
A PERIOD OF NOT MORE THAN 30 DAYS (MODEL ‘ EQUI -RE-ENTRY- 30’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Registered horse
I.21 I.22
I.23□For re- entry
L 113 /560  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /561
COUNTRY Certificate model EQUI -RE-ENTRY -30Part II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II. Animal health attestation
I, the undersigned official veterinarian, hereby certify that::
II.1. The equine animal described in Part I:
II.1.1. is a registered horse as defined in Article 2(30) of Commission Delegated Regulation (EU) 
2019/2035, not intended for slaughter in the framework of the eradication of a disease 
communicable to equine animals;
II.1.2. has not shown signs or symptoms of diseases listed for equine animals in Commission 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date dd/mm/yyyy )(1), this being within the 48 hour period or on the last 
working day prior to departure from the registered e stablishment;
II.1.3. meets the requirements attested in points II.2. to II.3. of this certificate;
II.1.4. is accompanied by a written declaration, signed by the operator of the animal, which forms part 
of this certificate.
II.2. Attestation on third coun try, territory or zone thereof and on establishment of dispatch
II.2.1. The animal is dispatched from …………… ( insert name of country, territory or zone thereof ), a 
country, territory or zone thereof which on the date of issuing this certificate has the Code : 
……………(2)and is assigned to Sanitary Group ………..…(2).
II.2.2. In the country or territory of dispatch the following diseases are compulsorily notifiable: African 
horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia mallei
(glanders), surra (Trypanosoma evansi), dourine ( Trypanosoma equiperdum ), equine infectious 
anaemia, infection with rabies virus and anthrax.
II.2.3. The equine animal described in Part I comes from a country, territory or zone thereof in which 
there has been no clinical, serological (in unvaccinated equine animals) or epidemiological 
evidence of African horse sickness during the 24 month period prior to the date of departure of the animal and there have been no systematic vaccinations against African horse sickness during 
the 12 month period prior to the date of departure.
II.2.4.
The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(3)either [infection with Burkholderia mallei (glanders) has not been reported during the 36 month period 
prior to the date of departure of the animal.]
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei (glanders) 
recognised by the European Union(2)has been carried out during the 36 month period prior to the 
date of departure, and
(3)either [infection with Burkholderia mallei (glanders) has not been reported in the 
establishment of dispatch during the 36 month period prior to the date of departure of 
the anim al.]]
(3)or [infection with Burkholderia mallei (glanders) has been reported in the establishment 
during the 36 month period prior to the date of departure of the animal and following 
the last outbreak, the establishment has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei
(glanders)
(4), carried out, with negative results at a serum dilution of 1 in 5, 
on samples t aken at least 6 months after the infected animals have been killed 
and destroyed.]]]
L 113 /562  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -RE-ENTRY -30
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was killed 
and destroyed.]]]
II.2.5. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(3)either [surra has not been reported during the 24 month period prior to the date of departure.]
(3)or [a surveillance and eradication programme for surra recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either [surra has not been reported in the establishment during the 24 months period prior to 
the date of departure of the animal.] ]
(3)or [surra has been reported in the establishment during the 24 month period prior to the 
date of departure of the animal, and following the last outbreak the establishment has 
remained under movement restrictions
(3)either [until the remaining animals in the establishment have been subjected to an 
enzyme- linked immunosorbent assay (ELISA) for trypanosomosis or card 
agglutina tion test for trypanosomosis (CATT) at a serum dilution of 1 in 4(4)
carried out, with negative results, on samples taken at least 6 months after the last infected animal has been removed from the establishment.]]]
(3)or [for at least 30 days from the dat e of cleaning and disinfection of the 
establishment, after the last animal of listed species on the establishment was 
either killed and destroyed or slaughtered.]]]
II.2.6. The equine animal described in Part I comes from an establishment situated in a cou ntry, 
territory or zone thereof in which
(3)either [dourine has not been reported during the 24 month period prior to the date of departure of the 
animal.]
(3)or [a surveillance and eradication programme for dourine recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either [dourine has not been reported in the establishment during the 24 month period prior to the date of departure of the animal.] ]
(3)or [dourine has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak, the establishment 
has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment, except castrated 
male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5
(4)on
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been castrated.]] ]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was either 
killed and destroyed or slaughtered.]] ]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /563
COUNTRY Certificate model EQUI -RE-ENTRY -30
II.2.7. The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the 60 day period prior to the date of its departure, and 
(3)either [it comes from an establishment situated in a country or territory in which Venezuelan equine 
encephalomyelitis has not been reported during the 24 month period prior to the date of its 
departure.]
(3)or [it comes from an establishment in which Venezuelan equine encephalomy elitis has not been 
reported during the 6 month period prior to the date of its departure and which is situated in a 
country, territory or zone thereof in which a surveillance and eradication programme for 
Venezuelan equine encephalomyelitis recognised by the European Union(2)has been carried out 
during the 24 month period prior to the date of its departure. ]
II.2.8. The equine animal described in Part I comes from an establishment in which 
(3)either [equine infectious anaemia has not been reported during the 12 month period prior to the date of 
departure of the animal.]
(3)or [equine infectious anaemia has been reported during the 12 month period prior to the date of 
departure of the animal and following the last outbreak the establishment has remained un der 
movement restriction s
(3)either [until the remaining equine animals in the establishment have been subjected to an agar gel immuno -diffusion test (AGID or Coggins test) or ELISA
(4)for equine 
infectious anaemia carried out, with negative results, on s amples taken on two 
occasions with a minimum interval of 90 days following cleaning and disinfection 
after the infected animals have been killed and destroyed or slaughtered.]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the e stablishment,
after the last equine animal on the establishment was either killed and destroyed or 
slaughtered.]]
II.2.9. The equine animal described in Part I comes from an establishment in which 
II.2.9.1. infection with rabies virus in kept terrestrial animals has not been reported during the 30 
day period prior to the date of departure of the animal;
II.2.9.2. anthrax in ungulates has not been reported during the 15 day period prior to the date of 
departure of the animal.
II.2.10. To the best of my knowledge and as declared by the operator, the equine animal described in 
Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.3. to II.2.9.1. during the 30 day period prio r to the date of 
departure of the animal, and with the requirement referred to in point II.2.9.2. during the 15 day 
period prior to the date of departure of the animal.
II.3. Attestation of residence and pre -export isolation
II.3.1. The animal described in
Part I was imported into the country, territory or zone thereof of 
dispatch on ………………………………… (insert date)
(3)either [directly from the European Union Member State ……………………..… ( insert name of EU 
Member State).]
(3)or [from a country, territory or zone thereof …………………… ( insert name of country, territory 
or zone thereof ) authorised for entry of registered horses into the Union, under conditions at 
least as strict as those set out in this certificate.]
L 113 /564  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -RE-ENTRY -30
II.3.2. The animal described in Part I exited from the European Union less than 30 days ago, and since 
exit from the European Union it was never in a country, territory or zone thereof(2)other than 
those of the same Sanitary Group as the country, territory or zone thereof of dispatch, and 
resident in esta blishments under veterinary supervision, accommodated in separated stables 
without coming into contact with equine animals of lower health status, except during racing, 
competition or the cultural event.
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27: “Identification system” : The animal must be individually identified with one of the 
means of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accor dance 
with Article 62 of that Regulation (e.g. brand) 
provided it is recorded in its 
identification document (passport). Specify the identification system and the anatomic place used on the animal. The number of the accompanying passport or the Unique 
Code
, if no passport number is available, should be stated and the name of the 
competent authority which validated it.
“Age” : Date of birth ( dd/mm/yyyy).
“Sex” : M = male, F = female, C = castrated.
Part II:
(1)The certificate must be issued within the 48 hours period of loading or on the last working day before 
loading of the animal for dispatch to the Member State of destination in the Union.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restrictive measures have been adopted by the Union against the 
entry of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of 
Part1 of Annex IV to Implementing Regulation (EU) 2021/404.
(2)Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex IV to Impl ementing Regulation (EU) 2021/404.
(3)Delete as appropriate.
(4)Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop
Official veterinarian
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /565
COUNTRY Certificate model EQUI -RE-ENTRY -30
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /566  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Declaration by the operator responsible for the re- entry in to the Union after temporary 
export of a registered horse for racing, competition and cultural events
Identification of the animal(1)
Species (Scientific name)
Equus caballusIdentification system
……………………….Identification number
……………………….Age
……………….Sex
…………
I, the undersigned operator of the registered horse described above, hereby declare, that:
- the registered horse 
(2)either [was temporarily exported from the Union to the country of dispatch on…………………... (insert date) less 
than 30 days prior to this declaration;]
(2)or [entered the country of dispatch on ……………….. (insert date) from………….……….(insert name of 
country from where horse entered country of dispatch);]
- during the period of 15 days prior to the date of dispatch the horse has not been in contact with animals suffering from 
infectious or contagious diseases transmissible to equine animals;
- the transportation will be effected in such a way that health and welfare of the horse can be protected effectively at all 
stages of the journey;
- the conditions for residence and pre -export isolation as applicable in accordance with point II. 3. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled.
Name and address of the operator: ……………………………………………………..
Date: …………………………(dd/mm/yyyy )
…………………………………………………………………………………………………………………..
(Signature )
(1)Identification system : The animal must be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to 
Delegated Regulation (EU) 2019/2035 ,or be identified by an alternative method in accordance with Article 62 of that Regulation provided it is recorded in its 
identification document (passport). Specify the identification system (such a s tattoo, brand, transponder etc.) and the anatomic place used on the animal.
The number of the accompanying passport or the Unique Code, if no passport number is available, should be stated and the name of the competent authority 
which validated the passp ort.
Age: Date of birth (dd/mm/yyyy).
Sex(M = male, F = female, C = castrated).
(2)Delete as appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /567
CHAPTER 17
MODEL ANIMAL HEALTH CERTIF ICATE AND MODEL DECLARATIO NFOR
THE RE- ENTRY INTO THE UNION OF REGISTERED HORSES FOR 
COMPETITION AFTER TEMPORARY EXPORT FOR A PERIOD OF NOT MORE 
THAN 90 DAYS TO PARTICIPATE IN EQUESTRIAN EVENTS ORGANISED 
UNDER THE AUSPICES O F THE FÉDÉRATION EQUESTRE INTERNATIONALE
(FEI) (MODEL ‘ EQUI -RE-ENTRY- 90-COMP ’)
(Test event in preparation of the Olympic Games, Paralympics, World Equestrian Games/World Championship, 
Asian Equestrian Games, American Equestrian Games (including the PanAmerican Games, South American 
Games, Central American and Caribbean Gam es), Endurance World Cup in United Arab Emirates, LG Global 
Champions Tour, United Arab Emirates International Show Jumping League)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Germinal products □Registered horse
I.21 I.22
I.23□For re- entry
L 113 /568  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /569
COUNTRY Certificate model EQUI -RE-ENTRY -90-COMPPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animal described in Part I:
II.1.1. is a registered horse as defined in Article 2(30) of Commission Delegated Regulation (EU) 
2019/2035, not intended for slaughter in the framework of the eradication of a disease 
communicable to equine animals;
II.1.2. has not shown signs or symptoms of diseases listed for equine animals in Commission 
Implementing Regula tion (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date dd/mm/yyyy )(1), this being within the 48 hour period or on the last 
working day prior to departure from the registered establishment;
II.1.3. meets the requirements att ested in points II.2. to II.3. of this certificate;
II.1.4. is accompanied by a written declaration, signed by the operator of the animal, which forms part 
of this certificate.
II.2. Attestation on third country, territory or zone thereof and on establishment of dispatch
II.2.1. The animal is dispatched from …………… ( insert name of country, territory or zone thereof ), a 
country, territory or zone thereof which on the date of issuing this certificate has the Code: 
……………(2)and is assigned to Sanitary Group ……… ..…(2).
II.2.2. In the country or territory of dispatch the following diseases are compulsorily notifiable: African 
horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia mallei
(glanders), surra (Trypanosoma evansi), dourine ( Trypanosoma equiperdum ), equine infectious 
anaemia, infection of rabies virus and anthrax.
II.2.3. The equine animal described in Part I comes from a country, territory or zone thereof in which 
there has been no clinical, serological (in unvaccinated equine a nimals) or epidemiological 
evidence of African horse sickness during the 24 month period prior to the date of departure of the animal and there have been no systematic vaccinations against African horse sickness during 
the 12 month period prior to the date of departure.
II.2.4.
The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(3)either [infection with Burkholderia mallei (glanders) has not been reported during the 36 month period 
prior to the date of departure of the animal.]
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei (glanders) 
recognised by the European Union(2)has been carri ed out during the 36 month period prior to the 
date of departure, and
(3)either [infection with Burkholderia mallei (glanders) has not been reported in the 
establishment of dispatch during the 36 month period prior to the date of departure of 
the animal.] ]
(3)or [infection with Burkholderia mallei (glanders) has been reported in the establishment 
during the 36 month period prior to the date of departure of the animal and following 
the last outbreak, the establishment has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei
(glanders)
(4), carried out, with negative results at a serum dilution of 1 in 5, 
on samples taken at least 6 months after the infected animals have been killed 
and destroyed.]]]
L 113 /570  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -RE-ENTRY -90-COMP
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was killed 
and destroyed.]]]
II.2.5. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(3)either [surra has not been reported during the 24 month period prior to the date of departure.]
(3)or [a surveillance and eradication programme for surra recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either [surra has not been reported in the establishment during the 24 month period pr ior to 
the date of departure of the animal.] ]
(3)or [surra has been reported in the establishment during the 24 month period prior to the 
date of departure of the animal, and following the last outbreak the establishment has 
remained under movement restric tions
(3)either [until the remaining animals in the establishment have been subjected to an 
enzyme- linked immunosorbent assay (ELISA) for trypanosomosis or card 
agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4(4)
carried out, with negative results, on samples taken at least 6 months after the 
last infected animal has been removed from the establishment.]]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last animal of listed s pecies on the establishment was 
either killed and destroyed or slaughtered.]]]
II.2.6. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(3)either [dourine has not been reported duri ng the 24 month period prior to the date of departure of the 
animal.]
(3)or [a surveillance and eradication programme for dourine recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either [dourine has not been reported in the establishment during the 24 month period prior 
to the date of departure of the animal.] ]
(3)or [dourine has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak, the establishment 
has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment, except castrated 
male equine animals, have been subjected to a complem ent fixation test for 
dourine, carried out with negative results at a serum dilution of 1 in 5(4)on
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been castrated.]]]
(3)or [for at least 30 days following cleaning and disinfection of the establishment,
after the last equine animal on the establishment was either killed and 
destroyed or slaughtered.]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /571
COUNTRY Certificate model EQUI -RE-ENTRY -90-COMP
II.2.7. The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the 60 day period prior to the date of its departure, and 
(3)either [it comes from an establishment situated in a country or territory in whic h Venezuelan equine 
encephalomyelitis has not been reported during the 24 month period prior to the date of its 
departure.]
(3)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been 
reported during the 6 month period p rior to the date of its departure and which is situated in a 
country, territory or zone thereof in which a surveillance and eradication programme for 
Venezuelan equine encephalomyelitis recognised by the European Union(2)has been carried out 
during the 24 month period prior to the date of its departure. ]
II.2.8. The equine animal described in Part I comes from an establishment in which 
(3)either [equine infectious anaemia has not been reported during the 12 month period prior to the date of departure of the animal.]
(3)or [equine infectious anaemia has been reported during the 12 month period prior to the date of departure of the animal and following the last outbreak the establishment has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment have been subjected to an agar gel immuno -diffusion test (AGID or Coggins test) or ELISA
(4)for equine 
infectious anaemia carried out, with negative results, on samples taken on two 
occasions with a minimum interval of 90 days following cleaning and disinfection 
after the infected animals have been killed and destroyed or slaughtered.]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the establishment,
after the last equine animal on the estab lishment was either killed and destroyed or 
slaughtered.]]
II.2.9. The equine animal described in Part I comes from an establishment in which 
II.2.9.1. infection with rabies virus in kept terrestrial animals has not been reported during the 30 
day period prior to the date of departure of the animal;
II.2.9.2. anthrax in ungulates has not been reported during the 15 day period prior to the date of 
departure of the animal.
II.2.10. To the best of my knowledge and as declared by the operator, the equine animal described in 
Part I has not been in contact with kept animals of listed species which did not comply with the 
requirements referred to in points II.2.3. to II.2.9.1 during the 30 day period prior to the date of departure of the animal, and with the requirement referred to in point II.2.9.2. during the 15 day 
period prior to the date of departure of the animal.
II.3. Attestation of residence and pre -export isolation
II.3.1. The animal described in Part I was imported into the country, territory or zon
e thereof of 
dispatch on ………………………………… (insert date)
(3)either [directly from the European Union Member State ……………………..… ( insert name of EU 
Member State).]
(3)or [from a country, territory or zone thereof …………………… (insert name of country, territory 
or zone thereof ) authorised for entry of equine animals into the Union, under conditions at least 
as strict as those set out in this certificate.]
L 113 /572  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -RE-ENTRY -90-COMP
II.3.2. the animal exited from the European Union
(3)either [less than 30 days ago, and since exit from the European Union was never in a country territory 
or zone thereof (1)other than those of the same Sanitary Group as the country, territory or zone 
thereof of dispatch, and resident in establishments under vete rinary supervision, accommodated 
in separated stables without coming into contact with equine animals of lower health status 
except during competition and has taken part in or was stabled together with horses participating in the LG Global Champions Tour
(3)either [in the Metropolitan area of Mexico City, Mexico;]
(3)and/or[in Miami, Unites States of America;]
(3)or [in Shanghai, China;]]
(3)or [less than 60 days ago, and since exit from the European Union was never in a country, territory or zone thereof
(1)other than those of the same Sanitary Group as the country, territory or zone 
thereof of dispatch, and resident in establishments under veterinary supervision, accommodated 
in separated stables without coming into contact with equine animals of lower he alth status 
except during competition and has taken part in or was stabled together with horses participating 
in
(3)either [the Asian Games in ………………………….………...………..(insert place).]]
(3)or [the American Games(5)in ………………..…………….….............(insert place).]]
(3)or [the Endurance World Cup in United Arab Emirates.]]
(3)or [less than 90 days ago, and since exit from the European Union was never in a country, territory 
or zone thereof(1)other than those of the sa me Sanitary Group as the country, territory or zone 
thereof of dispatch, and resident in establishments under veterinary supervision, accommodated 
in separated stables without coming into contact with equine animals of lower health status 
except during com petition and has taken part in or was stabled together with horses participating 
in
(3)either [the Test event for the Olympic Games in ……….…….…………( insert place ).]]
(3)or [the Olympic Games in ……………………..…………………..( insert place ).]]
(3)or [the Paralympics in … ……………………………………………..( insert place ).]]
(3)or [the World Equestrian Games/World Championships in ……………..( insert place ).]]
(3)or [the United Arab Emirates International Show Jumping League.]] 
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /573
COUNTRY Certificate model EQUI -RE-ENTRY -90-COMP
Part I:
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27: “Identification system” : The animal must be individually identified with one of the 
means of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated 
Regulation (EU) 2019/2035, or be identified by an alternative method in accordance 
with Article 62 of that Regulation (e.g. brand) provided it is recorded in its 
identification document (pass port). Specify the identification system  and the anatomic 
place used on the animal. The number of the accompanying passport or the Unique 
Code, if no passport number is available, should be stated and the name of the 
competent authority which validated it .
“Age” : Date of birth ( dd/mm/yyyy).
“Sex”: (M = male, F = female, C = castrated.
Part II:
(1)The certificate must be issued within the 48 hour period prior to loading or on the last working day before 
loading of the animal for dispatch to the Member Sta te of destination in the Union.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.1.1., or during a period where restrictive measures have been adopted by the Union against the 
entry of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of 
Part1 of Annex IV to Implementing Regulation (EU) 2021/404.
(2)Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 respectively in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
(3)Delete as appropriate.
(4)Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sites v2.anses.fr/en/minisite/equine -diseases/sop
(5)Including the PanAmerican Game s, South American Games, Central American and Caribbean Games.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /574  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Declaration by the operator responsible for the re- entry into the Union after temporary 
export of a registered horse for racing, competition and cultural events
Identification of the animal(1)
Species (Scientific name)
Equus caballusIdentification system
……………………….Identification number
……………………….Age
……………….Sex
…………
I, the undersigned operator of the registered horse described above, hereby declare, that:
- the registered horse 
(2)either [was temporarily exported from the Union to the country, territory or zone thereof of dispatch 
on…………………... (insert date) less than 90 days prior to this declaration;]
(2)or [entered the country or territory or zone thereof of dispatch on ……………….. (insert date)
from………….……….(insert name of country, terr itory or zone thereof from where horse entered country, 
territory or zone thereof of dispatch);]
- the registered horse has been temporarily exported from the Union to take part in
(2)either [the Asian Games in ………………………….………...………..( insert place );]
(2)or [the American Games in ………………..…………….….............(insert place );]
(2)or [the Endurance World Cup in United Arab Emirates;]
(2)or [the Test event for the Olympic Games in ……….…….…………(insert place );]
(2)or [the Olympic Games in ……………………..……………………..(insert place );]
(2)or [the Paralympics in ………………………………………………..(insert place );]
(2)or [the World Equestrian Games in …………………………………..(insert place); ]
(2)or [the LG Global Champions Tour in 
(2)either [the Metropolitan area of Mexico City, Mexico;] ]
(2)and/or[Miami, Unites States of America;] ]
(2)or [Shanghai, China;] ]
(2)or [the United Arab Emirates International Show Jumping League]
- during the period of 15 days prior to the date of dispatch the horse has not been in contact with animals suffering from 
infectious or contagious diseases transmissible to equine animals;
- the transportation will be effected in such a way that health and welfare of the horse can be protected effectively at all 
stages of the journey;
- the conditions for residence and pre -export isolation as applicable in accordance with point II. 3. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled.
Name and address of the operator: ……………………………………………………..
Date: …………………………(dd/mm/yyyy )
…………………………………………………………………………………………………………………..
(Signature )
(1)Identification system : The animal must be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to 
Delegated Regulation (EU) 2019/2035 ,or be identified by an alternative method in accordance with Article 62 of that Regulation provided it is recorded in its 
identification document (passport). Specify the identification system (such as tattoo, brand, transponder etc.) and the ana tomic place used on the animal.
The number of the accompanying passport or the Unique Code, if no passport number is available, should be stated and the name of the competent authority 
which validated the passport.
Age: Date of birth (dd/mm/yyyy).
Sex(M= male, F = female, C = castrated).
(2)Delete as appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /575
CHAPTER 18
MODEL ANIMAL HEALTH CERTIF ICATE AND MODEL DECLARATIO NFOR 
THERE-ENTRY INTO THE UNION OF REGISTERED HORSES FOR RACING 
AFTER TEMPORARY EXPO RT FOR A PERIOD OF NOT MORE THAN 90 DAYS
TO PARTICIPATE IN SP ECIFIC RACE EVENTS I N AUSTRALIA, CANADA, THE 
UNITED STATES OF AMERICA, HONG KONG, JAP AN, SINGAPORE, THE 
UNITED ARAB EM IRATES OR QATAR (MODEL ‘EQUI -RE-ENTRY- 90-RACE’ )
(International Group/Grade meetings, the Japan Cup, the Melbourne Cup, the Dubai Racing World- Cup, the 
Hong Kong International Races)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping □Germinal products □Registered horse
I.21 I.22
I.23□For re- entry
L 113 /576  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /577
COUNTRY Certificate model EQUI -RE-ENTRY -90-RACEPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II. Animal health attestation
I, the undersigned official veterinarian, hereby certify that:
II.1. The equine animal described in Part I:
II.1.1. is a registered horse as defined in Article 2(30) of Commission Delegated Regulation (EU) 
2019/2035, not intended for slaughter in the framework of the eradication of a disease 
communicable to equine animals;
II.1.2. has not shown signs or symp toms of diseases listed for equine animals in Commission 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date dd/mm/yyyy )(1), this being within the 48 hour period or on the last 
working day prior to departure from the registered establishment;
II.1.3. meets the requirements attested in points II.2. to II.3. of this certificate;
II.1.4. is accompanied by a written declaration, signed by the operator of the animal, which forms part 
of this certificate.
II.2. Attestation on third country, territory or zone thereof and on establishment of dispatch
II.2.1. The animal is dispatched from …………… ( insert name of country, territory or zone thereof ), a 
country, territory or zone thereof which on the date of issuing t his certificate has the Code: 
……………(2)and is assigned to Sanitary Group ………..…(2).
II.2.2. In the country or territory of dispatch the following diseases are compulsorily notifiable: African 
horse sickness, Venezuelan equine encephalomyelitis, infection w ith Burkholderia mallei
(glanders), surra (Trypanosoma evansi), dourine ( Trypanosoma equiperdum ), equine infectious 
anaemia, infection with rabies virus and anthrax.
II.2.3. The equine animal described in Part I comes from a country, territory or zone ther eof in which 
there has been no clinical, serological (in unvaccinated equine animals) or epidemiological 
evidence of African horse sickness during the 24 month period prior to the date of departure of 
the animal and there have been no systematic vaccinatio ns against African horse sickness during 
the 12 month period prior to the date of departure.
II.2.4. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(3)either [infection with Burkholderia mallei (glanders) has not been reported during the 36 month period 
prior to the date of departure of the animal.]
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei (glanders) 
recognised by the European Unio n(2)has been carried out during the 36 month period prior to the 
date of departure, and
(3)either [infection with Burkholderia mallei (glanders) has not been reported in the 
establishment of dispatch during the 36 month period prior to the date of departu re of 
the animal.] ]
(3)or [infection with Burkholderia mallei (glanders) has been reported in the establishment 
during the 36 month period prior to the date of departure of the animal and following the last outbreak, the establishment has remained under mo vement restriction s
(3)either [until the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei
(glanders)
(4), carried out, with negative results at a serum dilution of 1 in 5 , 
on samples taken at least 6 months after the infected animals have been killed and destroyed.]]]
L 113 /578  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -RE-ENTRY -90-RACE
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was killed 
and destroyed.]]]
II.2.5. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which 
(3)either [surra has not been reported during the 24 month period prior to the date of departure.]
(3)or [a surveillance and eradication programme for surra recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either [surra has not been reported in the establishment during the 24 month period prior to 
the date of departure of the animal.] ]
(3)or [surra has been reported in the establishment during the 24 month period prior to the 
date of departure of the animal, and following the last outbreak the establishment has 
remained und er movement restriction s
(3)either [until the remaining animals in the establishment have been subjected to an 
enzyme- linked immunosorbent assay (ELISA) for trypanosomosis or card 
agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4(4)
carried out, with negative results, on samples taken at least 6 months after the last infected animal has been removed from the establishment.]]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last animal of listed species on the establishment was 
either killed and destroyed or slaughtered.]]]
II.2.6. The equine animal described in Part I comes from an establishment situated in a country, 
territory or zone thereof in which
(3)either [dourine has not been reported during the 24 month period prior to the date of departure of the 
animal.]
(3)or [a surveillance and eradication programme for dourine recognised by the European Union(2)has 
been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either [dourine has not been reported in the establishment during the 24 month period prior 
to the date of departure of the animal.] ]
(3)or [dourine has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak, the establishment 
has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment, except castrated 
male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5
(4)on
samples taken at least 6 months after the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated.]] ]
(3)or [for at least 30 days from the date of cleaning and disinfection of the 
establishment, after the last equine animal on the establishment was either 
killed and destroyed or slaughtered.]] ]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /579
COUNTRY Certificate model EQUI -RE-ENTRY -90-RACE
II.2.7. The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the 60 day period prior to the date of its departure, and 
(3)either [it comes from an establishment situated in a country or territory in whic h Venezuelan equine 
encephalomyelitis has not been reported during the 24 month period prior to the date of its 
departure.]
(3)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been 
reported during the 6 month period p rior to the date of its departure and which is situated in a 
country, territory or zone thereof in which a surveillance and eradication programme for 
Venezuelan equine encephalomyelitis recognised by the European Union(2)has been carried out 
during the 24 month period prior to the date of its departure. ]
II.2.8. The equine animal described in Part I comes from an establishment in which 
(3)either [equine infectious anaemia has not been reported during the 12 month period prior to the date of departure of the animal.]
(3)or [equine infectious anaemia has been reported during the 12 month period prior to the date of departure of the animal and following the last outbreak the establishment has remained under movement restriction s
(3)either [until the remaining equine animals in the establishment have been subjected to an agar gel immuno -diffusion test (AGID or Coggins test) or ELISA
(4)for equine 
infectious anaemia carried out, with negative results, on samples taken on two 
occasions with a minimum interval of 90 days following cleaning and disinfection 
after the infected animals have been killed and destroyed or slaughtered.]]
(3)or [for at least 30 days from the date of cleaning and disinfection of the establishment,
after the last equine animal on the estab lishment was either killed and destroyed or 
slaughtered.]]
II.2.9. The equine animal described in Part I comes from an establishment in which 
II.2.9.1. infection with rabies virus in kept terrestrial animals has not been reported during the 30 
day period prior to the date of departure of the animal;
II.2.9.2. anthrax in ungulates has not been reported during the 15 day period prior to the date of 
departure of the animal.
II.2.10. To the best of my knowledge and as declared by the operator, the equine animal described in 
Part I has not been in contact with kept animals of listed species which did not comply with the 
requirements referred to in points II.2.3. to II.2.9.1 during the 30 day period prior to the date of departure of the animal, and with the requirement referred to in point II.2.9.2. during the 15 day 
period prior to the date of departure of the animal.
II.3. Attestation of residence and pre -export isolation
II.3.1. The animal described in Part I was imported into the country, territory or zon
e thereof of 
dispatch on ………………………………… (insert date)
(3)either [directly from the European Union Member State ……………………..… ( insert name of EU 
Member State) for the participation in 
(3)either [The Japan Cup;] ]
(3)or [The Melbourne Cup;] ]
(3)or [The Dubai Racing World -Cup;] ]
(3)or [The Hong Kong International Races;] ]
L 113 /580  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI -RE-ENTRY -90-RACE
(3)or [from Australia(3), Canada(3), the United States of America(3), Hong Kong(3), Japan(3), 
Singapore(3), United Arab Emirates(3)or Qatar(3)for the participation in International 
Group/Grade meetings in the country of dispatch;] 
II.3.2. as far as can be ascertained and based on the declaration of the operator of the horse 
accompanying this certificate, the animal was:
- not continuously outsi de the European Union for more than 90 days, the date of scheduled 
return in accordance with this certificate included;
- not outside the country of dispatch or in case of International Group/Grade meetings 
outside Australia, Canada, the United States of America, Hong Kong, Japan, Singapore, the 
United Arab Emirates or Qatar;
- resident in establishments under veterinary supervision, accommodated in separated stables 
without coming into contact with equine animals of lower health status except during 
racing.
II.3.3. the animal entered the country of dispatch under animal health conditions at least as strict as 
those laid down in this health certificate.
Notes:
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27: “Identification system” : The animal must be individually identified with one of the means of 
identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that
Regulation (e.g. brand) 
provided it is recorded in its identification document (passport). 
Specify the identification system and the anatomic place used on the animal. The number of 
the accompanying passport or the Unique Code, if no passport number is available, should be 
stated and the name of the competent authority which validated it.
“Age” : Date of birth ( dd/mm/yyyy).
“Sex”: M = male, F = female, C = castrated.
Part II:
(1)The certificate must be issued within the 48 hour period prior to loading or on the last working day before 
loading of the animal for dispatch to the Member State of destination in the Union.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union f rom the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restrictive measures have been adopted by the Union against the 
entry of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of 
Part1 of Annex IV to Implementing Regulation (EU) 2021/404 .
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /581
COUNTRY Certificate model EQUI -RE-ENTRY -90-RACE
(2)Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
(3)Delete as appropriate.
(4)Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /582  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Declaration by the operator responsible for the re- entry in to the Union after temporary 
export of a registered horse for racing
Identification of the animal(1)
Species (Scientific name)
Equus caballusIdentification system
……………………….Identification number
……………………….Age
……………….Sex
…………
I, the undersigned operator of the registered horse described above, hereby declare, that:
- the registered horse 
(2)either [was temporarily exported from the Union to the country, territory or zone thereof of dispatch 
on…………………... (insert date) less than 90 days prior to this declaration;]
(2)or [entered the country or territory or zone thereof of dispatch on ……………….. (insert date)
from………….……….(insert name of country, territory or zone thereof from where horse entered country, 
territory or zone thereof of dispatch);]
- the registered horse has been temporarily exported from the Union to take part in
(2)either [The Japan Cup;]
(2)or [The Melbourne Cup;]
(2)or [The Dubai Racing World-Cup;]
(2)or [The Hong Kong International Races;]
(2)or [International Group/Grade meetings in Australia(2), Canada(2), the United States of America(2), Hong 
Kong(2), Japan(2), Singapore(2), United Arab Emirates(2)or Qatar(2);]
- during the period of 15 days prior to the date of dispatch the horse has not been in contact with animals suffering from 
infectious or contagious diseases transmissible to equine animals;
- the transportation will be effected in such a way that health and welfare of the horse can be protected effectively at all 
stages of the journey;
- the conditions for residence and pre -export isolation as applicable in accordance with point II.3. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled.
Name and address of the operator: ……………………………………………………..
Date: …………………………(dd/mm/yyyy )
…………………………………………………………………………………………………………………..
(Signature )
(1)Identification system : The animal must be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to 
Delegated Regulation (EU) 2019/2035 ,or be identified by an alternative method in accordance with Article 62 of that Regulation provided it is recorded in its 
identification document (passport). Specify the identificat ion system (such as tattoo, brand, transponder etc.) and the anatomic place used on the animal.
The number of the accompanying passport or the Unique Code, if no passport number is available, should be stated and the name of the competent authority 
which v alidated the passport.
Age: Date of birth (dd/mm/yyyy).
Sex(M = male, F = female, C = castrated).
(2)Delete as appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /583
CHAPTER 19
(MODEL ‘ CONFINED- RUM’)
Section 1
List of animals originating from and intended for a confined establishment covered by model 
animal health certificate ‘CONFINED- RUM’ set out in section 2 of this Chapter
Order Family Genera/species 
Artiodactyla Antilocapridae Antilocapra ssp.
Bovidae Addax ssp., Aepyceros ssp., Alcelaphus ssp., Ammodorcas 
ssp., Ammotragus ssp., Antidorcas ssp., Antilope ssp., Bison 
ssp., Bos ssp. (including Bibos, Novibos, Poephagus), Boselaphus ssp., Bubalus ssp. (including anoa), Budorcas 
ssp., Capra ssp., Cephalophus ssp., Connochaetes ssp., 
Damaliscus ssp. (including Beatragus), Dorcatragus ssp., 
Gazella ssp., Hemitragus ssp., Hippotragus ssp., Kobus ssp., Litocranius ssp., Madoqua ssp., Naemorhedus ssp. 
(including Nemorhaedus and Capricornis), Neotragus s sp., 
Oreamnos ssp., Oreotragus ssp., Oryx ssp., Ourebia ssp., Ovibos ssp., Ovis ssp., Patholops ssp., Pelea ssp., Procapra 
ssp., Pseudois ssp., Pseudoryx ssp., Raphicerus ssp., 
Redunca ssp., Rupicapra ssp., Saiga ssp., Sigmoceros -
Alecelaphus ssp., Sylvicap ra ssp., Syncerus ssp., 
Taurotragus ssp., Tetracerus ssp., Tragelaphus ssp. 
(including Boocerus ). 
Camelidae Camelus ssp., Lama ssp., Vicugna ssp. 
Cervidae Alces ssp., Axis -Hyelaphus ssp., Blastocerus ssp., Capreolus 
ssp., Cervus -Rucervus ssp., Dama ssp., Elaphurus ssp., 
Hippocamelus ssp., Hydropotes ssp., Mazama ssp., 
Megamuntiacus ssp., Muntiacus ssp., Odocoileus ssp., 
Ozotoceros ssp., Pudu ssp., Rangifer ssp. 
Giraffidae Giraffa ssp., Okapia ssp. 
Moschidae Moschus ssp. 
Tragulidae Hyemoschus ssp., Tragulus -Moschiola ssp. 
L 113 /584  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Section 2
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
ANIMALS LISTED IN SECTION 1 OF CHAPTER 1 9 OF ANNEX II TO 
COMMISSION IMPLEMENTING REGULATION (EU) 2021/403 THAT ARE 
ORIGINATING FROM AND INTENDED FOR A CONFI NED ESTABLISHMENT 
(MODEL ‘ CONFINED- RUM’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Confined establishment
I.21 I.22□For internal market
I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /585
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Approval or registration 
number of 
plant/establishment/centre
L 113 /586  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -RUMPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.1.1. come from the zone with code: __ __ -__(2)which, at the date of issue of this certificate is 
authorised for the entry into the Union of animals of the families Antilocapridae, Bovidae, 
Camelidae, Cervidae, Giraffidae, Moschidae, Tragulidae intended for confined establishments 
and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404.
II.1.2. have remained continuously in the establishment of origin since birth or for a period of time of at 
least 6 months prior to the date of dispatch to the Union, into which during this period no 
ungulates of the families Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae, 
Tragulidae and no animals of other species listed for the same diseases as ungulates of the 
families Antilocapridae, Bovidae, Camelidae, Cervidae, Gir affidae, Moschidae, Tragulidae have 
been introduced.
II.1.3. had no contact with animals of a lower health status since birth or at least for 30 days prior to the 
date of dispatch to the Union.
II.1.4. are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/692 and emerging diseases.
II.1.5. have been dispatched directly from the establishment of origin to the Union without pas sing 
through any other establishment.
II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in 
point II.1.9. since they were dispatched from their establishment of origin until their dispatch to 
the Union and duri ng that period they have not been in contact with animals of a lower health 
status.
II.1.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.1.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch 
to the Union, carried out by an official veterinarian in the third country or territory of origin, who 
did not detect signs indicative of the occurrence of diseases, including the relevant listed diseases 
referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest virus.
(1)[II.1.10. have been vaccinated against:
–(1)[anthrax on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)],
–(1)[rabies on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)]].
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /587
COUNTRY Certificate model CONFINED -RUM
II.1.11. come from a confined establishment :
II.1.11.1. which is approved by the competent authority in accordance with the conditions set 
out in Article 30 of Delegated Regulation (EU) 2020/692.
II.1.11.2. which was not su bject to national restriction measures for animal health reasons, 
including listed diseases and emerging diseases, at the time of dispatch to the Union.
II.1.11.3. inwhich at the date of issue of this certificate the following diseases have not been 
repor ted for the last 6 months:
– foot and mouth disease, 
– infection with rinderpest virus, 
– [infection with Rift Valley fever virus,](1)(4)
– [infection with Mycoplasma mycoides subsp . mycoides SC (Contagious bovine 
pleuropneumonia),](1)(5)
– [infection with peste des petits ruminants virus,](1)(6)
– [sheep pox and goat pox,](1)(7)
– [contagious caprine pleuropneumonia,](1)(8)
– [infection with lumpy skin disease virus,](1)(9)
– [infection with Burkholderia mallei (glanders),](1)(10)
– infection with Brucella abortus, B. meli tensis andB. suis,
– infection with Mycobacterium tuberculosis complex (M. bovis, M.capare, 
M.Tuberculosis ), 
– [rabies,](1)11)
– infection with bluetongue virus (serotypes 1 -24).
II.1.11.3. in which at the date of issue of this certificate surra ( Trypanosoma evansi ) and anthrax 
have not been reported for the last [30 days](1)(12)[180 days](1)13).
II.1.11.4. around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch to the Union: 
– foot and mouth disease, 
– infection with rinderpest virus, 
– [infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine 
pleuropneumonia),](1)(5)
– [infection with peste des petits ruminants virus,](1)(6)
– [sheep pox and goat pox,](1)(7)
– [contagious caprine pleuropneumonia,](1)(8)
– [infection with lumpy skin disease virus,](1)(9)
– [infection with Burkholderia mallei (glanders),](1)(10)
L 113 /588  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -RUM
– infection with Brucella abortus, B. melitensis andB. suis,
– infection with Mycobacterium tuberculosis complex (M. bovis, M.capare, 
M.Tuberculosis ),
– [rabies](1)(11).
II.1.11.5. around which, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch to the Union: 
– [infection with Rift Valley fever virus,](1)(4)
– infection with bluetongue virus (serotypes 1 -24),
– infection with epizootic h aemorrhagic disease virus.
either (1)[II.1.12. come from a zone in which at the date of issue of this certificate foot and mouth 
disease has not been reported for the last 12 month period.]
or (1) [II.1.12. have been subjected to a virological and serological test for evidence of foot -and-
mouth disease virus infection carried out in accordance with one of the prescribed 
tests for international trade laid down in the World Organisation for Animal Health 
(OIE) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (OIE 
Terrestrial Manual), with negative results, on samples taken in the 10 days prior to 
dispatch to the Union; and] 
either (1)[II.1.13. come from a zone in which at the date of issue of th is certificate infection with Rift 
Valley fever virus has not been reported for the last 48 months.]
or (1) [II.1.13. have:
(i)been kept in quarantine in a vector -protected facility in the approved confined 
establishment for a period of at least 30 days prior to the date of dispatch to the Union; 
(ii)showed no disease symptoms of infection with Rift valley fever virus for a period of at 
least 30 days prior to the date of dispatch to the Union; 
(iii)been protected from vectors when transported between the vector -prote cted facility referred 
to in point (i) and loading for dispatch to the Union; and
(iv)undergone a virus neutralisation test with negative results for evidence of infection with 
Rift valley fever virus in accordance with the OIE Terrestrial Manual, carried out firstly on 
samples taken at the date of commencement of the quarantine period and secondly on 
samples taken at least 42 days from that date and during a period of 10 days prior to the 
dispatch to the Union. ]
either (1) [II.1.14. have not been vaccinated ag ainst infection with Brucella abortus, B. melitensis and 
B. suis and come from a zone in which at the date of issue of this certificate this 
disease has not been reported for the last 12 month period.]
or (1) [II.1.14. have undergone a test as laid down and prescribed for international trade by the OIE 
Terrestrial Manual, on samples taken during the period of the 30 days prior to the date of dispatch to the Union.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /589
COUNTRY Certificate model CONFINED -RUM
or (1) [II.1.14. they are castrated males of any age.]
either (1) [II.1.15. come from a zone in which at the date of issue of this certificate infection with
bluetongue virus (serotypes 1 -24) has not been reported for the last 24 month 
period.]
or (1) [II.1.15. they have been kept in quarantine in a vector -protected facility in t he confined 
establishment for a period of at least 30 days prior to the date of dispatch to the 
Union and have undergone a serology test for infection with bluetongue virus (1 -24) 
and infection with epizootic haemorrhagic disease virus carried out in accordance 
with the OIE Terrestrial Manual with negative results, carried out at least 28 days 
after the introduction of the animals into the confined establishment; ]
or (1) [II.1.15. they have been kept in quarantine in a vector- protected facility in the appr oved 
confined establishment for a period of at least 30 days prior to the date of dispatch to 
the Union and have undergone a PCR test for infection with bluetongue virus (1 -24) 
and infection with epizootic haemorrhagic disease virus in accordance with the OIE 
Terrestrial Manual, with negative results, carried out at least 14 days after the 
introduction into the confined establishment; ]
or (1) [II.1.15. they come from a seasonally disease- free area and have undergone during that 
disease- free period a serolog y test for infection with bluetongue virus (1- 24) and 
infection with epizootic haemorrhagic disease virus according to the OIE Terrestrial 
Manual, with negative results, carried out on samples taken at least 28 days after 
introduction of the animals into the confined establishment; ]
or (1) [II.1.15. they come from a seasonally free area and have undergone during that period a PCR 
test for infection with bluetongue virus (1 -24) and infection with epizootic 
haemorrhagic disease virus in accordance with the OIE Terrestrial Manual, with 
negative results, carried out on samples taken at least 14 days after the introduction of the animals into the approved confined establishment. ]
II.1.16. they have been treated at least twice during the period of 40 days prior to dispatch to 
the Union against internal and external parasites with the following 
product(s)………………………….. Specify the active ingredients and the doses of the products used ……………………………….............
Notes:
This certificate is intended for entry into the U nion of animals from third countries listed in Part 1 of Annex II Ito 
Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment.
In accordance with the Agreement on the withdrawal of the United Kingdom of Gr eat Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /590  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -RUM
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the animals in 
accordance with Article 21(1) or 21(3) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex III to Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in point II.1.1 ., or during a period where restriction measures have been adopted by 
the Union against entries of t hese animals from this third country, territory or zone thereof.
(4)Not applicable to animals of the family Tragulidae.
(5)Only applicable to bovine animals and Syncerus caffer.
(6)Only applicable to ovine animals, caprine animals, camelid animals and cervid animals.
(7)Only applicable to ovine and caprine animals.
(8)Only applicable to caprine animals and Gazella spp .
(9)Only applicable to bovine animals.
(10)Only applicable to caprine animals and camelid animals.
(11)Only applicable to animals of the family Bovidae, camelid animals and cervid animals.
(12)Not applicable to camelid animals.
(13)Only applicable to camelid animals.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /591
CHAPTER 20
(MODEL ‘CONFINED- SUI’)
Section 1
List of animals originating from and intended for a confined establishment covered by model 
animal health certificate ‘CONFINED- SUI’ set out in section 2 of this Chapter
Order Family Genera/species 
Artiodactyla Suidae Babyrousa ssp., Hylochoerus ssp., Phacochoerus ssp., 
Potamochoerus ssp., Sus ssp. 
Tayassuidae Catagonus ssp., Pecari -Tayassu ssp.
L 113 /592  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
Section 2
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
ANIMALS LISTED IN SECTION 1 OF CHAPTER 2 0 OF ANNEX II TO 
COMMISSION IMPLEMENT ING REGULATION (EU) 2021/403THAT ARE 
ORIGINATING FROM AND INTENDED FOR A CONFI NED ESTABLISHMENT 
(MODEL ‘ CONFINED- SUI’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Confined establishment
I.21 I.22□For internal market
I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /593
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Approval or registration 
number of 
plant/establishment/centre
L 113 /594  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -SUIPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.1.1. come from the zone with code: __ __ -__(2)which, at the date of issue of this certificate is 
authorised for the entry into the Union of animals of the families Suidae and Tayassuidae
intended for confined establishments and listed in Part 1 of Annex III to Commission 
Implementing Regulation (EU) 2021/404 .
II.1.2. have remained continuously in the establishment of origin since birth or for a period of 
time of at least 6 months prior to the date of dispatch to the Union, into which during this 
period no animals of the families Suidae and Tayassuidae and no animals of other species 
listed for the same diseases as animals of the families Suidae and Tayassuidae have been 
introduced.
II.1.3. had no contact with animals of a lower health status since birth or at least for 30 days prior 
to the date of dispatch to the Union.
II.1.4. are not to be killed under a national programme for the eradication of diseases, including the relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 and emerging diseases.
II.1.5.
have been dispatched directly from the establishment of origin to the Union without 
passing through any other establ ishment.
II.1.6. have not been unloaded in any place that does not comply with the requirements laid down 
in point II.1.9. since they were dispatched from their establishment of origin until their 
dispatch to the Union and during that period they have not been in contact with animals of 
a lower health status.
II.1.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means 
of transport which was cleaned and disinfected prior to loading with a disinfectant 
authorised by the compe tent authority in the third country or territory and constructed in 
such a way that:
(iv)animals cannot escape or fall out;
(v)visual inspection of the space where animals are kept is possible;
(vi)the escape of animal excrements, litter or feed is prevented or minim ized.
II.1.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for 
dispatch to the Union, carried out by an official veterinarian in the third country or 
territory of origin, who did not detect signs indicative of th e occurrence of diseases, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest 
virus.
(1[II.1.10. have been vaccinated against:
–(1)[anthrax on the ……………… (dd/mm/yyyy) with the following 
vaccine(s) …………………………… (name of vaccine (s) used)],
–(1)[rabies on the ……………… (dd/mm/yyyy) with the following 
vaccine(s) …………………………… (name of vaccine (s) used)]].
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /595
COUNTRY Certificate model CONFINED -SUI
II.1.11. come from a confined establishment :
II.1.11.1. which is approved by the competent authority in accordance with the 
conditions set out in Article 30 of Delegated Regulation (EU) 2020/692.
II.1.11.2. which was not subject to national res triction measures for animal health 
reasons, including listed diseases and emerging diseases, at the time of 
dispatch to the Union.
II.1.11.3. inwhich at the date of issue of this certificate the following diseases have not 
been reported for the last 6 mo nths:
– foot and mouth disease, 
– infection with rinderpest virus, 
– classical swine fever;
– [African swine fever](1)(4)
– infection with Brucella abortus, B. melitensis andB. suis,
– rabies.
II.1.11.3. in which at the date of issue of this certificate surra ( Trypanosoma 
evansi ) and anthrax have not been reported for the last 30 day period.
II.1.11.4. around which, in an area with a 10 km radius, including where 
appropriate the territory of a neighbouring country, none of the following listed 
diseases has been reported for at least 12 months prior to dispatch to the Union: 
– foot and mouth disease, 
– infection with rinderpest virus, 
– classical swine fever,
– [African swine fever,](1)(4)
– rabies.
either (1)[II.1.12. come from a zone in which at the date of issue of this certificate foot and 
mouth disease has not been reported for the last 12 month period.]
or (1) [II.1.12. have been subjected to a virological and serological test for evidence of foot -
and-mouth disease virus infection carried out in accordance with on e of the 
prescribed tests for international trade laid down in the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals (OIE Terrestrial 
Manual), with negative results, on samples taken in the 10 days prior to 
dispatch to the Union; and]
either (1)[II.1.13. come from a zone in which at the date of issue of this certificate classical 
swine fever has not been reported for the last 12 month period.]
L 113 /596  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -SUI
or (1) [II.1.13. have undergone a virology and serology test for the detection of classical 
swine fever in accordance with the test prescribed for international trade in the 
OIE Terrestrial Manual, carried out on samples taken during the period of 30 
days prior to the date of dispatch to the Union.
(1)(4)[either (1)[II.1.14. come from a zone in which at the date of issue of this certificate 
classical swine fever has not been reported for the last 12 month 
period.]]
or (1) [II.1.14. have undergone a virology and serology test for the detection of African 
swine fever and in accordance with the test prescribed for international 
trade in the OIE Terrestrial Manual, carried out on samples taken during 
the period of 30 days prior to the date of dispatch to the Union.]]
either (1)[II.1.15. have not been vaccinated against infection with Brucella abortus , B. 
melitensis and B. suis and come from a zone in which at the date of 
issue of this certificate this disease has not been reported for the last 12 
month period.]
or (1) [II.1.15. have undergone a test as laid down and prescribed for international 
trade by the OIE Terrestrial Manual, on samples taken during the period 
of the 30 days prior to the date of dispatch to the Union.]
or (1) [II.1.15. they are castrated males of any age.]
II.1.16. they have been treated at least twice during the period of 40 days prior 
to dispatch to the Union against internal and external parasites with the 
following product(s)………………………….. Specify the active 
ingredients and the doses of the products used 
……………………………….............
Notes:
This certificate is intended for entry into the Union of animals from third countries listed in Part 1 of Annex II Ito 
Commission Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined 
establishment.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the animals in 
accordance with Article 21(1) or 21(3) of Delegated Regulation (EU) 2020/692.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /597
COUNTRY Certificate model CONFINED -SUI
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex III to Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or zone thereof referred to in point II.1.1., or during a period where restriction measures have been adopted by 
the Union against entries of these animals from this third country, territory or zone thereof.
(4)Not applicable to animals of the family Tayassuidae.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /598  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 21
(MODEL ‘CONFINED- TRE’)
Section 1
List of animals originating from and intended for a confined establishment covered by model 
animal health certificate ‘CONFINED- TRE’ set out in section 2 of this Chapter
Order Family Genera/species 
Perissodactyla Tapiridae Tapirus ssp. 
Perissodactyla Rhinocerotidae Ceratotherium ssp., Dicerorhinus ssp., Diceros ssp., 
Rhinoceros ssp. 
Proboscidea Elephantidae Elephas ssp., Loxodonta ssp. 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /599
Section 2
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
ANIMALS LISTED IN SECTION 1 OF CHAPTER 2 1 OF ANNEX II TO 
COMMISSION IMPLEMENT ING REGULATION (EU) 2021/403 THAT ARE 
ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT
(MODEL ‘ CONFINED- TRE’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Confined establishment
I.21 I.22□For internal market
I.23
L 113 /600  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Approval or registration 
number of 
plant/establishment/centre
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /601
COUNTRY Certificate model CONFINED -TREPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.1.1. come from the zone with code: __ __ -__(2)which, at the date of issue of this certificate is 
authorised for the entry into the Union of animals of the families Tapiridae, Rhinocerotidae and 
Elephantidae intended for confined establishments and listed in Part 1 of Annex III to Commission 
Implementing Regulation (EU) 2021/404 .
II.1.2. have remained continuously in the establishment of origin since birth or for a period of time of at 
least 6 months prior to the date of dispatch to the Union, into which during this period no animals 
of the families Tapiridae, Rhinocerotidae and Elephantidae and no animals of other species listed 
for the same di seases as animals of the families Tapiridae, Rhinocerotidae and Elephantidae have 
been introduced.
II.1.3. had no contact with animals of a lower health status since birth or at least for 30 days prior to the 
date of dispatch to the Union.
II.1.4. are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/692 and emerging diseases.
II.1.5. have been dispatched directly from the es tablishment of origin to the Union without passing 
through any other establishment.
II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in 
point II.1.9. since they were dispatched from their establishment of ori gin until their dispatch to 
the Union and during that period they have not been in contact with animals of a lower health 
status.
II.1.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of 
transport which was cleaned a nd disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that: 
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is pos sible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.1.8. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch 
to the Union, carried out by an official veterinarian in the third country or territory of origin, who did not detect signs indicative of the occurrence of diseases, including the relevant listed diseases 
referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.1.9. have not been vacci nated against foot and mouth disease and infection with rinderpest virus.
(1)[II.1.10. have been vaccinated against:
–(1)[anthrax on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)],
–(1)[rabies on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)]].
L 113 /602  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -TRE
II.1.11. come from a confined establishment :
II.1.11.1. which is approved by the competent authority in accordance with the conditions set 
out in Article 30 of Delegated Regulation (EU) 2020/692.
II.1.11.2. which was not subject to national restriction measures for animal health reasons, 
including listed diseases and emerging diseases, at the time of dispatch to the Union.
II.1.11.3. inwhich at the date of issue of this certificate the following diseases have not been 
reported for the last 6 months:
– [foot and mouth disease,](1)(4)
– infection with rinderpest virus, 
– infection with Rift Valley fever virus,
II.1.11.4. in which at the date of issue of this certificate anthrax has not been reported for the 
last 30 day period.
[II.1.11.5. around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, foot and mouth disease has not been reported for at least 30 days prior to dis patch to the Union]
(1)(4)
II.1.11.6. around which, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring country, infection with Rift Valley fever virus has not been reported for at least 30 days prior to dispatch to the Union.
(1)(4)[either (1)[II.1.12. come from a zone in which at the date of issue of this certificate foot and mouth 
disease has not been reported for the last 12 month period.]]
or (1) [II.1.12. have been subjected to a virological and serological te st for evidence of foot -
and-mouth disease virus infection carried out in accordance with one of the 
prescribed tests for international trade laid down in the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals (OIE Terrestrial 
Manual), with negative results, on samples taken in the 10 days prior to dispatch 
to the Union; and]]
either (1)[II.1.13. come from a zone in which at the date of issue of this certificate infection with 
Rift Valley fever virus has not been reported for the last 48 mo nths.]
or (1) [II.1.13. have:
(i)been kept in quarantine in a vector -protected facility in the approved confined establishment 
for a period of at least 30 days prior to the date of dispatch to the Union; 
(ii)showed no disease symptoms of infection with Rift vall ey fever virus for a period of at least 
30 days prior to the date of dispatch to the Union; 
(iii)been protected from vectors when transported between the vector -protected facility referred 
to in point (i) and loading for dispatch to the Union; and
(iv)undergone a virus neutralisation test with negative results for evidence of infection with Rift 
valley fever virus in accordance with the OIE Terrestrial Manual, carried out firstly on samples taken at the date of commencement of the quarantine period and secondly on 
samples taken at least 42 days from that date and during a period of 10 days prior to the 
dispatch to the Union.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /603
COUNTRY Certificate model CONFINED -TRE
II.1.14. they have been treated at least twice during the period of 40 days prior to dispatch to the Union 
against internal and external parasites with the following product(s)………………………….. 
Specify the active ingredients and the doses of the products used 
……………………………….............
Notes:
This certificate is intended for entry into the Union of animals from third countries listed in Part 1 o fAnnex II Ito 
Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification codes of the ani mals in 
accordance with Article 21(1) or 21(3) of Delegated Regulation (EU) 2020/692.
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex III to Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of the se animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in point II.1.1. , or during a period whe re restriction measures have been adopted by 
the Union against entries of these animals from this third country, territory or zone thereof. 
(4)Only applicable to animals of the family Elephantidae.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /604  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 22
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
ANIMALS OF THE FAMILY OF HIPPOPOTAMIDAE THAT ARE ORIGINATING
FROM AND INTENDED FO R A CONFINED ESTABLI SHMENT (MODEL 
‘CONFINED- HIPPO’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Confined establishment
I.21 I.22□For internal market
I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /605
I.24 I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Approval or registration 
number of 
plant/establishment/centre
L 113 /606  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -HIPPOPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the animals described in Part I:
II.1.1. come from the zone with code: __ __ - __(2)which, at the date of issue of this certificate is authorised 
for the entry into the Union of animals of the famil yHippopotamidae intended for confined 
establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 
2021/404.
II.1.2. have remained continuously in the establishment of origin since birth or for a period of time of at le ast 
6 months prior to the date of dispatch to the Union, into which during this period no animals of the 
family Hippopotamidae and no animals of other species listed for the same diseases as animals of the 
family Hippopotamidae have been introduced.
II.1.3 .had no contact with animals of a lower health status since birth or at least for 30 days prior to the date 
of dispatch to the Union.
II.1.4. are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed di seases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 and 
emerging diseases.
II.1.5. have been dispatched directly from the establishment of origin to the Union without passing through 
any other establishment.
II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in point 
II.1.9. since they were dispatched from their establishment of origin until their dispatch to the Union 
and during that period they have not been in contact with animals of a lower health status.
II.1.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3)in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent 
authority in the third country or territory and constructed in such a way that:
(i)animals cannot escape or fall out;
(ii)visual inspection of the space where animals are kept is possible;
(iii)the escape of animal excrements, litter or feed is prevented or minimized.
II.1.8. have been sub jected to a clinical inspection within the 24 hour period prior to loading for dispatch to 
the Union, carried out by an official veterinarian in the third country or territory of origin, who did not detect signs indicative of the occurrence of diseases, in cluding the relevant listed diseases referred to in 
Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases.
II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest virus.
(1)[II.1.10. have been vaccinated against:
–(1)[anthrax on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)],
–(1)[rabies on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)]].
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /607
COUNTRY Certificate model CONFINED -HIPPO
II.1.11. come from a confined establishment :
II.1.11.1. which is approved by the competent authority in accordance with the conditions set out in 
Article 30 of Delegated Regulation (EU) 2020/692.
II.1.11.2. which was not subject to national restriction measures fo r animal health reasons, including 
listed diseases and emerging diseases, at the time of dispatch to the Union.
II.1.11.3. inwhich at the date of issue of this certificate the following diseases have not been reported 
for the last 6 month period:
– foot and mouth disease,
– infection with rinderpest virus,
– [infection with Rift Valley fever virus,](1)(4)
– infection with Brucella abortus, B. melitensis andB. suis,
– infection with Mycobacterium tuberculosis complex (M. bovis, M.capare, 
M.Tuberculosis ),
II.1.11.3. in which at the date of issue of this certificate surra ( Trypanosoma evansi) and anthrax 
have not been reported for the last 30 day period.
II.1.11.4. around which, in an area with a 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 
30 days prior to dispatch to the Union:
– foot and mouth disease,
– infection with rinderpest virus,
– infection with Brucella abortus, B. melitensis andB. suis,
– infection with Mycob acterium tuberculosis complex (
M. bovis, M.capare, 
M.Tuberculosis ).
II.1.11.5. around which, in an area with a 150 km radius, including where appropriate the territory of 
a neighbouring country, infection with Rift Valley fever virus has not been reported for at 
least 30 days prior to dispatch to the Union:
either (1)[II.1.12. come from a zone in which at the date of issue of this certificate foot and mouth disease has 
not been reported for the last 12 month period.]
or (1) [II.1.12. have been subjected to a virological and serological test for evidence of foot -and-mouth 
disease virus infection carried out in accordance with one of the prescribed tests for 
international trade laid down in the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Anima ls (OIE Terrestrial Manual), with negative results, on samples taken in 
the 10 days prior to dispatch to the Union; and]
either (1)[II.1.13. come from a zone in which at the date of issue of this certificate infection with Rift Valley 
fever virus has not been reported for the last 48 months.]
L 113 /608  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CONFINED -HIPPO
or (1) [II.1.13. have:
(i)been kept in quarantine in a vector -protected facility in the approved confined 
establishment for a period of at least 30 days prior to the date of dispatch to the Union; 
(ii)showed no disease symptoms of infection with Rift valley fever virus for a period of at 
least 30 days prior to the date of dispatch to the Union; 
(iii)been protected from vectors when transported between the vector -protected facility 
referred to in point (i) a nd loading for dispatch to the Union; and
(iv)undergone a virus neutralisation test with negative results for evidence of infection with 
Rift valley fever virus in accordance with the OIE Terrestrial Manual, carried out firstly 
on samples taken at the date of commencement of the quarantine period and secondly on 
samples taken at least 42 days from that date and during a period of 10 days prior to the 
dispatch to the Union.
either (1)[II.1.14. have not been vaccinated against infection with Brucella abortus, B. melitensis and B. suis
and come from a zone in which at the date of issue of this certificate this disease has not 
been reported for the last 12 month period.]
or (1) [II.1.14. have undergone a test as laid down and prescribed for int ernational trade by the OIE 
Terrestrial Manual, on samples taken during the period of the 30 days prior to the date of 
dispatch to the Union.]
or (1)[II.1.14. they are castrated males of any age.]
[II.1.15. they have been treated at least twice during the period of 40 days prior to dispatch to the 
Union against internal and external parasites with the following 
product(s)………………………….. Specify the active ingredients and the doses of the 
products used ……………………………….............
Notes:
This certificate is i ntended for entry into the Union of animals of the family Hippopotamidae that are originating 
from and intended for a confined establishment.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United K ingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235
Part I:
Box reference I.27: “Identification system and identification number”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Commission Delegated 
Regulation (EU) 2019/2035) and the individual identification
codes of the animals in 
accordance with Article 21(1) or 21(3) of Delegated Regulation (EU) 2020/692.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /609
COUNTRY Certificate model CONFINED -HIPPO
Part II:
(1)Keep as appropriate.
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex III to Implementing Regulation (EU) 2021/404.
(3)Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or zone thereof referred to in point II.1.1., or during a period where restriction measures have been adopted by 
the Union against entries of these animals from this third country, territory or zone thereof.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /610  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 23
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF BREEDING PO ULTRY OTHER THAN RATITES AND PRODUCTIVE 
POULTRY OTHER THAN RATITES (MODEL ‘ BPP ’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /611
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Quantity
L 113 /612  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BPPPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
I, the undersigned official veterinarian, hereby certifythe following as regards the [breeding poultry(6)other than 
ratites](3)[productive poultry(7)other than ratites](3)described in Part I:
(1)[II.1.1. The Salmonella control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Commission Regulation 
(EC) No 1177/2006, have been applied to the flock of origin and the flock has bee n tested for 
Salmonella serotypes of public health significance:
Identification of the 
flockAge of the 
birdsDate of last sampling of the 
flock from which the testing 
result is known 
[dd/mm/yyyy]Result of all testing in 
the flock(2)
positive negative
For reasons other than the Salmonella control programme, within the last three weeks prior to entry into 
the Union:
(3)either [antimicrobials were not administered to the breeding and productive poultry other than 
ratites;]
(3)(4)or [the following antimicrobials were administered to the breeding and productive poultry other 
than ratites: ……………………………………;]]
(1)[II.1.2. If breeding poultry, neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within 
the control programme referred to in point II.1.1.]
(5)[II.1.3. If the Member State of d estination is Finland or Sweden:
(3) either [the breeding poultry has tested negative for Salmonella in accordance with the rules laid down in 
Commission Decision 2003/644/EC;]
(3) or [the laying hens (productive poultry reared in view to producing eggs for consumption) have tested 
negative in accordance with the rules laid down in Commission Decision 2004/235/EC.]]
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the [breeding poultry(6)other than ratites](3)[productive 
poultry(7)other than ratites](3)described in Part I of this certificate:
II.2.1. come from the zone with code _ _ -_(8)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex V to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of breeding poultry other than ratites and productive poultry 
other than ratites;
(b) carries out a disease surveillance programme for high ly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Delegated Regulation (EU) 2020/692;
(d) is consi dered free from infection with Newcastle disease virus in accordance with Article 39 of 
Delegated Regulation (EU) 2020/692; 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /613
COUNTRY Certificate model BPP
II.2.2. come from the zone referred to in point II.2.1, in which: 
(3)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(3)(9)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to Delegated 
Regulation (EU) 2020/692;]
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]
(3)(10)or [(b) vaccination against infe ction with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, and the animals:
(i) have not been vaccinated with such vaccines for a period of at least the 12 m onth prior to 
the date of loading of the consignment for dispatch to the Union;
(ii) come from a flock or flocks which underwent a virus isolation test
(11)for infection with 
Newcastle disease virus carried out on a random sample of cloacal swabs from at least 60
birds in each flock, taken not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, and in which no avian paramyxoviruses with an 
ICPI of more than 0,4 were found;
(iii) were kept in isolation under official surveillance on the establishment of origin during the 
2 weeks mentioned in (ii);
(iv) during the period of 60 days prior to the date of loading of the consignment for dispatch 
to the Union, were not in contact with poultry which do not fulfil the conditions in (i) and 
(ii);]
II.2.3. have remained in the zone referred to in point II.2.1 for a continuous period of at least:
(3)(12)either [3 months immediately prior to the date of loading for dispatch to the Union or since hatching where 
they are less than 3 month s of age;]
(3)(13)or [6 weeks immediately prior to the date of loading for dispatch to the Union or since hatching where they 
are less than 6 weeks of age;]
and where they were imported into the zone referred to in point II.2.1, the import took place in 
accordance with animal health requirements that are at least as stringent as the relevant requirements of 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 and the zone from where the 
animals were imported, is listed in Part 1 of Annex V to Imp lementing Regulation (EU) 2021/404 for 
entry into the Union of breeding poultry other than ratites and productive poultry other than ratites;
II.2.4. come from the establishment, indicated in Box I.11, approved by the competent authority of the country or territory of origin in accordance with requirements which are at least as stringent as those laid down 
in Article 8 of Delegated Regulation (EU) 2019/2035 and:
(a) the approval of which has not been suspended or withdrawn;
(b) which is under the control of the com petent authority of the country or territory of origin and has 
a system in place to maintain and to keep records in accordance with Article 8 of Delegated 
Regulation (EU) 2020/692;
(c) which receives regular animal health visits from a veterinarian for the pur pose of the detection 
of, and information on, signs indicative of the occurrence of diseases, including the relevant
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 , and emerging 
diseases ,at a frequency that is proportional to the risk posed by the establishment;
L 113 /614  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BPP
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Delegated Re gulation (EU) 2020/692 relevant for the 
species and emerging diseases, at the time of dispatch of the animals to the Union;
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastl e disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
(f) in which no confirmed case of infection with low pathogenic avian influenza viruses has been 
reported for at least 21 days prior to the date of loading for dispatc h to the Union;
(g) in which:
(3)either [infection with Salmonella Pullorum, S. Gallinarum or S . arizonae was not confirmed during the 
last 12 months prior to date of loading of the consignment for dispatch to the Union;]
(3)or [infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was confirmed during the last 
12 months prior to date of loading of the consignment for dispatch to the Union and the measures 
provided for in Article 44(d) of Delegated Regulation (EU) 2020/692 have been applied;]
(h) in which:
(3)either [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not confirmed 
during the last 12 months prior to date of loading of the consignment for dispatch to the Union;]
(3)or [avian mycoplasmosis (Mycoplasma gallisepticum a nd M. meleagridis) was confirmed during 
the last 12 months prior to date of loading of the consignment for dispatch to the Union and the 
measures provided for in Article 44(e) of Delegated Regulation (EU) 2020/692 have been 
applied;]
II.2.5. come from a fl ock which:
(a) has not been vaccinated against highly pathogenic avian influenza;
(3)either [(b) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]
(3)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with both the general and specific criteria of An nex XV to Delegated Regulation (EU) 2020/692;
(14)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
(c) underwent a disease surveillance programme that meets the requirements set out in Annex II to 
Commission Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed any grounds for suspecting any infection, by the following agents:
(3)either [Salmon ellaPullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus 
gallus );]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /615
COUNTRY Certificate model BPP
(3)or [Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, 
Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);] 
(3)or [Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris , Coturnix 
coturnix , Phasianus colchicus , Perdix perdix and Anas spp );] 
(d) hasbeen subjected to a clinical inspection(15)within the 24 hours prior to loading of the animals 
for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
relevant for the species and emerging diseases;
II.2.6. have remained in the establishment indicated in Box I.11 since hatching or for a continuous period of at 
least:
(3)(12)either [6 weeks immediately prior to the date of loading for dispatch to the Union;]
(3)(13)or [30 days immediately prior to the da te of loading for dispatch to the Union;]
II.2.7. had no contact with animals of a lower health status since hatching or for a continuous period of at least:
(3)(12)either [6 weeks immediately prior to the date of loading for dispatch to the Union;]
(3)(13)or [30 days immediately prior to the date of loading for dispatch to the Union;]
II.2.8. are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Delegated Regulation (E U) 2020/692 relevant for the species and 
emerging diseases;
II.2.9. have been subjected to a clinical inspection(15)on ___/___/____ (dd/mm/yyyy) within the 24 hours prior 
to loading for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for 
the species and emerging diseases;
II.2.10. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that: 
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible ;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or minimized;
(b) contain only poultry of the same species and category coming from the same establishment;
(c) are:
(3)either [unused and purpose -designed disposable containers to be destroyed after first use;]
(3)or [cleaned and disinfected and dried or allowed to dry prior to loading of the animals;]
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) bear the information set out in Point 1 of Annex XVI to Delegated Regulation (EU) 2020/692 
relevant for breeding poultry and productive poultry;
II.2.11. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(16)in a means of transport which is 
constructed in accordance with II.2.10(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;
L 113 /616  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BPP
(17)[II.2.12. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation 
(EU) 2020/689, and they:
(a) have not been vaccinated ag ainst infection with Newcastle disease virus;
(b) were kept in isolation for at least 14 days prior to the date of loading of the consignment for 
dispatch to the Union in the establishment of origin or quarantine establishment under the 
supervision of an official veterinarian, where:
(i) no poultry was vaccinated against infection with Newcastle disease virus during the 
period of at least 21 days prior to the date of loading of the consignment;
(ii) no other birds have entered into the establishment during that time; 
(iii) no vaccination has been carried out;
(c) have tested(11)negative to serological tests to detect antibodies against Newcastle disease virus, 
performed on blood samples at a level which gives 95% confidence of detecting infection at 5% 
prevalence and which were taken during the period of at least 14 days prior to the date of loading 
for dispatch to the Union;]
Notes:
This certificate is intended for entry into the Union of breeding poultry other than ratites and productive poultry, 
other than ratites including when the Union is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
V to Implementing Regulation (EU) 2021/404.
Box reference I.27: Description of consignment:
“CN code ”: use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01. 05 or 01.06.39.
“Category ”
: select one of the following: Pure line/grandparents/parents/laying 
pullets/others.
Part II:
(1)This guarantee applies only for poultry belonging to the species of Gallus gallus and turkeys . 
(2)If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:
-flocks of breeding poultry: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis;
-flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium.
(3)Keep as appropriate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /617
COUNTRY Certificate model BPP
(4)Complete if appropriate: indicate the name and active substance of antimicrobials used.
(5)Delete if consignment is not intended for Finland or Sweden.
(6)‘Breeding poultry’ means poultry 72 hours old or more, intended for the production of hatching eggs, as 
defined in Article 2 of Delegated Regulation (EU) 2020/692.
(7)‘Productive poultry’ means poultry 72 hours old or more, reared for the production of meat, eggs for 
consumption or other products or for restocking sup plies of game birds, as defined in Article 2 of 
Delegated Regulation (EU) 2020/692.
(8)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(9)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are lis ted in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(10)This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus wh ich comply only with the general criteria of Annex XV to 
Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) thereof, and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in 
column 6 of the table.
(11)Tests should be carried out on samples taken by or under the control of the competent authority of the country or territory of origin and testing should be carried out in an official laboratory designated in accordance with Arti cle 37 of Regulation (EU) 2017/625.
(12)Applicable for breeding poultry and productive poultry for the production of meat ,eggs for 
consumption or other products.
(13)Applicable for productive poultry for restocking supplies of game birds.
(14)To be com pleted when animals were vaccinated against infection with Newcastle disease virus.
(15)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(16)The date of loading cannot be a date prior t o the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.
(17)This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /618  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 24
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
BREEDING RATITES AND PRODUCTIVE RATITES ( MODEL ‘ BPR’ )
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
I.21□For transit I.22□For internal market
Third country ISO country code I.23□For re- entry
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /619
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Identification 
systemIdentification number Quantity
L 113 /620  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BPRPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the [breeding ratites(1)](2)[productive ratites(3)](2)
described in this certificate:
II.1.1. come from the zone with code _ _ -_(4)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex V to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of breeding ratites and productive ratites;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Delegated Regulation (EU) 2020/692;
II.1.2. come from the zone referred to in point II.1.1, which at the date of issue of this certificate:
(2)either [is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Delegated Regulation (EU) 2020/692;]
(2)(5)or [is not considered free from infection with Newcastle disease virus in accor dance with Article 39 of 
Delegated Regulation (EU) 2020/692 and the animals:
(a) have been placed under official surveillance for a period of at least 21 days prior to the date of 
loading of the consignment for dispatch to the Union;
(b) have been kept in complete isolation during the period referred to in point (a), away from direct 
or indirect contact with other birds, in facilities approved by the competent authority of the 
country or territory of origin for this purpose;
(c) have undergone a virus detec tion test(6)for infection with Newcastle disease virus:
(i) which was carried out on cloacal swabs or faeces samples collected from each ratite 
within 7 to 10 days of the date the ratites were placed under official surveillance referred to in point (a);
(ii)
in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity 
Index (ICPI) of more than 0.4 have been found;
(iii) with favourable results being available for all birds in the consignment before they left the 
facilities referred t o in point (b) for dispatch to the Union;
(d) come from flocks in which surveillance for infection with Newcastle disease virus was carried 
out under a statistically- based sampling plan which produced negative results for a period of at 
least 6 months imme diately prior to the date of dispatch of the consignment for entry into the 
Union;]
II.1.3. come from the zone referred to in point II.1.1, in which: 
(2)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(2)(7)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to Delegated 
Regulation (EU) 2020/692;]
(2)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]
(2)(8)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, and the animals:
(i) have not been vaccinated with such vaccines for a period of at least the 12 months prior to 
the date of loading of the consignment for dispatch to the Union; 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /621
COUNTRY Certificate model BPR
(ii) come from a flock or flocks which underwent a virus isolation test(6)for infection with 
Newcastle disease virus carried out on a random sample of cloacal swabs from at least 60 
birds in each flock, taken not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, and in which no avia n paramyxoviruses with an 
ICPI of more than 0,4 were found;
(iii) were kept in isolation under official surveillance on the establishment of origin during the 
2 weeks mentioned in (i i);
(iv) during the period of 60 days prior to the date of loading of the consignment for dispatch to 
the Union, were not in contact with poultry which do not fulfil the conditions in (i) and 
(ii);]
II.1.4. have remained in the zone referred to in point II.1.1. for a continuous period of at least 3 months immediately prior to the date of l oading for dispatch to the Union or since hatching where they are less 
than 3 months of age; 
and where they were imported into the zone referred to in point II.1.1, the import took place in 
accordance with animal health requirements that are at least as s tringent as the relevant requirements of 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 and the zone from where the 
animals were imported, is listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 for 
entry into the Union of breeding ratites and productive ratites;
II.1.5. come from the establishment, indicated in Box I.11, approved by the competent authority of the country or territory of origin in accordance with requirements which are at least as stringent as those laid down 
in Article 8 of Commission Delegated Regulation (EU) 2019/2035 and:
(a) the approval of which has not been suspended or withdrawn;
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain and to keep records in accordance with Article 8 of Delegated 
Regulation (EU) 2020/692;
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the occurrence of the diseases, including the relevant 
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692, at a frequency that 
is proportional to the risk posed by the establishment;
(d) which was not subject to national restriction measures for animal health reasons, including the 
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the time of dispatch of the animals to the Union;
(e) within a 10 km radius of which, including, where a ppropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
(f) in which no confirmed case of infection with low pathogenic avian influenza viruses has been 
reported for at least 21 days prior to the date of loading for dispatch to the Union;
II.1.6. come from a flock which:
(a) has not been vaccinated against highly pathogenic avian influenza;
(2)either [(b) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]
L 113 /622  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BPR
(2)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;
(9)
Identificati
on of the 
flockAge of 
the 
birdsDate of 
vaccinatio
nName and 
type of virus 
strain usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacture
r of the 
vaccine
]
(c) hasbeen subjected to a clinical inspection(10)within the 24 hours prior to loading of the animals 
for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
relevant for the specie s and emerging diseases;
II.1.7. have remained in the establishment indicated in Box I.11 since hatching or for a continuous period of at 
least 6 weeks immediately prior to the date of loading for dispatch to the Union;
II.1.8. had no contact with animals of a lower health status since hatching or for a continuous period of at least 
6 weeks immediately prior to the date of loading for dispatch to the Union;
II.1.9. are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;
II.1.10. have been subjected to a clinical inspection
(10)on ___/___/____ (dd/mm/yyyy), within the 24 hours 
prior to loading for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;
II.1.11. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that: 
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter, feed or feathers is pr evented or minimized;
(b) contain only poultry of the same species and category coming from the same establishment;
(c) are:
(2)either [unused and purpose -designed disposable containers to be destroyed after first use;]
(2)or [cleaned and disinfected and dried or allowed to dry prior to loading of the animals;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /623
COUNTRY Certificate model BPR
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) bear the information set out in Point 1 of Annex XVI to Delegated Regulation (EU) 2020/692 
relevant for breeding poultry and productive poultry;
II.1.12. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(11)in a means of transport which is 
construc ted in accordance with II.1.11(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin; 
(12)[II.1.13. are intended for a Member State which has been granted the s tatus free from infection with Newcastle 
disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation 
(EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) were kept in isolation for at least 14 days prior to the date of loading of the consignment for 
dispatch to the Union in the establishment of origin or quarantine establishment under the 
supervision of an official veterinarian, where:(i) no poultry was vaccinated against infection with Newcastle disease virus during the 
period of at least 21 days prior to the date of loading of the consignment;
(ii) no other birds have entered into the establishment during that time; 
(iii) no vaccination has been carried out;
(c) have tested
(6)negative to serological tests to detect antibodies against Newcastle disease virus, 
performed on blood samples at a level which gives 95% confidence of detecting infection at 5% 
prevalence and which were taken during the period of at least 1 4 days prior to the date of loading 
for dispatch to the Union;]
Notes:
This certificate is intended for entry into the Union of breeding ratites or productive ratites, including when the 
Union is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235
Part I:
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
V to Implementing Regulation (EU) 2021/404.
Box reference I.27: Description of consignment:
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.06.39.
“Identification system”: The animal must be individually identified by neck- tags or an 
injectable transponder in accor dance with Article 43 of Delegated Regulation (EU) 
2020/692.
“Category” : select one of the following: Pure line/grandparents/parents/others.
“Identification number” : Indicate the identification number, which must include the 
code of the country or territor y of origin conforming with ISO standards in accordance 
with Article 43 of Delegated Regulation (EU) 2020/692.
L 113 /624  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BPR
Part II:
(1)‘Breeding ratites’ means ratites 72 hours old or more, intended for the production of hatching eggs, as 
defined in Delegated Regulation (EU) 2020/692.
(2)Keep as appropriate.
(3)‘Productive ratites’ means ratites 72 hours old or more, reared for the production of meat, eggs for consumption or other products, as defined in Delegated Regulation (EU) 2020/692.
(4)Code of the zon e as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(5)This guarantee is required only for consignments from zones which are not considered free from 
infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 
2020/692 and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry 
“C” in column 6 of the table. 
(6)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(7)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are listed in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/4 04with the entry “A” in column 6 of the table.
(8)This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Delegat ed Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) thereof, and 
are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in 
column 6 of the table. 
(9)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(10)The clinical inspection must have been carried out by an official veterinarian of the country or territory of origin.
(11)The date of loading cannot be a date prior to the date of authorisati on of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.
(12)This guarantee is required only for consignments intended for a Member St ate which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /625
CHAPTER 25
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF DAY- OLD CHICKS OTHER THAN RATITES (MODEL ‘ DOC’ )
COUNTRY Animal he alth/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /626  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /627
COUNTRY Certificate model DOCPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
(1)[II.1.1. The Salmonella control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Commission Regulation 
(EC) No 1177/2006, have been applied to the parent flock of origin and this parent flock has been 
tested for Salmonella serotypes of public health significance:
Identification of 
the flockAge of the 
birdsDate of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]Result of all testing in the 
flock(2)
positive negative
The specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No 1177/2006 
have been applied to the day -old chicks. 
For reasons other than the Salmonella control programme:
(3)either [antimicrobials were not administered to the day -old chicks (including in- ovo injection);]
(3)(4)or[the following antimicrobials were administered to the day -old chicks (including in- ovo
injection)…………………………………………………………..;]]
(1)[II.1.2. If the day -old chicks are intended for breeding, neither Salmonella Enteritidis nor Salmonella
Typhimurium were detected within the control programme referred to in point II.1.1.]
(5)[II.1.3. If the Member State of destination is Finland or Sweden, the day -old chicks for introduction into 
flocks of breeding poultry or flocks of productive poultry come from flocks which have tested 
negative for Salmonella in accordance with the rules laid down i nCommission Decision 
2003/644/EC .]
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the day -old chicks(6)other than ratites described in this 
certificate:
II.2.1. have hatched on the zone with code _ _ - _(7)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex V to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of day -old chicks other than ratites;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Delegated Regulation (EU) 2020 /692;
(d) is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Delegated Regulation (EU) 2020/692;
II.2.2. come from the zone referred to in point II.2.1, in which:
(3)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(3)(8)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to Delegated 
Regulation (EU) 2020/692;]
L 113 /628  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model DOC
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 
is prohibited;]
(3)(9)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, and the animals:
(i) have not been vaccinated with such vaccines;
(ii) come fro m flocks which:
-have not been vaccinated with such vaccines for a period of at least the 12 months 
prior to the date of loading of the consignment for dispatch to the Union;
-underwent a virus isolation test
(10)for infection with Newcastle disease virus ca rried 
out on a random sample of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the date of loading of the consignment for dispatch 
to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0, 4
were found;
-were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the date of loading of the consignment for dispatch to the 
Union;
-during the period of 60 days prior to the date of loading of the c onsignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second indent above;
(iii) come from hatching eggs which have not been in contact in the hatchery or during 
transport with poultry or hatching eggs not meeting the requirements set out in (ii);]
II.2.3. come from a hatchery, indicated in Box I.11, approved by the competent authority of the country or 
territory of origin in accordance with requirements which are at least as stringent as those laid down in 
Article 7 of Commission Delegated Regulation (EU) 2019/2035 and:
(a) the approval of which has not been suspended or withdrawn;
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain and to keep records in accordance with Article 8 of Delegated 
Regulation (EU) 2020/692;
(c) which receives regular animal health v isits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the occurrence of diseases, including the relevant 
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging 
diseases, at a frequency that is proportional to the risk posed by the establishment;
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the time of dispatch of the animals to the Union;
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian inf
luenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /629
COUNTRY Certificate model DOC
II.2.4. come from a flock which:
(a) has remained in zone referred to in point II.2.1 for a continuous period of at least 3 months 
immediately prior to the date of collection of the eggs from which the day -old chicks have 
hatched ;
and where the flock was imported into the zone referred to in point II.2.1, the import took place 
in accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 and the 
zone from where the animals were import ed, is listed in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 for entry into the Union of breeding poultry other than ratites and 
productive poultry other than ratites;
(b) has been kept for a continuous period of at least 6 weeks immediately pri or to the date of 
collection of the eggs from which the day -old chicks have hatched in an establishment:
(i) approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of 
Delegated Regulation (EU) 2019/2035;
(11)
Name of establishment Address Approval number
(ii) the approval of which has not been suspended or withdrawn at the time the hatching eggs, 
from which the day -old chicks have hatched, were sent to the hatchery;
(iii) in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of collection of the hatching eggs, from 
which the day -old chicks have hatched;
(iv) in which;
(3)either [infection with Salmonella Pullorum, S. Gallinarum or S . arizonae was not confirmed 
during the last 12 months prior to date of loading of the consignment for dispatch to the 
Union;]
(3)or [infection with Salmonella Pullorum, S. Gallinarum or S . arizonae was confirmed during 
the last 12 months prior to date of loading of the consignment for dispatch to the Union and the measures provided for in Article 46(d) of Delegated Regulation (EU) 2020/692 
have been applied;]
(v) in which:
(3)either [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not 
confirmed during the last 12 months prior to date of loading of the consignment for 
dispatch to the Union;]
(3)or [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the 
Union and the measures provided for in Article 46(e) of Delegated Regulation (EU) 
2020/692 have been applied;]
(3)either [(c) has not been vaccinated against highly pathogenic avian influenza;]
(3)(8)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation
(EU) 2020/692;]
(3)either [(d) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]
L 113 /630  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model DOC
(3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;
(12)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
(e) underwent a disease surveillance programme that meets the requirements set out in Annex II to 
Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed any grounds 
for suspecting any infection, by the following agents:
(3)either [Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus 
gallus );]
(3)or [Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, 
Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);] 
(3)or [Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris , Coturnix 
coturnix , Phasianus colchicus , Perdix perdix and Anas spp );] 
II.2.5. come from hatching eggs which:
(a) comply with the requirements for entry into the Union laid down in Title 2 of Pa rt III of 
Delegated Regulation (EU) 2020/692;
(b) prior to their dispatch to the hatchery, have been marked in accordance with the instructions of 
the competent authority of the country or territory of origin;
(c) have been disinfected in accordance with the instr uctions of the competent authority of the 
country or territory of origin;
(d) have had no contact with poultry or hatching eggs of lower health status, captive birds or wild 
birds, either during transport to the hatchery or in the hatchery;
II.2.6. have remain ed:
(a) in the country or territory or zone thereof referred to in point II.2.1 since hatching;
(b) in the establishment indicated in Box I.11 since hatching;
II.2.7. have not been vaccinated against highly pathogenic avian influenza;
II.2.8. are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;
II.2.9. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that: 
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or minim ized;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /631
COUNTRY Certificate model DOC
(b) contain only poultry of the same species and category coming from the same establishment;
(c) are disposable, clean and used for the first time;
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) bear the information set out in Point 3 of Annex XVI to Delegated Regulation (EU) 2020/692 
relevant for day -old chicks;
II.2.10. are loaded for dispatch to the Union on ___/__ _/____ (dd/mm/yyyy)(13)in a means of transport which is 
constructed in accordance with II.2.9(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;
(14)[II.2.1 1.are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation 
(EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from hatching eggs coming from flocks which:
(3)either [have not been vaccinated against infection with Newcastle disease virus;]
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine;]
(3)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the 
latest 60 days prior to the date the eggs were collected;]
(c) come from a hatchery where working practices ensure th at the hatching eggs from which the 
day-old chicks have hatched, were incubated at completely separate times and locations from 
eggs not satisfying the requirements of point (b);]
Notes:
This certificate is intended for entry into the Union of day -old chicks other than ratites, including when the Union 
is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomi c Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the z one as it appears in column 2 of the table in Part 1 of Annex 
V to Implementing Regulation (EU) 2021/404.
Box reference I.27: Description of consignment:
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.05 or 01.06.39.
“Category” : select one of the following: Pure line/grandparents/parents/laying 
stock/broilers/others.
L 113 /632  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model DOC
Part II:
(1)This guarantee applies only for day -old chicks belonging to the species of Gallus gallus and turkeys.
(2)If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:
-flocks of breeding poultry: Salmonella Hadar , Salmonella Virchow and Salmonella Infantis ;
-flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium .
(3)Keep as appropriate.
(4)Keep if appropriate: indicate the name and active substance of antimicrobials used.
(5)Delete if consignment is not intended for Finland or Sweden.
(6)‘Day -old chicks’ means poultry less than 72 hours old, as def ined in Article 2 of Delegated Regulation 
(EU) 2020/692. 
(7)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(8)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are lis ted in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(9)This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus whi ch comply only with the general criteria of Annex XV to 
Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) thereof, and 
are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in 
column 6 of the table.
(10)Tests should be carried out on samples taken by or under the control of the competent authority of the country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(11)Indicate the name, address and approval number of the establishment were the flock of origin of the 
day-old chicks was kept during the 6 weeks immediately prior to the date of collection of the eggs from 
which the da y-old chicks have hatched.
(12)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(13)The date of loading cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.
(14)This guarantee is required only for consignments intended for a Member State which has been granted the status free from infectio
n with Newcastle disease virus without vaccination in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /633
COUNTRY Certificate model DOC
(15)III. Supplementary health information concerning certificate reference number (Box I.2.)
…………………………………………………………………………………………………………….
I, the undersigned official veterinarian, hereby certify that:
(a)       the health conditions of Part II of this certificates continue to be met;
(b)       the day -old chicks described in this certificate:
(i) have hatched on ………………. (dd/mm/yyyy);(ii) have been subjected to a clinical inspection
(16)on __/__/__ (dd/mm/yyyy) , within the 24 
hours prior to loading for dispatch to the Union, and showed no signs indicative of the 
occurrence of diseases, including the listed diseases referred to in Annex I to Delegated 
Regulation (EU) 2020/692 relevant for the species and emerging diseases;
(iii) had no contact with animals of a lower health status since hatching.
(15) This section can be on a separate sheet provided it is attached to Part II of the animal health certificate .
(16)The clinical inspection must have been carried out by an official veterinarian of the countr y or territory 
of origin.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /634  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 26
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
DAY- OLD CHICKS OF RATITE S (MODEL ‘ DOR’ )
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISOcountry code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
I.21□For transit I.22□For internal market
Third country ISO country code I.23□For re- entry
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /635
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Quantity
L 113 /636  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model DORPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the day -old chicks(1)of ratites described in this 
certificate:
II.1.1. have hatched on the zone with code _ _ - _(2)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Ann ex V to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of day -old chicks of ratites;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Delegated Regulation (EU) 2020/692;
II.1.2. come from the zone referred to in point II.1.1, which at the date of issue of this certificate:
(3)either [is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Delegated Regulation (EU) 2020/692;]
(3)(4)or [is not considered free from infection with Newcastle disease virus in accordance with Art icle 39 of 
Delegated Regulation (EU) 2020/692 and the day -old chicks come from flocks:
(a) which have been placed in isolation under official surveillance for a period of at least 30 days 
prior to the date of laying of the hatching eggs from which the day -old chicks of this 
consignment have hatched ;
(b) which have undergone a virus detection test(5)for infection with Newcastle disease virus:
(i) which was carried out on cloacal swabs or faeces samples collected from each ratite 
within 7 to 10 days of the date the ratites were placed under official surveillance referred 
to in point (a);
(ii) in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity 
Index (ICPI) of more than 0.4 have been found;
(iii) with favourable results being a vailable for all birds before the day -old chicks left the 
hatchery for dispatch to the Union;
(c) in which surveillance for infection with Newcastle disease virus was carried out under a statistically -based sampling plan which produced negative results for
a period of at least 6 
months immediately prior to the date of dispatch of the consignment for entry into the Union; 
(d) have not been kept with poultry which do not fulfil the guarantees under points (a), (b) and (c) 
during the period of 30 days prior t o the date of laying and during the laying of the hatching eggs 
from which the day -old chicks of this consignment have hatched ;]
II.1.3. come from the zone referred to in point II.1.1, in which: 
(3)either [(a) vaccination against highly pathogenic avian i nfluenza is not carried out;]
(3)(6)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]
(3)(7)or [(b) vaccination against infe ction with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, and the animals:
(i) have not been vaccinated with such vaccines;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /637
COUNTRY Certificate model DOR
(ii) come from flocks which:
-have not been vaccinated with such vaccines for a period of at least the 12 months 
prior to the date of loading of the consignment for dispatch to the Union;
-underwent a virus isolation test(5)for infection with Newcastle disease virus carried 
out on a random sample of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the date of loading of the consignment for dispatch 
to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 
were found;
-were kep t in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the date of loading of the consignment for dispatch to the Union;
-during the period of 60 days prior to the date of loading of the consignment for 
dispatc
h to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second in dent above;
(iii) come from hatching eggs which have not been in contact in the hatchery or during 
transport with poultry or hatching eggs not meeting the requirements set out in (ii);]
II.1.4. come from a hatchery, indicated in Box I.11, approved by the competent authority of the country or 
territory of origin in accordance with requirements which are at least as stringent as those laid down in 
Article 7 of Commission Delegated Regulation (EU) 2019/2035 and:
(a) the approval of which has not been suspended or withdrawn;
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain and to keep records in accordance with Article 8 of Delegated 
Regulation (EU) 2020/692;
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the occurrence of diseases, including t he relevant 
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692  and emerging 
diseases, at a frequency that is proportional to the risk posed by the establishment;
(d) which was not subject to national restriction measures for animal h ealth reasons, including for 
the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the 
species and emerging diseases, at the time of dispatch of the animals to the Union;
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
II.1.5. come fr om a flock which:
(a) has remained in the zone referred to in point II.1.1 for a continuous period of at least 3 months 
immediately prior to the date of collection of the eggs from which the day -old chicks have 
hatched;
and where the flock was imported into the zone referred to in point II.1.1, the import took place in 
accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 and the zone from where the animals were imported, is listed in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 for entry into the Union of breeding ratites and productive ratites;
L 113 /638  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model DOR
(b) has been kept for a continuous period of at least 6 weeks immediately prior to the da te of 
collection of the eggs from which the day -old chicks have hatched in establishments:
(i) approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of 
Commission Delegated Regulation (EU) 2019/2035;
(8)
Name of establishment Address Approval number
(ii) the approval of which has not been suspended or withdrawn at the time the hatching eggs, 
from which the day -old chicks have hatched, were sen t to the hatchery;
(iii) in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of collection of the hatching eggs, from which the day -old chicks have hatched;
(3)either [(c) has not been vaccinated against highly pathogenic avian influenza;]
(3)(6)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out i n Annex XIII to Delegated Regulation 
(EU) 2020/692;]
(3)either [(d) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]
(3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Delegated Regul ation (EU) 2020/692;
(9)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
II.1.6. come from hatching eggs which:
(a) comply with the requirements for entry into the Union laid down in Title 2 of Part III of 
Commission Delegated Regulation (EU) 2020/692;
(b) prior to their dispatch to the hatchery, have been marked in accordance with the instructions of 
the competent auth ority of the country or territory of origin;
(c) have been disinfected in accordance with the instructions of the competent authority of the 
country or territory of origin;
(d) have had no contact with poultry or hatching eggs of lower health status, captive birds or wild 
birds, either during transport to the hatchery or in the hatchery;
II.1.7. have remained:
(a) in the country or territory or zone thereof referred to in point II.1.2 since hatching;
(b) in the establishment indicated in Box I.11 since hatching;
II.1.8. had no contact with animals of a lower health status since hatching;
II.1.9. have not been vaccinated against highly pathogenic avian influenza;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /639
COUNTRY Certificate model DOR
II.1.10. are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and 
emerging diseases;
II.1.11. have hatched on ………………..(dd/mm/yyyy);
II.1.12. have been subjected to a clinical inspection(10)on ___/___/____ (dd/mm/yyyy), within the 24 hours 
prior to loading for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for 
the species and emerging diseases;
II.1.13. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that: (i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possibl e;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or minimized;
(b) contain only poultry of the same species and category coming from the same establishment;
(c) are disposable, clean and used for the first time;
(d) are close
d in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) bear the information set out in Point 3 of Annex XVI to Delegated Regulation (EU) 2020/692 
relevant for day -old chicks;
II.1.14. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(11)in a means of transport which is 
constructed in accordance with II.1.13(a) and was cleaned and disinfected prior to loading with a 
disinfectant auth orised by the competent authority of the country or territory of origin;
(12)[II.1.15. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation 
(EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from hatching eggs coming from flocks which:
(3)either [have not been vaccinated against infection with Newcastle disease virus;]
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine;]
(3)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the 
latest 60 days prior t o the date the eggs were collected;]
(c) come from a hatchery where working practices ensure that the hatching eggs from which the 
day-old chicks have hatched, were incubated at completely separate times and locations from 
eggs not satisfying the requireme nts of point (b).]
Notes:
This certificate is intended for entry into the Union of day -old chicks of ratites, including when the Union is not 
the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to Europea n Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /640  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model DOR
Part I:
Box reference I.8: Provide the code of the country or territory or zone thereof as it appears in column 2 of 
the table in Part 1 of Annex V to Implementing Regulation (EU) 2021/404.
Box reference I.27: “CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.06.39.
“Category” : select one of the following: Pure line/grandparents/parents/others.
Part II:
(1)‘Day -old chicks’ means poultry less than 72 hours old, as defined in Article 2 of Delegated Regulation 
(EU) 2020/692.
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing Regulation 
(EU) 2021/404.
(3)Keep as appropriate.
(4)This guarantee is required only for consignments from z ones which are not considered free from infection 
with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692 and 
are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “C” in column 
6 of the table.
(5)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(6)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out in 
accordance with a vaccination programme that complies with the requirements set out in Annex XIII to 
Delegated Regulat ion (EU) 2020/692, and are listed in Part 1 of Annex V to Implementing Regulation 
(EU) 2021/404 with the entry “A” in column 6 of the table.
(7)This guarantee is required only for day -old chicks coming from zones in which the use of vaccines 
against infec tion with Newcastle disease virus which comply only with the general criteria of Annex XV 
to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) thereof, and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in column 
6 of the table.
(8)Indicate the name, address and approval number of the establishment were the flock of origin of the day -
old chicks was kept during the 6 weeks immediately prior to the date of collection of the eggs from which 
the day -old chicks have hatched.
(9)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(10)The clinical inspection must have been carried out by an official veterinarian of the country or territo ry of 
origin.
(11)The date of loading cannot be a date prior to the date of authorisation of the country or territory or zone thereof for entry into the Union, or a date in a period when restriction measures have been adopted by the 
Union in relation to t he entry of these animals from that country or territory or zone thereof.
(12)This guarantee is required only for consignments intended for a Member State which has been granted the 
status free from infection with Newcastle disease virus without vaccinati on in accordance with Article 66 
of Commission Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /641
CHAPTER 27
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF HATCHING EG GS OF POULTRY OTHER THAN RATITES (MODEL 
‘HEP ’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /642  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Identification 
systemIdentification number Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /643
COUNTRY Certificate model HEPPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the hatching eggs(1)of poultry other than ratites 
described in this certificate:
II.1.1. come from the zone with code _ _ -_(2)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of hatching eggs of poultry other than ratites;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 105(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Delegated Regulation (EU) 2020/692;
(d) is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Delegated Regulation (EU) 20 20/692; 
II.1.2. come from the zone referred to in point II.2.1, in which: 
(3)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(3)(4)or [(a) vaccination against highly pathogenic avian influenza is carried out in acco rdance with a 
vaccination programme that complies with the requirements set out in Annex XIII to Delegated 
Regulation (EU) 2020/692;]
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 
is prohibited;]
(3)(5)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Delegated Regu lation (EU) 2020/692 is not prohibited, 
and the hatching eggs:
(i) come from flocks which:
-have not been vaccinated with such vaccines for a period of at least the 12 month 
prior to the date of loading of the consignment for dispatch to the Union;
-underwent a virus isolation test(6)for infection with Newcastle disease virus carried 
out on a random sample of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 
were found;
-
were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the date of loading of the consignment for dispatch to the 
Unio n;
-during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second in dent above;
(ii) have not been in contact in the hatchery or during transport with poultry or hatching eggs 
not meeting the requirements set out in (i);]
II.1.3. come from the establishment, indicated in Box I.11:
(3)(7)either [(a) which is approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 7 of Commission 
Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or 
withdrawn at the time the hatching eggs were collected;]
L 113 /644  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HEP
(3)(8)or [(a) which is approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of Delegated 
Regulation (EU) 2019/2035 and the approval of whic h has not been suspended or withdrawn at 
the time the hatching eggs were collected;]
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain and to keep records in accordance with Ar ticle 8 of Delegated 
Regulation (EU) 2020/692;
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative the occurrence of diseases, including the relevant listed diseases refe rred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases, at 
a frequency that is proportional to the risk posed by the establishment;
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the 
species and emerging diseases, at the time of dispatch of the hatching eggs to the Union;
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
II.1.4. come from a flock which:
(a) hasremained in zone referred to in point II.1.1 for a continuous period of at least 3 months 
immediately prior to the date of loading of the hatching eggs for dispatch to the Union;
and where the flock was imported into the zone referred to in point II.1.1, the import took place 
in accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 and the 
zone from where the animals were imported, is listed in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 for entry into the Union of breeding poultry other than ratites and 
productive poultry other than ratites;
(b) has been kept for a continuous period of at least 6 weeks immediately prior to the date of loading 
of the hatching eggs for dispatch to the Union in an establishment:
(i) in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of collection of the hatching eggs;
(ii) in which:
(3)either [infection with Salmonella Pullorum, S. Gallinarum or S . arizonae was not confirmed 
during the last 12 months prior to date of collection of the hatching eggs for dispatch to the Union;]
(3)or [infection with Salmonella Pullorum, S. Gallinarum or S . arizonae was confirmed 
during the last 12 months prior to date of collection of the hatching eggs for dispatch to 
the Union and the measures provided for in Article 107(d) of Delegated Regulation 
(EU) 2020/692 have been applied;]
(iii) in which;
(3)either [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not 
confirmed during the last 12 months prior to date of collection of the hatching eggs for 
dispatch to the Union;]
(3)or [avian mycoplasmosis (Mycoplasma gallisept icum and M. meleagridis) was confirmed 
during the last 12 months prior to date of collection of the hatching eggs for dispatch to 
the Union and the measures provided for in Article 107(e) of Delegated Regulation 
(EU) 2020/692 have been applied;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /645
COUNTRY Certificate model HEP
(7)[(iv) approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of 
Delegated Regulation (EU) 2019/2035;
(9)
Name of establishment Address Approval number
(v) the approval of which has not been suspended or withdrawn at the time the hatching 
eggs were collected;
(vi) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
(vii)
which is under the control of the competent authority of the country or territory of 
origin and has a system in place to maintain and to keep records in accordance with 
Article 8 of Delegated Regulation (EU) 2020/692;
(viii) which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information
on, signs indicative of the occurrence of diseases, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases, at a frequency that is proportional to the risk posed by the establishment;
(ix) whic
h was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the time of dispatch of the hatching eggs to the Union;]
(3)either [(c) has not been vaccinated against highly pathogenic avian influenza;]
(3)(4)or[(c) has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Delegated Regulation 
(EU) 2020/692;]
(3)either [(d) has not been vaccinated against infection with Newcastle disease virus in the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]
(3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;
(10)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
(e) underwent a disease surveillance programme that meets the requirements set out in Annex II to 
Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed any grounds for suspecting any infection, by the following agents:
L 113 /646  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HEP
(3)either [Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus 
gallus );]
(3)or [Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, 
Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);] 
(3)or [Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris , Coturnix 
coturnix , Phasianus colchicus , Perdix perdix and Anas spp );] 
(f) had no contact with poultry or hatching eggs of a lower health status, or with captive or wild 
birds for a continuous period of at least 6 weeks immediately prior to the date of loading of the 
hatching eggs for dispatch to the Union;
(g) did not show symptoms of transmissible diseases at the time of collection of the hatching eg gs;
(h) hasbeen subjected to a clinical inspection(11)within the 24 hours prior to loading of the hatching 
eggs for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
relevant for the species and emerging diseases;
II.1.5. were:
(3)either [(a) not vaccinated against highly pathogenic avian influenza;]
(3)(4)or [(a) vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]
(3)either [(b) not vaccinated against infection with Newcastle disease virus;]
(3)or [(b) vaccinated against infection with Newc astle disease virus with vaccines that comply with the 
general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;]
(c) marked using colour ink, with a stamp indicating the unique approval number of the 
establishment of origin;
(d) disinfected in accordance with the instructions of the competent authority of the country or 
territory of origin;
II.1.6. were collected [on ___/___/____ (dd/mm/yyyy)](3)[from ___/___/____ (dd/mm/yyyy) to ___/___/____ 
(dd/mm/yyyy)](3); (12)
II.1.7. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that the hatching eggs cannot fall out;
(b) are designed to allow cleaning and disinfection; 
(c) contain only hatching eggs of the same species, category and type coming from the same 
establishment;
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) are:
(3)either [disposable, clean and used for the first time;]
(3)or [cleaned and disinfected before loading of the hatching eggs in accordance with the instructions 
of the competent authority of the country or territory of origin;]
(f) bear the information set out in Point 5 of Annex XVI to Delegated Regulation (EU) 2020/692 
relevant for hatching eggs of poultry;
II.1.8. are loaded for dispatch to the Union in a means of transport which is constructed in accordance with 
II.1.7(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the competent 
authority of the country or territory of origin and dried or allowed to dry immediately before loading of 
the hatching eggs for dispatch to the Union;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /647
COUNTRY Certificate model HEP
(13)[II.1.9. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation 
(EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from flocks which:
(3)either [have not been vaccinated against infection with Newcastle disease virus.]]
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine.]]
(3)or [have been vaccinated against infection with Newcastle dis ease virus with a live vaccine at the 
latest 60 days prior to the date the eggs were collected.]]
II.2. Public health attestation [*to delete when the Union is not the final destination of the hatching 
eggs](14)[II.2.1. The Salmonella control programme ref erred to in Article 10 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in Commission 
Regulation (EC) No 1177/2006, have been applied to the parent flock of origin and this parent flock has 
been tested for Salmonella serotypes of public health significance:
Identification of 
the flockAge of the 
birdsDate of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]Result of all testing in the 
flock(15)
Positive Negative
(14)[II.2.2. Neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control 
programme referred to in point II.1.1.]
(16)[II.2.3. If the Member State of destination is Finland or Sweden, the hatching eggs come from flocks which
have tested negative for Salmonella in accordance with the rules laid down in Commission Decision 
2003/644/EC .]
Notes:
This certificate is intended for entry into the Union hatching eggs of poultry other than ratites, including when the 
Union is not the final destination of those germinal products.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) o f the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be complete d according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
V to Implementing Regulation (EU) 2021/404.
Box reference I.27: “CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 04.07.
“Category”
: select one of the following: Pure line/grandparents/parents/laying 
pullets/others.
L 113 /648  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HEP
Part II:
(1)Hatching eggs as defined in Article 4 of Regulation (EU) 2016/429.
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(3)Keep as appropriate.
(4)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are lis ted in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(5)This guarantee is required only for hatching eggs coming from zones in which the use of vaccines 
against infection with Newcastle disease vir us which comply only with the general criteria of Annex 
XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry 
“B” in column 6 of the table.
(6)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in accordance with Article 37 of Regulation (EU) 2017/625.
(7)Keep in case the hatching eggs are dispatched from a hatchery.
(8)keep in case the hatching eggs are dispatched from the establishment of the flock of origin.
(9)Indicate the name, address and approval number o f the establishment were the flock of origin of the 
hatching eggs was kept during the 6 weeks immediately prior to the date of loading of the hatching eggs 
for dispatch to the Union.
(10)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(11)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(12)The date(s) of collection cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these hatching eggs from that zone.
(13)This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
(14)This guarantee applies only for hatching eggs belonging to the species of Gallus gallus and turkeys.
(15)If any of the results were positive for the following serotypes during the life of the parent flock, indicate 
as positive: Salmonella Hadar , Salmonella Virchow and Salmonella Infantis .
(16)Delete if consignment is not intended for Finland or Sweden.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /649
CHAPTER 28
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
HATCHING EGGS OF RATITES (MODEL ‘ HER’ )
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /650  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Identification 
systemIdentification number Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /651
COUNTRY Certificate model HERPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the hatching eggs(1)of ratites described in this 
certificate:
II.1.1. come from the zone with code _ _ -_(2)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of hatching eggs of ratites;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 105(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Delegated Regulation (EU) 2020/692;
II.1.2. come from the zone referred to in point II.1.1, which at the date of issue of thi s certificate:
(3)either [is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Delegated Regulation (EU) 2020/692;]
(3)(4)or [is not considered free from infection with Newcastle disease virus in accordance with A rticle 39 of 
Delegated Regulation (EU) 2020/692 and the hatching eggs come from flocks:
(a) which have been placed in isolation under official surveillance for a period of at least 30 days 
prior to the date of laying of the hatching eggs of this consignment;
(b) which have undergone a virus detection test(5)for infection with Newcastle disease virus:
(i) which was carried out on cloacal swabs or faeces samples collected from each ratite 
within 7 to 10 days of the date the ratites were placed under official surveillance referred 
to in point (a);
(ii) in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity 
Index (ICPI) of more than 0.4 have been found;
(iii) with favourable results being available for all birds before the day-old chicks left the 
hatchery for dispatch to the Union;
(c) in which surveillance for infection with Newcastle disease virus was carried out under a statistically -
based sampling plan which produced negative results for a period of at least 6 
months im mediately prior to the date of dispatch of the consignment for entry into the Union;
(d) have not been kept with poultry which do not fulfil the guarantees under points (a), (b) and (c) 
during the period of 30 days prior to the date of laying and during the laying of the hatching eggs 
of this consignment;]
II.1.3. come from the zone referred to in point II.1.1, in which:
(3)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(3)(6)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to Delegated 
Regulation (EU) 2020/692;]
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]
(3)(7)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with t he general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, 
and the hatching eggs:
(i) come from flocks which:
-have not been vaccinated with such vaccines for a period of at least the 12 months 
prior to the date of loading of the consignment for dispatch to the Union;
L 113 /652  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HER
-underwent a virus isolation test(5)for infection with Newcastle disease virus carried 
out on a random sample of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the da te of loading of the consignment for dispatch 
to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 
were found;
-were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the da te of loading of the consignment for dispatch to the 
Union;
-during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second in dentabove;
(ii) have not been in contact in the hatchery or during transport with poultry or hatching eggs not meeting the requirements set out in (i);]
II.1.4. come from the establishment, indicated in Box I.11:
(3)(8)either [(a which is approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 7 of Commission Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or withdrawn at the time the hatching eggs were collected;]
(3)(9)or [(a) which is approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of Del egated 
Regulation (EU) 2019/2035 and the approval of which has not been suspended or withdrawn at 
the time the hatching eggs were collected;]
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain and to keep records in accordance with Article 8 of Commission 
Delegated Regulation (EU) 2020/692;
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection of, 
and information on, signs indicative of the occurrence of diseases, including the relevant  listed 
diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases, at 
a frequency that is proportional to the risk posed by the establishment;
(d) which was not subject to nat ional restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the time of dispatch of the hatching eggs to the Union;
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loadi ng for dispatch to the Union;
II.1.5. come from a flock which:
(a) has remained in zone referred to in point II.1.1 for a continuous period of at least 3 months 
immediately prior to the date of loading of the hatching eggs for dispatch to the Union;
and where the flock was imported into the zone referred to in point II.1.1, the import took place in 
accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 and the 
zone from where the animals were imported, is listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 for entry into the Union of breeding ratites and productive ratites;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /653
COUNTRY Certificate model HER
(b) has been kept for a continuous period of at lea st 6 weeks immediately prior to the date of loading 
of the hatching eggs for dispatch to the Union in an establishment:
(i) in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of collection of the hatching eggs;
(8)[(ii) approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of 
Commission Delegated Regulation ( EU) 2019/2035;
(10)
Name of establishment Address Approval number
(iii) the approval of which has not been suspended or withdrawn at the time the hatching 
eggs were collected;
(iv) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of loading 
for dispatch to the Union;
(v) which is under the control of th e competent authority of the country or territory of 
origin and has a system in place to maintain and to keep records in accordance with 
Article 8 of Delegated Regulation (EU) 2020/692;
(vi) which receives regular animal health visits from a veterinarian f or the purpose of the 
detection of, and information on, signs indicative the occurrence of diseases, including 
the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 
2020/692 and emerging diseases, at a frequency that is proportio nal to the risk posed by 
the establishment;
(vii) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emergi ng diseases, at the time of dispatch of the 
hatching eggs to the Union;]
(3)either [(c) has not been vaccinated against highly pathogenic avian influenza;]
(3)(5)or[(c) has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Delegated Regulation 
(EU) 2020/692;]
(3)either [(d) has not been vaccinated against infection with Newcastle disease virus in the last 12 months prior to the date of loadi ng of the consignment for dispatch to the Union;]
(3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with
both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;
L 113 /654  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HER
(11)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
(e) had no contact with poultry or hatching eggs of a lower health status, or with captive or wild 
birds for a continuous period of at least 6 weeks immediately prior to the date of loading of the 
hatching eggs for dispatch to the Union;
(f) did not show symptoms of transmissible diseases at the time of collection of the hatching eggs;
(g) hasbeen subjected to a clinical inspection(12)within the 24 hours prior to loading of the hatching 
eggs for dispatch to the Uni on, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
relevant for the species and emerging diseases;
II.1.6. were:
(3)either [(a) not vaccinated against highly pathogenic avian influenza;]
(3)(6)or [(a) vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Delegated Regulation 
(EU) 2020/692;]
(3)either [(b) not vaccinated against infection with Newcastle disease virus;]
(3)or [(b) vaccinated against infection with Newcastle disease virus with vaccines that comply with the 
general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;]
(c) marked using colour ink, with a stamp indicating the ISO code of the country or territory of 
origin and the unique approval number of the establishment of origin;
(d) disinfected in accordance with the instructions of the competent authority of the country or 
territory of origin;
II.1.7. were collected [on ___/___/____ (dd/mm/yyyy)](3)[from ___/___/____ (dd/mm/yyyy) to ___/___/____ 
(dd/mm/yyyy)](3); (13)
II.1.8. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that t he hatching eggs cannot fall out;
(b) are designed to allow cleaning and disinfection;
(c) contain only hatching eggs of the same species, category and type coming from the same 
establishment;
(d) are closed in accordance with the instructions of the compe tent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) are:
(3)either [disposable, clean and used for the first time;]
(3)or [cleaned and disinfected before loading of the hatching eggs in accordance with the instructions 
of the competent authority of the country or territory of origin;]
(f) bear the information set out in Point 5 of Annex XVI to Delegated Regulation (EU) 2020/692 
relevant for hatching eggs of poultry;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /655
COUNTRY Certificate model HER
II.1.9. are loaded for dispatch to the Union in a means of transport which is constructed in accordance with 
II.1.8(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the competent 
authority of the country or territory of origin and dried or allowed to dry immediately before loading of 
the hatching eggs for dispatch to the Union;
(14)[II.1.10. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Arti cle 66 of Commission Delegated Regulation 
(EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from flocks which:
(3)either [have not been vaccinated against infection with Newcastle disease virus.] ]
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine.]]
(3)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the 
latest 60 days prior to the date the eggs were collected.]]
Notes:
This certificate is intended for entry into the Union hatching eggs of ratites, including when the Union is not the 
final destination of those germinal products.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to Europea n Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
V to Implementing Regulation (EU) 2021/404.
Box reference I.27: Description of consignment:
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 04.07.“Category” : select one of the following: Pure line/grandparents/parents/others.
Part II:
(1)Hatching eggs as defined in Article 4 of Regulation (EU) 2016/429. 
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(3)Keep as appropriate.
(4)This guarantee is required only for consignments from zones which are not considered free from 
infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 
2020/689 and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry 
“C” in column 6 of the table. 
(5)Tests should be carried out on samp les taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
L 113 /656  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HER
(6)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/689, and are lis ted in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(7)This guarantee is required only for hatching eggs coming from zones in which the use of vaccines 
against infection with Newcastle disease vir us which comply only with the general criteria of Annex 
XV to Delegated Regulation (EU) 2020/689 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry 
“B” in column 6 of the table.
(8)Keep in case the hatching eggs are dispatched from a hatchery.
(9)keep in case the hatching eggs are dispatched from the establishment of the flock of origin.
(10)Indicate the name, address and approval number of the estab lishment were the flock of origin of the 
hatching eggs was kept during the 6 weeks immediately prior to the date of loading of the hatching eggs 
for dispatch to the Union.
(11)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(12)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(13)The date(s) of collection cannot be a date prior to the date of authorisation of the zone for entry into the 
Unio n, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these hatching eggs from that zone.
(14)This guarantee is required only for consignments intended for a Member State which has been granted the s tatus free from infection with Newcastle disease virus without vaccination in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /657
CHAPTER 29
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
SPECIFIED PATHOGEN- FREE EGGS (MODEL ‘SP F’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /658  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Identification 
systemIdentification number Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /659
COUNTRY Certificate model SPFPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
Animal health attestation
I, the undersigned official veterinarian, hereby certify that the specified pathogen -free eggs(1)described in 
Part I of this certificate:
II.1. come from the zone with code _ _ - _(2)which, at the date of issue of this certificate is 
authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of specified pathogen -free eggs;
II.2. come from the establishment, indicated in Box I.11, which;
(a) is under the control of the competent authority of the country or territory of origin and 
has a system in place to maintain and to keep records in accordance with Article 8 of 
Commis sion Delegated Regulation (EU) 2020/692;
(b) compl ieswith the conditions described in the European Pharmacopoeia;
(c) is approved by the competent authority of the third country or territory of origin in 
accordance with requirements which are at least equivalent to those laid down in Article 
8 of Commission Delegated Regulation (EU) 2019/2035, the approval of which has not 
been suspended or withdrawn;
(d) receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative the occurrence of diseases, including the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692
and emerging diseases,
at a frequency that is proportional to the risk posed by the 
establishment;
(e) was not su bject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
relevant for the species and emerging diseases, at the time of dispatch of the eggs to the 
Unio n;
II.3. come from a flock which:
(a) has been kept for a continuous period of at least 6 weeks prior to the date of collection 
of the eggs for dispatch to the Union in the establishment referred to in point II.2;
(b) is free from specified pathogens as described in the European Pharmacopoeia and 
clinical examinations required for this specific status have been favourable, including negative testing results for highly pathogenic avian influenza, infection with Newcastle 
disease virus and infection with low pathogen
ic avian influenza viruses carried out 
within the period of 30 days prior to the date of the collection of the eggs for dispatch to 
the Union;
(c) has been clinically examined at least once a week as described in the European 
Pharmacopoeia and no disease symptoms or ground for suspecting the presence of any disease were detected; 
(d) has had no contact with poultry of a lower health status, or with bird s for a period of at 
least 6 weeks prior to the date of collection of the eggs;
(e) did not show symptoms of transmissible diseases at the time of collection of the eggs;
L 113 /660  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SPF
II.4. were:
(a)marked using colour ink, with a stamp indicating the ISO code country or territoryof 
origin and the unique approval number of the establishment of origin;
(b)disinfected in accordance with the instructions of the competent authority of the country 
or territory of origin;
II.5. were collected [on ___/___/____ (dd/mm/yyyy)](3)[from ___/___/____ (dd/mm/yyyy) to 
___/___/____ (dd/mm/yyyy)](3); (4)
II.6. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that the eggs cannot fall out;
(b) are designed to allow cleaning and disinfection;
(c) contain only eggs of the same species, category and type coming from the same 
establishment;
(d) are closed in accordance with the instructions of the competent authority of the country 
or territory of origin to avoid any possibility of substitution of the content;
(e) are:
(3)either [disposable, clean and used for the first time;]
(3)or [cleaned and disinfected before loading of the eggs in accordance with the instructions of the competent authority of the country or territory of origin; ]
(f) bear the information set out in Pont 6 of Annex XVI to Delegated Regulation (EU) 
2020/692 relevant for specified pathogen -free eggs;
II.7. are loaded for dispatch to the Union in a means of transport which is constructed in accordance 
with II.1.6(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the 
competent authority of the country or territory of origin and dried or allowed to dry 
immediately before loading of the eggs for dispatch to the Union.
Notes:
This certificate i s intended for entry into the specified pathogen- free eggs, including when the Union is not the 
final destination of those products.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the Eur opean Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.8.: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex V to 
Implementing Regulation (EU) 2021/404 .
Box I.27: Description of consignment
“CN code ”: use the appropriate Harmon ised System (HS) code of the World Customs Organis ation: 
04.07.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /661
COUNTRY Certificate model SPF
Part II:
(1)Specified pathogen -free eggs as defined in Article 2 of Delegated Regulation (EU) 2020/692. 
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(3)Keep as appropriate.
(4)The date(s) of collection cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these products from that zone.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /662  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 30
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF POULTRY INTENDED FOR SLAUGHTER OTHER THAN RATITES 
(MODEL ‘ SP’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Slaughter
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /663
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Quantity
L 113 /664  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SPPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the poultry intended for slaughter(1)other than ratites 
described in Part I of this certificate:
II.1.1. come from the zone with code _ _ -_(2)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex V to Commission Implementing Regulation (EU) 
2021/404 for entry into the Union of poultry intended for slaughter other than ratites;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Delegated Regulation (EU) 2020/692;
(d) is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Delegated Regulation (EU) 2020/692; 
II.1.2. come from the zone referred to in point II. 1.1, in which:
(3)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(3)(4)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requiremen ts set out in Annex XIII to Delegated 
Regulation (EU) 2020/692;]
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Delegated Regulation (EU ) 2020/692 
is prohibited;]
(3)(5)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited and the animals:
(i) have not been vaccinated with such vaccines for a period of at least the 12 months prior to 
the date of loading of the consignment for dispatch to the Union;
(ii) come from a flock or flocks which underwent a virus isolation test
(6)for infection with 
Newcastle disease viru s not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, carried out on a random sample of cloacal swabs 
taken from at least 60 birds in each flock and in which no avian paramyxoviruses with an 
ICPI of more than 0,4 were found;
(iii) were kept in isolation under official surveillance on the establishment of origin during the 2 weeks mentioned in (ii);
(iv) during the period of 60 days prior to the date of loading of the consignment for dispatch to 
the Union, were not in contact with poultry which do not fulfil the conditions in (i) and 
(ii);]
II.1.3. have remained in the zone referred to in point II. 1
.1 for a continuous period of at least 6 weeks 
immediately prior to the date of loading for dispatch to the Union or since hat ching where they are less 
than 6 weeks of age;
and where they were imported into the zone referred to in point II. 1.1, the import took place in accordance with 
animal health requirements that are at least as stringent as the relevant requirements of Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/692 and the zone from where the animals were 
imported, is listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 for entry into the 
Union of poultry intended for slaughter other than ratit es;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /665
COUNTRY Certificate model SP
II.1.4 come from the establishment, indicated in Box I.11:
(a) which is registered by and is under the control of the competent authority of the country or 
territory of origin and has a system in place to maintain and to keep records in accordance with 
Article 8 of Delegated Regulation (EU) 2020/692;
(b) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the occurrence of diseases, including the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging 
diseases, at a frequency that is proportional to the risk posed by the establishment;
(c) which was not subject to national restriction measures for animal health reasons, including for
the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the 
species and emerging diseases, at the time of dispatch of the animals to the Union;
(d) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
(e) in which no confirmed case of infect ion with low pathogenic avian influenza viruses has been 
reported for at least 21 days prior to the date of loading for dispatch to the Union;
II.1.5. come from a flock which:
(a) has not been vaccinated against highly pathogenic avian influenza;
(3)either [(b)has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]
(3)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;
(7)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
(c) hasbeen subjected to a clinical inspection(8)within the 24 hours prior to loading of the animals 
for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
relevant for the specie s and emerging diseases;
II.1.6. have remained in the establishment indicated in Box I.11 since hatching or for a continuous period of at 
least 30 days immediately prior to the date of loading for dispatch to the Union;
II.1.7. had no contact with animals of a lower health status since hatching or for a continuous period of at least 
30 days immediately prior to the date of loading for dispatch to the Union;
II.1.8 are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and 
emerging diseases;
L 113 /666  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SP
II.1.9. have been subjected to a clinical inspection(8)on ___/___/____ (dd/mm/yyyy), within the 24 hours prior 
to loading for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for 
the species and emerging diseases;
II.1.10. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that:(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or minimized;
(b) contain only poultry of the same species and category coming from the same establishment;
(c) are:
(3)either [unused and purpose -designed disposable c ontainers to be destroyed after first use;]
(3)or [cleaned and disinfected and dried or allowed to dry prior to loading of the animals;]
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) bear the information set out in Point 2 of Annex XVI to Delegated Regulation (EU) 2020/692 
relevant for poultry intended for slaughter;
II.1.11. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(9)in a means of transport which is 
constructed in accordance with II.1.10(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;
(10)[II.1.12. areintended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation 
(EU) 2020/689, and they:
(3)either [have not been vaccinate d against infection with Newcastle disease virus and have tested(6)negative to 
serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence and which were taken during 
the period of at least 14 days prior to the date of loading for dispatch to the Union.]]
(3)or [have been vaccinated against infection with Newcastle disease virus but not with a live vaccine during 
the period of the last 30 da ys prior to the date of loading for dispatch to the Union and tested negative to 
a virus isolation test(6)for infection with Newcastle disease virus, performed on a random sample of 
cloacal swabs or faeces samples taken from at least 60 bird within the 14 days prior to the date of 
loading for dispatch to the Union.]]
II.2. Public health attestation [*to delete when the Union is not the final destination of the animals]
II.2.1. I, the undersigned official veterinarian, hereby certify, that the animals described in Part I have 
not received:
-any stilbene or thyrostatic substances, 
-oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /667
COUNTRY Certificate model SP
II.2.2. I, the undersigned official veterinarian, hereby certify, that the animals described in Part I fulfil 
the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directi ve 96/23/EC and the concerned 
animals are listed in Commission Decision 2011/163/EU for the concerned country of origin.
(11)[II.2.3. The Salmonella control programme referred to in Article 10 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Commission Regulation (EC) No 1177/2006, have been applied to the flock of origin and 
this flock has been tested for Salmonella serotypes of public health significance:
Identification of 
the flockAge of the 
birdsDate of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]Result of all testing in the 
flock(12)
positive negative
For reasons other than the Salmonella control programme:
(3)either [antimicrobials were not administered to the slaughter poultry;]
(3)(13)or[the following antimicrobials were administered to the slaughter poultry: 
…………………………………………………………..;]]
(14)[II.2.4. If the Member State of destination is Finland or Sweden, the poultry underwent a 
microbiological test by sampling on the holding of origin and tested Salmonella negative in 
accordance with the procedures in Decision 95/410/EC pursuant to Article 9(3) of 
Regulation (EC) No 2160/2003 .]
Notes:
This certificate is intended for entry into the Union of poultry intended for slaughter other than ratites, including 
when the Union is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
V to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27: “CN code ”: use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.05 or 01.06.39.
L 113 /668  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SP
Part II:
(1)‘Poultry intended for slaughter’ means poultry to be transported directly to a slaughterhouse, as defined 
in Article 2 of Delegated Regulation (EU) 2020/692.
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(3)Keep as appropriate.
(4)This applies only to zones in which vaccination against highly patho genic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are listed in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(5)This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) thereof, and 
are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in 
column 6 of the table.
(6)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(7)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(8)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(9)The date of loading cannot be a date prior to the date of authorisation of the country or territory or zone 
thereo f for entry into the Union, or a date in a period when restriction measures have been adopted by 
the Union in relation to the entry of these animals from that country or territory or zone thereof.
(10)This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
(11)This guarantee applies only to poultry belonging to the species of Gallus gallus and turkeys. 
(12)If any of the results were positive for the following serotypes during the life of the flock, indicate as 
positive: Salmonella Enteritidis and Salmonella Typhimurium .
(13)Complete if appropriate: indicate the name and active substance of antimicrobials used.
(14)Delete if consignment is not intended for Finland or Sweden.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /669
CHAPTER 31
MODEL ANIMAL HEALTH /OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF RATITES INTENDED FOR SLAUGHTER (MODEL ‘ SR’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Slaughter
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /670  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /671
COUNTRY Certificate model SRPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
II.1.1. I, the undersigned official veterinarian, hereby certify, that the animals described in Part I have 
not received:
-any stilbene or thyrostatic substances, 
-oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
II.1.2. I, the undersigned official veterinari an, hereby certify, that the animals described in Part I fulfil 
the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23/EC and the concerned 
animals are list ed in Commission Decision 2011/163/EU for the concerned country of origin.
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the ratites intended for slaughter(1)described in 
this certificate:
II.2.1. come from the zone with code _ _ -_(2)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex V to Commission Implementing Regulation 
(EU) 2021/404 for entry into the Union of ratites intended for slaughter;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 3 8
of Delegated Regulation (EU) 2020/692;
II.2.2. come from the zone referred to in point II.2.1, which at the date of issue of this certificate:
(3)either [is considered free from infection with Newcastle disease virus in accordance with Article 39 of Del egated Regulation (EU) 2020/692;]
(3)(4)or [is not considered free from infection with Newcastle disease virus in accordance with Article 
39 of Delegated Regulation (EU) 2020/692 and the animals;
(a) have been placed under official surveillance for a perio d of at least 21 days prior to the 
date of loading of the consignment for dispatch to the Union;
(b) have been kept in complete isolation during the period referred to in point (a), away 
from direct or indirect contact with other birds, in facilities approved by the competent 
authority of the country or territory of origin for this purpose;
(c) have undergone a virus detection test(5)for infection with Newcastle disease virus:
(i) which was carried out within 7 to 10 days of the date the ratites were placed 
under official surveillance referred to in point (a) on cloacal swabs or faeces samples collected from each ratite;
(ii)
in which no avian paramyxovirus type 1 isolates with an Intracerebral 
Pathogenicity Index (ICPI) of more than 0.4 have been foun d;
(iii) with favourable results being available for all birds in the consignment before they left the facilities referred to in point (b) for dispatch to the Union;
L 113 /672  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SR
(d) come from flocks in which surveillance for infection with Newcastle disease virus was
carried out under a statistically -based sampling plan which produced negative results for 
a period of at least 6 months immediately prior to the date of dispatch of the 
consignment for entry into the Union;]
II.2.3. come from the zone referred to in point II.2.1, in which:
(3)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(3)(6)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with 
a vaccination programme that complies with the requirements set out in Annex XIII to 
Delegated Regulation (EU) 2020/692;]
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not 
comply with both the general and specific criteria of Annex XV to Delegated
Regulation (EU) 2020/692 is prohibited;]
(3)(7)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply 
only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited and the animals:
(i)
have not been vaccinated with such vaccines for a period of at least the 12 
months prior to the date of loading of the consignment for dispatch to the Union;
(ii) come from a flock or flocks which underwent a virus isolation test(5)for infection 
with Newcas tle disease virus not earlier than 2 weeks prior to the date of loading 
of the consignment for dispatch to the Union, carried out on a random sample of 
cloacal swabs taken from at least 60 birds in each flock and in which no avian 
paramyxoviruses with an ICPI of more than 0,4 were found;
(iii) were kept in isolation under official surveillance on the establishment of origin during the 2 weeks mentioned in (ii);
(iv) during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in (i) and (ii);]
II.2.4. have remained in the zone referred to in point II.2.1 for a continuous period of at least 6 weeks 
immediately prior to the date of loading for dispatch to the Union or since hatching where they 
are less than 6 weeks of age;
and where they were imported into the zone referred to in point II.2.1, the import took place in 
accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 and zone 
from where the animals were imported, is listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 for entry into the Union of ratites intended for slaughter;
II.2.5. come from the establishment, indicated in Box I.11:
(a) which is registered by and is under the control of the competent authority of the country 
or territory of origin and has a system in place to maintain and to keep records in 
accordance with Article 8 of Delegated Regulation (EU) 2020/692;
(b) which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of diseases, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emergi ng diseases, at a frequency that is proportional to the risk 
posed by the establishment;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /673
COUNTRY Certificate model SR
(c) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 
2020/692 relevant for the species and emerging diseases, at the time of dispatch of the 
animals to the Union;
(d) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of loading 
for dispatch to the Union;
(e) in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of loading for dispatch to the Union;
II.2.6. come from a flock which:
(a) has not been vaccinated against highly pathogenic avian influenza;
(3)either [(b) has not been vaccinated against infection with Newcastle disease virus in the last 12 
months prior to the date of loading of the consignment for dispatch to the Union;]
(3)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union, with vaccines 
that comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;
(8)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
(c) hasbeen subjected to a clinical inspection(9)within the 24 hours prior to loading of the 
animals for dispatch to the Union, and showed no signs indicative of the occurrence of 
diseases, including the listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 relevant for the specie s and emerging diseases;
II.2.7. have remained in the establishment indicated in Box I.11 since hatching or for a continuous 
period of at least 30 days immediately prior to the date of loading for dispatch to the Union;
II.2.8. had no contact with animals of a lower health status since hatching or for a continuous period 
of at least 30 days immediately prior to the date of loading for dispatch to the Union;
II.2.9 are not to be killed under a national programme for the eradication of diseases, including the
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the 
species and emerging diseases;
II.2.10. have been subjected to a clinical inspection(9)on ___/___/____ (dd/mm/yyyy), within the 24 
hours prior to loading for di spatch to the Union, and showed no signs indicative of the 
occurrence of diseases, including the listed diseases referred to in Annex I to Delegated 
Regulation (EU) 2020/692 relevant for the species and emerging diseases;
L 113 /674  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model SR
II.2.11. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that:
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or 
minimized;
(b) contain only poultry of the same species and category coming from the same 
establishment;
(c) are:
(3)either [unused and purpose -designed disposable containers to be destroyed after first use;]
(3)or [cleaned and disinfected and dried or allowed to dry prior to loading of the animals;]
(d) are closed in accordance with the instructions of the competent authority of the country 
or territory of origin to avoid any possibility of substitution of the content;
(e) bear the informat ion set out in Point 2 of Annex XVI to Delegated Regulation (EU) 
2020/692 relevant for poultry intended for slaughter;
II.2.12. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(10)in a means of transport 
which is constructed in accordance with II.2.11(a) and was cleaned and disinfected prior to 
loading with a disinfectant authorised by the competent authority of the country or territory of 
origin; 
(11)[II.2.13. are intended for a Member State which has been granted the status free from i nfection with 
Newcastle disease virus without vaccination in accordance with Article 66 of Commission 
Delegated Regulation (EU) 2020/689, and they:
(3)either [have not been vaccinated against infection with Newcastle disease virus and have tested(5)
negative to serological tests to detect antibodies against Newcastle disease virus, performed on 
blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence 
and which were taken during the period of at least 14 days prior t o the date of loading for 
dispatch to the Union.]]
(3)or [have been vaccinated against infection with Newcastle disease virus but not with a live vaccine 
during the period of the last 30 days prior to the date of loading for dispatch to the Union and 
tested negative to a virus isolation test(5)for infection with Newcastle disease virus, performed 
on a random sample of cloacal swabs or faeces samples taken from at least 60 bird within the 
14 days prior to the date of loading for dispatch to the Union.]]
Notes:
This certificate is intended for entry into the Union of ratites intended for slaughter, including when the Union is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certifica te include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (E U) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /675
COUNTRY Certificate model SR
Part I:
Box reference I.8: Provide the code of the country or territory or zone thereof as it appears in column 2 of 
the table in Part 1 of Annex V to Implementing Regulation (EU) 2021/404.
Box reference I.27: “CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.06.39.
Part II:
(1)‘Ratites intended for slaughter’ means ratites to be transported directly to a slaughterhouse, as defined 
in Article 2 of Delegated Regulation (EU) 2020/692.
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(3)Keep as appropriate.
(4)This guarantee is required only for consignments from zones which are not considered free from 
infectio n with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 
2020/692 and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry 
“C” in column 6 of the table. 
(5)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(6)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are listed in Part 1 of A nnex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(7)This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only wit h the general criteria of Annex XV to 
Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) thereof, and are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in 
column 6 of the table.
(8)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(9)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(10)The date of loading cannot b e a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.
(11)This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Article 66 of Commission Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /676  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 32
MODEL ANIMAL HEALTH/ OFFICIAL CERTIFICATE FOR ENTRY INTO THE 
UNION OF LESS THAN 2 0 HEADS OF POULTRY O THER THAN RATITES 
(MODEL ‘POU -LT20’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Slaughter
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /677
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Quantity
L 113 /678  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POU -LT20Part II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the animals]
II.1.1. I, the undersigned official veterinarian, hereby certify, that the animals described in Part I have 
not received:
-any stilbene or thyrostatic substances, 
-oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).
II.1.2. I, the undersigned official veterinarian, hereby certify, that the animals described in Part I fulfil 
the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Article 29 of Council Directive 96/23 /EC and the concerned 
animals and products are listed in Commission Decision 2011/163/EU for the concerned 
country of origin.
II.1.3. I, the undersigned official veterinarian, hereby certify the following as regards the [breeding 
poultry other than ratites ](2)[productive poultry other than ratites](2)[poultry intended for 
slaughter other than ratites](2)[day-old chicks other than ratites](2)described in this certificate:
(16)[II.1.3.1. The Salmonella control programme referred to in Article 10 of Regula tion (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Commission Regulation (EC) No 1177/2006, have been applied to the flock of origin 
and the flock has been tested for Salmonella serotypes of public health sig nificance:
Identification of the 
flockAge of the 
birdsDate of last sampling of the 
flock from which the testing 
result is known 
[dd/mm/yyyy]Result of all testing in 
the flock(17)
positive negative
For reasons other than the Salmonella control programme, within the last three weeks 
prior to entry into the Union:
(2)either [antimicrobials were not administered to the breeding and productive 
poultry other than ratites;]
(2)(18)or [the following antimicrobials were administered to the breeding and
productive poultry other than ratites: ……………………………………;]]
(16)[II.1.3.2. If breeding poultry, neither Salmonella Enteritidis nor Salmonella Typhimurium 
were detected within the control programme referred to in point II.1.3.1.]
(19)[II.1.3.3. If the Member State of destination is Finland or Sweden:
(2) either [the breeding poultry has tested negative for Salmonella in accordance 
with the rules laid down in Commission Decision 2003/644/EC;]
(2) or [the laying hens (productive poultry reared in view to producing eggs for 
consumption) have tested negative in accordance with the rules laid down in Commision Decision 2004/235/EC.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /679
COUNTRY Certificate model POU -LT20
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the [breeding poultry(1)other than ratites](2)
[productive poultry(3)other than ratites](2)[poultry intended for slaughter(4)other than ratites](2)[day-old 
chicks(5)other than ratites](2)described in this certificat e:
II.2.1. form a single consignment of less than 20 heads of poultry;
II.2.2. come from the zone with code _ _ -_(6)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulatio n
(EU) 2021/404 for entry into the Union of less than 20 heads of poultry other than 
ratites;
(b) carries out a disease surveillance programme for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 
of Delegated Regulation (EU) 2020/692;
(d) is considered free from infection with Newcastle disease virus in accordance with 
Article 39 of Delegated Regul ation (EU) 2020/692;
II.2.3. come from the zone referred to in point II.2.2, in which:
(2)either [vaccination against highly pathogenic avian influenza is not carried out;]
(2)(7)or [vaccination against highly pathogenic avian influenza is carried out in a ccordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to Delegated 
Regulation (EU) 2020/692;]
(2)either [II.2.4. the [breeding poultry other than ratites](2)[productive poultry other than ratites](2)[poultry 
intended for slaughter other than ratites](2):
II.2.4.1. come from the zone referred to in point II.2.2, in which: 
(2)either [vaccination against infection with Newcastle disease virus with vaccines which do 
not comply with both the general and specific criteria of Annex XV to Commission 
Delegated Regulation (EU) 2020/692 is prohibited;]
(2)(8)or[vaccination against infection with Newcastle disease virus with vaccines which 
comply only with the general criteria of Annex XV to Delegated Regulati on (EU) 
2020/692 is not prohibited, and the animals:
(a) have not been vaccinated with such vaccines for a period of at least the 12 
months prior to the date of loading of the consignment for dispatch to the 
Union;
(b) come from a flock or flocks which underwent a virus isolation test(11)for 
infection with Newcastle disease virus carried out on a random sample of 
cloacal swabs from at least 60 birds in each flock, taken not earlier than 2 
weeks prior to the date of loading of the consignment for dispatch to the Union, 
and in which no avia n paramyxoviruses with an ICPI of more than 0,4 were 
found;
L 113 /680  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POU -LT20
(c) were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks mentioned in point (b);
(d) during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in points (a) and (b);]
II.2.4.2. have remained:
(a) in the zone referred to in point II.2.2 for a continuous period of at least 3 
months immediately prior to the date of loading for dispatch to the Union or 
since hatching where they are less than 3 months of age;
and where they were imported into the zone referred to in point II.2.2, the 
import took place in accordance with animal health requirements that are at 
least as stringent as the relevant requirements of Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020/692 and the zone from where the animals 
were imported, is listed in Part 1 of Annex V to Implementing Regulation (EU) 
2021/404 for e ntry into the Union of less than 20 heads of poultry other than 
ratites;
(b) in the establishment indicated in Box I.11 for a continuous period of at least 3 
weeks immediately prior to the date of loading for dispatch to the Union or 
since hatching where t hey are less than 3 weeks of age;
(c) without contact with animals of a lower health status for a continuous period of 
at least 3 weeks immediately prior to the date of loading for dispatch to the 
Union or since hatching where they are less than 3 weeks of age;
II.2.4.3. come from the establishment, indicated in Box I.11:
(a) which is registered by and is under the control of the competent authority of the country or territory of origin and has a system in place to maintain and to keep 
records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;
(b) which receives regular animal health visits from a veterinarian for the purpose 
of the detection of, and information on, signs indicative of the occurrence of 
diseases, including the relevant listed diseas
es referred to in Annex I to 
Delegated Regulation (EU) 2020/692 and emerging diseases, at a frequency 
that is proportional to the risk posed by the establishment;
(c) which was not subject to national restriction measures for animal health 
reasons, including for the listed diseases referred to in Annex I to Delegated 
Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the time of dispatch of the animals to the Union;
(d) within a 10 km radius of which, including, where appropriate, the terr itory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza or infection with Newcastle disease virus for at least 30 days prior to 
the date of loading for dispatch to the Union;
(e) in which no confirmed case of infection with low pathogenic avian influenza 
viruses has been reported for at least 21 days prior to the date of loading for dispatch to the Union;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /681
COUNTRY Certificate model POU -LT20
II.2.4.4. come from a flock which:
(a) has not been vaccinated against highly pathogenic avian influenza;
(2)either [(b) has not been vaccinated against infection with Newcastle disease virus in the 
last 12 months prior to the date of loading of the consignment for dispatch to 
the Union;]
(2)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 
12 months prior to the date of loading of the consignment for dispatch to the 
Union, with vaccines that comply with both the general and specific criteria of 
Annex XV to Delegated Regulation (EU) 2020/692;
(9)
Identification 
of the flockAge of 
the
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
(c) hasbeen subjected to a clinical inspection(10)within the 24 hours prior to loading 
of the animals for dispatch to the Union, and showed no signs indicative of the 
occurrence of diseases, including the listed diseases referred to in Annex I to 
Delegated Regulation (EU) 2020/692 relevant for the specie s and emerging 
diseases;
II.2.4.5. the animals:
(a) have not been vaccinated against highly pathogenic avian influenza;
(b) are not to be killed under a national programme for the eradication of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 
2020/692 relevant for the species and emerging diseases;
(c) have been subjected to a clinical inspection(10)on ___/___/____ (dd/mm/yyyy) 
within the 24 hours prior to loading for dispatch to the Union, and show no signs 
indicative of the occurrence of diseases, including the listed diseases referred to 
in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;
(d) tested negative in serological and/or bacteriological tests
(11)within the period o f
30 days prior to the date of loading of the animals for dispatch to the Union and 
were found not to be infected or showed any grounds for suspecting any 
infection, by the following agents:
(2)either [Salmonella Pullorum, Salmonella Gallinarum and Mycopla sma gallisepticum
(in case of Gallus gallus );]
(2)or [Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella
Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of 
Meleagris gallopavo);] 
L 113 /682  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POU -LT20
(2)or [Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris , 
Coturnix coturnix , Phasianus colchicus , Perdix perdix and Anas spp );]
II.2.4.6. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that: 
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or 
minimized;
(b) contain only poultry of the same species and category coming from the same 
establishment;
(c) are:
(2)either [unused and purpose -designed disposable containers to be destroyed after first 
use;]
(2)or [cleaned and disinfected and dried or allowed to dry prior to loading of the 
animals;]
(d) are closed in accordance with the instructions of the competent authority of the 
country or territory of origin to avoid any possibility of substitution of the 
content;
(e) bear the information set out in Annex XVI to Delegated Regulation (EU) 
2020/692 relevant for [breeding poul try and productive poultry](2)[poultry 
intended for slaughter](2);
II.2.4.7. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(12) in a means of 
transport which is constructed in accordance with II.2.4.6(a) and was cleaned and 
disinfected prior to loading with a disinfectant authorised by the competent authority of 
the country or territory of origin;
(13) [II.2.4.8. are intended for a Member State which has been granted the status free from infection 
with Newcastle disease virus without va ccination in accordance with Article 66 of 
Commission Delegated Regulation (EU) 2020/689,
(2)(14)either [and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) were kept in isolation for at least 14 days prior to the dat e of loading of the 
consignment for dispatch to the Union in the establishment of origin or 
quarantine establishment under the supervision of an official veterinarian, where:
(i) no poultry was vaccinated against infection with Newcastle disease virus 
during the period of at least 21 days prior to the date of loading of the 
consignment;
(ii) no other birds have entered into the establishment during that time; 
(iii) no vaccination has been carried out;
(c) have tested(11)negative to serological tests to de tect antibodies against Newcastle 
disease virus, performed on blood samples at a level which gives 95% confidence 
of detecting infection at 5% prevalence and which were taken during the period of at least 14 days prior to the date of loading for dispatch t o the Union.]]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /683
COUNTRY Certificate model POU -LT20
(2)(15)or [and they:
(2)either [have not been vaccinated against infection with Newcastle disease virus and have 
tested(11)negative to serological tests to detect antibodies against Newcastle disease 
virus, performed on blood samples at a level which gives 95% confidence of detecting 
infection at 5% prevalence and which were taken during the period of at least 14 days 
prior t o the date of loading for dispatch to the Union.]]]
(2)or [have been vaccinated against infection with Newcastle disease virus but not with a 
live vaccine during the period of the last 30 days prior to the date of loading for 
dispatch to the Union and test ed negative to a virus isolation test(11)for infection with 
Newcastle disease virus, performed on a random sample of cloacal swabs or faeces 
samples taken from at least 60 bird within the 14 days prior to the date of loading for 
dispatch to the Union.]]]
(2)or[II.2.4. the day -old chicks other than ratites:
II.2.4.1. come from the zone referred to in point II.2.2, in which:
(2)either [vaccination against infection with Newcastle disease virus with vaccines which do not 
comply with both the general and specific criteria of Annex XV to Delegated 
Regulation (EU) 2020/692 is prohibited;]
(2)(8)or[vaccination against infection with Newcastle disease virus with vaccines which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is 
not prohibited, and the animals:
(a) have not been vaccinated with such vaccines;
(b) come from flocks which:
(i) have not been vaccinated with such vaccines for a period of at least the 12 
months prior to the date of loading of the consignment f or dispatch to the 
Union;
(ii) underwent a virus isolation test
(11)for infection with Newcastle disease 
virus carried out on a random sample of cloacal swabs taken from at least 
60 birds in each flock, not earlier than 2 weeks prior to the date of loading
of the consignment for dispatch to the Union, and in which no avian 
paramyxoviruses with an ICPI of more than 0,4 were found;
(iii) were kept in isolation under official surveillance on the establishment of 
origin during the 2 weeks prior to the date of l oading of the consignment 
for dispatch to the Union;
(iv) during the period of 60 days prior to the date of loading of the 
consignment for dispatch to the Union, were not in contact with poultry 
which do not fulfil the conditions in (i) and (ii);
(c) come from hatching eggs which have not been in contact in the hatchery or 
during transport with poultry or hatching eggs not meeting the requirements set out in point (b);]
L 113 /684  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POU -LT20
II.2.4.2. have remained:
(a) in the zone referred to in point II.2.2 since hatching;
(b) in the establishment indicated in Box I.11 since hatching;
(c) without contact with animals of a lower health status since hatching;
II.2.4.3. come from the establishment, indicated in Box I.11:
(a) which is registered by and is under the control of the competent authority of the 
country or territory of origin and has a system in place to maintain and to keep 
records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;
(b) which receives re gular animal health visits from a veterinarian for the purpose of 
the detection of, and information on, signs indicative of the occurrence of 
diseases, including the relevant listed diseases referred to in Annex I to Delegated 
Regulation (EU) 2020/692 and emerging diseases, at a frequency that is 
proportional to the risk posed by the establishment;
(c) which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulatio n
(EU) 2020/692 relevant for the species and emerging diseases, at the time of 
dispatch of the animals to the Union;
(d) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian 
influenza or infection with Newcastle disease virus for at least 30 days prior to 
the date of loading for dispatch to the Union;
(e) in which no confirmed case of infection with low pathogenic avian influenza 
viruses has been reported for at least 21 days prior to the date of loading for 
dispatch to the Union;
II.2.4.4. come from a flock which:
(a) has remained in the zone referred to in point II.2.2 for a continuous period of at 
least 3 months immediately prior to the date of loading of the day -old chicks for 
dispatch to the Union;
and where the flock was imported into the zone referred to in point II.2.2, the 
import took place in accordance with animal health requirements that are at least 
as stringent as the relevant requirements of Regulati
on (EU) 2016/429 and 
Delegated Regulation (EU) 2020/692 and the zone from where the animals were 
imported, is listed in Part 1 of Annex V to Implementing Regulation (EU) 
2021/404 for entry into the Union of breeding poultry other than ratites and 
productive poultry other than ratites;
(b) has remained for a continuous period of at least 3 weeks immediately prior to the 
date of loading of the day -old chicks for dispatch to the Union in an 
establishment:
(i) which is registered by and is under the control of the competent authority of the country or territory of origin and has a system in place to maintain 
and to keep 
record, in accordance with Article 8 of Commission 
Delegated Regulation (EU) 2020/692;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /685
COUNTRY Certificate model POU -LT20
(ii) which receives regular animal health visits from a veterinarian for the 
purpose of the detection of, and information on, signs indicative of the 
occurrence of diseases, including the relevant listed diseases referred to in 
Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases, 
at a frequency that is proportional to the risk posed by the establishment;
(iii) which was not subject to national restriction measures for animal health 
reasons, including for the listed diseases referred to in Annex I to 
Delegated Regulation (EU) 2020/692 relevant for the species and 
emerging diseases, at the time of dispatch of the animals to the Union; 
(iv) in which no confirmed case of infection with low pathogenic avian 
influenza viruses has been reported for at least 21 days prior to the date of 
collection of the hatching eggs, from which the day -old chicks have
hatched;
(v) within a 10 km radius of which, including, where appropriate, the territory 
of a neighbouring country, there has been no outbreak of highly 
pathogenic avian influenza or infection with Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
(2)either [(c) has not been vaccinated against highly pathogenic avian influenza;]
(2)(7)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with 
a vaccination programme which complies with the requirements set out in Annex 
XIII to Delegated Regulation (EU) 2020/692 ;]
(2)either [(d) has not been vaccinated against infection with Newcastle disease virus in the last 
12 months prior to the date of loading of the consignment for dispatch to the Union;]
(2)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 
months prior to the date of loading of t he consignment for dispatch to the Union, 
with vaccines that comply with both the general and specific criteria of Annex 
XV to Delegated Regulation (EU) 2020/692;
(9)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus s train 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
(e) underwent serological and/or bacteriological tests(11)within the period of 90 days 
prior to the date of loading of the day -old chicks for dispatch to the Union at a 
level which gives 95% confidence of detecting infection at 5% prev alenceand 
was found not to be infected or showed any grounds for suspecting any infection, 
by the following agents:
(2)either [Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum
(in case of Gallus gallus );]
L 113 /686  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POU -LT20
(2)or [Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella
Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of 
Meleagris gallopavo);]
(2)or [Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris , 
Coturnix coturnix , Phasianus colchicus , Perdix perdix and Anas spp );] 
(f) had no contact with animals of a lower health status for a continuous period of at 
least 3 weeks immediately prior to the date of collection of the eggs from which 
the day -old chicks have hatched;
(g) hasbeen subjected to a clinical inspection(10)within the 24 hours prior to loading 
of the day -old chicks for dispatch to the Uni on, and showed no signs indicative of 
the occurrence of diseases, including the listed diseases referred to in Annex I to 
Delegated Regulation (EU) 2020/692 relevant for the species and emerging 
diseases;]
II.2.4.5 the animals:
(a) have not been vaccinated against highly pathogenic avian influenza;
(b) are not to be killed under a national programme for the eradication of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 
2020/692 relevant for the species and emerging dis eases;
(c) have been subjected to a clinical inspection(10)on ___/___/____ (dd/mm/yyyy) 
within the 24 hours prior to loading for dispatch to the Union, and show no signs indicative of the occurrence of diseases, including the listed diseases referred to 
in An nex I to Delegated Regulation (EU) 2020/692 relevant for the species and 
emerging diseases;
(d)
come from hatching eggs which prior to incubation, have been disinfected in 
accordance with the instructions of the competent authority of the country or 
territ ory of origin;
II.2.4.6. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that: 
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or 
minimized;
(b) contain only poultry of the same species and category coming from the same 
establishment;
(c) are unused and purpose -designed disposable containers to be destroyed after first 
use;
(d) are closed in accordance with the instructions of the competent authority of the country or territory of origin to avoid any possibility of substitution of the 
content;
(e) bear the information set out in Point 3 of Annex XVI to Delegated Regulation 
(EU) 2020/692 relevant for day- old chicks;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /687
COUNTRY Certificate model POU -LT20
II.2.4.7. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(12)in a means of 
transport which is constructed in accordance with II.2.4.6(a) and was cleaned and 
disinfected prior to loading with a disinfectant authorised by the competent authority of 
the country or territory of origin;
(13)II.2.4.8. are intended for a Member State which has been granted the status free from infection 
with Newcastle disease virus without vaccination in accordance with Artic 66 of 
Commission Delegated Regulation (EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from hatching eggs coming from flocks which:
(2)either [have not been vaccinated against infection with Newcastle disease virus;]
(2)or [have been vaccinated against infection with Newcastle disease virus with an 
inactivated vaccine;]
(2)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the latest 60 days prior to the date the eggs were collected;]
(c)
come from a hatchery where working practices ensure that the hatching eggs 
from which the day -old chicks have hatched, were incubated at completely 
separate times and locations from eggs not satisfyi ng the requirements of point 
(b).]]
Notes:
This certificate is intended for entry into the Union of less than 20 heads of poultry other than ratites, including 
when the Union is not the final destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.8.: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex V to 
Implementing Regulation (EU) 2021/404 .
Box I.27: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organis ation: 
01.05 or 01.06.39.
Part II:
(1)‘Breeding poultry’ means poultry 72 hours old or more, intended for the production of hatching eggs, as 
defined in Article 2 of Delegated Regulation (EU) 2020/692.
(2)Keep as appropriate.
L 113 /688  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POU -LT20
(3)‘Productive poultry’ means poultry 72 hours old or more, reared for the production of meat, eggs for 
consumption or other products or for restocking supplies of game birds, as defined in Article 2 of 
Delegated Regulation (EU) 2020/692.
(4)‘Poultry intended for slaughter’ mean s poultry to be transported directly to a slaughterhouse, as defined 
in Article 2 of Commission Delegated Regulation (EU) 2020/692.
(5)‘Day -old chicks’ means poultry less than 72 hours old, as defined in Article 2 of Delegated Regulation 
(EU) 2020/692. 
(6)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(7)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vacc ination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are listed in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(8)This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with A rticle 37(e)(ii) thereof, and 
are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in 
column 6 of the table.
(9)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(10)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(11)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(12)The date of loading cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.
(13)This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infecti on with Newcastle disease virus without vaccination in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
(14)Applicable for breeding poultry and productive poultry.
(15)Applicable for poultry intended for slaughter.
(16)This guarantee ap plies only for poultry belonging to the species of Gallus gallus and turkeys .
(17)If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:
-flocks of breeding poultry: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis;
-flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium.
(18)Complete if appropriate: indicate the name and active substance of antimicrobials used.
(19)Delete if consignment is not intended for Finland or Sweden.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /689
CHAPTER 33
MODEL ANIMAL HEALTH/ OFFICIA L CERTIFICATE FOR ENTRY INTO THE 
UNION OF LESS THAN 2 0 HATCHING EGGS OF P OULTRY OTHER THAN
RATITES (MODEL ‘HE- LT20’)
COUNTRY Animal health/official certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /690  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Breed/Category Identification 
systemIdentification number Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /691
COUNTRY Certificate model HE -LT20Part II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Public health attestation [*to delete when the Union is not the final destination of the hatching eggs ]
I, the undersigned official veterinarian, hereby certify, that the hatching eggs described in Part I:
(12)[II.1.1. The Salmonella control programme referred to in Article 10 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Commission Regulation (EC) No 1177/2006, have been applied to the parent flock of origin 
and this parent flock has been tested for Salmonella serotypes of public health significance:
Identification of 
the flockAge of the 
birdsDate of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]Result of all testing in the 
flock(13)
Positive Negative
(12)[II.1.2. Neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control 
programme referred to in point II.1.1.]
(14)[II.1.3. If the Member State of destination is Finland or Sweden, the hatching eggs come from flocks 
which have tested negative for Salmonella in accordance with the rules laid down in 
Commission Decision 2003/644/EC.]
II.2. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the hatching eggs(1)of poultry other than ratites 
described in this certificate:
II.2.1. form a single consignment of less than 20 hatching eggs;
II.2.2. come from the zone with code _ _ -_(2)which, at the date of issue of this certificate:
(a) is authorised and listed in Part 1 of Annex V to Commission Implementing Regulation 
(EU) 2021/404 for entry into the Union of less than 20 hatching eggs of poultry other 
than ratites ;
(b) carries out a disease surveillance programme for highly pathogenic a vian influenza in 
accordance with Article 105(a) of Commission Delegated Regulation (EU) 2020/692;
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 
of Delegated Regulation (EU) 2020/692;
(d) is considered free from infection with Newcastle disease virus in accordance with 
Article 39 of Delegated Regulation (EU) 2020/692; 
L 113 /692  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HE -LT20
II.2.3. come from the zone referred to in point II.2.2, in which:
(3)either [(a) vaccination against highly pathogenic avian influenza is not carried out;]
(3)(4)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with 
a vaccination programme that complies with the requirements set out in Annex XIII to 
Delegated Regulation (EU) 2020/6 92;]
(3)either [(b) vaccination against infection with Newcastle disease virus with vaccines which do not 
comply with both the general and specific criteria of Annex XV to Delegated 
Regulation (EU) 2020/692 is prohibited;]
(3)(5)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply 
only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, and the hatching eggs:
(i) come from flocks which:
-have not been vaccinated with such vaccine s for a period of at least the 12 
months prior to the date of loading of the consignment for dispatch to the 
Union; 
-underwent a virus isolation test
(6)for infection with Newcastle disease virus 
carried out on a random sample of cloacal swabs taken from at least 60 birds 
in each flock, not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, and in which no avian 
paramyxoviruses with an ICPI of more than 0,4 were found; 
-were kept in isolation under official surve illance on the establishment of 
origin during the 2 weeks prior to the date of loading of the consignment for 
dispatch to the Union; 
-during the period of 60 days prior to the date of loading of the consignment 
for dispatch to the Union, were not in contac t with poultry which do not 
fulfil the conditions in first and second in dent above;
(ii) have not been in contact in the hatchery or during transport with poultry or 
hatching eggs not meeting the requirements set out in (i);]
II.2.4. come from the establishment, indicated in Box I.11:
(a) which is registered by and is under the control of the competent authority of the country 
or territory of origin and has a system in place to maintain and to keep records in 
accordance with Article 8 of Delegated Regul ation (EU) 2020/692;
(b) which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative the occurrence of diseases, including 
the relevant listed diseases referred to in Annex I to Dele gated Regulation (EU) 
2020/692 and emerging diseases, at a frequency that is proportional to the risk posed by 
the establishment;
(c) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred t o in Annex I to Delegated Regulation (EU) 
2020/692 relevant for the species and emerging diseases, at the time of dispatch of the 
hatching eggs to the Union;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /693
COUNTRY Certificate model HE -LT20
(d) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;
II.2.5. come from a flock which:
(a) has remained in zone referred to in point II.2.2 for a continuous period of at least 3 
months immediately prior to the date of loading of the hatching eggs for dispatch to the 
Union;
and where the flock was imported into the zone referred to in point II.2.2, the import 
took place in accor dance with animal health requirements that are at least as stringent as 
the relevant requirements of Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/692 and the zone from where the animals were imported, is listed in Part 1 of 
Annex V to Implem enting Regulation (EU) 2021/404
for entry into the Union of 
breeding poultry other than ratites and productive poultry other than ratites;
(b) has been kept for a continuous period of at least 3 weeks immediately prior to the date of loading of the hatching eg gs for dispatch to the Union in an establishment:
(i) in which no confirmed case of infection with low pathogenic avian influenza 
viruses has been reported for at least 21 days prior to the date of collection of 
the hatching eggs;
(7)[(ii) which is regist ered by and is under the control of the competent authority of the 
country or territory of origin and has a system in place to maintain and to keep 
records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;
(iii) which receives regular animal health visits from a veterinarian for the purpose 
of the detection of, and information on, signs indicative of the occurrence of 
diseases, including the relevant listed diseases referred to in Annex I to 
Delegated Regulation (EU) 2020/692 and emerging diseases, at a frequency 
that is proportional to the risk posed by the establishment;
(iv) which was not subject to national restriction measures for animal health 
reasons, including for the listed diseases referred to in Annex I to Commission Delegated Re
gulation (EU) 2020/692 relevant for the species and emerging 
diseases, at the time of dispatch of the hatching eggs to the Union;
(v) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no o utbreak of highly pathogenic avian 
influenza or infection with Newcastle disease virus for at least 30 days prior to 
the date of loading for dispatch to the Union;]
(3)either [(c) has not been vaccinated against highly pathogenic avian influenza;]
(3)(4)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with a 
vaccination programme which complies with the requirements set out in Annex XIII to 
Delegated Regulation (EU) 2020/692;]
(3)either [(d) has not been vaccinated agai nst infection with Newcastle disease virus in the last 12 
months prior to the date of loading of the consignment for dispatch to the Union;]
L 113 /694  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HE -LT20
(3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union, with vaccines 
that comply with both the general and specific criteria of Annex XV to Delegated 
Regulation (EU) 2020/692;
(8)
Identification 
of the flockAge of 
the 
birdsDate of 
vaccinationName and 
type of 
virus strain 
usedBatch 
number 
of the 
vaccineName of 
the 
vaccineManufacturer 
of the 
vaccine
]
(e) underwent serological and/or bacteriological tests(6)within the period of 90 days prior to 
the date of loading of the hatching eggs for dispatch to the Union at a level which gives 
95% confidence of detecting infection at 5% preva lence and was found not to be infected 
or showed any grounds for suspecting any infection, by the following agents:
(3)either [Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case 
of Gallus gallus );]
(3)or [Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella
Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of 
Meleagris gallopavo);] 
(3)or [Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris , 
Coturnix coturnix , Phasianus colchicus , Perdix perdix and Anas spp );] 
(f) has been isolated on the establishment of origin for a period of at least 21 days prior to the 
collection of the eggs;
(g) had no contact with poultry or hatching eggs of a lower health status, or with captive or 
wild birds for a continuous period of at least 3 weeks immediately prior to the date of loading of the hatching eggs for dispatch to t he Union;
(h) did not show symptoms of transmissible diseases at the time of collection of the hatching 
eggs;
(i) hasbeen subjected to a clinical inspection
(9)within the 24 hours prior to loading of the 
hatching eggs for dispatch to the Union, and showed no signs indicative of the occurrence 
of diseases, including the listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 relevant for the species and emerging diseases;
II.2.6. were:
(a) not vaccinated against highly pathogenic avian influenza;
(b) not vaccinated against infection with Newcastle disease virus;
(c) disinfected in accordance with the instructions of the competent authority of the country 
or territory of origin;
II.2.7. were collected [on ___/___/____ (dd/mm/yyyy)](3)[from _ __/___/____ (dd/mm/yyyy) to 
___/___/____ (dd/mm/yyyy)](3); (10)
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /695
COUNTRY Certificate model HE -LT20
II.2.8. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that the hatching eggs cannot fall out;
(b) are designed to allow cleaning and disinfection; 
(c) contain only hatching eggs of the same species, category and type coming from the same 
establishment;
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) are:
(3)either [disposable, clean and used for the first time;]
(3)or [cleaned and disinfected before loading of the hatching eggs in accordance with the 
instructions of the competent authority of the country or territory of origin;]
(f) bear the information set out in Point 5 of Annex XVI to Delegated Regulation (EU) 
2020/692 relevant for hatching eggs of poultry;
II.2.9. are loaded for dispatch to the Union in a means of transport which is constructed in accordance 
with II.2.8(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the 
competent authority of the country or territory of origin and dried or allowed to dry immediately 
before loading of the hatching eggs for dispatch to the Union;
(11)[II.2.10. are intended for a Member State which has been granted the status free from infection with 
Newcastle disease virus without vaccination in accordance with Article 66 of Commission 
Delegated Regulation ( EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) come from flocks which:
(3)either [have not been vaccinated against infection with Newcastle disease virus.]]
(3)or [have been vaccinated against inf ection with Newcastle disease virus with an inactivated 
vaccine.]]
(3)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine 
at the latest 60 days prior to the date the eggs were collected.]]
Notes:
This certificate is intended for entry into the Union less than 20 hatching eggs of poultry other than ratites, 
including when the Union is not the final destination of those germinal products.
In accordance with the Agreement on the withdrawal of the United Kingdom of Gre at Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health/official certificate shall be completed according to the notes for the completion of certificates 
provided for in Chapter 4 of Annex I to Commission Implementing Re gulation (EU) 2020/2235.
Part I:
Box I.8.: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex V to 
Implementing Regulation (EU) 2021/404 .
Box I.27: Description of consignment
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.
“Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.
L 113 /696  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HE -LT20
Part II:
(1)Hatching eggs as defined in Article 4 of Regulation (EU) 2016/429.
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 .
(3)Keep as appropriate.
(4)This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Delegated Regulation (EU) 2020/692, and are lis ted in Part 1 of Annex V to Implementing 
Regulation (EU) 2021/404 with the entry “A” in column 6 of the table.
(5)This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus whi ch comply only with the general criteria of Annex XV to 
Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37(e)(ii) thereof, and 
are listed in Part 1 of Annex V to Implementing Regulation (EU) 2021/404 with the entry “B” in 
column 6 of the table.
(6)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Articl e 37 of Regulation (EU) 2017/625.
(7)Keep in case the hatching eggs are dispatched from a hatchery.
(8)To be completed when animals were vaccinated against infection with Newcastle disease virus.
(9)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(10)The date(s) of collection cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these hatching eggs from that zone.
(11)This guarantee is required only for consignments intended for a Member State which has been granted the status free from infection with Newcastle disease virus without vaccinat
ion in accordance with 
Article 66 of Delegated Regulation (EU) 2020/689.
(12)This guarantee applies only for hatching eggs belonging to the species of Gallus gallus and turkeys.
(13)If any of the results were positive for the following serotypes during t he life of the parent flock, indicate 
as positive: Salmonella Hadar , Salmonella Virchow and Salmonella Infantis .
(14)Delete if consignment is not intended for Finland or Sweden.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /697
CHAPTER 34
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CAPTIVE BIRDS (MODEL ‘CAPTIVE- BIRDS’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Quarantine establishment □Confined establishment
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /698  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Identification 
systemIdentification number Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /699
COUNTRY Certificate model CAPTIVE -BIRDSPart II: CertificationII. Health information II.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the captive birds(1)described in this 
certificate:
II.1.1. come from the zone with code _ _ - _(2)which, at the date of issue of this certificate, is 
authorised and listed in Part 1 of Annex V Ito Commission Implementing Regulation ( EU) 
2021/404 for entry into the Union of captive birds;
II.1.2. come from the establishment(3), indicated in Box I.11 approved by the competent authority of 
the country or territory of origin in accordance with requirements which are at least as 
stringent as those laid down in Article 56 of Commission Delegated Regulation (EU) 
2020/692 and:
(a) the approval of which has not been suspended or withdrawn;
(b) which is under the control of the competent authority of the country or territory of 
origin and has a system i n place to maintain and to keep record, in accordance with 
Article 8 of Delegated Regulation (EU) 2020/692;
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative of the occ
urrence of diseases, 
including the relevant listed diseases referred to in Annex I to Delegated Regulation 
(EU) 2020/692 and emerging diseases , at a frequency that is proportional to the risk 
posed by the establishment;
(d) which was not subject to national re striction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 
2020/692 relevant for the species and emerging diseases, at the time of dispatch of the animals to the Union;
(e) within a 10 km
radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of 
loading for dispatc h to the Union;
(4)[(f) in which 
(5)either [avian chlamydiosis has not been confirmed for a period of at least 6 months prior to 
the date of loading of the captive birds for dispatch to the Union;]
(5)or [avian chlamydiosis has been confirmed during the last 6 months prior to the date of loading of the captive birds for dispatch to the Union, but not during the last 60 days, 
and the measures provided for in Article 55(e)(i) of Delegated Regulation (EU) 
2020/692 have been applied;]
(5)or [the animals have been kept under veterinary supervision for the 45 days prior to the 
date of loading for dispatch to the Union and were treated against avian chlamydiosis;]
L 113 /700  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CAPTIVE -BIRDS
II.1.3. come from a flock which has been subjected to a clinical inspection(6)within the 24 hours
prior to loading of the animals for dispatch to the Union, and showed no signs indicative of 
the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated 
Regulation (EU) 2020/692 relevant for the species and emerging disea ses;
II.1.4. the animals:
(a) have remained in the establishment indicated in Box I.11 since hatching or for a 
continuous period of at least 3 weeks immediately prior to the date of loading for 
dispatch to the Union;
(b) have not been vaccinated against highly pathogenic avian influenza;
(5)either [(c)      have not been vaccinated against infection with Newcastle disease virus;]
(5)or    [(c)      have been vaccinated against infection with Newcastle disease virus with vaccines that 
comply with both the general and specific criteria of Annex XV to Delegated 
Regulation (EU) 2020/692;]
(d) have been subjected to a virus detection test(7)for highly pathogenic avian influenza 
and infection with Newcastle disease virus with negative results within the period of 7 
to 14 days prior to the date of loading for dispatch to the Union;
(e) had no contact with animals of a lower health status since hatching or for a continuous 
period of at least 3 weeks immediately prior to the date of loading for dispatch to the 
Union;
(f) are not to b e killed under a national programme for the eradication of diseases, 
including the listed diseases referred to in Annex I to Delegated Regulation (EU) 
2020/692 relevant for the species and emerging diseases;
(g) have been subjected to a clinical inspection(6)on ___/___/____ (dd/mm/yyyy), within 
the 24 hours prior to loading for dispatch to the Union, and showed no signs indicative 
of the occurrence of diseases, including the listed diseases referred to in Annex I to 
Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;
II.1.5. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that:
(i) animals cannot escape or fall out;
(ii) visual inspection of the space where animals are kept is possible;
(iii) the escape of animal excrements, litter, feed or feathers is prevented or 
minimized;
(b) contain only captive birds of the same species coming from the same establishment;
(c) are used for the first time;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /701
COUNTRY Certificate model CAPTIVE -BIRDS
(d) are closed in accordance with the instructions of the competent authority of the country 
or territory of origin to avoid any possibility of substitution of the content;
(e) bear the information set out in Point 4 of Annex XVI to Delegated Regulation (EU) 
2020/692 relevant for captive birds;
II.1.6. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(8)in a means of transport 
which is constructed in accordance with II.1.5(a) and was cleaned and disinfected prior to loading with a disinfectant authorised by the competent a uthority of the country or territory of 
origin; 
(9)[II.1.7. are captive birds of galliformes species intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance 
with Article 66 Commission Delegated Regulation (EU) 2020/689, and they:
(a) have not been vaccinated against infection with Newcastle disease virus;
(b) were kept in isolation for at least 14 days prior to the date of loading of the 
consignment for dispatch to the Union in the establishment of origin or quarantine 
establishment under the supervision of an official veterinarian, where:
(i) no bird was vaccinated against infection with Newcastle disease virus during 
the period of at least 21 days prior to the date of loading of the consignment;
(ii) no other birds have entered into the establishment during that time;
(iii) no vaccination has been carried out;
(c) have tested(7)negative to serological tests to detect antibodies against Newcastle 
disease virus, perform ed on blood samples at a level which gives 95% confidence of 
detecting infection at 5% prevalence and which were taken during the period of at 
least 14 days prior to the date of loading for dispatch to the Union.]
Notes:
This certificate is intended for entry into the Union of captive birds, including when the Union is not the final 
destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern 
Ireland from the European Union and the Eu ropean Atomic Energy Community, and in particular Article 5(4) of 
the Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European 
Union in this certificate include the United Kingdom in respect of Northern Ir eland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
L 113 /702  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CAPTIVE -BIRDS
Part I:
Box I.8.: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex VI to 
Implementing Regulation (EU) 2021/404 .
Box I.12: In case of captive birds certified for a quarantine establishment, provide the information on the 
quarantine establishment approved in accordance with Article 14of Commission Delegated 
Regulation (EU) 2019/2035, where the captive birds must be transported without delay following entry into the Union
Box I.27: Description of consignment
“CN code”
: use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.06.31, 01.06.32 or 01.06.39.
“Identification system”: The animal must be individually identified by means of a unique marked 
closed leg -ring or an injectable transpond er in accordance with Article 53 of Delegated Regulation 
(EU) 2020/692.
Part II:
(1)‘Captive birds’ as defined in Article 4 of Regulation (EU) 2016/429.
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex VI to Implementing 
Regulation (EU) 2021/404 .
(3)The name and unique approval number of the establishment must appear on the list of establishments 
drawn up and published by the Commission.
(4)This guarantee is required only for consignments of psittacidae.
(5)Keep as appropriate.
(6)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(7)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or ter ritory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(8)The date of loading cannot be a date prior to the date of authorisation of the country or territory or zo ne 
thereof for entry into the Union, or a date in a period when restriction measures have been adopted by the Union in relation to the entry of these animals from that country or territory or zone thereof.
(9)This guarantee is required only for consignments of captive birds of galliformes species intended for a 
Member State which has been granted the status free from infection with Newcastle disease virus 
without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /703
CHAPTER 35
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
HATCHING EGGS OF CAP TIVE BIRDS (MODEL ‘H E-CAPTIVE- BIRDS ’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /704  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Breed/Category Identification 
systemIdentification number Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /705
COUNTRY Certificate model HE- CAPTIVE -BIRDSPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
II.1. Animal health attestation
I, the undersigned official veterinarian, hereby certify that the hatching eggs of captive birds(1)described in 
this certificate:
II.1.1. come from the zone with code _ _ -_(2)which, at the date of issue of this certificate, is authorised 
and listed in Part 1 of Annex V to Commission Implementing Regulation (EU) 2021/404 for entry 
into the Union of hatching eggs of captive birds;
II.1.2. come from the establishment(3)indicated in Box I.11, approved by the competent authority of the 
country or territory of origin in accor dance with requirements which are at least as stringent as 
those laid down in Article 56 of Commission Delegated Regulation (EU) 2020/692 and:(a) the approval of which has not been suspended or withdrawn;
(b) which is under the control of the competent authority of the country or territory of origin 
and has a system in place to maintain and to keep records in accordance with Article 8 of Commission Delegated Regulation (EU) 2020/692;
(c) which receives regular animal health visits from a veterinarian for the purpose o f the detection 
of, and information on, signs indicative of the occurrence of diseases, including the relevant
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging 
diseases , at a frequency that is proportional to the ri sk posed by the establishment;
(d) which was not subject to national restriction measures for animal health reasons, including 
for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 
relevant for the species and emerging diseases, at the time of dispatch of the animals to the 
Union;
(e)
within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza or 
infection with Newcastle disease virus for at least 30 days prior to the date of loading for 
dispatch to the Union;
(4)[(f) in which;
(5)either [avian chlamydiosis has not been confirmed for a period of at least 6 months prior to the 
date of loading of the hatching eggs of captive birds for dispatch to the Union;]
(5)or [avian chlamydiosis has been confirmed during the last 6 months prior to the date of 
loading of the hatching eggs of captive birds for dispatch to the Union, but not during the last 60 days, and the measures provided for in Article 55(e)(i) of Delegated Regulation 
(EU) 2020/692 have been applied;]
(5)or [the animals from which the hatching eggs have been obtained, have been kept under 
veterinary supervision for the 45 days prior to the date of collection of the hatching eggs and were treated against avian chlamydiosis;]
L 113 /706  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HE- CAPTIVE -BIRDS
II.1.3. come from animals which:
(a) have remained in the establishment indicated in Box I.11 since hatching or for a continuous 
period of at least 3 weeks immediately prior to the date of loading of the hatching eggs for 
dispatch to the Union;
(b) have not been vaccinated against highly pathogenic avian influenza;
(5)either [(c)      have not been vaccinated against infection with Newcastle disease virus;]
(5)or   [(c)    have been vaccinated against infection with Newcastle disease virus with vaccines that 
comply with both the general and specific criteria of Annex XV to Delegated Regulation 
(EU) 2020/692;
(d) have been subjected to a virus detection test(7)for highly pathogenic avian influenza and 
infection with Newcastle disease virus with negative results within the period of 7 to 14 
days prior to the date of collection of the hatching eggs;
(e) had no contact with animals of a lower health status since hatching or for a continuous period of at least 3 weeks immed iately prior to the date of collection of the eggs;
(f) are not to be killed under a national programme for the eradication of diseases, including the 
listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for 
the species and emerging diseases;
(g) have been subjected to a clinical inspection
(6)on ___/___/____ (dd/mm/yyyy), within the 24 
hours prior to loading of the hatching eggs for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I 
to Delegated Regulation ( EU) 2020/692 relevant for the species and emerging diseases;
II.1.4. are loaded for dispatch to the Union in containers which:
(a) are constructed in such a way that hatching eggs cannot fall out;
(b) contain only hatching eggs of captive birds of the same species coming from the same 
establishment;
(c) are used for the first time;
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;
(e) b
ear the information set out in Point 7 of Annex XVI to Delegated Regulation (EU) 
2020/692 relevant for hatching eggs of captive birds;
II.1.5. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(8) in a means of transport 
which is constructed in accordance with II.1.4(a) and was cleaned and disinfected prior to loading 
with a disinfectant authorised by the competent authority of the country or territory of origin;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /707
COUNTRY Certificate model HE- CAPTIVE -BIRDS
(9)[II.1.6. are intended for a Member State which has been granted the status free from infection with 
Newcastle disease virus without vaccination in accordance with Article 66 of Commission 
Delegated Regulation (EU) 2020/689, and they come from animals which:
(a) have not been vaccinated against infection with Newcastle disease vir us;
(b) were kept in isolation for at least 14 days prior to the date of loading of the consignment for 
dispatch to the Union in the establishment of origin or quarantine establishment under the supervision of an official veterinarian, where:
(i) no bird was vaccinated against infection with Newcastle disease virus during the 
period of at least 21 days prior to the date of loading of the consignment;
(ii) no other birds have entered into the establishment during that time;
(iii) no vaccination has been carried out;
(c) have tested
(7)negative to serological tests to detect antibodies against Newcastle disease 
virus, performed on blood samples at a level which gives 95% confidence of detecting 
infection at 5% prevalence and which were taken during the period of at least 14 days prior 
to the date of loading for dispatch to the Union.]
Notes:
This certificate is intended for entry into the Union of hatching eggs of captive birds, including when the Union is 
not the final destination of those products.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in co njunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.8.: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex VI to 
Implementing Regulation (EU) 2021/404 .
Box I.27: Description of consignment
‘CN code’ : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.
Part II:
(1)‘Captive birds’ as defined in Article 4 of Regulation (EU) 2016/429.
(2)Code of the zone as it appears in column 2 of the table in Part 1 of Annex VI to Implementing 
Regulation (EU) 2021/404 .
(3)The name and unique approval number of the establishment must appear on the list of establishments 
drawn up and published by the Com mission.
(4)This guarantee is required only for consignments of psittacidae.
(5)Keep as appropriate.
L 113 /708  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model HE- CAPTIVE -BIRDS
(6)The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.
(7)Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.
(8)The date of loading cannot be a date prior to the date of authorisation of the country or territory or zone 
thereof for entry into the Union, or a date in a period when restriction measures have been adopted by 
the Union in relation to the entry of these animals from that country or territory or zone thereof.
(9)This guarantee is required only for consignments of hatching eggs of captive birds of galliformes species 
intended for a Member State which has been granted the status free from infection with Newcastle diseas e virus without vaccination in accordance with Article 6 6 of Delegated Regulation (EU) 2020/689.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /709
CHAPTER 36
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
QUEEN HONEYBEES (MODEL ‘QUE’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /710  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Quantity
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /711
COUNTRY Certificate model QUEPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the honeybee queens described in Part I:
II.1. come from the zone with code: __ __ - __(2)which, at the date of issuing this certificate is listed in Part 1 
of Annex VII to Commission Implementing Regulation (EU) 2021/404 for entry into the Union of queen 
honeybees. 
II.2. have remained continuously: 
(i)in the zone referred to in point II.1 since hatching, and
(ii)in the establishment of origin since hatching. 
II.3. had no c ontact with honeybees of a lower health status since hatching. 
II.4. are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex Iof Commission Delegated Regulation (EU) 202 0/692 and emerging 
diseases.
II.5. have been dispatched in closed cages each containing one single queen honeybee with a maximum 20 accompanying attendants:
II.5.1. in packaging material which, before packing the queen honeybees of the consignment:
(i) wasnew; 
(ii) had not been in contact with any bees and brood combs; 
(iii)
has been subject to all precautions to prevent its contamination with pathogens causing 
diseases of honeybees.
II.5.2. accompanied by feedingstuff free from pathogens causing their diseases;
II.5.3. in packaging material and with accompanying products which have undergone a visual 
examination before dispatch to the Union to ensure that they do not pose an animal health risk and 
do not contain Aethina tumida (Small hive beetle) and Tropilaelaps mite in any of their life stages.
II.5.4. directly from the establishment of origin to the Union without passing through any other 
establishment without being unloaded in any place that does not comply with the requirements laid down in point II.7 since they were dispatched from their establishment of origin until dispatch to 
the Union and have not been in contact with animals of a lower health status.
II.6. have been subjected to a clinical inspection within the 24 hour period prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not detect 
signs indicative of the occurrence of diseases, including the relevant listed diseases referred to in Annex 
1 of Delegated R egulation (EU) 2020/692 and emerging diseases. 
II.7. originate from an apiary: 
II.7.1. in and around which, in an area of 100 km radius, including where appropriate the territory of 
a neighbouring country
(i) infestation with Aethina tumida (Small hive beetle) or infestation with Tropilaelaps spp. has 
not been reported; 
(ii) there are no restrictions in place due to a suspicion, case or outbreak of the diseases referred 
to (i). 
L 113 /712  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model QUE
II.7.2. in and around which, in an area of 3 km radius, including where appropriate the territory of a 
neighbouring country;
(i) American foulbrood has not been reported for at least 30 days prior to the date of dispatch 
to the Union; 
(ii) there are no restrictions in place due to a suspicion or a confirmed ca se of American 
foulbrood during the period referred to in point (i);
[(iii) there had been a previous confirmed case of American foulbrood before the period referred 
to in point (i) and all hives were subsequently checked by the competent authority in the 
third country or territory of origin and all infected hives were treated and subsequently 
inspected with favourable results within a period of 30 days from the date of last recorded 
case of that disease.] (1)
II.8. originate from hives from which samples o f the comb have been tested for American foulbrood with 
negative results within the period of 30 days prior to the date of their dispatch to the Union.
(1)(4)(5)[II.9. The queen honeybees:
(i)originate from a third country or territory or zone thereof free from infestation with 
Varroa spp
(ii)in the third country or territory of origin or zone thereof, infestation with Varroa spp. has 
not been reported for a period of 30 days prior to the date of loading for dispatch to the 
Union; 
(iii)every precaution has been taken to avoid contamination of the consignment with Varroa spp. during loading and dispatch to the Union.]
Notes:
This certificate is intended for entry into the Union of honeybee queens, inc luding when the Union is not the final 
destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in par ticular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shal l be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.27: “Category ”: indicate queens with maximum 20 attendants.
Part II:
(1)Delete as appropriate
(2)Code of the zone as it appears in Column 2 of Part 1 of Annex VII to Implementing Regulation (EU) 
2021/404.
(3)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /713
COUNTRY Certificate model QUE
(4)Only applicable when the Member State of destination either has disease -free status for the relevant category 
Cdisease or has an approved eradication programme.
(5)It can be certified by third countries or territories with entry VAR in Column 6 of Part 1 of Annex VII to 
Implementing Regulation (EU) 2021/404 recognised free of infestation with Varroa spp . (Varroasis).
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /714  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 37
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
BUMBLE BEES (MODEL ‘ BBEE’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /715
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Quantity
Netweight
Nature of 
commodityNumber of packages
L 113 /716  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BBEEPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that the bumble bees described in Part I:
II.1. come from the zone with code: __ __ - __(1)which, at the date of issuing this certificate is listed in Part 1 
of Annex V II to Commission Implementing Regulation (EU) 2021/404 for entry into the Union of
bumble bees. 
II.2. have remained continuously: 
(i)in the zone referred to in point II.1 since hatching, and
(ii)in the establishment of origin since hatching, in which no bumble bees have been introduced into 
their epidemiological u nit of origin during that period of time. 
II.3. had no contact with animals of a lower health status since hatching. 
II.4. are not to be killed under a national programme for the eradication of diseases, including listed diseases 
and emerging diseases.
II.5.have been dispatched in closed containers each containing a colony of maximum 200 adult bumble bees, 
with or without a queen:
II.5.1. in packaging material which, before packing the bumble bees of the consignment:
(i) was new; 
(ii) had not been in contact with any bees and brood combs; 
(iii) has been subject to all precautions to prevent its contamination with pathogens causing 
diseases of bumble bees.
II.5.2. accompanied by feedingstuff free from pathogens causing their diseases;
II.5.3. in packaging material and with accompanying products which have undergone a visual 
examination before dispatch to the Union to ensure that they do not pose an animal health risk and do not contain Aethina tumida (Small hive beetle), in any of their life stages.
II.5.4.
directly from the establishment of origin to the Union without passing through any other 
establishment and without being unloaded in any place that does not comply with the 
requirements laid down in points II.7, II.8 since they were dispatched from their 
establishment of origin until dispatch to the Union and have not been in contact with animals 
of a lower health status.
II.6. have been subjected to a clinical inspection within the 24 hour period prior to loading(2)for dispatch to 
the Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred to in 
Annex Iof Delegated Regulation (EU) 2020/692 and emerging diseases. 
II.7. have been bred and kept in an environmentally isolated bumble bee production establishment which: 
II.7.1. is registered by, and is under the control of, the competent authority of the third country or territory and hasa system in place to maintain and to keep records in accordance with Article 
8 of Delegated Regulation (EU) 2020/692;
II.7.2. has facilities which ensure that the production of bumble bees is carried out inside of a flying 
insect -proof building;
II.7.3.has facilities and equipment which ensure that the bumble bees are further isolated in separate 
epidemiological units and each colony in closed containers within the building throughout the 
whole production; 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /717
COUNTRY Certificate model BBEE
II.7.4. the storage and handling of pollen within the facilities is isolated from the bumble bees 
throughout the whole production of bumble bees until it is fed to them;
II.7.5. has standard operating procedures to prevent the entry of small hive beetle into the 
establishment and to regularly surve y for the presence of small hive beetle within the 
establishment.
II.8. come from an epidemiological unit with the establishment in which infestation with Aethina tumida
(Small hive beetle) has not been detected.
Notes:
This certificate is intended for en try into the Union of bumble bees, including when the Union is not the final 
destination of those animals.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part II:
(1)Code of the zone as it appears in Column 2 Part 1 of Annex VII to Implementing Regulation (EU) 
2021/404.
(2)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restrictio n measures have been adopted by the Union against entries 
of these animals from this zone.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /718  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 38
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
DOGS, CATS AND FERRETS (MODEL ‘CANIS -FELIS -FERRETS’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Further keeping
□Confined establishment
□Quarantine establishment
□Other
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /719
I.24 Total number of packages I.25 Total quantity I.26 Total net weight/gross weight (kg)
I.27 Description of consignment
CN code Species Subspecies/Category Sex Identification 
systemIdentification number Age Quantity
Nature of 
commodity
Test
L 113 /720  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CANIS- FELIS -FERRETSPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian hereby certify that the animals described in Part I:
II.1. come from a country, territory or zone thereof with code: __ __ -__(1)which, on the date of 
issue of this certificate is authorised for the entry into the Union of dogs, cats and ferrets and is 
listed in Part 1 of Annex VII Ito Commission Implementing Regulation (EU) 2021/404 ;
(2)(3)either [II.2. have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment]; 
(2)(3)or [II.2. have undergone one single assembly operation in the country, territory or zone thereof of origin 
which took place for not more than 6 days in an establishment fulfilling the following 
requirements:
-it is approved for conducting assembly operations of dogs, cats and ferre ts by the competent 
authority in the third country or territory in accordance with Article 10 of Commission 
Delegated Regulation (EU) 2019/2035; 
-it has a unique approval number assigned by the competent authority of the third country or 
territory;
-it is listed for that purpose by the competent authority of the third country or territory of 
dispatch , including the information set out in Article 21 of Delegated Regulation (EU) 
2019/2035;
-it complies with the record keeping requirements provided for in point (a)(iv) of Article 
73(2) of Delegated Regulation (EU) 2020/692. ]
(3)[II.3. have been loaded for dispatch to the Union on ___/___/____(dd/mm/yyyy)(4)in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by
the competent authority in the third country or territory and constructed in such a way that:
-animals cannot escape or fall out;
-visual inspection of the space where animals are kept is possible;
-the escape of animal excrements, litter or feed is prevent ed or minimized.]
II.4 have been subjected with negative result to a clinical inspection, carried out by an official 
veterinarian in the third country, territory or zone thereof of origin within 48 hour period prior to 
loading for dispatch to the Union for the detection of signs indicative of the occurrence of 
diseases, including the relevant listed diseases referred to in Annex 1 of Delegated Regulation 
(EU) 2020/692 and emerging diseases.
(2)either [II.5. are destined for direct entry into the Member State of destination to be isolated in:
(2)either [a confined establishment;]]
(2)or [an approved quarantine establishment;]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /721
COUNTRY Certificate model CANIS- FELIS -FERRETS
(2)or [II.5. were at least 12 weeks old at the time of vaccination against rabies and at least 21 days have 
elapsed since the completion of the primary anti -rabies vaccination(5)carried out in accordance 
with the validity requirements set out in Annex III to Regulation (EU) No 576/2013 of the 
European Parliament and of the Council, and any subsequent revaccination was carried out 
within the period of validity of the preceding vaccination(6), and
(2)either [they come from, and in case of transit are scheduled to transit through, a territory or third 
country listed in Annex II to Commission Implementing Regulation (EU) No 577/2013 and 
details of the current anti -rabies vaccination are provided in columns 1 to 7 in the table 
below;]]
(2)or [they come from or are scheduled to transit through a territory or third country not listed in 
Annex II to Commission Implementing Regulation (EU) No 577/2013, and
details of the current anti -rabies vaccination are provided in columns 1 to 7 in the table 
below, and
- a rabies antibody titration test(7), carried out on a blood sample taken by the 
veterinarian authorised by the competent authority not less than 30 days after the 
preceding vaccination and at least three months prior to the date of issue of this 
certificate, proved an antibody titre equal to or greater than 0,5 IU/ml(8)and any 
subsequent revaccination was carried out within the period o f validity of the 
preceding vaccination, and the date of sampling for testing the immune response are 
provided in column 8 in the table below:]]
Transponder 
Date of 
vaccination 
[dd/mm/yyyy]Name and 
manufacturer 
of vaccineBatch 
numberValidity of 
vaccination
Date of blood 
sampling 
[dd/mm/yyyy]Alphanumeric 
code of the 
animalDate of 
implantation 
and/or 
reading (9)
[dd/mm/yyyy
]
From 
dd/mm/yyyy
]
To 
dd/mm/yyyy
]
1 2 3 4 5 6 7 8
L 113 /722  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CANIS- FELIS -FERRETS
(2)either [II.6. the consignment includes dogs destined for a Member State listed in the Annex to Commission 
Implementing Regulation (EU) 2018/878 and those dogs have been treated against infestation 
with Echinococcus multilocularis , and the details of the treatment carried out by the 
administering veterinarian in accordance with point 2 of Annex XXI to Delegated Regulation 
(EU) 2020/692(10) (11)are provided in the table below
Transponder or tattoo. 
Alphanumeric code of 
the dogAnti -Echinococcus treatment Administering veterinarian
Name and 
manufacturer of 
the productDate 
[dd/mm/yyyy] and 
time of treatment 
[00:00]Name in capitals, stamp and 
signature
]
(2)or [II.6. the dogs have not been treated against infestation with Echinococcus multilocularis. ]
(2)or [II.6. the dogs are destined for direct entry into the Member State of destination to be isolated in :
(1)either [a confined establishment.]]
(1)or [an approved quarantine establishment.]]
Notes:
This certificate is intended for commercial entries into the Union of dogs, cats and ferrets, including when they are 
destined to a confined establishment or to an approved quarantine establishment and when the Union is not the 
final destination of the animals and for entry i nto the Union of dogs, cats and ferrets moved in accordance with 
Article 5(4) of Regulation (EU) No 576/2013 of the European Parliament and of the Council.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northe rn Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /723
COUNTRY Certificate model CANIS- FELIS -FERRETS
Part I:
Box I.20: Certified as or for: indicate
-"Further keeping" where dogs, cats or ferrets are moved in accordance with Title V of Part II of 
Delegated Regulation (EU) 2020/692;
-Confined establishment: as defined in Article 4(48) of Regulation (EU) 20 16/429 of the European 
Parliament and of the Council;
-Approved quarantine establishment: as defined in Article 3(9) of Commission Delegated 
Regulation (EU) 2020/688
-"others" where dogs ( Canis lupus familiaris ), cats ( Felis silvestris catus ) or ferrets (Mus tela 
putorius furo ) are moved in accordance with Article 5(4) of Regulation (EU) No 576/2013 of the 
European Parliament and of the Council. 
Part II:
(1)Code of the zone as it appears in Column 2 of Part 1 of Annex VIII to Implementing Regulation (EU) 
2021/404.
(2)Keep as appropriate.
(3)Not applicable to the movement of dogs, cats and ferrets other than non -commercial movements kept as 
pet animals in households that cannot be carried out in accordance with the conditions laid down in 
Article 245(2) or Article 246(1) and (2) of Regulation (EU) 2016/429.
(4)Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union against entries 
of these animals from the zone.
(5)Any revaccination must be considered a primary vaccination if it was not carried out within the period 
of validity of a previous vaccination.
(6)A certified copy of the identification and vaccination details of the animals concerned shall be attached 
to the certificate.
(7)The rabies antibody titration test referred to in point II.5:
-must be carried out on a sample collected by a veterinarian authorised by the competent authority, 
at least 30 days after the date of vaccination and three months before the date of import ;
-must measure a level of neutralising antibody to rabies virus in serum equal to or greater than 
0,5IU/ml;
-must be performed by an official laboratory ;
-does not have to be renewed on an animal, which following that test with satisfactory results, has 
been revaccinated against rabies within the period of validity of a previous vaccination.
A certified copy of the official report from the official laboratory on the result of the rabies antib ody test 
referred to in point II.5. shall be attached to the certificate.
(8)By certifying this result, the official veterinarian confirms that he has verified, to the best of his ability and where necessary with contacts with the laboratory indicated in the report, the authenticity of the laboratory report on the results of the antibody titration test referred to in point II.5.
(9)In conjunction with footnote (6), the marking of the animals concerned by the implantation of a 
transponder must be verified before any entry is made in this certificate and must always precede any vaccination, or where applicable, testing carried out on those animals.
(10)The treatment against infestation with Echinococcus multilocularis referred to in point II.6 must:
-be administered by a veterinarian within a period of not more than 48 hours and ending not less 
than 24 hours before the time of the scheduled entry of the dogs into one of the Member States or 
parts thereof listed in the Annex to Commission Implementing Regu lation (EU) 2018/878;
-consist of an approved medicinal product which contains the appropriate dose of praziquantel or 
pharmacologically active substances, which alone or in combination, have been proven to reduce 
the burden of mature and immature intesti nal forms of Echinococcus multilocularis in the host 
species concerned.
(11)The table referred to in point II.6 must be used to document the details of a further treatment if 
administered after the date the certificate was signed and prior to the scheduled entry into one of the 
Member States or parts thereof listed in the Annex to Commission Implementing Regulation (EU) 2018/878.
Official veterinarian
L 113 /724  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model CANIS- FELIS -FERRETS
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /725
CHAPTER 39
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF SEMEN OF BOVINE ANIM ALS COLLECTED, PROCESSED 
AND STORED IN ACCORD ANCE WITH REGULATION (EU) 2016/429 AND 
DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED 
FROM THE SEMEN COLLECTION CENTRE WH ERE THE SEMEN WAS 
COLLECTED (MODEL ‘BO V-SEM -A-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISOcountry code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /726  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /727
COUNTRY Certificate model BOV- SEM -A-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals 
which originate from a third country, territory or zone thereof
II.1.1. authorised for entry into the Union of semen of bovine animals and listed in Annex IX to 
Commission Implementing Regulation (EU) 2021/404 ;
(1)either [II.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediate ly prior to collection of the semen anduntil its date of dispatch ;]
(1)or[II.1.2. where foot -and-mouth disease was not reported for a period starting on the date(2)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the semen and until its date of 
dispatch ;]
II.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia and lumpy skin disease were not reported for a period of at least 12 
months immediately prior to collection of the semen and until its date of dispatch ;
II.1.4. where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been 
carried out for a period of at least 1 2 months immediately prior to collection of the semen and 
until its date of dispatch , and no vaccinated animals entered into the third country, territory or 
zone thereof during that period.
II.2. The semen described in Part I was obtained from donor animals which, before the commencement of the 
quarantine referred to in point II.4.8., originate from establishments 
II.2.1. situated in an area where foot -and-mouth disease has not been reported withi n a 10 -km radius 
centred on the establishment for a period of at least 30 days and in which foot -and-mouth 
disease has not been reported during a period of at least 3 months, and 
(1)either [they were not vaccinated against foot -and-mouth disease;]
(1)or[they were vaccinated against foot- and-mouth disease during the period of 12 months prior to 
the date of collection of the semen but not during the period of the last 30 days immediately 
prior to the date of collection of the semen, and 5 % (with a minimu m of five straws) of each 
quantity of semen taken from a donor animal at any time is submitted to a virus isolation test 
for foot -and-mouth disease with negative results;]
II.2.2. free from infection with Mycobacterium tuberculosis complex (M. bovis, M. ca prae and M. 
tuberculosis ) and they have never been kept previously in any establishment of a lower health 
status;
II.2.3. free from infection with Brucella abortus, B. melitensis and B. suis and they have never been 
kept previously in any establishment of a lower health status;
(1)either [II.2.4. free from enzootic bovine leukosis and they have never been kept previously in any 
establishment of a lower health status;]
(1)or[II.2.4. not free from enzootic bovine leukosis and the donor animals are younger than 2 years of age 
and have been produced by dams which have been subjected, with negative results, to a 
serological test for enzootic bovine leukosis after removal of the animal from the dam;]
(1)or[II.2.4. not free from enzootic bovine leukosis and the d onor animals have reached the age of 2 years 
and have been subjected, with a negative result, to a serological test for enzootic bovine 
leukosis;]
L 113 /728  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- SEM -A-ENTRY
(1)either [II.2.5. free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have 
never been kept previously in any establishment of a lower health status;]
(1)or[II.2.5. not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and the 
donor animals have been subjected, with a negative result, to a serolo gical test (whole virus) 
on a blood sample;]
II.2.6. in which surra ( Trypanosoma evansi) has not been reported during the last 30 days, and
(1)either [surra has not been reported in the establishments during the last 2 years;]
(1)or[surra has been reported in the establishments during the last 2 years and following the last 
outbreak the establishments have remained under movement restrictions until
−the infected animals have been removed from the establishment, and
−the remaining animals on the establ ishment have been subjected to a test for surra 
(Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of 
Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with 
negative results, on samples taken at least 6 mont hs after the infected animals have been 
removed from the establishment.]
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen 
collection centre(3)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686.
II.4. The semen des cribed in Part I was obtained from donor animals which
II.4.1. were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease;
II.4.2. remained for a period of at least 6 months prior to the date of collection of the semen in a 
third country or territory or zone thereof referred to in Box I.7.;
II.4.3. did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a seme n collection centre and on the day of collection of the semen; 
II.4.4.
are individually identified as provided for in Article 21(1) of Commission Delegated 
Regulation (EU) 2020/692;
II.4.5. for a period of at least 30 days prior to the date of collection of the semen and during the 
collection period 
II.4.5.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, contagious bovine pleuropneumonia orlumpy skin disease ,or of an emerging disease relevant for bovine animals;
II.4.5.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis andB. suis, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis ),rabies, anthrax, surra (Trypanosoma 
evansi), 
enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic 
haemorrhagic disease virus, infection with bluetongue virus (serotypes 1 -24), 
bovine genital campylobacteriosis and trichomonosis have not been reported;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /729
COUNTRY Certificate model BOV- SEM -A-ENTRY
II.4.5.3. were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.5.1. or from
establishments which do not meet the conditions referred to in point II.4.5.2.;
II.4.5.4. were not used for natural breeding;
II.4.6. have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health status 
were present, which on the day of their admission to the semen collection centre complied 
with the following conditions:
II.4.6.1. it was not situated in a restricted zone established due to diseases ref erred to in 
point II.4.5.1.;
II.4.6.2. none of the diseases referred to in point II.4.5.2. has been reported for a period of 
at least 30 days;
II.4.6.3. it was situated in an area where foot- and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;
II.4.6.4. has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;
II.4.7. were kept in the semen collection centre
II.4.7.1. which was not situated in a restricted zone established due to diseases referred to 
in point II.4.5.1.;
II.4.7.2. where none of the diseases referred to in point II.4.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and
(1)(4)[at least 30 days following the date of the collection;]
(1)(5)[until the date of dispatch of the consignment of semen to the Union;]
II.4.7.3. situated in an area where foo t-and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and
(1)(4)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the se men and 30 days from the date of collection;]
(1)(5)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment of semen to the Union and the donor anima
ls have been kept at that semen 
collection centre for a continuous period of at least 30 days immediately prior to 
the date of collection of the semen;]
II.4.8. comply with at least one of the following conditions as regards infection with bluetongue 
virus (serotypes 1 -24):
(1)either [II.4.8.1. they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a third country, territory or zone thereof free from infection with bluetongue virus (serotypes 1 -24)where no case of infection with bluetongue virus 
(serotypes 1 -24) has been confirmed during the last 24 months in the targeted animal 
population;]
L 113 /730  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- SEM -A-ENTRY
(1)and/or [II.4.8.2. they have been kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a third country, territory or zone thereof with an approved eradication 
programme against infection with bluetongue virus (serotype s1-24);]
(1)and/or [II.4.8.3. they have bee n kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a third country, territory or zone thereof where the competent authority of 
the place of o rigin of the consignment of semen has obtained the prior written 
consent of the competent authority of the Member State of destination to the 
conditions for establishment of that seasonally disease -free zone and to accept the 
consignment of semen;]
(1)and/or[II.4.8.4. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(1)and/or [II.4.8.5. they have been subjected to a serological test to detect antibodies to the bluetongue virus serogroup 1- 24, with negative results, between 28 and 60 days from the date of 
each collection of the semen;]
(1)and/or [II.4.8.6. they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood samples taken at commencement 
and final collection of the semen and during collection of the semen at intervals of at least every 7 days, in the case of the virus isolation test, or of at least every 28 days, 
in the case of PCR;]
II.4.9. comply wi th at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7):
(1)either [II.4.9.1. they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a third country, territory or zone thereof where EHDV 1 -7 has not been 
reported for a period of at least the preceding 2 years within a radius of 150 km of the establishment;]
(1)and/or [II.4.9.2. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(1)and/or [II.4.9.3. were resident in the exporting country in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to the following tests carried out in an 
official laboratory:
(1)either [II.4.9.3.1. a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days throughout the collection period and 
between 28 and 60 days from the date of the final collection of the 
semen;]]
(1)and/or [II.4.9.3.2. an agent identification test for EHDV 1 -7, with negative results, on 
blood samples taken at the commencement and final collection of the 
semen and during the collection of the semen at intervals of at least 
every 7 days, in the case of virus isolation test, or of at least every 28 
days, in the case of PCR.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /731
COUNTRY Certificate model BOV- SEM -A-ENTRY
II.4.10. have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to the commencement of the quarantine referred to in point II.4.6., 
with negative results, except for the bovine viral diarrhoea antibody test referred to in point 
II.4.10.5.2., required in accordance with point 1(b) of Chapter I of Part 1 of Annex II to 
Delegated Regulation (EU) 2020/686:
II.4.10.1. for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae 
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated R egulation (EU) 2020/688;
II.4.10.2. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(1)(6)[II.4.10.3. for enzootic bovine leukosis, a sero logical test referred to in point (a) of Part 4 of 
Annex I to Delegated Regulation (EU) 2020/688;]
II.4.10.4. for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample if the animals do not come from 
an establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;
II.4.10.5. for bovine viral diarrhoea: 
II.4.10.5.1. a virus isolation test, a test for virus genome or a test for virus 
antigen, and 
II.4.10.5.2. a serological test to determine the presence or absence of antibodies;
II.4.11. have been subjected to the following tests, carried out on blood samples taken within a period 
of at least 21 days, or 7 days in the case of the tests referred to in points II. 4.11.4. and 
II.4.11.5., after the commencement of the quarantine referred to in point II.4.6., with negative 
results, except for the bovine viral diarrhoea antibody test referred to in point II.4.11.3.2., 
required in accordance with point 1(c) of Chapter I
of Part 1 of Annex II to Delegated 
Regulation (EU) 2020/686:
II.4.11.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
II.4.11.2. for in fectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample;
II.4.11.3. for bovine viral diarrhoea: 
II.4.11.3.1. a virus isolation test, a test for virus genome or a test for virus 
antigen, and 
II.4.11.3.2. a serological test to determine the presence or absence of antibodies;
II.4.11.4. for bovine genital campylobacteriosis (Campylobacter fetus ssp. venerealis ): 
(1)either [II.4.11.4.1. a single test carried out on a sample of artificial vagina washings or 
preputial specimen, in the case of animals less than 6 months old or 
kept since that age in a single sex group without contact with 
females prior to the quarantine referred to in point II.4.6.;]
(1)or [II.4.11.4.2. tests carried out on samples of artificial vagina washings or preputial 
specimens taken on three occasions at intervals of at least 7 days;]
L 113 /732  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- SEM -A-ENTRY
II.4.11.5. for trichomonosis ( Trichomonas foetus ): 
(1)either [II.4.11.5.1. a single test carried out on a sample of preputial specimen, in th e
case of animals less than 6 months old or kept since that age in a 
single sex group without contact with females prior to the quarantine 
referred to in point II.4.6.;]
(1)or [II.4.11.5.2. tests carried out on preputial specimens taken on three occasions at 
intervals of at least 7 days;]
II.4.12. have been subjected at semen collection centre, at least once a year, to the following 
compulsory routine tests, required in accordance with point 2 of Chapter I of Part 1 of Annex 
II to Delegated Regulation (EU) 2020/686:
II.4.12.1. for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae 
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated Regulation (EU) 2020/688;
II.4.12.2. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
II.4.12.3. for enzootic bovine leukosis, a serological test referred to in point (a) of Pa rt 4 of 
Annex I to Delegated Regulation (EU) 2020/688;
II.4.12.4. for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample;
(1)(7)[II.4.12.5. for bovine viral diarrhoea, a serological test for detection of an antibody;]
(1)(8)[II.4.12.6. for bovine genital campylobacteriosis (Campylobacter fetus ssp. venerealis ), a 
test on a sample of preputial specimen;]
(1)(8)[II.4.12.7. for trichomonosis ( Trichomonas foetus ), a test on a sample of preput ial 
specimen;]
II.5. The semen described in Part I
II.5.1. has been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.5.2. isplaced in straws or other packages on w hich the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.27;
II.5.3. is transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in Box I.19;
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(1)(4)[II.5.3.3. has been filled in with the cryogenic agent which not have been previously used 
for other products.]
II.6. The semen is preserved by the addition of antibiotics as follows:
II.6.1. The following antibiotic or mixture of antibiotics, effective in particular against campylobacters, 
leptospires and mycoplasmas, has been added to the semen after final dilution, or is contained in 
the used semen diluents, to reach the indicated concentration per ml of semen:
(1)either[a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /733
COUNTRY Certificate model BOV- SEM -A-ENTRY
(1)or [a mixture of lincomycin- spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]
(1)or [a mixture of amikacin (75 μg) and divekacin (25 μg);]
(1)or [an antibiotic or a mixture of antibiotics(9)…………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg), tylosin (50 μg) and lincomycin- spectinomycin (150/300 μg) ;
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.6.2. Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature of at least 5°C for a period of not less than 45 minutes, or under a 
time-temperature regime with a documented equivalent bactericidal activity.
Notes
This certificate is intended for entry into the Union of semen of bovine animals, including when the Union is not 
the final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in part icular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only semen 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the numbe r of containers.
Box reference I.27: “Type” : Indicate semen.
“Species” : Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as 
appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : indicate mark on the straw or other packages where semen of 
the consignment is placed. 
“Date of collection/production”: Indicate the date on which semen of the 
consignment was collected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.“Quantity” : Indicate number of straws or other packages with the same mark.
L 113 /734  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- SEM -A-ENTRY
Part II:
(1)Delete if not applicable.
(2)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(3)Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm .
(4)Applicable for frozen semen.
(5)Applicable for fresh and chilled semen.
(6)Not applicable to animals which come from an establishment not free from enzootic bovine leukosis and which are less than 2 years of age as referred to in Article 20(2)(a) of Delegated Regulation (EU) 2020/686.
(7)Applicable only to seronegativ e animals.
(8)Applicable only to bulls in semen production or having contact with bulls in semen production. Bulls 
returning to collection after a lay- off period of more than 6 months shall be tested during a period of 30 days 
prior to resuming production.
(9)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /735
CHAPTER 40
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF SEMEN OF BOVINE ANIMALS COLLECTED, 
PROCESSED AND STORED AFTER 31 DECEMBER 20 04 AND BEFORE 21 APRIL 
2021 IN ACCORDANCE W ITH COUNCIL DIRECTIVE 88/407/EEC, AS AME NDED 
BY COUNCIL DIRECTIVE 2003/43/EC, DISPATCH ED AFTER 20 APRIL 2021 
FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS 
COLLECTED (MODEL ‘BO V-SEM -B-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /736  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /737
COUNTRY Certificate model BOV- SEM -B-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that :
II.1. ……………………………………………………………………………………………………………
(name of exporting country or part thereof)(1)
was free from rinderpest and foot -and-mouth disease during the 12 month period immediately prior to 
collection of the semen for export and until its date of dispatch to the Union and no vaccination against 
these diseases has taken place during the same period.
II.2. The centre(2)described in Box I.11. at which the semen to be exported was collected:
II.2.1. met the conditions laid down in Chapter I(1) of Annex A to Directive 88/407/EEC;
II.2.2. was operated and supervised in accordance with the conditions laid down in Chapter II(1) of 
Annex A to Directive 88/407/EEC.
II.3. The centre at which the semen to be exported was collected was free from rabies, tuberculosis, 
brucellosis, anthrax and contagious bovine pleuropneumonia during 30 days prior to the date of c ollection 
of the semen to be exported and the 30 days after collection (in the case of fresh semen until the day of 
dispatch to the Union).
II.4. The bovine animals standing at the semen collection centre:
(3)II.4.1. come from herds which satisfy the condi tions of paragraph 1(b) of Chapter I of Annex B to 
Directive 88/407/EEC;
II.4.2. come from herds or were born to dams which comply with the conditions of paragraph 1(c) of 
Chapter I of Annex B to Directive 88/407/EEC, or were tested at the age of at least 24 months in 
accordance with paragraph 1(c) of Chapter II of Annex B to that Directive;
II.4.3. underwent the tests required in accordance with paragraph 1(d) of Chapter I of Annex B to 
Directive 88/407/EEC in the 28 days preceding the quarantine isolation period;
II.4.4. have satisfied the quarantine isolation period and testing requirements laid down in paragraph 1(e) 
of Chapter I of Annex B to Directive 88/407/EEC;
II.4.5. have undergone, at least once a year, the routine tests referred to in Chapter II of Annex B to 
Directive 88/407/EEC.
II.5. The semen to be exported was obtained from donor bulls which:
II.5.1. satisfy the conditions laid down in Annex C of Directive 88/407/EEC;
(4)either [II.5.2. have remained in the exporting country for at least the last six months prior to collection of the 
semen to be exported;
(4)or [II.5.2. have remained in the exporting country for at least 30 days prior to the collection of the semen 
since entry and they were imported from ………………………….(1)during the period of less than 
six months prior to the collection of the semen and satisfied the animal health conditions applying 
to donors of the semen which is intended for export to the European Union;]
II.5.3. comply with at least one of the following conditions as regard s bluetongue, as detailed in the table 
in point I.27.:
(4)either [II.5.3.1. were kept in a bluetongue virus -free country or zone for at least 60 days prior to, and 
during, collection of the semen;]
(4)and/or [II.5.3.2. were kept during a bluetongue virus s easonally free period in a seasonally free zone for 
at least 60 days prior to, and during, collection of the semen;]
(4)and/or [II.5.3.3. were kept in a vector -protected establishment for at least 60 days prior to, and during, 
collection of the semen;]
L 113 /738  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- SEM -B-ENTRY
(4)and/or [II.5.3.4. were subjected to a serological test for the detection of antibody to the bluetongue virus 
serogroup, carried out in accordance with the OIE Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals, with negative results, at least every 60 days 
throughout the collection period and between 21 and 60 days after the final collection 
for this consignment of semen;]
(4)and/or [II.5.3.5. were subjected to an agent identification test for bluetongue virus, carried out in 
accordance w ith the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial 
Animals, with negative results, on blood samples taken at commencement and final 
collection for this consignment of semen and at least every 7 days (virus isolation test) 
or at least every 28 days, if carried out as polymerase chain reaction (PCR), during 
collection for this consignment of semen;]
II.5.4. comply with at least one of the following conditions as regards epizootic haemorrhagic disease 
(EHD), as detailed in the table in point I .27.:
(4)either [II.5.4.1. were resident in the exporting country which according to official findings is free from 
epizootic haemorrhagic disease (EHD);]
(4)(5)and/or [II.5.4.2. were resident in the exporting country in which according to official findings the 
following serotypes of epizootic haemorrhagic disease (EHD) exist: 
………………………… and were subjected with negative results in each case to the 
following tests carried out in an approved laboratory:
(4)either [II.5.4.2.1. a serological test(6)for the detection of antibody to the EHD virus 
serogroup, carried out on samples of blood taken on two occasions not 
more than 12 months apart prior to and not less than 21 days following 
collection for this consignment of semen;]]
(4)and/or [II.5.4.2.2. a ser ological test(6)for the detection of antibody to the EHD virus 
serogroup, carried out on samples taken at intervals of not more than 60days throughout the collection period and between 21 and 60 days after 
the final collection for this consignment of sem en.]]
(4)and/or [II.5.4.2.3. an agent identification test(6)carried out on blood samples collected at 
commencement and conclusion of, and at least every 7 days (virus isolation 
test) or at least every 28 days, if carried out as PCR, during collection for 
this consignment of semen.]]
II.6. The semen to be exported was collected after the date on which the centre was approved by the competent national authorities of the exporting country.
II.7. The semen to be exported was processed, stored and transported under conditions which satisfy the terms 
of Directive 88/407/EEC.
Notes
This certificate is intended for entry into the Union of semen of bovine animals, including when the Union is not 
the final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /739
COUNTRY Certificate model BOV- SEM -B-ENTRY
Part I:
Box I.6: “Operator responsible for the consignment” : this box is to be filled in only if it is a certificate for 
transit commodity.
Box I.11: “Place of dispatch” shall correspond to the semen collection centre listed in accordance with Article 
9(2) of Directive 88/407/EEC on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm and where the semen was collected.
Box I.19: Identification of container and seal number shall be indicated.
Box I.21: Fill in according to whether it is a transit or an import certificate.
Box I.22: Fill in according to whether it is a transit or an import certificate.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Species” : Select amongst “Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate.
Identification number shall correspond to the official identification of the animal.
“Date of collection/production” shall be indicated in the following format: dd/mm/yyyy.
“Quantity” shall correspond to the number of straws of semen collec ted on a particular date from an 
identified donor bull complying with particular conditions for bluetongue and EHD.
Part II:
(1)Only third country, territory or zone thereof listed in Annex IX to Commission Implementing Regulation 
(EU) 2021/404 for semen of bovine animals.
(2)Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the 
Commission website: http://ec.europa.eu/f ood/animal/semen_ova/bovine/index_en.htm .
(3)For New Zealand, appearing with the entry “XII” in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p.1), officially tuberculosis -free bovine herds shall be 
considere d equivalent to officially tuberculosis -free bovine herds in the Member States recognised based on 
the conditions laid down in paragraphs 1 and 2 of Annex A.I to Council Directive 64/432/EEC.
(4)Delete as necessary.
(5)Compulsory for Australia, Canada an d the United States.
(6)Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter (2.1.3) of the Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /740  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 41
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF SEMEN OF BOVINE ANIMALS COLLECTED, 
PROCESSED AND STORED BEFORE 1 JANUARY 200 5 IN ACCORDANCE WITH
COUNCIL DIRECTIVE 88/407/EEC, AS AMENDED BY COUNCI L DIRECTIVE 
93/60/EEC , DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN 
COLLECTION CENTRE WH ERE THE SEMEN WAS CO LLECTED (MODEL 
‘BOV -SEM -C-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /741
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /742  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV -SEM -C-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that :
II.1. ……………………………………………………………………………………………….
(name of exporting country)(1)
has been free from rinderpest and foot -and-mouth disease during the 12 month period immediately prior 
to collection of the semen for export and until its date of dispatch and no vaccination against these 
diseases has taken place during the same period.
II.2. The semen described above was collected before 31 December 2004 at the semen collection centre(2)
which:
II.2.1. met the conditions laid down in Chapter I of Annex A to Directive 88/407/EEC;
II.2.2. was operated and supervised in accordance with the con ditions laid down in Chapter II of Annex A to 
Directive 88/407/EEC.
II.3. The centre at which the semen to be exported was collected was free from rabies, tuberculosis, 
brucellosis, anthrax and contagious bovine pleuropneumonia during the period commencing 30 days 
prior to the date of collection of the semen to be exported and the 30 days after collection.
II.4. At the time semen described above was collected, all bovine animals standing at the semen collection 
centre:
II.4.1. came from herds and/or were bo rn to dams which satisfy the conditions of paragraph 1(b) and (c) of 
Chapter I of Annex B to Directive 88/407/EEC;
II.4.2. had tested negative, within the 30 days preceding the quarantine isolation period, to:
– the tests referred to in points 1(d)(i), (ii) and (iii) of Chapter I of Annex B to Directive 
88/407/EEC, and
– a serum neutralization test or an ELISA test for infectious bovine rhinotracheitis/infectious 
pustular vulvo- vaginitis, and
– a virus isolation test (fluorescent antibody test or immunoperoxidase test) for bovine viral 
diarrhoea, deferred until the animal reached the age of six months in the case of younger 
animals;
II.4.3. had undergone the 30- day quarantine isolation period and had tested negative to the following health 
tests:
– a serological test for brucellosis carried out in accordance with the procedure described in Annex 
C to Directive 64/432/EEC;
– either an immunofluorescent antibody test or a culture test for Campylobacter fetus infection on 
a sample of preputial material or artificial va gina washings, or, in the case of a female animal, a 
vaginal mucus agglutination test;
– a microscopic examination and culture test for Trichomonas foetus on a sample of preputial 
material or artificial vagina washings, or in the case of a female animal a va ginal mucus 
agglutination test;
II.4.4. had tested negative, at least once a year, to the routine tests referred to in points 1(a), (b) and (c) of 
Chapter II of Annex B to Directive 88/407/EEC.
II.5. At the time the semen described in Part I was collected,
II.5.1. all female bovine animals in the centre had tested negative at least once a year to a vaginal mucus 
agglutination test for Campylobacter fetus infection, and
II.5.2. all bulls used for semen production had tested negative either to an immunofluorescent antibody test or 
to a culture test for Campylobacter fetus infection on a sample of preputial material or artificial vagina 
washings carried out in 12 months prior to collection.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /743
COUNTRY Certificate model BOV -SEM -C-ENTRY
II.6. The semen to be exported was obtained from donor bulls which
II.6.1. satisfy the conditions laid down in Annex C of Directive 88/407/EEC;
(3)either [II.6.2. were resident in the exporting country during the six months immediately prior to collection of 
the semen for export;]
(3)or [II.6.2. were imported from ………………………….(1)after spending less than six months in the 
exporting country and at the time of import satisfied the animal health conditions applying to 
donors of the semen which is intended for export to the European Union;]
II.6.3. stand in a semen collection centre at which:
(3)either [all bovine animals were not vaccinated against infectious bovine rhinotracheitis and tested negative at 
least once a year to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/ 
infectious pustular vulvo -vaginitis;]
(3)or [bovine animals not vaccinated against infectious bovine rhinotracheitis tested negative, at least once a 
year, to a serum neutralisation test or an EL ISA test for infectious bovine rhinotracheitis/ infectious 
pustular vulvo -vaginitis, at which testing for infectious bovine rhinotracheitis was not carried out on 
bulls which had received their first vaccination against infectious bovine rhinotracheitis at the 
insemination centre after they had tested negative to a serum neutralisation test or an ELISA test for 
infectious bovine rhinotracheitis/ infectious pustular vulvo- vaginitis and which had been regularly re -
vaccinated at intervals of not more than six months since the first vaccination;]
(3)either [II.6.4. have not been vaccinated against infectious bovine rhinotracheitis,]
(3)or [II.6.4. have been vaccinated against infectious bovine rhinotracheitis in accordance with point II.6.3.,]
II.6.5. fulfil the import conditions for bovine semen laid down in the Bluetongue Chapter of the Terrestrial 
Animal Health Code of the OIE, depending on the status of the country or zone of residence;****
II.6.6. were resident in the country of export in which the following serotypes of epizootic haemorrhagic 
disease (EHD) exist: ……………………………..: and tested negative on two occasions not more than 
12 months apart to an agar -gel immuno- diffusion test(4)and to a virus neutralization test for all above -
listed serotypes of EHD, ca rried out in approved laboratory on samples of blood taken prior to and not 
less than 21 days following collection of the semen;***
II.6.7. were resident in the country of export in which the following serotypes of epizootic haemorrhagic 
disease (EHD) exis t: ……………………………..: and tested negative, prior to entry and at six -monthly 
intervals, to an agar- gel immuno- diffusion test(4)and a virus neutralization test for all above -listed 
serotypes of EHD, carried out in approved laboratory;**
II.6.8. tested negative on two occasions not more than 12 months apart to a serum neutralization test for 
Akabane virus carried out in approved laboratory on samples of blood taken prior to and not less than 
21 days following collection of the semen.*
II.7. The semen to be exported was collected after the date on which the centre was approved by the 
competent national authorities of the exporting country.
II.8. The semen to be exported was processed, stored and transported under conditions which satisfy the 
terms of Directive 88/407/EEC prior to its amendment by Directive 2003/43/EC.
Notes
This certificate is intended for entry into the Union of semen of bovine animals, including when the Union is not 
the final destination of the semen.
L 113 /744  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV -SEM -C-ENTRY
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Pr otocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Ann ex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.6: “Operator responsible for the consignment ”: This box is to be filled in only if it is a certificate for 
transit commodity.
Box I.11: “Place of dispatch ” shall correspond to the semen collection centre where the semen was collected.
Box I.12: “Place of destination ”: This box is to be filled in only if it is a certificate for transit commodity.
Box I.19: Identification of container and seal number shall be indicated.
Box I.21: Fillin according to whether it is a transit or an import certificate.
Box I.22: Fill in according to whether it is a transit or an import certificate.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: Identification nu mber shall correspond to the official identification of the animal.
“Date of collection/production” shall be prior to 31 December 2004 and indicated in the following 
format: dd/mm/yyyy.
“Approval or registration number of plant/establishment/centre” shall correspond to the approval 
number of the approved semen collection centre where the semen was collected.
Part II:
(1)Only third country, territory or zone thereof listed in Annex IX to Commission Implementing 
Regulation (EU) 2021/404 for semen of bovine animals.
(2)Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the 
Commission website:
http://ec.europa.eu/food/animal/semen_o va/bovine/index_en.htm .
(3)Delete as necessary.
(4)Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals.
**** To be used only by Australia, Canada and the USA.
*** To be used only by Australia and the USA. 
** To be used only by Canada.
* To be used only by Australia.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /745
CHAPTER 42
MODEL ANIMAL HEALTH CERTIFICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF OOCYTES AND EMBRYOS OF BOVINE ANIMALS 
COLLECTED OR PRODUCE D, PROCESSED AND STO RED IN ACCORDANCE 
WITH REGULATION (EU) 2016/429 AND DELEGAT ED REGULATION (EU) 
2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION 
OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE 
COLLECTED OR PRODUCE D (MODEL ‘BOV- OOCYTES -EMB- A-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /746  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /747
COUNTRY Certificate model BOV- OOCYTES -EMB- A-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The oocytes(1)/ in vivo derived embryos(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)
described in Part I are intended for artificial reproduction and were obtained from donor animals which 
originate from a third country, territory or zone thereof
II.1.1. authorised for entry into the Union of oocytes(1)/ embryos(1)of bovine animals and listed in 
Annex IX to Commission Implementing Regulation (EU) 2021/404 ;
(1)either [II.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1)and until their 
date of dispatch ;]
(1)or[II.1.2. where foot -and-mouth disease was not reported for a period starting on the date(2)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1)and until 
their date of dispatch ;]
II.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia and lumpy skin disease were not reported for a period of at least 12 
months immediately prior to collection(1)/production(1)of the oocytes(1)/ embryos(1)and until 
their date of dispatch ;
II.1.4. where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus and contagious bovine pleuropneumonia has be en 
carried out for a period of at least 12 months immediately prior to collection(1)/ production(1)
of the oocytes(1)/ embryos(1), and until their date of dispatch ,and no vaccinated animals 
entered into the third country, territory or zone thereof during that period.
(1)[II.2. The in vivo derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embryo collection team(3)which
II.3.1. is approved and listed by the competent authority of the third country or territ ory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
(1)[II.2. The oocytes(1)/ in vitro produced embryos(1)described in Part I have been collected or produced, 
processed and stored, and dispatched by the embryo production team(3)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]
II.3. The oocytes(1)/ embryos(1)described in Part I were obtained from the donor animals which originate from 
establishments 
II.3.1. free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis ), and they have never been kept previously in any establishment of a lower 
health status;
II.3.2. free from infection with Brucella abortus, B. melitensis and B. suis and they have never been 
kept previously in any establishment of a lower health status;
(1)either [II.3.3. free from enzootic bovine leukos is and they have never been kept previously in any 
establishment of a lower health status;]
(1)or[II.3.3. not free from enzootic bovine leukosis and the official veterinarian responsible for the 
establishment of origin has certified that there has been no clinical case of enzootic bovine 
leukosis during a period of at least the preceding 3 years;]
L 113 /748  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- OOCYTES -EMB- A-ENTRY
(1)either [II.3.4. free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have 
never been kept previously in any establishment of a lower health status;]
(1)or[II.3.4. not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and the 
official veterinarian responsible for the establishment of origin has certified that there has 
been no clinic al case of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis 
during a period of at least the preceding 12 months;]
II.3.5. in which surra (Trypanosoma evansi) has not been reported during the last 30 day period prior 
to collection(1)/ production(1)of the oocytes(1)/ embryos(1), and
(1)either [surra has not been reported in the establishments during the last 2 years prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)or [surra has been reported in the establishments d uring the last 2 years prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1)and following the last 
outbreak the establishments have remained under movement restrictions until
−the infected animals have been removed from the establishment, and
−the remaining animals on the establishment have been subjected to a test for 
surra (Trypanosoma evansi ) with one of the diagnostic methods provided for 
in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, 
carried out, with negative resul ts, on samples taken at least 6 months after the 
infected animals have been removed from the establishment;]
II.4. The oocytes(1)/ embryos(1)described in Part I were obtained from the donor animals which
II.4.1. were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever 
virus, contagious bovine pleuropneumonia and lumpy skin disease;
II.4.2. remained for a period of at least 6 months prior to the date of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1)in a thir d country or territory or zone thereof referred to in Box I.7.;
II.4.3. for a period of at least 30 days prior to the date of collection(1)/ production(1)of the oocytes(1)/ 
embryos(1)and during the collection period 
II.4.3.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, contagious bovine pleuropneumonia or
lumpy skin disease ,or of an emerging disease relevant for bovine animals;
II.4.3.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis andB. suis, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax, surra (Trypanosoma 
evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic 
haemorrhagic disease virus and infection with bluetongue virus (serotypes 1- 24) 
have not bee n reported;
II.4.3.3. were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.3.1. or from 
establishments which do not meet the conditions referred to in point II.4.3.2. ;
II.4.3.4. were not used for natural breeding;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /749
COUNTRY Certificate model BOV- OOCYTES -EMB- A-ENTRY
II.4.4. were examined by the team veterinarian or a team member and did not show symptoms or 
clinical signs of transmissible animal diseases on the day of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1); 
II.4.5. are individually identified as provided for in Article 21(1) of Commission Delegated 
Regulation (EU) 2020/692;
II.4.6. comply with the following conditions as regards foot -and-mouth disease 
II.4.6.1. they come from establishments 
−situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the establishment for a period of at least 30 
days immediately prior to the date of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1);
−in which fo ot-and-mouth disease has not been reported during a period of at 
least 3 months immediately prior to the date of collection(1)/ production(1)of 
the oocytes(1)/ embryos(1);
(1)either [II.4.6.2. they were not vaccinated against foot -and-mouth disease;]
(1)(4)or[II.4.6.2. they were vaccinated against foot- and-mouth disease during the period of 12 
months prior to the date of collection of the embryos and
II.4.6.2.1. have not been vaccinated against foot -and-mouth disease within the 
period of at least 30 days immediately prior to the date of collection 
of the embryos;
II.4.6.2.2. the semen used for fertilisation was collected from a male donor that 
complies with the conditions set out in point 1(b) of Chapter I of Part 
5 of Annex II to Delegated Regulation (EU ) 2020/686 or the semen 
complies with the conditions set out in point 2 of Chapter I of Part 5 
of Annex II to Delegated Regulation (EU) 2020/686;
II.4.6.2.3. prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance wi th the recommendations of the 
IETS Manual(5);
II.4.6.2.4. the embryos were stored deep frozen for a period of at least 30 days 
from the date of collection, and during this period the donor animal 
has not shown clinical signs of foot- and-mouth disease;]
(1)(6)[II.4.7. comply with at least one of the following conditions as regards infection with bluetongue 
virus (serotypes 1 -24):
(1)either [II.4.7.1. they have been kept for a period of at least 60 days prior to and during collection of 
the oocytes in a third country, territory or zone thereof free from infection with 
bluetongue virus (serotypes 1 -24)where no case of infection with bluetongue virus 
(serotypes 1 -24) has been confirmed during the last 24 months in the targeted animal 
population;]
(1)and/or [II.4.7.2. they have been kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection of the 
oocytes, in a third country, territory or zone thereof with an approved eradicat ion 
programme against infection with bluetongue virus (serotype s1-24);]
L 113 /750  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- OOCYTES -EMB- A-ENTRY
(1)and/or [II.4.7.3. they have been kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection of the 
oocytes, in a third country, territory or zone thereof where the competent authority 
of the place of origin of the consignment of oocytes(1)/ in vitro produced embryos(1)
has obtained the prior written consent of the competent authority o f the Member 
State of destination to the conditions for establishment of that seasonally disease -
free zone and to accept the consignment of oocytes(1)/ in vitro produced embryos(1);]
(1)and/or [II.4.7.4. they have been kept in a vector -protected establishm ent for a period of at least 60 
days prior to and during collection of the oocytes;]
(1)and/or [II.4.7.5. they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1- 24, with negative results, between 28 and 60 days from the date of 
each collection of the oocytes;]
(1)and/or [II.4.7.6. they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood sample taken on the day of 
collection of the oocytes;]]
(1)(6)[II.4.8. comply with at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7):
(1)either [II.4.8.1. they have been kept for a period of at least 60 days prior to and during collection of 
the oocytes in a third country, territory or zone thereof where EHDV 1 -7 has not 
been reported for a period of at least the preceding 2 years within a radius of 150 km 
of the establishment;]
(1)and/or [II.4.8.2. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the oocytes;]
(1)and/or [II.4.8.3. were resident in the exporting country in which according to official findings the following serotypes of EHDV exist: …………………………
and have been 
subjected with negative results in each case to the following tests carried out in an 
official laboratory:
(1)either [II.4.8.3.1. a serological test to detect antibodies to EHDV 1 -7, with negative 
results, on blood sample taken between 28 and 60 days from the date of 
the collection of the oocytes;]]
(1)and/or [II.4.8.3.2. an agent identification test for EHDV 1 -7, with negative results, on 
blood sample taken on the dayof collection of the oocytes.]]]
(1)(6)[II.4.9. comply with animal health requirements laid down in Chapter III of Part 1 of Annex II to 
Delegated Regulation (EU) 2020/686;]
II.5. The oocytes(1)/ embryos(1)described in Part I
II.5.1. has been collected, processed and stored in accordance with animal health requirements set 
out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to Delegated Regulation (EU) 
2020/686;
II.5.2. areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that 
mark is indicated in Box I.27;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /751
COUNTRY Certificate model BOV- OOCYTES -EMB- A-ENTRY
II.5.3. are transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch by the embryo collection or 
production team under responsibility of the team veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use 
container; 
(1)(7)[II.5.3.3. has been filled in with the cryo genic agent which not have been previously used 
for other products;]
(1)(8)[II.5.4. are placed in straws or other packages which are securely and hermetically sealed;
II.5.5. are transported in a container where they are separated from each other by physical compartments or by being placed in secondary protective bags.]
(1)(9)[II.6. The in vivo derived embryos(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)described in 
Part I were conceived by artificial insemination using semen coming from a semen collection centre, 
germinal product processing establishment or germinal product storage centre approved for the collection, 
processing and/or storage of semen by the competent authority of a third country, territory or zone thereof 
listed in Annex IX to Implementing Regulation (EU) 2021/404 for semen of bovine animals or by the 
competent authority of a Member State.]
(1)(10)[II.7. The following antibiotic or mixt ure of antibiotics(11)has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]
Notes
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I. 11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. Only embryo collection or production teams listed in accordance with 
Article 233(3) of Regulatio n (EU) 2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm .
Box reference I.12: “Place of destination”: Indicate th e address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
L 113 /752  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- OOCYTES -EMB- A-ENTRY
Box reference I.27: “Species” : Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as 
appropriate.
“Type”: Specify if oocytes, in vivo derived embryos, in vitro produced embryos or 
micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which oocytes or embryos of the 
consignment was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Imp lementing Regulation (EU) 2021/404.
(3)Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm .
(4)Option available only for the consignment of in vivo derived embryos.
(5)Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society ,1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA ( http://www.iets.org/ ).
(6)Applic able for the consignment of oocytes and in vitro produced embryos.
(7)Applicable for frozen oocytes or embryos.
(8)Applicable for the consignment where in one container oocytes, in vivo derived embryos, in vitro produced 
embryos and micromanipulated embryos of bovine animals are placed and transported.
(9)Does not apply to oocytes.
(10)Mandatory attestation in case antibiotics were added.
(11)Insert the name(s) of the antibiotic(s) added and its(their) concent ration.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /753
CHAPTER 43
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF IN VIVO DERIVED EMBRYOS OF BOVINE 
ANIMALS COLLECTED, P ROCESSED AND STORED BEFORE 21 APRIL 2021 IN 
ACCORDANCE WITH COUNCIL DIRECTIVE 89/556 /EEC, DISPATCHED AFTER 
20 APRIL 2021 BY THE EMBRYO COLLECTION TE AM BY WHICH THE 
EMBRYOS WERE COLLECTED (MODEL ‘BOV- in-vivo-EMB-B-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /754  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /755
COUNTRY Certificate model BOV- in-vivo- EMB- B-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian of the ……….…………..........……………….… certify that:
(exporting country)(1)
II.1. The embryos to be exported:
II.1.1. were collected in the exporting country, which according to official findings:
II.1.1.1. was free from rinderpest during the 12 month period immediately prior to their collection;
(2)either [II.1.1.2. was free from foot -and-mouth disease and lumpy skin disease during the 12 month period 
immediately prior to their collection and did not carry out vaccination against foot -and-mouth 
disease or lum py skin disease during that period.]
(2)or [II.1.1.2. was not free from foot -and-mouth disease or lumpy skin disease during the 12 months 
immediately prior to their collection or carried out vaccination against foot -and-mouth disease 
or lumpy skin disease during that period, and:
− the embryos were not subjected to penetration of the zona pellucida,
− the embryos were stored under approved conditions for at least 30 days immediately after 
their collection,
− the donor females come from holdings on which no animal was vaccinated against foot -and-
mouth disease or lumpy skin disease during the 30 days prior to collection and no animal of 
a susceptible species showed clinical signs of foot- and-mouth disease or lumpy skin disease 
during the 30 days prior to, and at lea st the 30 days after, the embryos were collected.]
II.1.2. were collected by the embryo collection team(3)which :
− had been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC;
− which carried out the collection, processing, storing and transport of the embryos in accordance with 
Chapter II of Annex A to Directive 89/556/EEC;
− was subject to inspection by an official veterinarian at least twice a year.
II.1.3. were collected and processed on premises situated in an area of at least 10 km r adius centred on them, on 
which according to official findings there was no occurrence of foot -and-mouth disease, epizootic 
haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or 
lumpy skin disease in the 30 day s immediately prior to their collection and until dispatch to the Union, in 
the case of fresh embryos, or during the 30 days after collection, in the case of embryos subject to a mandatory storage for at least 30 days in accordance with point II.1.1.2.
II.1.4. from the time of collection until 30 days thereafter or, in the case of fresh embryos until the day of their 
dispatch to the Union, they were stored on premises situated in an area of at least 10 km radius centred on 
them, on which according to offici al findings there was no occurrence of foot -and-
mouth disease, 
vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease.
II.1.5. were collected from the donor females, which:
II.1.5.1. were located, during the 30 day s immediately prior to collection, on premises situated in an area 
of at least 10 km radius centred on them, on which, according to official findings, there was no 
occurrence of foot -and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular 
stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease;
II.1.5.2. showed no clinical signs of disease on the day of collection;
II.1.5.3. spent the six months immediately prior to collection within the territory of the exporting country 
in no more than two herds:
− which, according to official findings, were free from tuberculosis during that time,
− which, according to official findings, were free from brucellosis during that time,
− which were free from enzootic bovine leuko sis or in which no bovine animal showed 
clinical signs of enzootic bovine leukosis during the previous three years,
− in which no bovine animal showed clinical signs of infectious bovine 
rhinotracheitis/infectious pustular vulvo -vaginitis during the previous 12 months.
L 113 /756  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- in-vivo- EMB- B-ENTRY
II.1.6. The embryos to be exported were conceived by artificial insemination using semen coming from semen 
collection or storage centres approved for the collection, processing and/or storage of semen by the 
competent authority of a third country or part thereof listed in Annex I to Implementing Decision 
2011/630/EU(4)or by the competent authority of a Member State.
Notes
This certificate is intended for entry into the Union of embryos of bovine animals, including when the Union is not 
the final destination of the embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box I.6: “Operator responsible for the consignme nt”: this box is to be filled in only if it is a certificate for 
transit commodity.
Box I.11: “Place of dispatch” shall correspond to the embryo collection team from which the embryos are 
dispatched to the Union and which is listed in accordance with Artic le 8(2) of Directive 89/556/EEC 
on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box I.19: Identification of container and seal number shall be indicated.
Box I.21: Fill in according to whether it is a transit or an import certificate.
Box I.22: Fill in according to whether it is a transit or an import certificate.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Species” : Select amongst “Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate.
“Type” : Select " in vivo derived embryos".
Identification number shall correspond to the official identification of the animal.
“Date of collection/production” shall be indicated in the following format: dd.mm.yyyy
“App roval or registration number of plant/establishment/centre” shall correspond to the embryo 
collection team by which the embryos were collected, processed and stored; and listed in accordance 
with Article 8(2) of Directive 89/556/EEC on the Commission websi te:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /757
COUNTRYCertificate model BOV -in-vivo-EMB -B-ENTRY
Part II:
(1)Only third country, territory or zone thereof listed in Annex IX to Commission Implementing 
Regulation (EU) 2021/404 for embryos of bovine animals.
(2)Delete as appropriate.
(3)Only embryo collection teams listed in accordance with Article 8(2) of Directive 89/556/EEC on 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
(4)OJ L 247, 24.9.2011, p. 32.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /758  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 44
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF IN VITRO PRODUCED EMBRYOS OF BOVINE 
ANIMALS PRODUCED, PROCESSED AND STORED BEFORE 21 APRIL 2021 IN 
ACCORDANCE WITH COUNCIL DIRECTIVE 89/556 /EEC, CONCEIVED USING
SEMEN COMPLYING WITH REQUIRE MENTS OF COUNCIL DIRECTIVE 
88/407/EEC, DISPATCH EDAFTER 20 APRIL 2021 BY THE EMBRYO 
PRODUCTION TEAM BY W HICH THE EMBRYOS WERE PRODUCED (MODEL 
‘BOV -in-vitro -EMB- C-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISOcountry code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /759
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /760  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- in-vitro -EMB- C-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian of ……….…………..........……………….… certify that:
(exporting country)(1)
II.1. The embryos to be exported:
II.1.1. were produced in the exporting country, which according to official findings:
II.1.1.1. was free from rinderpest during the 12 month period immediately prior to their production;
(2)either [II.1.1.2. was free from foot -and-mouth disease and lumpy skin disease during the 12 month period 
immediately prior to their production and did not carry out vaccination against foot -and-mouth 
disease or lumpy skin disease during that period.]
(2)or [II.1.1.2. was not free from foot -and-mouth disease or lumpy skin disease during the 12 month period 
immediately prior to their production or carried out vaccination against foot -and-mouth disease 
or lumpy skin disease during that period, and
−the embryos were produced without penetration of the zona pellucida,
−the embryos were stored under approved conditions for at least 30 days immediately af ter 
their production,
−the donor females come from holdings on which no animal was vaccinated against foot -and-
mouth disease or lumpy skin disease during the 30 days prior to collection and no animal of 
a susceptible species showed clinical signs of foot- and-mouth disease or lumpy skin disease 
during the 30 days prior to, and at least the 30 days after, the oocytes were collected.]
II.1.2. were produced by the embryo production team(3)which:
−had been approved in accordance with Chapter I of Annex A to Direc tive 89/556/EEC,
−carried out the production, processing, storing and transport in accordance with Chapter II of Annex A to Directive 89/556/EEC,
−was subject to inspection by an official veterinarian at least twice a year.
II.2. The oocytes used in the production of the embryos to be exported were collected on premises situated in 
an area of at least 10 km radius centred on them, on which according to official findings there was no occurrence of foot -and-mouth disease, epizootic haemorrhagic disease, ves icular stomatitis, Rift Valley 
fever, contagious bovine pleuropneumonia or lumpy skin disease in the 30 days immediately prior to their 
collection and until their dispatch to the Union, in the case of fresh embryos, or during the 30 days after 
collection, in the case of embryos subject to a mandatory storage for at least 30 days in accordance with 
point II.1.1.2.
II.3. From the time of collection of the oocytes until 30 days thereafter or, in the case of fresh embryos, until the day of dispatch, the embryos to be exported were stored on premises situated in an area of at least 10 
km radius centred on them, on which according to official findings there was no occurrence of foot- and-
mouth disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleu ropneumonia or lumpy skin 
disease.
II.4. The donors of oocytes used in the production of the embryos to be exported:
II.4.1. were located, during the 30 days immediately prior to collection of the oocytes, on premises 
situated in an area of at least 10 -km radius on which, according to official findings, there was 
no occurrence of foot- and-
mouth disease, bluetongue, epizootic haemorrhagic disease, 
vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin 
disease;
II.4.2. showed no clinical signs of disease on the day of collection;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /761
COUNTRY Certificate model BOV- in-vitro -EMB- C-ENTRY
II.4.3. spent the six months immediately prior to collection within the territory of the exporting 
country in no more than two herds:
−which, according to official findings, were free from tuberculosis during that time,
−which, according to official findings, were free from brucellosis during that time,
−which were free from enzootic bovine leukosis or in which no bovine animal showed 
clinical signs of enzootic bovine leukosis during the previ ous three years,
−in which no bovine animal showed clinical signs of infectious bovine 
rhinotracheitis/infectious pustular vulvo -vaginitis during the previous 12 months;
(2)either [II.4.4. were kept in a bluetongue virus -free country or zone for at least 60 days prior to, and during, 
collection of the oocytes.]
(2)or [II.4.4. were kept during a seasonally free period or protected from the vector for at least 60 days prior 
to, and during, the collection of the oocytes, and the embryos were produced without 
penetration of the zona pellucida, except if the donors underwent a serological test to detect 
antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection 
and giving negative results and the embryos were stored for at least 30 days.]
(2)or [II.4.4. underwent a serological test to detect antibodies to the bluetongue virus group, carried out in 
accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 
between 21 and 60 days after collection and giving negative results, and the embryos were 
stored for at least 30 days.]
(2)or [II.4.4. underwent an agent identification test, carried out in accordance with the OI E Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of 
collection or the day of slaughtering and giving negative results – the embryos having been 
produced, in the latter case, without penetration of the zona pellucida .]
II.5. The embryos to be exported were conceived by in vitro fertilisation using semen coming from semen 
collection or storage centres(4):
(2)either [II.5.1. approved in accordance with Article 5(1) of Directive 88/407/EEC and located in a Member 
State of the European Union, and the semen complies with the requirements of Directive 
88/407/EEC.]
(2)or [II.5.1. approved in accordance with Article 9(1) of Directive 88/407/EEC and located in a third 
country or part thereof listed in Annex I to I mplementing Decision 2011/630/EU, and the 
semen complies with the requirements set out in Section A of Part 1 of Annex II to that 
Decision.]
Notes
This certificate is intended for entry into the Union of embryos of bovine animals, including when the Union is not 
the final destination of the embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed accordin g to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
L 113 /762  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- in-vitro -EMB- C-ENTRY
Part I:
Box I.6: “Operator responsible for the consignment : this box is to be filled in only if it is a certificate for 
transit commodity.
Box I.11: “Place of dispatch” shall correspond to the embryo production team from which the embryos are 
dispatch to the Union and listed in accordance with Article 8(2) of Directive 89/556/EEC on the 
Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box I.19: Identification of container and seal number shall be indicated.
Box I.21: Fill in according to whether it is a transit or an import certificate.
Box I.22: Fill in according to w hether it is a transit or an import certificate.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Species” : Select amongst “Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate.
“Type” : Select " in vitro produced embryos".
“Identification number”:
“Dam identity” shall correspond to the official identification of the animal.
“Sire identity” shall correspond to the official identification of the animal.
“Approval or registration number of plant/establishment/centre” shall correspond to the embryo 
production team by which the embryos were produced, processed and stored; and listed in accordance 
with Article 8(2) of Directive 89/556/EEC on the Commission website: 
http://ec.europa.eu/food/anim al/semen_ova/bovine/ova_embryos_en.htm
Part II:
(1)Only third country, territory or zone thereof listed in Annex IX to Commission Implementing Regulation 
(EU) 2021/404 for embryos of bovine animals.
(2)Delete as appropriate.
(3)Only embryo production t eams listed in accordance with Article 8(2) of Directive 89/556/EEC on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
(4)Only semen collection centres approved by the competent authority of a third country, territory or zone 
thereof listed in Annex IX to Implementing Regulation (EU) 2021/404 for semen of bovine animals or by the 
competent authority of a Member State.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /763
CHAPTER 45
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF IN VITRO PRODUCED EMBRYOS OF BOVINE 
ANIMALS PRODUCED, PROCESSED AND STORED BEFORE 21 APRIL 2021 IN 
ACCORDANCE WITH COUNCIL DIRECTIVE 89/556 /EEC, CONCEIVED USING
SEMEN COMING FROM SEMEN COLLECTION OR STORAGE CENTRES 
APPROVED BY THE COMP ETENT AUTHORITY OF THE EXPORTING 
COUNTRY, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO 
PRODUCTION TEAM BY W HICH THE EMBRYOS WERE PRODUCED (MODEL 
‘BOV -in-vitro -EMB- D-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /764  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /765
COUNTRY Certificate model BOV- in-vitro -EMB- D-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian of ……….…………..........……………….… certify that:
(exporting country)(1)
II.1. The embryos to be exported
II.1.1. were produced in the exporting country, which according to official findings:
II.1.1.1 was free from rinderpest during the 12 month period immediately prior to their production;
(2)either [II.1.1.2. was free from foot -and-mouth disease and lumpy skin disease du ring the 12 month period 
immediately prior to their production and did not carry out vaccination against foot- and-mouth 
disease or lumpy skin disease during that period.]
(2)or [II.1.1.2. was not free from foot -and-mouth disease or lumpy skin disease during the 12 month period 
immediately prior to their production or carried out vaccination against foot -and-mouth disease 
or lumpy skin disease during that period, and
−the embryos were produced without penetration of the zona pellucida,
−the embryos were stored under approved conditions for at least 30 days immediately after 
their production,
−the donor females come from holdings on which no animal was vaccinated against foot -and-
mouth disease or lumpy skin disease during the 30 days prior to collection and no animal of 
a susceptible species showed clinical signs of foot- and-mouth disease or lumpy skin disease 
during the 30 days prior to, and at least the 30 days after, the oocytes were collected.]
II.1.2. were produced by the embryo production team(3)which:
−had been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC;
−carried out the production, processing, storing and transport of the embryos in accordance 
with Chapter II of Annex A to Directive 89/556/EEC;
−was subject to inspection by an of ficial veterinarian at least twice a year.
II.2. The oocytes used in the production of the embryos to be exported were collected on premises situated in 
an area of at least 10 km radius centred on them, on which according to official findings there was no 
occurrence of foot -and-mouth disease, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley 
fever, contagious bovine pleuropneumonia or lumpy skin disease in the 30 days immediately prior to their 
collection and until their dispatch to the Unio n, in case of fresh embryos, or during the 30 days after 
collection, in case of embryos subject to a mandatory storage for at least 30 days in accordance with point 
II.2.2.
II.3. From the time of collection of the oocytes until 30 days thereafter or, in th e case of fresh embryos, until 
the day of dispatch, the embryos to be exported were stored on premises situated in an area of at least 10 
km radius centred on them, on which according to official findings there was no occurrence of foot- and-
mouth disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin 
disease.
II.4. The donors of oocytes used in the production of the embryos to be exported:
II.4.1. were located, during the 30 days immediately prior to collection of the oocytes, on premises 
within a 10 -km radius of which, according to official findings, there was no occurrence of foot -
and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift 
Valley fever, contagious bovine pleuropneumonia or lumpy skin disease;
II.4.2. showed no clinical signs of disease on the day of collection;
L 113 /766  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- in-vitro -EMB- D-ENTRY
II.4.3. spent the six months immediately prior to collection within the territory of the exporting 
country in no more than two herds:
−which, according to official findings, were free from tuberculosis during that time,
−which, according to official findings, were free from brucellosis during that time,
−which were free from enzootic bovine leukosis or in which no animal showed clinical signs 
of enzootic bovine leukosis during the previous three years,
−in which no bovine animal showed clinical signs of infectious bovine 
rhinotracheitis/infectious pustular vulvo -vaginitis during the previous 12 months.
(2)either [II.4.4. were kept in a bluetongue virus -free coun try or zone for at least 60 days prior to, and during, 
collection of the oocytes.]
(2)or [II.4.4. were kept during a seasonally free period or protected from the vector for at least 60 days prior 
to, and during, the collection of the oocytes, and the embry os were produced without 
penetration of the zona pellucida, except if the donors underwent a serological test to detect 
antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection 
and giving negative results and the embryos were stored for at least 30 days.]
(2)or [II.4.4. underwent a serological test to detect antibodies to the bluetongue virus group, carried out in 
accordance with t he OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 
between 21 and 60 days after collection and giving negative results, and the embryos were 
stored for at least 30 days.]
(2)or [II.4.4. underwent an agent identification test, carried ou t in accordance with the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of 
collection or the day of slaughtering and giving negative results – the embryos having been 
produced, in the latter case, wit hout penetration of the zona pellucida.]
II.5. The embryos to be exported were conceived by in vitro fertilisation using semen coming from semen 
collection or storage centres approved for the collection, processing and/or storage of semen by the 
competent authority of a third country or a part thereof listed in Annex I to Implementing Decision 
2011/630/EU(4)or by the competent authority of a Member State.
Notes
This certificate is intended for entry into the Union of embryos of bovine animals, including when the Union is not 
the final destination of the embryos.
In accordance with Article 3(a) of Directive 89/556/EEC, the in vitro produced bovine embryos using semen from 
semen centres approved by the exporting country, imported subject to the conditions laid down in this certificate 
are excluded from intra- Union trade.
In accordance with the Agreement on the withdrawal of the Unite d Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implemen ting Regulation (EU) 2020/2235.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /767
COUNTRY Certificate model BOV- in-vitro -EMB- D-ENTRY
Part I:
Box I.6: “Operator responsible for the consignment” : This box is to be filled in only if it is a certificate for 
transit commodity.
Box I.11: “Place of dispatch” shall correspond to the embryo production team from which the embryos are 
dispatch to the Union and listed in accordance with Article 8(2) of Directive 89/556/EEC on the 
Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box I.19: Identification of container and seal number shall be indicated.
Box I.21: Fill in according to whether it is a transit or an import certificate.
Box I.22: Fill in according to w hether it is a transit or an import certificate.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Species” : Select amongst “Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate.
“Type” : Select " in vitro produced embryos".
“Identification number”:
“Dam identity ”shall correspond to the official identification of the animal.
“Sire identity” shall correspond to the official identification of the animal.
“Approval or registration number of plant/establishm ent/centre” shall correspond to the embryo 
production team by which the embryos were produced, processed and stored; and listed in accordance 
with Article 8(2) of Directive 89/556/EEC on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/bov ine/ova_embryos_en.htm.
Part II:
(1)Only third country, territory or zone thereof listed in Annex IX to Commission Implementing Regulation 
(EU) 2021/404 for embryos of bovine animals.
(2)Delete as appropriate.
(3)Only embryo production teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
(4)Only third country, territory or zone thereof listed in Annex IX to Implementing Regulation (EU) 2021/404
for semen of bovine animals.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /768  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 46
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIG NMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PRO CESSING 
ESTABLISHMENT:
-semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of s emen of bovine animals collected, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021;
-stocks of semen of bovine animals collected, processed and stored before 1 January 2005 in accordance 
with Council Directive 88/407/EEC, as amended by Council Directive 93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of in vivo derived embryos of bovine animals collected, processed and stored in accordance with 
Directive 89/556/EEC before 21 April 2021;
-stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance 
with Directive 89/556/EEC before 21 April 2021, conceived using semen complying with requirements 
of Council Directive 88/407/EEC;
-stocks of in vitro produced embryos of bovine animals produced, processed and st ored in accordance 
with Directive 89/556/EEC before 21 April 2021, conceived using semen coming from semen 
collection or storage centres approved by the competent authority of the exporting country
(MODEL ‘BOV- GP-PROCESSING -ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /769
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21 □For transit I.22□For internal market
Third country ISO country code I.23
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /770  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- GP-PROCESSING -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)to be exported to 
the European Union was/were processed and stored:
II.1.1. is located a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of bovine animals 
and listed in Annex IX toCommission Implementing Regulation (EU) 2021/404;
(2)either [II.1.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.2. where foot -and-mouth disease was not reported for a period starting on the date(3)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
II.1.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia and lumpy skin disease were not reported for a period of at least 12 months immediately prior to col lection
(2)/ production(2)of the semen(2)/ 
oocytes(2)/ embryos(2)and until its/their date of dispatch ;
II.1.1.4. where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus and contagious bo vine pleuropneumonia has been 
carried out for a period of at least 12 months immediately prior to collection(2)/ 
production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch, 
and no vaccinated animals entered into the third country, territory or zone thereof 
during that period;
II.1.2. is approved and listed by the competent authority of the third country or territory;
II.1.3. complies with requirements as regards responsibil ities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4),and/or processed and stored in a 
germinal product processing establishment(2)(4),and/or s tored in a germinal product storage 
centre(2)(4)complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of 
Annex I to Delegated Regulation (EU) 2020/686, and
(2)either [located in the exporting country;]
(2)and/or [located in ………………………….(5), and has /have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of bovine 
animals in accordance with Regulation (EU) 2016/429 and Commission Delegat ed 
Regulation(EU) 2020/692;]
II.2.2. was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at least as strict as described in:
(2)either [Model BOV -SEM -A-ENTRY(4);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /771
COUNTRY Certificate model BOV- GP-PROCESSING -ENTRY
(2)and/or [Model BOV -SEM -B-ENTRY(4);]
(2)and/or [Model BOV -SEM -C-ENTRY(4);]
(2)and/or [Model BOV -OOCYTES -EMB -A-ENTRY(4);]
(2)and/or [Model BOV -in-vivo-EMB -B-ENTRY(4);]
(2)and/or [Model BOV -in-vitro -EMB -C-ENTRY(4);]
(2)and/or [Model BOV -in-vitro -EMB -D-ENTRY(4);]
(2)and/or [Model BOV -GP-PROCESSI NG-ENTRY(4);]
(2)and/or [Model BOV -GP-STORAGE -ENTRY (4);]]
II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed an d numbered prior to the dispatch from the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.5.2. has been cleaned and eith er disinfected or sterilised before use, or is single -use 
container; 
(2)(7)[II.2.5.3. has been filled in with the cryogenic agent which not have been previously used for 
other products.]
(2)(8)[II.2.6. is/are placed in straws or other packages which are s ecurely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This certificate is intended for entry into the Union of semen, oocytes and embryos of bovine animals, including 
when the Union is not the final destination of the semen, oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the E uropean Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom i n respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes and/or embryos. Only germinal product processing establishments 
listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm .
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.
L 113 /772  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- GP-PROCESSING -ENTRY
Box reference I.17: “Accompanying documents” : Number(s) of re lated original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the ge rminal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) or those certificate(s) or the officially endorsed copies thereof mus t be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : Select amongst “ Bos taurus ”, “Bison bison " or "Bubalus bubalis
” as 
appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commissio n website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm .
(2)Delete if not applicable.
(3)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(4)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm .
(5)Only a third country, territory or zone thereof listed i n Annex IX to Implementing Regulation (EU) 2021/404
and the EU Member States.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /773
COUNTRY Certificate model BOV-GP-PROCESSING -ENTRY
(6)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of 
thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection 
centre where the semen was collected, and/or the embryo collection or production team by which the 
oocytes and/or embryos were collected or produced, and/or the germina l product processing 
establishment where the semen, oocytes or embryos were processed and stored, and/or the germinal 
product storage centre where the semen, oocytes or embryos were stored to the germinal product 
processing establishment of the semen, oocy tes and/or embryos dispatch described in Box I.11 must be 
attached to this certificate.
(7)Applicable for frozen semen, oocytes or embryos.
(8)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in
vitro produce d embryos and micromanipulated embryos of bovine animals are placed and transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /774  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 47
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIG NMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STO RAGE CENTRE:
-semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 88/407/EEC, as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021;
-stocks of semen of bovine animals collected, processed and stored before 1 January 2005 in accordance 
with Council Directive 88/407/EEC, as amended by Council Directive 93/60/EEC ;
-oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of in vivo derived embryos of bovine animals collected, processed and stored in accordance with 
Directive 89/556/EEC before 21 Apri l 2021;
-stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance 
with Directive 89/556/EEC before 21 April 2021, conceived using semen complying with requirements 
of Council Directive 88/407/EEC;
-stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance 
with Directive 89/556/EEC before 21 April 2021, conceived using semen coming from semen collection or storage centres approved by the competent authority of the exporting country
(MODEL ‘BOV- GP-STORAGE- ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /775
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21 □For transit I.22□For internal market
Third country ISO country code I.23
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /776  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- GP-STORAGE -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo
derived embryos(2)/ in vitro produced embryos(2/micromanipulated embryos(2)to be exported to the 
European Union was/were stored:II.1.1. is located a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen
(2)/ oocytes(2)/ embryos(2)of bovine animals 
and listed in Annex IX toCommission Implementing Regulation (EU) 2021/404;
(2)either [II.1.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.2. where foot -and-mouth disease was not reported for a period starting on the date(3)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryo s(2)and until its/their date of dispatch ;]
II.1.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia and lumpy skin disease were not reported for a period of at least 12 months immediately p rior to collection
(2)/ production(2)of the semen(2)/ 
oocytes(2)/ embryos(2)and until its/their date of dispatch ;
II.1.1.4. where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus and co ntagious bovine pleuropneumonia has been 
carried out for a period of at least 12 months immediately prior to collection(2)/ 
production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch, 
and no vaccinated animals entered into t he third country, territory or zone thereof 
during that period;
II.1.2. is approved and listed by the competent authority of the third country or territory;
II.1.3. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4),and/or processed and stored in a 
germinal product processing establishment(2)(4),and/or stored in a germinal product storage 
centre(2)(4)complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of 
Annex I to Delegated Regulation (EU) 2020/686, and
(2)either [loca ted in the exporting country;]
(2)and/or [located in ………………………….(5), and has /have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ in vivo derived 
embryos(2)/ in vitro produced embryos(2)of bovine animals in accordance with Regulation (EU) 
2016/429 and Commission Delegated Regulation (EU) 2020/692;]
II.2.2. was/were moved to the germinal product storage centre described in Box I.11. under conditions at 
least as strict as described in:
(2)either [Model BOV -SEM -A-ENTRY(4);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /777
COUNTRY Certificate model BOV- GP-STORAGE -ENTRY
(2)and/or [Model BOV -SEM -B-ENTRY(4);]
(2)and/or [Model BOV -SEM -C-ENTRY(4);]
(2)and/or [Model 1 in Section A of Part 1of Annex II to Decision 2011/630/EU(4);]
(2)and/or [Model 2 in Section B of Part 1of Annex II to Decision 2011/630/EU(4);]
(2)and/or [Model 3 in Section C of Part 1of Annex II to Decision 2011/630/EU(4);]
(2)and/or [Model BOV -OOCYTES -EMB -A-ENTRY(4);]
(2)and/or [Model BOV -in-vivo-EMB -B-ENTRY(4);]
(2)and/or[Model BOV -in-vitro -EMB -C-ENTRY(4);]
(2)and/or [Model BOV -in-vitro -EMB -D-ENTRY(4);]
(2)and/or [Model BOV -GP-PROCESSING -ENTRY(4);]
(2)and/or [Model BOV -GP-STORAGE -ENTRY(4);]]
II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;
II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(7)[II.2.5.3. has been filled in with the cryogenic agent which not have been previously used for 
other products.]
(2)(8)[II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by bei ng placed in secondary protective bags.]
Notes
This certificate is intended for entry into the Union of semen of bovine animals, including when the Union is not 
the final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germinal product storage centre listed in accordance with 
Article 233(3) of Regulation (EU) 2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm .
L 113 /778  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model BOV- GP-STORAGE -ENTRY
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
corre spond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection a nd/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the s emen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I. 19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : Select amongst “ Bos taurus ”, “Bison bison " or "Bubalus bubalis ” as 
appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm .
(2)Delete if not applicable.
(3)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(4)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm .
(5)Only a third country, territory or zone thereof listed i n Annex IX to Implementing Regulation (EU) 2021/404
and the EU Member States.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /779
COUNTRY Certificate model BOV-GP-STORAGE-ENTRY
(6)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of 
thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection 
centre where the semen was collected, and/or the embryo collection or production team by which the 
oocytes and/or embryos were collected or produced, and/or the germina l product processing 
establishment where the semen, oocytes or embryos were processed and stored, and/or the germinal 
product storage centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre of the semen, oocytes and/or embryos dispatch described in Box I.11 must be attached 
to this certificate.
(7)Applicable for frozen semen, oocytes or embryos.
(8)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in 
vitro produced embryos and micromanipulated embryos of bovine animals are placed and transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /780  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 48
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF SEMEN OF OVINE AND CAPRINE ANIMALS 
COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED REGULATION (EU) 2020/ 692
AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED (MODEL ‘OV/CAP -SEM -A-
ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISOcountry code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /781
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /782  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -SEM -A-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals 
which originate from a third country, territory or zone thereof
II.1.1. authorised for e ntry into the Union of semen of ovine(1)/caprine(1)animals and listed in Annex 
X toCommission Implementing Regulation (EU) 2021/404;
(1)either [II.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection of the semen and until its date of dispatch ;]
(1)or[II.1.2. where foot -and-mouth disease was not reported for a period starting on the date(2)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the semen and until its date of 
dispatch ;]
II.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia were not reported for a period of at least 12 months immediately prior to 
collection of the semen and until its date of dispatch ;
II.1.4. where no vaccination against foot -and-mouth disease, infection wit h rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep 
pox and goat pox and contagious caprine pleuropneumonia has been carried out for a period 
of at least 12 months immediately prior to collection of the semen and until its date of 
dispatch , and no vaccinated animals entered into the third country, territory or zone thereof 
during that period.
II.2. The semen described in Part I was obtained from donor animals which originate, before the 
commencement of the quarantine referred to in point II.4.6., from establishments 
II.2.1. situated in an area where foot -and-mouth disease has not been reported within a 10- km radius 
centred on the establishment for a period of at least 30 days and in which foot -and-mouth 
disease has not been reported during a period of at least 3 months, and 
(1)either [they were not vaccinated against foot -and-mouth disease;]
(1)or[they were vaccinated against foot- and-mouth disease during the period of 12 months prior to 
the date of collection of the semen but not during the period of the last 30 days immediately 
prior to the date of collection of the semen, and 5 % (with a minimu m of five straws) of each 
quantity of semen taken from a donor animal at any time is submitted to a virus isolation test 
for foot -and-mouth disease with negative results;]
II.2.2. free from infection with Brucella abortus, B. melitensis and B. suis and hav e never been kept 
previously in any establishment of a lower health status;
(1)(3)[II.2.3. in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis ) has not been reported during the last 42 days;]
(1)(5)[II.2.3. in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. 
caprae and M. tuberculosis) has been carried out on the caprine animals kept on the 
establishments during at least the last 12 months, in accordance with procedures pr ovided for 
in points 1 and 2 of Part 1 of Annex II to Commission Delegated Regulation (EU) 2020/688, 
and in case, during this period, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept on the 
establishment, measures were taken in accordance with Part 1(3) of Annex II to that 
Delegated Regulation;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /783
COUNTRY Certificate model OV/CAP -SEM -A-ENTRY
II.2.4. in which surra ( Trypanosoma evansi) has not been reported during the last 30 days, and 
(1)either [surra has not been reported in the establishments during the last 2 years;]
(1)or[surra has been reported in the establishments during the last 2 years and following the last 
outbreak the establishments have remained under movement restrictions until
−the infected animals have been removed from the establishment, and
−the remaining animals on the establishment have been subjected to a test for surra 
(Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of 
Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with 
negative results, on samples taken at least 6 months after the infected animals have been 
removed from the establishment;]
(1)(3)[II.2.5. where they have remained for a continuous period of at least 60 days and where ovine 
epididymitis ( Brucella ovis ) has not been reported during the period of 12 months;]
(1)(4)[II.2.6. where, during the period of 60 days prior to their stay in the quarantine accommodation, 
referred to in point II.4.6. they have been subjected to a serological test for ovine epididymitis 
(Brucella ovis ) or any other test with an equivalent documented sensitivity and specificity,
with negative results, required in accordance with point 1(b) of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/686; ]
(1)(5)[II.2.7. where infection with Burkholderia mallei (glanders) was not reported during the period of 6 
months.]
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen 
collection centre(6)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Delegated Regulation (EU) 2020/686.
II.4. The semen described in Part I was obtained from donor animals which
II.4.1. were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever 
virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious 
caprine pleuropneumonia;
II.4.2. remained for a period of at least 6 months prior to the date of collection of the semen in a 
third country or territory or zone thereof referred to in Box I.7.;
II.4.3. did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen; 
II.4.4. are individually identified as provided for in Article 21(1) of Commission Delegated 
Regulation ( EU) 2020/692;
II.4.5. for a period of at least 30 days prior to the date of collection of the semen and during the 
collection period 
II.4.5.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mout h disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants 
virus, sheep pox and goat pox orcontagious caprine pleuropneumonia ,or of an 
emerging disease relevant for ovine and caprine anim als;
L 113 /784  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -SEM -A-ENTRY
II.4.5.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis andB. suis, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax, surra (Trypanosoma 
evansi), infection with epizootic haemorrhagic disease virus, infection with 
bluetongue virus (serotypes 1 -24) and, in case of ovine animals and those caprine 
animals which are kept together with ovine animals, ovine epididymitis ( Brucella 
ovis) have not been reported;
II.4.5.3. were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.5.1. or from 
establishments which do not meet the conditions referred to in point II.4.5.2.;
II.4.5.4. were not used for natural breeding;
II.4.6. have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health status 
were presen t, which on the day of their admission to the semen collection centre complied 
with the following conditions:
II.4.6.1. it was not situated in a restricted zone established due to diseases referred to in 
point II.4.5.1.;
II.4.6.2. none of the diseases refe rred to in point II.4.5.2. has been reported for a period of 
at least 30 days;
II.4.6.3. it was situated in an area where foot- and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;
II.4.6.4. has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;
II.4.7. were kept in the semen collection centre
II.4.7.1. which was not situated in a restricted zone established due to diseases referred to in point II.4.5.1.;
II.4.7.2. where none of the diseases referred to in point II.4.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the s emen, and
(1)(7)[at least 30 days following the date of the collection;]
(1)(8)[until the date of dispatch of the consignment of semen to the Union;]
II.4.7.3. situated in an area where foot- and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and
(1)(7)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and 30 days from the date of collection;]
(1)(8)[free from foot- and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment 
of semen to the Union and the donor animals have been kept at that semen 
collection centre for a continuo us period of at least 30 days immediately prior to 
the date of collection of the semen;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /785
COUNTRY Certificate model OV/CAP -SEM -A-ENTRY
II.4.8. comply with at least one of the following conditions as regards infection with bluetongue 
virus (serotypes 1 -24):
(1)either [II.4.8.1. they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a third country, territory or zone thereof free from infection with 
bluetongue virus (serotypes 1 -24)where no case of infection with bluetongue virus 
(serotypes 1 -24) has been confirmed during the last 24 months in the targeted animal 
population;]
(1)and/or [II.4.8.2. they have been kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a third country, territory or zone thereof with an approved eradication 
programme against infection with bluetongue virus (serotype s1-24);]
(1)and/or [II.4.8.3. they have been kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a third country, territory or zone thereof where the competent authority of 
the place of origin of the consignment of semen has obtained the prior written
consent of the competent authority of the Member State of destination to the 
conditions for establishment of that seasonally disease -free zone and to accept the 
consignment of semen;]
(1)and/or [II.4.8.4. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(1)and/or [II.4.8.5. they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1- 24, with negative results, between 28 and 60 days from the date of 
each collection of the semen;]
(1)and/or [II.4.8.6. they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood samples taken at commencement 
and final collect ion of the semen and during collection of the semen at intervals of at 
least every 7 days, in the case of the virus isolation test, or of at least every 28 days, 
in the case of PCR;]
II.4.9. comply with at least one of the following conditions as regards i nfection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7):
(1)either [II.4.9.1. they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a third country, territory or zone thereof where EHDV 1-7 has not been 
reported for a period of at least the preceding 2 years within a radius of 150 km of 
the establishment;]
(1)and/or [II.4.9.2. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]
(1)and/or [II.4.9.3. were resident in the exporting country in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to the following tests ca rried out in an 
official laboratory:
(1)either [II.4.9.3.1. a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days throughout the collection period and 
between 28 and 60 days from the date of the final collection of the 
semen;]]
L 113 /786  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -SEM -A-ENTRY
(1)and/or [II.4.9.3.2. an agent identification test for EHDV 1 -7, with negative results, on 
blood samples taken at the commencement and final collection of the 
semen and during the collection of the semen at intervals of at least 
every 7 days, in the case of virus isolation test, or of at least every 28 
days, in the case of PCR.]]
II.4.10. have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to the commencement of the quarantine referred to in point II.4.6., 
with negative results, required in accordance with point 1(c) of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/686:
II.4.10.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(1)(9)[II.4.10.2. for ovine epididymitis (Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]
II.4.11. have been subjected to the following tests, carried out on blood samples taken within a period 
of at least 21 days after the commencement of the quarantine referred to in point II.4.6., with 
negative results, required in accordance with point 1(d) of Chapter I of Part 3 of Annex II to 
Delegated Regulation (EU) 2020/686:
II.4.11.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(1)(9)[II.4.11.2. for ovine epididymitis (Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]
II.4.12. have been subjected at semen collection centre, at least once a year, to the following 
compulsory routine tes ts, required in accordance with point 2 of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/686:
II.4.12.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/688;
(1)(9)[II.4.12.2. for ovine epididymitis (Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity. ]]
(10)[II.4.13. comply with the following conditions as regards classical scrapie:
II.4.13.1. they have been kept continuously since birth in a country where the following 
conditions are fulfilled:
II.4.13.1.1. classical scrapie is compulsorily notifiable;
II.4.13.1.2. an awareness, surveillance and monitoring system is in place;
II.4.13.1.3. ovine and caprine animals affected with classical scrapie are 
killed and completely destroyed;
II.4.13.1.4. the feeding to ovine and caprine animals of meat -and-bone 
meal, or greaves of ruminant origin, as defined in the 
Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and effectively enforced 
in the whole country for a period of at least the last seven 
years;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /787
COUNTRY Certificate model OV/CAP -SEM -A-ENTRY
And
(1)either [II.4.13.2. they have been kept continuously for the last three years preceding the date of 
the collection of the semen to be exported in a holding or holdings which has/have fulfilled 
during that period all the requirements set out in points 1. 3. (a) to (f) of Section A of Chapter 
A of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were 
kept at a semen collection centre that complied during that period with the conditions set out 
in the four indents of point 1.3.(c )(iv) of that Section;]
(1)or [II.4.13.2. they are ovine animals of the ARR/ARR prion protein genotype.] ]
II.5. The semen described in Part I
II.5.1. has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/686;
II.5.2. isplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.27;
II.5.3. is transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use 
container; 
(1)(7)[II.5.3.3. has been filled in with the cryogenic agent which not have been previously used 
for other products.]
(1)(11)[II.6. The semen is preserved by the addition of antibiotics as follows:
II.6.1. The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, 
or is contained in the used semen diluents, to reach the indicated concentration per ml of semen:
(1)either [gentamicin (250 μg);]
(1)or [a mixture of penicillin (500 IU) and streptomycin (500 μg);]
(1)or [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]
(1)or [a mixture of lincomycin- spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]
(1)or [a mixture of amikacin (75 μg) and divekacin (25 μg);]
(1)or [an antibiotic or a mixture of antibiotics(12)…………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg); 
-penicillin (500 IU) and streptomycin (500 μg);
-gentamicin (250 μg), tylosin (50 μg) and lincomycin- spectinomycin (150/300 μg);
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.6.2. Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature of at least 5°C for a period of not less than 45 minutes, or under a 
time-temperature regime with a documented equivalent bactericidal activity.]
L 113 /788  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -SEM -A-ENTRY
Notes
This certificate is intended for entry into the Union of semen of ovine and caprine animals, including when the 
Union is not the final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only semen 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission websi te:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the numbe r of containers.
Box reference I.27: “Type” : Indicate semen.
“Species” : Select amongst “ Ovis aries ” or “Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on th e straw or other packages where semen of 
the consignment is placed. 
“Date of collection/production”: Indicate the date on which semen of the 
consignment was collected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(3)Applicable for ovine animals.
(4)Applicable for ovine animals and for those caprine anima ls which are kept together with ovine animals.
(5)Applicable for caprine animals.
(6)Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
(7)Applicable for frozen semen.
(8)Applicable for fresh and chilled semen.
(9)Applicable for ovine animals and for those caprine animals which are kept together with ovine animals.
(10)Delet e if the Union is not the final destination of the semen
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /789
COUNTRY Certificate model OV/CAP -SEM -A-ENTRY
(11)Mandatory attestation in case antibiotics were added.
(12)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /790  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 49
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF SEMEN OF O VINE AND CAPRINE ANI MALS 
COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH DIRECTIVE 
92/65/EEC BEFORE 21 APRIL 2021, DISPATCH EDAFTER 20 APRIL 2021 FROM 
THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED 
(MODEL ‘OV/CAP -SEM -B-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /791
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /792  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -SEM -B-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, hereby certify that:
II.1. The exporting country ……………………………………………………………………
(name of exporting country )(1)
II.1.1. has been free from rinderpest, infection with peste des petits ruminants virus , sheep and goat 
pox, contagious caprine pleuropneumonia and Rift Valley fever during the 12 month periods 
immediately prior to collection of the semen to be exported and until its date of dispatch to the 
Union and no vaccination against these diseases took place during that pe riod;
II.1.2. has been free from foot -and-mouth disease during the 12 month period immediately prior to 
collection of the semen to be exported and until its date of dispatch to the Union and no 
vaccination against this disease took place during that period .
II.2. The semen collection centre(2)described in Box I.11. and at which the semen to be exported was 
collected and stored:
II.2.1. met the conditions for the approval of semen collection centres laid down in Chapter I(I)(1) of Annex D to Directive 92/65/EEC;
II.2.2. was operated and supervised in accordance with the conditions applicable to semen collection centres and storage centres laid down in Chapter I(II)(1) of Annex D to Directive 92/65/EEC.
II.3. The ovine
(3)/caprine(3)animals standing at the se men collection centre:
II.3.1. prior to their stay in the quarantine accommodation described in point II.3.3.,
(3)(4)either [II.3.1.1. originate from the territory described in Box I.8., which has been recognised as officially 
brucellosis ( B. melitensis )-free,]
(3)or [II.3.1.1. have belonged to a holding which has obtained and maintained its officially brucellosis ( B. 
melitensis )-free status in accordance with Directive 91/68/EEC,]
(3)or [II.3.1.1. originate from a holding, where in respect of brucellosi s (B. melitensis ) all susceptible animals 
have been free from clinical or any signs of this disease for the last 12 month period, none of 
the ovine and caprine animals have been vaccinated against this disease, save those vaccinated 
with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals over six 
months of age have been subjected to at least two tests(5), carried out with negative results on 
samples taken on ……………. ( date) and on …………. ( date) at least six months apart, the 
latter be ing within 30 days before entry into the quarantine accommodation,]
and have not been kept previously in a holding of a lower status;
II.3.1.2. have been kept continuously for at least 60 days on a holding where no case of contagious 
epididymitis ( Brucella ovis) has been diagnosed in the last 12 month period,
(3)and [they are animals of the ovine species and have undergone during the 60 days prior to their 
stay in the quarantine accommodation described in point II.3.3. a complement fixation test, or any other test with an equivalent documented sensitivity and specificity, to detect contagious 
epididymitis with result of less than 50 ICFTU/ml;]
II.3.1.3. to the best of my knowledge do not come from holdings and have not been in contact with 
animals of a holdi ng, in which, based on the official notification system and according to the 
written declaration made by the owner, any of the following diseases has been clinically 
detected within the periods referred to in points (a) to (d) prior to their stay in the quarantine 
accommodation described in point II.3.3.
(a) contagious agalactia of sheep or goats ( Mycoplasma agalactiae, Mycoplasma 
capricolum, Mycoplasma mycoides var. mycoides " large colony"), within the last six 
months,
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /793
COUNTRY Certificate model OV/CAP -SEM -B-ENTRY
(b) paratuberculosis and caseous lymphadenitis, within the last 12 month period,
(c) pulmonary adenomatosis, within the last three years;
(3)either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 
three years;]
(3)or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 
12 month period, and all the infected animals were slaughtered and remaining 
animals subsequently reacted negatively to two tests carried out at least six months apart;]
II.3.2. have undergone the following tests carried out on a blood sample collected within the 28 days 
preceding the commencement of the period of quarantine specified in point II.3.3. for:
– brucellosis ( B. melitensis ), with negative results in each case in accordance with 
Annex C to Directive 91/68/EEC;
– contagious epididymitis (Brucella. ovis ), in the case of sheep only, with negative 
results in each case in accordance with Annex D to Directive 91/68/EEC, or any 
other test with an equivalent documented sensitivity and specificity;
–
border disease in accordance with point 1.4(c) of Chapter II(II) of Annex D to 
Directive 92/65/EEC;
II.3.3. have satisfied the quarantine isolation period of at least 28 days in a quarantine 
accommodation specifically approved for the purpose by the competent authority and during 
that period:
II.3.3.1. only animals of at least the same health status were present in the quarantine accommodation;
II.3.3.2. the animals have undergone the following tests, carried out by the laboratory approved by the 
competent authority of the exporting country on samples taken not earlier than 21 days after 
the animals were admitted to the quarantine accommodation, for:
– brucellosis ( B. melitensis ) with negative results in each case in accordance with 
Annex C to Directive 91/68/EEC;
– contagious epididymitis (Brucella ovis ), in the case of sheep only, with negative 
results in each case in accordance with Annex D to Directive 91/68/EEC, or any 
other test with an equivalent documented sensitivity and specificity;
– border disease in accordance with point 1.6 of Chapter II(II) of Annex D to Directive 
92/65/EEC;
II.3.4. have undergone at least once a year the routine tests for:
– brucellosis ( B. melitensis ) with negative results in each case in accordance with 
Annex C to Directive 91/68/EEC;
– contagious epididymitis (Brucella ovis), in the case of sheep only, with negative 
results in each case in accordance with Annex D to Directive 91/68/EEC, or any 
other test with an equivalent documented sensitivity and specifici ty;
– border disease in accordance with point 5(c) of Chapter II(II) of Annex D to 
Directive 92/65/EEC.
II.4. The semen to be exported was obtained from donor rams(3)/bucks(3)which:
II.4.1. were admitted to the approved semen collection centre with the ex press permission of the 
centre veterinarian.
II.4.2. show no clinical signs of disease on the day of admission to the approved semen collection 
centre and on the day the semen was collected;
L 113 /794  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -SEM -B-ENTRY
(3)either [II.4.3. have not been vaccinated against foot-and-mouth disease during the 12 month period prior to 
collection of the semen;]
(3)or [II.4.3. have been vaccinated against foot -and-mouth disease at least 30 days prior to the collection, 
and 5 % (with a minimum of five straws) of each collection have been submitted to a virus 
isolation test for foot -and-mouth disease with negative results;]
II.4.4. have been kept at an approved semen collection centre for a continuous period of at least 
30days immediately prior to collection of the semen, in the case of collections of fresh 
semen;
II.4.5. have not served naturally after their entry to the quarantine accommodation described in point 
II.3.3. and up to and including the day of semen collection;
II.4.6. have been kept at approved semen collection cent res: 
II.4.6.1. which have been free from foot -and-mouth disease for at least three months prior to collection 
of the semen and 30 days after collection or, in the case of fresh semen, until the date of 
dispatch, and which are situated in the centre of an area of 10 kilometres radius in which there 
has been no case of foot -and-mouth disease for at least 30 days prior to collection of the 
semen;
II.4.6.2. which have been free, during the period commencing 30 days prior to collection and ending 30days after collection of the semen or, in the case of fresh semen, until the date of dispatch, 
from brucellosis ( B. melitensis ), contagious epididymitis ( Brucella. ovis ), anthrax and rabies;
(3)either [II.4.7. have remained in the exporting country for at least the past six months prior to collection of 
the semen to be exported;]
(3)or [II.4.7. during the last six months prior to collection of the semen they complied with the animal 
health conditions applying to donors of the semen which is intended for export to the Union 
and they have been imported into the exporting country at least 30 days prior to collection of 
the semen from ………………………….(1);]
(3)either [II.4.8. were kept in a bluetongue virus -free country or zone for at least 60 days prior to, and during, 
collecti on of the semen;]
(3)or [II.4.8. were kept during a bluetongue virus seasonally free period in a seasonally free zone for at 
least 60 days prior to, and during collection of the semen;]
(3)or [II.4.8. were kept in a vector -protected establishment for at le ast 60 days prior to, and during 
collection of the semen;]
(3)or [II.4.8. were subjected to a serological test for the detection of antibody to the bluetongue virus 
group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals, with negative results, on blood samples taken at least every 60 days 
throughout the collection period and between 21 and 60 days after the final collection for this 
consignment of semen;]
(3)or [II.4.8. were subjected to an agent identification test for bluetongue virus, carried out in accordance 
with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals with negative 
results on blood samples taken at commencement and final collection for this consignment of 
semen and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) 
during collection for this consignment of semen;]
(3)(6)either [II.4.9. were resident in the exporting country which according to official findings is free from 
epizootic haemorr hagic disease (EHD);]
(3)or [II.4.9. were resident in the exporting country in which according to official findings the following 
serotypes of epizootic haemorrhagic disease (EHD) exist: …………………… and were 
subjected with negative results in each case to:
(3)either [a serological test(7)for the detection of antibody to the EHDV group carried out in an 
approved laboratory on samples of blood taken on two occasions not more than 12 months 
apart prior to and not less than 21 days after the final collection for this consignment of 
semen.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /795
COUNTRY Certificate model OV/CAP -SEM -B-ENTRY
(3)or [a serological test(7)for the detection of antibody to the EHDV group, carried out in an 
approved laboratory on samples of blood taken at intervals of not more than 60 days 
throughout the collection period and between 21 and 60 days after the final collection for this 
consignm ent of semen.]]
(3)or [an agent identification test(7)carried out in an approved laboratory on samples of blood taken 
at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least 
every 28 days (PCR test) during collectio n for this consignment of semen.]]
II.4.10. comply with the following conditions as regards classical scrapie:
II.4.10.1. they have been kept continuously since birth in a country where the following 
conditions are fulfilled:II.4.10.1.1. classical scrapie is compulsorily notifiable;
II.4.10.1.2. an awareness, surveillance and monitoring system is in place;
II.4.10.1.3.
ovine and caprine animals affected with classical scrapie are 
killed and completely destroyed;
II.4.10.1.4. the feeding to ovine and caprine animals of meat -and-bone meal, 
or greaves of ruminant origin has been banned and effectively 
enforced in the whole country for a period of at least the last 
seven years;
And
(3)either [II.4.10.2. they have been kept continuously for the last three years preceding the date of 
the collection of the semen to be exported in a holding or holdings which has/have been 
complying for the last three years before the collection of the semen to be exported with the 
requirements set out in points 1.3. (a) to (f) of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001;]
(3)or [II.4.10.2. they are ovine animals of the ARR/ARR prion protein genotype.]
II.5. The semen to be exported:
II.5.1. was collected after the date on which the semen collection centre was approved by the 
competent authority of the exporting country;
II.5.2. was collected, processed, preserved, stored and transported in accordance with the 
requirements applicable to semen laid down in Chapter III(I) of Annex D to Directive 
92/65/EEC;
II.5.3. was sent to the place of loading in a sealed container in accordance with the requirements for 
semen to be subject to trade laid down in point 1.4 of Chapter III(I) of Annex D to Directive 
92/65/EEC and bearing the number indicated in Box I.19.
(3)either [II.6. No antibiotics were added to the semen.]
(3)or [II.6. The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than
(8):
……………………………………………………………. .]
Notes
This certificate is intended for entry into the Union of semen of ovine and caprine animals, including when the 
Union is not the final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
L 113 /796  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -SEM -B-ENTRY
Part I:
Box I. 6:“Operator responsible for the consignment” : this box is to be filled in only if it is a certificate for transit 
commodity.
Box I.11: Place of dispatch shall correspond to the semen collection centre in which the semen was collected and 
listed in accorda nce with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
Box I.19: Identification of container and seal number shall be indicated.
Box I.21: Fill in according to whether it is a transit or an import certificate.
Box I.22: Fill in according to whether it is a transit or an import certificate.
Box I.24: “Number of packages ” shall correspond to the number of containers.
Box I.27: “Species” : select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. 
Identification number shall correspond to the official identification of the animal.
“Date of collection/production” shall be indicated in th e following format: dd.mm.yyyy.
“Approval or registration number of plant/establishment/centre” shall correspond to the approval 
number of the semen collection centre indicated in Box I.11.
Part II:
(1)Only third country, territory or zone thereof liste d in Annex X to Commission Implementing Regulation (EU) 
2021/404 for semen of ovine and caprine animals.
(2)Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
(3)Delete as necessary.
(4)Only for the territory appearing with the entry "V" in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1.).
(5)Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.
(6)See remarks for exporting country concerned in Annex I to Decision 2010/472/EU.
(7)Standards for EHD virus diagnostic tests are described in Chapter 2.1.3. of the OIE Manual of Diagnostic 
Tests and Vaccines for Terrestrial Animals.
(8)Insert names and concentrations.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /797
CHAPTER 50
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF OOCYTES AND EMBRYOS OF OVINE AND CAPRINE
ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH REGULATION (EU) 2016/429 AND DELEGATED 
REGULATION (EU) 2020 /692 AFTER 20 APRIL 2021, DISPATCHED BY THE
EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (M ODEL ‘OV/CAP -
OOCYTES -EMB- A-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /798  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/estab lishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /799
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- A-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The oocytes(1)/ in vivo derived embryos(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)
described in Part I are intended for artificial reproduction and were obtained from donor animals which 
originate from a third country, territory or zone thereof
II.1.1. authorised for entry into the Union of oocytes(1)/ embryos(1)of ovine(1)/caprine(1)animals and 
listed in Annex X to Commission Implementing Regulation (EU) 2021/404;
(1)either [II.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(1)/ production(1)of the oocytes(1)/ embr yos(1)and until their 
date of dispatch ;]
(1)or[II.1.2. where foot -and-mouth disease was not reported for a period starting on the date(2)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1)and until 
their date of dispatch ;]
II.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia were not reported for a period of at least 12 months immediately prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1)and until their date of dispatch ;
II.1.4. where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, i nfection with peste des petits ruminants virus, sheep 
pox and goat pox and contagious caprine pleuropneumonia has been carried out for a period 
of at least 12 months immediately prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1)and until their date of dispatch ,and no vaccinated animals entered into the third 
country, territory or zone thereof during that period.
(1)[II.2. The in vivo derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embr yo collection team(3)which
II.2.1. is approved and listed by the competent authority of the third country or territory;
II.2.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of A nnex I to Commission Delegated Regulation (EU) 2020/686.]
(1)[II.2. The oocytes(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)described in Part I have been 
collected or produced, processed and stored, and dispatched by the embryo production team(3)which
II.2.1. is approved and listed by the competent authority of the third country or territory;
II.2.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]
II.3. The oocytes
(1)/ embryos(1)described in Part I were obtained from donor animals which originate from 
establishments 
II.3.1. free from infection with Brucella abortus, B. melitensis and B. suis and have never been kept 
previously in any establishment of a lower health status.
(1)(4)[II.3.2. in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis ) has not been reported during the last 42 days;]
L 113 /800  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- A-ENTRY
(1)(5)[II.3.2. in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. 
caprae and M. tuberculosis) has been carried out on the caprine animals kept on the 
establishments during at least the last 12 months, in accordance with pro cedures provided for 
in points 1 and 2 of Part 1 of Annex II to Commission Delegated Regulation (EU) 2020/688, 
and in case, during this period, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept on the 
establishment, measures were taken in accordance with Part 1(3) of Annex II to that 
Delegated Regulation;]
II.3.3. in which surra ( Trypanosoma evansi) has not been reported during the last 30 days, and 
(1)either [surra has not been reported in the establishments during the last 2 years.]
(1)or[surra has been reported in the establishments during the last 2 years and following the last outbreak the establishments have remained under movement restrictions until
−the infected anim als have been removed from the establishment, and
−
the remaining animals on the establishment have been subjected to a test for surra 
(Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of 
Annex I to Commission Delegated Regulatio n (EU) 2020/688, carried out, with 
negative results, on samples taken at least 6 months after the infected animals have been 
removed from the establishment.]
II.4. The oocytes(1)/ embryos(1)described in Part I were obtained from donor animals which
II.4.1. were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever 
virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious 
caprine pleuropneumonia;
II.4.2. remained for a period of at least 6 months prior to the date of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1)in a third country or territory or zone thereof referred to in Box I.7.;
II.4.3. for a period of at least 30 days prior to the date of collection(1)/ production(1)of the oocytes(1)/ 
embryos(1)and during the collection(1)/ production(1)period 
II.4.3.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants 
virus, sheep pox and goat pox orcontagious caprine pleuropneumonia ,or of an 
emerging disease relevant for ovine and caprine animals;
II.4.3.2. were kept on a single establishme nt where infection with Brucella abortus, B. 
melitensis andB. suis, infection with Mycobacterium tuberculosis complex (M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax, surra (Trypanosoma 
evansi), infection with epizootic haemorrhagic disease vir us, infection with 
bluetongue virus (serotypes 1 -24) and, in case of ovine animals and those caprine 
animals which are kept together with ovine animals, ovine epididymitis ( Brucella 
ovis) have not been reported;
II.4.3.3. were not in contact with animals f rom establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.3.1. or from 
establishments which do not meet the conditions referred to in point II.4.3.2.;
II.4.3.4. were not used for natural breeding;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /801
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- A-ENTRY
II.4.4. were examined by the team veterinarian or a team member and did not show symptoms or 
clinical signs of transmissible animal diseases on the day of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1); 
II.4.5. are individually identified as p rovided for in Article 21(1) of Commission Delegated 
Regulation (EU) 2020/692;
II.4.6. comply with the following conditions as regards foot -and-mouth disease 
II.4.6.1. they come from establishments 
−situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the establishment for a period of at least 30 
days immediately prior to the date of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1);
−in which foot -and-mouth disease has not been reported during a period of at 
least 3 months immediately prior to the date of collection(1)/ production(1)of 
the oocytes(1)/ embryos(1);
(1)either [II.4.6.2. they were not vaccinated against foot -and-mouth disease;]
(1)(6)or[II.4.6.2. they were vaccinated against foot- and-mouth disease during the period of 12 
months prior to the date of collection of the embryos and
II.4.6.2.1. have not been vaccinated against foot -and-mouth disease within the 
period of at least 30 days immediately prior to the date of collection 
of the embryos;
II.4.6.2.2. the semen used for fertilisation was collected from a male donor that 
complies with the conditions set out in point 1(b) of Chapter I of Part 
5 of Annex II to Delegated Regulation (EU) 2020/686 or the semen 
complies with the conditions set out in point 2 of Chapter I of Part 5 
of Annex II to Delegated Regulation (EU) 2020/686;
II.4.6.2.3. prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the recommendations of the 
IETS Manual(7);
II.4.6 .2.4. the embryos were stored deep frozen for a period of at least 30 days 
from the date of collection, and during this period the donor animal 
has not shown clinical signs of foot- and-mouth disease;]
II.4.7. comply with at least one of the following condi tions as regards infection with bluetongue 
virus (serotypes 1 -24):
(1)either [II.4.7.1. they have been kept for a period of at least 60 days prior to and during collection(1)/ 
production(1)of the oocytes(1)/ embryos(1)in a third country, territory or zon e thereof 
free from infection with bluetongue virus (serotypes 1- 24) where no case of 
infection with bluetongue virus (serotypes 1 -24) has been confirmed during the last 
24 months in the targeted animal population;]
(1)and/or [II.4.7.2. they have been kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection(1)/ 
production(1)of the oocytes(1)/ embryos(1), in a third country, territory or zone thereof 
with an approved e radication programme against infection with bluetongue virus 
(serotype s1-24);]
L 113 /802  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- A-ENTRY
(1)and/or [II.4.7.3. they have been kept in a seasonally disease -free zone, during the seasonally disease-
free period, for a period of at least 60 days prior to and during collection(1)/ 
production(1)of the oocytes(1)/ embryos(1), in a third country, territory or zone thereof 
where the competent authority of the place of origin of the consignment of the 
oocytes(1)/ embryos(1)has obtained the prior written consent of the competent 
authority of the Member State of destination to the conditions for establishment of 
that seasonally disease -free zone and to accept the consignment of the oocytes(1)/ 
embryos(1);]
(1)and/or [II.4.7.4. they have been kept in a vector -protected estab lishment for a period of at least 60 
days prior to and during collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)and/or [II.4.7.5. they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1- 24, with negative results, between 28 and 60 days from the date of 
each collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)and/or [II.4.7.6. they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood sample taken on the day of 
collection of the oocytes(1)/ embryos(1);]
II.4.8. comply with at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7):
(1)either [II.4.8.1. they have been kept for a period of at least 60 days prior to and during collection(1)/ 
production(1)of the oocytes(1)/ embryos(1)in a third country, territory or zone thereof 
where EHDV 1 -7 has not been reported for a period of at least the preceding 2 years 
within a radius of 150 km of the establishment;]
(1)and/or [II.4.8.2. they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)and/or [II.4.8.3. were resident in the exporting country in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to the following tests carried out in an 
offic ial laboratory:
(1)either [II.4.8.3.1. a serological test to detect antibodies to EHDV 1 -7, with negative 
results, on blood sample taken between 28 and 60 days from the date of 
the collection(1)/ production(1)of the oocytes(1)/ embryos(1);]]
(1)and/or [II.4.8.3.2. an agent identification test for EHDV 1 -7, with negative results, on 
blood sample taken on the day of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1).]]
(8)[II.4.9. comply with the following conditions as regards classical scrapie:
II.4.9.1. have been kept continuously since birth in a country where the following 
conditions are fulfilled:
II.4.9.1.1. classical scrapie is compulsorily notifiable;
II.4.9.1.2. an awareness, surveillance and monitoring system is in 
place;
II.4.9.1.3. ovine and caprine animals affected with classical scrapie are 
killed and completely destroyed;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /803
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- A-ENTRY
II.4.9.1.4. the feeding to ovine and caprine animals of meat -and-bone 
meal or greaves of ruminant origin, as defined in the 
Terrestrial Animal Health Code of the World Organisation 
for Animal Health, has been banned and effectively 
enforced in the whole country for a period of at least the last 
seven years;
And
(1)either [II.4.9.2. have been kept continuously for the last three years preceding the date of the 
collection of the embryos to be exported in a holding or holdings which has/have fulfilled 
during that period all the requirements set out in points 1.3. (a) to (f) of Section A of Chapter 
A of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were 
kept at a semen collection centre that complied during that period with the conditions set out 
in the four indents of point 1.3.(c)(iv) of that Section;]
(1)or [II.4.9.2. they are ovine animals and the embryos 
(1)either [are of the ARR/ARR prion protein genotype;]
(1)or [carry at least one ARR allele.]] ]
II.5. The oocytes(1)/ embryos(1)described in Part I 
II.5.1. has been collected, processed and stored in accordance with animal health requirements set 
out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to Delegated Regulation (EU) 
2020/686;
II.5.2. areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that 
mark is indicated in Box I.27;
II.5.3. are transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch by the embryo collection or 
production team under responsibility of the team veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use 
container; 
(1)(8)[II.5.3.3. has been filled in with the cryogenic agent which not have been previously used 
for other products;
(1)(10)[II.5.4. are placed in straws or other packages which are securely and hermetically sealed;
II.5.5. are transported in a container w here they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
(1)(11 )[II.6. The in vivo derived embryos(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)
described in Part I were conceived by artificial insemination using semen coming from a semen collection 
centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing and/or storage of semen b y the competent authority of a third country, territory or 
zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404
for semen of ovine and 
caprine animals or by the competent authority of a Member State.]
(1)(12)[II.7. The following antibiot ic or mixture of antibiotics(13)has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]
L 113 /804  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- A-ENTRY
Notes
This certificate is intended for entry into the Union of oocytes and embryos of ovine and caprine animals, 
including when the Union is not the final destination of the oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Communit y, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health cer tificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. Only embryo collection or production teams listed in accordance with 
Article 233(3) of Regulatio n (EU) 2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19: Seal number ” shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of contai ners.
Box reference I.27: “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced 
embryos or micromanipulated embryos.
“Species” : Select amongst “ Ovis aries ” or “Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which oocytes or embryos of the 
consignment was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(3)Only embryo collection or production teams listed in accordance with Article 233(3) of Reg ulation (EU) 
2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /805
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- A-ENTRY
(4)Applicable for ovine animals.
(5)Applicable for caprine animals.(6)Option available only for the consignment of in vivo derived embryos.
(7)Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society ,1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA ( http://www.iets.org/ ).
(8)Delete if the Union is not the final destination of the oocytes and e mbryos.(9)Applicable for frozen 
oocytes or embryos.
(10)Applicable for the consignment where in one container oocytes, in vivo derived embryos, in vitro produced 
embryos and micromanipulated embryos of ovine or caprine animals are placed and transported.
(11)Does not apply to oocytes.
(12)Mandatory attestation in case antibiotics were added.
(13)Insert the name(s) of the antibiotic(s) added and its(their) concentration.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /806  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 51
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF OOCYTES AND EMBRYOS OF O VINE AND CAPRINE 
ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH DIRECTIVE 92/65/EEC BEFO RE 21 APRIL 2021, 
DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO COLLECTION O R
PRODUCTION TEAM BY W HICH THE OOCYTES OR EMBRYOS WERE 
COLLECTED OR PRODUCE D (MODEL ‘ OV/CAP -OOCYTES -EMB -B-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /807
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /808  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- B-ENTRY -Part II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, hereby certify that:
II.1. The exporting country ………………………………………………………………………..
(name of exporting country )(1)
II.1.1. has been free from rinderpest, infection with peste des petits ruminants virus , sheep and goat 
pox, contagious caprine pleuropneumonia, and Rift Valley fever during the 12 month period 
immediately prior to collection of the ova(2)/embryos(2)to be exported and until their date of 
dispatch to the Union and no va ccination against these diseases took place during that period;
(2)either [II.1.2. has been free from foot -and-mouth disease during the 12 month period immediately prior to 
collection of the ova(2)/embryos(2)and did not carry out vaccination against foot -and-mouth 
disease during that period;]
(2)or [II.1.2. has not been free from foot -and-mouth disease during the 12 month period immediately prior 
to collection of the ova(2)/embryos(2)and/or carried out vaccination against foot -and-mouth 
disease during tha t period and the donor females come from holdings on which no animal was 
vaccinated against foot -and-mouth disease during 30 days prior to collection and no animal of 
susceptible species showed clinical signs of foot -and-mouth disease during the 30 days prior 
to, and at least 30 days after, the ova(2)/embryos(2)were collected and the ova(2)/embryos(2)
were not subjected to penetration of zona pellucida;]
II.2. The ova(2)/embryos(2)to be exported:
II.2.1. were collected(2)/produced(2)and processed on premises within a 10 -km radius of which there 
was no incidence of foot -and-mouth disease, vesicular stomatitis, Rift Valley fever in the 
30days immediately prior to their collection;
II.2.2. were stored at all times on approved premises within a 10 -km radius of which there was no 
incidence of foot -and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of 
their collection until 30 days thereafter;
II.2.3. were collected(2)/produced(2)by the team described in Box I.11., which had been approved and 
supervised in accordance with the conditions for the approval and supervision of embryo 
collection teams and embryo production teams(3)laid down in Chapter I(III) of Annex D to 
Directive 92/65/EEC;
II.2.4. meet the conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 
92/65/EEC;
II.2.5. come from the donor females of ovine(2)/caprine(2)species which:
(2)either [II.2.5.1. were kept in a bluetongue virus -free country or zone for at least 60 days pri or to, and during 
collection of the ova(2)/embryos(2);]
(2)or [II.2.5.1. were kept during a bluetongue virus seasonally free period in a seasonally free zone;]
(2)or [II.2.5.1. were kept protected from the vector for at least 60 days prior to, and during t he collection of 
the ova(2)/embryos(2);]
(2)or [II.2.5.1. underwent a serological test for the detection of antibody to the bluetongue virus serogroup, 
carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial 
Animals betwe en 21 and 60 days after collection of the ova(2)/embryos(2)and giving negative 
results;]
(2)or [II.2.5.1. underwent an agent identification test for bluetongue virus, carried out in accordance with the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on 
the day of the ova(2)/embryos(2)collection or the day of slaughtering and giving negative 
results;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /809
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- B-ENTRY -
II.2.5.2. to the best of my knowledge do not come from holdings and have not been in contact with 
animals of a holding, in which, based on the official notification system and according to the 
written declaration made by the owner, any of the following diseases has been clinically 
detected within the periods referred to in points (a) to (d) prior to collection of the 
ova(2)/embryos(2)to be exported:
(a) contagious agalactia of sheep or goats ( Mycoplasma agalactiae, Mycoplasma 
capricolum, Mycoplasma mycoides var. mycoides "large colony"), within the last six 
months;
(b) paratuberculosis and caseous lymphadeniti s, within the last 12 month period;
(c) pulmonary adenomatosis, within the last three years;
(2)either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 
three years;]
(2)or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 
12month period, and all the infected animals were slaughtered and remaining animals 
subsequently reacted negatively to two tests carried out at least six months apart;]
II.2.5.3. showed no clinical s igns of disease on the day of the ova(2)/embryos(2)collection;
(2)(4)either [II.2.5.4. originate from the region described in Box I.8., which has been recognised as officially 
brucellosis (B. melitensis) -free, and]
(2)or [II.2.5.4. have belonged to a holding which has obtained and maintained its officially brucellosis 
(B.melitensis) -free status in accordance with Directive 91/68/EEC, and]
(2)or [II.2.5.4. originate from a holding, where in respect of brucellosis ( B. melitensis ) all susceptible animals 
have been free from any clinical or any signs of this disease for the last 12 month period, none 
of the ovine and caprine animals have been vaccinated against this disease, save those 
vaccinated with Rev. 1 vaccine more than two years ago, and all ovine and c aprine animals 
over six months of age have been subjected to at least two tests(5), carried out with negative 
results on samples taken on ……………. ( date) and on …………. ( date) at least six months 
apart, the latter being within 30 days prior to collection of th e ova(2)/embryos(2),]
and have not been kept previously in a holding of a lower status;
(2)either [II.2.5.5. have remained in the exporting country for at least the past six months prior to collection of 
the ova(2)/embryos(2)to be exported;]
(2)or [II.2.5.5. during the past six months prior to collection of the ova(2)/embryos(2)they complied with the 
animal health conditions applying to donors of the ova/embryos(2)which are intended for 
export to the Union and they have been imported into the expo rting country at least 30 days 
prior to collection of the ova(2)/embryos(2)from ………………………….(1);]
II.2.5.6. comply with the following conditions as regards classical scrapie:
II.2.5.6.1 they have been kept continuously since birth in a country where the following 
conditions are fulfilled:
II.2.5.6.1.1. classical scrapie is compulsorily notifiable;
II.2.5.6.1.2. an awareness, surveillance and monitoring system is in place;
II.2.5.6.1.3. ovine and caprine animals affected with classical scrapie are killed a nd
completely destroyed;
II.2.5.6.1.4. the feeding to ovine and caprine animals of meat -and-bone meal or 
greaves of ruminant origin has been banned and effectively enforced in 
the whole country for a period of at least the last seven years;
L 113 /810  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- B-ENTRY -
And
(2)either [II.2.5.6.2 they have been kept continuously for the last three years before the collection of the 
embryos to be exported in a holding or holdings which has/have been complying for 
the last three years before the collection of the embryos to be exported w ith the 
requirements laid down in points (a) to (f) of point 1.3. of Section A of Chapter A of 
Annex VIII to Regulation (EC) No 999/2001;]
(2)or [II.2.5.6.2 they are ovine animals and the embryos 
(2)either [are of the ARR/ARR prion protein genotype;]
(2)or [carry at least one ARR allele and were collected after the date of 1 January 2015.]]
[II.2.6. were collected(2)/produced(2)in the exporting country,
(2)either [II.2.6.1. which according to official findings is free from epizootic haemorrhagic disease (EHD);]]
(2)(6)or [II.2.6.1. in which according to official findings the following serotypes of epizootic haemorrhagic 
disease (EHD) exist: …………………… and the donor females of ovine(2)/caprine(2)species 
were subjected with negative results in each case to th e following tests carried out in an 
approved laboratory:
(2)either [a serological test(7)for the detection of antibody to the EHD virus serogroup, carried out on 
samples of blood taken on two occasions not more than 12 months apart prior to and not less than 21 days following collection for this consignment of ova
(2)/embryos(2);]]
(2)or [a serological test(7)for the detection of antibody to the EHD virus serogroup, carried out on 
samples of blood taken at intervals of not more than 60 days throughout the collection period 
and between 21 and 60 days after the final collection for this consignm ent of 
ova(2)/embryos(2);]]
(2)or [an agent identification test(7), carried out on samples of blood collected at commencement 
and conclusion of, and at least every 7 days, if carried out as virus isolation test, or at least 
every 28 days, if carried out as polymerase chain reaction, during collection for this 
consignment of ova(2)/embryos(2);]]
II.2.7. were collected(2)/produced(2)after the date on which the embryo collection team was approved 
by the competent authority of the exporting country;
II.2.8. were processed and stored under approved conditions for at least 30 days immediately after 
their collection(2)/production(2)and transported under conditions for ova and embryos laid 
down in Chapter III(II) of Annex D to Directive 92/65/EEC;
II.2.9. were sen t to the place of loading in a sealed container in accordance with the requirements for 
the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 
92/65/EEC and bearing the number detailed in Box I.19.
(2)[II.2.10. the consign ment consists of embryos of the ovine or caprine species which were conceived by 
artificial insemination(2)/as a result of in vitro fertilisation(2)using semen coming from semen 
collection centres approved(8)in accordance with:
(2)either [II.2.10.1. Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; and the semen complies with the requirements of Directive 92/65/EEC.]]
(2)or [II.2.10.1. Article 17(3)(b) of Directive 92/65/EEC and located in a third country or par t thereof listed in 
Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in 
Part 2 of Annex II to that Decision.]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /811
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- B-ENTRY -
Notes
This certificate is intended for entry into the Union of oocytes and embryos of ovine and caprine animals, 
including when the Union is not the final destination of the oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal h ealth certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.
Part I:
Box I.6: “Operator responsible for the consignment” : This box is to be filled in only if it is a certificate 
for transit commodity.
Box I.11: Place of dispatch shall correspond to the embryo collection team or embryo production team by 
which the oocytes/embryos were collected/produced, processed and stored; and list
ed in 
accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
Box I.19: Identificati on of container and Seal number shall be indicated.
Box I.21: Fill in according to whether it is a transit or an import certificate.
Box I.22: Fill in according to whether it is a transit or an import certificate.
Box I.24: “Number of packages ” shall correspond to the number of containers.
Box I.27: “Species” : Select amongst “ Ovis aries ” or “Capra hircus ” as appropriate.
“Type” : Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos 
or micromanipulated embryos.
Identificati on number shall correspond to the official identification of the animal.
“Date of collection/production” shall be indicated for in vivo derived embryos and in the 
following format: dd.mm.yyyy.
“Approval or registration number of plant/establishment/centre” shall correspond to the 
embryo collection team or embryo production team by which the ova /embryos were 
collected/produced, processed and stored; and listed in accordance with Article 233(3) of 
Regulation (EU) 2016/429 on the Com mission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
Part II:
(1)Only third country, territory or zone thereof listed in Annex X to Commission Impl ementing Regulation 
(EU) 2021/404 for oocytes/embryos of ovine and caprine animals.
(2)Delete as appropriate.
(3)Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
(4)Only for the territory appearing with the entry "V" in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1).
(5)Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.
L 113 /812  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -OOCYTES -EMB- B-ENTRY -
(6)See remarks for exporting country or part thereof concerned in Annex III to Decision 2010/472/EU.
(7)Standards for EHD virus diagnostic tests are described in Chapter 2.1.3. of the OIE Manual of Diagnostic 
Tests and Vaccines for Terrestrial Animals.
(8)Only semen collection centres approved by the competent authorit y of a third country, territory or zone 
thereof listed in Annex X to Implementing Regulation (EU) 2021/404 for semen of ovine and caprine 
animals or by the competent authority of a Member State.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /813
CHAPTER 52
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PRO CESSING 
ESTABLISHMENT:
-semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC before 21 April 2021;
-oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 
2021
-stock s of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 April 2021
(MODEL ‘ OV/CAP -GP-PROCESSING -ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /814  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approva l or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /815
COUNTRY Certificate model OV/CAP -GP-PROCESSING -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)to be exported to 
the European Union was/were processed and stored:
II.1.1. is located a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of 
ovine(2)/caprine(2)animals and listed i n Annex X toCommission Implementing 
Regulation (EU) 2021/404 ;
(2)either [II.1.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.2. where foot -and-mouth disease was not reported for a period starting on the date(3)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryo s(2)and until its/their date of dispatch ;]
II.1.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, infection 
with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia were not reported for a period of at least 12 months immediately prior 
to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their 
date of dispatch ;
II.1.1.4. where no vaccination against foot -and-mouth disease, infection with rinderpes t virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants virus, 
sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out 
for a period of at least 12 months immediately prior to collection(2)/ prod uction(2)of the 
semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ,and no vaccinated 
animals entered into the third country, territory or zone thereof during that period;
II.1.2. is approved and listed by the competent authority of the third country or territory;
II.1.3. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4),and/or processed and stored in a 
germinal product processing establishment(2)(4),and/or stored in a germinal product storage 
centre(2)(4)complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of 
Annex I to Delegated Regu lation (EU) 2020/686, and
(2)either [located in the exporting country;]
(2)and/or [located in ………………………….(5), and has /have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of 
ovine(2)/caprine(2)animals in accordance with Regulation (EU) 2016/429 and Commission 
Delegated Regulation (EU) 2020/692;]
L 113 /816  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -GP-PROCESSING -ENTRY
II.2.2. was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at least as strict as described in:
(2)either [Model OV/CAP- SEM -A-ENTRY(6);]
(2)and/or [Model OV/CAP- SEM -B-ENTRY(6);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -A-ENTRY(6);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -B-ENTRY(6);]
(2)and/or [Model OV/CAP- GP-PROCESSING -ENTRY(6);]
(2)and/or [Model OV/CAP- GP-STORAGE -ENTRY(6);]
II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.5.2. has b een cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(7)[II.2.5.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;]
(2)(8)[II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This certificate is intended for entry into the Union of semen, oocytes and embryos of ovine and caprine animals, 
including when the Union is not the final destination of the semen, oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain a nd Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificat e include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/22 35.
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes and/or embryos. Only germinal product proce ssing establishments 
listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en. htm.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /817
COUNTRY Certificate model OV/CAP -GP-PROCESSING -ENTRY
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes and/or embryos were processed and st ored, and/or the germinal product 
storage centre where the semen, oocytes and/or embryos were stored to the germinal 
product processing establishment described in Box I.11. The original(s) of those 
document(s) or those certificate(s) or the officially endo rsed copies thereof must be 
attached to this certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : Indicate “Ovis aries ” and/or “ Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the o ocytes and/or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
(2)Delete if not applicable.
(3)Only for a third country, territory or zone there of with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(4)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.europa.eu/food/animal/se men_ova/ovine/index_en.htm .
(5)Only a third country, territory or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404
and the EU Member States.
L 113 /818  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -GP-PROCESSING -ENTRY
(6)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where 
the semen was collected, and/or the embryo collection or pro duction team by which the oocytes and/or 
embryos were collected or produced, and/or the germinal product processing establishment where the semen, 
oocytes and/or embryos were processed and stored, and/or the germinal product storage centre where the 
semen, oocytes and/or embryos were stored to the germinal product processing establishment of the semen, 
oocytes and/or embryos dispatch described in Box I.11 must be attached to this certificate.
(7)Applicable for frozen semen, oocytes or embryos.
(8)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /819
CHAPTER 53
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STO RAGE CENTRE:
-semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of semen of ovine and caprine animals collec ted, processed and stored in accordance with 
Council Directive 92/65/EEC before 21 April 2021;
-oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 
2021
-stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 April 2021
(MODEL ‘ OV/CAP -GP-STORAGE- ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISOcountry code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /820  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /821
COUNTRY Certificate model OV/CAP -GP-STORAGE -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo
derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)to be exported to the 
European Union was/were stored:II.1.1. is located a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen
(2)/ oocytes(2)/ embryos(2)of 
ovine(2)/caprine(2)animals and listed in Annex X toCommission Implementing 
Regulation (EU) 2021/404 ;
(2)either [II.1.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.2. where foot -and-mouth disease was not reported for a period starting on the date(3)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
II.1.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, infection 
with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia were not reported for a period of at least 12 months immediately prior 
to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their 
date of dispatch ;
II.1.1.4. where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants virus, 
sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out 
for a period of at least 12 months immediately prior to collection(2)/ production(2)of the 
semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ,and no vaccinated 
animals entered into the third country, territory or zone thereof during that period;
II.1.2. is approved and listed by the competent authority of the third country or territory;
II.1.3. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4),and/or processed and stored in a 
germinal product processing establishment(2)(4),and/or stored in a germinal product storage 
centre(2)(4)complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of 
Annex I to Delegated Regulation (EU) 2020/686, and
(2)either [located in the exporting country;]
(2)and/or [located in ………………………….(5), and has /have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of
ovine(2)/caprine(2)animals in accordance with Regulation (EU) 2016/429 and Commission 
Delegated Regulation (EU) 2020/692;]
L 113 /822  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -GP-STORAGE -ENTRY
II.2.2. was/were moved to the germinal product storage centre described in Box I.11. under conditions at 
least as strict as described in:
(2)either [Model OV/CAP- SEM -A-ENTRY(6);]
(2)and/or [Model OV/CAP- SEM -B-ENTRY(6);]
(2)and/or [Model 1 in Section A of Part 2 of Annex II to Decision 2010/472/EU(6);]
(2)and/or [Model 2 in Section B of Part 2 of Annex II to Decision 2010/472/E U(6);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -A-ENTRY(6);]
(2)and/or [Model OV/CAP- OOCYTES -EMB -B-ENTRY(6);]
(2)and/or [Model OV/CAP- GP-PROCESSING -ENTRY(6);]
(2)and/or [Model OV/CAP- GP-STORAGE -ENTRY(6);]
II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delega ted Regulation (EU) 2020/692 and that mark 
is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product storage centre 
under responsibility of the centre veteri narian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;
II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(7)[II.2.5.3. has been filled in with the cryogenic agent which not have been previously 
used for other products;]
(2)(8)[II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This certificate is intended for entry into the Union of semen, oocytes and embryos of ovine animals, including 
when the Union is not the final destination of the semen, oocytes and embryos. 
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to Europe an Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implement ing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germi nal product storage centres listed in accordance with 
Article 233(3) of Regulation (EU) 2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/in dex_en.htm .
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /823
COUNTRY Certificate model OV/CAP -GP-STORAGE -ENTRY
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre whe re the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes and/or embryos were processed and stored, and/or the germinal product 
storage centre where the semen, oocytes and/or embryos were stored to the germinal product storage centre described in Box I.11. The original(s) of those document(s) or 
those certificate(s) or the officially endorsed cop ies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived e mbryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Species” : indicate “Ovis aries ” and/or “ Capra hircus ” as appropriate.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes, in vi voderived 
embryos or in vitro produced embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product storage centres listed in accordance with Article 233(3) of Regulati on (EU) 2016/429 
on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
(2)Delete if not applicable.
(3)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(4)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .
(5)Only a third country, territory or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404
and the EU Member States.
L 113 /824  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model OV/CAP -GP-STORAGE -ENTRY
(6)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where 
the semen was collected, and/or the embryo collection or production team by which the oocytes and/or 
embryos were collected or produced, and/or the ger minal product processing establishment where the semen, 
oocytes and/or embryos were processed and stored, and/or the germinal product storage centre where the 
semen, oocytes and/or embryos were stored to the germinal product storage centre of the semen, oocytes 
and/or embryos dispatch described in Box I.11 must be attached to this certificate.
(7)Applicable for frozen semen, oocytes or embryos.
(8)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produ ced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /825
CHAPTER 54
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF SEMEN OF PORCINE ANIMALS COLLECTED, 
PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 
2016/429 AND DELEGAT ED REGULATION (EU) 2 020/692 AFTER 20 APRIL 2021,
DISPATCHED FROM THE SEMEN COLLECTION CEN TRE WHERE THE SEMEN 
WAS COLLECTED (MODEL ‘POR -SEM -A-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /826  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /827
COUNTRY Certificate model POR -SEM -A-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals 
which originate from a third country, territory or zone thereof
II.1.1. authorised for entry into the Union of semen of porcine animals and listed in Annex XI to 
Commission Implementing Regulation (EU) 2021/404 ;
(1)either [II.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection of the semen and until its date of dispatch ;]
(1)or[II.1.2. where foot -and-mouth disease was not reported for a period starting on the date(2)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the semen and until its date of 
dispatch ;]
(1)either [II.1.3. where classical swine fever was not reported for a period of at least 12 months immediately 
prior to collection of the semen and until its date of dispatch ;]
(1)or[II.1.3. where classical swine fever was not reported for a period starting on the date(3)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the semen and until its date of 
dispatch ;]
II.1.4. where infec tion with rinderpest virus and African swine fever were not reported for a period 
of at least 12 months immediately prior to collection of the semen and until its date of 
dispatch ;
II.1.5. where no vaccination against foot -and-mouth disease, infection with rinderpest virus and 
classical swine fever has been carried out for a period of at least 12 months immediately prior 
to collection of the semen and until its date of dispatch , and no vaccinated animals entered 
into the third country, territory or zone thereof during that period.
II.2. The semen described in Part I was obtained from donor animals which originate, before the 
commencement of the quarantine referred to in point II.4.6., from establishments
II.2.1. situated in an area where foot -and-mouth di sease has not been reported within a 10- km radius 
centred on the establishment for a period of at least 30 days and in which foot -and-mouth 
disease has not been reported during a period of at least 3 months, and 
(1)either [they were not vaccinated against foot -and-mouth disease;]
(1)or[they were vaccinated against foot- and-mouth disease during the period of 12 months prior to 
the date of collection of the semen but not during the period of the last 30 day period 
immediate ly prior to the date of collection of the semen, and 5 % (with a minimum of five 
straws) of each quantity of semen taken from a donor animal at any time is submitted to a 
virus isolation test for foot- and-mouth disease with negative results;]
II.2.2. free from infection with Brucella abortus, B. melitensis and B. suis in accordance with the 
requirements laid down in Chapter IV of Part 5 of Annex II to Commission Delegated 
Regulation (EU) 2020/686;
II.2.3. where no clinical, serological, virological or patho logical evidence of infection with 
Aujeszky’s disease virus had been detected during the period of at least 12 months;
II.2.4. where, during the period of at least 3 months prior to the date of entry into the quarantine 
accommodation, no animal was vaccina ted against infection with porcine reproductive and 
respiratory syndrome virus and no infection with porcine reproductive and respiratory 
syndrome virus was detected.
L 113 /828  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -SEM -A-ENTRY
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen 
collection centre(4)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipme nt set out in Part 1 of Annex I to Delegated Regulation (EU) 2020/686.
II.4. The semen described in Part I was obtained from donor animals which
II.4.1. were not vaccinated against infection with rinderpest virus, classical swine fever and infection 
with p orcine reproductive and respiratory syndrome virus;
II.4.2. remained for a period of at least 3 months prior to the date of collection of the semen in a 
third country or territory or zone thereof referred to in Box I.7.;
II.4.3. did not show symptoms or cl inical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen; 
II.4.4. are individually identified as provided for in Article 21(1) of Commission Delegated 
Regulation (EU ) 2020/692;
II.4.5. for a period of at least 30 days prior to the date of collection of the semen and during the 
collection period 
II.4.5.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
classical swine fever orAfrican swine fever ,or of an emerging disease relevant 
for porcine animals;
II.4.5.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis and B. suis , infection with rabies virus, anthrax, infection with 
Aujeszky’s disease virus and infection with porcine reproductive and respiratory 
syndrome virus have not been reported;
II.4.5.3. were not in contact with animals from establishments situated in a restri cted zone 
due to the occurrence of diseases referred to in point II.4.5.1. or from 
establishments which do not meet the conditions referred to in point II.4.5.2.;
II.4.5.4. were not used for natural breeding;
II.4.6. have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health status 
were present, which on the day of their admission to the semen collection centre complied 
with the following conditions:
II.4.6.1. it was not situated in a restricted zone established due to diseases referred to in 
point II.4.5.1.;
II.4.6.2. none of the diseases referred to in point II.4.5.2. has been reported for a period of 
at least 30 days;
II.4.6.3. it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;
II.4.6.4. has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;
II.4.6.5. it was free from infection with Brucella abortus, Brucella melitensis and 
Brucella suis for the period of at least the preceding 3 months;
II.4.7. were kept in the semen collection centre
II.4.7.1. which was not situated in a restricted zone established due to diseases referred to 
in point II.4.5.1.;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /829
COUNTRY Certificate model POR -SEM -A-ENTRY
II.4.7.2. where none of the diseases referred to in point II.4.5.2. has been reported for a 
period of at least 30 da ys prior to the date of collection of the semen, and
(1)(5)[at least 30 days following the date of the collection;]
(1)(6)[until the date of dispatch of the consignment of semen to the Union;]
II.4.7.3. situated in an area where foot- and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and
(1)(5)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and 30 days from the date of collection;]
(1)(6)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment 
of semen to the Union and the donor animals have been kept at tha t semen 
collection centre for a continuous period of at least 30 days immediately prior to 
the date of collection of the semen;]
II.4.7.4. where no clinical, serological, virological or pathological evidence of infection 
with Aujeszky’s disease virus had b een reported for a period comprising at least 
30 days prior to the date of admission and at least 30 days immediately prior to 
the date of collection of the semen;
II.4.8. have been subjected to the following tests, carried out within the period of 30 days prior to the 
commencement of the quarantine referred to in point II.4.6., with negative results, required in 
accordance with point 1(b) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 
2020/686:
II.4.8.1. as regards infection with Brucella abortus, B. melitensis and B. suis, a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella species;
II.4.8.2. as regards infection with Aujeszky’s disease virus 
(1)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV- gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]
(1)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect 
antibodies to glycoprotein E (ADV- gE) of Aujeszky’s disease virus;]
(1)[II.4.8.3. as regards classical swine fever, an antibody ELISA or serum neutralisation test, 
in case of animals coming from a Member State or zone thereof where classical 
swine fever has been reported or vaccination against this disease has been 
practiced for the period of the preceding 12 months;]
II.2.8.4. as regards infection with porcine reproductive and respiratory syndrome virus, a 
serological test (the immunoperoxidase monolayer assay (IPMA), 
immunofluorescence assay (IFA), or ELISA);
L 113 /830  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -SEM -A-ENTRY
II.4.9. have been subjected to the following tests, carried out on samples taken within a period of at 
least 21 days after the commencement of the quarantine referred to in point II.4.6., with 
negative results, required in accordance with point 1(c) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020/686:
II.4.9.1. as regards infection with Brucella abortus, B. melitensis and B. suis, a buffere d
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella species;
II.4.9.2. as regards infection with Aujeszky’s disease virus 
(1)[in the case of non -vaccinated animals, an ELI SA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV- gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]
(1)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect 
antibod ies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]
(1)[II.4.9.3. as regards classical swine fever, an antibody ELISA or serum neutralisation test, 
in case of animals coming from a Member State or zone thereof where classical 
swine fever has not been reported and vaccination against this disease has not 
been practiced for the period of the preceding 12 months;]
II.4.9.4. as regards infection with porcine reproductive and respiratory syndrome virus, a 
serological test (IPMA, IFA, or ELISA) and a te st for virus genome (reverse -
transcription polymerase chain reaction (RT -PCR), nested set RT -PCR, real -time 
RT-PCR);
II.4.10. have been subjected, at semen collection centre, to the following compulsory routine tests, required in accordance with point 2(a)
of Chapter I of Part 2 of Annex II to Delegated 
Regulation (EU) 2020/686:
II.4.10.1. as regards infection with Brucella abortus, B. melitensis and B. suis, a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for t he detection of antibodies to smooth Brucella species;
II.4.10.2. as regards infection with Aujeszky’s disease virus 
(1)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV- gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]
(1)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect 
antibodies to glycoprotein E (ADV- gE) of Aujeszky’s disease virus;]
II.4.10.3. as regards classi cal swine fever, an antibody ELISA or serum neutralisation test;
II.4.10.4. as regards infection with porcine reproductive and respiratory syndrome virus, a 
serological test (IPMA, IFA, or ELISA);
II.4.11. have been subjected to the tests referred to in po int II.4.10. carried out, in accordance with 
point 2(b) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020/686, on 
samples taken from:
(1)either [all animals immediately prior to leaving the semen collection centre, or upon arrival at th e
slaughterhouse, and in no case later than 12 months from the date of admission to the semen 
collection centre.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /831
COUNTRY Certificate model POR -SEM -A-ENTRY
(1)or[at least 25 % of the animals in the semen collection centre every 3 months to test for 
infection with Brucella abortus, Brucella melitensis and Brucella suis , infection with 
Aujeszky’s disease virus and classical swine fever and from at least 10 % of the animals in 
the semen collection centre every month to test for infection with porcine reproductive and respiratory syndrome virus.]
(1)or[at least 10 % of the animals in the semen collection centre every month to test for infection 
with Brucella abortus, Brucella melitensis and Brucella suis , infection with Aujeszky’s 
disease virus, classical swine fever and infection with porcine reproductive and respiratory 
syndrome virus.]
II.5. The semen described in Part I
II.5.1. has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/686;
II.5.2. isplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that 
mark is indicated in Box I.27;
II.5.3. is transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use 
container; 
(1)(5)[II.5.3.3. has been filled in with the cryogenic agent which not have been previously used for other products.]
II.6. The semen is preserved by the addition of antibiotics as follows:
II.6.1. The following antibiotic or mixture of antibiotics, effective in particular against leptospires, has 
been added to the semen after final dilution, or is contained in the used semen diluents, to reach the 
indicated concentration per ml of semen:
(1)either [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]
(1)or [a mixture of lincomycin- spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500
μg);]
(1)or [a mixture of amikacin (75 μg) and divekacin (25 μg);]
(1)or [an antibiotic or a mixture of antibiotics(7)…………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg), tylosin (50 μg) and lincomycin- spectinomycin (150/300 μg);
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.6.2. Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature of at least 5°C or 15°C for a period of not less than 45 minutes, or under a time -temperature regime with a documented equivalent bactericidal activity.
Notes
‘Porcine animal’ means a porcine animal as defined in point (4) of Article 2 of Regulation (EU) 2020/686.
This certificate is intended for entry into the Union of semen of porcine animals, including when the Union is not 
the final destination of the semen. 
L 113 /832  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -SEM -A-ENTRY
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Cha pter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only semen 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission websi te:
https://ec.europa.eu/food/animals/semen/porcine_en
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the numbe r of containers.
Box reference I.27: “Type”: indicate semen.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen of 
the consignment is placed.
“Date ofcollection/production”: Indicate the date on which semen of the 
consignment was collected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected .
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(3)Only for a third country, territory or zone thereof with opening date in accordance with c olumn 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(4)Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en .
(5)Applicable for frozen semen.
(6)Applicable for fresh and chilled semen.
(7)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /833
CHAPTER 55
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF SEMEN OF PORCI NE ANIMALS 
COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH DIRECTIVE 
90/429/EEC BEFORE 21 APRIL 2021, DISPATCH EDAFTER 20 APRIL 2021 FROM 
THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED
(MODEL ‘POR -SEM -B-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISOcountry code I.23
L 113 /834  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /835
COUNTRY Certificate model POR -SEM -B-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, hereby certify that:
II.1. the exporting country …………………………………………………………………………
(name of exporting country)(1)
(2)either [II.1.1. has during the past 12 months been free of foot -and-mouth disease, classical swine fever and
African swine fever,
and that no vaccinations have been carried out against any of these diseases during the past 12 
months;]
(2)or [II.1.1. is recognised as free of foot -and-mouth disease without vaccination by the World Organisation 
for Animal Health (O IE) and free of classical swine fever and African swine fever, in 
accordance with the recommendations laid down in the OIE Terrestrial Animal Health Code;]
II.2. the semen collection centre(3)in which the semen in this consignment was collected:
II.2.1. was approved for export to the Union by the veterinary services of ………………………. 
(name of third country(2))and complied on date of collection with the conditions for approval 
and supervision set out in Chapter I and Chapter II of Annex A to Directive 90/429/ EEC;
II.2.2. was, during the period commencing three months prior to the date of collection of the semen in this consignment until the date of its dispatch, situated in an area not restricted due to an 
outbreak of foot -and-mouth disease, classical swine fever, African swine fever, swine vesicular 
disease, and vesicular stomatitis;
II.2.3. was, during the period commencing 30 days prior to the date of collection of the semen in this 
consignment until the date of its dispatch, free from brucellosis and Aujesz ky's disease;
(2)either [II.2.4. contained only animals that have not been vaccinated against Aujeszky's disease and met the 
requirements of Annex B to Directive 90/429/EEC.]
(2)(4)and/or [II.2.4. was a centre in which some or all of the animals have been vaccinated against Aujeszky's 
disease using a gE deleted vaccine and met the requirements of Annex B to Directive 
90/429/EEC.]
Conditions for the admission of animals to the semen collection centre
II.3. Prior to be admitted to the semen collection centre, all animals:
II.3.1. were subjected to a period of quarantine of at least 30 days in accommodation specifically 
approved for the purpose by the competent authority, and where only animals having at least 
the same health status were present (quarantine accommodation);
II.3.2. prior to entering the quarantine accommodation, were chosen from herds or holdings:
II.3.2.1. which were free of brucellosis in accordance with the Chapter on porcine brucellosis 
of the Terrestrial Animal Health Code of the World Organisation for Animal Health 
(OIE);
II.3.2.2. in which no animal vaccinated against foot and -mouth disease was present in the 
preceding 12 months;
II.3.2.3. which were not situated in a restricted area defined under the provisions of the 
national legisla tion due to an outbreak of foot -and-mouth disease, classical swine 
fever, African swine fever, swine vesicular disease, vesicular stomatitis and 
Aujeszky's disease;
II.3.2.4. in which no clinical, serological, virological or pathological evidence of Aujesz ky's 
disease was detected in the preceding 12 months;
II.3.3. prior to entering the quarantine accommodation, were not previously kept in any herd of a lower health status than described in II.3.2.;
L 113 /836  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -SEM -B-ENTRY
II.3.4. within 30 days prior to entering the quarantine accommodation referred to in point II.3.1., were 
subjected to the following tests, performed in accordance with international standards, with 
negative results:
II.3.4.1. as regards brucellosis, a buffered Bru cella antigen test (rose Bengal test), or a 
cELISA or an iELISA;
II.3.4.2. as regards Aujeszky’s disease,
(2)either [II.3.4.2.1. in the case of non -vaccinated animals, a serum neutralisation test or an 
ELISA for detecting antibodies to the whole Aujeszky’s disease virus or 
to its glycoprotein B (ADV -gB) or glycoprotein D (ADV -gD);]
(2)or [II.3.4.2.1. in the case of animals vaccinated with a gE deleted vaccine, an ELISA 
for detecting antibodies to glycoprotein E (ADV -gE);]
(2)either [II.3.5. were admitted to the centre after all of the animals had reacted with negative result to a buffered 
Brucella antigen test (rose Bengal test), or a cELISA or an iELISA carried out on samples 
collected during the last 15 days of the period of quarantine specified in point II.3.1.;]
(2)or [II.3.5. were admitted to the centre after not all of the animals had reacted with negative result to a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA carried out on 
samples collected during the last 15 days of t he period of quarantine specified in point II.3.1. 
and the suspicion of brucellosis was ruled out in accordance with point 1.5. of Chapter I of 
Annex B to Directive 90/429/EEC;]
II.3.6. were subjected to the following tests for Aujeszky's disease carried o ut on samples collected 
during the last 15 days of the period of quarantine specified in point II.3.1.:
(2)either [II.3.6.1. in the case of non -vaccinated animals, a serum neutralisation test or an ELISA for 
detecting antibodies to the whole Aujeszky’s disease virus or to its glycoprotein B 
(ADV -gB) or glycoprotein D (ADV- gD);]
(2)or [II.3.6.1. in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting 
antibodies to glycoprotein E (ADV- gE);]
(2)either [II.3.6.2. the tests referre d to in point II.3.6.1. were carried out with negative result in each 
case;]
(2)or [II.3.6.2. the animals that proved positive in a test referred to in point II.3.6.1. were removed 
immediately from the quarantine accommodation and the competent authority t ook 
all necessary measures to ensure that the remaining animals had a satisfactory health status before being admitted to the collection centre in accordance with point II.3.;]
II.3.7. All tests were carried out in a laboratory approved by the competent au thority;
II.3.8. Animals were only admitted to the semen collection centre with the express permission of the 
centre veterinarian and all animal movements, entering and exiting the semen collection centre, 
are recorded;
II.3.9. No animal admitted to the se men collection centre showed any clinical sign of disease on the 
day of admission; all animals came directly from the quarantine accommodation which, on the 
day of consignment and during the period of residency of the animals, officially fulfilled the 
following conditions:
II.3.9.1.
it was not situated in a restricted area defined under the provisions of national 
legislation due to an outbreak of foot -and-mouth disease, classical swine fever, 
African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's 
disease;
II.3.9.2. no clinical, serological, virological or pathological evidence of foot -and-mouth 
disease, classical swine fever, African swine fever, swine vesicular disease, vesicular 
stomatitis and Aujeszky's disease had been recorded for the past 30 days.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /837
COUNTRY Certificate model POR -SEM -B-ENTRY
Compulsory routine tests for animals kept at the semen collection centre
II.4. All animals kept at the semen collection centre are subjected to the following routine tests carried out 
in a laboratory approved by the competent authority:
II.4.1. as regards brucellosis, a buffered Brucella antigen test (rose Bengal test), or a cELISA or an 
iELISA;
II.4.2. as regards Aujeszky’s disease virus ,
(1)either [II.4.2.1. in the case of non -vaccinated animals, a serum neutralisation test or an ELISA for 
detecting antibodies to the whole Aujeszky’s disease virus or to its glycoprotein B 
(ADV -gB) or glycoprotein D (ADV- gD);
(1)or [II.4.2.1. in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detectin g
antibodies to glycoprotein E (ADV- gE);
II.4.3. The routine tests referred to in points II.4.1. and II.4.2. are carried out on samples taken in accordance with point 1.2. of Chapter II of Annex B to Directive 90/429/EEC in order to ensure 
that all animals in the centre have been tested at least once during their stay at that centre and at 
least every 12 months from the date of admission, if their stay exceeds 12 months;
(2)either [II.4.4. All of the animals have reacted with negative results in the routine tests referred to in points 
II.4.1. and II.4.2. carried out on samples referred to in point II.4.3.]
(2)or [II.4.4. Not all of the animals have reacted with negative results in the tests referred to in points II.4.1. 
and II.4.2., which were carried out on samples referred to in point II.4.3.:
(a) the animals which proved positive were isolated,
(b) the semen collected from each animal at the centre since the date of that animal's last 
negative test was held in separate storage from semen eligible for expor t to the 
European Union which was collected before the animal's last negative test or after the 
health status of the centre had been re -established under responsibility of the competent 
authority of the exporting country .
Conditions for semen collected at a semen collection centre and intended for export to the Union
II.5. The semen in this consignment was obtained from animals which:
II.5.1. have been resident in ………………………………(name of third country(1))for a minimum 
period of three months immediately prior to collection;
II.5.2. showed no clinical signs of disease on the day the semen was collected;
II.5.3. had not been vaccinated against foot -and-mouth disease;
II.5.4. satisfy the requirements referred to in point II.3.;
II.5.5. have not been allowed to ser ve naturally;
II.5.6. were kept in semen collection centres which were not situated in a restricted area designated 
under the provisions of the national legislation relating to foot- and-mouth disease, classical 
swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's 
disease;
II.5.7. were kept in semen collection centres in which no clinical, serological, virological or 
pathological evidence of foot -and-mouth disease, classical swine fever, African swine fever, 
swine vesicular disease, vesicular stomatitis and Aujeszky's disease has been detected in the 30 -
day period immediately prior to collection.
L 113 /838  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -SEM -B-ENTRY
II.6. An effective combination of antibiotics, in particular against leptospires, was added to the semen in this 
consignment after final dilution or to the diluent. In the case of frozen semen, antibiotics were added 
before the semen was frozen.
II.6.1. The combination of antibiotics referred to in point II.6. produced an effect at least equivalent to 
the following concentration in the final diluted semen:
(a) not less than 500 μg streptomycin per ml final dilution,
(b) not less than 500 IU penicillin per ml final dilution,
(c) not less than 150 μg lincomycin per ml final dilution,
(d) not less than 300 μg spectinomy cin per ml final dilution;
II.6.2. Immediately after the addition of the antibiotics the diluted semen was kept at a temperature of 
at least 15°C for a period of not less than 45 minutes.
II.7. The semen in this consignment:
II.7.1. has been stored as laid down in point 2(d) of Chapter I and point 6(a), (b), (e) and (f) of Chapter 
II of Annex A to Directive 90/429/EEC prior to dispatch;
II.7.2. is being transported to the country of destination in flasks which were cleaned and disinfected 
or sterilised befo re use and which have been sealed prior to dispatch from the approved storage 
facilities.
Notes
‘Porcine animal’ means a porcine animal as defined in point (4) of Article 2 of Regulation (EU) 2020/686.
This certificate is intended for entry into the Union of semen of porcine animals, including when the Union is not 
the final destination of the semen. 
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include th e United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I :
Box I.6: “Operator responsible for the consignment ”: this box is to be filled in only if it is a certificate for 
transit commodity.
Box I.7: Provide the code of the third country.
Box I.11: Place of dispatch shall correspond to the semen collection centre of the semen dispatch listed in accordance with Article 8(2) of Directive 90/429/EEC:
http://ec.europa.eu/food/animal/semen_ova/porcine/index_en.htm .
Box I.12: “Place of destination” : This box is to be filled in only if it is a certificate for transit commodity.
Box I.19: “Container number/Seal number” : Identification of container and Seal number shall be 
indicated.
Box I.21: Fill in according to whether it is a transit or an import certificate.
Box I.22: Fill in according to whether it is a transit or an import certificate.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: Identification number shall correspond to the official id entification of the animal.
“Date of collection/production” shall be indicated in the following format: dd/mm/yyyy.
“Approval or registration number of plant/establishment/centre” shall correspond to the 
approval number of the semen collection centre where the semen was collected.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /839
COUNTRY Certificate model POR -SEM -B-ENTRY
Part II:
(1)Only third country, territory or zone thereof listed in Annex XI to Commission Implementing Regulation 
(EU) 2021/404 for semen of porcine animals.
(2)Delete as necessary.
(3)Only semen collection centres listed in accordance with Article 8(2) of Directive 90/429/EEC on the 
Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.
(4)This option shall be deleted in case the Member State, or a region thereof, of destination is free of 
Aujeszky ’s disease in accordance with Article 10 of Directive 64/432/EEC, has informed the Commission 
in accordance with point 4 of Annex C to Directive 90/429/EEC and is listed on the following website: 
https://ec.europa.eu/food/animals/semen/porcine_en
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /840  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 56
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF OOCYTES AND EMBRYOS OF P ORCINE ANIMALS 
COLLECTED OR PRODUCE D, PROCESSED AND STO RED IN ACCORDANCE 
WITH REGULATION (EU) 2016/429 AND DELEGAT ED REGULATION (EU) 
2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION 
OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE 
COLLECTED OR PRODUCE D (MODEL ‘POR- OOCYTES -EMB- ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /841
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /842  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -OOCYTES- EMB- ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The oocytes(1)/ in vivo derived embryos(1)/ in vitro produced embryos(1)described in Part I are intended for 
artificial reproduction and were obtained from donor animals which originate from a third country, 
territory or zone thereof
II.1.1. authorised for entry into the Union of oocytes(1)/ in vivo derived embryos(1)/ in vitro produced 
embryos(1)/micromanipulated embryos(1)of porcine animals and listed in Annex X Ito
Commission Implementing Regulation (EU) 2021/404 ;
(1)either [II.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediate ly prior to collection of the oocytes(1)/ embryos(1)and until their date of dispatch ;]
(1)or[II.1.2. where foot -and-mouth disease was not reported for a period starting on the date(2)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1)and until 
their date of dispatch ;]
(1)either [II.1.3. where classical swine fever was not reported for a period of at least 12 months immediately 
prior to collection of the oocytes(1)/ embryos(1)and until their date of dispatch ;]
(1)or[II.1.3. where classical swine fever was not reported for a period starting on the date(3)…………. 
(insert date dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1)and until 
their date of dispatch ;]
II.1.4. where infection with rinderpest virus and African swine fever were not reported for a period 
of at least 12 months immediately prior to collection of the oocytes(1)/ embryos(1)and until 
their date of dispatch ;
II.1.5. where no vaccination against foot -and-mouth disease, infecti on with rinderpest virus and 
classical swine fever has been carried out for a period of at least 12 months immediately prior 
to collection of the oocytes(1)/ embryos(1)and until their date of dispatch ,and no vaccinated 
animals entered into the third country, territory or zone thereof during that period.
(1)(4)[II.1.6. free from infection with Aujeszky’s disease virus or where an approved eradication 
programme for infection with Aujeszky’s disease virus is carried out.]
II.2. The oocytes(1)/ embryos(1)described in Part I were obtained from donor animals which originate from 
establishments 
II.2.1. in which infection with Brucella abortus, B. melitensis and B. suis in porcine animals has not 
been reported during the last 42 days prior to collection of t he oocytes(1)/ embryos(1), and in 
which during at least the last 12 month period prior to collection of the oocytes(1)/ embryos(1)
(1)either [II.2.2.1. biosecurity and risk mitigating measures, including housing conditions and feeding 
systems, have been a pplied as necessary to prevent transmission of infection with 
Brucella abortus, B. melitensis and B. suis from wild animals of listed species to 
porcine animals kept on the establishment and only porcine animals from 
establishments applying equivalent bios ecurity measures have been introduced;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /843
COUNTRY Certificate model POR -OOCYTES- EMB- ENTRY
(1)and/or [II.2.2.2. surveillance for infection with Brucella abortus, B. melitensis and B. suis has been
carried out on the porcine animals kept on the establishments in accordance with 
Annex III to Commission Delegated Regulation (EU) 2020/688, and during the 
same period
–only porcine animals from establishments applying the biosecurity measures or 
the surveillance measures provided for in point II.2.2.1. or II.2.2.2. have been 
introduced in the establishment; and
–in case infection with Brucella abortus, B. melitensis and B. suis has been 
reported in porcine animals kept on the establishment, measures were taken in 
accordance with Part 1(3) of Annex II to Delegated Regulation (EU) 
2020/688;]
II.2.2. where no clinical, serological, virological or pathological evidence of infection with 
Aujeszky’s disease virus had been detected during the period of at least 12 months prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1).
(1)[II.3. The in vivo derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embryo collection team(5)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 2020/686.]
(1)[II.3. The oocytes(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)described in Part I have been 
collected or produced, processed and stored, and dispatched by the embryo production team(5)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Parts 2 and 3 of Annex I to Commission Delegated Regulation (EU) 
2020/686.]
II.4. The oocytes(1)/ embryos(1)described in Part I were obtained from donor animals which
II.4.1. were not vaccinated against infection with rinderpest virus, classical swine fever and infection 
with porcine reproductive and respiratory syndrome virus;
II.4.2. remained for a period of at least 3 months prior to the date of collection(1)/ production(1)ofthe 
oocytes(1)/ embryos(1)in a third country or territory or zone thereof referred to in Box I.7.;
II.4.3. for a period of at least 30 days prior to the date of collection(1)/ production(1)of the oocytes(1)/ 
embryos(1)and during the collection period 
II.4.3.1. were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
classical swine fever orAfrican swine fever ,or of an emerging disease relevant 
for porci ne animals;
II.4.3.2. were kept on a single establishment where infection with Brucella abortus, B. 
melitensis and B. suis , infection with rabies virus, anthrax, infection with 
Aujeszky’s disease virus and infection with porcine reproductive and respirator y
syndrome virus have not been reported;
II.4.3.3. were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.3.1. or from 
establishments which do not meet the conditions r eferred to in point II.4.3.2.;
II.4.3.4. were not used for natural breeding;
L 113 /844  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -OOCYTES- EMB- ENTRY
II.4.4. have been clinically examined by the team veterinarian or a team member and did not show 
symptoms of transmissible diseases on the day of collection(1)/ production(1)of the oocytes(1)/ 
embryos(1); 
II.4.5. are individually identified as provided for in Article 21(1) of Commission Delegated 
Regulation (EU) 2020/692;
II.4.6. comply with the following conditions as regards foot -and-mouth disease 
II.4.6.1. they come from establishments 
−situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the establishment for a period of at least 30 
days immediately prior to the date of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1);
−in which foot -and-mouth disease has not been reported during a period of at 
least 3 months immediately prior to the date of collection(1)/ production(1)of 
the oocytes(1)/ embryos(1);
(1)either [II.4.6.2. they were not vaccinated against foot -and-mouth disease;]
(1)(6)or[II.4.6.2. they were vaccinated against foot- and-mouth disease during the period of 12 
months prior to the date of collection of the embryos and
II.4.6.2.1. have not been vaccinated against foot -and-mouth disease within the 
period of at least 30 days immediately prior to the date of collection 
of the embryos;
II.4.6.2.2. the semen used for fertilisation was collected from a male donor that 
complies with the conditions set out in point 1(b) of Chapter I of Part 
5 of Annex II t o Delegated Regulation (EU) 2020/686 or the semen 
complies with the conditions set out in point 2 of Chapter I of Part 5 
of Annex II to Delegated Regulation (EU) 2020/686;
II.4.6.2.3. prior to freezing, the embryos have been subjected to trypsin 
washing ca rried out in accordance with the recommendations of the 
IETS Manual(7);
II.4.6.2.4. the embryos were stored deep frozen for a period of at least 30 days 
from the date of collection, and during this period the donor animal 
has not shown clinical signs of fo ot-and-mouth disease;]
(1)(8)[II.4.7. were subjected to a serological test for infection with porcine reproductive and respiratory 
syndrome virus, with negative results, on two occasions, at an interval of not less than 21 
days, the second test being perf ormed within a period of 15 days prior to embryo collection.]
II.5. The oocytes(1)/ embryos(1)described in Part I
II.5.1. has been collected, processed and stored in accordance with animal health requirements set 
out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to Delegated Regulation (EU) 
2020/686;
II.5.2. areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that 
mark is indicated in Box I.27;
II.5.3. are transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch by the embryo collection or 
production team under responsibility of the team veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /845
COUNTRY Certificate model POR -OOCYTES- EMB- ENTRY
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use 
container; 
(1)(9)[II.5.3.3. has been filled in with the cryogenic agent which not have been previously used
for other products;]
(1)(10)[II.5.4. are placed in straws or other packages which are securely and hermetically sealed;
II.5.5. are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
(1)(11)[II.6. The in vivo derived embryos(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)
described in Part I were conceived by artificial insemination using semen coming from a semen collection 
centre, germinal product pr ocessing establishment or germinal product storage centre approved for the 
collection, processing and/or storage of semen by the competent authority of a third country, territory or zone thereof listed in Annex XI to Implementing Regulation (EU) 2021/404 for semen of porcine animals 
or by the competent authority of a Member State.]
(1)(12)[II.7. The following antibiotic or mixture of antibiotics(13)has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]
Notes
‘Porcine animal’ means a porcine animal as defined in point (4) of Article 2 of Regulation (EU) 2020/686.
This certificate is intended for entry into the Union of oocytes and embryos of porcine animals, including when the 
Union is not the final destination of the oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to t he notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the emb ryo collection or production team of dispatch of the consignment of oocytes or 
embryos. Only embryo collection or production teams listed in accordance with 
Article 233(3) of Regulation (EU) 2016/429 on the Commission website:
https://ec.europa.eu/food/animals/semen/porcine_en .
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of des tination of the consignment of oocytes or embryos.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
L 113 /846  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -OOCYTES- EMB- ENTRY
Box reference I.27: “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced 
embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where oocy tes or 
embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which oocytes or embryos of the 
consignment was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(3)Only for a third country, territory or zone thereof with opening date in accordance with column 9 i n part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(4)Not applicable for in vivo derived embryos subject to trypsin treatment.
(5)Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine _en.
(6)Option available only for the consignment of in vivo derived embryos.
(7)Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society ,1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA ( http://www.iets.org/ ).
(8)Applicable for in vivo derived embryos.
(9)Applicable for frozen oocytes or embryos.
(10)Applicable for the consignment where in one container oocytes, in vivo derived embryos, in vitro produced 
embryos and micromanipulated embryos of porcine animals are placed and transported.
(11)Does not apply to oocytes.
(12)Mandatory attes tation in case antibiotics were added.
(13)Insert the name(s) of the antibiotic(s) added and its(their) concentration.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /847
CHAPTER 57
MODEL ANIMAL HEALTH CERTIFICATE FOR ENTRY INTO THE UNION OF 
CONSIG NMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PRO CESSING 
ESTABLISHMENT:
-semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of semen of porcine animals collected, processed and stored in accordance with Council 
Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine ani mals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021
(MODEL ‘POR -GP-PROCESSING -ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /848  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /849
COUNTRY Certificate model POR -GP-PROCESSING -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)to be exported to 
the European Union was/were processed and stored:II.1.1. is located in a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen
(2)/ oocytes(2)/ in vivo derived embryos(2)/ in 
vitro produced embryos(2)/ micromanipulated embryos(2)of porcine animals and listed 
in Annex XI to Commission Implementing Regulation (EU) 2021/404 ;
(2)either [II.1.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.2. where foot -and-mouth disease was not reported for a period starting on the date(3)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
(2)either [II.1.1.3. where classical swine fever was not reported for a period of at least 12 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.3. where classical swine fever was not reported for a period starting on the date(4)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
II.1.1.4. where infection with rinderpest virus and African swine fever were not reported for a 
period of at least 12 months immediately prior to collection(2)/ production(2)of the 
semen(2)/ oocytes(2)/embryos(2)and until its/their date of dispatch ;
II.1.1.5. where no vaccination against foot -and-mouth disease, infection with rinderpest virus 
and classical swine fever has been carried out for a period of at least 12 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ,and no vaccinated animals entered into the third 
country, territory or zone thereof during that period;
II.1.2. is approved and listed by the competent authority of the third country or territory;
II.1.3. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(5)/ by an 
embryo collection team(2)(5)/ by an embryo production team(2)(5),and/or processed and stored in a 
germinal product processing establishment(2)(5),and/or stored in a germinal product storage 
centre(2)(5)complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of 
Annex I to De legated Regulation (EU) 2020/686, and
(2)either [located in the exporting country;]
L 113 /850  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -GP-PROCESSING -ENTRY
(2)and/or [located in ………………………….(6), and has/have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of porcine 
animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation 
(EU) 2020/692;]
II.2.2. was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at lea st as strict as described in:
((2)either [Model POR -SEM -A-ENTRY(7);]
(2)and/or [Model POR -SEM -B-ENTRY(7);]
(2)and/or [Model POR -OOCYTES -EMB -ENTRY(7);]
(2)and/or [Model POR -GP-PROCESSING -ENTRY(7);]
(2)and/or [Model POR -GP-STORAGE -ENTRY(7);]
II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/are
placed in straws or other packages on which the mark is applied in accordance with 
requir ements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark 
is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.5.2. has been cleaned and either disinfected or sterilised before u se, or is single -use 
container; 
(2)(8)[II.2.5.3. has been filled in with the cryogenic agent which not have been previously used for other products.]
(2)(9)[II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
‘Porcine animal’ means a porcine animal as defined in point (4) of Article 2 of Regulation (EU) 2020/686.
This certificate is intended for entry into the Union of semen, oocytes and embryos of porcine animals, including 
when the Union is not the final destination of the semen, oocytes and embryos. 
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protoc ol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /851
COUNTRY Certificate model POR -GP-PROCESSING -ENTRY
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes and/or embryos. Only germinal product processing establishments 
listed in accordance with Articl e 233(3) of Regulation (EU) 2016/429 on the 
Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm . 
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s ) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centr e where the semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certif icate.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are pl aced. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/sem en/porcine_en .
(2)Delete if not applicable.
(3)Only for a third country, territory or zone thereof with opening date in accordance with column 1 in part 9 of 
Annex II to Implementing Regulation (EU) 2021/404.
(4)Only for a third country, territory or zone thereof with opening date in accordance with column 1 in part 9 of 
Annex II to Implementing Regulation (EU) 2021/404.
L 113 /852  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -GP-PROCESSING -ENTRY
(5)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porc ine_en .
(6)Only a third country, territory or zone thereof listed in Annex XI to Implementing Regulation (EU) 2021/404
for semen of porcine animals and the EU Member States.
(7)The original(s) of the document(s) or the health certificate(s) or the offic ially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were col lected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product proce ssing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.
(8)Applicable for frozen semen, oocytes or embryos.
(9)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro 
produced embryos and micromanipulated embryos of porcine animals are placed and transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /853
CHAPTER 58
MODEL ANIMAL HEALTH CERTIFICATE FOR ENTRY INTO THE UNION OF 
CONSIG NMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STO RAGE CENTRE:
-semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of semen of porcine animals collected, processed and stored in accordance with Council 
Directive 90/429/EEC before 21 April 2021;
-oocytes and embryos of porcine animals collec ted or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021
(MODEL ‘POR -GP-STORAGE- ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /854  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /855
COUNTRY Certificate model POR -GP-STORAGE -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo
derived embryos(2)/ in vitro produced embryos(2)to be exported to the European Union was/were stored:
II.1.1. is located in a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen(2)/ oocytes(2)/ in vivo derived embryos(2)/ in 
vitro produced embryos(2)/ micromanipulated embryos(2)of porcine animals and listed 
in Annex XI to Commission Implementing Regulation (EU) 2021/404 ;
(2)either [II.1.1.2. where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.2. where foot -and-mouth disease was not reported for a period starting on the date(3)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
(2)either [II.1.1.3. where cla ssical swine fever was not reported for a period of at least 12 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ;]
(2)or[II.1.1.3. where classical swine fever was not reported for a period starting on the date(4)
…………. ( insert date dd/mm/yyyy) immediately prior to collection(2)/ production(2)of 
the semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
II.1.1.4. where infection with rinderpest virus and African swine fever were not reported for a 
period of at least 12 months immediately prior to collection(2)/ production(2)of the 
semen(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch ;
II.1.1.5. where no vaccination against foot -and-mouth disease, infection with rinderpest virus 
and classical swine fever has been carried out for a period of at least 12 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch ,and no vaccinated animals entered into the third 
country, territory or zone thereof during that period;
II.1.2. is approved and listed by the competent authority of the third country or territory;
II.1.3. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(5)/ by an 
embryo collection team(2)(5)/ by an embryo production team(2)(5),and/or processed and stored in a 
germinal product processing establishment(2)(5),and/or stored in a germinal product storage 
centre(2)(5)complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of 
Annex I to Delegated Regulation (EU) 2020/686, and
(2)either [located in the exporting country;]
L 113 /856  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -GP-STORAGE -ENTRY
(2)and/or [located in ………………………….(6), and has/have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of porcine 
animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation 
(EU) 2020/692;]
II.2.2. was/were moved to the germinal product storage centre described in Box I.11. under conditions at 
least as strict as described in:
(2)either [Model POR -SEM -A-ENTRY(7);]
(2)and/or [Model POR -SEM -B-ENTRY(7);]
(2)and/or [Model POR -OOCYTES -EMB -ENTRY(7);]
(2)and/or [Model POR -GP-PROCESSING -ENTRY(7);]
(2)and/or [Model POR -GP-STORAGE -ENTRY(7);]
II.2.3. has/have been collected, processed and stored in accor dance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark 
is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;
II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(8)[II.2.5.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;]
(2)(9)[II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
‘Porcine animal’ means a porcine animal as defined in point (4) of Article 2 of Regulation (EU) 2020/686.
This certificate is intended for entry into the Union of semen, oocytes and embryos of porcine animals, including 
when the Union is not the final destination of the semen, oocytes and embryos. 
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /857
COUNTRY Certificate model POR -GP-STORAGE -ENTRY
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germinal product storage centres listed in accordance with 
Article 233(3) of Regulati on (EU) 2016/429 on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
corre spond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection a nd/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the s emen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.
Box reference I. 19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are pl aced. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission website: https://ec.europa.eu/food/animals/semen/porcine _en.
(2)Delete if not applicable.
(3)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of Annex II to Implementing Regulation (EU) 2021/404.
L 113 /858  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model POR -GP-STORAGE -ENTRY
(4)Only for a third country, territory or zone thereof with opening date in accordance with column 9 in part 1 of 
Annex II to Implementing Regulation (EU) 2021/404.
(5)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en .
(6)Only a third country, territory or zone thereof listed in Annex XI to Impleme nting Regulation (EU) 2021/404
for semen of porcine animals and the EU Member States.
(7)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch described in Box I.11 must be atta ched to this certificate.
(8)Applicable for frozen semen, oocytes or embryos.
(9)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of porcine animals are placed and transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /859
CHAPTER 59
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF SEMEN OF EQUINE ANIM ALS COLLECTED, PROCESSED 
AND STORED IN ACCORD ANCE WITH REGULATION (EU) 2016/429 AND 
DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED 
FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS 
COLLECTED (MODEL ‘EQ UI-SEM -A-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /860  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /861
COUNTRY Certificate model EQUI- SEM -A-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals 
which originate 
II.1.1.  from a third country, territory or zone thereof
II.1.1. 1.authorised for entry into the Union of semen of equine animals and listed in Annex X IIto 
Commission Implementing Regulation (EU) 2021/404 ;
II.1.1.2.in which African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei (glanders), surra ( Trypanosoma evansi), dourine (Trypanosoma 
equiperdum), equine infectious anaemia, infection with rabies virus, anthrax, infection with 
equine arteritis virus and contagious equine metritis ( Taylorella equigenitalis ) are notifiable 
diseases;
II.1.1.3.free from African horse sickness for a period of at least 24 months immediately prior to 
collection of the semen and until its date of dispatch in accordance with Article 22(2)(a) of 
Delegated Regulation (EU) 2020/692, and where no systematic vaccination aga inst African 
horse sickness has been carried out for a period of at least 12 months immediately prior to 
collection of the semen and until its date of dispatch in accordance with Article 22(4)(b) of 
that Regulation;
II.1.1.4.where Venezuelan equine encephalomyelitis was not reported for a period of at least 24 
months immediately prior to collection of the semen and until its date of dispatch ;
II.1.2.  from an establishment in a third country, territory or zone thereof
(1)eithe r[II.1.2.1.where infection with Burkholderia mallei (glanders) was not reported for a period of at least 
36 months immediately prior to collection of the semen and until its date of dispatch ;]
(1)or[II.1.2 .1.from the establishment of origin where infec tion with Burkholderia mallei (glanders) was not 
reported for a period of at least 6 months immediately prior to collection of the semen and until its date of dispatch , and the Commission has recognised the surveillance programme 
carried out in breeding eq uine animals in the establishment of origin to demonstrate absence 
of infection during that period of 6 months;]
(1)either [II.2.2.where dourine was not reported for a period of at least 24 months immediately prior to 
collection of the semen and until its date of dispatch ;]
(1)or[II.1.2 .2.from the establishment of origin where dourine was not reported for a period of at least 6 
months immediately prior to collection of the semen and until its date of dispatch , and the 
Commission has recognised the sur veillance programme carried out in breeding equine 
animals in the establishment of origin to demonstrate absence of infection during that period of 6 months;]
(1)either [II.2.3.where surra ( Trypanosoma evansi) was not reported for a period of at least 24 months 
immediately prior to collection of the semen and until its date of dispatch .]
(1)or[II.2.3.from the establishment of origin where surra ( Trypanosoma evansi) was not reported for a 
period of at least 6 months immediately prior to collection of the semen and until its date of 
dispatch , and the Commission has recognised the surveillance programme carried out in 
breeding equine animals in the establishment of origin to demonstrate absence of infection 
during that period of 6 months.]
L 113 /862  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -A-ENTRY
II.2. The semen described in Part I was obtained from donor animals which originate, before entering the semen 
collection centre, from establishments 
II.2.1. in which surra (Trypanosoma evansi) has not been reported during the period of the preceding 30 days pr ior to collection of the semen, and 
(1)either [surra has not been reported in the establishment during the period of the preceding 2 years prior to collection of the semen;]
(1)or [surra has been reported in the establishment during the period of the prec eding 2 years prior to 
collection of the semen and following the last outbreak the establishment has remained under 
movement restriction s
(1)either [until the remaining animals in the establishment have been subjected to a test for surra with one of the di agnostic methods provided for in Part 3 of Annex I to Commission Delegated 
Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 
months after the last infected animal has been removed from the establishment;]]
(1)or [for at least 30 days from the date of cleaning and disinfection after the last animal of listed 
species on the establishment was either killed and destroyed or slaughtered.]]
II.2.2. in which dourine has not been reported during the period of the preceding 6 months prior to 
collection of the semen, and
(1)either [dourine has not been reported in the establishment during the period of the preceding 2 years prior 
to collection of the semen;]
(1)or [dourine has been reported in the establishment during the perio d of the preceding 2 years prior to 
collection of the semen and following the last outbreak, the establishment has remained under 
movement restriction s
(1)either [untilthe remaining equine animals in the establishment, except castrated male equine 
animals, have been subjected to a test for dourine with the diagnostic method provided for in 
Part 8 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, 
on samples taken at least 6 months after the infected animals have been kille d and destroyed 
or slaughtered, or the infected entire male equine animals have been castrated;]]
(1)or [for at least 30 days after the last equine animal on the establishment was either killed and 
destroyed or slaughtered, and the premises were cleaned a nd disinfected;]]
II.2.3. in which equine infectious anaemia has not been reported during the period of the preceding 90 days 
prior to collection of the semen, and
(1)either [equine infectious anaemia has not been reported on the establishment during the period of the 
preceding 12 months prior to collection of the semen;]
(1)or [equine infectious anaemia has been reported on the establishment during the period of the preceding 
12 months prior to collection of the semen and following the last outbreak the e stablishment has 
remained under movement restrictions
(1)either [until the remaining equine animals in the establishment have been subjected to a test for 
equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I to Delegated R egulation (EU) 2020/688, carried out, with negative results, on samples taken 
on two occasions with a minimum interval of 3 months after the infected animals have been 
killed and destroyed or slaughtered and the establishment was cleaned and disinfected;]]
(1)or [for at least 30 days after the last equine animal on the establishment was either killed and 
destroyed or slaughtered, and the premises were cleaned and disinfected;]]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /863
COUNTRY Certificate model EQUI- SEM -A-ENTRY
II.2.4. in which during the period of 30 days prior to the date of collection of the semen no equine animal 
has shown signs of infection with equine arteritis virus and of contagious equine metritis.
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen 
collection centre(2)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686.
II.4. The semen described in Part I was obtained from donor animals which
II.4.1. were not vaccinated against African horse sickness at least in the last 40 days prior to collection of 
the semen; 
II.4.2. were not vaccin ated against Venezuelan equine encephalomyelitis at least in the last 60 day period 
prior to collection of the semen;
II.4.3. remained for a period of at least 3 months prior to the date of collection of the semen in a third 
country or territory or zone th ereof referred to in Box I.7.;
II.4.4. for a period of at least 30 days prior to the date of collection of the semen and during the collection 
period 
II.4.4.1. were kept on establishments not situated in a restricted zone established due to the 
occurrence of African horse sickness, infection with Burkholderia mallei (glanders) or of an 
emerging disease relevant for equine animals;
II.4.4.2. were kept on a single establishment where Venezuelan equine encephalomyelitis, dourine, surra ( Trypanosoma evansi ), equine infections anaemia, infection with equine arteritis virus, 
contagious equine metritis, infection with rabies virus and anthrax have not been reported;
II.4.4.3. were not in contact with animals from establishments situated in a restricted zone due to the 
occurrence of diseases referred to in point II.4.4.1. or from establishments which do not 
meet the conditions referred to in point II.4.4.2.;
II.4.5. were not used for natural breeding during a period of at least 30 days prior to the date of first sem en 
collection and between the dates of the first sample referred to in points II.4.8.1., II.4.8.2. and/or 
II.4.8.3. and until the end of the collection period;
II.4.6. did not show symptoms of transmissible diseases on the day of admission to the semen col lection 
centre and on the day the semen was collected;
II.4.7. are individually identified as provided for in Article 21(2) of Delegated Regulation (EU) 2020/692;
II.4.8. have been subjected to the following tests, referred to in point 1(a) of Chapter I of Part 4 of Annex II 
to Delegated Regulation (EU) 2020/686, as follows:
(3)[II.4.8.1. for infection with equine infectious anaemia (EIA), an agar -gel immuno -diffusion test 
(AGID or Coggins test) or an enzyme -linked immunosorbent assay (ELISA) with a negative
result;]
II.4.8.2. for infection with equine arteritis virus (EVA),
(1)either [II.4.8.2.1.a serum neutralisation test with a negative result at a serum dilution of one in 
four;]
(1)and/or [II.4.8.2.2.a virus isolation test, polymerase chain reaction (PCR) or real -time PCR with a 
negative result on an aliquot of the entire semen of the donor stallion;]
L 113 /864  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -A-ENTRY
II.4.8.3. for contagious equine metritis (CEM), an agent identification test carried out on three 
specimens (swabs) taken from the donor stallion on two occasions with an interval of not 
less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis;
The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local 
treatment) after antimicrobial treatment of the donor stallion and were placed in transport 
medium with activated charcoal, such as Amies medium, before dispatch to the laboratory 
where they were subjected with a negative result to a test for:
(1)either [II.4.8.3.1.the isolation of Taylorella equigenitalis after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within 24 hours after taking the 
specimens from the donor animal, or 48 hours where the specimens are kept cool 
during transport;]
(1)and/or [II.4.8.3.2.the detection of genome of Taylorella equigenitalis by PCR or real -time PCR, 
carried out within 48 hours after taking the specimens from the donor animal;]
II.4.9. were subjected with the results specified in point II.4.8. in each case to at least one of the following 
testing programmes detailed respectively in points 1(b)(i), (ii) and (iii) of Chapter I of Part 4 of 
Annex II to Delegated Regulation (EU) 2020/686:
(4)[II.4.9.1. The donor stallion was continuously resident at the semen collecti on centre for a period of 
at least 30 days prior to the date of the first collection and during the period of collection of 
the semen described in Part I, and no equine animals in the semen collection centre came 
during that time into direct contact with e quine animals of lower health status than the donor 
stallion.
The tests described in point II.4.8. were carried out on samples taken(5)from the donor 
stallion at least once a year at the beginning of the breeding season or prior to the first 
collection of semen intended for entry into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commence ment of the residence period of at 
least 30 days prior to the first semen collection.]
(4)[II.4.9.2. The donor stallion was resident on the semen collection centre for a period of at least 30 
days prior to the date of the first collection and during the pe riod of collection of the semen 
described in Part I, but left the semen collection centre under the responsibility of the centre 
veterinarian for a continuous period of less than 14 days during the collection period, or 
other equine animals in the semen collection centre came into direct contact with equine 
animals of a lower health status.
The tests described in point II.4.8. were carried out on samples taken(5)from the donor 
stallion at least once a year at the beginning of the breeding season or prior to the date of the 
first collection of semen intended for entry into the Union of fresh, chilled or frozen semen 
and not less than 14 days following the date of the commencement of the residence period 
of at least 30 days prior to the first semen collection , and during the period of collection of 
the semen intended for entry into the Union of fresh, chilled or frozen semen the donor 
stallion was subjected to the tests described in point II.4.8., as follows:
(a) for equine infectious anaemia, one of the tests described in point II.4.8.1. was last 
carried out on a sample of blood taken(5)not more than 90 days prior to the collection 
of the semen described in Part I;
(b) for infection with equine arteritis virus, one of the tests described
(1)either [in point I I.4.8.2. was last carried out on a sample taken(5)not more than 30 days prior 
to the date of the collection of the semen described in Part I;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /865
COUNTRY Certificate model EQUI- SEM -A-ENTRY
(1)or [in point II.4.8.2.2., in case the non- shedder state of a donor stallion seropositive for 
infection with equine arteritis virus is confirmed, was carried out on an aliquot of the 
entire semen of the donor stallion taken(5)not more than 6 months prior to the date of 
the collection of the semen described in Part I and a blood sample taken(5)from the 
donor st allion during the 6 months period reacted with a positive result in a serum 
neutralisation test for infection with equine arteritis virus at a serum dilution of more 
than one in four;] 
(c) for contagious equine metritis, the test described in point II.4.8.3. was last carried out 
on three specimens (swabs) taken(5)not more than 60 days prior to the date of the 
collection of semen described in Part I
(1)either [on two occasions;]
(1)or [on a single occasion and subjected to a PCR or real -time PCR.]]
(4)[II.4.9.3. The donor stallion does not meet the conditions set out in points 1(b)(i) and (ii) of Chapter 
I of Part 4 of Annex II to Delegated Regulation (EU) 2020/686 and the semen is collected 
for entry into the Union as frozen semen.
The tests described in points II.4.8.1, II.4.8.2 and II.4.8.3 were carried out on samples 
taken(5)from the donor stallion at least once a year at the beginning of the breeding season, 
and the tests described in points II.4.8.1 and II.4.8.3. were carried out on samples taken(5)
from the donor stallion during the storage period of the semen of a minimum period of 30 
days from the date of the collection of the semen and before the semen is removed from the semen collection centre, not less than 14 days and not more than 90 days after the collection 
of the semen described in Part I, and
(1)either [the tests for infection with equine arteritis virus described in point II.4.8.2. were carried out 
on samples taken(5)during the storage period of the semen of a minimum period of 30 day s
from the date of the collection of the semen and before the semen is removed from the 
semen collection centre or used, not less than 14 days and not more than 90 days after the 
date of the collection of the semen described in Part I.]
(1)or [the non- shedder state of a donor stallion seropositive for infection with equine arteritis virus 
was confirmed by virus isolation test, PCR or real -time PCR carried out with a negative 
result on samples of an aliquot of the entire semen of the donor stallion taken(5)twice a year 
at an interval of at least 4 months and the donor stallion has reacted with a positive result at a 
serum dilution of at least one in four in a serum neutralisation test for infection with equine 
arteritis virus.]
L 113 /866  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -A-ENTRY
II.4.10. underwent the testing provided for in point II.4.9. on samples taken on the following dates:Identification 
of semen
Test 
programmeStart date(5)Date of sampling for health tests(5)
Donor 
residenceSemen 
collectionEIA II.4.8.1.EVA II.
4.8.2.CEM
II.4.8.3.
Blood 
sampleSemen 
sample1. sample 2. sample
II.5. The semen described in Part I
II.5.1. has been collected, processed and stored in accordance with animal health requirements set out in 
points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/686;
II.5.2. isplaced in straws or other packages on which the mark is applied in accordance with requirements 
provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in 
Box I.27;
II.5.3. is transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch from the semen collection centre under 
responsibility of the centre veterinarian, or by an official veteri narian, and the seal bears the 
number as indicated in Box I.19;
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use container; 
(1)(6)[II.5.3.3. has been filled in with the cryogenic agent which not have been previously used for other products.]
(1)(7)[II.6. The semen is preserved by the addition of antibiotics as follows:
II.6.1. The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or 
is contained in the used semen di luents, to reach the indicated concentration per ml of semen:
(1)either [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]
(1)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]
(1)or [a mixture of amikacin (75 μg) and divekacin (25 μg);]
(1)or [an antibiotic or a mixture of antibiotics(8)…………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:
-gentamicin (250 μg), tylosin (50 μg) and lincomycin- spectinomycin (150/300 μg);
-lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);
-amikacin (75 μg) and divekacin (25 μg).]
II.6.2. Immediately after the addition of the antibiotics, and before any possible freezing, the diluted semen 
was kept at a temperature of at least 5°C for a period of not less than 45 minutes, or under a time -
temperature regime with a documented equivalent bactericidal activity.]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /867
COUNTRY Certificate model EQUI- SEM -A-ENTRY
Notes
This certificate is intended for entry into the Union of semen of equine animals, including when the Union is not the 
final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the Europe an Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in res pect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only semen 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission website:
https://ec.europa.eu/food/animals/semen/equine_en
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval number 
of the establishment of destination of the consignment of semen.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the numbe r of containers.
Box reference I.27: “Type” : Indicate semen.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen of the 
consignment is placed. 
“Date of collection/production”: Indicate the date on which semen of the consignment 
was collected in the following format: dd.mm.yyyy.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
Guidance for the completion of the table in point II.4.10.
Abbreviations:
EIA-1 Equine infectious anaemia (EIA) testing f irst occasion
EIA-2 EIA testing second occasion
EVA -B1 Infection with equine arteritis virus (EVA) testing on blood sample first occasion
EVA -B2 EVA testing on blood sample second occasion
EVA -S1 EVA testing on semen sample first occasion
EVA -S2 EVA testing on semen sample second occasion
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11
CEM -21 CEM testing second occasion first sample
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21
L 113 /868  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -A-ENTRY
Instructions:
For each semen identified in column A in correspondence with Box I.27, the test programme (points II.4.9.1., 
II.4.9.2. and/or II.4.9.3.) shall be specified in column B, and columns C and D shall be completed with the dates 
required.
The dates when samples were taken for laboratory testing prior to the first collection of the semen described in 
Part I as required in points II.4.9.1., II.4.9.2. and II.4.9.3., shall be entered in the uppe r line of columns 5 to 9 of 
the table, this being the boxes marked with EIA -1, EVA -B1 or EVA- S1 and CEM -11 and CEM- 12 in the 
example below.
The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.9.2. 
or II.4.9.3. shall be entered in the lower line of columns 5 to 9 in table, this being the boxes EIA- 2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM- 22 in the example below.Identification 
of semen
Test 
programmeStart date Date of sampling for health tests
Donor 
residenceSemen 
collectionEIA II.4.8.1.EVA
II.4.8.2.CEM
II.4.8.3.
Blood 
sampleSemen 
sample1.sample 2.sample
A B C DEIA-1 EVA-B1 EVA-S1 CEM -11 CEM -12
EIA-2 EVA-B2 EVA-S2 CEM -21 CEM -22
(1)Delete if not applicable.
(2)Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: https://ec.europa.eu/food/animals/semen/equine_en .
(3)The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not 
required for donor equine animals which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equine animals and their semen, oocytes and embryos have been introduced into Iceland from outside prior to and during the period the semen 
was collected.
(4)Cross out the programmes that do not apply to the consignment.
(5)Inser t date in table in point II.4.10 (follow Guidance in Part II of the Notes).
(6)Applicable for frozen semen.
(7)Mandatory attestation in case antibiotics were added.
(8)Insert the name(s) of the antibiotic(s) added and its(their) concentration or the com mercial name of the semen 
diluent containing antibiotics.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /869
CHAPTER 60
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED,
PROCESSED AND STORED IN ACCORDANCE WITH DIRECTIVE 92/65/EEC 
AFTER 30 SEPTEMBER 2014 AND B EFORE 21 APRIL 2021, DISPATCHED AFTER 
20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEM EN 
WAS COLLECTED (MODEL ‘EQUI -SEM -B-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /870  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /871
COUNTRY Certificate model EQUI- SEM -B-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, of the exporting country (1)………………………………….… hereby
(name of exporting country )
certify that:
II.1. The semen collection centre(2), in which the semen described in Part I was collected, processed and 
stored for export to the Union was approved and supervised by the competent authority in 
accordance with the conditions of Chapters I(I)(1) and I(II)(1) of Annex D to Directive 
92/65/EEC(3);
II.2. During the period commencing 30 days prior to the date of first collection of the semen described in 
Part I until the date the fresh or chilled semen was dispatched or until the 30 days storage period for 
frozen semen elapsed, the semen collection centre:
II.2.1. was situated in the exporting country or, in t he case of regionalisation according to Article 13 of 
Directive 2009/156/EC(4), in that part of the territory of the exporting country which was:
‒not considered to be infected with African horse sickness in accordance with Article 5(2)(a)and 
(b) of Direc tive 2009/156/EC,
‒free from Venezuelan equine encephalomyelitis for a period of at least 2 years,
‒free from glanders and dourine for a period of at least 6 months;
II.2.2. fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in 
particular:
(5)either [II.2.2.1. following a case of a disease mentioned below not all the animals of species susceptible to 
that disease located in the holding were slaughtered or killed and the holding has been 
free:
‒ from any type of equine encephalomyelitis for a period of at least 6 months, 
beginning on the day on which the equidae suffering from the disease are 
slaughtered,
‒ from equine infectious anaemia (EIA) for at least the period required to obtain a 
negative result in an aga r gel immunodiffusion test (AGID or Coggins test) carried 
out on samples taken after the infected animals were slaughtered on two occasions 
three months apart from each of the remaining animals,
‒ from vesicular stomatitis (VS) for a period of at least 6 m onths from the last recorded 
case,
‒ from rabies for a period of at least one month from the last recorded case,
‒ from anthrax for a period of at least 15 days from the last recorded case,]
(5)or [II.2.2.1. following a case of a disease mentioned below al l the animals of species susceptible to that 
disease located in the holding have been slaughtered or killed and the premises 
disinfected, and the holding was free for a period of at least 30 days from any type of 
equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 
days in the case of anthrax, beginning on the day on which following the destruction of the 
animals the disinfection of the premises was satisfactorily completed;]
II.2.3. contained only equidae which were free of clinical signs of equine viral arteritis and contagious 
equine metritis,
L 113 /872  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -B-ENTRY
II.3. Prior to entering the semen collection centre the donor stallions and any other equidae located in the 
centre:
II.3.1. were continuously resident for a period of three months (or since entry if they were directly 
imported from a Member State of the Union during the three months period) in the exporting 
country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC, in 
that part of the territory of the exporting country which was during that period:
‒not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and 
(b) of Directive 2009/156/EC,
‒free from Venezuelan equine encephalomyelitis for a period o f at least 2 years,
‒free from glanders and dourine for a period of at least 6 months;
(5)either [II.3.2. originated from the country of export which was on the day of admission into the centre free from 
vesicular stomatitis (VS) for a period of at least 6 months,]
(5)or [II.3.2. were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a negative 
result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result in accordance 
with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of 
the OIE on a blood sample taken(6)within 14 days prior to entering the centre;]
II.3.3. originated from holdings which on the day of admission onto the centre fulfilled the require ments of 
point II.2.2.;
II.4. The semen described in Part I was collected from donor stallions which:
II.4.1. did not show any clinical sign of an infectious or contagious disease at the time of admission onto the semen collection centre and on the day the semen was collected;
II.4.2. were kept for a period of at least 30 days prior to the date of semen collection in holdings where no equine animal has shown any clinical sign of equine viral arteritis or contagious equine metritis 
during that period;
II.4.3 .were not used for natural mating during a period of at least 30 days prior to the date of first semen 
collection and between the dates of the first sample referred to in points II.4.5.1., II.4.5.2. and/or II.4.5.3. and until the end of the collection per iod;
II.4.4. underwent the following tests, which meet at least the requirements of the relevant Chapter of the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a 
laboratory which is recognised by the competent aut hority and has the tests referred to hereinafter 
included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 
882/2004(7), as follows:
(8)[II.4.4.1. for equine infectious anaemia (EIA), an agar -gel immuno -diffusion test (AGID or 
Coggins test) or an enzyme -linked immunosorbent assay (ELISA) for equine infectious 
anaemia with a negative result;]
II.4.4.2. for equine viral arteritis (EVA),
(5)either [II.4.4.2.1. a serum neutralisation test with a negative result at a serum dilution of one in four;]
(5)and/or [II.4.4.2.2. a virus isolation test, polymerase chain reaction (PCR) or real -time PCR with a 
negative result on an aliquot of the entire semen of the donor stallion;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /873
COUNTRY Certificate model EQUI- SEM -B-ENTRY
II.4.4.3. for contagious equine metritis (CEM), an agent identification test carried out on three 
specimens (swabs) taken from the donor stallion on two occasions with an interval of not 
less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis;
The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local 
treatment) after antimicrobial treatment of the donor stallion and were placed in transport 
medium with activated charcoal, such as Amies medium, before dispatch to the laboratory 
where th ey were subjected with a negative result to a test for:
(5)either [II.4.4.3.1. the isolation of Taylorella equigenitalis after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within 24 hours after taking the 
specimens from the donor animal, or 48 hours where the specimens are kept 
cool during transport;]
(5)and/or [II.4.4.3.2. the detection of genome of Taylorella equigenitalis by PCR or real- time PCR, 
carried out within 48 hours after taking the specimens from the donor animal;]
II.4.5. were subjected with the results specified in point II.4.4. in each case to at least one of t he test 
programmes detailed respectively in points 1.6(a), (b) and (c) of Chapter II of Annex D to Directive 
92/65/EEC as follows:
(9)[II.4.5.1. The donor stallion was continuously resident on the semen collection centre for a period of at least 30 days pr ior to the date of the first collection and during the period of collection 
of the semen described in Part I, and no equidae on the semen collection centre came 
during that time into direct contact with equidae of lower health status than the donor stallio n.
The tests described in point II.4.4. were carried out on samples taken
(6)from the donor 
stallion at least once a year at the beginning of the breeding season or prior to the first 
collection of semen intended for imports into the Union of fresh, chille d or frozen semen 
and not less than 14 days following the date of the commencement of the residence period 
of at least 30 days prior to the first semen collection.]
(9)[II.4.5.2. The donor stallion was resident on the semen collection centre for a period o f at least 30 
days prior to the date of the first collection and during the period of collection of the 
semen described in Part I, but left the semen collection centre under the responsibility of 
the centre veterinarian for a continuous period of less than 14days, and/or other equidae 
on the semen collection centre came into direct contact with equidae of a lower health 
status.
The tests described in point II.4.4. were carried out on samples taken(6)from the donor 
stallion at least once a year at the begi nning of the breeding season or prior to the date of 
the first collection of semen intended for imports into the Union of fresh, chilled or frozen 
semen and not less than 14 days following the date of the commencement of the residence 
period of at least 30 days prior to the first semen collection,
and during the period of collection of the semen intended for imports into the Union of fresh, 
chilled or frozen semen the donor stallion was subjected to the tests described in point 
II.4.4., as follows:
(a) for equine infectious anaemia, one of the tests described in point II.4.4.1. was last 
carried out on a sample of blood taken(6)not more than 90 days prior to the 
collection of the semen described in Part I;
(b) for equine viral arteritis, one of the tests described
(5)either [in point II.4.4.2. was last carried out on a sample taken(6)not more than 30 days 
prior to the date of the collection of the semen described In Part I;]
L 113 /874  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -B-ENTRY
(5)or [in point II.4.4.2.2 was carried out on an aliquot of the entire semen of the donor 
stallion taken(6)not more than 6 months prior to the date of the collection of the 
semen described in Part I and a blood sample taken(6)from the donor stallion 
during the 6 months period reacted with a positive result in a serum neutralisation
test for equine viral arteritis at a serum dilution of more than one in four;]
(c) for contagious equine metritis, the test described in point II.4.4.3. was last carried 
out on three specimens (swabs) taken(6)not more than 60 days prior to the date of 
the collection of semen described in Part I
(5)either [on two occasions;]
(5)or [on a single occasion and subjected to a PCR or real -time PCR.]]
(9)[II.4.5.3. The donor stallion does not meet the conditions set out in points 1.6(a) and (b) of Chapter 
II of Annex D to Directive 92/65/EEC and the semen is collected for imports into the 
Union of frozen semen.
The tests described in points II.4.4.1, II.4.4.2 and II.4.4.3 were carried out on samples 
taken(6)from the donor stallion at least once a year at the beg inning of the breeding season,
and the tests described in points II.4.4.1 and II.4.4.3. were carried out on samples taken(6)from 
the donor stallion during the storage period of the semen of a minimum period of 30 days 
from the date of the collection of th e semen and before the semen is removed from the 
semen collection centre, not less than 14 days and not more than 90 days after the 
collection of the semen described in Part I,
and(5)either [the tests for equine viral arteritis described in point II.4.4.2 . were carried out on 
samples taken(6)during the storage period of the semen of a minimum period of 
30 days from the date of the collection of the semen and before the semen is 
removed from the semen collection centre or used, not less than 14 days and not 
more than 90 days after the date of the collection of the semen described in Part 
I.]
(5)or [the non -shedder state of a donor stallion seropositive for equine viral arteritis 
was confirmed by virus isolation test, PCR or real -time PCR carried out with a 
negative result on samples of an aliquot of the entire semen of the donor stallion 
taken(6)twice a year at an interval of at least four months and the donor stallion 
has reacted with a positive result at a serum dilution of at least one in four in a 
serum neutralisation test for equine viral arteritis.]
II.4.6. underwent the testing provided for in points II.3.2.(5)and II.4.5. on samples taken on the following dates:Identification 
of semen
Test 
programmeStart date(6)Date of sampling for health tests(6)
Donor 
residenceSemen 
collectionVS(5)
II.3.2EIA 
II.4.4.1.EVA II.
4.4.2.CEM
II.4.4.3.
Blood 
sampleSemen 
sample1. sample 2. sample
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /875
COUNTRY Certificate model EQUI- SEM -B-ENTRY
(5)either [II.5. No antibiotics were added to the semen;]
(5)or [II.5. The following antibiotic or combination of antibiotics was added to produce a concentration in the 
final diluted semen of not less than(10):
……………………………………………………………….....................................
……………………………………………………….…………………………….. ;]
II.6. The semen described in Part I was:
II.6.1. collected, processed, stored and transported under conditions which comply with the requirements of 
Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;
II.6.2. sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter III(I) of 
Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.19.
Notes
This certificate is intended for entry into the Union of semen of equine animals, including when the Union is not the 
final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Com munity, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box I.11: The place of dispatch shall correspond to the semen col lection centre of the semen origin.
Box I.19: The identification of container and Seal number shall be indicated.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Identification number” : The donor identity shall correspond to the official identification of the animal.
“Date of collection/production”: The date of collection shall be indicated in the following format: 
dd/mm/yyyy.
Part II:
Guidance for the completion of the table in point II.4.6.
Abbreviations:
VS Vesicular stomatitis (VS) testing if required in accordance with point II.3.2
EIA-1 Equine infectious anaemia (EIA) testing first occasion
EIA-2 EIA testing second occasion
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion
EVA -B2 EVA testing on blood sample second occasion
EVA -S1 EVA testing on semen sample first occasion
EVA -S2 EVA testing on semen sample second occasion
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample
CEM -12 CEM testing first occasion se cond sample taken 7 days after CEM -11
CEM -21 CEM testing second occasion first sample
CEM -22 CEM testing second occasion second sample taken 7 days after CEM- 21
Instructions:
For each semen identified in column A in correspondence with Box I.27, the test programme (points II.4.5.1., 
II.4.5.2. and/or II.4.5.3.) shall be specified in column B, and columns C and D shall be completed with the dates 
required.
L 113 /876  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -B-ENTRY
The dates when samples were taken for laboratory testing prior to the first collection of the semen described in 
Part I as required in points II.4.5.1., II.4.5.2. and II.4.5.3., shall be entered in the upper line of columns 5 to 9 of 
the table, this being the boxes marked with EIA -1, EVA -B1 or EVA- S1 and CEM -11 and CEM- 12 in the 
example below.
The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.5.2. 
or II.4.5.3. shall be entered in the lower line of columns 5 to 9 in table, this being the boxes EIA -2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM- 22 in the examp le below.Identification 
of semen
Test 
programmeStart date Date of sampling for health tests
Donor 
residenceSemen 
collectionVS 
II.3.2.EIA 
II.4.4.1.EVA
II.4.4.2.CEM
II.4.4.3.
Blood 
sampleSemen 
sample1.sample 2.sample
A B C D VSEIA-1 EVA-B1 EVA-S1 CEM -11 CEM -12
EIA-2 EVA-B2 EVA-S2 CEM -21 CEM -22
(1)Imports of equine semen are authorised from a third country listed in column 1 of Annex XII to Commission 
Implementing Regulation (EU) 2021/404 provided that the semen was collected in the part of the territory of 
the third country detailed in column 2 of that Annex from a donor stallion of the category of equine animals indicated in column 3 of that Annex.
(2)Only semen collection centres liste d in accordance with Article 17(3)(b) of Directive 92/65/EEC on the 
Commission website: https://ec.europa.eu/food/animals/semen/equine_en.
(3)Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements 
laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268, 
14.9.1992, p. 54).
(4)Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement 
and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1).
(5)Delete as necessary.
(6)Insert date in table in point II.4.6 (follow Guidance in Part II of the Notes).
(7)Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official 
controls performed to ensure the verification of compliance with feed and food law, animal health and animal 
welfare rules (OJ L 165, 30.4.2004, p. 1).
(8)The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are 
not required for donor equine animals which have continuously resided in Iceland since birth, provided that Iceland has remained officially free of e quine infectious anaemia and no equine animals and their semen, ova 
and embryos have been introduced into Iceland from outside prior to and during the period the semen was 
collected.
(9)Cross out the programmes that do not apply to the consignment.
(10)Insert names and concentrations.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /877
CHAPTER 61
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED,
PROCESSED AND STORED IN ACCORDANCE WITH DIRECTIVE 92/65/EEC 
AFTER 31 AUGUST 2010 AND BEFORE 1 OCTOBER 2014, DISPATCHED AFTER 
20 APRIL 2021 FROM THE SEMEN COLLECTION C ENTRE WHERE THE SEME N
WAS COLLECTED (MODEL ‘EQUI -SEM -C-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /878  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /879
COUNTRY Certificate model EQUI- SEM -C-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, of the exporting country (1)………………………………….… hereby
(name of exporting country )
certify that :
II.1. The semen collection centre(2), in which the semen described in Part I was collected, processed and stored 
for export to the European Union was approved and supervised by the competent authority in accordance 
with the conditions of Chapter I(I)(1) and Chapter I(II)(1) of Annex D to Directive 92/65/EEC,
II.2. during the period commencing 30 days prior to the date of first collection of the semen described in Part I 
until the 30 days storage period for frozen semen elapsed, the semen collection centre:
II.2.1. was situated in the exporting country or, in the case of regionalisation according to Article 13 of
Directive 2009/156/EC(3), in that part of the territory of the exporting country which was:
‒not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and 
(b) of Directive 2009/156/EC(3),
‒free from Venezuelan equine encephalomyelitis for 2 years,
‒free from glanders and dourine for 6 months;
II.2.2. fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC(3)and in 
particular:
(4)either [II.2.2.1. following a case of a disease mention ed below not all the animals of species susceptible to 
the disease located on the holding were slaughtered or killed and the holding has been free:
‒from any type of equine encephalomyelitis for at least 6 months, beginning on the day 
on which the equidae suffering from the disease are slaughtered,
‒from equine infectious anaemia for at least the period required to obtain a negative result 
in an agar gel immunodiffusion test (Coggins test) carried out on samples taken after the 
infected animals were slaug htered on two occasions three months apart from each of the 
remaining animals,
‒from vesicular stomatitis for at least 6 months from the last recorded case,
‒from rabies for at least one month from the last recorded case,
‒from anthrax for at least 15 d ays from the last recorded case,]
(4)or[II.2.2.1. following a case of a disease mentioned below all the animals of species susceptible to the 
disease located on the holding have been slaughtered or killed and the premises disinfected, 
the holding has been free for at least 30 days from any type of equine encephalomyelitis, 
equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, 
beginning on the day on which following the destruction of the animals the disinfection of 
the premises was satisfactorily completed;]
II.2.3. contained only equidae which were free of clinical signs of equine viral arteritis and contagious 
equine metritis,
L 113 /880  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -C-ENTRY
II.3. Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre:
II.3.1. were continuously resident for three months (or since entry if they were directly imported from a 
Member State of the European Union during the three months period) in the exporting country or, in 
the case of regionalisation according to Article 13 of Directive 2009/156/EC(3), in that part of the 
territory of the exporting country which was during that period
‒not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and 
(b) of Direc tive 2009/156/EC(3),
‒free from Venezuelan equine encephalomyelitis for at least 2 years,
‒free from glanders and dourine for at least 6 months;
(4)either [II.3.2. originated from the country of export which was on the day of admission into the centre free of 
vesicular stomatitis (VS) for at least 6 months,]
(4)or [II.3.2. were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with negative 
result at a serum dilution of 1 in 12 on a blood sample taken(5)within 14 days p rior to entering the 
centre;]
II.3.3. originated from holdings which on the day of admission onto the centre fulfilled the requirements of 
point II.2.2.;
II.4. The semen described in Part I was collected from donor stallions, which:
II.4.1. have not shown any clinical sign of an infectious or contagious disease at the time of admission onto 
the centre and on the day the semen was collected;
II.4.2. have been kept for 30 days prior to the date of semen collection on holdings where no equine animal 
has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period;
II.4.3. have not been used for natural mating during at least 30 days prior to the date of first semen 
collection and between the dates of the first sample referred to in points II.4.5.1., II.4.5.2. and/or 
II.4.5.3. and until the end of the collection period;
II.4.4. have undergone the following tests, which meet at least the requirements of the relevant Chapter of 
the Manual of Diagnostic Tests and Vaccines for Te rrestrial Animals of the OIE, carried out on 
samples taken in accordance with one of the programmes specified in point II.4.5. in a laboratory 
recognised by the competent authority:
(4)(6)either [II.4.4.1. an agar -gel immuno- diffusion test (Coggins test) f or equine infectious anaemia (EIA) with 
negative result; ]
(4)(6)or [II.4.4.1. an ELISA for equine infectious anaemia (EIA) with negative result;]
and(4)either [II.4.4.2. a serum neutralisation test for equine viral arteritis (EVA) with negative result at a serum 
dilution of one in four;]
(4)or [II.4.4.2. a virus isolation test for equine viral arteritis (EVA) carried out with negative result on an 
aliquot of the entire semen of the donor stallion;]
and II.4.4.3. an agent identification test for contagious equine metritis (CEM) carried out on two 
occasions on samples collected with an interval of seven days by isolation of Taylorella 
equigenitalis after a cultivation of 7 to 14 days from pre -ejaculatory fluid or a semen 
sample and from genital swabs taken a t least from the penile sheath, urethra and urethral 
fossa with negative result in each case;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /881
COUNTRY Certificate model EQUI- SEM -C-ENTRY
II.4.5. have been subjected with the results specified in II.4.4. in each case to at least one of the test 
programmes(7)detailed in points II.4.5.1., II.4.5.2. and II.4.5.3. as follows:
II.4.5.1. The donor stallion was continuously resident on the semen collection centre for at least 30 
days prior to the date of the first collection and during the period of collection of the semen 
described in Part I, and no equidae on the semen collection centre came during that time into direct contact with equidae of lower health status than the donor stallion.
The tests described in point II.4.4. have been carried out on samples taken
(5)prior to the 
first semen collection and at least 14 days following the date of the commencement of the 
residence period of at least 30 days.
II.4.5.2. The donor stallion was resident on the semen collection centre for at least 30 days prior to 
the date of the first collection and during the period of collection of the semen described in 
Part I, but has left the centre under the responsibility of the centre veterinarian for a 
continuous period of less than 14 days, or other equidae on the collection centr e came into 
direct contact with equidae of lower health status.
The tests described in point II.4.4. have been carried out on samples taken(5)prior to the 
date of the first semen collection of the breeding season or collection period in the year the 
semen described in Part I was collected and at least 14 days following the date of the 
commencement of the residence period of at least 30 days, 
and the test described in point II.4.4.1. for equine infectious anaemia was last carried out on a sample of blood t aken
(5)not more than 90 days before the semen described in Part I was 
collected; 
and(4)either [one of the tests described in point II.4.4.2. for equine viral arteritis was last carried out on 
a sample taken(5)not more than 30 days before the semen desc ribed in Part I was collected, 
]
(4)or [a virus isolation test for equine viral arteritis was carried out with negative result on an 
aliquot of the entire semen of the donor stallion taken(5)not more than 6 months before the 
semen described in Part I was collected and a blood sample taken on the same date(5)
reacted positive in a serum neutralisation test for equine viral arteritis at a serum dilution of more than one in four,]
and the test described in point II.4.4.3. for contagious equine metritis was la st carried out on 
samples taken
(5), not more than 60 days before the semen described in Part I was collected.
II.4.5.3. The tests described in point II.4.4. have been carried out on samples taken(5)prior to the 
date of the first semen collection of the br eeding season or collection period in the year the 
semen described in Part I was collected,
and the tests described in point II.4.4. have been carried out on samples taken(5)between 14 and 
90 days after the collection of the semen described in Part I.
L 113 /882  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -C-ENTRY
II.4.6. have undergone the testing provided for in points II.3.2.(4)and II.4.5. on samples taken on the following 
dates:
Identifica tion 
of semen
Test 
programmeStart date(5)Date of sampling for health tests(5)
Donor 
residenceSemen 
collectionVS(4)
II.3.2EIA 
II.4.4.1.EVA II.
4.4.2.CEM
II.4.4.3.
Blood 
sampleSemen 
sample1. sample 2. sample
(4)either [II.5. No antibiotics were added to the semen;]
(4)or [II.5. The following antibiotic or combination of antibiotics was added to produce a concentration in the 
final diluted semen of not less than(8):
……………………………………………………………….....................................
……………………………………………………….…………………………….. ;]
II.6. The semen described in Part I was:II.6.1. collected, processed, stored and transported under conditions which comply with the requirements of 
Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;
II.6.2.sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter III(I) of 
Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.19.
Notes
This certificate is intended for entry into the Union of semen of e quine animals, including when the Union is not the 
final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Communi ty, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health ce rtificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box I.11: The place of dispatch shall correspond to the semen collection centre of the semen origin.
Box I.19: The identification of container and seal number shall be indicated.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Identification number” : The donor identity shal l correspond to the official identification of the animal.
“Date of collection/production”: The date of collection shall be indicated in the following format: 
dd/mm/yyyy.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /883
COUNTRY Certificate model EQUI- SEM -C-ENTRY
Part II:
Guidance for the completion of the table in point II.4.6.
Abbreviations:
VS Vesicular stomatitis (VS) testing if required in accordance with point II.3.2
EIA-1 Equine infectious anaemia (EIA) testing first occasion
EIA-2 EIA testing second occasion
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion
EVA -B2 EVA testing on blood sample second occasion
EVA -S1 EVA testing on semen sample first occasion
EVA -S2 EVA testing on semen sample second occasion
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11
CEM -21 CEM testing second occasion first sample
CEM -22 CEM testing second occasion second sample taken 7 days after CEM- 21
Instructions:
For each semen identified in column A in correspondence with Box I.27, the test programme (II.4.5.1., II.4.5.2. 
and/or II.4.5.3.) must be specified in column B, and columns C and D must be completed with the dates 
required.
The dates when samples were taken for laboratory testing prior to the first collection of the semen described in 
Part I as required in II.4.5.1., II.4.5.2. and II.4.5.3., are entered in the upper line of columns 5 to 9 of the table, 
this being the boxes marked with EIA- 1, EVA -B1 or EVA- S1 and CEM -11 and CEM- 12 in the example below.
The dates when samples were taken for repeat laboratory testing as required in accordance with II.4.5.2. or 
II.4.5.3. are entered in the lower line of columns 5 to 9 in table, this being the boxes EIA -2, EVA -B2 or EVA -
S2 and CEM -21 and CEM- 22 in the example below.Identifica tion 
of semen
Test 
programmeStart date Date of sampling for health tests
Donor 
residenceSemen 
collectionVS 
II.3.2.EIA 
II.4.4.1.EVA
II.4.4.2.CEM
II.4.4.3.
Blood 
sampleSemen 
sample1.sample 2.sample
A B C D VSEIA-1 EVA-B1 EVA-S1 CEM -11 CEM -12
EIA-2 EVA-B2 EVA-S2 CEM -21 CEM -22
(1)Imports of equine semen are authorised from a third country listed in column 1 of Annex XII to Commission 
Implementing Regulation (EU) 2021/404 provided the semen was collected in the part of the territory of the 
third country detailed in column 2 of that Annex from a donor stallion of the category of equine animals 
indicated in column 3 of that Annex.
(2)Only semen collection centres listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the 
Commission website: https://ec.europa.eu/food/animals/semen/equine_en.
(3)OJ L 192, 23.7.2010, p. 1.
(4)Delete as necessary.
(5)Insert date in table in point II.4.6 (follow Guidance in Part II of the Notes)
(6)The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not 
required for donor equine animals which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equine animals and their semen, ova 
and embryos have been introduced into Iceland from outside prior to and during the period the semen was collected.
L 113 /884  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -C-ENTRY
(7)Cross out the programmes that do not apply to the consignment.
(8)Insert names and concentrations.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /885
CHAPTER 62
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED,
PROCESSED AND STORED IN ACCORDANCE WITH DIRECTIVE 92/65/EEC 
BEFORE 1 SEPTEMBER 2 010, DISPATCHED AFTER 20 APRIL 2021 FROM THE
SEMEN COLLECTION CEN TRE WHERE THE SEMEN WAS COLLECTED 
(MODEL ‘EQUI -SEM -D-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISOcountry code I.23
L 113 /886  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /887
COUNTRY Certificate model EQUI- SEM -D-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, of the exporting country(1)………………………………….… hereby 
(name of exporting country )
certify that:
II.1. The semen collection centre(2)in which the semen described in Part I was collected, processed and stored 
for export to the European Union:
II.1.1. was approved and supervised by the competent authority according to the conditions of Chapter I, 
Annex D to Directive 92/65/EEC,
II.1.2. is situated in the territory or in the case of regionalisation according to Article 13 of Directive 
2009/156/EC(3)in a part of the territory of the country of export which was on the day the semen was 
collected until the date of dispatch free of:
− African horse sickness, in accordance with EU legislation,
− Venezuelan equine encephalomyelitis for 2 years,
− glanders and dourine for 6 months;
II.1.3. was during the period commencing 30 days prior to the date of collection of the semen until the day of its 
dispatch not subject to a prohibition order for animal health reasons which laid down one of the 
following conditions:
II.1.3.1. if not all the animals of species susceptible to the disease located in the holding were slaughtered or 
killed, the prohibition lasted for:
− 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, in 
the case of equine encephalomyelitis,
− a period required to carry out with negative result two Coggins tests three months apart in the 
animals remaining after the infected animals have been slaughtered, in the case of infectious 
equine anaemia,
− 6 months, in the case of vesicular stomatitis,
− one month from the last recorded case, in the case of rabies,
− 15 days from the last recorded case, in the case of anthrax.
II.1.3.2. if all the animals of species susceptible to the disease located in the holding have been slaughtered or 
killed and the premises disinfected, the prohibition lasted for 30 days, or 15 days in the case of anthrax, 
beginning on the day on which following the destruction of the animals the disinfection of the premises 
was satisfactorily completed;
II.1.4. contained during the period commencing 30 days prior to semen collection and lasting until the date of 
its dispatch only eq uidae which were free of clinical signs of equine viral arteritis and contagious equine 
metritis,
II.2. Prior to entering the semen collection centre the donor stallions and any other equidae located in the 
centre:
II.2.1. were continuously resident for th ree months (or since entry if they were directly imported from a 
Member State of the Union during the three months period) in the territory or in the case of 
regionalisation in a part of the territory(4)of the country of export which was during that period free of:
− African horse sickness, in accordance with EU legislation,
− Venezuelan equine encephalomyelitis for 2 years,
− glanders for 6 months,
− dourine for 6 months;
(4)either [II.2.2. originated from the territory of the country of export which was on the day of admission into 
the centre free of vesicular stomatitis for 6 months,]
L 113 /888  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- SEM -D-ENTRY
(4)or [II.2.2. were tested by a virus neutralisation test for vesicular stomatitis in a blood sample taken on 
.............................(5), this being within 14 days prior to entering the centre, with negative result 
at a serum dilution of 1 in 12;]
II.2.3. originated from holdings which on the day of admission onto the centre fulfilled the requirements of 
point II.1.3.;
II.3. The semen described in part I was collected from donor stallions, which:
II.3.1. on the day the semen was collected have not shown clinical signs of an infectious or contagious disease,
II.3.2. during at least 30 days prior to collection of the semen have not been used for natural service, 
II.3.3 .during the last 30 day period prior to collection of the semen have been kept on holdings where no equine animal showed clinical signs of equine viral arteritis, 
II.3.4. during the last 60 day period prior to collection of the semen have been kept on holdings where no equine 
animal showed clinical signs of contagious equine metritis, 
II.3.5. to the best of my knowledge and as far as I could ascertain have not been in contact with equidae 
suffering from an infectious or contagious disease the 15 days immediately preceding the collection of 
the semen;
II.3.6. have undergone the following animal health tests carried out in a laboratory recognised by the competent 
authority, in accordance with a test programme as specified in point II.3.7.:
II.3.6.1. an agar-gel immuno- diffusion test (Coggins test) for equine infectious anaemia with negative result
(6);
(4)either [II.3.6.2. a serum neutralisation test for equine viral arteritis with negative result at a serum dilution of 1 
in 4;]
(4)or [II.3.6.2. a virus isolation test for equine viral arteritis carried out with negative result on an aliquot of the 
entire semen;]
II.3.6.3. a test for contagious equine metritis carried out on two occasions with an interval of seven days by 
isolation of Taylorella equigenitalis from pre -ejaculatory fluid or a semen sample and from genital swabs 
taken at least from the penile sheath, urethra and from the urethral fossa with negative result in each case;
II.3.7. have been subjected to one of the following test programmes(7):
II.3.7.1. The donor stallion was continuously resident on the collection centre for at least 30 days prior to the 
semen collection, and during the collection period, and no equidae in the collection centre came during 
that time into direct contact with equid ae of lower health status than the donor stallions.
The tests required in point II.3.6. have been carried out on samples taken on ………………………..(5)
and on ………………………..(5)at least 14 days after the commencement of the above residence period 
and at least at th e beginning of the breeding season;
II.3.7.2. The donor stallion was not continuously resident on the collection centre or other equidae on the 
collection centre came into direct contact with equidae of lower health status than the donor stallions.
The te sts required in point II.3.6. have been carried out on samples taken on ………………………..(5)
and on ……………....(5), within the 14 days period before the first semen collection and at least at the 
beginning of breeding season. 
The test required in point II.3.6.1. was last carried out on a sample of blood taken not more than 120 days 
before the semen was collected on ………………………..(5);
(4)either [The test required in point II.3.6.2. was last carried out not more than 30 days before the semen was 
collected on …………………..(5);]
(4)or [The non -shedder state of the seropositive stallion for equine viral arteritis was confirmed by a virus 
isolation test which was carried out not more than one year before the semen was collected on 
…………………………..(5);]
II.3.7.3. The tests required in point II.3.6. have been carried out during the 30 days mandatory storage period of 
frozen semen and not less than 14 days after the collection of the semen on samples taken on 
……………………(5)and on …………………….(5);
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /889
COUNTRY Certificate model EQUI- SEM -D-ENTRY
II.4. The semen described in Part I was collected, processed, stored and transported under conditions which 
comply with the requirements of Chapter II and III of Annex D of Directive 92/65/EEC.
Notes
This certificate is intended for entry into the Union of semen of equine animals, including whe n the Union is not 
the final destination of the semen.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be com pleted according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box I.11: The place of dispatch shall correspond to the semen collection centre of the semen origin. 
Box I.19: The identification of container and seal number shall be indicated.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I .27: “Identification number”
: The donor identity shall correspond to the official identification of the 
animal.
“Date of collection/production”: The date of collection shall be indicate in the following format: 
dd/mm/yyyy.
Part II:
(1)Imports of equine semen are authorised from a third country listed in column 1 of Annex XII to 
Commission Implementing Regulation (EU) 2021/404 provided the semen was collected in the part of the 
territory of the third country detailed in column 2 of that Annex from a donor stallion of the category of 
equine animals indicated in column 3 of that Annex.
(2)Only semen collection centres listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the 
Commission website: https://ec.europa.eu/food/animals/semen/equine_en.
(3)OJ L 192, 23.7.2010, p. 1.
(4)Delete as necessary.
(5)Insert date.
(6)The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not 
required for donor equine animals which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equine animals and their semen, 
ova and embryos have been introduced into Iceland from outside prior to and during the period the semen 
was collected.
(7)Cross out the programmes that do not apply to the consignment.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /890  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 63
MODEL ANIMAL HEALTH CERTIFICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF OOCYTES AND EMBRYOS OF EQUINE ANIMALS 
COLLECTED OR PRODUCE D, PROCESSED AND STORED IN ACCORDANCE
WITH REGULATION (EU) 2016/429 AND DELEGAT ED REGULATION (EU) 
2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION 
OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE 
COLLECTED OR PRODUCE D (MODEL ‘EQUI -OOCYTES -EMB- A-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /891
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /892  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- A-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The oocytes(1)/ in vivo derived embryos(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)
described in Part I are intended for artificial reproduction and were obtained from donor animals which 
originate 
II.1.1. from a third country, territory or zone thereof
II.1.1. 1. authorised for entry into the Union of oocytes(1)/ embryos(1)of equine an imals and listed in 
Annex X IItoCommission Implementing Regulation (EU) 2021/404 ;
II.1.1.2.in which African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei (glanders), surra (Trypanosoma evansi ), dourine (Trypanosoma 
equiperdum), equine infectious anaemia, infection with rabies virus, anthrax, infection 
with equine arteritis virus and contagious equine metritis ( Taylorella equigenitalis ) are 
notifiable diseases;
II.1.1.3.free from African horse sickness for a period of at least 24 months immediately prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1)and until their date of dispatch in
accordance with Article 22(2)(a) of Commission Delegated Regulation (EU) 2020/692, 
and where no systematic vaccination against African horse sickness has been carried out 
for a period of at least 12 months immediately prior to collection(1)/ production(1)of the 
oocytes(1)/ embryos(1)and until their date of dispatch in accordance with Article 22(4)(b) 
of that Regulation;
II.1.1.4.where Venezuelan equine encephalomyelitis was not reported for a period of at least 24 months immediately prior to collection
(1)/ production(1)of the oocytes(1)/ embryos(1)and 
until their date of dispatch ;
II.1.2. from an establishm ent in a third country, territory or zone thereof
(1)either [II.1.2 .1.where infection with Burkholderia mallei (glanders) was not reported for a period of at 
least 36 months immediately prior to collection(1)/ production(1)of the oocytes(1)/ 
embryos(1)and until their date of dispatch ;]
(1)or[II.1.2 .1.where infection with Burkholderia mallei (glanders) was not reported for a period of at 
least 6 months immediately prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1)
and until their date of dispatch, and the Commission has recognised the surveillance 
programme carried out in breeding equine animals in the establishment of origin to 
demonstrate absence of infection during that period of 6 months;]
(1)either [II.1.2 .2.where dourine not reported for a period of at least 24 months immediately prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1)and until their date of dispatch ;]
(1)or[II.1.2 .2.where dourine was not reported for a period of at least 6 months immediately pri or to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1)and until their date of dispatch , and 
the Commission has recognised the surveillance programme carried out in breeding 
equine animals in the establishment of origin to demonstrate absence of infection during that period of 6 months;]
(1)either [II.1.2 .3.where surra ( Trypanosoma evansi ) was not reported for a period of at least 24 months 
immediately prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1)and until their 
date of dis patch ;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /893
COUNTRY Certificate model EQUI- OOCYTES- EMB- A-ENTRY
(1)or[II.1.2.3. where surra ( Trypanosoma evansi) was not reported for a period of at least 6 months 
immediately prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1)and until their 
date of dispatch, and the Commission has recognised the surveillance programme carried 
out in breeding equine animals in the establishment of origin to demonstrate absence of 
infection during that period of 6 months.]
II.2. The oocytes(1)/embryos(1)described in Part I were obtained from donor animals which originate from 
establishments 
II.2.1. in which surra ( Trypanosoma evansi) has not been reported during the period of the preceding 30 
days prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1), and 
(1)either [surra has not been reported in the establishment during the period of the preceding 2 years prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)or [surra has been reported in the establishment during the period of the preceding 2 years prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1)and following the last outbreak the 
establishment has remained under movement restriction s
(1)either [until the remaining animals in the establis hment have been subjected to a test for surra 
with one of the diagnostic methods provided for in Part 3 of Annex I to Commission 
Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken 
at least 6 months after the last infec ted animal has been removed from the establishment;]]
(1)or [for at least 30 days from the date of cleaning and disinfection after the last animal of 
listed species on the establishment was either killed and destroyed or slaughtered.]]
II.2.2. in which do urine has not been reported during the period of the preceding 6 months prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1), and
(1)either [dourine has not been reported in the establishment during the period of the preceding 2 years prior 
to collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
(1)or [dourine has been reported in the establishment during the period of the preceding 2 years prior to 
collection(1)/ production(1)of the oocytes(1)/ embryos(1)and following the last outbreak, the 
establishment has remained under movement restriction s
(1)either [until the remaining equine animals in the establishment, except castrated male equine 
animals, have been subjected to a test for dourine with the diagnostic method provided for 
in Part 8 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative 
results, on samples taken at least 6 months after the infected animals have been killed and 
destroyed or slaughtered, or the infected entire mal e equine animals have been castrated;]]
(1)or [for at least 30 days after the last equine animal on the establishment was either killed and 
destroyed or slaughtered, and the premises were cleaned and disinfected;]]
II.2.3. in which equine infectious anaem ia has not been reported during the period of the preceding 90 
days prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1), and
(1)either [equine infectious anaemia has not been reported on the establishment during the period of the 
preceding 12 months prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1);]
L 113 /894  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- A-ENTRY
(1)or [equine infectious anaemia has been reported on the establishment during the period of the 
preceding 12 months prior to collection(1)/ production(1)of the oocytes(1)/ embryos(1)and following 
the last outbreak the establishment has remained under movement restriction s
(1)either [until the remaining equine animals in the establishment have been subjected to a test for 
equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I to 
Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken 
on two occasions with a minimum interval of 3 months after the infected animals have 
been killed and destroyed or slaughtered and the establishment was cleaned and 
disinfected.]]
(1)or [for at least 30 days after the last equine animal on the establishment was either killed and 
destroyed or slaughtered, and the premises were cleaned and disinfected.]]
(1)[II.3. The in vivo derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embryo collection team(2)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with require ments as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
(1)[II.3. The oocytes(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)describe d in Part I have been 
collected or produced, processed and stored, and dispatched by the embryo production team(2)which
II.3.1. is approved and listed by the competent authority of the third country or territory;
II.3.2. complies with requirements as rega rds responsibilities, operational procedures, facilities and 
equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]
II.4. The oocytes(1)/ embryos(1)described in Part I were obtained from donor animals which
II.4.1. were not vaccinated against African horse sickness at least in the last 40 days prior to collection(1)/ 
production(1)of the oocytes(1)/ embryos(1); 
II.4.2. were not vaccinated against Venezuelan equine encephalomyelitis at least in the last 60 days prior 
to colle ction(1)/ production(1)of the oocytes(1)/ embryos(1);
II.4.3. remained for a period of at least 3 months prior to the date of collection(1)/ production(1)of the 
oocytes(1)/ embryos(1)in a third country or territory or zone thereof referred to in Box I.7 .;
II.4.4. for a period of at least 30 days prior to the date of collection(1)/ production(1)of the oocytes(1)/ 
embryos(1)and during the collection period 
II.4.4.1. were kept on establishments not situated in a restricted zone established due to the occurrence of African horse sickness, infection with Burkholderia mallei (glanders) or of 
an emerging disease relevant for equine animals;
II.4.4.2. were kept on a single establishment where Venezuelan equine encephalomyelitis, dourine, 
surra ( Trypanosoma eva nsi
), equine infections anaemia, contagious equine metritis, 
infection with rabies virus and anthrax have not been reported;
II.4.4.3. were not in contact with animals from establishments situated in a restricted zone due to 
the occurrence of diseases refe rred to in point II.4.4.1. or from establishments which do 
not meet the conditions referred to in point II.4.4.2.;
II.4.5. were not used for natural breeding during a period of at least 30 days prior to the date of the 
collection of the oocytes(1)/ embryos(1)and between the date on which the first samples referred to 
in points II.4.8.1. and II.4.8.2. were taken and the date of the collection of the oocytes(1)/ 
embryos(1);
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /895
COUNTRY Certificate model EQUI- OOCYTES- EMB- A-ENTRY
II.4.6. were examined by the team veterinarian or a team member and did not show symptoms or clinical 
signs of transmissible animal diseases on the day of collection(1)/ production(1)of the oocytes(1)/ 
embryos(1); 
II.4.7. are individually identified as provided for in Article 21(2) of Delegated Regulatio n (EU) 2020/692;
II.4.8. have been subjected to the following tests, referred to in points 2(b) and (c) of Chapter II of Part 4 
of Annex II to Delegated Regulation (EU) 2020/686, as follows:
(3)[II.4.8.1. for equine infectious anaemia (EIA), an agar -gel im muno- diffusion test (AGID or Coggins 
test) or an enzyme -linked immunosorbent assay (ELISA) with a negative result carried out 
on a blood sample taken on ……………….(4), being not less than 14 days following the 
date of commencement of the period referred to in point II.4.5, and the test was last 
carried out on a blood sample taken on …………………….(4); being not more than 
90days prior to the date of the collection of the oocytes(1)/embryos(1)intended for entry 
into the Union;]
II.4.8.2. for contagious equine metritis (CEM), an agent identification test carried out with a 
negative result on at least two specimens (swabs) taken during the period referred to in 
point II.4.5. from at least the mucosal surfaces of the clitoral fossa and the clitoral sinuses of the donor mare
(1)either [II.4.8.2.1. on two occasions with an interval of not less than 7 days on…………(4)and 
on………………..(4), in the case of isolation of Taylorella equigenitalis after 
cultivation under microaerophilic conditions for a period of at least 7 days, set 
up within 24 hour period after taking the specimens from the donor animal, or 
48 hour period where the specimens are kept cool during transport.]
(1)and/or [II.4.8.2.2 .on one occasion on………………..(4), in the case of detection of genome of 
Taylorella equigenitalis by a polymerase chain reaction (PCR) or real- time 
PCR, carried out within 48 hour period after taking the specimens from the donor animal.]
The samples referred to in points II.4.8.2.1. and II.4.8.2.2. were in no case taken earlier than 
7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the 
donor mare and were placed in transport medium with activated charcoal, such as Amies
medium, before dispatch to the laboratory.
II.5. The oocytes
(1)/ embryos(1)described in Part I
II.5.1. has been collected, processed and stored in accordance with animal health requirements set out in 
Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1)and Part 6 of Annex III to Delegated Regulation (EU) 2020/686;
II.5.2. areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in Box I.27;
II.5.3. are transported in a container which:
II.5.3.1. was sealed and numbered prior to the dispatch by the embryo collection or production team under responsibility of the team veterinarian, or by an official veterinarian, and the 
seal bears th e number as indicated in Box I.19;
II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single- use container; 
(1)(5)[II.5.3.3. has been filled in with the cryogenic agent which not have been previously used for other 
products.]
L 113 /896  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- A-ENTRY
(1)(6)[II.5.4. are placed in straws or other packages which are securely and hermetically sealed;
II.5.5. are transported in a container where they are separated from each other by physical compartments 
or by being placed in secondary protecti ve bags.]
(1)(7)[II.6. The in vivo derived embryos(1)/ in vitro produced embryos(1)/ micromanipulated embryos(1)described in 
Part I were conceived by artificial insemination using semen coming from a semen collection centre, 
germinal product processing establishment or germinal product storage centre approved for the collection, 
processing and/or storage of semen by the competent authority of a third country, territory or zone thereof 
listed in Annex XII to Implementing Regulation (EU) 2021/404 for semen of equine animals or by the 
competent authority of a Member State(8).]
(1)(9)[II.7. The following antibiotic or m ixture of antibiotics(10)has been added to the collection, processing, washing 
or storage media: …………………………………………………………………………]
Notes
This certificate is intended for entry into the Union of oocytes and embryos of equine animals, including when the 
Union is not the final destination of the oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Arti cle 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be complet ed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. Only embryo collection or production teams listed in accordance with 
Article 233(3) of Regulation (EU) 2016/429 on the Commission website:
https://ec.europa.eu/food/animals/semen/equine_en
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced 
embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which oocytes or embryos of the 
consignment was collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /897
COUNTRY Certificate model EQUI- OOCYTES- EMB- A-ENTRY
Part II:
(1)Delete if not applicable.
(2)Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en . 
(3)The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are 
not required for donor equine animals which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equine animals and their semen, ova 
and embryos have been introduced into Iceland from outside prior to and during the period the ova or 
embryos were collected and the semen was used for fertilisation.
(4)Insert date in the following format: dd.mm.yyyy.
(5)Applicable for frozen oocytes or embryos.
(6)Applicable for the consignment where in one container o ocytes, in vivo derived embryos, in vitro produced 
embryos and micromanipulated embryos of equine animals are placed and transported.
(7)Does not apply to oocytes.
(8)Only a semen collection centre, germinal product processing establishment or germinal p roduct storage 
centre listed on the Commission websites:
-a third country, territory or zone thereof:
https://ec.europa.eu/food/animals/live_animals/approved -establishments_en
-of a Member State: https://ec.europa.eu/food/animals/semen/equine_en
(9)Mandatory attestation in case antibiotics were added.
(10)Insert the name(s) of the antibiotic(s) added and its(their) concentration.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /898  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 64
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF OOCYTES AND EM BRYOS OF EQUINE 
ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH DIRECTIVE 92/65/EEC AFTE R 30 SEPTEMBER 2014 AND
BEFORE 21 APRIL 2021 , DISPATCHED AFTER 20 APRIL 2021 BYTHE EMBRYO 
COLLECTION OR PRODUC TION TEAM BY WHICH THE OOCYTES OR 
EMBRYOS WERE COLLECTED OR PRODUCED (MODEL ‘EQUI -OOCYTES -
EMB- B-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /899
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /900  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- B-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, of the exporting country(1)………………………………….… hereby
(name of exporting country )
certify that:
II.1. The ova(2)/embryos(2)described in Part I:
II.1.2. were collected(2)/produced(2)by the team(3)described in Box I.11, which had been approved and 
supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC(4)and was subject to 
inspection by an official veterinarian at least once every calendar year;
II.1.3. were collected(2)/produced(2), processed and stored in accordance with the requirements of Chapter III(II) 
of Annex D to Directive 92/65/EEC;
II.1.4. were collected at a place separated from o ther parts of the premises or holding which is in good repair 
and was cleaned and disinfected prior to the collection;
II.1.5. were examined, processed and packed in laboratory facilities which are not situated in a zone subject to 
prohibition or quarantin e measures as set out in Box II.1.6., in a section which is separated from the 
section for storing equipment and materials used in contact with donor animals and from the area where 
the donor animals are handled;
II.1.6. come from donor mares which:
II.1.6 .1. were continuously resident for a period of three months (or since entry if they were directly 
imported from a Member State of the Union during the three months period) in the exporting 
country or, in the case of regionalisation in accordance with Artic le 13 of Directive 
2009/156/EC(5), in that part of the territory of the exporting country which was during that 
period
− not considered to be infected with African horse sickness in accordance with 
Article 5(2)(a) and (b) of Directive 2009/156/EC,
− free from Venezuelan equine encephalomyelitis for a period of at least 2 years,
− free from glanders and dourine for a period of at least 6 months;
(2)either [II.1.6.2. originated from a country of export which was on the day of collection free from vesicular 
stomatitis (VS) for a period of at least the last 6 months from that date;]
(2)or [II.1.6.2. were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a 
negative result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result 
in accordance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals of the OIE on a blood sample taken on …………………(6)within 30 days 
prior to the collection of the ova(2)/embryos(2);]
(2)either [II.1.6.3. during a period of the past 30 days prior to the date of the collection were located in holdings 
under veterinary supervision which fulfilled from the day of the collection of the 
ova(2)/embryos(2)until the date of their dispatch the conditions for a holding laid down in 
Article 4(5) of Directive 2009/156/EC, and in particular:]
(2)or [II.1.6.3. in the case of frozen ova(2)/embryos(2), during a period of the past 30 days prior to the date of 
the collection were kept in holdings under veterinary supervision which fulfilled, from the 
day of the collection of the ova(2)/embryos(2)until the end of the period of 30 days mandatory 
storage at approved premises, the conditions for a holding laid down in Article 4(5) of 
Directive 2009/156/EC, a nd in particular:]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /901
COUNTRY Certificate model EQUI- OOCYTES- EMB- B-ENTRY
(2)either [II.1.6.3.1. following a case of a disease mentioned below not all the animals of species 
susceptible to that disease located in the holding were slaughtered or killed and 
the holding has been free:
− from any type of equine encephalomyelitis for a period of at least 6 
months, beginning on the day on which the equidae suffering from the 
disease are slaughtered,
− from equine infectious anaemia for at least the period required to obtain a 
negative result in an agar gel immunodiff usion test (AGID or Coggins 
tests) carried out on samples taken after the infected animals were 
slaughtered on two occasions three months apart from each of the 
remaining equidae,
− from vesicular stomatitis for a period of at least 6 months from the last 
recorded case,
− from rabies for a period of at least one month from the last recorded case,
− from anthrax for a period of at least 15 days from the last recorded case,]
(2)or [II.1.6.3.1. following a case of a disease mentioned below all the animals of species
susceptible to that disease located in the holding were slaughtered or killed and 
the premises disinfected, the holding was free for a period of at least 30 days 
from any type of equine encephalomyelitis, equine infectious anaemia, 
vesicular stomatitis an d rabies or a period of at least 15 days in the case of 
anthrax, beginning on the day on which following the destruction of the 
animals the disinfection of the premises was satisfactorily completed;]
II.1.6.4. during a period of the past 30 days prior to the collection the ova(2)/embryos(2)were kept in 
holdings in which none of the equidae has shown clinical signs of contagious equine metritis for a period of at least 60 days;
II.1.6.5. were not used for natural breeding during a period of at least 30 days prior to the date of the 
collection of the ova
(2)/embryos(2)and between the date of the first samples referred to in 
points II.1.6.6.1. and II.1.6.6.2. and the date of the collection of the ova(2)/embryos(2); 
II.1.6.6. have undergone the tests, which me et at least the requirements of the relevant Chapters of the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a 
laboratory which is recognised by the competent authority and has the tests referred to 
hereinafter in cluded in its accreditation equivalent to that provided for in Article 12 of 
Regulation (EC) No 882/2004(7), as follows:
(8)[II.1.6.6.1. for equine infectious anaemia (EIA), an agar -gel immuno- diffusion test (AGID or 
Coggins test) or an enzyme -linked immun osorbent assay (ELISA) with a 
negative result carried out on a blood sample taken on ……………….(6), being 
not less than 14 days following the date of commencement of the period referred 
to in point II.1.6.5, and the test was last carried out on a blood sample taken on 
…………………….(6); being not more than 90 days prior to the date of the 
collection of the ova(2)/embryos(2)intended for imports into the Union;]
L 113 /902  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- B-ENTRY
II.1.6.6.2. for contagious equine metritis (CEM), an agent identification test carried out with 
anegative result on at least two specimens (swabs) taken during the period 
referred to in point II.1.6.5. from at least the mucosal surfaces of the clitoral fossa and the clitoral sinuses of the donor mare
(2)either [II.1.6.6.2.1. on two occasions with an i nterval of not less than 7 days 
on…………(6)and on………………..(6), in the case of isolation 
of Taylorella equigenitalis after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within 24 hours 
after taking the specimens from the donor animal, or 48 hours 
where the specimens are kept cool during transport,]
(2)and/or [II.1.6.6.2.2. on one occasion on………………..(6), in the case of detection of 
genome of Taylorella equigenitalis by a polymerase chain 
reaction (PCR) or real -time PCR, ca rried out within 48 hours 
after taking the specimens from the donor animal,]
The samples referred to in points II.1.6.6.2.1. and II.1.6.6.2.2. were in no case 
taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after 
antimicrobial t reatment of the donor stallion and were placed in transport 
medium with activated charcoal, such as Amies medium, before dispatch to the 
laboratory.
II.1.6.7. to the best of my knowledge and as far as I could ascertain, were not in contact with equidae 
suffering from an infectious or contagious disease during the period of 15 days immediately 
preceding the collection;
II.1.6.8. on the day of the collection of the ova(2)/embryos(2)did not show clinical signs of an 
infectious or contagious disease;
II.1.7 . were collected(2)/produced(2)after the date on which the embryo collection(2)/production(2)team 
described in Box I.11 was approved by the competent authority of the exporting country;
II.1.8. were processed and stored under approved conditions for a period of at least 30 days immediately after 
their collection(2)/production(2), and were transported under conditions which satisfy the terms laid down 
in Chapter III(II) of Annex D to Directive 92/65/EEC;
II.2. The embryos described in Part I were conceived by artificial insemination(1)/as a result of in vitro
fertilisation(2)using semen meeting the requirements of Directive 92/65/EEC and coming from semen 
collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC(9)and 
located respectively in a Member State of the Union or in a third country or parts of the territory of a 
third country listed in columns 2 and 4 of Annex I to Commission Implementing Regulation (EU) 
2018/659 from which the import of equine semen colle cted from registered horses, registered equidae or 
equidae for breeding and production is authorised in accordance with Article 4 of Commission 
Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I 
thereto.(10)(11);
(12)[II.3. The ova used for in vitro production of the embryos described in Part I comply with the requirements of 
Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1. to II.1.8. of 
this certificate.]
Notes
This certificate is intended for entry into the Union of oocytes and embryos of equine animals, including when the 
Union is not the final destination of the oocytes and embryos. 
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /903
COUNTRY Certificate model EQUI- OOCYTES- EMB- B-ENTRY
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certifica te include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box I.11: The place of dispatch shall correspond to the embryo collection team or embryo production team by 
which the ova/embryos were collected/produced, processed, stored and approved in accordance with 
Article 17(3)(b) of Directive 92/65/EEC and listed on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm .
Box I.19: The identification of container and seal number shall be indicated.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Type”: Specify if in vivo derived embryos, in vivo derived ova, in vitro produced embryos or 
micromanipulated embryos.
“Identification number” : The donor identity shall correspond to the official identification of the 
animal.
“Date of collection/production”: The date of collection shall be indicate in the following format: 
dd/mm/yyyy.
Part II:
(1)Only third countries or parts of the territory of th ird countries listed in column 1 of Annex XII to 
Commission Implementing Regulation (EU) 2021/404 from which entry into Union of equine animals not 
for slaughter also authorised and as indicated in column 3 of that Annex.
(2)Delete as appropriate.
(3)Only embryo collection or production teams listed in accordance with Article 17(3)(b) of Directive 
92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.
(4)Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in 
and imports into the Community of animals, semen, ova and embryos not subject to animal health 
requirements laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC 
(OJ L 268, 14.9.1992, p. 54).
(5)Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the 
movement and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1).
(6)Insert date. (follow Guidance in Part II of the Notes).
(7)Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (OJ L 165, 30.4.2004, p. 1).
(8)The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are 
not required for donor equidae which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, ova and 
embryos have been introduced into Iceland from outside prior to and during the period the ova or embryos 
were collected and the semen was used for fertilisation.
L 113 /904  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- B-ENTRY
(9)Only semen collection centres approved by the competent authority of a third country, territory or zone 
thereof listed in Annex XII to Commission Implementing Regulation (EU) 2021/404 for semen of equine 
animals or by the competent authority of a Member State.
(10)Imports of equine semen are authorised from third countries listed in column 2 of Annex I to Commission Implementing Regulation (EU) 2018/659 provided that the semen was col lected in the part of the territory 
of the third country detailed in column 4 from a donor stallion of the category of equidae positively 
indicated in column 11, 12 or 13 of Annex I thereto.
(11)Does not apply to ova.
(12)Delete if none of the embryos in the consignment was produced by in vitro fertilisation of ova.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /905
CHAPTER 65
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF STOCKS OF OOCYTES AND EM BRYOS OF EQUINE 
ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH DIRECTIVE 92/65/EEC AFTE R 31 AUGUST 2010 AND 
BEFORE 1 OCTOBER 201 4, DISPATCHED AFTER 20 APRIL 2021 BY THE
EMBRYO COLLECTION OR PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (M ODEL ‘EQUI -OOCYTES -
EMB- C-ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /906  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /907
COUNTRY Certificate model EQUI- OOCYTES- EMB- C-ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned, official veterinarian, of the exporting country(1)………………………………….… hereby
(name of exporting country )
certify that:
II.1. The ova(2)/embryos(2)described in Part I:
II.1.2. were collected(2)/produced(2)by the team(3)described in Box I.11, which had been approved and 
supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC and was subject 
to inspection by an offi cial veterinarian at least once every calendar year;
II.1.3. were collected(2)/produced(2), processed and stored in accordance with the requirements of Chapter 
III(II) of Annex D to Directive 92/65/EEC;
II.1.4. were collected at a place separated from othe r parts of the premises or holding which is in good 
repair and was cleaned and disinfected prior to the collection;
II.1.5. were examined, processed and packed in laboratory facilities which are not situated in a zone 
subject to prohibition or quarantine m easures as set out in Box II.1.6., in a section which is 
separated from the section for storing equipment and materials used in contact with donor animals 
and from the area where the donor animals are handled;
II.1.6. come from donor mares which:
II.1.6.1. were continuously resident for three months (or since entry if they were directly 
imported from a Member State of the European Union during the three months period) 
in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC
(4), in that part of the territory of the exporting country which was 
during that period
− not considered to be infected with African horse sickness in accordance with 
Article 5(2)(a) and (b) of Directive 2009/156/EC,
− free from Venezuelan e quine encephalomyelitis for at least 2 years,
− free from glanders and dourine for at least 6 months;
(2)either [II.1.6.2. originated from a country of export which was on the day of collection free of vesicular 
stomatitis for at least 6 months;]
(2)or [II.1.6.2. were tested by a virus neutralisation test for vesicular stomatitis on a blood sample taken 
on …………………(5)within 30 days prior to collection, with negative result at a serum 
dilution of 1 in 12;]
(2)either [II.1.6.3. during the past 30 day period prior to collection have been located in holdings under 
veterinary supervision which fulfilled from the day of collection of ova(2)/embryos(2)
until the date of their dispatch the conditions for a holding laid down in Article 4(5) of 
Directive 2009/156/EC, and in particular:]
(2)or [II.1.6.3. during the past 30 day period prior to collection have been located in holdings under 
veterinary supervision which fulfilled from the day of collection of ova(2)/embryos(2)
until, in the case of frozen ova(2)/embryos(2), the period of 30 days mandatory storage at 
approved premises elapsed, the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in particular:]
L 113 /908  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- C-ENTRY
(2)either [II.1.6.3.1. following a case of a disease mentioned below not a ll the animals of species 
susceptible to the disease located on the holding were slaughtered or killed 
and the holding has been free:
− from any type of equine encephalomyelitis for at least 6 months, 
beginning on the day on which the equidae suffering from the disease 
are slaughtered,
− from equine infectious anaemia for at least the period required to 
obtain a negative result in an agar gel immunodiffusion test (Coggins 
tests) carried out on samples taken after the infected animals were 
slaughtered on two occ asions three months apart from each of the 
remaining equidae;
− from vesicular stomatitis for at least 6 months from the last recorded case,
− from rabies for at least one month from the last recorded case,
− from anthrax for at least 15 days from the last recorded case,]
(2)or [II.1.6.3.1. following a case of a disease mentioned below all the animals of species 
susceptible to the disease located in the holding have been slaughtered or 
killed and the premises disinfected, the holding has been free for at least 30 
days from any type of equine encephalomyelitis, equine infectious anaemia, 
vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning 
on the day on which following the destruction of the animals the 
disinfection of the premises was satisfactorily completed;]
II.1.6.4. during the past 30 days prior to collection have been kept in holdings each of them 
having been free from clinical signs of contagious equine metritis for at least 60 days;
II.1.6.5. have not been used for natural breed ing during at least 30 days prior to the date of 
collection of ova or embryos and between the date of the first samples referred to in 
points II.1.6.6. and II.1.6.7. and the date of the collection of ova and embryos; 
II.1.6.6. have been subjected with neg ative result to an agar -gel immuno- diffusion test (Coggins 
test) or an ELISA for equine infectious anaemia carried out on a blood sample taken on 
……………….(5), being during the past 30 days prior to the date of the first collection of 
ova or embryos and the test was last carried out on a sample of blood taken on 
…………………….(5), being not more than 90 days before the ova or embryos were 
collected(6); 
II.1.6.7. have been subjected to an agent identification test for contagious equine metritis by 
isolation of Tay lorella equigenitalis after a cultivation of 7 to 14 days carried out with 
negative results in each case on samples taken during the past 30 days prior to the date of the first collection of ova or embryos from mucosal surfaces of the clitoral fossa and 
clitoral sinuses on two consecutives oestrus periods on…………
(5)and 
on………………..(5), and on an additional culture specimen taken during one of the 
oestrus periods from the endometrial cervix on……………….(5);
II.1.6.8. to the best of my knowledge and as far as I co uld ascertain, have not been in contact 
with equidae suffering from an infectious or contagious disease during the 15 days 
immediately preceding the collection;
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /909
COUNTRY Certificate model EQUI- OOCYTES- EMB- C-ENTRY
II.1.6.9. have on the day of collection of ova(2)/embryos(2)not shown clinical signs of an 
infectious or contagious disease;
II.1.7. were collected(2)/produced(2)after the date on which the embryo collection(2)/production(2)team 
described in Box I.11 was approved by the competent authority of the exporting country;
II.1.8. were processed and stored under approved conditions for at least 30 days immediately after their 
collection(2)/production(2), and were transported under c onditions which satisfy the terms laid down 
in Chapter III(II) of Annex D to Directive 92/65/EEC;
II.2. The embryos described in Part I were conceived by artificial insemination(2)/as a result of in vitro
fertilisation(2)using semen meeting the requiremen ts of Directive 92/65/EEC and coming from semen 
collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC and 
located respectively in a Member State of the European Union or in a third country or parts of the territory
of third country listed in columns 2 and 4 of Annex I to Commission Implementing Regulation (EU) 
2018/659 from which the import of equine semen collected from registered horses, registered equidae or 
equidae for breeding and production is authorised in ac cordance with Article 4 of Commission 
Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I thereto.(7)(8);
II.3. The ova used for in vitro production of the embryos described above comply with the requirements of 
Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1. to II.1.8. of this 
certificate(2).
Notes
This certificate is intended for entry into the Union of oocytes and embryos of equine animals, including when the 
Union is not the final destination of the oocytes and embryos. 
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box I.11: The place of dispatch shall correspond to the embryo collection team or embryo production team by 
which the ova /embryos were collected/produced, processed, stored and approved in accordance with 
Article 17(3)(b) of Council Directive 92/65/EEC and listed on the Commission website:
http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm .
Box I.19: The identification of container and seal number shall be indicated.
Box I.24: Total number of packages shall correspond to the number of containers.
Box I.27: “Type”: specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or 
micromanipulated embryos.
“Identification number” : The donor identity shall correspond to the official identification of the 
animal.
“Date of collection/production”: The date of collection shall be indicate in the following format: 
dd/mm/yyyy.
L 113 /910  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- OOCYTES- EMB- C-ENTRY
Part II:
(1)Only third countries or parts of the territory of third countries listed in column 1 of Annex XII to 
Commission Implementing Regulation (EU) 2021/404 from which entry into the Union of equine animals 
not for slaughter are also authorised and as indicated in column 3 of that Annex.
(2)Delete as appropriate.
(3)Only embryo collection or production teams listed in accordance with Article 17(3)(b) of Dir ective 
92/65/EEC on the Commission website:
https://ec.europa.eu/food/animals/semen/equine_en
(4)OJ L 192, 23.7.2010, p. 1.
(5)Insert date.
(6)The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not 
required for donor equine animals which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, oocytes 
and embryos have been introduced into Iceland from outs ide prior to and during the period the semen was 
collected.
(7)Only semen collection centres approved by the competent authority of a third country, territory or zone 
thereof listed in Annex XII to Implementing Regulation (EU) 2021/404 for semen of equine animals or by 
the competent authority of a Member State.
(8)Does not apply to ova.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /911
CHAPTER 66
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIG NMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PRO CESSING 
ESTABLISHMENT:
-semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of semen of equine animal s collected, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010;
-oocyt es and embryos of equine animals collected or produced, process ed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of oocytes and embryos of equine animals collected or produced, proc essed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC after 31 August 2010 and before 1 October 2014
(MODEL ‘EQUI -GP-PROCESSING -ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
L 113 /912  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21 □For transit I.22□For internal market
Third country ISO country code I.23
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN 
codeSpecies Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishm ent/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /913
COUNTRY Certificate model EQUI- GP-PROCESSING -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that all:
II.1. The germinal product processing establishment(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)to be exported to 
the European Union was/were processed and stored:
II.1.1. is located a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of equine animals 
and listed in Annex X IIto Commission Implementing Regulation (EU) 2021/404;
II.1.1.2. in which African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei (glanders), surra (Trypanosoma evansi), dourine ( Trypanosoma 
equiperdum ), equine infectious anaemia, infection with rabies virus, anthrax, infection 
with equine arteritis virus and contagious equine metritis ( Taylorella equigenitalis ) are 
notifiable diseases;
II.1.1.3. free from African horse sickness for a period of at least 24 months immediately prior to 
collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date 
of dispatch in accordance with Article 22(2)(a) of Commission Delegated Regula tion 
(EU) 2020/692, and where no systematic vaccination against African horse sickness has 
been carried out for a period of at least 12 months immediately prior to collection of the semen
(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch in accordance with 
Article 22(4)(b) of that Regulation;
II.1.1.4. where Venezuelan equine encephalomyelitis was not reported for a period of at least 24 
months immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ 
embryos(2)and until its/their date of dispatch ;
II.1.1. is an establishment
(2)either [II.1.2 .1.where infection with Burkholderia mallei (glanders) was not reported for a period of at 
least 36 months immediately prior to collection(2)/ production(2)of the semen(2)/ 
oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
(2)or[II.1.2 .1.where infection with Burkholderia mallei (glanders) was not reported for a period of at 
least 6 months immediately prior to collection(2)/ production(2)of the semen(2)/ 
oocytes(2)/ em bryos(2)and until its/their date of dispatch ,and the Commission has 
recognised the surveillance programme carried out in breeding equine animals in the 
establishment of origin to demonstrate absence of infection during that period of 6 
months;]
(2)either [II.1.2 .2.where dourine was not reported for a period of at least 24 months immediately prior to 
collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date 
of dispatch;]
L 113 /914  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- GP-PROCESSING -ENTRY
(2)or[II.1.2.2. where dourine was not reported for a period of at least 6 months immediately prior to 
collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date 
of dispatch, and the Commission has recognised the surveillance programme carried out 
in breeding equine animals in the establishment of origin to demonstrate absence of 
infection during that period of 6 months;]
(2)either [II.1.2 .3. where surra ( Trypanosoma evansi ) was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch;]
(2)or[II.1.2.3. where surra ( Trypanos oma evansi ) was not reported for a period of at least 6 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch, and the Commission has recognised the surveillance 
programme carr ied out in breeding equine animals in the establishment of origin to 
demonstrate absence of infection during that period of 6 months.]
II.1.2. is approved and listed by the competent authority of the third country or territory;
II.1.3. complies with requir ements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or proce ssed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)complying with requirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to 
Delegated Regulation (EU) 2020/686, and
(2)either [located in the exporting country;]
(2)and/or [located in ………………………….(4), and has/have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of equine 
animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692;]
II.2.2. was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at least as strict as described in:
(2)either [Model EQUI -SEM -A-ENTRY(5);]
(2)and/or [Model EQUI -SEM -B-ENTRY(5);]
(2)and/or [Model EQUI -SEM -C-ENTRY(5);]
(2)and/or [Model EQUI -SEM -D-ENTRY(5);]
(2)and/or [Model EQUI -OOCYTES -EMB -A-ENTRY(5);]
(2)and/or [Model EQUI -OOCYTES -EMB -B-ENTRY(5);]
(2)and/or [Model EQUI -OOCYTES -EMB -C-ENTRY (5);]
(2)and/or [Model EQUI -GP-PROCESSING -ENTRY(5);]
(2)and/or [Model EQUI -GP-STORAGE -ENTRY(5);]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /915
COUNTRY Certificate model EQUI- GP-PROCESSING -ENTRY
II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Ar ticle 83(a) of Delegated Regulation (EU) 2020/692 and that mark 
is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product processing 
establishment under resp onsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;
II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(6)[II.2.5.3. has bee n filled in with the cryogenic agent which not have been previously used for 
other products;]
(2)(7)[II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This certificate is intended for entry into the Union of semen, oocytes and embryos of equine animals, including 
when the Union is not the final destination of the semen, oocytes and embryos. 
In accordance with the Agreement on the withdrawal of the Unite d Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implemen ting Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes or embryos. Onl y germinal product processing establishments listed in 
accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission 
website:
https://ec.europa.eu/food/animals/semen/equine_en
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes or 
embryos.
L 113 /916  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- GP-PROCESSING -ENTRY
Box reference I.17: “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored , and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) or those certificate(s) or the officially endorsed cop ies thereof must be attached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived e mbryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
Identification mark
: Indicate mark on the straw or other packages where semen, 
oocytes a nd/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or ot her packages with the same mark.
Part II:
(1)Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commission website:
https://ec.europa.eu/food/animals/semen/equine_en
(2)Delete if not applicable.
(3)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:
https://ec.europa.eu/food/animals/semen/equine_en
(4)Only a third country, territory or zone thereof listed in Annex XII to Implementing Regulation (EU) 
2021/404 and the EU Member States.
(5)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /917
COUNTRY Certificate model EQUI -GP-PROCESSING -ENTRY
(6)Applicable for frozen semen, oocytes or embryos.
(7)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of equine animals are placed and transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /918  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 67
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIG NMENTS OF GERMINAL PRODUCTS LI STED BELOW ,DISPATCHED 
AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STO RAGE CENTRE:
-semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Reg ulation (EU) 2020/692 after 20 April 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014;
-stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010;
-oocytes and embryos of equine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;
-stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accor dance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;
-stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014
(MODEL ‘EQUI -GP-STORAGE -ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17 Accompanying documents
□Railway □Road vehicle Type Code
IdentificationCountry ISO country code
Commercial document reference
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /919
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN 
codeSpecies Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
L 113 /920  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- GP-STORAGE -ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b. IMSOC reference
I, the undersigned official veterinarian, hereby certify that:
II.1. The germinal product storage centre(1)described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo
derived embryos(2)/ in vitro produced embryos(2)/ micromanipulated embryos(2)to be exported to the 
European Union was/were stored:II.1.1. is located a third country, territory or zone thereof
II.1.1.1. authorised for entry into the Union of semen
(2)/ oocytes(2)/ embryos(2)of equine animals 
and listed in Annex X IIto Commission Implementing Regulation (EU) 2021/404;
II.1.1.2. in which African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei (glanders), surra (Trypanosoma evansi), dourine ( Trypanosoma 
equiperdum), equine infectious a naemia, infection with rabies virus, anthrax, infection 
with equine arteritis virus and contagious equine metritis ( Taylorella equigenitalis ) are 
notifiable diseases;
II.1.1.3. free from African horse sickness for a period of at least 24 months immediately prior to 
collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date 
of dispatch in accordance with Article 22(2)(a) of Commission Delegated Regulation 
(EU) 2020/692, and where no systematic vaccination against African horse sickness has 
been carried out for a period of at least 12 months immediately prior to collection of the semen
(2)/ oocytes(2)/ embryos(2)and until its/their date of dispatch in accordance with 
Article 22(4)(b) of that Regulation;
II.1.1.4. where Vene zuelan equine encephalomyelitis was not reported for a period of at least 24 
months immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ 
embryos(2)and until its/their date of dispatch ;
II.1.2. is an establishment
(2)either [II.1.2 .1.where infection with Burkholderia mallei (glanders) was not reported for a period of at 
least 36 months immediately prior to collection(2)/ production(2)of the semen(2)/ 
oocytes(2)/ embryos(2)and until its/their date of dispatch ;]
(2)or[II.1.2 .1.where infection with Burkholderia mallei (glanders) was not reported for a period of at 
least 6 months immediately prior to collection(2)/ production(2)of the semen(2)/ 
oocytes(2)/ embryos(2)and until its/their date of dispatch ,and the Commission has 
recognised the surveillance programme carried out in breeding equine animals in the 
establishment of origin to demonstrate absence of infection during that period of 6 
months;]
(2)either [II.1.2 .2.where dourine was not reported for a period of at least 24 months immediately prior to 
collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date 
of dispatch;]
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /921
COUNTRY Certificate model EQUI- GP-STORAGE -ENTRY
(2)or[II.1.2.2. where dourine was not reported for a period of at least 6 months immediately prior to 
collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)and until its/their date 
of dispatch, and the Commission has recognised the surveillance programme carried out 
in breeding equine animals in the establishment of origin to demonstrate absence of 
infection during that period of 6 months;]
(2)either [II.1.2.3. where surra ( Trypanosoma evansi ) was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch.]
(2)or[II.1.2.3. where surra ( Trypanosoma evansi ) was not reported for a period of at least 6 months 
immediately prior to collection(2)/ production(2)of the semen(2)/ oocytes(2)/ embryos(2)
and until its/their date of dispatch, and the Commission has recognised the surveillance 
programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period of 6 months;]
II.1.2. is approved and listed by the compe tent authority of the third country or territory;
II.1.3.
complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
II.2. The semen(2)/ oocytes(2)/ embryos(2)described in Part I is/are intended for artificial reproduction and 
II.2.1. has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3),and/or processed and stored in a 
germinal product processing establishment(2)(3),and/or stored in a germinal product storage 
centre(2)(3)complying with requirements as regards responsibilities, operational procedures, 
facilities an d equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2)of Annex I to 
Delegated Regulation (EU) 2020/686, and
(2)either [located in the exporting country;]
(2)and/or [located in ………………………….(4), and has/have been imported to the exporting c ountry under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2)of equine 
animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692;]
II.2.2. was/were moved to the germinal product storage centre described in Box I.11. under conditions at 
least as strict as described in:
(2)either [Model EQUI -SEM -A-ENTRY(5);]
(2)and/or [Model EQUI -SEM -B-ENTRY(5);]
(2)and/or [Model EQUI -SEM -C-ENTRY(5);]
(2)and/or [Model EQUI -SEM -D-ENTRY(5);]
(2)and/or [Model EQUI -OOCYTES -EMB -A-ENTRY(5);]
(2)and/or [Model EQUI -OOCYTES -EMB -B-ENTRY(5);]
(2)and/or [Model EQUI -OOCYTES -EMB -C-ENTRY (5);]
(2)and/or [Model EQUI -GP-PROCESSING -ENTRY (5);]
(2)and/or [Model EQUI -GP-STORAGE -ENTRY (5);]
(2)and/or [Model 1 in Section A of Part 1 of Annex III to Regulation (EU) 2018/659(5);]
L 113 /922  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- GP-STORAGE -ENTRY
(2)and/or [Model 2 in Section B of Part 1 of Annex III to Regulation (EU) 2018/659(5);]
(2)and/or [Model 3 in Section C of Part 1 of Annex III to Regulation (EU) 2018/659(5);]
(2)and/or [Model 4 in Section D of Part 1 of Annex III to Regulation (EU) 2018/659(5);]
(2)and/or [Model 1 in Section A of Part 2 of Annex II to Decision 2010/471/EU(5);]
(2)and/or [Model 2 in Section B of Part 2 of Annex II to Decision 2010/471/EU(5);]
(2)and/or [Mod el 3 in Section C of Part 2 of Annex II to Decision 2010/471/EU(5);]
(2)and/or [Model in Annex to Commission Decision 96/539/EC(5);]
II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/686;
II.2.4. is/areplaced in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a) of Delegated Regulation (EU) 2020/692 and that mark 
is indicated in Box I.27;
II.2.5. is/are transported in a container which:
II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;
II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container; 
(2)(6)[II.2.5.3. has been filled in with the cryogenic agent which not have been previously used for 
other products.]
(2)(7)[II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.7. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
Notes
This certificate is intended for entry into the Union of semen, oocytes and embryos of equine animals, including when the Union is not the final destination of the semen, oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /923
COUNTRY Certificate model EQUI- GP-STORAGE -ENTRY
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germinal product storage centre listed in accordance with 
Article 233(3) of Regulation (EU) 2016/429 on the Commission website:
https://ec.europa.eu/food/animals/semen/equine_en
Box reference I.12: “Place of destination”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.
Box reference I.17: “Accompanying documents ”: Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I 
from the semen collection centre where the semen wa s collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those certificate(s) or the officially endorsed copies thereof must be att
ached to this 
certificate.
Box reference I.19: Seal number shall be indicated.
Box reference I.24: Total number of packages shall correspond to the number of containers.
Box reference I.27: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.
“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission website:
https://ec.europa.eu/food/animals/semen/equine_en
(2)Delete if not applicable.
(3)Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en .
(4)Only a third country, territory or zone thereof listed in Annex XII to Implementing Regulation (EU) 
2021/404 and the EU Member Stat es.
(5)The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the 
semen was collected, and/or t he embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.
(6)Applicable for frozen semen, oocytes or embryos.
(7)Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro
produced embryos and micromanipulated embryos of equine animals are placed and transported.
L 113 /924  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model EQUI- GP-STORAGE -ENTRY
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /925
CHAPTER 68
MODEL ANIMAL HEALTH CERTIF ICATE FOR ENTRY INTO THE UNION OF 
CONSIGNMENTS OF SEMEN, OOCYTES AND EMBRYOS OF TERRESTRIAL
ANIMALS KEPT AT CONF INED ESTABLISHMENT W HICH WERE COLLECTED 
OR PRODUCED, P ROCESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED REGULATION (EU) 2020/ 692
(MODEL ‘GP -CONFINED- ENTRY’)
COUNTRY Animal health certificate to the EUPart I: Description of consignmentI.1 Consignor/Exporter I.2 Certificate reference I.2a IMSOC reference
Name
Address I.3 Central Competent Authority QR CODE
Country ISO country code I.4 Local Competent Authority
I.5 Consignee/Importer I.6 Operator responsible for the consignment
Name Name
Address Address
Country ISO country code Country ISO country code
I.7 Country of origin ISO country code I.9 Country of destination ISO country code
I.8 Region of origin Code I.10 Region of destination Code
I.11 Place of dispatch I.12 Place of destination
Name Registration/Approval No Name Registration/Approval No
Address Address
Country ISO country code Country ISO country code
I.13 Place of loading I.14 Date and time of departure
I.15 Means of transport I.16 Entry Border Control Post
□Aircraft □VesselI.17
□Railway □Road vehicle
Identification
I.18 Transport conditions □Ambient □Chilled □Frozen
I.19 Container number/Seal number
Container No Seal No 
I.20 Certified as or for
□Germinal products
I.21□For transit I.22□For internal market
Third country ISO country code I.23
L 113 /926  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
I.24 Total number of packages I.25 Total quantity I.26
I.27 Description of consignment
CN code Species Subspecies/Category Identification number Quantity
Type Approval or registration 
number of 
plant/establishment/centreIdentification 
markDate of collection/production Test
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /927
COUNTRY Certificate model GP -CONFINED- ENTRYPart II: CertificationII. Health informationII.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify, that:
II.1. The semen(1)/ in vivo derived embryos(1)/ oocytes(1)/ in vitro produced embryos(1)/
micromanipulated embryos(1)described in Part I is/are intended for artificial reproduction and 
was/were obtained from donor animals which
II.1.1. originate from a third country, territory or zone thereof authorised for entry into the 
Union of the particular species and category of animals and listed in Annex II Ito 
Commission Implementing Regulation (EU) 2021/404 ;
II.1.2. originate from a confined establishment in the third country, territory or zone of 
origin, which is included in a list of confined establishments, established in 
accordance with Article 29 of Commission Delegated Regulation (EU) 2020/692, 
from which the entry of animals of specific species into the Union may be authorised;
II.1.3. do not come from an establishment, nor have been in contact with animals from an 
estab lishment, situated in a restricted zone established due to the occurrence of a 
category A disease, referred to in the Annex to Commission Implementing 
Regulation (EU) 2018/1882, or of an emerging disease relevant for species of those kept terrestrial anima ls;
II.1.4. come from an establishment where no category D disease, relevant for species of 
those kept terrestrial animals as referred to in the Annex to Implementing Regulation 
(EU) 2018/1882, has been reported for a period of at least the preceding 30 da ys;
II.1.5. have remained in a single confined establishment of origin for a period of at least 30 
days prior to the collection of the semen
(1)/ oocytes(1)/ embryos(1)intended for entry 
into the Union;
(1)(2)[II.1.6. are bovine, porcine, ovine, caprine or equine animals and they are identified in 
accordance with Article 21 of Delegated Regulation (EU) 2020/692;] or
(1)(3)[II.1.6. are terrestrial animals other than bovine, porcine, ovine, caprine or equine animals 
and they are identified and registered in accordance with the rules of the confined 
establishment;]
II.1.7. have been clinically examined by the establishment veterinarian responsible for the 
activities carried out at the confined establishment and showed no disease symptoms 
on the day of collecti on of the semen(1)/ oocytes(1)/ embryos(1);
II.1.8. as much as possible, were not used for natural breeding during a period of at least 30 
days prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1)and during 
the collection period.
II.2. The semen(1)/ oocytes(1)/ embryos(1)described in Part I
II.2.1. is/are placed in straws or other packages on which the mark is applied in accordance 
with requirements provided for in 
(1)(2)[Article 83(a) of Delegated Regulation (EU) 2020/692 and that mar k is indicated in 
Box I.27;]
L 113 /928  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
COUNTRY Certificate model GP -CONFINED- ENTRY
(1)(3)[Article 119(a) of Delegated Regulation (EU) 2020/692 and that mark is indicated in 
Box I.27;]
II.2.2. is/are placed in a transport container which:
II.2.2.1. was sealed and numbered prior to the dispatch from the confined 
establishment by the establishment veterinarian responsible for the 
activities of the confined establishment and the seal bears the number as 
indicated in Box I.19;
II.2.2.2. has been cleaned and either disinfected or sterilised before use, or is 
single -use container;
(1)(4)[II.2.2.3. has been filled in with the cryogenic agent which not have been 
previously used for other products.]
(1)(2)(5)[II.2.3. is/are placed in straws or other packages which are securely and hermetically sealed;
II.2.4. is/are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]
II.3. The consignment of semen(1)/ oocytes(1)/ embryos(1)
II.3.1. is destined to a confined establishment in the Union, which is approved in accordance 
with Article 95 of Regulation (EU) 2016/429;
II.3.2. is transported directly to the confined establishment as indicated in Box I.12.
Notes
This certificate is intended for entry into the Union of semen, oocytes and embryos of terrest rial animals kept at 
confined establishments, including when the Union is not the final destination of the semen, oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the 
Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union 
in this certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed according to the notes for the completion of certificates provided 
for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235 .
Part I:
Box reference I.11: “Place of dispatch”: Indicate the unique approval number, if assigned by the 
competent authority, and the name and address of the confined establishment of 
dispatch of the consignment of semen, oocytes or embryos. 
Box reference I.12: “Place of destination”: Indicate the name, address and unique approval number of the 
confined establishment of destination in the Union of the consignment of semen, 
oocytes or embryos.
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /929
COUNTRY Certificate model GP -CONFINED- ENTRY
Box reference I.27: “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro
produced embryos or micromanipulated embryos.
“Identification number” : Indicate identification number of each donor animal.
“Identification mark” : Indicate mark on the straw or other packages where seme n, 
oocytes or embryos of the consignment are placed. 
“Date of collection/production”: Indicate the date on which semen, oocytes or 
embryos of the consignment were collected or produced.
“Approval or registration number of plant/establishment”: Indicate t he unique 
approval number, if assigned by the competent authority, and the name and address of 
the confined establishment of the collection or production of semen, oocytes or 
embryos of the consignment.“Quantity” : Indicate number of straws or other packages with the same mark.
Part II:
(1)Delete if not applicable.
(2)Applicable for the consignment of semen, oocytes or embryos of bovine, porcine, ovine, caprine or equine 
animals.
(3)Applicable for the consignment of semen, oocytes or embryos of terrestrial animals other than bovine, 
porcine, ovine, caprine or equine animals.
(4)Applicable for frozen semen, oocytes or embryos.
(5)Applicable for the consignment where in one container oocytes, in vivo derived embryos, in vitro produced 
embryos and micromanipulated embryos of bovine, porcine, ovine, caprine or equine animals are placed and 
transported.
Official veterinarian
Name (in capital letters)
Date Qualification and title
Stamp Signature
L 113 /930  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
ANNEX III
Annex III contains the following model official declarations:
Model
AT-TERRE -SEA Chapter 1: Model declaration by the master of the vessel: Addendum for 
transport of terrestrial animals entering the Union by sea
EQUI -TRANS Chapter 2: Model declaration transhipment of equidae
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /931
CHAPTER 1
MODEL DECLARATION BY THE MASTER OF THE VESSEL: ADDENDUM FOR 
TRANSPORT OF TERRESTRIAL ANIMALS ENTERING THE UNION BY SEA 
(MODEL ‘AT- TERRE- SEA’) *
(To be completed and attached to the relevant animal health certificate or animal 
health/ official certificate where transport to the Union border includes transport by vessel, 
even for part of the journey)
Declaration by the master of the vessel
I, the undersigned master of the vessel (name ………………………………………………………………………………….. )
declare that the animals refe rred to in the attached [animal health certificate](1)[animal health/ official certificate ](1)
…………….…………….(3)have remained on board the vessel during the journey from …………….……………. in 
…………….……………. (exporting country ) to …………….……………. in the European Union and that the vessel did not call 
at any place outside …………….……………. (exporting country ) en route to the European Union other than 
…………….……………. (Ports of call en route ). Moreover, during the journey, these animals have not been in contact with 
other animals on board of a lower health status.
Done at ……………………………………………………………….. on ……………………………………………………………….. 
(Port of arrival) (Date of arrival)
Stamp (Signature of the master)
(Name in capital letters and title)
*In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern 
Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of 
the Protocol on Ireland / Northern Ireland in conjunction with Annex 2 to that Protoc ol, references to European 
Union in this declaration include the United Kingdom in respect of Northern Ireland.
(1)Delete as appropriate.
(2)Indicate certificate reference: the unique alphanumeric code assigned be the competent authority of the third country or assigned by the IMSOC.
L 113 /932  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
CHAPTER 2
MODEL DECLARATION ON TRANSHIPMENT OF EQUI DAE (MODEL ‘EQUI -
TRANS’)
(To be completed and attached to the relevant animal health or animal health/ official 
certificate where transport to the Union border includes transhipment from one aircraft to 
another aircraft or from one vessel to another vessel in a country, territory or zone thereof 
not listed in columns 1 and 2 respectively in Part 1 of Annex III to Commission Implementing 
Regulation (EU) 2021/404 )
Serial Number:……………………………………………………..………..
Reference N° of Air Cargo Transfer Manifest:……………………….……(1)
Country where transhipment takes place:.…………………………….……….………………………………….…
Airport (2)/Port (2)of
arrival:.……………………………………….…………………………………….………………………………..…
Date of arrival::.……………………………………….…………………….…………………….…………………..
Date of transhipment:.……………………………………….………………………………………………………..Transferring Carrier:.……………………………………….………………………….……………………….……Receivi ng Carrier:.……………………………………….…………………………………….……………………
Description of consignment:
Animal species:.……………………….……………………
Total number of animals:……………………………………
Certificate reference (3)
Remarks
I, the undersigned, official veterinarian (2)/customs officer (2) at the above airport (2)/port (2) declare that the transhipment took 
place under my supervision and in compliance with the following conditions:
(a) the equidae were during the transhipment protected from attacks by insects vectors of diseases transmissible to equidae;
(b) the equidae did not come into contact with equidae of a different health status;
(c) the crates, containers or jet -stalls and the surrounding airspace in the transport compartment were sprayed with an appropriate 
insect repell ent in combination with an insecticide immediately after the closing of the doors of the aircraft (2)/vessel (2).
The consignment has been transhipped in full and apparent good order and conditions except as noted in the “Remarks” column.
Done at ……………………….……………………………………………… on…………………….……………….…………………
………..………………………………………………………………..
(signature of the official veterinarian or customs officer)
………..………………………………………………………………..
(name in capital letters and title)Stamp
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /933
Notes
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland 
from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol 
on Ireland / Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this 
declaration include the United Kingdom in respect of Northern Ireland.
(1)Keep empty if transhipment from vessel to vessel
(2)Delete as appropriate
(3)Indicate certificate reference: the unique alphanumeric code assigned be the competent authority of the third country or assigned by the IMSOC.
L 113 /934  EN  Official Jourial Jfl thl ouJohirl  rcJr  31.3.2021
ANNEX IV
Correlation table referred to in Article 2 6(2)
Decision 2010/470/EU
Decision 2010/470/EU This Regulation
Article 1(a) Article 12 (a)(b)(c)(d)
Article 1(b) Article 12 (e)(f)(g)
Article 1(c) Article 10 (a)(b)(c)
Article 1(d) Article 10 (d)(e)
Article 1(e) Article 11 (c)(d)
Article 2(a) Article 12 (a)
Article 2(b) Article 12 (b)
Article 2(c) Article 12 (c)
Article 2(d)(i) -
Article 2(d)(ii) Article 12 (d)
Article 3(a) Article 12 (e)
Article 3(b) Article 12 (f)
Article 3(c) Article 12 (g)
Article 4(a) Article 10 (a)
Article 4(b) Article 10 (b)
Article 4(c) Article 10 (c)
Article 5(a) Article 10 (d)
Article 5(b) Article 10 (e)
Article 6(a) Article 11 (c)
Article 6(b) Article 11 (d)
Annex I Part A Annex I, Chapter 46 (model EQUI -SEM -B-
INTRA)
Annex I Part B Annex I, Chapter 47 (model EQUI -SEM -C-
INTRA)
Annex I Part C Annex I, Chapter 48 (model EQUI -SEM -D-
INTRA)
Annex I Part D Annex I, Chapter 54 (model EQUI -GP-
STORAGE -INTRA)
Annex II Part A Annex I, Chapter 50 (model EQUI -
OOCYTES -EMB -B-INTRA)
Annex II Part B Annex I, Chapter 51 (model EQUI -
OOCYTES -EMB -C-INTRA)
Annex II Part C Annex I, Chapter 52 (model EQUI -
OOCYTES -EMB -D-INTRA)
Annex III Part A Annex I, Chapter 31 (model OV/CAP -SEM -
B-INTRA)
Annex III Part B Annex I, Chapter 32 (model OV/CAP -SEM -
C-INTRA)
31.3.2021  EN  Official Jourial Jfl thl ouJohirl  rcJr  L 113 /935
Annex III Part C Annex I, Chapter 37 (model OV/CAP -GP-
STORAGE -INTRA)
Annex IV Part A Annex I, Chapter 34 (model OV/CAP -
OOCYTES -EMB -B-INTRA)
Annex IV Part B Annex I, Chapter 35 (model OV/CAP -
OOCYTES -EMB -C-INTRA)
Annex V Part A Annex I, Chapter 41 (model POR -
OOCYTES -EMB -B-INTRA)
Annex V Part B Annex I, Chapter 42 (model POR -
OOCYTES -EMB -C-INTRA)